data_2jx9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jx9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -150.58 137.11 18.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.944 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -129.8 144.7 51.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.991 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.01 141.91 38.3 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.467 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -142.77 142.67 31.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.399 0.619 . . . . 0.0 111.49 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.6 m -66.78 135.17 53.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.133 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HG3' ' OH ' ' A' ' 63' ' ' TYR . 77.3 tt0 -47.61 134.93 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.509 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.61 -16.67 60.63 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.452 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 13.4 m-85 -107.47 155.86 38.83 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 118.272 1.036 . . . . 0.0 108.831 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.23 154.47 28.65 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.512 1.475 . . . . 0.0 112.188 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 tt -116.44 150.68 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.035 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 33.0 tt0 -126.93 130.89 50.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.0 mt -122.07 136.1 54.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.692 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.55 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 87.0 mtt180 -146.43 134.7 21.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.0 110.705 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.422 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.1 m -103.63 145.53 30.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.092 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -70.23 155.74 63.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.988 1.792 . . . . 0.0 112.51 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.21 -131.69 24.88 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.63 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.9 p -102.86 22.32 14.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.497 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.95 165.07 24.53 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.58 145.67 32.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.837 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.422 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 97.9 mt -67.89 135.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.6 ptm -131.65 98.04 4.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 93' ' ' SER . 22.8 t -61.73 122.44 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.591 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -99.33 -51.66 3.74 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -151.24 150.01 30.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.97 154.21 7.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.098 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' A' ' 84' ' ' TYR . 2.5 t30 -148.75 146.19 27.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' OH ' ' HG3' ' A' ' 42' ' ' GLU . 49.3 t80 -114.49 118.08 32.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.34 -139.3 5.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.949 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.694 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 11.5 ttm-85 -151.36 119.69 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.123 0.487 . . . . 0.0 111.475 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.764 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 8.3 p -126.86 4.78 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.116 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 51.7 t0 -146.99 153.28 39.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.777 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 24.8 p-10 -110.31 4.87 21.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.956 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -103.98 4.07 34.16 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.138 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.7 mm -110.23 133.84 54.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m 57.14 70.12 0.68 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.138 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -54.01 120.43 6.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.572 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.44 -161.88 1.25 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.782 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.662 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.4 p-10 -61.96 137.21 95.4 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.801 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.535 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 7.0 Cg_endo -55.38 -36.2 93.38 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.351 2.034 . . . . 0.0 113.327 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.55 -33.4 74.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 0.0 110.753 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.481 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 25.0 mt-30 -85.08 -18.87 32.97 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.293 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 68.6 mtp -97.87 -0.4 45.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 56.9 mt-10 -64.68 -46.65 81.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -78.49 112.99 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.12 30.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.163 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -142.04 84.37 1.88 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.082 0.468 . . . . 0.0 111.92 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.461 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 44.1 t -145.24 119.94 9.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' HA ' HD22 ' A' ' 62' ' ' ASN . 93.0 m-85 -127.16 155.15 43.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 111.077 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 58.3 tp -146.28 90.0 5.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.779 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.1 -47.38 24.08 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.523 2.149 . . . . 0.0 113.457 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.0 -22.4 15.17 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.24 -0.287 . . . . 0.0 111.701 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 85' ' ' LEU . . . -52.59 -33.94 48.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.72 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.96 -45.44 85.7 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 12.0 ptmt -64.43 -38.77 92.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.922 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 70.2 mt -60.34 -48.93 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.905 0.383 . . . . 0.0 111.666 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.0 mmm -70.39 -37.74 74.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.501 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.4 m -60.42 -46.99 88.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -64.79 -36.39 84.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 111.231 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.566 HH11 ' CG1' ' A' ' 104' ' ' VAL . 99.5 mtt180 -78.47 -32.7 48.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.8 m -112.22 -15.01 13.28 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 93' ' ' SER . 61.7 m-20 -59.84 133.05 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.043 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 67.7 14.28 9.46 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.118 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -115.95 147.21 41.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.272 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.7 m -72.28 -33.51 67.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 151.48 33.83 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.34 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -152.75 147.27 25.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.791 0.329 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.8 t -128.45 129.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.02 0.438 . . . . 0.0 110.032 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.566 ' CG1' HH11 ' A' ' 95' ' ' ARG . 46.3 t -135.65 148.75 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 ' C ' ' H ' ' A' ' 107' ' ' GLY . 59.6 t -82.56 115.33 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.93 39.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.96 -127.31 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.98 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.469 0.652 . . . . 0.0 112.033 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -66.56 1.09 1.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.557 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.34 -11.64 55.98 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.647 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.4 m-85 -143.74 128.31 9.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.672 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 38.1 Cg_exo -50.64 -149.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.148 1.898 . . . . 0.0 111.125 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.37 97.11 5.19 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.461 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 61.6 Cg_endo -88.35 -10.49 4.66 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.592 2.195 . . . . 0.0 112.325 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.441 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.5 p -166.58 90.29 0.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.635 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -76.55 155.61 35.94 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.355 2.037 . . . . 0.0 111.912 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.22 89.62 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.489 HG22 ' N ' ' A' ' 119' ' ' TYR . 89.0 m -126.49 147.66 49.79 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 t80 -79.25 108.73 12.98 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.441 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 30.9 mtmm -87.61 -167.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.388 1.09 . . . . 0.0 113.093 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.764 ' HH ' ' H ' ' A' ' 66' ' ' THR . 3.8 p90 -171.6 174.64 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.044 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -133.01 125.2 29.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.219 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HG2' HE21 ' A' ' 125' ' ' GLN . 65.4 tt0 -119.34 125.61 49.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.73 123.94 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.685 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.427 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.2 mt-30 -107.57 130.23 54.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -155.9 164.42 38.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.555 0.693 . . . . 0.0 112.259 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -119.16 156.27 30.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.228 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.9 m -107.78 120.98 43.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 129' ' ' VAL . 2.5 m -121.63 152.87 59.21 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--N 1.308 -1.584 0 C-N-CA 122.258 1.972 . . . . 0.0 112.128 179.432 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.4 ttp180 -147.05 131.38 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.725 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 72.1 mm-40 -128.16 143.85 51.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.98 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -138.57 136.61 36.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -134.16 140.1 46.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.113 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.3 138.18 58.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -45.56 129.84 8.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.598 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.04 -12.37 67.03 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.856 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -109.19 149.27 39.49 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 118.841 1.321 . . . . 0.0 110.19 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.75 150.82 87.54 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.852 1.701 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -121.33 141.91 39.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.638 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 74.4 tt0 -130.16 130.29 44.54 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.664 -0.814 . . . . 0.0 112.519 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.9 mt -116.24 139.35 50.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.048 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.638 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 48.2 mtt180 -145.75 135.22 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.442 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.436 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.4 m -100.59 146.59 32.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -70.0 160.37 49.89 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.764 2.309 . . . . 0.0 112.489 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.26 -120.98 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.738 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -120.94 25.29 9.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.31 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -76.18 169.91 17.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.0 110.02 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.26 145.24 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.436 HG12 ' SG ' ' A' ' 50' ' ' CYS . 77.9 mt -68.4 137.15 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.603 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.1 ptm -130.85 99.67 5.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.561 0.696 . . . . 0.0 109.257 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 89' ' ' PHE . 24.1 t -63.21 123.25 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 80.5 mm-40 -100.31 -51.67 3.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 58.6 m-20 -151.72 148.98 28.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.056 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.33 153.97 8.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.862 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 84' ' ' TYR . 29.6 t30 -147.88 148.05 30.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.457 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -114.21 114.98 26.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.27 -142.22 7.57 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.38 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -150.84 119.2 6.39 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.317 0.58 . . . . 0.0 111.568 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.51 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 59.9 p -125.95 6.97 7.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.811 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.646 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 35.0 t0 -140.44 -174.75 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.128 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 22.4 p30 -144.96 -1.06 0.87 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -101.59 3.88 40.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.408 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.502 HG23 HD11 ' A' ' 70' ' ' ILE . 30.5 mm -112.76 135.35 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.981 0.42 . . . . 0.0 110.309 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 70' ' ' ILE . 67.1 m 60.46 64.24 1.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.256 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.592 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 42.5 p30 -50.02 96.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.539 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.52 -163.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.683 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -60.68 139.1 93.15 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.639 178.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.62 -38.01 96.43 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.433 2.089 . . . . 0.0 113.326 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -62.19 -33.32 74.31 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.71 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.8 mt-30 -85.01 -6.36 59.33 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.415 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 83.9 mtp -109.95 -3.02 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 82.2 mt-10 -64.79 -46.15 83.3 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.97 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -79.68 112.88 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.072 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.432 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 35.8 m -107.3 31.38 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.6 mm-40 -138.24 84.53 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.86 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.0 t -146.1 125.84 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.563 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.48 ' CE2' HG23 ' A' ' 66' ' ' THR . 59.0 m-85 -134.04 154.71 50.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.4 tp -146.91 93.67 4.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.346 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.61 -48.4 22.17 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.497 2.798 . . . . 0.0 114.576 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -57.81 -19.92 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.88 -32.03 63.34 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.567 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.3 t80 -63.72 -43.81 95.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.714 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.21 -39.61 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.48 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 65.2 mt -58.08 -51.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.548 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 40.0 mtp -70.46 -33.22 71.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.528 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.567 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 20.1 m -58.39 -47.17 84.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.83 -34.67 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.501 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.476 ' NE ' HG21 ' A' ' 104' ' ' VAL . 17.7 mtp180 -80.54 -32.4 36.75 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 59.2 m -111.74 -20.16 12.19 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.479 ' CG ' ' O ' ' A' ' 93' ' ' SER . 42.6 m-20 -56.16 135.19 53.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.845 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 64.44 13.84 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.972 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -112.95 144.3 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.604 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -33.21 73.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.099 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 158.71 42.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.043 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.2 p -155.38 135.0 12.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.138 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 129.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.476 HG21 ' NE ' ' A' ' 95' ' ' ARG . 59.2 t -143.41 145.72 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.769 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.466 ' N ' HG13 ' A' ' 104' ' ' VAL . 50.2 t -79.05 116.4 22.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.58 41.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.67 -116.82 0.53 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.659 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 28.56 -160.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.14 0.495 . . . . 0.0 111.737 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.659 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-20 -69.47 2.09 3.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.968 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.05 -13.75 49.45 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.383 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.574 ' O ' ' O ' ' A' ' 112' ' ' PRO . 72.8 m-85 -141.09 126.62 11.1 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.7 Cg_exo -51.41 -150.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.224 1.949 . . . . 0.0 111.575 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 20.1 t0 -144.9 90.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.77 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.55 -8.68 13.65 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.093 2.528 . . . . 0.0 113.236 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -172.22 80.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.437 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.32 159.02 55.39 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.149 1.899 . . . . 0.0 111.505 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.1 -4.71 86.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 119' ' ' TYR . 63.2 m -125.36 147.87 48.98 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.48 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 45.3 t80 -85.81 118.7 25.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 13.0 mttt -95.17 -156.91 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.0 p90 -174.86 176.5 2.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.556 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.548 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 34.3 tp -133.69 126.79 31.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.816 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.67 ' CD ' ' N ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -120.74 130.72 54.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 11.8 t -133.28 123.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -107.04 125.72 51.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -154.65 170.08 22.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.302 0.572 . . . . 0.0 112.223 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -127.0 161.57 28.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.8 115.86 29.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.115 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.431 HG13 ' SD ' ' A' ' 57' ' ' MET . 17.2 m -117.78 158.93 44.36 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.495 1.599 0 C-N-CA 122.181 1.92 . . . . 0.0 112.055 179.441 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.609 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -151.74 138.68 19.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.343 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -133.78 146.77 51.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.36 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -134.88 132.11 38.15 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.435 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -129.67 139.96 51.25 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.546 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.1 137.16 53.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.597 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 87.2 tt0 -48.06 133.37 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.028 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.8 -17.96 58.0 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.94 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -111.72 148.18 38.36 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 118.283 1.041 . . . . 0.0 110.308 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.76 151.71 82.42 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.489 2.126 . . . . 0.0 113.36 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.9 tt -119.07 147.01 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -136.0 125.38 24.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -110.9 145.93 37.43 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -148.47 136.56 21.03 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.9 m -104.41 143.99 27.8 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.23 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 56.6 Cg_endo -71.71 161.19 45.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.361 2.041 . . . . 0.0 112.13 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.34 -132.2 34.23 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.449 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.8 p -107.92 23.36 14.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.351 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -78.58 167.89 20.59 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -130.73 145.21 35.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.82 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 82.7 mt -68.66 139.78 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.068 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.3 ptm -131.98 99.53 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.834 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.05 124.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.361 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -101.98 -48.53 4.22 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -151.41 147.52 26.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.06 155.58 11.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.0 t30 -151.81 145.65 25.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -116.73 118.04 31.46 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.49 -138.04 5.16 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.55 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 12.3 ttm-85 -152.4 118.94 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.232 0.539 . . . . 0.0 111.717 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.459 HG23 ' CE2' ' A' ' 84' ' ' TYR . 29.1 p -121.99 8.4 9.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.012 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.582 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 27.6 t0 -143.54 -164.23 1.82 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.059 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.582 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 47.2 p30 -149.16 -1.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.237 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -102.88 4.49 37.7 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' ' 71' ' ' CYS . 14.3 mm -106.64 135.28 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 70' ' ' ILE . 47.7 m 59.44 66.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.481 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.3 p30 -47.8 108.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.95 -162.99 1.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.015 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.6 p-10 -63.44 138.31 97.32 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.8 Cg_endo -58.81 -32.45 97.16 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.212 1.941 . . . . 0.0 112.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -60.79 -37.82 83.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.654 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.472 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 24.5 mt-30 -86.21 -10.88 53.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.334 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -108.84 0.52 20.34 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.128 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 75.5 mt-10 -64.78 -43.92 91.65 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.365 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.2 t30 -78.78 114.28 17.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -106.1 32.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.4 mm-40 -140.68 86.51 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.75 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.51 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 32.8 t -147.7 120.88 8.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.459 ' CE2' HG23 ' A' ' 66' ' ' THR . 89.2 m-85 -132.51 152.71 51.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.883 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 tp -144.13 93.42 6.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.027 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.48 -49.05 16.69 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.558 2.838 . . . . 0.0 113.829 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -57.37 -24.58 56.17 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.24 -31.52 21.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -66.63 -45.8 77.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.89 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 ptmt -64.38 -39.24 93.47 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.675 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 94.4 mt -60.18 -52.91 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.3 mmm -70.12 -35.24 73.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 111.526 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.4 m -59.95 -47.33 86.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -66.87 -36.75 83.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.421 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.643 ' HE ' ' CG2' ' A' ' 104' ' ' VAL . 72.9 mtp85 -77.23 -32.68 55.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 23.7 m -112.69 -17.24 12.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -57.17 136.22 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.297 0.57 . . . . 0.0 111.964 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 64.76 12.98 8.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.653 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 67.2 mtt-85 -112.32 144.93 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.228 0.537 . . . . 0.0 110.307 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 m -70.31 -33.76 71.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.38 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 154.29 37.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.88 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.0 p -155.01 139.03 16.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.859 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 48.5 t -122.46 135.82 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.643 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 33.4 t -143.04 152.99 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.98 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.432 ' N ' HG11 ' A' ' 104' ' ' VAL . 70.6 t -84.05 115.74 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.03 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.32 36.64 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -176.62 -118.23 0.53 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.646 ' O ' ' O ' ' A' ' 107' ' ' GLY . 46.5 t 27.0 -158.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.424 0.631 . . . . 0.0 112.02 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.612 ' H ' ' HG ' ' A' ' 108' ' ' SER . 89.1 m-20 -69.27 1.09 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.08 -11.2 58.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.671 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.1 m-85 -144.94 133.69 11.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.805 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.1 Cg_exo -53.2 -147.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.04 1.826 . . . . 0.0 110.559 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.576 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 11.0 t0 -144.38 91.24 6.37 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.0 110.255 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HD2' ' CE ' ' A' ' 120' ' ' LYS . 62.4 Cg_endo -80.94 -11.7 12.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.124 2.549 . . . . 0.0 113.734 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.507 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -165.27 76.58 1.35 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 121.538 0.685 . . . . 0.0 111.531 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.84 153.25 38.18 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.753 2.302 . . . . 0.0 112.619 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.19 8.09 53.41 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.049 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.478 HG21 ' N ' ' A' ' 119' ' ' TYR . 30.8 m -119.3 148.88 42.66 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 6.5 t80 -83.31 108.88 16.82 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.576 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 28.1 mttt -89.56 -163.06 0.94 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.754 1.264 . . . . 0.0 112.833 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.455 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -173.54 175.52 2.98 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.007 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 tp -133.4 125.75 29.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -123.62 128.64 49.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.0 t -133.27 126.94 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -108.17 128.58 54.83 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.6 175.32 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.236 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -131.85 161.16 33.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.272 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.609 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 88.4 m -108.38 122.53 47.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.183 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' A' ' 57' ' ' MET . 3.5 m -120.93 155.84 57.2 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.519 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 C--N 1.31 -1.461 0 C-N-CA 122.33 2.02 . . . . 0.0 111.904 -179.805 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.559 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 28.3 ttm180 -147.21 134.51 20.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.0 111.673 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 40.5 mp0 -131.35 144.11 50.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.751 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.75 141.28 38.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.31 141.63 33.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -66.36 135.32 54.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.66 138.95 7.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.294 0.569 . . . . 0.0 112.032 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 -16.64 60.59 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.961 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -109.32 150.34 40.96 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 117.741 0.77 . . . . 0.0 110.117 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.97 151.18 67.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.884 2.39 . . . . 0.0 113.264 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -123.98 142.0 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.608 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 65.9 tt0 -128.02 130.36 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 111.82 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 64.7 mt -111.21 145.99 37.72 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.095 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.608 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 96.6 mtt180 -149.43 128.23 12.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.431 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.7 m -101.01 144.43 28.54 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.05 158.08 50.01 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.424 2.083 . . . . 0.0 112.543 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.73 -139.18 36.41 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.428 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 p -99.57 23.87 8.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.405 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -81.29 165.16 21.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.243 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.8 m -129.95 146.55 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 110.584 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.431 HG12 ' SG ' ' A' ' 50' ' ' CYS . 81.2 mt -68.25 136.59 26.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.753 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.472 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -130.8 99.39 4.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.01 123.06 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.512 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.502 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.8 mm-40 -103.39 -46.94 4.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.184 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 24.7 m-20 -147.16 144.48 29.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.78 149.99 11.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.743 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' A' ' 84' ' ' TYR . 29.7 t30 -148.07 147.45 29.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.167 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -118.64 120.02 36.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -138.68 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.997 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -154.79 116.29 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.661 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.437 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 14.9 p -122.43 9.65 9.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.923 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.617 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.0 t0 -147.59 -173.52 4.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.61 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.2 p30 -145.78 1.99 0.91 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.051 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.67 5.01 41.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.323 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 70' ' ' ILE . 28.2 mm -115.42 137.84 47.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.74 0.305 . . . . 0.0 110.523 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 30.9 m 52.88 75.91 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -56.41 122.19 11.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.484 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.84 -167.55 2.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.552 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -61.4 134.15 93.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.7 Cg_endo -53.1 -33.57 64.21 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.789 1.66 . . . . 0.0 113.506 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -63.65 -34.91 78.9 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.039 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.682 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.9 mt-30 -83.35 -14.88 51.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.548 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 mtp -99.54 -0.61 40.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.3 mt-10 -62.05 -52.13 65.19 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 39.2 t30 -81.72 115.98 21.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.03 35.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.559 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.43 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 2.4 mm100 -139.52 85.8 2.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.0 t -148.56 118.56 7.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' HA ' HD22 ' A' ' 62' ' ' ASN . 69.7 m-85 -130.02 154.24 47.61 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.814 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.4 tp -146.28 85.69 7.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.388 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -47.09 -47.69 16.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.902 2.402 . . . . 0.0 113.614 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -56.79 -22.76 38.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.35 62.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.972 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.556 ' O ' ' OG ' ' A' ' 93' ' ' SER . 11.6 t80 -64.1 -42.53 96.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.4 ptpt -66.09 -42.17 89.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.963 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 82.2 mt -58.39 -49.73 81.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.529 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.555 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 31.7 mtp -71.07 -33.19 70.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.745 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.556 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 49.6 m -59.14 -45.57 90.6 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.919 0.39 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -65.59 -37.4 86.54 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.078 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 93.6 mtt-85 -76.73 -35.3 57.89 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 59.4 m -109.28 -21.5 12.51 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CG ' ' O ' ' A' ' 93' ' ' SER . 75.9 m-20 -57.24 134.09 55.64 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.207 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 67.95 12.48 8.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.798 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 99' ' ' ARG . 51.3 mtt180 -113.47 146.44 39.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.215 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.7 m -73.45 -28.74 62.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.452 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -151.98 152.48 32.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.498 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.1 p -153.58 142.81 21.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.716 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.67 126.06 72.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.9 t -139.04 146.68 25.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.845 0.355 . . . . 0.0 111.374 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.9 t -78.78 113.67 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.95 42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.581 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -121.62 0.8 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.6 t 28.05 -157.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 111.892 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.38 1.22 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.175 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.87 -12.49 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.433 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 63.9 m-85 -144.58 128.14 8.75 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.979 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -50.45 -146.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.387 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 120' ' ' LYS . 31.7 t0 -142.88 84.62 10.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.01 -5.53 14.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.812 2.341 . . . . 0.0 113.424 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.484 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -164.68 71.6 1.53 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.544 0.688 . . . . 0.0 111.47 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.43 140.46 93.22 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.396 2.064 . . . . 0.0 110.594 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.77 71.51 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.951 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.5 HG21 ' N ' ' A' ' 119' ' ' TYR . 21.3 m -124.4 146.3 48.97 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.538 0.669 . . . . 0.0 110.331 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.5 ' N ' HG21 ' A' ' 118' ' ' THR . 26.0 t80 -81.64 116.23 21.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 24.3 mttt -89.82 -165.93 1.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.805 1.288 . . . . 0.0 114.037 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.539 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.2 p90 -167.68 169.49 11.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.17 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.555 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 65.8 tp -130.31 122.71 28.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.687 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 71.5 tt0 -117.94 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.456 HG23 ' SD ' ' A' ' 92' ' ' MET . 45.7 t -133.64 125.17 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.88 128.71 55.15 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.424 ' CD2' HG22 ' A' ' 56' ' ' ILE . 28.6 p90 -154.3 169.64 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.23 0.538 . . . . 0.0 111.735 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 76.9 m-20 -123.04 159.31 28.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.965 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.9 m -109.15 112.13 24.13 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 55' ' ' VAL . 4.2 m -121.02 158.68 51.92 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 N--CA 1.493 1.447 0 C-N-CA 121.9 1.733 . . . . 0.0 112.154 -179.756 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.573 HH21 ' HG3' ' A' ' 51' ' ' PRO . 94.6 mtt-85 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -145.15 132.91 21.07 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.495 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -124.4 145.33 49.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -137.26 141.03 41.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.79 139.86 36.52 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.471 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.03 135.73 55.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.911 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 82.0 tt0 -46.17 134.27 8.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.284 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 -11.89 68.29 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.267 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.8 m-85 -112.26 148.75 39.8 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 118.451 1.125 . . . . 0.0 109.828 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.91 150.26 73.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.288 1.992 . . . . 0.0 112.867 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.6 tt -116.34 147.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.42 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -125.2 127.94 47.57 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.036 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.23 138.29 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.059 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.569 HH12 ' CD ' ' A' ' 101' ' ' GLN . 65.5 mtp85 -148.2 135.46 20.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.021 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -100.34 144.14 27.88 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.573 ' HG3' HH21 ' A' ' 36' ' ' ARG . 61.2 Cg_endo -72.02 159.17 50.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.258 2.638 . . . . 0.0 112.55 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.79 -131.02 27.46 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.9 p -108.42 23.93 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.78 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.38 165.4 24.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.31 147.71 32.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.136 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.0 mt -69.92 136.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.104 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.7 ptp -134.44 106.06 6.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.478 HG12 ' CE1' ' A' ' 89' ' ' PHE . 36.4 t -64.44 124.5 19.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -102.96 -53.12 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.225 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -147.17 143.47 28.25 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.168 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.37 154.46 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.82 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -149.96 145.97 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.405 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -116.84 118.31 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.29 -133.64 3.34 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.7 ttm-85 -157.71 117.11 3.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.334 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.621 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 18.9 p -122.29 9.46 9.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 14.5 t70 -144.86 -168.99 3.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.5 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 8.0 p30 -148.41 -0.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.402 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -101.42 7.71 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.039 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.53 136.61 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.089 0.471 . . . . 0.0 111.07 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.8 m 51.96 78.95 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 59.1 p30 -55.77 125.04 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.72 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.99 -164.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.931 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.66 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -64.72 142.97 98.66 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 110.61 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.6 Cg_endo -60.96 -35.78 86.26 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 113.713 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.74 -36.16 82.11 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.455 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 22.3 mt-30 -86.34 -14.13 44.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.453 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 74.9 mtp -106.27 -2.54 22.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.001 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 4.6 mt-10 -65.58 -44.75 85.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.897 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -80.82 121.04 25.46 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -110.08 34.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.626 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -139.62 90.1 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.456 . . . . 0.0 110.886 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 25.5 t -152.62 119.2 5.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.584 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 13.6 m-85 -132.45 154.01 50.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.64 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -144.29 96.15 5.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.72 -44.08 46.94 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.558 2.172 . . . . 0.0 112.623 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.4 m-20 -58.08 -21.59 46.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.91 62.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.977 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.619 ' O ' ' OG ' ' A' ' 93' ' ' SER . 57.1 t80 -63.96 -46.43 84.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.1 pttp -66.64 -39.74 88.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.351 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.63 -46.5 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.203 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.31 -37.74 77.93 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.789 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.5 m -59.88 -48.43 81.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -65.72 -37.45 86.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.015 0.435 . . . . 0.0 111.213 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -76.94 -33.52 57.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.8 m -113.88 -16.44 12.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -57.81 137.89 56.17 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.693 -0.629 . . . . 0.0 111.974 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 49.9 m-20 69.5 14.39 8.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -117.2 149.3 40.63 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.401 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -72.17 -31.37 65.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.526 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.569 ' CD ' HH12 ' A' ' 49' ' ' ARG . 0.1 OUTLIER -142.88 156.99 45.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.318 178.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 39.7 t -152.93 135.8 15.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 111.747 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.9 132.32 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.054 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.5 146.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.735 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 107' ' ' GLY . 46.5 t -79.43 117.13 24.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.834 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.37 35.49 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.287 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.14 -121.01 0.69 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.5 t 33.42 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.242 0.544 . . . . 0.0 110.905 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.07 4.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.035 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -87.66 -7.58 57.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.374 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' O ' ' A' ' 112' ' ' PRO . 35.4 m-85 -147.76 132.82 9.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.95 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.9 Cg_exo -51.79 -148.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.702 1.601 . . . . 0.0 110.639 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.684 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 46.4 t0 -146.83 92.15 5.09 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.1 Cg_endo -79.37 -4.65 13.83 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.979 2.453 . . . . 0.0 113.241 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.477 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -167.91 67.99 0.82 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.672 0.749 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -52.26 149.81 21.46 Favored 'Trans proline' 0 C--N 1.292 -2.426 0 C-N-CA 122.487 2.124 . . . . 0.0 110.867 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.0 -4.36 76.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.871 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.473 HG21 ' N ' ' A' ' 119' ' ' TYR . 54.5 m -116.97 149.59 39.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.406 0.603 . . . . 0.0 110.602 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.53 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.7 t80 -83.94 112.42 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.684 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 19.0 mttt -92.22 -161.5 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.653 1.215 . . . . 0.0 114.169 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.621 ' HH ' ' H ' ' A' ' 66' ' ' THR . 8.3 p90 -174.91 175.98 2.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.754 -2.021 . . . . 0.0 111.046 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.2 tp -132.57 123.45 26.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.348 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HG2' HE21 ' A' ' 125' ' ' GLN . 84.8 tt0 -115.94 124.03 49.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.5 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.555 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.519 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.4 mp0 -113.5 128.6 56.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.451 ' CD2' HG23 ' A' ' 56' ' ' ILE . 47.8 p90 -146.23 162.2 38.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.128 0.489 . . . . 0.0 111.295 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -113.4 157.14 22.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.214 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.0 m -113.3 108.38 17.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.364 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.28 161.07 33.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 121.532 1.488 . . . . 0.0 111.517 179.666 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.734 ' NH1' ' SG ' ' A' ' 128' ' ' CYS . 14.4 mmt85 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.604 HH21 ' CD ' ' A' ' 123' ' ' GLU . 40.2 ttt180 -143.2 138.51 29.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.647 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.1 mp0 -135.67 139.89 44.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.123 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -137.78 136.48 37.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.914 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -137.61 142.47 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.564 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.6 140.79 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.518 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -47.67 129.52 13.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.85 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 -11.49 71.97 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.92 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -106.47 150.06 39.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.907 0.853 . . . . 0.0 109.883 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.09 152.62 45.89 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.195 1.93 . . . . 0.0 112.856 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -122.97 142.26 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.19 128.84 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.191 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.3 mt -113.05 144.9 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.726 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -150.52 135.2 17.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.846 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.464 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -102.74 149.65 36.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.316 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 47.9 Cg_endo -71.63 160.15 49.05 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.027 2.485 . . . . 0.0 113.403 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.18 -126.36 22.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.587 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.5 p -113.75 23.15 13.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.361 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.22 170.2 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.751 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.16 146.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.298 0.571 . . . . 0.0 110.544 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.464 HG12 ' SG ' ' A' ' 50' ' ' CYS . 81.6 mt -68.84 136.93 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.298 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.605 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.7 ptm -132.45 98.29 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.984 0.897 . . . . 0.0 108.946 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG11 ' CE1' ' A' ' 89' ' ' PHE . 5.9 t -64.5 124.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.519 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.8 mt-10 -103.86 -48.92 3.78 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 20.6 m-20 -146.6 144.3 29.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.15 151.97 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.054 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.56 151.52 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.571 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -118.72 114.92 23.46 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.35 -139.56 5.92 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.091 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.696 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -153.57 119.02 5.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.026 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.47 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 11.7 p -125.44 3.96 7.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.679 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 48.2 t0 -143.48 149.24 37.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.184 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -110.5 1.21 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -102.7 8.43 39.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 70' ' ' ILE . 33.1 mm -109.51 137.75 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.192 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.598 ' O ' ' C ' ' A' ' 72' ' ' ASP . 63.8 m 60.3 17.45 7.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' ' O ' ' A' ' 71' ' ' CYS . 42.1 m-20 3.44 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.976 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.36 -165.22 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -61.79 146.48 90.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.22 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 14.7 Cg_endo -58.31 -40.74 73.03 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.41 2.073 . . . . 0.0 112.856 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.81 -37.81 88.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.581 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 23.4 mt-30 -83.95 -7.57 59.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -104.19 -1.48 27.13 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.98 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 91.6 mt-10 -63.31 -51.17 67.14 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -76.79 110.67 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.861 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.569 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 27.2 m -103.5 27.23 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.7 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.569 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 14.1 mm100 -140.46 87.85 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.89 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.7 t -144.74 120.95 10.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.46 ' CZ ' HG23 ' A' ' 66' ' ' THR . 81.7 m-85 -133.31 157.07 46.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.336 0.589 . . . . 0.0 112.221 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -147.07 87.13 6.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.501 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -47.65 -47.98 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.56 2.174 . . . . 0.0 112.865 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -56.69 -18.4 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.1 -35.2 66.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.816 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CE1' HG11 ' A' ' 58' ' ' VAL . 81.3 t80 -65.14 -44.65 87.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.732 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.3 pttp -64.33 -42.89 96.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.782 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.513 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 68.7 mt -59.17 -44.5 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.558 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 97.2 mmm -70.49 -40.28 73.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.227 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.7 m -56.63 -43.21 80.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.368 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.53 -41.51 88.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.645 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.558 ' NH2' ' SD ' ' A' ' 92' ' ' MET . 46.1 mtm180 -73.85 -33.53 64.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.5 m -111.55 -15.09 13.58 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 38.6 m-20 -61.65 133.7 55.92 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.159 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 66.02 14.46 9.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -116.0 148.52 40.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.595 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -70.04 -31.78 69.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.82 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.03 157.08 41.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.092 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.7 p -153.64 140.94 19.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -120.95 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.299 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 105' ' ' VAL . 98.0 t -140.65 147.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.212 0.529 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 107' ' ' GLY . 62.1 t -81.86 115.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.052 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.77 38.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.842 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.6 -120.69 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.692 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.591 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.4 t 27.16 -155.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.857 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.25 -0.57 8.22 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.621 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.98 58.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.187 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -143.22 129.91 10.55 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -54.4 -146.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.662 1.575 . . . . 0.0 111.231 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.62 90.03 7.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.047 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.34 -6.12 12.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.807 2.338 . . . . 0.0 113.545 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.529 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -167.53 71.63 0.95 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.707 0.765 . . . . 0.0 112.192 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.05 141.54 56.99 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.243 2.629 . . . . 0.0 111.989 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.33 -3.29 86.67 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.621 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 119' ' ' TYR . 71.2 m -118.2 148.69 42.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.778 0.789 . . . . 0.0 110.325 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.1 t80 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.529 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.0 mttp -93.48 -160.32 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.459 1.123 . . . . 0.0 113.655 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.0 p90 -176.34 178.21 1.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.627 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 24.0 tp -133.7 127.52 33.05 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.787 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.604 ' CD ' HH21 ' A' ' 37' ' ' ARG . 77.0 tt0 -119.65 129.47 54.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.26 122.93 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.86 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -109.2 128.15 54.81 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' MET . 26.8 p90 -156.07 170.9 21.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.767 -0.773 . . . . 0.0 112.023 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.52 159.09 34.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.436 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.734 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 78.5 m -109.8 118.82 37.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.259 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.36 157.77 48.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 C-N-CA 122.045 1.83 . . . . 0.0 112.227 179.477 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.621 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 77.5 mtt85 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.686 ' HE ' ' CD ' ' A' ' 123' ' ' GLU . 13.9 ttt180 -146.69 126.68 13.66 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.394 0.616 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.672 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 32.1 mp0 -126.13 143.35 51.16 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.024 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -139.2 145.04 38.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 39' ' ' LEU . . . -142.06 141.19 32.76 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.23 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.81 135.47 54.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.46 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.402 ' O ' ' OH ' ' A' ' 119' ' ' TYR . 81.5 tt0 -47.71 135.44 11.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 111.444 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.63 -15.77 62.16 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.985 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 7.0 m-85 -111.4 149.75 41.09 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 118.132 0.966 . . . . 0.0 110.79 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.25 151.28 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.652 2.235 . . . . 0.0 113.033 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 tt -120.65 140.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.222 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -121.09 128.45 52.6 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.005 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.479 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 24.4 mt -115.82 141.42 48.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -150.74 132.91 15.35 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.933 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.416 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -102.91 143.0 25.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.839 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.58 158.76 52.95 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.579 2.186 . . . . 0.0 112.913 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.84 -137.19 40.28 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.446 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.1 p -102.08 23.89 10.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.384 -0.408 . . . . 0.0 111.14 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 75.9 m-20 -81.06 165.77 21.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 m -128.2 147.0 32.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.547 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG12 ' SG ' ' A' ' 50' ' ' CYS . 77.8 mt -68.34 138.45 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.8 ptp -132.42 100.02 4.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 t -65.49 125.22 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.715 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.02 -48.79 3.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.626 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -152.08 150.27 29.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.4 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.6 157.97 10.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.892 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -150.73 143.17 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.83 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -112.36 114.53 27.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 163.16 -134.37 3.39 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.15 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.557 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 9.7 ttm180 -156.64 117.79 3.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.499 0.666 . . . . 0.0 110.727 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.602 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 15.9 p -126.22 6.35 7.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.892 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 49.0 t0 -145.31 151.72 38.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.214 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.671 ' O ' ' CE ' ' A' ' 78' ' ' MET . 54.5 p30 -110.78 3.7 19.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.956 0.408 . . . . 0.0 109.943 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -102.72 1.75 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.985 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -110.93 135.12 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.837 0.351 . . . . 0.0 110.199 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m 58.81 65.26 1.26 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.904 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -48.61 99.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.524 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -111.03 -166.93 1.12 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.272 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.84 144.97 97.96 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.419 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.86 -41.99 60.08 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.461 2.107 . . . . 0.0 112.792 -178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.85 -35.93 81.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.988 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.472 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 22.8 mt-30 -87.01 -6.86 58.61 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.671 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 85.1 mtp -104.68 -6.09 20.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.63 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.4 mt-10 -65.16 -47.0 78.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.216 -0.593 . . . . 0.0 112.095 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.88 117.71 19.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.8 m -109.15 32.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.837 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -143.18 88.53 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.468 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.8 t -145.84 122.18 10.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CZ ' HG21 ' A' ' 66' ' ' THR . 59.0 m-85 -135.09 152.74 51.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.319 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 tp -145.58 88.66 6.49 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.871 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.56 -49.83 12.59 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 123.042 2.494 . . . . 0.0 113.367 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 46.5 m-20 -55.01 -19.2 6.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.55 0.214 . . . . 0.0 111.307 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.54 69.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.398 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -64.62 -40.87 96.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.11 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 ptmt -65.96 -40.54 91.36 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.747 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 73.0 mt -59.61 -48.66 86.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.452 ' SD ' HG13 ' A' ' 104' ' ' VAL . 96.3 mmm -69.55 -39.54 77.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.267 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 61.3 m -59.44 -45.56 91.23 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.038 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -66.02 -36.01 82.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 61.6 mtt180 -76.63 -32.11 57.82 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 76.4 m -112.94 -14.58 13.01 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.9 m-20 -61.76 134.84 57.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.488 0.661 . . . . 0.0 112.464 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 63.84 13.04 7.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -112.93 145.02 41.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.298 0.571 . . . . 0.0 109.865 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -32.71 67.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.645 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.484 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -153.02 153.74 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 13.4 p -152.53 156.28 39.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.06 124.75 53.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.452 HG13 ' SD ' ' A' ' 92' ' ' MET . 59.7 t -133.44 145.66 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.514 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' N ' HG12 ' A' ' 104' ' ' VAL . 96.4 t -82.6 116.71 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.126 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.71 36.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.19 -123.33 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.599 ' O ' ' O ' ' A' ' 107' ' ' GLY . 20.9 t 31.28 -160.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.73 1.68 0.82 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.384 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.1 -13.77 49.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.069 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.8 m-85 -145.23 129.94 9.02 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.414 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.3 Cg_exo -51.79 -144.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.057 1.838 . . . . 0.0 111.182 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.649 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 15.2 t0 -146.42 87.25 6.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.235 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.468 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.1 Cg_endo -77.74 -4.44 14.53 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.749 2.299 . . . . 0.0 113.466 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.613 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.11 63.35 0.82 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.289 0.566 . . . . 0.0 111.669 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.41 145.81 65.9 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 121.763 1.642 . . . . 0.0 110.463 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.16 -8.54 79.38 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 119' ' ' TYR . 29.0 m -122.72 148.85 44.84 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.687 -0.302 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.5 t80 -84.05 118.4 24.04 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.649 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 11.6 mttp -94.61 -160.52 0.78 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.592 1.187 . . . . 0.0 113.798 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.602 ' HH ' ' H ' ' A' ' 66' ' ' THR . 3.8 p90 -172.4 173.29 4.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.953 -1.931 . . . . 0.0 110.669 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.8 tp -131.99 125.01 30.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.719 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.686 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 10.2 tp10 -120.01 127.48 52.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.85 123.23 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.359 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.446 HE21 ' HG3' ' A' ' 123' ' ' GLU . 1.8 mt-30 -106.95 129.12 54.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -154.04 171.97 18.23 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.439 0.637 . . . . 0.0 112.077 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.472 ' O ' ' CG ' ' A' ' 57' ' ' MET . 97.8 m-20 -129.06 161.7 29.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.578 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.621 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.9 m -111.55 127.77 55.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.236 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 33.6 m -132.5 153.58 81.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.09 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 C--N 1.312 -1.377 0 C-N-CA 121.531 1.488 . . . . 0.0 112.165 -178.68 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 36' ' ' ARG . 56.5 mtp85 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.582 HH11 ' HG3' ' A' ' 123' ' ' GLU . 66.7 ttp85 -148.82 138.95 22.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.545 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -130.19 145.79 51.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.791 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.5 tt -137.33 142.98 41.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.63 139.71 36.78 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.274 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.6 m -65.81 137.25 57.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.107 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 76.5 tt0 -45.08 129.39 7.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.12 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.92 -12.41 67.17 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.029 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.17 148.72 38.93 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 118.532 1.166 . . . . 0.0 110.349 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.07 150.47 88.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.783 2.322 . . . . 0.0 112.884 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 104' ' ' VAL . 21.0 tt -116.64 149.42 18.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.666 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 35.6 tt0 -132.0 129.83 40.64 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' SG ' ' A' ' 96' ' ' CYS . 32.8 mt -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.334 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.666 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 89.2 mtt180 -147.76 132.42 17.84 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.023 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.5 m -98.51 146.69 32.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 34.4 Cg_endo -67.37 158.86 55.05 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.866 2.377 . . . . 0.0 112.069 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.1 -119.05 5.7 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.213 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.4 p -121.52 23.82 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.595 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -76.08 169.53 18.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.97 149.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.847 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 56' ' ' ILE . 59.6 mt -70.35 136.73 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.219 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -131.7 98.12 4.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.09 125.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.231 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -100.23 -48.11 4.72 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -152.21 150.56 29.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.253 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.27 156.71 12.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 84' ' ' TYR . 5.1 t30 -151.39 142.28 22.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.357 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -112.39 116.94 31.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.59 -139.73 6.05 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.343 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.612 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.0 ttm-85 -152.1 117.44 5.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.078 0.466 . . . . 0.0 111.697 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.0 p -124.3 4.82 8.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.4 t0 -149.76 157.23 43.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 36.6 p30 -113.05 5.53 17.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.964 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -105.16 3.67 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.569 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 70' ' ' ILE . 19.2 mm -112.5 136.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.8 m 52.55 76.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p30 -54.36 119.25 4.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.407 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.71 -164.86 1.52 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.531 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.7 p-10 -66.35 140.36 96.69 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.331 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.1 Cg_endo -53.26 -38.46 81.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.42 2.08 . . . . 0.0 113.57 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.52 -36.99 84.31 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.154 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.501 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 23.5 mt-30 -85.56 -9.89 56.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.474 ' HE2' HH12 ' A' ' 65' ' ' ARG . 82.4 mtp -103.89 -3.79 24.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.145 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.0 mt-10 -64.62 -48.22 75.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -81.61 116.31 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.548 0.69 . . . . 0.0 112.374 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.567 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -106.57 36.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.017 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -141.38 86.88 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.155 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.7 t -147.92 119.18 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' A' ' 66' ' ' THR . 91.6 m-85 -131.4 153.44 49.68 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.302 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 tp -147.41 88.12 5.84 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.655 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -47.73 -47.57 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.277 1.985 . . . . 0.0 112.402 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -52.59 -25.53 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.334 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.91 -36.29 65.05 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.947 0.403 . . . . 0.0 111.22 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.46 -42.27 96.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.6 pttm -64.82 -39.82 94.19 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.104 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.429 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.6 mt -59.83 -46.65 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.83 -35.98 79.55 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.938 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.0 m -58.85 -45.74 89.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.9 -40.51 91.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.235 0.54 . . . . 0.0 110.847 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.78 -35.49 72.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.352 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.457 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -112.8 -14.72 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 30.3 m-20 -62.3 132.24 51.99 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.079 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 63.76 13.17 7.23 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.27 146.45 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.291 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.7 m -69.83 -32.68 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.312 0.577 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 158.14 43.47 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.484 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.5 p -156.81 139.44 15.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -124.07 125.1 70.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 105' ' ' VAL . 43.5 t -134.86 146.34 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.938 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.0 t -77.83 118.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.262 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.14 35.77 0.05 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.086 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.675 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.44 -117.51 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 27.97 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.207 0.527 . . . . 0.0 111.608 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.76 1.97 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.392 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.73 -13.78 47.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.399 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.9 m-85 -145.72 130.19 8.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.113 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 111' ' ' PHE . 45.2 Cg_exo -51.53 -146.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.282 1.988 . . . . 0.0 112.027 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.616 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 17.9 t0 -145.27 84.57 8.51 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.622 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.24 -4.95 14.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.345 2.696 . . . . 0.0 113.527 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.578 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.88 60.74 0.58 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.111 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.35 147.47 21.74 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.56 -11.25 70.68 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.664 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 119' ' ' TYR . 1.0 OUTLIER -114.92 150.33 35.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.466 0.633 . . . . 0.0 109.913 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.612 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 27.8 t80 -82.16 111.95 18.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.616 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 15.0 mttp -90.73 -163.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.824 1.297 . . . . 0.0 113.539 -176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.3 p90 -173.58 175.81 2.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.807 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 61.7 tp -133.0 126.72 32.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.582 ' HG3' HH11 ' A' ' 37' ' ' ARG . 79.5 tt0 -121.34 128.66 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.607 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.89 123.61 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.377 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.412 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mp0 -105.36 127.61 53.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 56' ' ' ILE . 41.7 p90 -152.88 167.97 27.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.886 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -128.46 161.94 28.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.18 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.3 m -111.05 116.5 31.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.97 158.98 41.02 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.311 -1.425 0 C-N-CA 121.793 1.662 . . . . 0.0 111.38 178.527 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.535 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 65.3 mtp85 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -151.45 140.83 21.48 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 59.2 mm-40 -133.18 145.31 50.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.011 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tt -135.6 133.15 37.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.849 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.93 140.54 46.85 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.377 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HB3' ' HH ' ' A' ' 119' ' ' TYR . 74.2 m -66.48 136.21 55.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.271 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 81.4 tt0 -48.63 134.68 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.823 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.73 -18.54 56.34 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.718 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -104.1 153.17 39.1 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 118.114 0.957 . . . . 0.0 108.905 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.98 154.41 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.259 1.973 . . . . 0.0 112.614 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 tt -119.62 151.09 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.853 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.691 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 55.5 tt0 -131.78 130.65 42.1 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 mt -120.68 138.96 53.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.158 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.691 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 55.9 mtt180 -148.31 129.64 14.73 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.816 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -98.69 143.97 27.31 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 30.4 Cg_endo -66.48 162.28 37.35 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.93 2.42 . . . . 0.0 113.267 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -121.26 9.34 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.792 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -120.62 26.18 9.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -77.88 169.51 18.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.662 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.87 145.86 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.427 0.632 . . . . 0.0 110.884 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.444 HG12 ' SG ' ' A' ' 50' ' ' CYS . 72.8 mt -68.77 138.49 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.928 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.2 ptm -130.62 104.04 6.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 89' ' ' PHE . 48.5 t -68.54 124.73 24.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.168 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -105.01 -51.57 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -147.01 142.96 28.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.13 0.49 . . . . 0.0 110.479 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.19 152.42 14.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.406 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.429 HD22 ' HA ' ' A' ' 84' ' ' TYR . 11.5 t30 -148.75 143.92 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -114.93 120.0 38.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.99 -135.2 3.87 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.736 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.3 ttm-85 -154.09 116.83 4.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.364 0.602 . . . . 0.0 111.157 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.591 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 28.7 p -124.02 4.33 8.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.877 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 16.7 t70 -144.67 151.96 39.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 26.7 p30 -109.17 0.47 19.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.617 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 43.3 mtpt -101.22 3.22 40.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.287 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mm -109.71 137.27 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.809 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.0 m 55.66 66.24 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 10.5 p30 -50.58 111.63 0.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.935 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.54 -161.89 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -58.8 136.96 87.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.673 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.9 Cg_endo -59.39 -33.45 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.834 1.69 . . . . 0.0 112.63 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -62.68 -33.91 76.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.658 0.266 . . . . 0.0 110.878 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.514 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 22.6 mt-30 -85.64 -17.99 34.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.419 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.3 mtp -97.72 -0.35 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.454 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -60.99 -50.74 72.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.475 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.3 t30 -76.48 113.93 14.63 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.25 -0.281 . . . . 0.0 111.595 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.68 25.61 2.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.089 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -137.87 82.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.277 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.1 t -143.98 121.86 12.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.472 ' CZ ' HG22 ' A' ' 66' ' ' THR . 90.6 m-85 -130.4 154.78 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.405 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -144.86 90.65 6.24 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.595 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.89 -44.74 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.783 2.322 . . . . 0.0 113.06 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -55.21 -21.15 12.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.67 71.17 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.745 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 58' ' ' VAL . 57.0 t80 -65.06 -44.69 88.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.851 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.7 pttm -63.62 -43.43 96.87 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.863 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 59.0 mt -58.44 -50.59 78.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.552 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HG22 ' A' ' 124' ' ' VAL . 1.5 mtp -69.62 -32.34 70.98 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.474 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 58.2 m -61.12 -45.4 94.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.207 0.527 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.16 -37.71 84.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.36 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.712 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 99.6 mtt180 -78.1 -33.14 50.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.0 m -111.52 -19.22 12.63 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -61.5 138.97 58.3 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.605 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 62.52 12.54 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.499 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.712 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 65.7 mtt180 -114.93 147.47 39.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.149 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 m -70.75 -34.52 71.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.162 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.74 155.46 39.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.729 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 19.8 p -154.07 132.78 12.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.83 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.42 132.21 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.696 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.529 HG13 HH11 ' A' ' 95' ' ' ARG . 86.6 t -144.96 151.67 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.624 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 107' ' ' GLY . 90.6 t -83.83 114.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.04 41.32 0.1 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.8 -126.07 0.98 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.325 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.697 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 5.0 t 28.49 -156.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.076 0.465 . . . . 0.0 111.24 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.697 ' H ' ' HG ' ' A' ' 108' ' ' SER . 27.4 m-20 -69.38 1.4 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.828 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HB3' HH12 ' A' ' 95' ' ' ARG . . . -84.3 -8.98 58.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.849 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -144.1 134.49 12.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.926 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -58.86 -150.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.92 1.747 . . . . 0.0 111.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.653 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 26.1 t0 -144.9 92.5 5.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.468 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.21 -10.84 14.92 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.729 2.286 . . . . 0.0 112.625 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.463 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.3 p -171.15 87.96 0.47 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.301 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.13 157.75 55.71 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.38 12.01 84.3 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.699 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.512 HG22 ' N ' ' A' ' 119' ' ' TYR . 31.6 m -126.32 146.62 49.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.037 0.418 . . . . 0.0 110.137 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.683 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.5 t80 -82.66 107.18 15.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.653 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 24.9 mttt -88.99 -164.1 1.09 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.638 1.208 . . . . 0.0 113.019 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HH ' ' H ' ' A' ' 66' ' ' THR . 6.3 p90 -171.89 174.81 4.06 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.771 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.416 HD21 ' SD ' ' A' ' 92' ' ' MET . 20.6 tp -132.37 124.7 29.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.429 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG2' HE21 ' A' ' 125' ' ' GLN . 78.7 tt0 -122.53 124.31 43.26 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.456 HG22 ' SD ' ' A' ' 92' ' ' MET . 6.0 t -133.18 130.54 57.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.638 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.474 HE21 ' HG2' ' A' ' 123' ' ' GLU . 7.2 mp0 -109.91 132.66 53.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.719 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -152.83 168.45 25.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.416 0.627 . . . . 0.0 111.896 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.409 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 71.1 m-20 -126.22 158.24 36.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.434 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.535 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 74.7 m -108.53 124.89 51.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.528 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 m -126.53 159.37 63.76 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo . . . . . 0 N--CA 1.492 1.388 0 C-N-CA 121.537 1.491 . . . . 0.0 111.854 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.729 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 52.4 mtt-85 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -146.71 137.41 23.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.613 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 19.1 mt-10 -135.54 144.91 46.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.593 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 tt -138.19 137.7 37.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.768 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 139.24 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.304 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.12 140.41 58.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.29 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -45.97 129.62 9.67 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.785 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.42 -12.51 69.5 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.708 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -104.15 155.21 37.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 118.248 1.024 . . . . 0.0 109.396 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.16 153.5 36.43 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.71 1.607 . . . . 0.0 112.577 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.06 143.23 39.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.0 tt0 -126.88 130.52 50.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.124 0.488 . . . . 0.0 112.165 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -114.18 141.71 47.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -148.1 131.16 16.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.754 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.04 142.03 23.8 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.49 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 24.2 Cg_endo -69.6 161.66 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.269 1.979 . . . . 0.0 112.208 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.64 20.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.719 0.621 . . . . 0.0 112.311 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -101.17 21.2 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.06 165.0 25.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.21 144.04 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.792 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.81 134.84 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.641 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.8 ptm -130.46 100.59 5.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.511 0.672 . . . . 0.0 109.232 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.41 124.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.866 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.22 -43.73 4.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -146.23 143.42 29.21 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.02 149.11 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.531 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 84' ' ' TYR . 7.5 t30 -148.74 152.12 36.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 76.2 t80 -121.57 120.11 33.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.81 -134.91 3.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -159.7 119.79 3.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.215 0.531 . . . . 0.0 111.463 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.9 8.3 8.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.085 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 44.8 t0 -144.1 150.63 38.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.369 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 14.6 p30 -104.46 -1.11 27.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.403 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 8.1 mtmp? -105.03 10.86 33.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.37 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.556 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 12.5 mm -107.52 135.03 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' ALA . 71.8 m 56.76 67.37 1.0 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 52.2 p-10 -46.35 93.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.594 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -111.82 -162.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.645 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p-10 -63.68 140.52 97.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.578 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 5.5 Cg_endo -56.54 -38.94 94.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.596 2.197 . . . . 0.0 113.526 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 2.9 m-30 -61.4 -36.53 80.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.333 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.463 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 20.4 mt-30 -86.52 -11.79 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.6 mmm -101.95 -3.11 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 43.9 mt-10 -66.26 -44.69 82.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -78.61 114.02 17.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.99 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.6 m -105.67 32.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -142.13 85.93 1.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.313 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 21.7 t -143.81 125.67 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.465 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.9 m-85 -135.66 149.73 49.39 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 tp -148.9 88.5 5.16 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.438 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.07 -44.24 47.1 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.503 2.135 . . . . 0.0 113.848 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 83.1 m-20 -53.7 -24.58 15.06 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.188 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.22 -34.26 44.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -64.79 -42.24 95.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.478 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.52 -36.18 83.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.028 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.532 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 71.5 mt -62.99 -50.37 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.258 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.99 -38.63 86.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 42.0 m -58.15 -45.74 86.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.56 -36.51 82.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.686 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 70.1 mtt180 -78.74 -31.36 46.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.8 m -111.81 -19.9 12.26 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 84.5 m-20 -56.6 134.04 54.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.406 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 67.12 13.14 9.33 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.786 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.686 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 75.2 mtt180 -113.0 146.0 39.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.36 0.6 . . . . 0.0 110.132 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.9 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.488 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 155.76 40.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.6 p -154.6 146.3 23.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.419 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.47 127.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.743 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.457 HG13 ' NH1' ' A' ' 95' ' ' ARG . 48.5 t -137.12 143.81 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.353 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.2 t -78.1 115.29 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.759 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.84 35.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.212 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.51 -119.92 0.65 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.302 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.2 t 31.26 -160.38 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.405 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.12 1.67 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.25 -13.49 55.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.9 m-85 -144.36 131.98 10.57 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.819 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 111' ' ' PHE . 21.7 Cg_exo -56.6 -147.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.104 1.869 . . . . 0.0 112.345 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -146.21 86.28 7.08 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.492 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.22 -9.92 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.544 2.163 . . . . 0.0 112.814 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -166.38 77.19 1.14 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.654 0.74 . . . . 0.0 111.05 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.25 149.93 42.97 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.337 2.025 . . . . 0.0 110.857 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.2 -4.93 64.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.386 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 119' ' ' TYR . 31.3 m -113.25 148.32 35.78 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.932 0.866 . . . . 0.0 109.343 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.745 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.1 t80 -84.94 113.7 21.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 13.7 mtmm -93.87 -162.9 0.98 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.854 1.312 . . . . 0.0 113.82 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.9 p90 -168.84 170.29 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.55 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 tp -128.89 124.67 35.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 126.31 49.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.88 125.18 57.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.561 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -105.8 127.88 53.38 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.247 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.48 170.3 19.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.353 0.597 . . . . 0.0 111.372 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.456 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 73.5 m-20 -127.47 158.75 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.057 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.729 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 86.7 m -108.05 114.74 28.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.74 158.26 45.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.951 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo . . . . . 0 N--CA 1.498 1.767 0 C-N-CA 122.29 1.994 . . . . 0.0 112.798 179.62 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.703 0.763 . . . . 0.0 111.194 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 54.9 mp0 -134.21 140.16 46.3 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.433 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.9 tt -137.74 135.33 36.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.794 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.22 136.64 56.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.991 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -46.67 133.11 10.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.336 0.589 . . . . 0.0 112.526 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.74 -13.28 67.48 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.593 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.94 147.03 34.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 118.437 1.118 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.99 147.71 89.22 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.391 2.061 . . . . 0.0 112.064 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.0 tt -117.68 147.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.68 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.4 tt0 -123.15 129.47 51.47 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.096 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -118.0 137.31 52.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.68 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 87.3 mtt180 -149.2 127.85 12.42 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -95.45 149.55 36.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.557 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 49.2 Cg_endo -72.11 157.41 54.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.951 2.434 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 48.43 -134.96 19.15 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.912 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -101.82 24.12 10.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -78.45 164.96 24.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.5 146.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.662 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.469 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.6 mt -67.62 133.53 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.627 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -130.71 99.1 4.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.447 HG11 ' CE1' ' A' ' 89' ' ' PHE . 34.1 t -66.45 124.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.913 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -108.75 -47.33 3.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.203 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -146.85 145.82 29.99 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.309 0.576 . . . . 0.0 110.324 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.93 155.73 16.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.594 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 84' ' ' TYR . 11.4 t30 -147.13 138.57 24.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.212 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -115.36 117.65 31.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.5 -135.26 4.06 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 17.8 ttm180 -155.21 117.76 4.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.367 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.481 HG23 ' CZ ' ' A' ' 84' ' ' TYR . 5.1 p -123.45 5.79 9.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -146.97 154.08 40.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.236 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 36.9 p30 -113.69 2.44 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.357 . . . . 0.0 110.426 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 30.0 mttp -103.65 6.69 37.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.7 mm -108.28 135.62 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.895 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m 52.18 71.89 0.43 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 10.3 p-10 -45.03 114.34 0.71 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.847 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.14 -169.32 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.553 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.663 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -61.05 139.41 94.25 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 13.6 Cg_endo -57.83 -34.49 98.34 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.149 1.899 . . . . 0.0 112.988 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -64.72 -35.49 81.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.703 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 22.8 mt-30 -86.93 -13.43 44.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.607 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.479 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mtm -104.61 0.85 29.01 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.598 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 3.7 mt-10 -67.31 -43.83 80.68 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -79.87 114.26 18.66 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.692 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -104.55 34.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 79.9 mm-40 -141.07 84.44 1.93 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.05 119.17 8.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.481 ' CZ ' HG23 ' A' ' 66' ' ' THR . 93.4 m-85 -132.49 152.56 51.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.695 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.1 tp -142.09 87.6 9.64 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.961 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.91 -50.26 11.12 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.0 -26.97 40.6 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.56 -33.42 45.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.89 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.447 ' CE1' HG11 ' A' ' 58' ' ' VAL . 15.5 t80 -64.71 -43.9 91.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.24 -38.75 92.38 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.247 -178.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -59.94 -51.81 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.814 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -68.44 -33.02 73.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.175 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 33.2 m -59.89 -45.54 92.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 54.8 mt-30 -64.68 -37.75 88.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.35 0.595 . . . . 0.0 110.957 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.676 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 25.2 mtp180 -75.86 -33.11 59.99 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.514 ' N ' HH21 ' A' ' 99' ' ' ARG . 6.9 m -113.7 -14.01 12.63 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.774 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 53.8 m-20 -60.06 131.65 51.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.844 -0.743 . . . . 0.0 111.641 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 66.59 13.2 9.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.902 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 97' ' ' ASN . 29.6 mtm-85 -111.29 144.29 40.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.9 m -71.18 -30.51 66.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 154.09 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.428 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 3.2 p -154.69 137.26 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.712 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.79 128.63 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 105' ' ' VAL . 23.1 t -141.04 151.87 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.158 0.504 . . . . 0.0 112.051 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' N ' HG12 ' A' ' 104' ' ' VAL . 45.2 t -82.16 116.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.005 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.6 39.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.96 -120.68 0.69 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.709 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER 31.87 -161.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 110.76 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.709 ' N ' ' OG ' ' A' ' 108' ' ' SER . 66.5 m-20 -68.93 2.9 2.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.419 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.07 -11.99 48.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.68 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.0 m-85 -142.87 126.89 9.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.001 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 18.1 Cg_exo -50.78 -148.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.34 2.026 . . . . 0.0 111.765 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.659 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 32.4 t0 -144.48 85.59 8.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -5.1 14.73 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.901 2.401 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.463 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.5 p -166.04 67.31 1.07 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.546 0.689 . . . . 0.0 111.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 142.73 98.67 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 121.997 1.798 . . . . 0.0 110.269 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.25 69.57 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 90.3 m -122.87 147.06 47.0 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 19.3 t80 -81.28 118.44 22.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.659 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 33.9 mttt -92.17 -162.11 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 123.091 1.424 . . . . 0.0 113.868 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -170.54 172.92 5.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.543 -2.117 . . . . 0.0 110.876 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 45.0 tp -132.92 123.76 26.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -121.09 126.28 49.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.4 121.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.258 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -104.23 125.4 50.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.469 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.6 p90 -153.92 169.03 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.002 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -124.2 159.39 30.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.259 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.442 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.9 m -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.18 153.56 68.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.105 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 C--N 1.313 -1.315 0 C-N-CA 121.636 1.557 . . . . 0.0 111.331 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.441 HH21 ' HG3' ' A' ' 51' ' ' PRO . 78.3 mtt-85 . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.126 0.488 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.521 ' HE ' ' HG3' ' A' ' 123' ' ' GLU . 58.4 ttt180 -145.46 130.06 17.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.73 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -127.8 143.1 51.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.677 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -138.21 135.24 35.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.805 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -132.48 138.18 47.48 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.351 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.32 136.83 57.03 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.767 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -45.78 132.67 8.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 0.0 112.348 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.53 -12.58 66.22 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.195 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.3 149.21 40.24 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.536 1.168 . . . . 0.0 110.316 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.36 151.46 85.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.68 2.254 . . . . 0.0 113.02 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 tt -119.12 144.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -128.7 128.45 44.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.302 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 102' ' ' CYS . 33.5 mt -116.38 141.18 48.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.073 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 49' ' ' ARG . 17.7 mtp180 -148.13 135.05 20.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.809 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.0 m -102.36 141.03 21.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.853 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HG3' HH21 ' A' ' 36' ' ' ARG . 29.4 Cg_endo -67.16 157.74 60.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.469 2.112 . . . . 0.0 112.332 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.76 -134.49 11.13 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.604 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 p -99.82 22.12 11.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.505 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.32 167.3 21.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.07 148.81 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 111.461 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.461 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 97.2 mt -72.41 138.43 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.723 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.8 ptm -133.26 103.71 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.75 124.98 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.18 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 86.3 mt-10 -105.6 -51.13 3.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.963 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -146.85 147.52 30.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.103 0.478 . . . . 0.0 110.126 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.68 157.53 10.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.56 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 84' ' ' TYR . 15.0 t30 -151.1 148.94 28.92 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.275 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -118.57 115.24 24.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.86 -136.3 4.25 Favored Glycine 0 C--N 1.319 -0.379 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 10.2 ttm-85 -156.68 117.1 3.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.204 0.526 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 p -121.68 9.58 10.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 35.3 t0 -145.58 -174.82 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 50.1 p30 -141.33 -0.03 1.46 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.199 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -101.52 5.3 41.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.137 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 32.2 mm -107.59 133.64 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.963 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.9 m 52.72 75.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.932 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 36.1 t0 -55.11 106.77 0.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.091 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.72 -164.6 1.05 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.295 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.703 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -60.79 142.14 92.3 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.303 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 9.5 Cg_endo -55.34 -39.09 92.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.462 2.108 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -64.51 -36.24 83.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.423 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.55 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.6 mt-30 -89.34 -6.59 56.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.692 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.554 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 61.3 mmm -115.47 -1.31 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.164 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.0 mt-10 -67.47 -42.79 82.44 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -79.98 120.62 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.25 34.7 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.816 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.83 85.39 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.804 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.6 t -149.21 124.88 10.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.285 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.405 ' HA ' HD22 ' A' ' 62' ' ' ASN . 92.7 m-85 -132.6 149.77 52.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.723 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -142.1 94.84 6.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -54.34 -47.63 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.948 2.432 . . . . 0.0 114.106 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.1 m-20 -55.13 -26.09 36.17 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.692 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.95 51.38 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.91 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -66.81 -47.17 72.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 6.0 pttm -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -59.27 -50.85 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.729 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 6.0 mtp -68.46 -33.62 74.51 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.505 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.5 m -59.59 -44.04 93.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.565 ' HE ' ' CG2' ' A' ' 104' ' ' VAL . 75.5 mtp85 -76.21 -34.57 59.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.69 -11.47 12.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 93' ' ' SER . 59.1 m-20 -62.79 134.77 56.77 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.653 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 67.62 14.93 9.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -114.58 147.43 39.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.112 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.5 m -70.11 -32.98 71.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 158.44 44.15 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.509 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 48' ' ' LEU . 14.5 p -157.02 145.0 19.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.384 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.94 128.43 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.565 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 41.5 t -138.14 140.72 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.168 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 107' ' ' GLY . 48.4 t -77.45 116.39 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.27 38.56 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.127 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.643 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.86 -119.43 0.63 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.643 ' O ' ' O ' ' A' ' 107' ' ' GLY . 48.4 t 27.55 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.291 0.567 . . . . 0.0 111.776 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.523 ' N ' ' OG ' ' A' ' 108' ' ' SER . 91.4 m-20 -68.83 1.85 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.01 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.11 54.67 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.064 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -144.88 129.95 9.26 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.152 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.3 Cg_exo -51.03 -148.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.85 2.366 . . . . 0.0 112.461 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.05 89.45 6.04 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.529 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.97 -10.31 18.07 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.009 2.473 . . . . 0.0 114.095 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -170.81 69.76 0.53 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.92 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.33 155.51 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.082 1.855 . . . . 0.0 111.531 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.88 85.14 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.493 HG21 ' N ' ' A' ' 119' ' ' TYR . 95.7 m -126.27 149.91 48.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.493 ' N ' HG21 ' A' ' 118' ' ' THR . 41.8 t80 -83.99 113.54 21.07 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -90.06 -162.84 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.314 1.054 . . . . 0.0 113.376 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -171.77 172.75 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.091 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.523 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 28.0 tp -132.77 126.57 32.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.521 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 81.9 tt0 -122.05 126.06 47.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.47 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 47.4 t -130.55 127.87 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' NE2' ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.24 127.0 53.9 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -151.37 162.12 41.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.635 . . . . 0.0 112.146 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.417 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 78.5 m-20 -117.96 158.99 23.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.592 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 36' ' ' ARG . 95.6 m -109.93 108.6 18.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.719 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.77 156.67 43.37 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.757 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 122.079 1.852 . . . . 0.0 112.316 178.568 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.584 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 48.9 ttp180 -146.92 136.94 23.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.605 . . . . 0.0 111.289 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.599 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 18.6 mp0 -130.77 141.33 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.595 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 5.3 tt -140.03 144.11 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.817 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.04 34.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 110.699 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.662 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 80.8 tt0 -48.18 133.81 14.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.374 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.54 -15.58 62.98 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.187 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -107.09 147.35 34.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.927 0.863 . . . . 0.0 111.323 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.41 149.68 75.16 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.739 2.293 . . . . 0.0 112.445 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -120.92 143.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.585 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -121.29 129.33 53.07 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.275 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 60.9 mt -117.23 140.1 49.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.548 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -152.19 134.05 14.83 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.549 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.7 m -95.22 137.9 22.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.99 164.71 32.71 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.517 1.478 . . . . 0.0 110.85 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.53 -140.19 29.71 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.703 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 p -106.38 21.3 17.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.757 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.35 170.19 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.714 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.07 144.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.0 0.429 . . . . 0.0 110.665 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 94.8 mt -69.02 138.43 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.299 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.5 ptp -130.95 100.94 5.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.79 123.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.04 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -101.38 -48.85 4.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -148.63 146.59 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.415 0.626 . . . . 0.0 110.9 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.12 152.1 12.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.147 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 84' ' ' TYR . 29.3 t30 -148.74 144.44 27.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.841 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.463 ' HH ' ' HG3' ' A' ' 42' ' ' GLU . 64.5 t80 -115.63 118.88 34.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.27 -135.33 4.01 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.4 ttm180 -155.58 118.7 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.317 0.579 . . . . 0.0 111.753 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.483 HG21 ' CE2' ' A' ' 84' ' ' TYR . 25.9 p -125.21 3.62 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.739 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 52.8 t0 -146.42 154.64 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.792 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.659 ' O ' ' CE ' ' A' ' 78' ' ' MET . 29.3 p30 -113.73 0.34 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.777 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -102.48 7.9 40.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.767 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 70' ' ' ILE . 41.9 mm -109.1 133.78 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.1 m 49.49 83.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -61.05 106.02 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -112.44 -166.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.178 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -64.54 139.97 97.88 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.467 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -52.92 -39.38 78.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.375 2.05 . . . . 0.0 113.212 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -64.77 -36.32 83.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.725 0.298 . . . . 0.0 111.468 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.569 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 21.6 mt-30 -85.74 -6.67 59.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.646 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.659 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 95.1 mtp -105.6 -4.8 20.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.181 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.2 mt-10 -63.25 -47.55 81.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.982 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -79.33 119.57 22.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.7 m -108.79 33.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.824 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -141.41 83.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.436 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 37.1 t -142.8 123.24 13.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.483 ' CE2' HG21 ' A' ' 66' ' ' THR . 88.7 m-85 -135.07 156.17 49.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.9 tp -148.04 88.68 5.44 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.877 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.18 -48.18 13.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.791 2.327 . . . . 0.0 113.16 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -57.26 -21.85 37.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.49 -35.11 67.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -65.05 -45.04 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.124 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.688 ' O ' ' NE2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -66.02 -35.88 81.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.255 -179.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.563 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 76.5 mt -61.96 -50.12 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.625 0.25 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.521 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 53.8 mtp -71.44 -34.23 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.301 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.2 m -59.85 -46.2 90.04 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.564 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.56 -35.22 79.69 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.748 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.453 ' CZ ' HG11 ' A' ' 104' ' ' VAL . 28.4 mtp180 -76.72 -34.26 58.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.1 m -113.02 -10.1 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.592 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -63.45 132.52 51.65 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 65.77 13.14 8.81 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -111.55 144.58 40.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.303 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -72.08 -30.58 65.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.994 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.34 152.4 35.76 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.315 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 3.7 p -156.78 131.61 8.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.03 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -116.85 134.07 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.787 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.453 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 61.0 t -143.68 150.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.2 t -82.23 117.46 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.436 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.84 39.95 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.769 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.95 -120.45 0.68 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.87 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 28.04 -157.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.489 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -69.02 -1.04 6.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.99 -16.3 47.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.6 m-85 -139.57 130.08 14.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.551 ' O ' ' O ' ' A' ' 111' ' ' PHE . 39.7 Cg_exo -52.93 -149.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.255 1.97 . . . . 0.0 111.186 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.546 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 28.3 t0 -145.34 82.64 9.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 70.1 Cg_endo -73.01 -6.05 18.3 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.728 2.286 . . . . 0.0 113.65 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.89 68.54 0.98 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.422 0.629 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -52.42 149.02 24.47 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.249 1.966 . . . . 0.0 111.197 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.16 -0.49 83.65 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 119' ' ' TYR . 39.5 m -118.54 148.68 42.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.619 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 41.3 t80 -86.04 111.6 20.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.546 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 12.1 mttt -91.52 -162.61 0.94 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.149 1.452 . . . . 0.0 113.964 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.1 p90 -173.84 176.11 2.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 112.152 -2.295 . . . . 0.0 110.143 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.458 HD23 ' SD ' ' A' ' 92' ' ' MET . 40.4 tp -130.82 120.74 24.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -118.14 129.73 55.7 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.521 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 93.5 t -137.21 127.24 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.542 ' NE2' ' N ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -107.48 131.84 53.86 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 126' ' ' TYR . 22.7 p90 -155.78 171.91 19.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.647 0.736 . . . . 0.0 112.622 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 72.7 m-20 -130.37 158.87 38.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.027 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.0 m -112.13 109.1 18.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -104.95 156.24 36.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.967 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 C-N-CA 121.981 1.787 . . . . 0.0 110.732 179.234 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 47.9 ttp180 -141.79 137.72 31.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.1 mp0 -133.47 137.43 45.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.828 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.488 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.4 tt -139.02 139.49 37.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.939 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -140.37 141.85 35.59 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.848 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -63.95 134.91 55.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.278 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -46.21 131.47 10.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.66 67.7 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.375 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 145.47 31.76 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.655 1.228 . . . . 0.0 111.661 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.0 149.95 89.41 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.083 2.522 . . . . 0.0 112.519 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 tt -122.07 145.97 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 83.7 tt0 -125.79 127.53 46.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.09 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.1 mt -116.21 145.76 42.86 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.678 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 87.6 mtt-85 -151.2 135.96 17.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.303 0.573 . . . . 0.0 112.033 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.477 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.4 m -100.49 137.77 20.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.837 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.7 157.8 53.9 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.331 2.02 . . . . 0.0 111.623 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.14 -126.1 29.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.447 -0.406 . . . . 0.0 112.522 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -116.52 24.24 11.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.093 0.473 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.31 169.4 18.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.61 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.98 144.98 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 111.018 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.477 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 80.4 mt -67.41 136.99 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.988 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -132.35 100.02 4.87 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.87 123.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.705 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.5 mm-40 -101.6 -51.57 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.941 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 66.2 m-20 -149.11 143.18 25.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.624 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -162.75 155.24 18.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.079 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' A' ' 84' ' ' TYR . 14.4 t30 -152.34 146.76 25.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.653 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -114.02 115.1 27.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.1 -136.54 4.29 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.203 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.5 ttm180 -162.17 122.4 2.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.277 0.561 . . . . 0.0 111.905 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.467 HG23 ' CE2' ' A' ' 84' ' ' TYR . 43.5 p -123.72 12.52 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.593 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 29.7 t0 -146.82 -168.72 3.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.568 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 44.6 p30 -146.88 4.57 0.85 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.705 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -103.45 0.43 31.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.63 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 70' ' ' ILE . 22.2 mm -109.86 138.46 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.913 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.3 m 53.49 72.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.324 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -57.25 120.32 7.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.512 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.46 -161.71 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -57.55 133.74 82.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.235 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.535 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -55.61 -34.48 90.33 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.613 1.542 . . . . 0.0 111.715 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -61.44 -39.19 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.392 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.491 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 19.9 mt-30 -83.94 -10.28 58.07 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.02 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.3 mtp -103.2 -1.93 28.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.019 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 54.9 mm-40 -63.84 -45.76 88.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.44 114.64 19.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.77 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 19.2 m -104.64 34.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.104 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.692 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.1 mm-40 -142.72 84.17 1.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.251 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.4 t -142.01 126.05 17.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.467 ' CE2' HG23 ' A' ' 66' ' ' THR . 41.3 m-85 -136.13 154.0 51.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -146.71 89.26 5.79 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.174 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -50.67 -49.88 15.39 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.88 2.387 . . . . 0.0 113.343 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 54.3 m-20 -58.23 -21.94 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.34 -31.33 43.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.9 t80 -66.27 -45.9 78.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.735 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.6 ptpt -66.33 -39.86 89.5 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.701 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 HH21 ' A' ' 95' ' ' ARG . 56.9 mt -59.75 -49.79 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.679 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.555 ' HG2' HH12 ' A' ' 95' ' ' ARG . 58.2 mtp -70.01 -37.95 75.81 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.042 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 48.1 m -55.97 -42.91 77.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 93.6 mt-30 -66.24 -38.54 88.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.051 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.621 HH21 HG22 ' A' ' 91' ' ' ILE . 14.3 mtm105 -74.86 -34.14 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 71.0 m -110.15 -18.91 13.21 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' CG ' ' O ' ' A' ' 93' ' ' SER . 79.7 m-20 -54.65 135.38 46.77 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.059 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 65.79 14.58 9.63 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.24 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -113.6 145.64 40.95 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.646 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.0 m -69.67 -33.39 72.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.297 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.91 155.93 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.674 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.8 p -155.1 136.84 14.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.244 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.4 127.63 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.612 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.534 HG22 HH11 ' A' ' 95' ' ' ARG . 42.5 t -142.59 145.55 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 111.374 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.501 ' N ' HG13 ' A' ' 104' ' ' VAL . 66.4 t -75.8 114.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.977 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.98 40.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.48 -121.93 0.73 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 27.2 -155.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.322 0.582 . . . . 0.0 111.868 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -68.52 1.15 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.295 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.01 -15.63 46.95 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.518 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.9 m-85 -146.13 125.15 6.57 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.542 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.9 Cg_exo -51.16 -142.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.528 2.152 . . . . 0.0 112.607 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 116' ' ' PRO . 9.4 t0 -145.31 87.72 6.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.199 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.14 -8.58 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.55 2.167 . . . . 0.0 113.131 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.459 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -165.09 69.69 1.36 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.53 0.681 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.2 Cg_exo -53.73 147.25 41.22 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.381 2.054 . . . . 0.0 111.048 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.51 -5.38 81.44 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.881 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 119' ' ' TYR . 88.8 m -118.3 148.05 42.85 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.8 t80 -84.42 116.37 23.03 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.459 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 7.9 mtmm -94.24 -157.83 0.58 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.576 1.179 . . . . 0.0 113.994 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.6 p90 -174.01 175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.881 -1.963 . . . . 0.0 110.239 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 52.2 tp -130.78 123.67 29.67 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.079 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.452 ' HG2' HE21 ' A' ' 125' ' ' GLN . 66.1 tt0 -121.28 126.79 50.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.501 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 77.9 t -132.73 127.15 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.452 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.452 HE21 ' HG2' ' A' ' 123' ' ' GLU . 9.4 mp0 -108.61 129.02 55.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -156.02 171.69 19.67 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.698 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -131.64 162.24 30.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.0 m -108.3 131.23 54.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.623 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' SD ' ' A' ' 57' ' ' MET . 28.5 m -130.99 157.57 77.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.491 1.358 0 C-N-CA 122.014 1.81 . . . . 0.0 111.576 179.121 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt85 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -146.22 135.5 22.84 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.559 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 58.8 mm-40 -134.0 146.68 50.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.221 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.96 139.68 38.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.742 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -138.36 142.27 39.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.452 0.644 . . . . 0.0 111.009 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 23.9 m -64.58 137.72 58.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.757 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 72.5 tt0 -43.44 126.32 4.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.179 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.47 -8.21 74.79 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.241 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.34 148.62 38.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.945 1.373 . . . . 0.0 110.005 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.78 149.95 67.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.899 2.399 . . . . 0.0 113.287 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -118.99 146.62 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.673 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 49' ' ' ARG . 82.0 tt0 -126.05 129.84 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.109 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' SG ' ' A' ' 102' ' ' CYS . 48.7 mt -116.01 139.81 49.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.986 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 47' ' ' GLU . 3.9 mtp180 -150.28 131.49 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.287 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 56' ' ' ILE . 11.6 m -97.98 151.92 37.8 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.058 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HG3' HH21 ' A' ' 36' ' ' ARG . 93.4 Cg_endo -77.11 160.03 33.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.908 2.406 . . . . 0.0 112.318 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.64 -116.69 6.21 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -131.54 27.47 4.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.05 170.71 15.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.765 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.2 142.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.41 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG21 ' CD2' ' A' ' 126' ' ' TYR . 93.5 mt -67.15 137.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.785 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.3 ptp -134.9 102.52 5.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.09 124.54 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.123 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -100.41 -52.1 3.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.245 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -152.27 150.65 30.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.31 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.855 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -145.58 147.77 32.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 111' ' ' PHE . 40.2 t80 -119.59 117.94 29.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.86 -133.14 3.2 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.663 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -157.34 120.46 4.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 0.0 111.191 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.459 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 20.7 p -120.27 8.66 10.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.854 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.5 t0 -145.21 -166.13 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.185 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.591 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 38.0 p-10 -150.24 0.31 0.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -102.78 2.91 36.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.252 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.89 135.68 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m 52.71 74.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.1 p30 -52.37 102.93 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.662 0.744 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 -170.21 1.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.838 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -59.56 141.99 87.82 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.21 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 6.5 Cg_endo -53.63 -40.08 80.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.932 2.421 . . . . 0.0 112.993 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.54 -33.62 76.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.963 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.471 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 22.2 mt-30 -90.2 -8.26 51.56 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 74.5 mmm -107.36 -4.8 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.6 mt-10 -67.06 -42.34 84.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 9.3 t30 -77.98 121.22 23.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.26 31.63 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -138.74 86.7 2.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.008 0.432 . . . . 0.0 110.148 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.426 ' SG ' ' HA3' ' A' ' 64' ' ' GLY . 4.4 t -147.6 120.96 9.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 66' ' ' THR . 73.8 m-85 -135.74 157.13 47.63 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.192 0.52 . . . . 0.0 112.372 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -147.53 89.44 5.44 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.434 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.16 -51.33 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.759 2.306 . . . . 0.0 113.123 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 53.8 m-20 -54.93 -22.79 16.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.69 68.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' O ' ' OG ' ' A' ' 93' ' ' SER . 31.0 t80 -64.14 -44.14 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 111.515 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.04 -38.3 90.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.505 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 65.8 mt -61.03 -47.79 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.03 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.7 -36.45 80.67 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.5 m -59.39 -46.55 88.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -66.48 -35.98 81.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 111.145 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HE ' HG21 ' A' ' 104' ' ' VAL . 51.1 mtp85 -75.34 -35.22 61.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.3 m -112.92 -18.1 12.32 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 46.3 m-20 -52.82 136.39 34.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 66.34 13.19 9.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.207 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -112.89 145.38 40.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.0 m -74.62 -32.32 62.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.013 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -149.2 150.24 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.458 ' SG ' HD11 ' A' ' 48' ' ' LEU . 9.4 p -153.5 143.64 22.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.287 0.565 . . . . 0.0 111.448 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.12 123.59 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.443 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 105' ' ' VAL . 41.7 t -135.56 143.88 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.432 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.482 ' N ' HG13 ' A' ' 104' ' ' VAL . 61.8 t -82.87 119.47 32.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.329 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.17 42.45 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.75 -125.27 0.95 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 29.54 -157.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 110.855 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.63 2.75 3.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.967 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.05 -12.71 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.727 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.1 m-85 -143.53 126.13 8.72 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -51.86 -144.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.137 1.891 . . . . 0.0 111.178 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.609 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 8.7 t0 -146.02 96.34 4.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 92.5 Cg_endo -84.89 -8.92 9.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.029 2.486 . . . . 0.0 112.768 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -162.02 64.45 1.7 Allowed Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.275 0.56 . . . . 0.0 111.475 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.51 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 23.4 Cg_exo -53.94 145.29 52.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.925 1.75 . . . . 0.0 111.022 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.8 -11.66 71.6 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.865 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 119' ' ' TYR . 47.2 m -117.93 150.41 39.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.1 0.45 . . . . 0.0 110.099 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 45.3 t80 -81.26 116.34 21.08 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.609 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 10.7 mttt -93.19 -162.52 0.95 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.6 p90 -173.21 174.14 3.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.369 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 54.3 tp -131.86 123.65 27.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.233 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HG2' HE21 ' A' ' 125' ' ' GLN . 77.1 tt0 -118.76 126.69 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.49 125.2 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.402 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.1 mp0 -106.43 128.22 53.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.559 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 38.7 p90 -153.68 168.76 25.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.819 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.6 OUTLIER -127.57 163.1 24.92 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.556 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.489 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 72.9 m -113.21 114.55 26.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.31 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.8 m -116.66 151.69 47.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.056 1.838 . . . . 0.0 111.799 179.191 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.781 HH12 ' CD ' ' A' ' 51' ' ' PRO . 52.1 mtt180 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -153.54 134.88 14.18 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.201 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.43 148.6 45.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.583 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -139.88 140.94 36.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.57 142.5 33.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.457 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.34 137.26 54.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.721 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 84.2 tt0 -48.88 136.22 14.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.9 38.23 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.981 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.4 m-30 -108.14 151.5 41.4 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 118.129 0.965 . . . . 0.0 109.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.47 155.0 70.59 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.515 2.143 . . . . 0.0 113.453 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.48 146.35 23.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.068 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' CG ' HH11 ' A' ' 49' ' ' ARG . 0.7 OUTLIER -122.09 130.72 53.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.569 0.7 . . . . 0.0 112.511 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.51 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 76.1 mt -121.99 130.88 53.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.661 177.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.523 HH11 ' CG ' ' A' ' 47' ' ' GLU . 3.6 mtt85 -147.23 130.54 16.58 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.218 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.472 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.4 m -97.56 143.57 26.43 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.781 ' CD ' HH12 ' A' ' 36' ' ' ARG . 18.8 Cg_endo -70.6 163.61 38.34 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.677 2.251 . . . . 0.0 112.717 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.63 -126.65 21.26 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -115.73 24.74 11.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.497 -0.352 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.94 169.15 18.77 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.911 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.91 145.91 33.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.398 0.618 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 95.8 mt -68.91 138.06 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.649 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -131.14 100.09 5.09 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.469 HG12 ' CE1' ' A' ' 89' ' ' PHE . 75.0 t -65.09 122.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.032 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.551 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 61.4 mt-10 -100.05 -47.06 5.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.551 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 59.4 m-20 -151.24 150.8 31.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.555 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.83 154.52 13.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.785 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.413 HD22 ' HA ' ' A' ' 84' ' ' TYR . 11.6 t30 -152.19 149.9 29.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 112.115 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.522 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 87.2 t80 -121.93 119.08 30.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.509 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.64 -136.79 4.56 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.02 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.611 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.8 ttm180 -155.29 117.55 4.18 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.135 0.493 . . . . 0.0 110.797 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -123.66 10.66 9.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 30.8 t0 -146.65 -169.01 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 29.6 p30 -145.33 -0.17 0.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.784 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 31.9 mtpt -102.7 6.23 39.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.538 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.9 mm -110.52 135.02 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' ALA . 83.5 m 62.13 51.58 3.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.951 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.56 95.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.738 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -116.68 -162.46 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -60.1 132.51 89.93 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.691 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.8 Cg_endo -54.64 -34.77 84.69 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.94 2.426 . . . . 0.0 114.278 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -62.32 -33.43 74.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.448 0.642 . . . . 0.0 109.79 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.509 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 25.2 mt-30 -87.41 -0.05 56.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 4.8 mtm -119.8 0.3 10.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.9 mt-10 -62.69 -50.05 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.218 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -80.13 111.53 16.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.0 m -102.59 35.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.236 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -141.49 87.81 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.401 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.2 t -145.16 122.24 11.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.413 ' HA ' HD22 ' A' ' 62' ' ' ASN . 96.7 m-85 -132.61 153.87 50.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.232 0.539 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 tp -148.59 88.33 5.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.303 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.69 -47.77 21.75 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.864 2.376 . . . . 0.0 113.868 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -54.61 -24.98 23.7 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.22 -30.96 40.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.673 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -65.77 -45.51 82.26 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.1 pttt -65.2 -43.03 92.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.681 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.55 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 59.6 mt -58.83 -45.68 91.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 93.8 mmm -69.78 -35.63 75.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.198 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.497 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 50.8 m -61.0 -47.32 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.25 -37.85 88.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.165 0.507 . . . . 0.0 111.049 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.766 ' NH2' ' SD ' ' A' ' 92' ' ' MET . 47.8 mtm180 -77.55 -33.91 53.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 33.1 m -112.52 -19.75 12.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 90.3 m-20 -61.15 135.61 57.81 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.353 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 67.34 13.68 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.303 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -113.04 145.34 41.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.328 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -70.97 -31.68 68.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.76 155.01 38.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.938 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.51 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 8.5 p -156.39 132.86 10.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.25 129.28 71.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.72 139.05 45.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.762 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 107' ' ' GLY . 58.2 t -72.94 116.18 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.81 40.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.701 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -122.66 0.85 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.6 t 29.58 -157.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.651 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -67.38 0.37 2.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.337 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.82 -13.7 50.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.571 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 112' ' ' PRO . 47.8 m-85 -144.43 126.69 8.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.199 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.593 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -48.88 -149.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.756 2.304 . . . . 0.0 112.202 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 21.8 t0 -145.18 80.11 11.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.483 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.401 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 69.6 Cg_endo -75.33 -3.56 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.25 2.633 . . . . 0.0 112.842 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.58 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.2 p -164.05 63.43 1.14 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.752 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.08 144.09 59.54 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.096 1.864 . . . . 0.0 110.299 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.72 -4.34 81.89 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 119' ' ' TYR . 80.4 m -125.73 147.86 49.24 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.666 0.733 . . . . 0.0 109.869 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.611 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 4.6 t80 -80.54 113.7 18.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 28.0 mttp -91.85 -160.3 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.575 1.178 . . . . 0.0 113.291 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -175.41 177.11 1.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.13 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.7 tp -130.39 121.45 25.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.563 ' HG2' HE21 ' A' ' 125' ' ' GLN . 56.0 tt0 -120.9 127.44 51.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.799 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -135.38 129.03 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.563 HE21 ' HG2' ' A' ' 123' ' ' GLU . 8.6 mp0 -107.97 130.26 55.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.2 173.72 15.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.364 0.602 . . . . 0.0 111.764 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 80.0 m-20 -133.23 161.13 35.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.835 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 95.4 m -111.71 111.05 21.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.97 158.53 37.55 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.355 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 C--N 1.313 -1.302 0 C-N-CA 121.862 1.708 . . . . 0.0 111.698 179.315 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 36' ' ' ARG . 79.9 mtt-85 . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 49.1 ttp180 -148.99 137.76 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.7 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 31.5 mp0 -130.8 145.62 52.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.536 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.53 141.74 37.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.17 35.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.2 m -67.76 137.2 55.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.505 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -46.7 134.53 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.02 52.39 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.3 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.7 m-85 -107.28 147.01 34.41 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.279 1.039 . . . . 0.0 110.139 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -67.14 153.27 78.03 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.546 2.164 . . . . 0.0 112.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 ' O ' HG21 ' A' ' 46' ' ' ILE . 16.6 tt -118.14 141.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -120.22 128.22 53.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.464 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 102' ' ' CYS . 73.2 mt -116.78 142.62 46.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.391 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -152.94 133.41 13.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.84 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.2 m -102.01 147.52 34.04 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.06 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.2 Cg_endo -70.35 158.21 56.88 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 123.686 2.924 . . . . 0.0 113.317 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.92 -132.89 32.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.9 p -105.26 27.89 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.353 0.597 . . . . 0.0 109.742 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.44 162.37 25.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.097 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -126.49 147.99 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.58 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.477 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -71.18 134.8 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.635 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.6 ptm -130.32 100.72 5.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.49 0.662 . . . . 0.0 109.264 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.16 122.67 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.602 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -102.51 -48.05 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -149.4 148.66 29.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.474 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.18 154.4 10.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.8 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.521 HD22 ' HA ' ' A' ' 84' ' ' TYR . 17.7 t30 -152.3 149.69 28.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.692 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.88 121.16 37.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.81 -135.5 4.25 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.76 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -158.12 119.63 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.271 0.558 . . . . 0.0 111.1 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.511 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 38.6 p -122.6 9.77 9.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.557 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 28.5 t0 -145.36 -169.36 3.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 59.8 p30 -147.21 -1.01 0.66 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.657 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -100.09 3.41 43.97 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.708 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 44.7 mm -106.27 133.45 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 72.8 m 63.09 57.52 1.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.1 p30 -42.33 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.303 0.573 . . . . 0.0 111.843 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.95 -165.1 1.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.681 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -59.06 137.29 87.95 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.595 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.38 -35.55 75.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.383 2.056 . . . . 0.0 112.261 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -62.45 -40.53 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.509 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 15.1 mt-30 -88.3 -5.42 58.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.983 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.472 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.8 mmm -107.22 -4.6 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.507 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.3 mt-10 -65.56 -48.65 71.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -77.79 122.32 25.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 112.338 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 32.25 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -140.44 86.28 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.136 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 28.8 t -144.76 123.06 12.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.521 ' HA ' HD22 ' A' ' 62' ' ' ASN . 88.8 m-85 -134.83 153.76 51.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.241 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.1 tp -147.0 91.81 5.09 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.78 -45.26 42.36 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.773 2.315 . . . . 0.0 113.718 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.82 -15.68 32.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.51 -28.93 57.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.6 -44.16 91.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.11 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.44 -42.07 92.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.514 HG21 ' NH1' ' A' ' 95' ' ' ARG . 68.6 mt -59.68 -47.57 90.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.216 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.9 mmm -70.07 -35.51 74.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.442 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 74.1 m -63.44 -45.28 91.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.755 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.99 -36.91 85.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 0.0 111.407 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.585 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.1 mtt85 -79.9 -32.68 40.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.1 m -113.45 -13.29 12.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 87.6 m-20 -61.56 135.28 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.554 -0.859 . . . . 0.0 112.054 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 65.31 11.02 6.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -110.62 144.43 39.52 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.407 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 m -70.56 -31.79 68.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.904 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.81 154.15 41.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.738 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.88 137.08 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.511 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.94 128.92 75.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 105' ' ' VAL . 19.2 t -136.87 144.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.623 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.6 t -76.72 115.57 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.77 33.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.952 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.6 -119.76 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.99 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.4 t 32.1 -159.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.75 0.309 . . . . 0.0 111.042 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.467 ' H ' ' HG ' ' A' ' 108' ' ' SER . 86.2 m-20 -67.5 2.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.577 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.72 -11.81 56.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.187 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.587 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -146.6 129.97 8.22 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.2 Cg_exo -50.43 -146.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.461 2.107 . . . . 0.0 112.207 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -144.34 83.73 9.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.27 -7.02 17.76 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.024 2.483 . . . . 0.0 114.234 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.557 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.45 68.77 1.07 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 121.605 0.717 . . . . 0.0 111.267 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -51.74 144.28 35.0 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 122.667 2.245 . . . . 0.0 111.2 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.86 2.23 90.48 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.942 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.6 m -120.43 146.06 46.59 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.055 0.928 . . . . 0.0 109.542 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.76 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 7.6 t80 -80.88 110.5 16.46 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.557 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.9 mttp -90.49 -164.84 1.23 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.517 1.151 . . . . 0.0 113.858 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.3 p90 -170.56 169.57 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.033 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 62' ' ' ASN . 32.8 tp -127.43 124.57 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HG2' HE21 ' A' ' 125' ' ' GLN . 73.0 tt0 -120.42 125.62 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.2 125.66 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.587 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.423 HE21 ' HG2' ' A' ' 123' ' ' GLU . 4.2 mp0 -108.57 126.1 52.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.752 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.477 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.5 p90 -153.31 173.03 16.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.9 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -125.27 159.39 31.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.198 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.418 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 95.3 m -108.95 121.34 44.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.009 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 55' ' ' VAL . 29.9 m -132.03 158.63 75.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.51 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 C--N 1.313 -1.32 0 C-N-CA 122.053 1.835 . . . . 0.0 112.424 -179.494 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -152.0 138.25 18.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.124 0.488 . . . . 0.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.618 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.3 mt-10 -130.18 149.76 51.74 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.836 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tt -137.42 140.45 41.32 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.99 138.0 38.47 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.338 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.442 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 45.8 m -66.68 137.02 56.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -45.2 130.73 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.992 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.2 -14.44 62.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.004 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 12.5 m-85 -109.34 151.59 42.18 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.884 1.342 . . . . 0.0 110.083 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.36 155.48 60.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.664 2.243 . . . . 0.0 113.039 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 tt -123.21 147.97 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.2 tt0 -128.98 124.23 34.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -113.27 141.89 46.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 49' ' ' ARG . 17.8 mtp-105 -147.86 138.92 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.919 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.511 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.3 m -106.79 142.76 25.66 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.351 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -68.83 160.8 48.21 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.532 2.155 . . . . 0.0 112.907 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.94 -132.34 10.19 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.364 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -101.74 22.23 13.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.201 -0.5 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -77.39 165.51 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.258 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.511 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 95.5 mt -68.66 139.7 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.669 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -132.45 100.57 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' A' ' 97' ' ' ASN . 8.5 t -63.44 125.33 19.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.755 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 93.3 mt-10 -101.67 -48.79 4.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.2 m-20 -149.98 150.69 32.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.203 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -170.66 157.38 5.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.878 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 84' ' ' TYR . 13.7 t30 -150.18 146.91 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -117.61 120.63 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 155.88 -131.23 2.98 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.789 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 7.3 ttm-85 -157.1 115.01 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.483 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.443 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 28.0 p -118.25 11.14 13.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 46.0 t0 -147.89 -171.67 3.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.785 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 26.1 p-10 -145.62 -2.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 34.9 mttp -100.7 6.32 43.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.0 mm -111.9 135.83 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.15 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.3 m 53.63 75.0 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.281 0.562 . . . . 0.0 109.894 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.77 120.12 7.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.55 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.82 -164.15 1.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.607 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -59.96 134.55 90.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 119.159 -1.017 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -53.6 -33.28 68.09 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.545 2.163 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.28 -37.68 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.691 0.281 . . . . 0.0 111.146 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -86.48 2.51 47.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.203 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 38.8 mmm -121.85 -0.18 9.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 63.0 mt-10 -64.96 -48.52 73.76 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.29 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -78.38 116.85 19.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.543 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 26.5 m -105.34 36.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 71.9 mm-40 -141.14 83.42 1.88 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.547 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 31.7 t -147.13 116.86 7.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 8.7 m-85 -130.18 157.49 42.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.606 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.35 90.75 5.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -48.73 -46.8 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.121 2.547 . . . . 0.0 113.805 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -57.84 -18.33 21.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.53 65.38 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.627 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' O ' ' OG ' ' A' ' 93' ' ' SER . 56.2 t80 -65.47 -46.39 79.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.765 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -64.65 -41.05 96.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.669 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.544 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 97.8 mt -60.38 -49.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.741 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.532 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 74.7 mtp -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.401 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.1 m -55.74 -44.01 77.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.96 -37.94 82.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -75.77 -34.41 60.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -110.38 -19.78 12.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 76.4 m-20 -58.34 136.95 57.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.613 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 65.2 13.55 8.82 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.646 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -114.29 146.22 40.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.202 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.0 m -69.45 -31.03 69.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 156.15 41.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.605 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -152.4 130.18 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.09 131.59 66.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.629 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 105' ' ' VAL . 78.0 t -145.82 148.8 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.359 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 107' ' ' GLY . 95.3 t -81.44 118.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.636 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.01 38.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.083 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.662 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.3 -118.65 0.58 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.156 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.662 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.1 t 24.63 -156.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.231 0.539 . . . . 0.0 111.823 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -69.51 2.7 2.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.82 -14.38 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.548 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -144.8 130.17 9.42 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.41 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.6 Cg_exo -51.72 -145.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.981 1.787 . . . . 0.0 112.063 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -144.96 86.63 7.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.548 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.5 Cg_endo -75.63 -5.03 16.05 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.376 2.051 . . . . 0.0 112.666 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.417 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -169.78 73.7 0.67 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.246 0.546 . . . . 0.0 111.636 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -53.23 148.09 33.3 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.674 2.25 . . . . 0.0 111.6 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.58 75.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.09 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.9 m -118.97 146.79 44.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.461 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 14.5 t80 -82.82 109.24 16.78 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 28.0 mtmm -87.88 -165.2 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.507 1.146 . . . . 0.0 113.799 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 64' ' ' GLY . 5.3 p90 -170.53 171.24 6.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.048 -1.887 . . . . 0.0 111.034 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 92' ' ' MET . 27.8 tp -129.67 120.71 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.116 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.61 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -114.16 125.59 54.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.787 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.532 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 38.8 t -134.37 122.51 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.839 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.61 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 3.4 mt-30 -105.97 127.28 53.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.358 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.442 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 31.5 p90 -149.83 168.26 24.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 111.846 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -124.96 160.08 29.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.1 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.6 m -110.77 122.11 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.0 156.35 62.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.149 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo . . . . . 0 N--CA 1.492 1.414 0 C-N-CA 122.194 1.929 . . . . 0.0 111.845 179.253 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 41.5 ttm180 -142.4 138.89 31.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.392 0.615 . . . . 0.0 110.742 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -135.03 140.61 45.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.61 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 5.4 tt -139.6 133.6 30.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.49 141.1 46.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.203 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.4 m -67.67 136.65 54.69 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.573 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 88.6 tt0 -49.31 134.14 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.629 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.73 -17.94 56.74 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.21 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -113.12 152.66 45.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 118.302 1.051 . . . . 0.0 109.943 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.56 153.76 76.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.272 1.981 . . . . 0.0 113.14 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.61 139.51 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 81.2 tt0 -128.49 129.05 45.51 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.293 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 30.5 mt -111.85 144.58 40.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.44 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.641 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 91.6 mtt180 -149.26 130.33 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.675 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -96.93 145.13 29.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.813 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.84 161.91 40.49 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.329 2.019 . . . . 0.0 111.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.43 -126.73 31.99 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.69 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -117.92 23.87 11.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -75.16 168.46 19.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 m -125.84 145.6 33.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.89 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.481 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.1 mt -69.0 137.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.782 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.639 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.1 ptm -131.6 99.35 4.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.95 125.92 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.955 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.73 -50.78 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.736 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 42.8 m-20 -149.83 149.12 30.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.4 154.06 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 84' ' ' TYR . 5.5 t30 -151.18 144.1 24.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.508 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -115.41 120.32 39.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.65 -135.88 4.34 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.859 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.8 ttm180 -156.91 117.12 3.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 111.246 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.0 p -121.2 11.53 10.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 35.5 t0 -144.96 -167.02 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.422 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 13.1 p30 -149.83 -1.71 0.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -100.86 6.35 43.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.287 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 121' ' ' TYR . 8.5 mt -104.47 131.92 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.1 m 50.06 81.0 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.606 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 37.7 p30 -53.79 98.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.502 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.65 -172.94 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.097 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -58.15 134.71 84.36 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.191 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.1 Cg_endo -50.18 -35.82 44.06 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.629 1.553 . . . . 0.0 112.096 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -61.95 -38.34 88.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.783 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.464 ' O ' ' CG2' ' A' ' 118' ' ' THR . 24.2 mt-30 -84.3 -8.69 58.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.26 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 74.0 mtp -104.43 -0.86 27.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.267 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.4 mt-10 -61.82 -49.91 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -78.22 117.89 19.92 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.8 m -109.74 30.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.969 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.6 mm-40 -140.99 86.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.426 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 3.7 t -145.37 122.09 11.18 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.448 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.0 m-85 -131.96 157.42 44.11 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.9 tp -148.18 90.12 5.07 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.821 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -46.8 -47.79 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.673 2.248 . . . . 0.0 112.783 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 83.6 m-20 -56.38 -24.55 45.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.49 62.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.529 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -66.03 -44.97 83.11 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -64.66 -38.3 90.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 99.0 mt -59.33 -48.63 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.37 -36.13 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 15.6 m -58.25 -45.58 87.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.17 -38.25 85.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.67 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.622 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 80.9 mtt180 -75.76 -34.05 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 58.4 m -110.31 -20.51 12.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.48 ' CG ' ' O ' ' A' ' 93' ' ' SER . 72.5 m-20 -57.33 137.82 55.6 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.614 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.94 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -115.69 147.21 41.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.241 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.4 m -70.07 -35.75 74.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.966 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 157.76 43.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.521 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 28.4 p -153.84 141.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 111.822 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.9 126.52 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 105' ' ' VAL . 21.9 t -139.26 141.55 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.964 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.588 ' C ' ' H ' ' A' ' 107' ' ' GLY . 88.5 t -72.68 113.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.528 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.05 34.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.895 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.11 -123.21 0.81 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.678 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 6.9 t 32.76 -161.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.785 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.678 ' H ' ' HG ' ' A' ' 108' ' ' SER . 82.9 m-20 -69.06 4.49 1.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -81.28 -11.93 59.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.4 m-85 -143.01 129.82 10.68 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.0 Cg_exo -51.86 -149.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.249 1.966 . . . . 0.0 111.213 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.82 88.92 6.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.426 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 68.0 Cg_endo -84.67 -4.98 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.245 2.63 . . . . 0.0 113.274 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -168.4 73.9 0.84 Allowed Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.873 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.67 154.24 70.41 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.635 2.223 . . . . 0.0 112.728 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.25 4.65 90.43 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 29.8 m -127.11 148.01 50.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 48.6 t80 -83.85 114.48 21.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.515 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 12.6 mttt -91.14 -163.83 1.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.552 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.6 p90 -171.41 172.77 5.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.513 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 48.1 tp -133.72 126.82 31.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.418 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -121.49 127.21 50.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.09 125.1 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.159 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 60' ' ' ASN . 12.0 mp0 -110.3 129.14 55.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.481 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.3 p90 -153.09 166.91 30.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.377 0.608 . . . . 0.0 112.065 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 38.8 m-20 -118.22 157.69 26.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.31 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.4 m -108.82 118.47 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.37 155.81 58.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.139 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 C--N 1.31 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 111.597 179.763 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.479 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 62.4 mtp85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -153.04 142.92 22.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.204 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.1 mt-10 -133.91 149.91 51.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.946 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -141.3 134.5 29.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.243 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.515 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.6 143.77 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.705 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 m -67.39 139.04 57.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.952 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -45.13 133.12 6.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.628 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.1 63.95 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.333 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -108.24 149.43 39.21 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 118.733 1.267 . . . . 0.0 110.722 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.0 149.54 77.32 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.387 2.058 . . . . 0.0 112.935 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.8 tt -121.46 143.63 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 56.8 tt0 -129.6 128.34 42.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.252 0.549 . . . . 0.0 112.148 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 HD11 ' SG ' ' A' ' 102' ' ' CYS . 32.4 mt -113.25 141.98 46.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.952 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.622 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 82.2 mtt180 -146.95 127.55 14.18 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 m -96.52 141.56 23.29 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.76 163.79 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.59 2.193 . . . . 0.0 112.264 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.68 -138.65 18.62 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -102.37 23.2 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.745 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 92.9 m-20 -79.35 164.82 23.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.34 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.5 m -128.67 149.04 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.328 0.585 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.466 HG21 ' CD2' ' A' ' 126' ' ' TYR . 99.1 mt -69.79 135.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.504 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -131.24 98.61 4.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.9 t -61.97 122.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.713 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -100.61 -46.21 5.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -149.6 144.13 25.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.127 0.489 . . . . 0.0 110.572 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.35 147.49 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 84' ' ' TYR . 27.7 t30 -149.85 155.83 40.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.958 0.409 . . . . 0.0 111.545 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -121.01 120.59 35.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.8 -139.74 6.17 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.68 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 13.6 ttm180 -155.35 115.07 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.943 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -126.95 8.49 6.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.953 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -148.57 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.149 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 78' ' ' MET . 23.7 p-10 -114.37 5.13 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.441 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -102.48 3.4 37.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.918 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.489 HG23 HD13 ' A' ' 70' ' ' ILE . 26.3 mm -112.52 134.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.536 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.85 67.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.199 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 26.4 p-10 -52.57 102.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.009 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -116.52 -165.7 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -60.04 139.25 90.96 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.898 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 Cg_endo -54.14 -40.25 82.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.261 1.974 . . . . 0.0 113.078 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -61.95 -37.29 84.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.248 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.538 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 21.5 mt-30 -86.4 -4.79 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.53 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 89.3 mtp -107.16 -1.11 22.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 79.7 mt-10 -64.35 -48.52 75.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -79.9 119.79 23.24 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.27 31.23 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -138.47 84.2 2.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.071 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 43.3 t -146.78 121.04 9.55 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.411 ' HA ' HD22 ' A' ' 62' ' ' ASN . 80.1 m-85 -130.98 153.95 48.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.12 91.36 5.15 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.68 -46.14 28.47 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 123.303 2.669 . . . . 0.0 113.972 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.2 m-20 -57.91 -20.22 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.67 65.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 58' ' ' VAL . 74.0 t80 -63.54 -42.75 98.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.488 ' NZ ' HE22 ' A' ' 94' ' ' GLN . 4.0 ptmm? -66.86 -40.57 87.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.128 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 44.8 mt -59.51 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.91 -37.8 76.08 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.5 m -59.76 -46.74 88.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.803 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.488 HE22 ' NZ ' ' A' ' 90' ' ' LYS . 66.8 mt-30 -65.83 -38.9 90.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.169 0.509 . . . . 0.0 111.127 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 95' ' ' ARG . 51.9 mtt180 -75.37 -34.13 61.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.5 m -111.59 -16.05 13.35 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 25.0 m-20 -58.85 136.73 57.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.854 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 65.89 13.86 9.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.02 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -112.34 144.45 41.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.559 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.3 m -71.93 -30.91 65.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.976 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 152.65 36.58 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.02 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 p -155.28 137.21 14.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.09 127.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.806 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.9 t -138.15 149.12 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.517 ' C ' ' H ' ' A' ' 107' ' ' GLY . 97.3 t -78.56 115.03 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.355 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.11 36.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.564 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.52 -119.95 0.65 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 107' ' ' GLY . 17.0 t 28.45 -158.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.98 0.93 5.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.242 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.48 -14.81 56.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.123 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.2 m-85 -141.75 130.82 12.32 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.228 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.9 Cg_exo -51.44 -150.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.216 1.944 . . . . 0.0 111.628 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 20.2 t0 -146.99 93.86 4.7 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 96.6 Cg_endo -84.23 -11.35 8.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.04 2.493 . . . . 0.0 114.814 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.463 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 3.9 p -166.85 66.94 0.92 Allowed Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.4 153.56 33.91 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.315 2.01 . . . . 0.0 110.743 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.36 73.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.481 HG21 ' N ' ' A' ' 119' ' ' TYR . 97.5 m -126.12 148.33 49.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.59 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.6 t80 -81.04 113.36 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 13.0 mtmm -91.29 -160.77 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.131 0.967 . . . . 0.0 113.166 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.9 p90 -174.35 175.33 2.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.801 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -133.58 127.14 32.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.0 tt0 -119.23 130.11 55.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.8 t -133.08 121.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.928 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.472 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mt-30 -108.8 132.21 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.466 ' CD2' HG21 ' A' ' 56' ' ' ILE . 48.6 p90 -155.02 173.18 16.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.485 0.659 . . . . 0.0 111.856 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 57' ' ' MET . 41.9 m-20 -125.5 156.0 39.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.453 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.479 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 85.7 m -108.66 115.76 30.69 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.163 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.9 m -120.49 155.24 56.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 122.28 1.987 . . . . 0.0 112.682 179.468 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.476 HH21 ' HG3' ' A' ' 51' ' ' PRO . 92.9 mtt-85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.973 0.415 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -146.14 130.05 17.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.558 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -127.25 145.21 50.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.5 tt -138.73 140.78 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.283 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.72 136.61 37.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.559 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.7 m -65.01 140.76 58.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 110.481 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.07 126.66 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.488 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.2 65.87 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.691 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -107.36 154.59 40.52 Favored Pre-proline 0 C--O 1.226 -0.136 0 CA-C-N 118.801 1.301 . . . . 0.0 109.812 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -71.93 152.08 57.24 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.953 1.769 . . . . 0.0 112.38 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.19 147.49 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.65 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 72.1 tt0 -130.01 129.76 44.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.466 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 ' SG ' ' A' ' 102' ' ' CYS . 31.1 mt -115.84 136.93 52.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.65 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 90.6 mtt180 -144.48 140.1 28.7 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.877 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -104.41 143.99 27.79 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.154 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HG3' HH21 ' A' ' 36' ' ' ARG . 37.8 Cg_endo -70.76 160.44 49.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.988 2.458 . . . . 0.0 112.193 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -127.06 23.85 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.0 p -114.3 24.97 11.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.46 168.28 20.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.202 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.24 144.86 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.196 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 126' ' ' TYR . 82.7 mt -68.89 138.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.779 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.611 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.5 ptm -132.54 100.66 5.04 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.12 125.0 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.524 -178.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 90.3 mt-10 -102.66 -47.82 4.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.3 m-20 -149.73 149.35 30.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.662 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.0 153.82 14.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -150.27 139.45 21.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HH ' ' HD2' ' A' ' 120' ' ' LYS . 63.1 t80 -111.65 118.01 34.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.42 -137.37 4.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 10.0 ttm-85 -154.77 120.27 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.493 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.749 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 4.8 p -121.43 9.19 10.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.636 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 34.4 t0 -143.47 -164.6 1.9 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 4.1 p30 -149.18 -1.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 109.808 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -104.61 5.88 34.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.887 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.445 HD12 HG23 ' A' ' 70' ' ' ILE . 45.3 mm -107.82 136.85 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.106 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.1 m 54.22 69.71 0.69 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.1 p-10 -49.26 103.67 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.786 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.47 -165.62 1.22 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.689 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -61.97 144.76 93.62 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 111.333 -179.693 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.3 Cg_endo -61.17 -39.4 59.1 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.606 2.204 . . . . 0.0 112.838 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -62.67 -32.13 73.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.689 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 71.0 mt-30 -89.23 -11.53 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 67.1 mmm -104.13 -2.76 25.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.877 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.1 mt-10 -66.9 -45.24 78.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.65 114.52 19.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.478 0.656 . . . . 0.0 112.091 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 15.9 m -104.94 34.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.06 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.5 mm-40 -142.64 87.37 2.0 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.372 0.606 . . . . 0.0 110.894 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.8 t -145.22 118.08 8.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -130.77 154.18 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.715 -178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 13.3 tp -143.29 85.86 9.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.45 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.64 -50.0 11.21 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.052 2.501 . . . . 0.0 114.006 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -57.61 -22.99 48.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.588 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 85' ' ' LEU . . . -52.01 -32.63 34.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.95 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.87 -42.23 95.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.565 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.5 pttt -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.925 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.3 mt -60.52 -47.74 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.795 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -70.03 -37.5 75.61 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.013 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.8 m -60.35 -46.64 89.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.03 -36.0 82.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.612 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -79.34 -30.93 42.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.7 m -112.03 -19.74 12.22 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 71.6 m-20 -55.61 131.4 46.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.86 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 69.37 13.8 8.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -113.89 146.53 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.131 178.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 m -69.91 -29.04 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.901 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 158.3 41.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.907 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HD13 ' A' ' 48' ' ' LEU . 3.6 p -156.44 139.08 15.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.9 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.56 127.32 75.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.248 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.8 t -136.66 144.02 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.0 t -77.14 114.15 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 36.99 0.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.417 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.02 -121.42 0.71 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.7 t 29.0 -158.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.124 0.487 . . . . 0.0 111.222 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' N ' ' OG ' ' A' ' 108' ' ' SER . 21.7 m-20 -68.72 2.76 2.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.36 -15.82 48.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.281 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.6 m-85 -143.42 126.26 8.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.589 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.0 Cg_exo -52.03 -143.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.945 . . . . 0.0 111.495 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 23.8 t0 -143.25 83.39 11.04 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.68 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.26 -5.19 16.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.938 2.426 . . . . 0.0 112.763 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.581 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -168.35 74.29 0.85 Allowed Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 110.974 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.98 144.2 94.82 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 121.901 1.734 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.3 -8.32 78.99 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.266 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' N ' ' A' ' 119' ' ' TYR . 94.9 m -115.37 148.45 39.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.036 0.918 . . . . 0.0 109.759 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' HG23 ' A' ' 118' ' ' THR . 28.9 t80 -81.28 113.92 19.72 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.581 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 14.8 mttp -92.98 -161.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.939 1.352 . . . . 0.0 114.161 -176.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.749 ' HH ' ' H ' ' A' ' 66' ' ' THR . 4.9 p90 -174.06 174.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.377 -2.192 . . . . 0.0 110.491 176.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 31.0 tp -128.32 122.11 30.8 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -131.51 127.45 59.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.841 -179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -105.92 124.66 49.93 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.456 ' CD1' HG22 ' A' ' 56' ' ' ILE . 29.5 p90 -149.86 168.35 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 m-20 -124.64 161.52 26.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.0 m -110.1 113.0 25.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -118.61 159.41 44.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.92 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.5 1.901 0 C-N-CA 122.695 2.263 . . . . 0.0 112.573 179.284 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 23.5 mtp180 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' OE2' ' A' ' 123' ' ' GLU . 32.2 ttp180 -150.99 139.43 20.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.274 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 52.4 mp0 -132.87 145.64 51.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.819 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -137.09 138.76 40.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -137.32 143.92 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.218 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 m -68.17 135.62 52.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.686 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 80.8 tt0 -46.94 136.0 8.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.443 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 -17.45 58.78 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.044 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 31.7 m-85 -108.69 149.78 39.91 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 118.135 0.968 . . . . 0.0 110.314 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.59 149.68 68.28 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.08 1.853 . . . . 0.0 112.636 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.57 146.54 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.181 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 49' ' ' ARG . 80.6 tt0 -130.98 127.26 38.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.75 -179.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -111.37 140.06 46.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.427 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.575 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 6.5 mtt180 -145.17 133.04 21.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.448 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -99.85 144.11 27.75 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.041 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.6 Cg_endo -68.22 161.51 44.28 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.376 2.051 . . . . 0.0 112.57 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.32 -133.13 25.19 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.512 178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.8 p -103.3 22.87 13.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.679 -0.761 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -78.95 167.6 20.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.23 0.538 . . . . 0.0 111.65 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.99 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.321 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.448 HG12 ' SG ' ' A' ' 50' ' ' CYS . 62.1 mt -71.06 137.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.651 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.626 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -131.81 98.4 4.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.814 0.816 . . . . 0.0 109.222 178.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.69 124.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.648 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.508 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 97.7 mt-10 -104.01 -47.2 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.541 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 33.2 m-20 -149.61 147.17 27.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.747 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.47 154.16 9.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.292 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 84' ' ' TYR . 12.7 t30 -149.3 144.5 26.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HH ' ' HG3' ' A' ' 42' ' ' GLU . 66.7 t80 -113.87 116.49 29.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.67 -133.74 3.34 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.736 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 4.8 ttm180 -153.97 117.68 4.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 84' ' ' TYR . 26.8 p -122.53 3.21 9.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.049 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -148.33 156.68 42.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -114.4 3.86 15.14 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -104.19 4.0 33.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.698 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 HG22 ' A' ' 70' ' ' ILE . 45.3 mm -112.16 138.41 41.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 m 56.83 69.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.679 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -57.14 118.89 5.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.378 0.608 . . . . 0.0 111.815 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -134.41 -162.07 1.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.623 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -63.2 134.9 96.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.037 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.0 Cg_endo -56.1 -34.52 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.195 1.93 . . . . 0.0 113.584 -177.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -61.85 -37.04 83.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.22 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.441 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 21.6 mt-30 -84.92 -1.23 56.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.736 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 mtm -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.308 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.0 mt-10 -63.19 -43.41 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.854 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -79.87 117.02 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.74 33.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -141.72 83.02 1.83 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.191 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.412 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 24.1 t -143.16 125.85 15.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CE2' HG22 ' A' ' 66' ' ' THR . 65.0 m-85 -136.0 153.6 51.33 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.0 tp -147.88 92.61 4.66 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.584 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -49.97 -44.78 35.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.783 2.322 . . . . 0.0 113.147 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.58 -19.13 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.22 67.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 110.29 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' O ' ' OG ' ' A' ' 93' ' ' SER . 18.1 t80 -66.78 -46.57 74.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.563 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.64 -39.55 93.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.789 -178.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' HE ' ' A' ' 95' ' ' ARG . 83.7 mt -62.15 -54.01 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.6 mmm -66.58 -36.26 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.699 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 50.9 m -60.88 -45.38 94.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.004 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -65.3 -36.21 83.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.36 0.6 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.473 ' HE ' HG22 ' A' ' 91' ' ' ILE . 91.2 mtt-85 -78.36 -32.64 49.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.9 m -112.28 -16.55 12.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 44.1 m-20 -61.18 133.43 55.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.378 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 66.75 10.88 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.394 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -110.6 144.93 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.321 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -68.77 -35.16 76.71 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.98 156.56 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.54 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -153.59 138.89 17.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 0.0 111.486 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 t -118.92 130.94 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.549 178.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 105' ' ' VAL . 57.5 t -143.46 148.69 18.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.103 -178.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' N ' HG12 ' A' ' 104' ' ' VAL . 23.8 t -84.83 115.66 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.171 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.11 38.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.514 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.82 -124.11 0.88 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.8 t 30.24 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -65.91 0.84 1.62 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.224 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -84.62 -11.3 56.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.583 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.8 m-85 -145.96 128.17 7.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.1 Cg_exo -49.55 -149.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.177 1.918 . . . . 0.0 111.945 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.22 82.16 12.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.313 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.408 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 91.1 Cg_endo -76.97 -6.6 16.84 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.149 2.566 . . . . 0.0 113.459 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.5 p -165.94 74.23 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.343 0.592 . . . . 0.0 111.171 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.94 148.45 88.72 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.974 1.782 . . . . 0.0 111.476 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.11 -5.04 78.54 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 119' ' ' TYR . 94.0 m -115.88 148.8 39.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.972 0.886 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 13.6 t80 -83.31 114.14 21.2 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.454 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 16.3 mttp -91.11 -161.45 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.574 1.178 . . . . 0.0 113.245 -176.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.478 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 3.5 p90 -171.98 172.03 4.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.062 -1.881 . . . . 0.0 110.643 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -129.0 123.3 32.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 79.4 tt0 -118.6 122.79 43.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.21 126.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.497 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -109.55 130.79 55.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -153.61 171.99 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 111.691 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.508 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 74.3 m-20 -125.19 158.59 33.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.89 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.4 m -107.66 119.98 40.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.443 HG12 ' SD ' ' A' ' 57' ' ' MET . 20.7 m -122.57 154.82 63.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.183 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.026 1.817 . . . . 0.0 111.098 178.828 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.516 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 32.4 ttp180 -146.91 133.81 20.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.531 0.682 . . . . 0.0 111.899 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.688 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -133.07 144.76 50.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.484 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tt -140.12 137.52 34.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.541 179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.9 140.99 42.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.247 0.546 . . . . 0.0 110.618 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -66.39 136.18 55.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.23 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -47.12 136.06 9.19 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 111.628 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.94 61.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.12 178.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.18 156.02 38.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 118.118 0.959 . . . . 0.0 110.732 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.08 149.99 29.13 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.998 1.799 . . . . 0.0 111.38 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.4 tt -120.74 145.63 26.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.685 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 75.8 tt0 -128.69 128.28 43.77 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.871 -178.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.8 mt -111.53 145.34 39.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.179 178.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.685 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 69.6 mtt180 -148.69 133.28 17.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.662 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.469 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -100.75 148.35 34.9 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.937 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.23 159.29 40.7 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.509 2.14 . . . . 0.0 112.169 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.22 -128.42 34.59 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.491 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.8 p -112.8 24.86 11.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.333 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.95 167.3 21.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 179.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.53 145.98 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.485 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.478 HG22 ' CD1' ' A' ' 126' ' ' TYR . 79.7 mt -69.62 137.95 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.723 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.44 ' N ' HG23 ' A' ' 56' ' ' ILE . 2.5 ptp -130.93 102.11 5.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.87 124.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.873 -177.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -102.46 -51.83 3.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.993 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 22.9 m-80 -148.59 144.32 27.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 0.0 110.463 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.97 150.85 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.945 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 84' ' ' TYR . 39.4 t30 -148.81 157.25 43.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' HH ' ' HD2' ' A' ' 120' ' ' LYS . 80.0 t80 -125.53 121.94 35.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.559 179.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.7 -134.5 3.73 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.709 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 14.6 ttm180 -157.96 119.5 3.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 0.0 111.579 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 p -125.09 9.86 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.28 158.62 44.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.128 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 53.7 p-10 -117.59 5.77 12.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -100.59 4.83 43.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.98 135.63 51.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.707 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.3 m 57.25 66.13 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 56.6 p30 -45.82 94.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.988 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -112.53 -162.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -62.67 142.59 96.86 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 121.446 0.641 . . . . 0.0 111.488 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 15.1 Cg_endo -57.21 -39.54 89.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.402 2.068 . . . . 0.0 112.78 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -64.74 -35.12 80.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.482 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.558 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.8 mt-30 -85.9 -7.18 58.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.825 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.709 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 3.8 mmm -107.64 -2.52 20.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.44 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 40.4 mm-40 -62.88 -49.95 72.81 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -78.06 113.13 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.598 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.7 m -104.55 30.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.362 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -142.14 89.63 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 16.7 t -146.06 120.05 9.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.786 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.462 ' HA ' HD22 ' A' ' 62' ' ' ASN . 95.1 m-85 -132.1 151.63 51.67 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.998 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -146.89 88.46 5.94 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.102 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -48.5 -48.4 17.4 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.25 2.633 . . . . 0.0 113.847 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 78.5 m-20 -51.65 -29.58 18.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.549 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.1 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.135 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 48.1 t80 -62.45 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.492 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.555 ' O ' ' NE2' ' A' ' 94' ' ' GLN . 3.5 pttt -66.03 -38.93 89.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.853 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 18.6 mt -60.26 -52.47 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.353 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.3 mmm -66.86 -37.55 84.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.385 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.4 m -61.78 -47.37 85.46 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.139 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -69.84 -34.38 73.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.08 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.528 HH11 HG12 ' A' ' 104' ' ' VAL . 61.0 mtt180 -75.4 -32.46 60.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.6 m -112.46 -16.96 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.565 ' CG ' ' O ' ' A' ' 93' ' ' SER . 89.7 m-20 -58.15 133.87 55.98 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.052 -178.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 67.69 13.12 9.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.283 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -115.19 148.27 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.036 178.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.5 m -71.44 -31.6 67.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.009 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.71 157.47 42.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.449 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.5 p -155.68 143.03 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.907 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 89.1 t -121.58 125.06 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.528 HG12 HH11 ' A' ' 95' ' ' ARG . 39.2 t -137.68 145.43 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' A' ' 107' ' ' GLY . 43.3 t -79.7 117.02 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.018 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.97 36.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.71 -121.65 0.75 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.733 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 31.9 -160.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.197 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.39 -0.42 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -84.12 -14.33 50.61 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.812 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 112' ' ' PRO . 48.9 m-85 -143.38 127.37 9.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.166 178.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.3 Cg_exo -49.62 -149.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.331 2.021 . . . . 0.0 112.119 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.495 ' CG ' ' HZ2' ' A' ' 120' ' ' LYS . 10.5 t0 -145.82 82.46 9.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.431 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.5 Cg_endo -77.24 -2.25 12.45 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.103 2.535 . . . . 0.0 113.697 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.541 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -167.85 68.51 0.84 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 110.511 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.14 151.09 29.48 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.98 2.454 . . . . 0.0 111.775 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 -1.71 60.37 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 m -117.65 146.7 43.5 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.628 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.1 t80 -84.89 115.81 22.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.074 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.541 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 17.8 mttp -92.62 -160.33 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -174.18 176.49 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.525 -1.671 . . . . 0.0 111.909 176.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 tp -135.68 125.82 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.995 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.451 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.1 tt0 -118.68 127.24 53.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.47 123.75 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.199 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.451 HE21 ' HG2' ' A' ' 123' ' ' GLU . 1.8 mt-30 -110.07 129.66 55.65 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.327 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.478 ' CD1' HG22 ' A' ' 56' ' ' ILE . 40.3 p90 -152.94 169.56 22.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.352 0.596 . . . . 0.0 111.437 -178.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.439 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 85.9 m-20 -122.88 158.44 30.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.57 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 96.7 m -111.33 111.67 22.89 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.407 HG11 ' CE ' ' A' ' 57' ' ' MET . 20.3 m -112.55 154.2 44.72 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo . . . . . 0 N--CA 1.49 1.316 0 C-N-CA 122.109 1.873 . . . . 0.0 112.216 -179.792 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.475 0.178 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 31.4 ttm105 -146.44 136.08 23.13 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.839 0.828 . . . . 0.0 111.373 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 45.5 mp0 -134.67 145.54 48.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.238 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.32 139.78 35.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.389 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -136.65 137.42 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.13 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.2 m -70.41 139.67 51.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 0.0 110.503 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.504 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 80.7 tt0 -47.51 135.17 11.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.129 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.96 -19.0 56.3 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.93 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.56 148.71 38.67 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 118.376 1.088 . . . . 0.0 109.78 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.57 154.57 73.15 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.38 144.15 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -124.79 127.04 46.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.582 -179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 72.2 mt -118.1 141.06 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.037 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -148.58 136.31 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.909 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.9 147.97 35.11 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.205 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 62.8 Cg_endo -75.3 156.92 41.71 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.005 2.47 . . . . 0.0 112.136 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -132.23 39.75 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.5 p -109.4 27.45 9.53 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.18 0.514 . . . . 0.0 111.143 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.45 163.9 25.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.28 145.28 34.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.927 178.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.494 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.2 mt -68.67 138.09 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.409 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.447 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.4 ptp -131.24 98.6 4.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.67 124.76 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.165 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.3 mm-40 -100.99 -47.33 4.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.3 m-20 -149.21 147.47 28.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.825 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.47 151.15 11.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.585 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.482 HD22 ' HA ' ' A' ' 84' ' ' TYR . 32.0 t30 -150.26 146.49 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.229 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.504 ' HH ' ' HG3' ' A' ' 42' ' ' GLU . 94.7 t80 -117.17 120.73 39.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.32 -137.72 5.16 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.132 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.0 ttm-85 -155.78 113.45 3.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.218 0.532 . . . . 0.0 109.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.539 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 16.6 p -121.23 11.05 10.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.968 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.655 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 47.3 t0 -146.74 -173.67 4.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.431 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.655 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 39.4 p30 -145.55 1.05 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.501 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -101.24 4.86 42.21 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.724 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.06 135.5 52.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.472 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.3 m 58.05 66.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.311 0.577 . . . . 0.0 109.814 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -53.2 122.15 8.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.105 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.82 -164.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.872 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.667 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.8 p30 -59.91 135.41 90.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.828 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.19 -32.22 59.01 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 113.283 -178.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -63.62 -38.03 89.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.667 HE21 ' CG ' ' A' ' 74' ' ' ASP . 35.3 mt-30 -85.5 -0.92 56.37 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.417 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 81.5 mtp -115.27 -1.25 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.172 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -62.42 -47.56 83.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 50.7 t30 -80.97 117.62 21.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.49 33.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.172 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -140.05 84.55 1.97 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.456 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 54.1 t -147.2 117.33 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.482 ' HA ' HD22 ' A' ' 62' ' ' ASN . 96.9 m-85 -128.02 155.72 43.87 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.322 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.5 tp -148.55 83.47 6.98 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.92 -45.36 20.94 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.792 2.328 . . . . 0.0 114.441 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -57.21 -20.77 29.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.929 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.34 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.868 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' OG ' ' A' ' 93' ' ' SER . 24.4 t80 -65.29 -43.56 90.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.776 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HZ3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -65.32 -39.85 92.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.178 -179.038 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.564 HG21 ' HE ' ' A' ' 95' ' ' ARG . 75.8 mt -58.38 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.48 -38.68 87.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.038 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.597 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.1 m -59.28 -45.67 90.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.93 -37.95 89.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.979 0.418 . . . . 0.0 110.56 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.564 ' HE ' HG21 ' A' ' 91' ' ' ILE . 92.7 mtt-85 -73.59 -34.46 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.51 -16.57 12.84 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -58.79 133.54 56.07 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.798 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 65.9 13.45 9.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.13 178.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -115.44 147.31 40.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.17 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.8 m -74.12 -30.26 62.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 153.27 32.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 27.2 p -154.92 141.63 18.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.622 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.61 127.73 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.85 146.87 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.731 0.3 . . . . 0.0 111.01 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 107' ' ' GLY . 89.5 t -78.98 114.41 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.214 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.76 39.26 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.849 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.45 -125.09 0.9 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.418 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.65 -157.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.395 0.616 . . . . 0.0 111.935 -179.298 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -66.39 -1.49 3.54 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.426 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.09 -14.9 57.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.243 -179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 58.2 m-85 -144.99 127.07 8.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.9 Cg_exo -51.78 -145.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.904 1.736 . . . . 0.0 112.355 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 12.4 t0 -145.75 85.2 7.85 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.537 -179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.456 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 74.2 Cg_endo -74.24 -6.25 18.14 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.225 . . . . 0.0 113.537 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.564 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -169.93 70.78 0.63 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.634 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 51.6 Cg_exo -48.76 153.52 3.58 Favored 'Trans proline' 0 C--N 1.294 -2.296 0 C-N-CA 123.003 2.469 . . . . 0.0 111.922 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.76 10.46 83.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.795 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 119' ' ' TYR . 91.9 m -124.67 147.73 48.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.481 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 11.4 t80 -86.15 109.49 18.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.1 mttp -91.28 -161.75 0.85 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.46 1.124 . . . . 0.0 114.02 -175.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.539 ' HH ' ' H ' ' A' ' 66' ' ' THR . 7.6 p90 -171.76 171.43 5.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.694 177.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.1 tp -130.37 127.97 40.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.165 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.515 ' HG3' HE21 ' A' ' 125' ' ' GLN . 8.0 tp10 -124.19 128.35 49.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.55 129.09 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.444 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.515 HE21 ' HG3' ' A' ' 123' ' ' GLU . 10.0 mp0 -109.97 130.59 55.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.494 ' CD1' HG23 ' A' ' 56' ' ' ILE . 24.2 p90 -153.37 173.08 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 -178.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 57' ' ' MET . 76.9 m-20 -128.57 163.05 25.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.333 178.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.411 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -109.82 120.43 42.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.574 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.67 152.15 74.35 Favored Pre-proline 0 N--CA 1.463 0.184 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 C-N-CA 121.555 1.503 . . . . 0.0 112.034 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.32 138.31 29.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.495 0.664 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -135.62 141.56 45.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.86 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -137.92 137.09 37.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.129 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -137.79 140.5 40.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.491 . . . . 0.0 110.446 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.71 136.72 55.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -178.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.664 ' CD ' ' HH ' ' A' ' 63' ' ' TYR . 86.2 tt0 -47.85 137.9 9.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.003 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.3 56.96 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.823 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -105.71 150.71 39.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.904 0.852 . . . . 0.0 110.241 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.26 149.73 46.03 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.593 2.195 . . . . 0.0 112.761 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -118.4 147.73 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.612 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 84.0 tt0 -129.39 126.51 39.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.118 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -113.84 148.08 37.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.042 178.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.612 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 95.4 mtt180 -153.8 129.63 10.15 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.67 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.3 m -96.23 147.25 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.871 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.0 Cg_endo -70.07 156.64 62.06 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.07 1.847 . . . . 0.0 111.669 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.7 -139.28 17.45 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.845 0.691 . . . . 0.0 113.099 177.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.4 p -96.25 21.25 9.2 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.237 -0.981 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.54 165.07 24.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.732 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.32 147.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.755 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.476 HG12 ' SG ' ' A' ' 50' ' ' CYS . 62.0 mt -69.92 137.41 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.847 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.6 ptp -130.82 100.11 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.63 123.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.362 -178.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.513 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 93.6 mt-10 -102.08 -51.75 3.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.816 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -150.02 146.37 26.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.232 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.08 155.74 12.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.353 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.506 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.8 t30 -149.91 144.33 25.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.664 ' HH ' ' CD ' ' A' ' 42' ' ' GLU . 78.3 t80 -116.65 121.62 42.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.68 -141.09 7.23 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 16.0 ttm180 -146.57 116.91 7.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.23 0.538 . . . . 0.0 110.805 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.623 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 22.1 p -125.26 2.51 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.644 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 61.2 t0 -144.76 150.21 36.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.795 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 54.6 p30 -110.12 5.46 22.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 58.8 mttm -100.33 -0.46 38.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.416 -178.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.38 136.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.516 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.1 m 59.23 64.0 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -54.33 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.066 -178.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.25 -160.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.79 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.694 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -60.01 134.96 90.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.885 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.91 -34.32 75.7 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.127 1.885 . . . . 0.0 112.81 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.14 -36.8 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.679 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.2 mt-30 -86.72 -10.72 53.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.491 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.498 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 81.7 mtp -102.03 -3.67 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.71 -44.86 88.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.109 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 51.9 t30 -81.28 118.65 22.8 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.06 29.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -139.49 81.76 1.85 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.175 178.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 2.2 t -142.81 118.8 10.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 62' ' ' ASN . 71.9 m-85 -130.96 156.44 45.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.808 -178.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -145.17 88.72 6.66 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.241 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.4 -45.11 19.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.247 1.964 . . . . 0.0 112.822 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 89.8 m-20 -57.45 -16.66 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.21 72.56 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' OG ' ' A' ' 93' ' ' SER . 47.9 t80 -65.28 -45.56 83.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.83 -37.87 89.08 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.561 -178.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG21 ' NH1' ' A' ' 95' ' ' ARG . 91.1 mt -58.95 -52.74 56.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.817 0.341 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.8 mmm -67.26 -33.42 75.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.179 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.583 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.8 m -59.93 -49.73 76.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -66.95 -39.02 87.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 112.069 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' HG21 ' A' ' 91' ' ' ILE . 65.9 mtt85 -77.05 -32.43 56.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.51 -15.58 12.55 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.583 ' CG ' ' O ' ' A' ' 93' ' ' SER . 58.2 m-20 -61.32 133.77 56.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.034 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 70.36 14.74 7.45 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -111.44 143.95 41.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.07 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.0 m -68.67 -28.28 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.09 158.3 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.064 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.9 t -152.81 139.06 18.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.465 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.09 126.63 64.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.038 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.3 t -143.49 141.57 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.036 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 107' ' ' GLY . 64.7 t -76.73 115.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.957 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.66 35.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.091 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -177.44 -127.7 1.08 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.51 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.635 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 1.4 t 32.29 -159.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.017 0.437 . . . . 0.0 111.02 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.635 ' H ' ' HG ' ' A' ' 108' ' ' SER . 92.3 m-20 -66.43 1.94 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.54 -13.0 55.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.688 -179.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 44.4 m-85 -144.6 133.07 10.9 Favored Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.984 179.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.3 Cg_exo -56.05 -145.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.6 1.533 . . . . 0.0 111.471 178.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -145.25 90.55 6.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.93 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.414 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 95.7 Cg_endo -81.16 -4.09 12.42 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.297 2.664 . . . . 0.0 114.25 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.448 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -167.68 66.36 0.78 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -52.74 147.7 30.7 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.71 2.273 . . . . 0.0 111.588 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.16 -6.76 74.31 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 119' ' ' TYR . 87.2 m -118.88 148.08 43.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 45.8 t80 -85.72 120.74 27.48 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.5 mttm -96.86 -157.51 0.6 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -176.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.623 ' HH ' ' H ' ' A' ' 66' ' ' THR . 7.1 p90 -174.6 177.27 2.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.498 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.88 122.29 24.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.82 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -116.49 127.89 54.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -136.82 127.37 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.008 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -114.6 132.28 56.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 56' ' ' ILE . 31.8 p90 -155.01 169.98 22.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.219 0.533 . . . . 0.0 112.427 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 79.6 m-20 -120.91 160.45 23.45 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.4 m -112.05 118.33 35.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.694 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.79 159.35 61.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.774 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.497 1.734 0 C-N-CA 122.121 1.881 . . . . 0.0 112.331 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 mt 55.95 72.22 1.06 Allowed Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -47.84 155.68 1.56 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 123.123 2.549 . . . . 0.0 112.85 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -80.37 -20.12 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.83 13.1 82.74 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -157.82 65.41 0.47 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.972 0.415 . . . . 0.0 110.411 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 34' ' ' LEU . 13.9 mtt 54.87 150.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -90.76 149.0 22.19 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -150.58 137.11 18.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.944 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -129.8 144.7 51.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.991 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.01 141.91 38.3 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.467 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -142.77 142.67 31.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.399 0.619 . . . . 0.0 111.49 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.6 m -66.78 135.17 53.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.133 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HG3' ' OH ' ' A' ' 63' ' ' TYR . 77.3 tt0 -47.61 134.93 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.509 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.61 -16.67 60.63 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.452 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 13.4 m-85 -107.47 155.86 38.83 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 118.272 1.036 . . . . 0.0 108.831 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.23 154.47 28.65 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.512 1.475 . . . . 0.0 112.188 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 tt -116.44 150.68 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.035 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 33.0 tt0 -126.93 130.89 50.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.0 mt -122.07 136.1 54.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.692 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.55 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 87.0 mtt180 -146.43 134.7 21.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.0 110.705 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.422 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.1 m -103.63 145.53 30.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.092 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -70.23 155.74 63.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.988 1.792 . . . . 0.0 112.51 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.21 -131.69 24.88 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.63 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.9 p -102.86 22.32 14.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.497 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.95 165.07 24.53 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.58 145.67 32.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.837 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.422 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 97.9 mt -67.89 135.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.6 ptm -131.65 98.04 4.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 93' ' ' SER . 22.8 t -61.73 122.44 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.591 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -99.33 -51.66 3.74 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -151.24 150.01 30.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.97 154.21 7.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.098 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' A' ' 84' ' ' TYR . 2.5 t30 -148.75 146.19 27.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' OH ' ' HG3' ' A' ' 42' ' ' GLU . 49.3 t80 -114.49 118.08 32.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.34 -139.3 5.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.949 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.694 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 11.5 ttm-85 -151.36 119.69 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.123 0.487 . . . . 0.0 111.475 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.764 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 8.3 p -126.86 4.78 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.116 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 51.7 t0 -146.99 153.28 39.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.777 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 24.8 p-10 -110.31 4.87 21.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.956 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -103.98 4.07 34.16 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.138 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.7 mm -110.23 133.84 54.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m 57.14 70.12 0.68 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.138 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -54.01 120.43 6.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.572 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.44 -161.88 1.25 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.782 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.662 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.4 p-10 -61.96 137.21 95.4 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.801 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.535 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 7.0 Cg_endo -55.38 -36.2 93.38 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.351 2.034 . . . . 0.0 113.327 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.55 -33.4 74.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 0.0 110.753 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.481 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 25.0 mt-30 -85.08 -18.87 32.97 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.293 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 68.6 mtp -97.87 -0.4 45.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 56.9 mt-10 -64.68 -46.65 81.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -78.49 112.99 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.12 30.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.163 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -142.04 84.37 1.88 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.082 0.468 . . . . 0.0 111.92 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.461 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 44.1 t -145.24 119.94 9.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' HA ' HD22 ' A' ' 62' ' ' ASN . 93.0 m-85 -127.16 155.15 43.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 111.077 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 58.3 tp -146.28 90.0 5.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.779 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.1 -47.38 24.08 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.523 2.149 . . . . 0.0 113.457 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.0 -22.4 15.17 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.24 -0.287 . . . . 0.0 111.701 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 85' ' ' LEU . . . -52.59 -33.94 48.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.72 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.96 -45.44 85.7 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 12.0 ptmt -64.43 -38.77 92.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.922 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 70.2 mt -60.34 -48.93 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.905 0.383 . . . . 0.0 111.666 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.0 mmm -70.39 -37.74 74.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.501 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.4 m -60.42 -46.99 88.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -64.79 -36.39 84.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 111.231 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.566 HH11 ' CG1' ' A' ' 104' ' ' VAL . 99.5 mtt180 -78.47 -32.7 48.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.8 m -112.22 -15.01 13.28 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 93' ' ' SER . 61.7 m-20 -59.84 133.05 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.043 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 67.7 14.28 9.46 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.118 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -115.95 147.21 41.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.272 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.7 m -72.28 -33.51 67.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 151.48 33.83 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.34 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -152.75 147.27 25.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.791 0.329 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.8 t -128.45 129.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.02 0.438 . . . . 0.0 110.032 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.566 ' CG1' HH11 ' A' ' 95' ' ' ARG . 46.3 t -135.65 148.75 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 ' C ' ' H ' ' A' ' 107' ' ' GLY . 59.6 t -82.56 115.33 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.93 39.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.96 -127.31 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.98 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.469 0.652 . . . . 0.0 112.033 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -66.56 1.09 1.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.557 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.34 -11.64 55.98 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.647 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.4 m-85 -143.74 128.31 9.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.672 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 38.1 Cg_exo -50.64 -149.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.148 1.898 . . . . 0.0 111.125 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.37 97.11 5.19 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.461 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 61.6 Cg_endo -88.35 -10.49 4.66 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.592 2.195 . . . . 0.0 112.325 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.441 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.5 p -166.58 90.29 0.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.635 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -76.55 155.61 35.94 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.355 2.037 . . . . 0.0 111.912 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.22 89.62 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.489 HG22 ' N ' ' A' ' 119' ' ' TYR . 89.0 m -126.49 147.66 49.79 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 t80 -79.25 108.73 12.98 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.441 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 30.9 mtmm -87.61 -167.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.388 1.09 . . . . 0.0 113.093 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.764 ' HH ' ' H ' ' A' ' 66' ' ' THR . 3.8 p90 -171.6 174.64 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.044 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -133.01 125.2 29.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.219 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HG2' HE21 ' A' ' 125' ' ' GLN . 65.4 tt0 -119.34 125.61 49.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.73 123.94 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.685 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.427 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.2 mt-30 -107.57 130.23 54.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -155.9 164.42 38.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.555 0.693 . . . . 0.0 112.259 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -119.16 156.27 30.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.228 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.9 m -107.78 120.98 43.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 129' ' ' VAL . 2.5 m -121.63 152.87 59.21 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -55.58 145.21 70.97 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.258 1.972 . . . . 0.0 112.128 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.441 ' CD2' ' NZ ' ' A' ' 132' ' ' LYS . 40.4 t80 -73.32 -4.65 34.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.135 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.441 ' NZ ' ' CD2' ' A' ' 131' ' ' TYR . 31.5 mttm -149.4 -92.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.288 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.45 124.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.868 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.535 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.92 162.47 34.93 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 121.185 0.517 . . . . 0.0 111.145 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.72 -91.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.224 2.616 . . . . 0.0 112.49 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -79.02 -15.38 58.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.686 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.98 -48.99 0.11 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.215 -0.448 . . . . 0.0 113.208 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -160.67 119.53 2.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.112 0.456 . . . . 0.0 110.427 -178.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' LEU . 28.2 mtt 60.04 136.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.063 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.77 151.35 22.45 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.4 ttp180 -147.05 131.38 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.725 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' O ' ' OE2' ' A' ' 123' ' ' GLU . 72.1 mm-40 -128.16 143.85 51.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.98 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.459 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -138.57 136.61 36.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -134.16 140.1 46.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.113 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.9 m -65.3 138.18 58.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -45.56 129.84 8.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.598 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.04 -12.37 67.03 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.856 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -109.19 149.27 39.49 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 118.841 1.321 . . . . 0.0 110.19 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.75 150.82 87.54 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.852 1.701 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -121.33 141.91 39.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.638 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 74.4 tt0 -130.16 130.29 44.54 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.664 -0.814 . . . . 0.0 112.519 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 43.9 mt -116.24 139.35 50.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.048 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.638 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 48.2 mtt180 -145.75 135.22 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.442 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.436 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.4 m -100.59 146.59 32.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -70.0 160.37 49.89 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.764 2.309 . . . . 0.0 112.489 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.26 -120.98 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.738 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -120.94 25.29 9.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.31 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -76.18 169.91 17.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.0 110.02 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.26 145.24 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.436 HG12 ' SG ' ' A' ' 50' ' ' CYS . 77.9 mt -68.4 137.15 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.603 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.1 ptm -130.85 99.67 5.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.561 0.696 . . . . 0.0 109.257 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 89' ' ' PHE . 24.1 t -63.21 123.25 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 80.5 mm-40 -100.31 -51.67 3.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 58.6 m-20 -151.72 148.98 28.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.056 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.33 153.97 8.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.862 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 84' ' ' TYR . 29.6 t30 -147.88 148.05 30.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.457 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -114.21 114.98 26.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.27 -142.22 7.57 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.38 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -150.84 119.2 6.39 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.317 0.58 . . . . 0.0 111.568 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.51 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 59.9 p -125.95 6.97 7.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.811 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.646 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 35.0 t0 -140.44 -174.75 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.128 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 22.4 p30 -144.96 -1.06 0.87 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -101.59 3.88 40.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.408 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.502 HG23 HD11 ' A' ' 70' ' ' ILE . 30.5 mm -112.76 135.35 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.981 0.42 . . . . 0.0 110.309 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 70' ' ' ILE . 67.1 m 60.46 64.24 1.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.256 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.592 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 42.5 p30 -50.02 96.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.539 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.52 -163.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.683 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -60.68 139.1 93.15 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.639 178.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.62 -38.01 96.43 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.433 2.089 . . . . 0.0 113.326 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -62.19 -33.32 74.31 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.71 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.8 mt-30 -85.01 -6.36 59.33 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.415 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 83.9 mtp -109.95 -3.02 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 82.2 mt-10 -64.79 -46.15 83.3 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.97 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -79.68 112.88 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.072 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.432 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 35.8 m -107.3 31.38 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.6 mm-40 -138.24 84.53 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.86 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.0 t -146.1 125.84 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.563 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.48 ' CE2' HG23 ' A' ' 66' ' ' THR . 59.0 m-85 -134.04 154.71 50.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.4 tp -146.91 93.67 4.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.346 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.61 -48.4 22.17 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.497 2.798 . . . . 0.0 114.576 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -57.81 -19.92 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.88 -32.03 63.34 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.567 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.3 t80 -63.72 -43.81 95.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.714 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.21 -39.61 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.48 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 65.2 mt -58.08 -51.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.548 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 40.0 mtp -70.46 -33.22 71.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.528 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.567 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 20.1 m -58.39 -47.17 84.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.83 -34.67 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.501 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.476 ' NE ' HG21 ' A' ' 104' ' ' VAL . 17.7 mtp180 -80.54 -32.4 36.75 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 59.2 m -111.74 -20.16 12.19 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.479 ' CG ' ' O ' ' A' ' 93' ' ' SER . 42.6 m-20 -56.16 135.19 53.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.845 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 64.44 13.84 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.972 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -112.95 144.3 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.604 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -33.21 73.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.099 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 158.71 42.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.043 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.2 p -155.38 135.0 12.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.138 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 129.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.476 HG21 ' NE ' ' A' ' 95' ' ' ARG . 59.2 t -143.41 145.72 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.769 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.466 ' N ' HG13 ' A' ' 104' ' ' VAL . 50.2 t -79.05 116.4 22.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.58 41.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.67 -116.82 0.53 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.659 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 28.56 -160.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.14 0.495 . . . . 0.0 111.737 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.659 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-20 -69.47 2.09 3.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.968 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.05 -13.75 49.45 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.383 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.574 ' O ' ' O ' ' A' ' 112' ' ' PRO . 72.8 m-85 -141.09 126.62 11.1 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.7 Cg_exo -51.41 -150.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.224 1.949 . . . . 0.0 111.575 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 20.1 t0 -144.9 90.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.77 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.55 -8.68 13.65 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.093 2.528 . . . . 0.0 113.236 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -172.22 80.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.437 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.32 159.02 55.39 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.149 1.899 . . . . 0.0 111.505 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.1 -4.71 86.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 119' ' ' TYR . 63.2 m -125.36 147.87 48.98 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.48 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 45.3 t80 -85.81 118.7 25.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 13.0 mttt -95.17 -156.91 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.0 p90 -174.86 176.5 2.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.556 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.548 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 34.3 tp -133.69 126.79 31.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.816 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.67 ' CD ' ' N ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -120.74 130.72 54.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 11.8 t -133.28 123.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -107.04 125.72 51.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -154.65 170.08 22.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.302 0.572 . . . . 0.0 112.223 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -127.0 161.57 28.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.941 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.8 115.86 29.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.115 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.431 HG13 ' SD ' ' A' ' 57' ' ' MET . 17.2 m -117.78 158.93 44.36 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.42 146.79 96.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.181 1.92 . . . . 0.0 112.055 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -79.35 134.68 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -95.8 136.07 36.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.9 p -103.44 127.49 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.695 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.012 179.877 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.2 mt -121.16 78.42 33.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.859 0.362 . . . . 0.0 110.599 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' LEU . 52.7 Cg_exo -52.86 -162.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.694 2.263 . . . . 0.0 111.508 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.83 -13.2 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.889 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.97 70.44 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.462 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.648 ' O ' ' O ' ' A' ' 35' ' ' MET . 25.9 tp -154.36 99.28 2.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.718 0.259 . . . . 0.0 110.449 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.648 ' O ' ' O ' ' A' ' 34' ' ' LEU . 7.3 mtt 49.95 132.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.28 0.562 . . . . 0.0 111.067 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.609 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt-85 -92.96 143.66 26.02 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -151.74 138.68 19.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.343 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -133.78 146.77 51.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.36 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -134.88 132.11 38.15 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -129.67 139.96 51.25 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.546 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.1 137.16 53.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.597 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 87.2 tt0 -48.06 133.37 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.028 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.8 -17.96 58.0 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.94 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -111.72 148.18 38.36 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 118.283 1.041 . . . . 0.0 110.308 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.76 151.71 82.42 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.489 2.126 . . . . 0.0 113.36 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.9 tt -119.07 147.01 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -136.0 125.38 24.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -110.9 145.93 37.43 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -148.47 136.56 21.03 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.9 m -104.41 143.99 27.8 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.23 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 56.6 Cg_endo -71.71 161.19 45.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.361 2.041 . . . . 0.0 112.13 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.34 -132.2 34.23 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.449 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.8 p -107.92 23.36 14.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.351 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -78.58 167.89 20.59 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -130.73 145.21 35.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.82 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 82.7 mt -68.66 139.78 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.068 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.3 ptm -131.98 99.53 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.834 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.05 124.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.361 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -101.98 -48.53 4.22 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -151.41 147.52 26.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.06 155.58 11.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.0 t30 -151.81 145.65 25.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -116.73 118.04 31.46 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.49 -138.04 5.16 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.55 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 12.3 ttm-85 -152.4 118.94 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.232 0.539 . . . . 0.0 111.717 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.459 HG23 ' CE2' ' A' ' 84' ' ' TYR . 29.1 p -121.99 8.4 9.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.012 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.582 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 27.6 t0 -143.54 -164.23 1.82 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.059 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.582 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 47.2 p30 -149.16 -1.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.237 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -102.88 4.49 37.7 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' ' 71' ' ' CYS . 14.3 mm -106.64 135.28 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 70' ' ' ILE . 47.7 m 59.44 66.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.481 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.3 p30 -47.8 108.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.95 -162.99 1.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.015 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.6 p-10 -63.44 138.31 97.32 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.8 Cg_endo -58.81 -32.45 97.16 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.212 1.941 . . . . 0.0 112.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -60.79 -37.82 83.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.654 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.472 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 24.5 mt-30 -86.21 -10.88 53.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.334 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -108.84 0.52 20.34 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.128 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 75.5 mt-10 -64.78 -43.92 91.65 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.365 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.2 t30 -78.78 114.28 17.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -106.1 32.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.4 mm-40 -140.68 86.51 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.75 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.51 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 32.8 t -147.7 120.88 8.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.459 ' CE2' HG23 ' A' ' 66' ' ' THR . 89.2 m-85 -132.51 152.71 51.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.883 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 tp -144.13 93.42 6.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.027 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.48 -49.05 16.69 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.558 2.838 . . . . 0.0 113.829 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -57.37 -24.58 56.17 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.24 -31.52 21.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -66.63 -45.8 77.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.89 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 ptmt -64.38 -39.24 93.47 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.675 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 94.4 mt -60.18 -52.91 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.3 mmm -70.12 -35.24 73.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 111.526 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.4 m -59.95 -47.33 86.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -66.87 -36.75 83.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.421 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.643 ' HE ' ' CG2' ' A' ' 104' ' ' VAL . 72.9 mtp85 -77.23 -32.68 55.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 23.7 m -112.69 -17.24 12.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -57.17 136.22 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.297 0.57 . . . . 0.0 111.964 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 64.76 12.98 8.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.653 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 67.2 mtt-85 -112.32 144.93 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.228 0.537 . . . . 0.0 110.307 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 m -70.31 -33.76 71.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.38 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 154.29 37.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.88 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.0 p -155.01 139.03 16.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.859 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 48.5 t -122.46 135.82 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.643 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 33.4 t -143.04 152.99 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.98 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.432 ' N ' HG11 ' A' ' 104' ' ' VAL . 70.6 t -84.05 115.74 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.03 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.32 36.64 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -176.62 -118.23 0.53 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.646 ' O ' ' O ' ' A' ' 107' ' ' GLY . 46.5 t 27.0 -158.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.424 0.631 . . . . 0.0 112.02 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.612 ' H ' ' HG ' ' A' ' 108' ' ' SER . 89.1 m-20 -69.27 1.09 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.08 -11.2 58.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.671 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.1 m-85 -144.94 133.69 11.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.805 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.1 Cg_exo -53.2 -147.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.04 1.826 . . . . 0.0 110.559 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.576 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 11.0 t0 -144.38 91.24 6.37 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.0 110.255 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.42 ' HD2' ' CE ' ' A' ' 120' ' ' LYS . 62.4 Cg_endo -80.94 -11.7 12.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.124 2.549 . . . . 0.0 113.734 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.507 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -165.27 76.58 1.35 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 121.538 0.685 . . . . 0.0 111.531 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.84 153.25 38.18 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.753 2.302 . . . . 0.0 112.619 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.19 8.09 53.41 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.049 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.478 HG21 ' N ' ' A' ' 119' ' ' TYR . 30.8 m -119.3 148.88 42.66 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 6.5 t80 -83.31 108.88 16.82 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.576 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 28.1 mttt -89.56 -163.06 0.94 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.754 1.264 . . . . 0.0 112.833 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.455 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -173.54 175.52 2.98 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.007 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 tp -133.4 125.75 29.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -123.62 128.64 49.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.0 t -133.27 126.94 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -108.17 128.58 54.83 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -155.6 175.32 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.236 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -131.85 161.16 33.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.272 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.609 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 88.4 m -108.38 122.53 47.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.183 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.451 HG21 ' SD ' ' A' ' 57' ' ' MET . 3.5 m -120.93 155.84 57.2 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.519 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.21 143.99 95.02 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.33 2.02 . . . . 0.0 111.904 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -82.13 153.84 25.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.583 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.52 114.01 26.12 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.008 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.67 129.97 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.812 0.339 . . . . 0.0 110.69 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.026 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -39.15 -52.58 4.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.863 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 32.3 Cg_exo -52.32 -178.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.012 1.808 . . . . 0.0 111.075 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.03 -61.37 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.397 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 34' ' ' LEU . . . 76.61 43.64 18.35 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -158.19 -10.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.9 0.381 . . . . 0.0 110.372 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' LEU . 6.6 mtt 58.81 140.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.874 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -90.57 150.28 21.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.925 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 28.3 ttm180 -147.21 134.51 20.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.0 111.673 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 40.5 mp0 -131.35 144.11 50.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.751 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.75 141.28 38.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.31 141.63 33.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -66.36 135.32 54.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.66 138.95 7.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.294 0.569 . . . . 0.0 112.032 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 -16.64 60.59 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.961 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -109.32 150.34 40.96 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 117.741 0.77 . . . . 0.0 110.117 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.97 151.18 67.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.884 2.39 . . . . 0.0 113.264 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -123.98 142.0 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.608 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 65.9 tt0 -128.02 130.36 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 111.82 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 101' ' ' GLN . 64.7 mt -111.21 145.99 37.72 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.095 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.608 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 96.6 mtt180 -149.43 128.23 12.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.431 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.7 m -101.01 144.43 28.54 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.05 158.08 50.01 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.424 2.083 . . . . 0.0 112.543 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.73 -139.18 36.41 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.428 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 p -99.57 23.87 8.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.405 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -81.29 165.16 21.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.243 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.8 m -129.95 146.55 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 110.584 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.431 HG12 ' SG ' ' A' ' 50' ' ' CYS . 81.2 mt -68.25 136.59 26.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.753 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.472 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -130.8 99.39 4.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.01 123.06 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.512 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.502 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.8 mm-40 -103.39 -46.94 4.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.184 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 24.7 m-20 -147.16 144.48 29.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.78 149.99 11.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.743 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' A' ' 84' ' ' TYR . 29.7 t30 -148.07 147.45 29.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.167 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -118.64 120.02 36.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -138.68 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.997 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -154.79 116.29 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.661 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.437 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 14.9 p -122.43 9.65 9.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.923 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.617 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.0 t0 -147.59 -173.52 4.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.61 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.2 p30 -145.78 1.99 0.91 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.051 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.67 5.01 41.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.323 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 70' ' ' ILE . 28.2 mm -115.42 137.84 47.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.74 0.305 . . . . 0.0 110.523 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 30.9 m 52.88 75.91 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -56.41 122.19 11.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.484 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.84 -167.55 2.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.552 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -61.4 134.15 93.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.7 Cg_endo -53.1 -33.57 64.21 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.789 1.66 . . . . 0.0 113.506 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -63.65 -34.91 78.9 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.039 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.682 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 72.9 mt-30 -83.35 -14.88 51.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.548 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 mtp -99.54 -0.61 40.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.3 mt-10 -62.05 -52.13 65.19 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 39.2 t30 -81.72 115.98 21.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.03 35.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.559 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.43 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 2.4 mm100 -139.52 85.8 2.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.0 t -148.56 118.56 7.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' HA ' HD22 ' A' ' 62' ' ' ASN . 69.7 m-85 -130.02 154.24 47.61 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.814 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.4 tp -146.28 85.69 7.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.388 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -47.09 -47.69 16.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.902 2.402 . . . . 0.0 113.614 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -56.79 -22.76 38.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.35 62.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.972 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.556 ' O ' ' OG ' ' A' ' 93' ' ' SER . 11.6 t80 -64.1 -42.53 96.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.4 ptpt -66.09 -42.17 89.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.963 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 82.2 mt -58.39 -49.73 81.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.529 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.555 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 31.7 mtp -71.07 -33.19 70.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.745 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.556 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 49.6 m -59.14 -45.57 90.6 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.919 0.39 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -65.59 -37.4 86.54 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.078 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 93.6 mtt-85 -76.73 -35.3 57.89 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 59.4 m -109.28 -21.5 12.51 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CG ' ' O ' ' A' ' 93' ' ' SER . 75.9 m-20 -57.24 134.09 55.64 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.207 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 67.95 12.48 8.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.798 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 99' ' ' ARG . 51.3 mtt180 -113.47 146.44 39.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.215 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.7 m -73.45 -28.74 62.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.452 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -151.98 152.48 32.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.498 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.1 p -153.58 142.81 21.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.716 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.67 126.06 72.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.9 t -139.04 146.68 25.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.845 0.355 . . . . 0.0 111.374 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.9 t -78.78 113.67 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.95 42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.581 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -121.62 0.8 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.6 t 28.05 -157.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 111.892 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.38 1.22 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.175 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.87 -12.49 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.433 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 63.9 m-85 -144.58 128.14 8.75 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.979 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -50.45 -146.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.387 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 120' ' ' LYS . 31.7 t0 -142.88 84.62 10.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.01 -5.53 14.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.812 2.341 . . . . 0.0 113.424 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.484 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -164.68 71.6 1.53 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.544 0.688 . . . . 0.0 111.47 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.43 140.46 93.22 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.396 2.064 . . . . 0.0 110.594 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.77 71.51 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.951 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.5 HG21 ' N ' ' A' ' 119' ' ' TYR . 21.3 m -124.4 146.3 48.97 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.538 0.669 . . . . 0.0 110.331 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.5 ' N ' HG21 ' A' ' 118' ' ' THR . 26.0 t80 -81.64 116.23 21.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 24.3 mttt -89.82 -165.93 1.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.805 1.288 . . . . 0.0 114.037 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.539 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.2 p90 -167.68 169.49 11.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.17 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.555 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 65.8 tp -130.31 122.71 28.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.687 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 71.5 tt0 -117.94 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 HG23 ' SD ' ' A' ' 92' ' ' MET . 45.7 t -133.64 125.17 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.88 128.71 55.15 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.424 ' CD2' HG22 ' A' ' 56' ' ' ILE . 28.6 p90 -154.3 169.64 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.23 0.538 . . . . 0.0 111.735 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 76.9 m-20 -123.04 159.31 28.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.965 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.9 m -109.15 112.13 24.13 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 55' ' ' VAL . 4.2 m -121.02 158.68 51.92 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.51 146.22 53.94 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.9 1.733 . . . . 0.0 112.154 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -72.01 -30.32 65.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -97.33 140.9 31.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.62 132.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.838 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.22 75.56 77.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.609 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -50.89 146.08 22.41 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.136 1.891 . . . . 0.0 110.902 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 34' ' ' LEU . 97.3 m-85 -82.34 -9.57 59.41 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.05 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.11 -45.03 0.91 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -162.92 123.31 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.963 0.411 . . . . 0.0 111.017 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.9 mtm 64.33 149.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.499 0.666 . . . . 0.0 111.349 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.573 HH21 ' HG3' ' A' ' 51' ' ' PRO . 94.6 mtt-85 -91.75 150.75 20.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.261 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -145.15 132.91 21.07 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.495 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -124.4 145.33 49.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -137.26 141.03 41.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.79 139.86 36.52 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.471 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.03 135.73 55.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.911 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 82.0 tt0 -46.17 134.27 8.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.284 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 -11.89 68.29 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.267 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.8 m-85 -112.26 148.75 39.8 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 118.451 1.125 . . . . 0.0 109.828 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.91 150.26 73.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.288 1.992 . . . . 0.0 112.867 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.6 tt -116.34 147.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.42 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -125.2 127.94 47.57 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.036 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.23 138.29 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.059 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.569 HH12 ' CD ' ' A' ' 101' ' ' GLN . 65.5 mtp85 -148.2 135.46 20.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.021 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -100.34 144.14 27.88 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.573 ' HG3' HH21 ' A' ' 36' ' ' ARG . 61.2 Cg_endo -72.02 159.17 50.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.258 2.638 . . . . 0.0 112.55 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.79 -131.02 27.46 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.9 p -108.42 23.93 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.78 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.38 165.4 24.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.31 147.71 32.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.136 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.0 mt -69.92 136.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.104 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.7 ptp -134.44 106.06 6.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 HG12 ' CE1' ' A' ' 89' ' ' PHE . 36.4 t -64.44 124.5 19.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -102.96 -53.12 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.225 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -147.17 143.47 28.25 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.168 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.37 154.46 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.82 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -149.96 145.97 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.405 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -116.84 118.31 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.29 -133.64 3.34 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.7 ttm-85 -157.71 117.11 3.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.334 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.621 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 18.9 p -122.29 9.46 9.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 14.5 t70 -144.86 -168.99 3.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.5 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 8.0 p30 -148.41 -0.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.402 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -101.42 7.71 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.039 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.53 136.61 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.089 0.471 . . . . 0.0 111.07 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.8 m 51.96 78.95 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 59.1 p30 -55.77 125.04 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.72 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.99 -164.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.931 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.66 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -64.72 142.97 98.66 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 110.61 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.6 Cg_endo -60.96 -35.78 86.26 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 113.713 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.74 -36.16 82.11 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.455 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 22.3 mt-30 -86.34 -14.13 44.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.453 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 74.9 mtp -106.27 -2.54 22.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.001 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 4.6 mt-10 -65.58 -44.75 85.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.897 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -80.82 121.04 25.46 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -110.08 34.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.626 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -139.62 90.1 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.456 . . . . 0.0 110.886 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 25.5 t -152.62 119.2 5.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.584 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 13.6 m-85 -132.45 154.01 50.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.64 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -144.29 96.15 5.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.72 -44.08 46.94 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.558 2.172 . . . . 0.0 112.623 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.4 m-20 -58.08 -21.59 46.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.91 62.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.977 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.619 ' O ' ' OG ' ' A' ' 93' ' ' SER . 57.1 t80 -63.96 -46.43 84.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.1 pttp -66.64 -39.74 88.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.351 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.63 -46.5 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.203 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.31 -37.74 77.93 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.789 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.5 m -59.88 -48.43 81.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -65.72 -37.45 86.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.015 0.435 . . . . 0.0 111.213 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -76.94 -33.52 57.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.8 m -113.88 -16.44 12.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -57.81 137.89 56.17 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.693 -0.629 . . . . 0.0 111.974 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 49.9 m-20 69.5 14.39 8.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -117.2 149.3 40.63 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.401 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -72.17 -31.37 65.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.526 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.569 ' CD ' HH12 ' A' ' 49' ' ' ARG . 0.1 OUTLIER -142.88 156.99 45.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.318 178.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 39.7 t -152.93 135.8 15.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 111.747 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.9 132.32 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.054 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.5 146.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.735 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 107' ' ' GLY . 46.5 t -79.43 117.13 24.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.834 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.37 35.49 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.287 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.14 -121.01 0.69 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.5 t 33.42 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.242 0.544 . . . . 0.0 110.905 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.07 4.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.035 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -87.66 -7.58 57.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.374 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' O ' ' A' ' 112' ' ' PRO . 35.4 m-85 -147.76 132.82 9.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.95 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.9 Cg_exo -51.79 -148.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.702 1.601 . . . . 0.0 110.639 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.684 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 46.4 t0 -146.83 92.15 5.09 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.1 Cg_endo -79.37 -4.65 13.83 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.979 2.453 . . . . 0.0 113.241 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.477 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -167.91 67.99 0.82 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.672 0.749 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -52.26 149.81 21.46 Favored 'Trans proline' 0 C--N 1.292 -2.426 0 C-N-CA 122.487 2.124 . . . . 0.0 110.867 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.0 -4.36 76.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.871 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.473 HG21 ' N ' ' A' ' 119' ' ' TYR . 54.5 m -116.97 149.59 39.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.406 0.603 . . . . 0.0 110.602 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.53 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.7 t80 -83.94 112.42 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.684 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 19.0 mttt -92.22 -161.5 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.653 1.215 . . . . 0.0 114.169 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.621 ' HH ' ' H ' ' A' ' 66' ' ' THR . 8.3 p90 -174.91 175.98 2.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.754 -2.021 . . . . 0.0 111.046 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.2 tp -132.57 123.45 26.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.348 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HG2' HE21 ' A' ' 125' ' ' GLN . 84.8 tt0 -115.94 124.03 49.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.5 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.555 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.519 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.4 mp0 -113.5 128.6 56.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.451 ' CD2' HG23 ' A' ' 56' ' ' ILE . 47.8 p90 -146.23 162.2 38.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.128 0.489 . . . . 0.0 111.295 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -113.4 157.14 22.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.214 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.0 m -113.3 108.38 17.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.364 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.28 161.07 33.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.94 150.97 60.46 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.532 1.488 . . . . 0.0 111.517 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.657 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 24.2 t80 -76.19 9.21 2.67 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.318 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.76 -133.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.62 135.11 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 0.0 111.444 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.085 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -127.8 80.42 72.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 30' ' ' LEU . 34.5 Cg_exo -51.99 -129.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 28.9 m-85 -147.44 37.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.091 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.29 -39.84 0.58 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.361 -0.382 . . . . 0.0 112.802 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' MET . 6.0 mt -154.63 83.4 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.872 0.336 . . . . 0.0 110.282 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.478 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 49.2 178.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.318 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.734 ' NH1' ' SG ' ' A' ' 128' ' ' CYS . 14.4 mmt85 -90.71 139.69 30.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.716 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.604 HH21 ' CD ' ' A' ' 123' ' ' GLU . 40.2 ttt180 -143.2 138.51 29.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.647 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.1 mp0 -135.67 139.89 44.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.123 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -137.78 136.48 37.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.914 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -137.61 142.47 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.564 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.6 140.79 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.518 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -47.67 129.52 13.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.85 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 -11.49 71.97 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.92 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -106.47 150.06 39.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.907 0.853 . . . . 0.0 109.883 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.09 152.62 45.89 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.195 1.93 . . . . 0.0 112.856 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -122.97 142.26 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.19 128.84 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.191 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.3 mt -113.05 144.9 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.726 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -150.52 135.2 17.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.846 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.464 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -102.74 149.65 36.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.316 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 47.9 Cg_endo -71.63 160.15 49.05 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.027 2.485 . . . . 0.0 113.403 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.18 -126.36 22.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.587 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.5 p -113.75 23.15 13.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.361 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.22 170.2 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.751 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.16 146.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.298 0.571 . . . . 0.0 110.544 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.464 HG12 ' SG ' ' A' ' 50' ' ' CYS . 81.6 mt -68.84 136.93 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.298 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.605 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.7 ptm -132.45 98.29 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.984 0.897 . . . . 0.0 108.946 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG11 ' CE1' ' A' ' 89' ' ' PHE . 5.9 t -64.5 124.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.519 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.8 mt-10 -103.86 -48.92 3.78 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 20.6 m-20 -146.6 144.3 29.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.15 151.97 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.054 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.56 151.52 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.571 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -118.72 114.92 23.46 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.35 -139.56 5.92 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.091 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.696 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -153.57 119.02 5.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.026 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.47 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 11.7 p -125.44 3.96 7.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.679 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 48.2 t0 -143.48 149.24 37.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.184 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -110.5 1.21 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -102.7 8.43 39.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 70' ' ' ILE . 33.1 mm -109.51 137.75 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.192 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.598 ' O ' ' C ' ' A' ' 72' ' ' ASP . 63.8 m 60.3 17.45 7.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' ' O ' ' A' ' 71' ' ' CYS . 42.1 m-20 3.44 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.976 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.36 -165.22 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -61.79 146.48 90.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.22 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 14.7 Cg_endo -58.31 -40.74 73.03 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.41 2.073 . . . . 0.0 112.856 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.81 -37.81 88.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.581 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 23.4 mt-30 -83.95 -7.57 59.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -104.19 -1.48 27.13 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.98 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 91.6 mt-10 -63.31 -51.17 67.14 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -76.79 110.67 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.861 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.569 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 27.2 m -103.5 27.23 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.7 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.569 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 14.1 mm100 -140.46 87.85 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.89 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.7 t -144.74 120.95 10.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.46 ' CZ ' HG23 ' A' ' 66' ' ' THR . 81.7 m-85 -133.31 157.07 46.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.336 0.589 . . . . 0.0 112.221 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -147.07 87.13 6.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.501 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -47.65 -47.98 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.56 2.174 . . . . 0.0 112.865 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -56.69 -18.4 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.1 -35.2 66.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.816 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.444 ' CE1' HG11 ' A' ' 58' ' ' VAL . 81.3 t80 -65.14 -44.65 87.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.732 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.3 pttp -64.33 -42.89 96.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.782 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.513 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 68.7 mt -59.17 -44.5 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.558 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 97.2 mmm -70.49 -40.28 73.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.227 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.7 m -56.63 -43.21 80.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.368 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.53 -41.51 88.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.645 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.558 ' NH2' ' SD ' ' A' ' 92' ' ' MET . 46.1 mtm180 -73.85 -33.53 64.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.5 m -111.55 -15.09 13.58 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 38.6 m-20 -61.65 133.7 55.92 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.159 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 66.02 14.46 9.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -116.0 148.52 40.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.595 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -70.04 -31.78 69.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.82 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.03 157.08 41.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.092 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.7 p -153.64 140.94 19.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -120.95 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.299 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 105' ' ' VAL . 98.0 t -140.65 147.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.212 0.529 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 107' ' ' GLY . 62.1 t -81.86 115.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.052 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.77 38.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.842 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.6 -120.69 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.692 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.591 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.4 t 27.16 -155.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.857 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.25 -0.57 8.22 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.621 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.98 58.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.187 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -143.22 129.91 10.55 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -54.4 -146.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.662 1.575 . . . . 0.0 111.231 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.62 90.03 7.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.047 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.34 -6.12 12.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.807 2.338 . . . . 0.0 113.545 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.529 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -167.53 71.63 0.95 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.707 0.765 . . . . 0.0 112.192 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.05 141.54 56.99 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.243 2.629 . . . . 0.0 111.989 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.33 -3.29 86.67 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.621 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 119' ' ' TYR . 71.2 m -118.2 148.69 42.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.778 0.789 . . . . 0.0 110.325 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.1 t80 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.529 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.0 mttp -93.48 -160.32 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.459 1.123 . . . . 0.0 113.655 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.0 p90 -176.34 178.21 1.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.627 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 24.0 tp -133.7 127.52 33.05 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.787 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.604 ' CD ' HH21 ' A' ' 37' ' ' ARG . 77.0 tt0 -119.65 129.47 54.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.26 122.93 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.86 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -109.2 128.15 54.81 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' MET . 26.8 p90 -156.07 170.9 21.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.767 -0.773 . . . . 0.0 112.023 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.41 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 95.2 m-20 -126.52 159.09 34.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.734 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 78.5 m -109.8 118.82 37.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.259 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.36 157.77 48.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.93 144.62 99.44 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.045 1.83 . . . . 0.0 112.227 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -76.65 159.97 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.844 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 133' ' ' VAL . 14.5 ttmm -86.86 164.53 16.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.061 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.429 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 8.0 t -83.52 133.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.125 0.488 . . . . 0.0 111.405 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.222 -0.369 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.371 179.655 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.584 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.65 88.49 53.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -52.61 146.01 35.99 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.758 2.306 . . . . 0.0 112.375 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.655 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 44.9 t80 -84.36 5.55 26.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.044 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.98 3.31 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.32 64.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.563 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 0.1 OUTLIER 58.72 172.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.27 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.621 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 77.5 mtt85 -90.36 147.89 23.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.686 ' HE ' ' CD ' ' A' ' 123' ' ' GLU . 13.9 ttt180 -146.69 126.68 13.66 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.394 0.616 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.672 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 32.1 mp0 -126.13 143.35 51.16 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.024 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -139.2 145.04 38.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 39' ' ' LEU . . . -142.06 141.19 32.76 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.23 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.81 135.47 54.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.46 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.402 ' O ' ' OH ' ' A' ' 119' ' ' TYR . 81.5 tt0 -47.71 135.44 11.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 111.444 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.63 -15.77 62.16 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.985 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 7.0 m-85 -111.4 149.75 41.09 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 118.132 0.966 . . . . 0.0 110.79 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.25 151.28 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.652 2.235 . . . . 0.0 113.033 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 tt -120.65 140.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.222 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -121.09 128.45 52.6 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.005 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.479 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 24.4 mt -115.82 141.42 48.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -150.74 132.91 15.35 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.933 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.416 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -102.91 143.0 25.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.839 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.58 158.76 52.95 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.579 2.186 . . . . 0.0 112.913 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.84 -137.19 40.28 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.446 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.1 p -102.08 23.89 10.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.384 -0.408 . . . . 0.0 111.14 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 75.9 m-20 -81.06 165.77 21.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 m -128.2 147.0 32.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.547 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG12 ' SG ' ' A' ' 50' ' ' CYS . 77.8 mt -68.34 138.45 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.8 ptp -132.42 100.02 4.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 t -65.49 125.22 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.715 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.02 -48.79 3.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.626 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -152.08 150.27 29.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.4 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.6 157.97 10.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.892 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -150.73 143.17 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.83 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -112.36 114.53 27.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 163.16 -134.37 3.39 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.15 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.557 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 9.7 ttm180 -156.64 117.79 3.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.499 0.666 . . . . 0.0 110.727 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.602 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 15.9 p -126.22 6.35 7.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.892 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 49.0 t0 -145.31 151.72 38.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.214 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.671 ' O ' ' CE ' ' A' ' 78' ' ' MET . 54.5 p30 -110.78 3.7 19.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.956 0.408 . . . . 0.0 109.943 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -102.72 1.75 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.985 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -110.93 135.12 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.837 0.351 . . . . 0.0 110.199 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m 58.81 65.26 1.26 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.904 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -48.61 99.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.524 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -111.03 -166.93 1.12 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.272 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.84 144.97 97.96 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.419 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.86 -41.99 60.08 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.461 2.107 . . . . 0.0 112.792 -178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.85 -35.93 81.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.988 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.472 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 22.8 mt-30 -87.01 -6.86 58.61 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.671 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 85.1 mtp -104.68 -6.09 20.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.63 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.4 mt-10 -65.16 -47.0 78.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.216 -0.593 . . . . 0.0 112.095 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.88 117.71 19.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.8 m -109.15 32.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.837 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -143.18 88.53 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.468 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.8 t -145.84 122.18 10.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' CZ ' HG21 ' A' ' 66' ' ' THR . 59.0 m-85 -135.09 152.74 51.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.319 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 tp -145.58 88.66 6.49 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.871 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.56 -49.83 12.59 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 123.042 2.494 . . . . 0.0 113.367 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 46.5 m-20 -55.01 -19.2 6.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.55 0.214 . . . . 0.0 111.307 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.54 69.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.398 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -64.62 -40.87 96.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.11 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 ptmt -65.96 -40.54 91.36 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.747 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 73.0 mt -59.61 -48.66 86.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.452 ' SD ' HG13 ' A' ' 104' ' ' VAL . 96.3 mmm -69.55 -39.54 77.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.267 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 61.3 m -59.44 -45.56 91.23 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.038 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -66.02 -36.01 82.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 61.6 mtt180 -76.63 -32.11 57.82 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 76.4 m -112.94 -14.58 13.01 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.9 m-20 -61.76 134.84 57.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.488 0.661 . . . . 0.0 112.464 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 63.84 13.04 7.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -112.93 145.02 41.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.298 0.571 . . . . 0.0 109.865 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -32.71 67.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.645 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.484 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -153.02 153.74 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 13.4 p -152.53 156.28 39.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.06 124.75 53.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.452 HG13 ' SD ' ' A' ' 92' ' ' MET . 59.7 t -133.44 145.66 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.514 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' N ' HG12 ' A' ' 104' ' ' VAL . 96.4 t -82.6 116.71 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.126 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.71 36.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.19 -123.33 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.599 ' O ' ' O ' ' A' ' 107' ' ' GLY . 20.9 t 31.28 -160.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.73 1.68 0.82 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.384 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.1 -13.77 49.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.069 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.8 m-85 -145.23 129.94 9.02 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.414 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.3 Cg_exo -51.79 -144.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.057 1.838 . . . . 0.0 111.182 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.649 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 15.2 t0 -146.42 87.25 6.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.235 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.468 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.1 Cg_endo -77.74 -4.44 14.53 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.749 2.299 . . . . 0.0 113.466 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.613 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.11 63.35 0.82 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.289 0.566 . . . . 0.0 111.669 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.41 145.81 65.9 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 121.763 1.642 . . . . 0.0 110.463 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.16 -8.54 79.38 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 119' ' ' TYR . 29.0 m -122.72 148.85 44.84 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.687 -0.302 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.5 t80 -84.05 118.4 24.04 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.649 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 11.6 mttp -94.61 -160.52 0.78 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.592 1.187 . . . . 0.0 113.798 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.602 ' HH ' ' H ' ' A' ' 66' ' ' THR . 3.8 p90 -172.4 173.29 4.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.953 -1.931 . . . . 0.0 110.669 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.8 tp -131.99 125.01 30.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.719 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.686 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 10.2 tp10 -120.01 127.48 52.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.85 123.23 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.359 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.446 HE21 ' HG3' ' A' ' 123' ' ' GLU . 1.8 mt-30 -106.95 129.12 54.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -154.04 171.97 18.23 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.439 0.637 . . . . 0.0 112.077 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.563 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 97.8 m-20 -129.06 161.7 29.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.578 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.621 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.9 m -111.55 127.77 55.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.236 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 33.6 m -132.5 153.58 81.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.09 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 132' ' ' LYS . 16.9 Cg_exo -55.48 142.99 79.74 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.531 1.488 . . . . 0.0 112.165 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -76.55 44.59 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.108 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 130' ' ' PRO . 55.9 mttm -138.89 -70.06 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.535 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.2 134.09 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.55 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.853 -178.903 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.405 ' H81' HD21 ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -58.87 146.25 76.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.603 0.239 . . . . 0.0 111.181 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.53 142.14 13.84 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.101 1.867 . . . . 0.0 111.986 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' C ' ' H ' ' A' ' 34' ' ' LEU . 98.2 m-85 -77.79 -51.6 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.7 -34.22 0.47 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.163 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' H ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -156.96 144.28 18.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.42 0.61 . . . . 0.0 111.725 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt 58.91 135.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.625 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 36' ' ' ARG . 56.5 mtp85 -93.96 151.72 19.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.496 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.582 HH11 ' HG3' ' A' ' 123' ' ' GLU . 66.7 ttp85 -148.82 138.95 22.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.545 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -130.19 145.79 51.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.791 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.5 tt -137.33 142.98 41.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.63 139.71 36.78 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.274 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.6 m -65.81 137.25 57.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.107 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 76.5 tt0 -45.08 129.39 7.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.12 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.92 -12.41 67.17 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.029 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.17 148.72 38.93 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 118.532 1.166 . . . . 0.0 110.349 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.07 150.47 88.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.783 2.322 . . . . 0.0 112.884 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 104' ' ' VAL . 21.0 tt -116.64 149.42 18.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.666 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 35.6 tt0 -132.0 129.83 40.64 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' SG ' ' A' ' 96' ' ' CYS . 32.8 mt -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.334 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.666 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 89.2 mtt180 -147.76 132.42 17.84 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.023 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.5 m -98.51 146.69 32.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 34.4 Cg_endo -67.37 158.86 55.05 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.866 2.377 . . . . 0.0 112.069 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.1 -119.05 5.7 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.213 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.4 p -121.52 23.82 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.595 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -76.08 169.53 18.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.97 149.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.847 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 56' ' ' ILE . 59.6 mt -70.35 136.73 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.219 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -131.7 98.12 4.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.09 125.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.231 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -100.23 -48.11 4.72 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -152.21 150.56 29.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.253 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.27 156.71 12.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 84' ' ' TYR . 5.1 t30 -151.39 142.28 22.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.357 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -112.39 116.94 31.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.59 -139.73 6.05 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.343 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.612 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.0 ttm-85 -152.1 117.44 5.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.078 0.466 . . . . 0.0 111.697 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 84' ' ' TYR . 13.0 p -124.3 4.82 8.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.183 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.4 t0 -149.76 157.23 43.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 36.6 p30 -113.05 5.53 17.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.964 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -105.16 3.67 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.569 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 70' ' ' ILE . 19.2 mm -112.5 136.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.8 m 52.55 76.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p30 -54.36 119.25 4.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.407 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.71 -164.86 1.52 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.531 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.7 p-10 -66.35 140.36 96.69 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.331 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.1 Cg_endo -53.26 -38.46 81.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.42 2.08 . . . . 0.0 113.57 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.52 -36.99 84.31 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.154 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.501 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 23.5 mt-30 -85.56 -9.89 56.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.474 ' HE2' HH12 ' A' ' 65' ' ' ARG . 82.4 mtp -103.89 -3.79 24.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.145 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.0 mt-10 -64.62 -48.22 75.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -81.61 116.31 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.548 0.69 . . . . 0.0 112.374 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.567 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -106.57 36.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.017 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -141.38 86.88 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.155 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.7 t -147.92 119.18 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' A' ' 66' ' ' THR . 91.6 m-85 -131.4 153.44 49.68 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.302 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 tp -147.41 88.12 5.84 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.655 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -47.73 -47.57 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.277 1.985 . . . . 0.0 112.402 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -52.59 -25.53 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.334 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.91 -36.29 65.05 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.947 0.403 . . . . 0.0 111.22 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -64.46 -42.27 96.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.6 pttm -64.82 -39.82 94.19 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.104 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.429 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.6 mt -59.83 -46.65 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.83 -35.98 79.55 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.938 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.0 m -58.85 -45.74 89.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.9 -40.51 91.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.235 0.54 . . . . 0.0 110.847 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.78 -35.49 72.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.352 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.457 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -112.8 -14.72 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 30.3 m-20 -62.3 132.24 51.99 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.079 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 63.76 13.17 7.23 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.27 146.45 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.291 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.7 m -69.83 -32.68 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.312 0.577 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 158.14 43.47 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.484 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.5 p -156.81 139.44 15.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -124.07 125.1 70.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 105' ' ' VAL . 43.5 t -134.86 146.34 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.938 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.0 t -77.83 118.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.262 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.14 35.77 0.05 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.086 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.675 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.44 -117.51 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 27.97 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.207 0.527 . . . . 0.0 111.608 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.76 1.97 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.392 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.73 -13.78 47.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.399 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.9 m-85 -145.72 130.19 8.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.113 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 111' ' ' PHE . 45.2 Cg_exo -51.53 -146.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.282 1.988 . . . . 0.0 112.027 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.616 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 17.9 t0 -145.27 84.57 8.51 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.622 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.24 -4.95 14.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.345 2.696 . . . . 0.0 113.527 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.578 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.88 60.74 0.58 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.111 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.35 147.47 21.74 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.56 -11.25 70.68 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.664 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 119' ' ' TYR . 1.0 OUTLIER -114.92 150.33 35.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.466 0.633 . . . . 0.0 109.913 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.612 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 27.8 t80 -82.16 111.95 18.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.616 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 15.0 mttp -90.73 -163.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.824 1.297 . . . . 0.0 113.539 -176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.3 p90 -173.58 175.81 2.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.807 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 61.7 tp -133.0 126.72 32.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.582 ' HG3' HH11 ' A' ' 37' ' ' ARG . 79.5 tt0 -121.34 128.66 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.607 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.89 123.61 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.377 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.412 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mp0 -105.36 127.61 53.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 56' ' ' ILE . 41.7 p90 -152.88 167.97 27.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.886 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -128.46 161.94 28.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.18 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.43 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.3 m -111.05 116.5 31.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.97 158.98 41.02 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -61.55 143.4 97.03 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.793 1.662 . . . . 0.0 111.38 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 87.8 t80 -78.37 -0.58 29.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.918 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -96.46 -72.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.648 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.2 m -91.33 132.1 36.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.498 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.934 -1.032 . . . . 0.0 111.482 178.601 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.79 116.54 66.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.518 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.52 -110.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.876 2.384 . . . . 0.0 113.155 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -79.42 -8.37 59.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.672 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 74.62 36.1 49.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.314 -0.47 . . . . 0.0 111.972 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' MET . 2.1 mt -158.59 -168.68 2.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 111.48 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.592 ' O ' ' O ' ' A' ' 34' ' ' LEU . 1.5 mtt 51.69 134.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.03 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.535 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 65.3 mtp85 -93.63 144.17 25.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.36 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -151.45 140.83 21.48 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 59.2 mm-40 -133.18 145.31 50.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.011 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tt -135.6 133.15 37.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.849 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.93 140.54 46.85 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.377 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HB3' ' HH ' ' A' ' 119' ' ' TYR . 74.2 m -66.48 136.21 55.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.271 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 81.4 tt0 -48.63 134.68 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.823 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.73 -18.54 56.34 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.718 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -104.1 153.17 39.1 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 118.114 0.957 . . . . 0.0 108.905 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.98 154.41 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.259 1.973 . . . . 0.0 112.614 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 tt -119.62 151.09 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.853 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.691 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 55.5 tt0 -131.78 130.65 42.1 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 mt -120.68 138.96 53.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.158 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.691 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 55.9 mtt180 -148.31 129.64 14.73 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.816 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -98.69 143.97 27.31 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 30.4 Cg_endo -66.48 162.28 37.35 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.93 2.42 . . . . 0.0 113.267 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -121.26 9.34 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.792 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -120.62 26.18 9.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -77.88 169.51 18.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.662 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.87 145.86 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.427 0.632 . . . . 0.0 110.884 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.444 HG12 ' SG ' ' A' ' 50' ' ' CYS . 72.8 mt -68.77 138.49 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.928 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.2 ptm -130.62 104.04 6.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 89' ' ' PHE . 48.5 t -68.54 124.73 24.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.168 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -105.01 -51.57 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -147.01 142.96 28.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.13 0.49 . . . . 0.0 110.479 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.19 152.42 14.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.406 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.429 HD22 ' HA ' ' A' ' 84' ' ' TYR . 11.5 t30 -148.75 143.92 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -114.93 120.0 38.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.99 -135.2 3.87 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.736 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.3 ttm-85 -154.09 116.83 4.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.364 0.602 . . . . 0.0 111.157 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.591 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 28.7 p -124.02 4.33 8.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.877 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 16.7 t70 -144.67 151.96 39.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 26.7 p30 -109.17 0.47 19.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.617 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 43.3 mtpt -101.22 3.22 40.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.287 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 21.0 mm -109.71 137.27 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.809 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.0 m 55.66 66.24 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 10.5 p30 -50.58 111.63 0.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.935 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.54 -161.89 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -58.8 136.96 87.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.673 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.9 Cg_endo -59.39 -33.45 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.834 1.69 . . . . 0.0 112.63 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -62.68 -33.91 76.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.658 0.266 . . . . 0.0 110.878 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.514 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 22.6 mt-30 -85.64 -17.99 34.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.419 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.3 mtp -97.72 -0.35 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.454 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -60.99 -50.74 72.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.475 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.3 t30 -76.48 113.93 14.63 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.25 -0.281 . . . . 0.0 111.595 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.68 25.61 2.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.089 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -137.87 82.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.277 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.1 t -143.98 121.86 12.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.472 ' CZ ' HG22 ' A' ' 66' ' ' THR . 90.6 m-85 -130.4 154.78 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.405 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -144.86 90.65 6.24 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.595 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.89 -44.74 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.783 2.322 . . . . 0.0 113.06 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -55.21 -21.15 12.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.67 71.17 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.745 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 58' ' ' VAL . 57.0 t80 -65.06 -44.69 88.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.851 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.7 pttm -63.62 -43.43 96.87 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.863 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 59.0 mt -58.44 -50.59 78.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.552 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.456 ' SD ' HG22 ' A' ' 124' ' ' VAL . 1.5 mtp -69.62 -32.34 70.98 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.474 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 58.2 m -61.12 -45.4 94.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.207 0.527 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.16 -37.71 84.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.36 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.712 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 99.6 mtt180 -78.1 -33.14 50.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.0 m -111.52 -19.22 12.63 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -61.5 138.97 58.3 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.605 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 62.52 12.54 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.499 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.712 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 65.7 mtt180 -114.93 147.47 39.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.149 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 m -70.75 -34.52 71.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.162 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.74 155.46 39.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.729 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 19.8 p -154.07 132.78 12.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.83 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.42 132.21 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.696 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.529 HG13 HH11 ' A' ' 95' ' ' ARG . 86.6 t -144.96 151.67 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.624 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 107' ' ' GLY . 90.6 t -83.83 114.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.04 41.32 0.1 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.8 -126.07 0.98 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.325 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.697 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 5.0 t 28.49 -156.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.076 0.465 . . . . 0.0 111.24 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.697 ' H ' ' HG ' ' A' ' 108' ' ' SER . 27.4 m-20 -69.38 1.4 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.828 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HB3' HH12 ' A' ' 95' ' ' ARG . . . -84.3 -8.98 58.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.849 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -144.1 134.49 12.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.926 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -58.86 -150.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.92 1.747 . . . . 0.0 111.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.653 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 26.1 t0 -144.9 92.5 5.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.468 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.21 -10.84 14.92 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.729 2.286 . . . . 0.0 112.625 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.463 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.3 p -171.15 87.96 0.47 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.301 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.13 157.75 55.71 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.38 12.01 84.3 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.699 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.512 HG22 ' N ' ' A' ' 119' ' ' TYR . 31.6 m -126.32 146.62 49.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.037 0.418 . . . . 0.0 110.137 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.683 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.5 t80 -82.66 107.18 15.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.653 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 24.9 mttt -88.99 -164.1 1.09 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.638 1.208 . . . . 0.0 113.019 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HH ' ' H ' ' A' ' 66' ' ' THR . 6.3 p90 -171.89 174.81 4.06 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.771 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.416 HD21 ' SD ' ' A' ' 92' ' ' MET . 20.6 tp -132.37 124.7 29.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.429 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' HG2' HE21 ' A' ' 125' ' ' GLN . 78.7 tt0 -122.53 124.31 43.26 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 HG22 ' SD ' ' A' ' 92' ' ' MET . 6.0 t -133.18 130.54 57.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.638 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.474 HE21 ' HG2' ' A' ' 123' ' ' GLU . 7.2 mp0 -109.91 132.66 53.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.719 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -152.83 168.45 25.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.416 0.627 . . . . 0.0 111.896 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.409 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 71.1 m-20 -126.22 158.24 36.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.434 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.535 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 74.7 m -108.53 124.89 51.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.528 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 m -126.53 159.37 63.76 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -59.35 144.82 99.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.537 1.491 . . . . 0.0 111.854 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -77.16 -86.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.51 ' C ' ' CD ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -140.42 154.5 46.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.359 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.5 133.06 29.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.13 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.679 -179.465 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 tt 39.69 66.27 3.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -82.53 -78.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.793 2.329 . . . . 0.0 112.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 34' ' ' LEU . 97.1 m-85 -77.88 -15.49 59.0 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.25 -55.83 0.11 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.332 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' PHE . 20.1 tp -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.1 mtt 60.69 120.65 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.729 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 52.4 mtt-85 -88.33 152.82 21.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.425 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -146.71 137.41 23.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.613 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 19.1 mt-10 -135.54 144.91 46.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.593 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 tt -138.19 137.7 37.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.768 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.3 139.24 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.304 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.12 140.41 58.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.29 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -45.97 129.62 9.67 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.785 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.42 -12.51 69.5 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.708 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -104.15 155.21 37.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 118.248 1.024 . . . . 0.0 109.396 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.16 153.5 36.43 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.71 1.607 . . . . 0.0 112.577 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.06 143.23 39.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.0 tt0 -126.88 130.52 50.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.124 0.488 . . . . 0.0 112.165 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.3 mt -114.18 141.71 47.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -148.1 131.16 16.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.754 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.04 142.03 23.8 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.49 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 24.2 Cg_endo -69.6 161.66 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.269 1.979 . . . . 0.0 112.208 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.64 20.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.719 0.621 . . . . 0.0 112.311 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -101.17 21.2 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.06 165.0 25.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.21 144.04 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.792 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.4 mt -67.81 134.84 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.641 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.8 ptm -130.46 100.59 5.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.511 0.672 . . . . 0.0 109.232 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.41 124.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.866 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.22 -43.73 4.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -146.23 143.42 29.21 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.02 149.11 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.531 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 84' ' ' TYR . 7.5 t30 -148.74 152.12 36.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 76.2 t80 -121.57 120.11 33.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.81 -134.91 3.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -159.7 119.79 3.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.215 0.531 . . . . 0.0 111.463 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.9 8.3 8.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.085 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 44.8 t0 -144.1 150.63 38.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.369 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 14.6 p30 -104.46 -1.11 27.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.403 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 8.1 mtmp? -105.03 10.86 33.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.37 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.556 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 12.5 mm -107.52 135.03 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' ALA . 71.8 m 56.76 67.37 1.0 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 52.2 p-10 -46.35 93.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.594 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -111.82 -162.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.645 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p-10 -63.68 140.52 97.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.578 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 5.5 Cg_endo -56.54 -38.94 94.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.596 2.197 . . . . 0.0 113.526 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 2.9 m-30 -61.4 -36.53 80.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.333 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.463 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 20.4 mt-30 -86.52 -11.79 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.6 mmm -101.95 -3.11 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 43.9 mt-10 -66.26 -44.69 82.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -78.61 114.02 17.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.99 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.6 m -105.67 32.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -142.13 85.93 1.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.313 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 21.7 t -143.81 125.67 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.465 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.9 m-85 -135.66 149.73 49.39 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 tp -148.9 88.5 5.16 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.438 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.07 -44.24 47.1 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.503 2.135 . . . . 0.0 113.848 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 83.1 m-20 -53.7 -24.58 15.06 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.188 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.22 -34.26 44.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -64.79 -42.24 95.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.478 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.52 -36.18 83.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.028 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 71.5 mt -62.99 -50.37 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.258 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.99 -38.63 86.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 42.0 m -58.15 -45.74 86.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.56 -36.51 82.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.686 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 70.1 mtt180 -78.74 -31.36 46.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 15.8 m -111.81 -19.9 12.26 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 84.5 m-20 -56.6 134.04 54.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.406 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 67.12 13.14 9.33 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.786 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.686 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 75.2 mtt180 -113.0 146.0 39.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.36 0.6 . . . . 0.0 110.132 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.9 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.488 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 155.76 40.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.6 p -154.6 146.3 23.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.419 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.47 127.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.743 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.457 HG13 ' NH1' ' A' ' 95' ' ' ARG . 48.5 t -137.12 143.81 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.353 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.2 t -78.1 115.29 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.759 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.84 35.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.212 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.51 -119.92 0.65 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.302 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.2 t 31.26 -160.38 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.405 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.12 1.67 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.25 -13.49 55.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.9 m-85 -144.36 131.98 10.57 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.819 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 111' ' ' PHE . 21.7 Cg_exo -56.6 -147.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.104 1.869 . . . . 0.0 112.345 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -146.21 86.28 7.08 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.492 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.22 -9.92 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.544 2.163 . . . . 0.0 112.814 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -166.38 77.19 1.14 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.654 0.74 . . . . 0.0 111.05 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.25 149.93 42.97 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.337 2.025 . . . . 0.0 110.857 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.2 -4.93 64.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.386 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 119' ' ' TYR . 31.3 m -113.25 148.32 35.78 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.932 0.866 . . . . 0.0 109.343 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.745 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.1 t80 -84.94 113.7 21.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.447 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 13.7 mtmm -93.87 -162.9 0.98 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.854 1.312 . . . . 0.0 113.82 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.9 p90 -168.84 170.29 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.55 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 tp -128.89 124.67 35.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 126.31 49.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.88 125.18 57.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.561 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -105.8 127.88 53.38 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.247 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -151.48 170.3 19.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.353 0.597 . . . . 0.0 111.372 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.456 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 73.5 m-20 -127.47 158.75 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.057 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.729 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 86.7 m -108.05 114.74 28.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.74 158.26 45.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.951 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 132' ' ' LYS . 18.5 Cg_exo -63.48 149.21 91.65 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.29 1.994 . . . . 0.0 112.798 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.649 ' CD2' ' O ' ' A' ' 131' ' ' TYR . 67.7 t80 -77.61 12.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 130' ' ' PRO . 26.9 mmtt -90.68 165.48 13.68 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.139 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.29 137.13 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 111.46 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.733 178.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -41.51 -52.23 8.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.371 0.129 . . . . 0.0 111.244 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 52.8 Cg_exo -51.83 157.16 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.339 2.026 . . . . 0.0 112.338 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -61.03 2.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.188 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.94 32.05 79.83 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -157.51 45.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.145 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.553 ' CE ' ' OE1' ' A' ' 59' ' ' GLU . 1.4 mtt 54.71 149.45 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -89.11 144.8 25.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.337 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.703 0.763 . . . . 0.0 111.194 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 54.9 mp0 -134.21 140.16 46.3 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.433 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.9 tt -137.74 135.33 36.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.794 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.22 136.64 56.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.991 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -46.67 133.11 10.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.336 0.589 . . . . 0.0 112.526 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.74 -13.28 67.48 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.593 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.94 147.03 34.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 118.437 1.118 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.99 147.71 89.22 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.391 2.061 . . . . 0.0 112.064 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.0 tt -117.68 147.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.68 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.4 tt0 -123.15 129.47 51.47 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.096 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.5 mt -118.0 137.31 52.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.68 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 87.3 mtt180 -149.2 127.85 12.42 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -95.45 149.55 36.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.557 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 49.2 Cg_endo -72.11 157.41 54.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.951 2.434 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 48.43 -134.96 19.15 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.912 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -101.82 24.12 10.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -78.45 164.96 24.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.5 146.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.662 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.6 mt -67.62 133.53 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.627 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -130.71 99.1 4.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.447 HG11 ' CE1' ' A' ' 89' ' ' PHE . 34.1 t -66.45 124.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.913 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.553 ' OE1' ' CE ' ' A' ' 35' ' ' MET . 92.9 mt-10 -108.75 -47.33 3.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.203 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -146.85 145.82 29.99 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.309 0.576 . . . . 0.0 110.324 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.93 155.73 16.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.594 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 84' ' ' TYR . 11.4 t30 -147.13 138.57 24.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.212 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -115.36 117.65 31.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.5 -135.26 4.06 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 17.8 ttm180 -155.21 117.76 4.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.367 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.481 HG23 ' CZ ' ' A' ' 84' ' ' TYR . 5.1 p -123.45 5.79 9.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -146.97 154.08 40.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.236 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 36.9 p30 -113.69 2.44 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.357 . . . . 0.0 110.426 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 30.0 mttp -103.65 6.69 37.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.7 mm -108.28 135.62 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.895 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m 52.18 71.89 0.43 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 10.3 p-10 -45.03 114.34 0.71 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.847 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.14 -169.32 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.553 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.663 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -61.05 139.41 94.25 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 13.6 Cg_endo -57.83 -34.49 98.34 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.149 1.899 . . . . 0.0 112.988 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -64.72 -35.49 81.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.703 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 22.8 mt-30 -86.93 -13.43 44.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.607 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.479 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mtm -104.61 0.85 29.01 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.598 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 3.7 mt-10 -67.31 -43.83 80.68 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -79.87 114.26 18.66 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.692 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -104.55 34.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 79.9 mm-40 -141.07 84.44 1.93 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.05 119.17 8.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.481 ' CZ ' HG23 ' A' ' 66' ' ' THR . 93.4 m-85 -132.49 152.56 51.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.695 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.1 tp -142.09 87.6 9.64 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.961 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.91 -50.26 11.12 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.0 -26.97 40.6 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.56 -33.42 45.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.89 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.447 ' CE1' HG11 ' A' ' 58' ' ' VAL . 15.5 t80 -64.71 -43.9 91.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.24 -38.75 92.38 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.247 -178.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -59.94 -51.81 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.814 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mtp -68.44 -33.02 73.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.175 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 33.2 m -59.89 -45.54 92.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 54.8 mt-30 -64.68 -37.75 88.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.35 0.595 . . . . 0.0 110.957 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.676 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 25.2 mtp180 -75.86 -33.11 59.99 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.514 ' N ' HH21 ' A' ' 99' ' ' ARG . 6.9 m -113.7 -14.01 12.63 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.774 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 53.8 m-20 -60.06 131.65 51.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.844 -0.743 . . . . 0.0 111.641 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 66.59 13.2 9.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.902 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 97' ' ' ASN . 29.6 mtm-85 -111.29 144.29 40.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.9 m -71.18 -30.51 66.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 154.09 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.428 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 3.2 p -154.69 137.26 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.712 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.79 128.63 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 105' ' ' VAL . 23.1 t -141.04 151.87 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.158 0.504 . . . . 0.0 112.051 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.522 ' N ' HG12 ' A' ' 104' ' ' VAL . 45.2 t -82.16 116.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.005 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.6 39.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.96 -120.68 0.69 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.709 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER 31.87 -161.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 110.76 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.709 ' N ' ' OG ' ' A' ' 108' ' ' SER . 66.5 m-20 -68.93 2.9 2.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.419 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.07 -11.99 48.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.68 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.0 m-85 -142.87 126.89 9.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.001 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 18.1 Cg_exo -50.78 -148.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.34 2.026 . . . . 0.0 111.765 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.659 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 32.4 t0 -144.48 85.59 8.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -5.1 14.73 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.901 2.401 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.463 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.5 p -166.04 67.31 1.07 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.546 0.689 . . . . 0.0 111.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 142.73 98.67 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 121.997 1.798 . . . . 0.0 110.269 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.25 69.57 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 90.3 m -122.87 147.06 47.0 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 19.3 t80 -81.28 118.44 22.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.659 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 33.9 mttt -92.17 -162.11 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 123.091 1.424 . . . . 0.0 113.868 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -170.54 172.92 5.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.543 -2.117 . . . . 0.0 110.876 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 45.0 tp -132.92 123.76 26.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -121.09 126.28 49.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -127.4 121.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.258 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -104.23 125.4 50.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.469 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.6 p90 -153.92 169.03 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.002 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -124.2 159.39 30.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.259 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.442 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.9 m -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.18 153.56 68.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.105 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -56.2 144.39 81.3 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.636 1.557 . . . . 0.0 111.331 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 62.4 t80 -73.63 -3.72 29.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.727 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -98.53 163.24 12.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.64 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.431 ' H ' HG11 ' A' ' 133' ' ' VAL . 3.8 p -84.56 125.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.997 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.277 -179.25 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.35 64.68 72.14 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.36 150.42 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.395 2.063 . . . . 0.0 111.718 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -79.38 -12.13 59.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.343 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.03 23.81 75.31 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 tt -161.06 121.54 2.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.747 0.308 . . . . 0.0 110.414 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 mtt 59.75 129.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.385 0.612 . . . . 0.0 111.658 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.441 HH21 ' HG3' ' A' ' 51' ' ' PRO . 78.3 mtt-85 -90.65 147.99 22.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.521 ' HE ' ' HG3' ' A' ' 123' ' ' GLU . 58.4 ttt180 -145.46 130.06 17.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.73 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -127.8 143.1 51.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.677 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -138.21 135.24 35.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.805 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -132.48 138.18 47.48 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.351 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.32 136.83 57.03 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.767 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -45.78 132.67 8.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 0.0 112.348 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.53 -12.58 66.22 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.195 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.3 149.21 40.24 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.536 1.168 . . . . 0.0 110.316 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.36 151.46 85.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.68 2.254 . . . . 0.0 113.02 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 tt -119.12 144.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -128.7 128.45 44.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.302 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 102' ' ' CYS . 33.5 mt -116.38 141.18 48.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.073 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 49' ' ' ARG . 17.7 mtp180 -148.13 135.05 20.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.809 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.0 m -102.36 141.03 21.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.853 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HG3' HH21 ' A' ' 36' ' ' ARG . 29.4 Cg_endo -67.16 157.74 60.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.469 2.112 . . . . 0.0 112.332 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.76 -134.49 11.13 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.604 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 p -99.82 22.12 11.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.505 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.32 167.3 21.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.07 148.81 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 111.461 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.461 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 97.2 mt -72.41 138.43 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.723 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.8 ptm -133.26 103.71 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.75 124.98 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.18 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 86.3 mt-10 -105.6 -51.13 3.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.963 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -146.85 147.52 30.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.103 0.478 . . . . 0.0 110.126 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.68 157.53 10.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.56 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 84' ' ' TYR . 15.0 t30 -151.1 148.94 28.92 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.275 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -118.57 115.24 24.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.86 -136.3 4.25 Favored Glycine 0 C--N 1.319 -0.379 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 10.2 ttm-85 -156.68 117.1 3.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.204 0.526 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 p -121.68 9.58 10.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 35.3 t0 -145.58 -174.82 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 50.1 p30 -141.33 -0.03 1.46 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.199 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -101.52 5.3 41.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.137 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 32.2 mm -107.59 133.64 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.963 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.9 m 52.72 75.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.932 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 36.1 t0 -55.11 106.77 0.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.091 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.72 -164.6 1.05 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.295 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.703 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -60.79 142.14 92.3 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.303 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 9.5 Cg_endo -55.34 -39.09 92.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.462 2.108 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -64.51 -36.24 83.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.423 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.55 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.6 mt-30 -89.34 -6.59 56.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.692 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.554 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 61.3 mmm -115.47 -1.31 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.164 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.0 mt-10 -67.47 -42.79 82.44 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -79.98 120.62 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.25 34.7 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.816 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.83 85.39 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.804 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.6 t -149.21 124.88 10.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.285 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.405 ' HA ' HD22 ' A' ' 62' ' ' ASN . 92.7 m-85 -132.6 149.77 52.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.723 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -142.1 94.84 6.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -54.34 -47.63 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.948 2.432 . . . . 0.0 114.106 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.1 m-20 -55.13 -26.09 36.17 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.692 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.95 51.38 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.91 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -66.81 -47.17 72.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 6.0 pttm -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -59.27 -50.85 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.729 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.523 ' SD ' ' CD2' ' A' ' 122' ' ' LEU . 6.0 mtp -68.46 -33.62 74.51 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.505 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.5 m -59.59 -44.04 93.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.565 ' HE ' ' CG2' ' A' ' 104' ' ' VAL . 75.5 mtp85 -76.21 -34.57 59.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.69 -11.47 12.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.548 HD21 ' H82' ' A' ' 135' ' ' NAG . 59.1 m-20 -62.79 134.77 56.77 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.653 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 67.62 14.93 9.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -114.58 147.43 39.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.112 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.5 m -70.11 -32.98 71.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 158.44 44.15 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.509 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 48' ' ' LEU . 14.5 p -157.02 145.0 19.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.384 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.94 128.43 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.565 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 41.5 t -138.14 140.72 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.168 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 107' ' ' GLY . 48.4 t -77.45 116.39 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.27 38.56 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.127 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.643 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.86 -119.43 0.63 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.643 ' O ' ' O ' ' A' ' 107' ' ' GLY . 48.4 t 27.55 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.291 0.567 . . . . 0.0 111.776 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.523 ' N ' ' OG ' ' A' ' 108' ' ' SER . 91.4 m-20 -68.83 1.85 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.01 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.11 54.67 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.064 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -144.88 129.95 9.26 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.152 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.3 Cg_exo -51.03 -148.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.85 2.366 . . . . 0.0 112.461 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.05 89.45 6.04 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.529 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.97 -10.31 18.07 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.009 2.473 . . . . 0.0 114.095 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -170.81 69.76 0.53 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.92 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.33 155.51 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.082 1.855 . . . . 0.0 111.531 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.88 85.14 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.493 HG21 ' N ' ' A' ' 119' ' ' TYR . 95.7 m -126.27 149.91 48.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.493 ' N ' HG21 ' A' ' 118' ' ' THR . 41.8 t80 -83.99 113.54 21.07 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -90.06 -162.84 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.314 1.054 . . . . 0.0 113.376 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -171.77 172.75 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.091 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.523 ' CD2' ' SD ' ' A' ' 92' ' ' MET . 28.0 tp -132.77 126.57 32.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.521 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 81.9 tt0 -122.05 126.06 47.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.47 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 47.4 t -130.55 127.87 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' NE2' ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.24 127.0 53.9 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -151.37 162.12 41.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.635 . . . . 0.0 112.146 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.417 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 78.5 m-20 -117.96 158.99 23.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.592 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 36' ' ' ARG . 95.6 m -109.93 108.6 18.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.719 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.77 156.67 43.37 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.757 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.84 142.99 83.11 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.079 1.852 . . . . 0.0 112.316 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -76.68 -3.15 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.009 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -91.43 1.71 56.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.136 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.3 t -83.69 133.1 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.244 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.941 -179.237 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . 0.616 ' O3 ' ' O7 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.498 2.779 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.3 mt -37.32 -59.86 0.95 Allowed Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.878 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 30' ' ' LEU . 10.8 Cg_endo -60.56 145.64 98.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.557 2.171 . . . . 0.0 111.523 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.638 ' O ' ' N ' ' A' ' 34' ' ' LEU . 26.5 p90 -80.78 -16.6 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.128 0.489 . . . . 0.0 109.682 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' C ' ' CD1' ' A' ' 34' ' ' LEU . . . 55.0 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.739 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -151.15 113.37 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.149 0.499 . . . . 0.0 110.21 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 34' ' ' LEU . 9.3 mtp 58.32 154.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.755 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -95.19 150.99 19.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.985 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.584 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 48.9 ttp180 -146.92 136.94 23.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.605 . . . . 0.0 111.289 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.599 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 18.6 mp0 -130.77 141.33 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.595 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 5.3 tt -140.03 144.11 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.817 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.82 140.04 34.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 110.699 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.662 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 80.8 tt0 -48.18 133.81 14.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.374 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.54 -15.58 62.98 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.187 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -107.09 147.35 34.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.927 0.863 . . . . 0.0 111.323 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.41 149.68 75.16 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.739 2.293 . . . . 0.0 112.445 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -120.92 143.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.585 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -121.29 129.33 53.07 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.275 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 60.9 mt -117.23 140.1 49.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.548 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -152.19 134.05 14.83 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.549 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.7 m -95.22 137.9 22.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.99 164.71 32.71 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.517 1.478 . . . . 0.0 110.85 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.53 -140.19 29.71 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.703 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 p -106.38 21.3 17.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.757 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.35 170.19 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.714 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.07 144.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.0 0.429 . . . . 0.0 110.665 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 94.8 mt -69.02 138.43 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.299 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.5 ptp -130.95 100.94 5.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.79 123.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.04 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -101.38 -48.85 4.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -148.63 146.59 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.415 0.626 . . . . 0.0 110.9 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.12 152.1 12.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.147 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 84' ' ' TYR . 29.3 t30 -148.74 144.44 27.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.841 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.463 ' HH ' ' HG3' ' A' ' 42' ' ' GLU . 64.5 t80 -115.63 118.88 34.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.27 -135.33 4.01 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.4 ttm180 -155.58 118.7 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.317 0.579 . . . . 0.0 111.753 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.483 HG21 ' CE2' ' A' ' 84' ' ' TYR . 25.9 p -125.21 3.62 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.739 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 52.8 t0 -146.42 154.64 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.792 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.659 ' O ' ' CE ' ' A' ' 78' ' ' MET . 29.3 p30 -113.73 0.34 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.777 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -102.48 7.9 40.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.767 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 70' ' ' ILE . 41.9 mm -109.1 133.78 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.1 m 49.49 83.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -61.05 106.02 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -112.44 -166.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.178 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -64.54 139.97 97.88 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.467 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -52.92 -39.38 78.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.375 2.05 . . . . 0.0 113.212 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -64.77 -36.32 83.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.725 0.298 . . . . 0.0 111.468 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.569 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 21.6 mt-30 -85.74 -6.67 59.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.646 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.659 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 95.1 mtp -105.6 -4.8 20.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.181 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.2 mt-10 -63.25 -47.55 81.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.982 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -79.33 119.57 22.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.7 m -108.79 33.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.824 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -141.41 83.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.436 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 37.1 t -142.8 123.24 13.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.483 ' CE2' HG21 ' A' ' 66' ' ' THR . 88.7 m-85 -135.07 156.17 49.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.9 tp -148.04 88.68 5.44 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.877 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.18 -48.18 13.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.791 2.327 . . . . 0.0 113.16 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -57.26 -21.85 37.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.49 -35.11 67.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -65.05 -45.04 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.124 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.688 ' O ' ' NE2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -66.02 -35.88 81.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.255 -179.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.563 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 76.5 mt -61.96 -50.12 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.625 0.25 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.521 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 53.8 mtp -71.44 -34.23 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.301 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.2 m -59.85 -46.2 90.04 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.564 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.56 -35.22 79.69 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.748 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.453 ' CZ ' HG11 ' A' ' 104' ' ' VAL . 28.4 mtp180 -76.72 -34.26 58.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.1 m -113.02 -10.1 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.592 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -63.45 132.52 51.65 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 65.77 13.14 8.81 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -111.55 144.58 40.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.303 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -72.08 -30.58 65.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.994 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.34 152.4 35.76 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.315 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 3.7 p -156.78 131.61 8.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.03 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -116.85 134.07 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.787 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.453 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 61.0 t -143.68 150.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.2 t -82.23 117.46 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.436 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.84 39.95 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.769 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.95 -120.45 0.68 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.87 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 28.04 -157.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.489 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -69.02 -1.04 6.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.99 -16.3 47.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.6 m-85 -139.57 130.08 14.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.551 ' O ' ' O ' ' A' ' 111' ' ' PHE . 39.7 Cg_exo -52.93 -149.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.255 1.97 . . . . 0.0 111.186 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.546 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 28.3 t0 -145.34 82.64 9.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 70.1 Cg_endo -73.01 -6.05 18.3 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.728 2.286 . . . . 0.0 113.65 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.89 68.54 0.98 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.422 0.629 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -52.42 149.02 24.47 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.249 1.966 . . . . 0.0 111.197 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.16 -0.49 83.65 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 119' ' ' TYR . 39.5 m -118.54 148.68 42.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.619 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 41.3 t80 -86.04 111.6 20.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.546 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 12.1 mttt -91.52 -162.61 0.94 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.149 1.452 . . . . 0.0 113.964 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.1 p90 -173.84 176.11 2.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 112.152 -2.295 . . . . 0.0 110.143 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.458 HD23 ' SD ' ' A' ' 92' ' ' MET . 40.4 tp -130.82 120.74 24.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -118.14 129.73 55.7 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.521 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 93.5 t -137.21 127.24 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.542 ' NE2' ' N ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -107.48 131.84 53.86 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 126' ' ' TYR . 22.7 p90 -155.78 171.91 19.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.647 0.736 . . . . 0.0 112.622 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 72.7 m-20 -130.37 158.87 38.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.027 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.0 m -112.13 109.1 18.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -104.95 156.24 36.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.967 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -57.4 144.7 90.91 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.981 1.787 . . . . 0.0 110.732 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -79.29 5.11 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.715 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.87 -73.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -85.29 134.45 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.708 -179.383 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.91 144.1 98.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.436 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.78 140.29 92.6 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.791 2.327 . . . . 0.0 112.096 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -87.06 5.98 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.64 16.48 73.13 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -162.58 92.1 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.33 . . . . 0.0 110.417 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 125' ' ' GLN . 48.5 ttm 58.38 154.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.468 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -90.44 152.05 21.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.678 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 47.9 ttp180 -141.79 137.72 31.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.1 mp0 -133.47 137.43 45.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.828 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.4 tt -139.02 139.49 37.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.939 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -140.37 141.85 35.59 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.848 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -63.95 134.91 55.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.278 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -46.21 131.47 10.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.66 67.7 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.375 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 145.47 31.76 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.655 1.228 . . . . 0.0 111.661 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.0 149.95 89.41 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.083 2.522 . . . . 0.0 112.519 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 tt -122.07 145.97 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 83.7 tt0 -125.79 127.53 46.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.09 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.1 mt -116.21 145.76 42.86 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.678 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 87.6 mtt-85 -151.2 135.96 17.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.303 0.573 . . . . 0.0 112.033 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.477 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.4 m -100.49 137.77 20.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.837 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.7 157.8 53.9 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.331 2.02 . . . . 0.0 111.623 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.14 -126.1 29.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.447 -0.406 . . . . 0.0 112.522 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -116.52 24.24 11.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.093 0.473 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.31 169.4 18.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.61 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.98 144.98 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 111.018 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.477 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 80.4 mt -67.41 136.99 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.988 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -132.35 100.02 4.87 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.87 123.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.705 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.5 mm-40 -101.6 -51.57 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.941 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 66.2 m-20 -149.11 143.18 25.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.624 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -162.75 155.24 18.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.079 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.453 HD22 ' HA ' ' A' ' 84' ' ' TYR . 14.4 t30 -152.34 146.76 25.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.653 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -114.02 115.1 27.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.1 -136.54 4.29 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.203 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.5 ttm180 -162.17 122.4 2.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.277 0.561 . . . . 0.0 111.905 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.467 HG23 ' CE2' ' A' ' 84' ' ' TYR . 43.5 p -123.72 12.52 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.593 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 29.7 t0 -146.82 -168.72 3.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.568 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 44.6 p30 -146.88 4.57 0.85 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.705 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -103.45 0.43 31.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.63 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 70' ' ' ILE . 22.2 mm -109.86 138.46 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.913 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.3 m 53.49 72.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.324 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -57.25 120.32 7.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.512 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.46 -161.71 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -57.55 133.74 82.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.235 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.535 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -55.61 -34.48 90.33 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.613 1.542 . . . . 0.0 111.715 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -61.44 -39.19 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.392 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.491 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 19.9 mt-30 -83.94 -10.28 58.07 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.02 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.3 mtp -103.2 -1.93 28.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.019 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 54.9 mm-40 -63.84 -45.76 88.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.44 114.64 19.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.77 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 19.2 m -104.64 34.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.104 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.692 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.1 mm-40 -142.72 84.17 1.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.251 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.4 t -142.01 126.05 17.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.467 ' CE2' HG23 ' A' ' 66' ' ' THR . 41.3 m-85 -136.13 154.0 51.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -146.71 89.26 5.79 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.174 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -50.67 -49.88 15.39 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.88 2.387 . . . . 0.0 113.343 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 54.3 m-20 -58.23 -21.94 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.34 -31.33 43.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.9 t80 -66.27 -45.9 78.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.735 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.6 ptpt -66.33 -39.86 89.5 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.701 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 HH21 ' A' ' 95' ' ' ARG . 56.9 mt -59.75 -49.79 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.679 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.555 ' HG2' HH12 ' A' ' 95' ' ' ARG . 58.2 mtp -70.01 -37.95 75.81 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.042 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 48.1 m -55.97 -42.91 77.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 93.6 mt-30 -66.24 -38.54 88.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.051 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.621 HH21 HG22 ' A' ' 91' ' ' ILE . 14.3 mtm105 -74.86 -34.14 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 71.0 m -110.15 -18.91 13.21 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' CG ' ' O ' ' A' ' 93' ' ' SER . 79.7 m-20 -54.65 135.38 46.77 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.059 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 65.79 14.58 9.63 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.24 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -113.6 145.64 40.95 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.646 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.0 m -69.67 -33.39 72.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.297 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.91 155.93 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.674 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.8 p -155.1 136.84 14.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.244 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.4 127.63 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.612 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.534 HG22 HH11 ' A' ' 95' ' ' ARG . 42.5 t -142.59 145.55 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 111.374 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.501 ' N ' HG13 ' A' ' 104' ' ' VAL . 66.4 t -75.8 114.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.977 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.98 40.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.48 -121.93 0.73 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 27.2 -155.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.322 0.582 . . . . 0.0 111.868 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -68.52 1.15 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.295 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.01 -15.63 46.95 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.518 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.9 m-85 -146.13 125.15 6.57 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.542 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.9 Cg_exo -51.16 -142.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.528 2.152 . . . . 0.0 112.607 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 116' ' ' PRO . 9.4 t0 -145.31 87.72 6.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.199 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.14 -8.58 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.55 2.167 . . . . 0.0 113.131 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.459 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -165.09 69.69 1.36 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.53 0.681 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.2 Cg_exo -53.73 147.25 41.22 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.381 2.054 . . . . 0.0 111.048 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.51 -5.38 81.44 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.881 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 119' ' ' TYR . 88.8 m -118.3 148.05 42.85 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.8 t80 -84.42 116.37 23.03 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.459 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 7.9 mtmm -94.24 -157.83 0.58 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.576 1.179 . . . . 0.0 113.994 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.6 p90 -174.01 175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.881 -1.963 . . . . 0.0 110.239 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 52.2 tp -130.78 123.67 29.67 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.079 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.452 ' HG2' HE21 ' A' ' 125' ' ' GLN . 66.1 tt0 -121.28 126.79 50.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.501 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 77.9 t -132.73 127.15 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.452 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.452 HE21 ' HG2' ' A' ' 123' ' ' GLU . 9.4 mp0 -108.61 129.02 55.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -156.02 171.69 19.67 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.698 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 35' ' ' MET . 49.9 m-20 -131.64 162.24 30.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.427 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.0 m -108.3 131.23 54.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.623 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' SD ' ' A' ' 57' ' ' MET . 28.5 m -130.99 157.57 77.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 132' ' ' LYS . 22.9 Cg_exo -57.16 145.33 87.11 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.014 1.81 . . . . 0.0 111.576 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -77.4 29.08 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.404 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 130' ' ' PRO . 3.2 tptp -89.8 135.37 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.626 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.564 ' O ' ' O ' ' A' ' 134' ' ' GLU . 12.7 p -89.97 140.57 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.766 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' O ' ' O ' ' A' ' 133' ' ' VAL . 41.4 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.81 140.13 60.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.24 137.71 52.91 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.291 1.994 . . . . 0.0 111.842 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' C ' ' H ' ' A' ' 34' ' ' LEU . 87.3 m-85 -81.45 -13.09 58.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.58 -38.06 0.17 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -161.23 123.31 3.02 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.465 ' HG3' ' CD1' ' A' ' 34' ' ' LEU . 46.0 mtt 60.88 148.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.296 0.57 . . . . 0.0 112.042 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt85 -87.69 145.48 26.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -146.22 135.5 22.84 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.559 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 58.8 mm-40 -134.0 146.68 50.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.221 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.96 139.68 38.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.742 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -138.36 142.27 39.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.452 0.644 . . . . 0.0 111.009 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 23.9 m -64.58 137.72 58.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.757 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 72.5 tt0 -43.44 126.32 4.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.179 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.47 -8.21 74.79 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.241 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.34 148.62 38.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.945 1.373 . . . . 0.0 110.005 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.78 149.95 67.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.899 2.399 . . . . 0.0 113.287 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -118.99 146.62 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.673 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 49' ' ' ARG . 82.0 tt0 -126.05 129.84 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.109 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' SG ' ' A' ' 102' ' ' CYS . 48.7 mt -116.01 139.81 49.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.986 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 47' ' ' GLU . 3.9 mtp180 -150.28 131.49 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.287 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 56' ' ' ILE . 11.6 m -97.98 151.92 37.8 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.058 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HG3' HH21 ' A' ' 36' ' ' ARG . 93.4 Cg_endo -77.11 160.03 33.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.908 2.406 . . . . 0.0 112.318 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.64 -116.69 6.21 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -131.54 27.47 4.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.05 170.71 15.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.765 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.2 142.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.41 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG21 ' CD2' ' A' ' 126' ' ' TYR . 93.5 mt -67.15 137.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.785 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.3 ptp -134.9 102.52 5.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.09 124.54 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.123 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -100.41 -52.1 3.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.245 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -152.27 150.65 30.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -168.5 155.31 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.855 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -145.58 147.77 32.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 111' ' ' PHE . 40.2 t80 -119.59 117.94 29.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.86 -133.14 3.2 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.663 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -157.34 120.46 4.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 0.0 111.191 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.459 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 20.7 p -120.27 8.66 10.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.854 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.5 t0 -145.21 -166.13 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.185 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.591 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 38.0 p-10 -150.24 0.31 0.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -102.78 2.91 36.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.252 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.89 135.68 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m 52.71 74.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.1 p30 -52.37 102.93 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.662 0.744 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 -170.21 1.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.838 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -59.56 141.99 87.82 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.21 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 6.5 Cg_endo -53.63 -40.08 80.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.932 2.421 . . . . 0.0 112.993 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.54 -33.62 76.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.963 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.471 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 22.2 mt-30 -90.2 -8.26 51.56 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 74.5 mmm -107.36 -4.8 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.6 mt-10 -67.06 -42.34 84.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 9.3 t30 -77.98 121.22 23.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.26 31.63 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -138.74 86.7 2.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.008 0.432 . . . . 0.0 110.148 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.426 ' SG ' ' HA3' ' A' ' 64' ' ' GLY . 4.4 t -147.6 120.96 9.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 66' ' ' THR . 73.8 m-85 -135.74 157.13 47.63 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.192 0.52 . . . . 0.0 112.372 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -147.53 89.44 5.44 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.434 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.16 -51.33 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.759 2.306 . . . . 0.0 113.123 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 53.8 m-20 -54.93 -22.79 16.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.69 68.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' O ' ' OG ' ' A' ' 93' ' ' SER . 31.0 t80 -64.14 -44.14 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 111.515 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.04 -38.3 90.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.505 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 65.8 mt -61.03 -47.79 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.03 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.7 -36.45 80.67 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.5 m -59.39 -46.55 88.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -66.48 -35.98 81.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 111.145 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HE ' HG21 ' A' ' 104' ' ' VAL . 51.1 mtp85 -75.34 -35.22 61.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.3 m -112.92 -18.1 12.32 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 46.3 m-20 -52.82 136.39 34.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 66.34 13.19 9.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.207 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -112.89 145.38 40.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.0 m -74.62 -32.32 62.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.013 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -149.2 150.24 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.458 ' SG ' HD11 ' A' ' 48' ' ' LEU . 9.4 p -153.5 143.64 22.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.287 0.565 . . . . 0.0 111.448 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.12 123.59 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.443 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 105' ' ' VAL . 41.7 t -135.56 143.88 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.432 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.482 ' N ' HG13 ' A' ' 104' ' ' VAL . 61.8 t -82.87 119.47 32.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.329 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.17 42.45 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.75 -125.27 0.95 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 29.54 -157.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 110.855 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.63 2.75 3.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.967 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.05 -12.71 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.727 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.1 m-85 -143.53 126.13 8.72 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -51.86 -144.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.137 1.891 . . . . 0.0 111.178 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.609 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 8.7 t0 -146.02 96.34 4.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 92.5 Cg_endo -84.89 -8.92 9.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.029 2.486 . . . . 0.0 112.768 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -162.02 64.45 1.7 Allowed Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.275 0.56 . . . . 0.0 111.475 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.51 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 23.4 Cg_exo -53.94 145.29 52.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.925 1.75 . . . . 0.0 111.022 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.8 -11.66 71.6 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.865 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 119' ' ' TYR . 47.2 m -117.93 150.41 39.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.1 0.45 . . . . 0.0 110.099 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 45.3 t80 -81.26 116.34 21.08 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.609 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 10.7 mttt -93.19 -162.52 0.95 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.6 p90 -173.21 174.14 3.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.369 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 54.3 tp -131.86 123.65 27.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.233 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HG2' HE21 ' A' ' 125' ' ' GLN . 77.1 tt0 -118.76 126.69 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.49 125.2 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.402 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.1 mp0 -106.43 128.22 53.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.559 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 38.7 p90 -153.68 168.76 25.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.819 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.6 OUTLIER -127.57 163.1 24.92 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.556 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.489 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 72.9 m -113.21 114.55 26.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.31 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.8 m -116.66 151.69 47.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.56 150.21 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.056 1.838 . . . . 0.0 111.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -84.15 -4.9 59.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.644 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.63 165.75 13.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.217 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.46 135.11 26.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.421 -178.417 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.01 75.84 40.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.48 155.2 17.29 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.386 2.724 . . . . 0.0 112.287 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.692 ' O ' ' N ' ' A' ' 34' ' ' LEU . 99.3 m-85 -79.41 -0.31 32.37 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.961 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.69 -67.27 0.0 OUTLIER Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.692 ' N ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -158.21 47.85 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 mtp 59.62 160.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.729 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.781 HH12 ' CD ' ' A' ' 51' ' ' PRO . 52.1 mtt180 -93.08 147.27 22.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -153.54 134.88 14.18 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.201 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.43 148.6 45.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.583 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -139.88 140.94 36.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.57 142.5 33.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.457 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.34 137.26 54.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.721 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 84.2 tt0 -48.88 136.22 14.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.9 38.23 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.981 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.4 m-30 -108.14 151.5 41.4 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 118.129 0.965 . . . . 0.0 109.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.47 155.0 70.59 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.515 2.143 . . . . 0.0 113.453 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.48 146.35 23.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.068 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' CG ' HH11 ' A' ' 49' ' ' ARG . 0.7 OUTLIER -122.09 130.72 53.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.569 0.7 . . . . 0.0 112.511 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.51 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 76.1 mt -121.99 130.88 53.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.661 177.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.523 HH11 ' CG ' ' A' ' 47' ' ' GLU . 3.6 mtt85 -147.23 130.54 16.58 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.218 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.472 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.4 m -97.56 143.57 26.43 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.781 ' CD ' HH12 ' A' ' 36' ' ' ARG . 18.8 Cg_endo -70.6 163.61 38.34 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.677 2.251 . . . . 0.0 112.717 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.63 -126.65 21.26 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -115.73 24.74 11.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.497 -0.352 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.94 169.15 18.77 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.911 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.91 145.91 33.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.398 0.618 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 95.8 mt -68.91 138.06 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.649 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -131.14 100.09 5.09 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.469 HG12 ' CE1' ' A' ' 89' ' ' PHE . 75.0 t -65.09 122.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.032 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 61.4 mt-10 -100.05 -47.06 5.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.551 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 59.4 m-20 -151.24 150.8 31.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.555 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.83 154.52 13.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.785 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.413 HD22 ' HA ' ' A' ' 84' ' ' TYR . 11.6 t30 -152.19 149.9 29.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 112.115 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.522 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 87.2 t80 -121.93 119.08 30.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.509 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.64 -136.79 4.56 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.02 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.611 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.8 ttm180 -155.29 117.55 4.18 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.135 0.493 . . . . 0.0 110.797 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -123.66 10.66 9.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 30.8 t0 -146.65 -169.01 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 29.6 p30 -145.33 -0.17 0.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.784 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 31.9 mtpt -102.7 6.23 39.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.538 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.9 mm -110.52 135.02 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' ALA . 83.5 m 62.13 51.58 3.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.951 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.56 95.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.738 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -116.68 -162.46 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -60.1 132.51 89.93 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.691 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.8 Cg_endo -54.64 -34.77 84.69 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.94 2.426 . . . . 0.0 114.278 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -62.32 -33.43 74.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.448 0.642 . . . . 0.0 109.79 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.509 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 25.2 mt-30 -87.41 -0.05 56.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 4.8 mtm -119.8 0.3 10.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.9 mt-10 -62.69 -50.05 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.218 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -80.13 111.53 16.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.0 m -102.59 35.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.236 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -141.49 87.81 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.401 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.2 t -145.16 122.24 11.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.413 ' HA ' HD22 ' A' ' 62' ' ' ASN . 96.7 m-85 -132.61 153.87 50.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.232 0.539 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 tp -148.59 88.33 5.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.303 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.69 -47.77 21.75 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.864 2.376 . . . . 0.0 113.868 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -54.61 -24.98 23.7 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.22 -30.96 40.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.673 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -65.77 -45.51 82.26 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.1 pttt -65.2 -43.03 92.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.681 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.55 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 59.6 mt -58.83 -45.68 91.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 93.8 mmm -69.78 -35.63 75.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.198 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.497 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 50.8 m -61.0 -47.32 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.25 -37.85 88.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.165 0.507 . . . . 0.0 111.049 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.766 ' NH2' ' SD ' ' A' ' 92' ' ' MET . 47.8 mtm180 -77.55 -33.91 53.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 33.1 m -112.52 -19.75 12.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 90.3 m-20 -61.15 135.61 57.81 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.353 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 67.34 13.68 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.303 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -113.04 145.34 41.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.328 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -70.97 -31.68 68.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.76 155.01 38.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.938 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.51 ' SG ' ' CD1' ' A' ' 48' ' ' LEU . 8.5 p -156.39 132.86 10.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.25 129.28 71.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.72 139.05 45.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.762 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 107' ' ' GLY . 58.2 t -72.94 116.18 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.81 40.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.701 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -122.66 0.85 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.6 t 29.58 -157.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.651 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -67.38 0.37 2.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.337 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.82 -13.7 50.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.571 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 112' ' ' PRO . 47.8 m-85 -144.43 126.69 8.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.199 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.593 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -48.88 -149.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.756 2.304 . . . . 0.0 112.202 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 21.8 t0 -145.18 80.11 11.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.483 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.401 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 69.6 Cg_endo -75.33 -3.56 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.25 2.633 . . . . 0.0 112.842 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.58 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.2 p -164.05 63.43 1.14 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.752 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.08 144.09 59.54 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.096 1.864 . . . . 0.0 110.299 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.72 -4.34 81.89 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 119' ' ' TYR . 80.4 m -125.73 147.86 49.24 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.666 0.733 . . . . 0.0 109.869 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.611 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 4.6 t80 -80.54 113.7 18.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 28.0 mttp -91.85 -160.3 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.575 1.178 . . . . 0.0 113.291 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -175.41 177.11 1.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.13 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.7 tp -130.39 121.45 25.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.563 ' HG2' HE21 ' A' ' 125' ' ' GLN . 56.0 tt0 -120.9 127.44 51.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.799 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -135.38 129.03 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.563 HE21 ' HG2' ' A' ' 123' ' ' GLU . 8.6 mp0 -107.97 130.26 55.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.2 173.72 15.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.364 0.602 . . . . 0.0 111.764 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 80.0 m-20 -133.23 161.13 35.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.835 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 95.4 m -111.71 111.05 21.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.97 158.53 37.55 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.355 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.99 142.04 96.48 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.862 1.708 . . . . 0.0 111.698 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -75.68 137.12 40.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.781 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -134.65 134.22 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.208 0.528 . . . . 0.0 111.154 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.2 p -92.27 129.55 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.856 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 C--O 1.223 -0.32 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.825 -179.191 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 tp -130.52 80.09 70.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.31 143.47 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.119 1.879 . . . . 0.0 112.182 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.31 -8.99 58.55 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.28 37.35 32.14 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.3 OUTLIER -164.67 49.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 0.0 110.766 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.6 mtp 55.25 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 111.075 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 36' ' ' ARG . 79.9 mtt-85 -93.21 148.21 22.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 49.1 ttp180 -148.99 137.76 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.7 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 31.5 mp0 -130.8 145.62 52.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.536 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.53 141.74 37.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.17 35.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.449 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.2 m -67.76 137.2 55.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.505 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -46.7 134.53 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.02 52.39 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.3 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.7 m-85 -107.28 147.01 34.41 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.279 1.039 . . . . 0.0 110.139 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -67.14 153.27 78.03 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.546 2.164 . . . . 0.0 112.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 ' O ' HG21 ' A' ' 46' ' ' ILE . 16.6 tt -118.14 141.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -120.22 128.22 53.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.464 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 102' ' ' CYS . 73.2 mt -116.78 142.62 46.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.391 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -152.94 133.41 13.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.84 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.2 m -102.01 147.52 34.04 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.06 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.2 Cg_endo -70.35 158.21 56.88 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 123.686 2.924 . . . . 0.0 113.317 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.92 -132.89 32.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.9 p -105.26 27.89 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.353 0.597 . . . . 0.0 109.742 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.44 162.37 25.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.097 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -126.49 147.99 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.58 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.477 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -71.18 134.8 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.635 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.6 ptm -130.32 100.72 5.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.49 0.662 . . . . 0.0 109.264 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.16 122.67 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.602 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -102.51 -48.05 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -149.4 148.66 29.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.474 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.18 154.4 10.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.8 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.521 HD22 ' HA ' ' A' ' 84' ' ' TYR . 17.7 t30 -152.3 149.69 28.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.692 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.88 121.16 37.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.81 -135.5 4.25 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.76 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -158.12 119.63 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.271 0.558 . . . . 0.0 111.1 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.511 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 38.6 p -122.6 9.77 9.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.557 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 28.5 t0 -145.36 -169.36 3.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 59.8 p30 -147.21 -1.01 0.66 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.657 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -100.09 3.41 43.97 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.708 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 44.7 mm -106.27 133.45 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 72.8 m 63.09 57.52 1.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.1 p30 -42.33 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.303 0.573 . . . . 0.0 111.843 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.95 -165.1 1.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.681 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -59.06 137.29 87.95 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.595 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.38 -35.55 75.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.383 2.056 . . . . 0.0 112.261 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -62.45 -40.53 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.509 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 15.1 mt-30 -88.3 -5.42 58.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.983 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.472 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.8 mmm -107.22 -4.6 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.507 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.3 mt-10 -65.56 -48.65 71.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -77.79 122.32 25.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 112.338 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 32.25 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -140.44 86.28 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.136 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.49 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 28.8 t -144.76 123.06 12.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.521 ' HA ' HD22 ' A' ' 62' ' ' ASN . 88.8 m-85 -134.83 153.76 51.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.241 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.1 tp -147.0 91.81 5.09 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.78 -45.26 42.36 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.773 2.315 . . . . 0.0 113.718 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.82 -15.68 32.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.51 -28.93 57.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.6 -44.16 91.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.11 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.44 -42.07 92.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.514 HG21 ' NH1' ' A' ' 95' ' ' ARG . 68.6 mt -59.68 -47.57 90.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.216 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.9 mmm -70.07 -35.51 74.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.442 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 74.1 m -63.44 -45.28 91.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.755 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.99 -36.91 85.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 0.0 111.407 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.585 HH11 ' HG3' ' A' ' 95' ' ' ARG . 51.1 mtt85 -79.9 -32.68 40.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.1 m -113.45 -13.29 12.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 87.6 m-20 -61.56 135.28 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.554 -0.859 . . . . 0.0 112.054 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 65.31 11.02 6.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -110.62 144.43 39.52 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.407 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 m -70.56 -31.79 68.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.904 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.81 154.15 41.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.738 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.88 137.08 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.511 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.94 128.92 75.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 105' ' ' VAL . 19.2 t -136.87 144.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.623 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.6 t -76.72 115.57 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.77 33.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.952 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.6 -119.76 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.99 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.4 t 32.1 -159.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.75 0.309 . . . . 0.0 111.042 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.467 ' H ' ' HG ' ' A' ' 108' ' ' SER . 86.2 m-20 -67.5 2.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.577 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.72 -11.81 56.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.187 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.587 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -146.6 129.97 8.22 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.2 Cg_exo -50.43 -146.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.461 2.107 . . . . 0.0 112.207 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -144.34 83.73 9.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.27 -7.02 17.76 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.024 2.483 . . . . 0.0 114.234 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.557 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.45 68.77 1.07 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 121.605 0.717 . . . . 0.0 111.267 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -51.74 144.28 35.0 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 122.667 2.245 . . . . 0.0 111.2 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.86 2.23 90.48 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.942 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.6 m -120.43 146.06 46.59 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.055 0.928 . . . . 0.0 109.542 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.76 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 7.6 t80 -80.88 110.5 16.46 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.557 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.9 mttp -90.49 -164.84 1.23 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.517 1.151 . . . . 0.0 113.858 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.3 p90 -170.56 169.57 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.033 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 62' ' ' ASN . 32.8 tp -127.43 124.57 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HG2' HE21 ' A' ' 125' ' ' GLN . 73.0 tt0 -120.42 125.62 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.2 125.66 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.587 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.423 HE21 ' HG2' ' A' ' 123' ' ' GLU . 4.2 mp0 -108.57 126.1 52.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.752 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.477 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.5 p90 -153.31 173.03 16.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.9 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -125.27 159.39 31.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.198 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.418 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 95.3 m -108.95 121.34 44.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.009 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 55' ' ' VAL . 29.9 m -132.03 158.63 75.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.51 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.89 144.04 79.37 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.053 1.835 . . . . 0.0 112.424 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.437 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 14.8 t80 -76.1 -10.11 59.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.665 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -141.02 128.87 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.575 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 p -92.87 138.99 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.131 -179.308 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' H ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -109.22 159.15 32.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.69 136.51 71.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.109 1.873 . . . . 0.0 111.137 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 34' ' ' LEU . 1.6 m-85 -78.95 -2.8 41.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.43 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 54.63 -69.35 0.0 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tp -164.07 109.99 1.05 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.849 -0.206 . . . . 0.0 110.894 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.4 ttm 58.13 164.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.001 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 -99.04 140.37 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -152.0 138.25 18.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.124 0.488 . . . . 0.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.618 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.3 mt-10 -130.18 149.76 51.74 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.836 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tt -137.42 140.45 41.32 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.99 138.0 38.47 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.338 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.442 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 45.8 m -66.68 137.02 56.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -45.2 130.73 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.992 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.2 -14.44 62.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.004 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 12.5 m-85 -109.34 151.59 42.18 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.884 1.342 . . . . 0.0 110.083 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.36 155.48 60.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.664 2.243 . . . . 0.0 113.039 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 tt -123.21 147.97 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.2 tt0 -128.98 124.23 34.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.1 mt -113.27 141.89 46.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 49' ' ' ARG . 17.8 mtp-105 -147.86 138.92 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.919 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.511 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.3 m -106.79 142.76 25.66 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.351 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -68.83 160.8 48.21 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.532 2.155 . . . . 0.0 112.907 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.94 -132.34 10.19 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.364 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -101.74 22.23 13.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.201 -0.5 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -77.39 165.51 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.258 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 95.5 mt -68.66 139.7 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.669 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -132.45 100.57 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' A' ' 97' ' ' ASN . 8.5 t -63.44 125.33 19.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.755 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 93.3 mt-10 -101.67 -48.79 4.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.2 m-20 -149.98 150.69 32.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.203 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -170.66 157.38 5.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.878 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 84' ' ' TYR . 13.7 t30 -150.18 146.91 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -117.61 120.63 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 155.88 -131.23 2.98 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.789 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 7.3 ttm-85 -157.1 115.01 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.483 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.443 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 28.0 p -118.25 11.14 13.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 46.0 t0 -147.89 -171.67 3.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.785 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 26.1 p-10 -145.62 -2.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 34.9 mttp -100.7 6.32 43.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.0 mm -111.9 135.83 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.15 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.3 m 53.63 75.0 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.281 0.562 . . . . 0.0 109.894 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.77 120.12 7.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.55 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.82 -164.15 1.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.607 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -59.96 134.55 90.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 119.159 -1.017 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -53.6 -33.28 68.09 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.545 2.163 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.28 -37.68 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.691 0.281 . . . . 0.0 111.146 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -86.48 2.51 47.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.203 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 38.8 mmm -121.85 -0.18 9.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 63.0 mt-10 -64.96 -48.52 73.76 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.29 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -78.38 116.85 19.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.543 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 26.5 m -105.34 36.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 71.9 mm-40 -141.14 83.42 1.88 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.547 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 31.7 t -147.13 116.86 7.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 8.7 m-85 -130.18 157.49 42.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.606 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.35 90.75 5.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -48.73 -46.8 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.121 2.547 . . . . 0.0 113.805 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -57.84 -18.33 21.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.53 65.38 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.627 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' O ' ' OG ' ' A' ' 93' ' ' SER . 56.2 t80 -65.47 -46.39 79.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.765 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -64.65 -41.05 96.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.669 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.544 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 97.8 mt -60.38 -49.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.741 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.532 ' SD ' ' CG2' ' A' ' 124' ' ' VAL . 74.7 mtp -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.401 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.1 m -55.74 -44.01 77.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.96 -37.94 82.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -75.77 -34.41 60.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -110.38 -19.78 12.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 76.4 m-20 -58.34 136.95 57.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.613 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 65.2 13.55 8.82 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.646 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -114.29 146.22 40.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.202 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.0 m -69.45 -31.03 69.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 156.15 41.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.605 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -152.4 130.18 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.09 131.59 66.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.629 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 105' ' ' VAL . 78.0 t -145.82 148.8 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.359 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 107' ' ' GLY . 95.3 t -81.44 118.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.636 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.01 38.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.083 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.662 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.3 -118.65 0.58 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.156 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.662 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.1 t 24.63 -156.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.231 0.539 . . . . 0.0 111.823 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -69.51 2.7 2.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.82 -14.38 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.548 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -144.8 130.17 9.42 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.41 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.6 Cg_exo -51.72 -145.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.981 1.787 . . . . 0.0 112.063 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -144.96 86.63 7.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.548 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.5 Cg_endo -75.63 -5.03 16.05 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.376 2.051 . . . . 0.0 112.666 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.417 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -169.78 73.7 0.67 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.246 0.546 . . . . 0.0 111.636 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -53.23 148.09 33.3 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.674 2.25 . . . . 0.0 111.6 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.58 75.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.09 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.9 m -118.97 146.79 44.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.461 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 14.5 t80 -82.82 109.24 16.78 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 28.0 mtmm -87.88 -165.2 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.507 1.146 . . . . 0.0 113.799 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 64' ' ' GLY . 5.3 p90 -170.53 171.24 6.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.048 -1.887 . . . . 0.0 111.034 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 92' ' ' MET . 27.8 tp -129.67 120.71 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.116 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.61 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -114.16 125.59 54.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.787 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.532 ' CG2' ' SD ' ' A' ' 92' ' ' MET . 38.8 t -134.37 122.51 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.839 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.61 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 3.4 mt-30 -105.97 127.28 53.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.358 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.442 ' C ' ' OD1' ' A' ' 127' ' ' ASP . 31.5 p90 -149.83 168.26 24.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 111.846 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -124.96 160.08 29.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.1 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.6 m -110.77 122.11 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.0 156.35 62.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.149 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -62.63 144.84 94.88 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.194 1.929 . . . . 0.0 111.845 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -79.03 -7.56 58.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.435 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -93.42 157.06 16.41 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.276 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.621 ' O ' ' O ' ' A' ' 134' ' ' GLU . 15.5 m -94.58 135.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.356 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.621 ' O ' ' O ' ' A' ' 133' ' ' VAL . 96.5 mt-10 . . . . . 0 C--O 1.218 -0.592 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.8 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.622 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.0 tp -123.78 78.94 56.77 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.622 ' O ' ' O ' ' A' ' 30' ' ' LEU . 72.7 Cg_exo -46.46 -131.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.975 2.45 . . . . 0.0 112.537 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 34' ' ' LEU . 55.4 p90 -77.66 -36.1 51.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.508 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.67 -47.95 0.11 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 32' ' ' PHE . 2.2 mp -160.1 117.79 2.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.034 0.445 . . . . 0.0 110.542 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 125' ' ' GLN . 43.0 ttm 70.83 144.12 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.736 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -88.13 158.02 18.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 41.5 ttm180 -142.4 138.89 31.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.392 0.615 . . . . 0.0 110.742 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -135.03 140.61 45.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.61 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 5.4 tt -139.6 133.6 30.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.49 141.1 46.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.203 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.4 m -67.67 136.65 54.69 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.573 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 88.6 tt0 -49.31 134.14 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.629 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.73 -17.94 56.74 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.21 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -113.12 152.66 45.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 118.302 1.051 . . . . 0.0 109.943 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.56 153.76 76.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.272 1.981 . . . . 0.0 113.14 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.61 139.51 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 81.2 tt0 -128.49 129.05 45.51 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.293 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 30.5 mt -111.85 144.58 40.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.44 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.641 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 91.6 mtt180 -149.26 130.33 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.675 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -96.93 145.13 29.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.813 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.84 161.91 40.49 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.329 2.019 . . . . 0.0 111.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.43 -126.73 31.99 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.69 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -117.92 23.87 11.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -75.16 168.46 19.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 m -125.84 145.6 33.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.89 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.481 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.1 mt -69.0 137.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.782 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.639 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.1 ptm -131.6 99.35 4.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.95 125.92 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.955 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.73 -50.78 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.736 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 42.8 m-20 -149.83 149.12 30.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.4 154.06 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 84' ' ' TYR . 5.5 t30 -151.18 144.1 24.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.508 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -115.41 120.32 39.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.65 -135.88 4.34 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.859 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 11.8 ttm180 -156.91 117.12 3.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 111.246 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.0 p -121.2 11.53 10.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 35.5 t0 -144.96 -167.02 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.422 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 13.1 p30 -149.83 -1.71 0.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -100.86 6.35 43.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.287 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 121' ' ' TYR . 8.5 mt -104.47 131.92 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.1 m 50.06 81.0 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.606 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 37.7 p30 -53.79 98.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.502 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.65 -172.94 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.097 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -58.15 134.71 84.36 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.191 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.1 Cg_endo -50.18 -35.82 44.06 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.629 1.553 . . . . 0.0 112.096 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -61.95 -38.34 88.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.783 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.464 ' O ' ' CG2' ' A' ' 118' ' ' THR . 24.2 mt-30 -84.3 -8.69 58.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.26 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 74.0 mtp -104.43 -0.86 27.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.267 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.4 mt-10 -61.82 -49.91 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -78.22 117.89 19.92 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 20.8 m -109.74 30.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.969 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.6 mm-40 -140.99 86.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.426 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 3.7 t -145.37 122.09 11.18 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.448 ' HA ' HD22 ' A' ' 62' ' ' ASN . 97.0 m-85 -131.96 157.42 44.11 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.9 tp -148.18 90.12 5.07 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.821 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -46.8 -47.79 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.673 2.248 . . . . 0.0 112.783 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 83.6 m-20 -56.38 -24.55 45.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.49 62.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.529 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -66.03 -44.97 83.11 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -64.66 -38.3 90.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 99.0 mt -59.33 -48.63 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.37 -36.13 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 15.6 m -58.25 -45.58 87.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.17 -38.25 85.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.67 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 80.9 mtt180 -75.76 -34.05 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 58.4 m -110.31 -20.51 12.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.48 ' CG ' ' O ' ' A' ' 93' ' ' SER . 72.5 m-20 -57.33 137.82 55.6 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.614 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.94 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -115.69 147.21 41.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.241 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.4 m -70.07 -35.75 74.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.966 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 157.76 43.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.521 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 28.4 p -153.84 141.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 111.822 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.9 126.52 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 105' ' ' VAL . 21.9 t -139.26 141.55 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.964 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.588 ' C ' ' H ' ' A' ' 107' ' ' GLY . 88.5 t -72.68 113.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.528 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.05 34.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.895 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.11 -123.21 0.81 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.678 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 6.9 t 32.76 -161.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.785 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.678 ' H ' ' HG ' ' A' ' 108' ' ' SER . 82.9 m-20 -69.06 4.49 1.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -81.28 -11.93 59.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.4 m-85 -143.01 129.82 10.68 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.0 Cg_exo -51.86 -149.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.249 1.966 . . . . 0.0 111.213 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.82 88.92 6.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.426 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 68.0 Cg_endo -84.67 -4.98 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.245 2.63 . . . . 0.0 113.274 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -168.4 73.9 0.84 Allowed Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.873 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.67 154.24 70.41 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.635 2.223 . . . . 0.0 112.728 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.25 4.65 90.43 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 77' ' ' GLN . 29.8 m -127.11 148.01 50.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 48.6 t80 -83.85 114.48 21.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.515 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 12.6 mttt -91.14 -163.83 1.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.552 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.6 p90 -171.41 172.77 5.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.513 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 48.1 tp -133.72 126.82 31.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.418 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -121.49 127.21 50.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.09 125.1 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.159 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 60' ' ' ASN . 12.0 mp0 -110.3 129.14 55.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.481 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.3 p90 -153.09 166.91 30.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.377 0.608 . . . . 0.0 112.065 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 38.8 m-20 -118.22 157.69 26.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.31 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.4 m -108.82 118.47 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.37 155.81 58.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.139 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -53.81 147.49 41.0 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 111.597 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 41.2 t80 -75.58 -2.97 31.66 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.11 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -132.77 112.83 12.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.5 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 134' ' ' GLU . 94.1 t -93.77 132.15 38.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.522 ' C ' ' CD ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.779 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.051 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.7 mp -44.0 -50.06 20.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.009 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 55.8 Cg_exo -47.32 134.62 20.03 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.566 2.177 . . . . 0.0 112.305 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -84.96 0.46 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.34 -67.24 0.24 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' PHE . 14.1 tp -159.21 51.85 0.37 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.285 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.437 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 48.6 mtm 54.22 170.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.877 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.479 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 62.4 mtp85 -94.45 148.47 22.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -153.04 142.92 22.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.204 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.1 mt-10 -133.91 149.91 51.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.946 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -141.3 134.5 29.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.243 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.515 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.6 143.77 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.705 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 m -67.39 139.04 57.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.952 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -45.13 133.12 6.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.628 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.1 63.95 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.333 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -108.24 149.43 39.21 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 118.733 1.267 . . . . 0.0 110.722 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.0 149.54 77.32 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.387 2.058 . . . . 0.0 112.935 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.8 tt -121.46 143.63 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 56.8 tt0 -129.6 128.34 42.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.252 0.549 . . . . 0.0 112.148 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 HD11 ' SG ' ' A' ' 102' ' ' CYS . 32.4 mt -113.25 141.98 46.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.952 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.622 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 82.2 mtt180 -146.95 127.55 14.18 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 m -96.52 141.56 23.29 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.76 163.79 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.59 2.193 . . . . 0.0 112.264 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.68 -138.65 18.62 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -102.37 23.2 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.745 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 92.9 m-20 -79.35 164.82 23.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.34 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.5 m -128.67 149.04 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.328 0.585 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.466 HG21 ' CD2' ' A' ' 126' ' ' TYR . 99.1 mt -69.79 135.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.504 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -131.24 98.61 4.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.9 t -61.97 122.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.713 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -100.61 -46.21 5.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -149.6 144.13 25.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.127 0.489 . . . . 0.0 110.572 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.35 147.49 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 84' ' ' TYR . 27.7 t30 -149.85 155.83 40.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.958 0.409 . . . . 0.0 111.545 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -121.01 120.59 35.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.8 -139.74 6.17 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.68 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 13.6 ttm180 -155.35 115.07 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.943 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -126.95 8.49 6.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.953 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -148.57 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.149 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 78' ' ' MET . 23.7 p-10 -114.37 5.13 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.441 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -102.48 3.4 37.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.918 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.489 HG23 HD13 ' A' ' 70' ' ' ILE . 26.3 mm -112.52 134.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.536 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.85 67.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.199 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 26.4 p-10 -52.57 102.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.009 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -116.52 -165.7 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -60.04 139.25 90.96 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.898 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 Cg_endo -54.14 -40.25 82.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.261 1.974 . . . . 0.0 113.078 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -61.95 -37.29 84.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.248 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.538 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 21.5 mt-30 -86.4 -4.79 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.53 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 89.3 mtp -107.16 -1.11 22.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 79.7 mt-10 -64.35 -48.52 75.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -79.9 119.79 23.24 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.27 31.23 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -138.47 84.2 2.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.071 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 43.3 t -146.78 121.04 9.55 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.411 ' HA ' HD22 ' A' ' 62' ' ' ASN . 80.1 m-85 -130.98 153.95 48.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.7 tp -147.12 91.36 5.15 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.68 -46.14 28.47 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 123.303 2.669 . . . . 0.0 113.972 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.2 m-20 -57.91 -20.22 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.67 65.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 58' ' ' VAL . 74.0 t80 -63.54 -42.75 98.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.488 ' NZ ' HE22 ' A' ' 94' ' ' GLN . 4.0 ptmm? -66.86 -40.57 87.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.128 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.465 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 44.8 mt -59.51 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.91 -37.8 76.08 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.5 m -59.76 -46.74 88.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.803 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.488 HE22 ' NZ ' ' A' ' 90' ' ' LYS . 66.8 mt-30 -65.83 -38.9 90.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.169 0.509 . . . . 0.0 111.127 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 95' ' ' ARG . 51.9 mtt180 -75.37 -34.13 61.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.5 m -111.59 -16.05 13.35 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 25.0 m-20 -58.85 136.73 57.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.854 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 65.89 13.86 9.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.02 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -112.34 144.45 41.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.559 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.3 m -71.93 -30.91 65.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.976 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 152.65 36.58 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.02 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 p -155.28 137.21 14.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.09 127.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.806 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.9 t -138.15 149.12 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.517 ' C ' ' H ' ' A' ' 107' ' ' GLY . 97.3 t -78.56 115.03 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.355 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.11 36.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.564 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.52 -119.95 0.65 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 107' ' ' GLY . 17.0 t 28.45 -158.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.98 0.93 5.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.242 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.48 -14.81 56.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.123 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.2 m-85 -141.75 130.82 12.32 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.228 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.9 Cg_exo -51.44 -150.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.216 1.944 . . . . 0.0 111.628 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 20.2 t0 -146.99 93.86 4.7 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 96.6 Cg_endo -84.23 -11.35 8.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.04 2.493 . . . . 0.0 114.814 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.463 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 3.9 p -166.85 66.94 0.92 Allowed Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.4 153.56 33.91 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.315 2.01 . . . . 0.0 110.743 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.36 73.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.481 HG21 ' N ' ' A' ' 119' ' ' TYR . 97.5 m -126.12 148.33 49.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.59 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.6 t80 -81.04 113.36 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 13.0 mtmm -91.29 -160.77 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.131 0.967 . . . . 0.0 113.166 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.9 p90 -174.35 175.33 2.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.801 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -133.58 127.14 32.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.0 tt0 -119.23 130.11 55.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.8 t -133.08 121.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.928 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.472 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mt-30 -108.8 132.21 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.466 ' CD2' HG21 ' A' ' 56' ' ' ILE . 48.6 p90 -155.02 173.18 16.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.485 0.659 . . . . 0.0 111.856 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.437 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 41.9 m-20 -125.5 156.0 39.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.453 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.479 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 85.7 m -108.66 115.76 30.69 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.163 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.9 m -120.49 155.24 56.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -54.84 145.62 60.62 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.28 1.987 . . . . 0.0 112.682 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -76.38 127.41 32.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.46 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -120.01 133.95 55.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.226 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.87 140.53 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.358 179.942 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.477 ' H1 ' ' H ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.477 ' H ' ' H1 ' ' A' ' 29' ' ' GLY . 1.3 mp 52.17 77.84 0.43 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.936 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.07 154.13 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.805 2.336 . . . . 0.0 111.736 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.35 -29.8 42.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.618 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.26 8.61 12.71 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 35' ' ' MET . 14.6 tp -160.82 119.13 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.576 ' O ' ' O ' ' A' ' 34' ' ' LEU . 1.6 mtm 52.95 130.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.599 0.714 . . . . 0.0 111.1 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.476 HH21 ' HG3' ' A' ' 51' ' ' PRO . 92.9 mtt-85 -91.26 149.9 21.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.216 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -146.14 130.05 17.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.558 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -127.25 145.21 50.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 6.5 tt -138.73 140.78 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.283 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.72 136.61 37.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.559 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.7 m -65.01 140.76 58.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 110.481 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.07 126.66 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.488 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.2 65.87 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.691 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -107.36 154.59 40.52 Favored Pre-proline 0 C--O 1.226 -0.136 0 CA-C-N 118.801 1.301 . . . . 0.0 109.812 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -71.93 152.08 57.24 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.953 1.769 . . . . 0.0 112.38 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.19 147.49 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.65 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 72.1 tt0 -130.01 129.76 44.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.466 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 ' SG ' ' A' ' 102' ' ' CYS . 31.1 mt -115.84 136.93 52.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.65 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 90.6 mtt180 -144.48 140.1 28.7 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.877 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -104.41 143.99 27.79 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.154 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HG3' HH21 ' A' ' 36' ' ' ARG . 37.8 Cg_endo -70.76 160.44 49.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.988 2.458 . . . . 0.0 112.193 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -127.06 23.85 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.0 p -114.3 24.97 11.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.46 168.28 20.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.202 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.24 144.86 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.196 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 126' ' ' TYR . 82.7 mt -68.89 138.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.779 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.611 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.5 ptm -132.54 100.66 5.04 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.12 125.0 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.524 -178.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 90.3 mt-10 -102.66 -47.82 4.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.3 m-20 -149.73 149.35 30.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.662 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.0 153.82 14.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -150.27 139.45 21.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HH ' ' HD2' ' A' ' 120' ' ' LYS . 63.1 t80 -111.65 118.01 34.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.42 -137.37 4.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 10.0 ttm-85 -154.77 120.27 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.493 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.749 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 4.8 p -121.43 9.19 10.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.636 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 34.4 t0 -143.47 -164.6 1.9 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 4.1 p30 -149.18 -1.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 109.808 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -104.61 5.88 34.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.887 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.445 HD12 HG23 ' A' ' 70' ' ' ILE . 45.3 mm -107.82 136.85 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.106 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.1 m 54.22 69.71 0.69 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.1 p-10 -49.26 103.67 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.786 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.47 -165.62 1.22 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.689 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -61.97 144.76 93.62 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 111.333 -179.693 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.3 Cg_endo -61.17 -39.4 59.1 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.606 2.204 . . . . 0.0 112.838 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -62.67 -32.13 73.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.689 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 71.0 mt-30 -89.23 -11.53 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 67.1 mmm -104.13 -2.76 25.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.877 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.1 mt-10 -66.9 -45.24 78.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.65 114.52 19.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.478 0.656 . . . . 0.0 112.091 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 15.9 m -104.94 34.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.06 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.5 mm-40 -142.64 87.37 2.0 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.372 0.606 . . . . 0.0 110.894 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.8 t -145.22 118.08 8.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -130.77 154.18 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.715 -178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 13.3 tp -143.29 85.86 9.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.45 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.64 -50.0 11.21 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.052 2.501 . . . . 0.0 114.006 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -57.61 -22.99 48.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.588 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 85' ' ' LEU . . . -52.01 -32.63 34.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.95 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.87 -42.23 95.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.565 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.5 pttt -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.925 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.3 mt -60.52 -47.74 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.795 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -70.03 -37.5 75.61 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.013 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.8 m -60.35 -46.64 89.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.03 -36.0 82.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.612 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -79.34 -30.93 42.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.7 m -112.03 -19.74 12.22 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 71.6 m-20 -55.61 131.4 46.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.86 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 69.37 13.8 8.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -113.89 146.53 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.131 178.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 m -69.91 -29.04 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.901 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 158.3 41.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.907 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HD13 ' A' ' 48' ' ' LEU . 3.6 p -156.44 139.08 15.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.9 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.56 127.32 75.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.248 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.8 t -136.66 144.02 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.0 t -77.14 114.15 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.24 36.99 0.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.417 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.02 -121.42 0.71 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.7 t 29.0 -158.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.124 0.487 . . . . 0.0 111.222 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' N ' ' OG ' ' A' ' 108' ' ' SER . 21.7 m-20 -68.72 2.76 2.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.36 -15.82 48.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.281 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.6 m-85 -143.42 126.26 8.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.589 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.0 Cg_exo -52.03 -143.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.945 . . . . 0.0 111.495 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 23.8 t0 -143.25 83.39 11.04 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.68 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.26 -5.19 16.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.938 2.426 . . . . 0.0 112.763 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.581 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -168.35 74.29 0.85 Allowed Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 110.974 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.98 144.2 94.82 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 121.901 1.734 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.3 -8.32 78.99 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.266 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' N ' ' A' ' 119' ' ' TYR . 94.9 m -115.37 148.45 39.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.036 0.918 . . . . 0.0 109.759 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' HG23 ' A' ' 118' ' ' THR . 28.9 t80 -81.28 113.92 19.72 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.581 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 14.8 mttp -92.98 -161.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.939 1.352 . . . . 0.0 114.161 -176.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.749 ' HH ' ' H ' ' A' ' 66' ' ' THR . 4.9 p90 -174.06 174.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.377 -2.192 . . . . 0.0 110.491 176.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 31.0 tp -128.32 122.11 30.8 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -131.51 127.45 59.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.841 -179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -105.92 124.66 49.93 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.456 ' CD1' HG22 ' A' ' 56' ' ' ILE . 29.5 p90 -149.86 168.35 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 m-20 -124.64 161.52 26.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.0 m -110.1 113.0 25.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 m -118.61 159.41 44.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.92 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.49 150.24 69.82 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.695 2.263 . . . . 0.0 112.573 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.86 -14.25 59.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.195 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -91.59 139.7 30.45 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.505 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 134' ' ' GLU . 7.9 p -93.78 137.3 23.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.849 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 133' ' ' VAL . 64.3 mt-10 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.534 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.491 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -50.52 -52.19 57.81 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.897 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 30' ' ' LEU . 39.6 Cg_endo -71.27 -110.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.536 2.158 . . . . 0.0 112.551 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -77.43 -40.32 43.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.849 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.77 42.88 30.18 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 34' ' ' LEU . 7.0 tt -158.08 11.59 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.551 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.446 ' O ' ' O ' ' A' ' 34' ' ' LEU . 3.4 mtt 56.46 140.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.317 0.58 . . . . 0.0 112.104 178.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 23.5 mtp180 -93.98 148.55 22.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' OE2' ' A' ' 123' ' ' GLU . 32.2 ttp180 -150.99 139.43 20.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.274 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 52.4 mp0 -132.87 145.64 51.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.819 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -137.09 138.76 40.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -137.32 143.92 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.218 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 m -68.17 135.62 52.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.686 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 80.8 tt0 -46.94 136.0 8.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.443 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 -17.45 58.78 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.044 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 31.7 m-85 -108.69 149.78 39.91 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 118.135 0.968 . . . . 0.0 110.314 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.59 149.68 68.28 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.08 1.853 . . . . 0.0 112.636 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.57 146.54 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.181 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 49' ' ' ARG . 80.6 tt0 -130.98 127.26 38.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.75 -179.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -111.37 140.06 46.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.427 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.575 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 6.5 mtt180 -145.17 133.04 21.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.448 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -99.85 144.11 27.75 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.041 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.6 Cg_endo -68.22 161.51 44.28 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.376 2.051 . . . . 0.0 112.57 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.32 -133.13 25.19 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.512 178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.8 p -103.3 22.87 13.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.679 -0.761 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -78.95 167.6 20.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.23 0.538 . . . . 0.0 111.65 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.99 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.321 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.448 HG12 ' SG ' ' A' ' 50' ' ' CYS . 62.1 mt -71.06 137.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.651 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.626 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -131.81 98.4 4.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.814 0.816 . . . . 0.0 109.222 178.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.69 124.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.648 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 97.7 mt-10 -104.01 -47.2 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.541 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 33.2 m-20 -149.61 147.17 27.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.747 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.47 154.16 9.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.292 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 84' ' ' TYR . 12.7 t30 -149.3 144.5 26.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HH ' ' HG3' ' A' ' 42' ' ' GLU . 66.7 t80 -113.87 116.49 29.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.67 -133.74 3.34 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.736 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 4.8 ttm180 -153.97 117.68 4.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 84' ' ' TYR . 26.8 p -122.53 3.21 9.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.049 179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -148.33 156.68 42.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -114.4 3.86 15.14 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -104.19 4.0 33.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.698 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 HG22 ' A' ' 70' ' ' ILE . 45.3 mm -112.16 138.41 41.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 m 56.83 69.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.679 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -57.14 118.89 5.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.378 0.608 . . . . 0.0 111.815 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -134.41 -162.07 1.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.623 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -63.2 134.9 96.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.037 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.476 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.0 Cg_endo -56.1 -34.52 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.195 1.93 . . . . 0.0 113.584 -177.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -61.85 -37.04 83.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.22 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.441 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 21.6 mt-30 -84.92 -1.23 56.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.736 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 mtm -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.308 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.0 mt-10 -63.19 -43.41 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.854 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -79.87 117.02 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.74 33.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -141.72 83.02 1.83 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.191 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.412 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 24.1 t -143.16 125.85 15.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CE2' HG22 ' A' ' 66' ' ' THR . 65.0 m-85 -136.0 153.6 51.33 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.0 tp -147.88 92.61 4.66 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.584 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -49.97 -44.78 35.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.783 2.322 . . . . 0.0 113.147 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.58 -19.13 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.22 67.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 110.29 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' O ' ' OG ' ' A' ' 93' ' ' SER . 18.1 t80 -66.78 -46.57 74.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.563 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.64 -39.55 93.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.789 -178.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' HE ' ' A' ' 95' ' ' ARG . 83.7 mt -62.15 -54.01 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.6 mmm -66.58 -36.26 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.699 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 50.9 m -60.88 -45.38 94.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.004 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -65.3 -36.21 83.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.36 0.6 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.473 ' HE ' HG22 ' A' ' 91' ' ' ILE . 91.2 mtt-85 -78.36 -32.64 49.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 5.9 m -112.28 -16.55 12.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 44.1 m-20 -61.18 133.43 55.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.378 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 66.75 10.88 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.394 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -110.6 144.93 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.321 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -68.77 -35.16 76.71 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.98 156.56 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.54 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -153.59 138.89 17.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 0.0 111.486 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.8 t -118.92 130.94 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.549 178.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 105' ' ' VAL . 57.5 t -143.46 148.69 18.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.103 -178.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' N ' HG12 ' A' ' 104' ' ' VAL . 23.8 t -84.83 115.66 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.171 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.11 38.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.514 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.82 -124.11 0.88 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.8 t 30.24 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -65.91 0.84 1.62 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.224 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -84.62 -11.3 56.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.583 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.8 m-85 -145.96 128.17 7.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.1 Cg_exo -49.55 -149.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.177 1.918 . . . . 0.0 111.945 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.22 82.16 12.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.313 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.408 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 91.1 Cg_endo -76.97 -6.6 16.84 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.149 2.566 . . . . 0.0 113.459 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.5 p -165.94 74.23 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.343 0.592 . . . . 0.0 111.171 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.94 148.45 88.72 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.974 1.782 . . . . 0.0 111.476 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.11 -5.04 78.54 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 119' ' ' TYR . 94.0 m -115.88 148.8 39.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.972 0.886 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 13.6 t80 -83.31 114.14 21.2 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.454 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 16.3 mttp -91.11 -161.45 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.574 1.178 . . . . 0.0 113.245 -176.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.478 ' OH ' ' OG1' ' A' ' 66' ' ' THR . 3.5 p90 -171.98 172.03 4.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.062 -1.881 . . . . 0.0 110.643 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.3 tp -129.0 123.3 32.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 79.4 tt0 -118.6 122.79 43.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.21 126.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.497 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -109.55 130.79 55.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -153.61 171.99 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 111.691 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.508 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 74.3 m-20 -125.19 158.59 33.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.89 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.4 m -107.66 119.98 40.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.443 HG12 ' SD ' ' A' ' 57' ' ' MET . 20.7 m -122.57 154.82 63.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.183 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.5 143.81 54.06 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.026 1.817 . . . . 0.0 111.098 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.51 105.07 7.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -92.68 141.16 28.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.743 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -85.55 137.42 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.575 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.918 179.714 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -38.77 -64.11 0.52 Allowed Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 30' ' ' LEU . 10.4 Cg_endo -54.72 150.94 34.03 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.005 2.47 . . . . 0.0 112.25 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.704 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 47.1 p90 -151.68 -62.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.704 ' N ' ' CD2' ' A' ' 32' ' ' PHE . . . 61.64 6.36 8.59 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -157.1 107.64 2.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 110.75 -179.902 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 7.4 mtt 53.71 137.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -88.26 151.12 22.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.943 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 32.4 ttp180 -146.91 133.81 20.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.531 0.682 . . . . 0.0 111.899 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.688 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -133.07 144.76 50.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.484 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.3 tt -140.12 137.52 34.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.541 179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.9 140.99 42.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.247 0.546 . . . . 0.0 110.618 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -66.39 136.18 55.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.23 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -47.12 136.06 9.19 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 111.628 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.94 61.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.12 178.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.18 156.02 38.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 118.118 0.959 . . . . 0.0 110.732 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.08 149.99 29.13 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.998 1.799 . . . . 0.0 111.38 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.4 tt -120.74 145.63 26.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.685 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 75.8 tt0 -128.69 128.28 43.77 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.871 -178.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.8 mt -111.53 145.34 39.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.179 178.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.685 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 69.6 mtt180 -148.69 133.28 17.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.662 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.469 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -100.75 148.35 34.9 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.937 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.23 159.29 40.7 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.509 2.14 . . . . 0.0 112.169 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.22 -128.42 34.59 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.491 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.8 p -112.8 24.86 11.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.333 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.95 167.3 21.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 179.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.53 145.98 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.485 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.478 HG22 ' CD1' ' A' ' 126' ' ' TYR . 79.7 mt -69.62 137.95 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.723 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.44 ' N ' HG23 ' A' ' 56' ' ' ILE . 2.5 ptp -130.93 102.11 5.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.87 124.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.873 -177.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -102.46 -51.83 3.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.993 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 22.9 m-80 -148.59 144.32 27.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 0.0 110.463 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' GLU . . . -166.97 150.85 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.945 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 84' ' ' TYR . 39.4 t30 -148.81 157.25 43.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' HH ' ' HD2' ' A' ' 120' ' ' LYS . 80.0 t80 -125.53 121.94 35.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.559 179.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.7 -134.5 3.73 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.709 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 14.6 ttm180 -157.96 119.5 3.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 0.0 111.579 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 p -125.09 9.86 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.28 158.62 44.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.128 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 53.7 p-10 -117.59 5.77 12.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -100.59 4.83 43.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.98 135.63 51.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.707 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.3 m 57.25 66.13 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 56.6 p30 -45.82 94.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.988 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -112.53 -162.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -62.67 142.59 96.86 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 121.446 0.641 . . . . 0.0 111.488 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 15.1 Cg_endo -57.21 -39.54 89.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.402 2.068 . . . . 0.0 112.78 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -64.74 -35.12 80.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.482 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.558 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.8 mt-30 -85.9 -7.18 58.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.825 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.709 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 3.8 mmm -107.64 -2.52 20.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.44 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 40.4 mm-40 -62.88 -49.95 72.81 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -78.06 113.13 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.598 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.7 m -104.55 30.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.362 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -142.14 89.63 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 16.7 t -146.06 120.05 9.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.786 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' HA ' HD22 ' A' ' 62' ' ' ASN . 95.1 m-85 -132.1 151.63 51.67 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.998 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -146.89 88.46 5.94 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.102 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -48.5 -48.4 17.4 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.25 2.633 . . . . 0.0 113.847 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 78.5 m-20 -51.65 -29.58 18.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.549 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.1 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.135 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 48.1 t80 -62.45 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.492 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.555 ' O ' ' NE2' ' A' ' 94' ' ' GLN . 3.5 pttt -66.03 -38.93 89.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.853 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 18.6 mt -60.26 -52.47 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.353 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.3 mmm -66.86 -37.55 84.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.385 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.4 m -61.78 -47.37 85.46 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.139 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -69.84 -34.38 73.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.08 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.528 HH11 HG12 ' A' ' 104' ' ' VAL . 61.0 mtt180 -75.4 -32.46 60.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.6 m -112.46 -16.96 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.565 ' CG ' ' O ' ' A' ' 93' ' ' SER . 89.7 m-20 -58.15 133.87 55.98 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.052 -178.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 67.69 13.12 9.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.283 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -115.19 148.27 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.036 178.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.5 m -71.44 -31.6 67.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.009 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.71 157.47 42.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.449 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.5 p -155.68 143.03 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.907 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 89.1 t -121.58 125.06 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.528 HG12 HH11 ' A' ' 95' ' ' ARG . 39.2 t -137.68 145.43 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' A' ' 107' ' ' GLY . 43.3 t -79.7 117.02 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.018 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.97 36.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.71 -121.65 0.75 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.733 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 31.9 -160.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.197 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.39 -0.42 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -84.12 -14.33 50.61 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.812 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 112' ' ' PRO . 48.9 m-85 -143.38 127.37 9.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.166 178.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.3 Cg_exo -49.62 -149.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.331 2.021 . . . . 0.0 112.119 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.495 ' CG ' ' HZ2' ' A' ' 120' ' ' LYS . 10.5 t0 -145.82 82.46 9.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.431 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.5 Cg_endo -77.24 -2.25 12.45 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.103 2.535 . . . . 0.0 113.697 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.541 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -167.85 68.51 0.84 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 110.511 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.14 151.09 29.48 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.98 2.454 . . . . 0.0 111.775 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 -1.71 60.37 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 m -117.65 146.7 43.5 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.628 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.1 t80 -84.89 115.81 22.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.074 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.541 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 17.8 mttp -92.62 -160.33 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -174.18 176.49 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.525 -1.671 . . . . 0.0 111.909 176.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 tp -135.68 125.82 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.995 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.451 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.1 tt0 -118.68 127.24 53.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.47 123.75 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.199 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.451 HE21 ' HG2' ' A' ' 123' ' ' GLU . 1.8 mt-30 -110.07 129.66 55.65 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.327 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.478 ' CD1' HG22 ' A' ' 56' ' ' ILE . 40.3 p90 -152.94 169.56 22.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.352 0.596 . . . . 0.0 111.437 -178.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.439 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 85.9 m-20 -122.88 158.44 30.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.57 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 96.7 m -111.33 111.67 22.89 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.407 HG11 ' CE ' ' A' ' 57' ' ' MET . 20.3 m -112.55 154.2 44.72 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -58.27 145.82 91.7 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.109 1.873 . . . . 0.0 112.216 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -74.58 136.63 42.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -94.03 146.22 24.1 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.083 -178.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.4 t -86.67 132.89 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.478 -179.431 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER 56.44 49.39 4.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.809 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 10.7 Cg_endo -60.87 146.85 96.93 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.467 2.111 . . . . 0.0 111.825 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -79.38 -9.29 59.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.556 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 0.01 25.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 35' ' ' MET . 25.8 tp -164.98 88.77 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.043 0.449 . . . . 0.0 110.281 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.3 mtt 60.41 142.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -91.1 148.39 22.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.668 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 31.4 ttm105 -146.44 136.08 23.13 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.839 0.828 . . . . 0.0 111.373 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 45.5 mp0 -134.67 145.54 48.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.238 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -140.32 139.78 35.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.389 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' N ' HD21 ' A' ' 39' ' ' LEU . . . -136.65 137.42 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.13 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.2 m -70.41 139.67 51.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 0.0 110.503 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.504 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 80.7 tt0 -47.51 135.17 11.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.129 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.96 -19.0 56.3 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.93 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.56 148.71 38.67 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 118.376 1.088 . . . . 0.0 109.78 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.57 154.57 73.15 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.38 144.15 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -124.79 127.04 46.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.582 -179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 72.2 mt -118.1 141.06 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.037 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -148.58 136.31 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.909 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.9 147.97 35.11 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.205 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 62.8 Cg_endo -75.3 156.92 41.71 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.005 2.47 . . . . 0.0 112.136 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -132.23 39.75 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.5 p -109.4 27.45 9.53 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.18 0.514 . . . . 0.0 111.143 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.45 163.9 25.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.28 145.28 34.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.927 178.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.494 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.2 mt -68.67 138.09 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.409 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.447 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.4 ptp -131.24 98.6 4.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.67 124.76 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.165 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.3 mm-40 -100.99 -47.33 4.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.3 m-20 -149.21 147.47 28.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.825 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.47 151.15 11.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.585 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.482 HD22 ' HA ' ' A' ' 84' ' ' TYR . 32.0 t30 -150.26 146.49 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.229 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.504 ' HH ' ' HG3' ' A' ' 42' ' ' GLU . 94.7 t80 -117.17 120.73 39.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.32 -137.72 5.16 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.132 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.0 ttm-85 -155.78 113.45 3.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.218 0.532 . . . . 0.0 109.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.539 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 16.6 p -121.23 11.05 10.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.968 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.655 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 47.3 t0 -146.74 -173.67 4.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.431 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.655 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 39.4 p30 -145.55 1.05 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.501 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -101.24 4.86 42.21 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.724 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.06 135.5 52.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.472 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.3 m 58.05 66.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.311 0.577 . . . . 0.0 109.814 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -53.2 122.15 8.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.105 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.82 -164.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.872 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.667 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.8 p30 -59.91 135.41 90.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.828 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.19 -32.22 59.01 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 113.283 -178.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -63.62 -38.03 89.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.667 HE21 ' CG ' ' A' ' 74' ' ' ASP . 35.3 mt-30 -85.5 -0.92 56.37 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.417 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 81.5 mtp -115.27 -1.25 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.172 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -62.42 -47.56 83.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.434 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 50.7 t30 -80.97 117.62 21.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.49 33.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.172 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -140.05 84.55 1.97 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.456 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 54.1 t -147.2 117.33 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.482 ' HA ' HD22 ' A' ' 62' ' ' ASN . 96.9 m-85 -128.02 155.72 43.87 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.322 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.5 tp -148.55 83.47 6.98 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.92 -45.36 20.94 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.792 2.328 . . . . 0.0 114.441 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -57.21 -20.77 29.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.929 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.34 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.868 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' OG ' ' A' ' 93' ' ' SER . 24.4 t80 -65.29 -43.56 90.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.776 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HZ3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -65.32 -39.85 92.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.178 -179.038 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.564 HG21 ' HE ' ' A' ' 95' ' ' ARG . 75.8 mt -58.38 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.48 -38.68 87.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.038 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.597 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.1 m -59.28 -45.67 90.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.93 -37.95 89.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.979 0.418 . . . . 0.0 110.56 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.564 ' HE ' HG21 ' A' ' 91' ' ' ILE . 92.7 mtt-85 -73.59 -34.46 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.51 -16.57 12.84 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -58.79 133.54 56.07 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.798 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 65.9 13.45 9.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.13 178.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -115.44 147.31 40.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.17 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.8 m -74.12 -30.26 62.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 153.27 32.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 27.2 p -154.92 141.63 18.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.622 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.61 127.73 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.85 146.87 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.731 0.3 . . . . 0.0 111.01 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 107' ' ' GLY . 89.5 t -78.98 114.41 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.214 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.76 39.26 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.849 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.45 -125.09 0.9 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.418 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.65 -157.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.395 0.616 . . . . 0.0 111.935 -179.298 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -66.39 -1.49 3.54 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.426 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.09 -14.9 57.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.243 -179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 58.2 m-85 -144.99 127.07 8.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.9 Cg_exo -51.78 -145.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.904 1.736 . . . . 0.0 112.355 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 12.4 t0 -145.75 85.2 7.85 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.537 -179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 74.2 Cg_endo -74.24 -6.25 18.14 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.225 . . . . 0.0 113.537 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.564 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -169.93 70.78 0.63 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.634 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 51.6 Cg_exo -48.76 153.52 3.58 Favored 'Trans proline' 0 C--N 1.294 -2.296 0 C-N-CA 123.003 2.469 . . . . 0.0 111.922 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.76 10.46 83.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.795 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 119' ' ' TYR . 91.9 m -124.67 147.73 48.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.481 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 11.4 t80 -86.15 109.49 18.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.1 mttp -91.28 -161.75 0.85 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.46 1.124 . . . . 0.0 114.02 -175.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.539 ' HH ' ' H ' ' A' ' 66' ' ' THR . 7.6 p90 -171.76 171.43 5.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.694 177.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.1 tp -130.37 127.97 40.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.165 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.515 ' HG3' HE21 ' A' ' 125' ' ' GLN . 8.0 tp10 -124.19 128.35 49.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -135.55 129.09 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.444 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.515 HE21 ' HG3' ' A' ' 123' ' ' GLU . 10.0 mp0 -109.97 130.59 55.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.494 ' CD1' HG23 ' A' ' 56' ' ' ILE . 24.2 p90 -153.37 173.08 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 -178.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 57' ' ' MET . 76.9 m-20 -128.57 163.05 25.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.333 178.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.411 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -109.82 120.43 42.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.574 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.67 152.15 74.35 Favored Pre-proline 0 N--CA 1.463 0.184 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 132' ' ' LYS . 11.2 Cg_exo -54.27 142.74 67.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.555 1.503 . . . . 0.0 112.034 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 31.2 t80 -75.05 12.47 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.261 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 130' ' ' PRO . 70.8 mmtt -92.79 152.76 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 134' ' ' GLU . 38.5 t -93.07 141.31 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.507 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 133' ' ' VAL . 70.4 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.5 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.62 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -66.8 123.62 86.44 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.519 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -51.71 132.26 40.76 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.645 1.563 . . . . 0.0 111.159 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' O ' ' N ' ' A' ' 34' ' ' LEU . 39.4 p90 -78.13 -9.34 59.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.083 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.34 -67.38 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 32' ' ' PHE . 13.7 tp -160.01 115.08 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.1 mtp 57.23 157.65 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -90.76 146.22 24.15 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.32 138.31 29.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.495 0.664 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -135.62 141.56 45.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.86 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -137.92 137.09 37.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.129 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' N ' HD22 ' A' ' 39' ' ' LEU . . . -137.79 140.5 40.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.491 . . . . 0.0 110.446 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.71 136.72 55.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -178.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.664 ' CD ' ' HH ' ' A' ' 63' ' ' TYR . 86.2 tt0 -47.85 137.9 9.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.003 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.3 56.96 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.823 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -105.71 150.71 39.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.904 0.852 . . . . 0.0 110.241 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.26 149.73 46.03 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.593 2.195 . . . . 0.0 112.761 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 tt -118.4 147.73 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.612 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 84.0 tt0 -129.39 126.51 39.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.118 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -113.84 148.08 37.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.042 178.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.612 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 95.4 mtt180 -153.8 129.63 10.15 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.67 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.3 m -96.23 147.25 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.871 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.0 Cg_endo -70.07 156.64 62.06 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.07 1.847 . . . . 0.0 111.669 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.7 -139.28 17.45 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.845 0.691 . . . . 0.0 113.099 177.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.4 p -96.25 21.25 9.2 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.237 -0.981 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.54 165.07 24.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.732 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.512 HG11 ' CG ' ' A' ' 131' ' ' TYR . 35.1 m -130.32 147.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.755 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.476 HG12 ' SG ' ' A' ' 50' ' ' CYS . 62.0 mt -69.92 137.41 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.847 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.6 ptp -130.82 100.11 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.63 123.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.362 -178.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.513 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 93.6 mt-10 -102.08 -51.75 3.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.816 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -150.02 146.37 26.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.232 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.08 155.74 12.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.353 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.506 HD22 ' HA ' ' A' ' 84' ' ' TYR . 10.8 t30 -149.91 144.33 25.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.664 ' HH ' ' CD ' ' A' ' 42' ' ' GLU . 78.3 t80 -116.65 121.62 42.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.68 -141.09 7.23 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 16.0 ttm180 -146.57 116.91 7.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.23 0.538 . . . . 0.0 110.805 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.623 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 22.1 p -125.26 2.51 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.644 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 61.2 t0 -144.76 150.21 36.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.795 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 54.6 p30 -110.12 5.46 22.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 58.8 mttm -100.33 -0.46 38.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.416 -178.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.38 136.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.516 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.1 m 59.23 64.0 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -54.33 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.066 -178.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.25 -160.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.79 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.694 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -60.01 134.96 90.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.885 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.91 -34.32 75.7 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.127 1.885 . . . . 0.0 112.81 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.14 -36.8 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.679 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.2 mt-30 -86.72 -10.72 53.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.491 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.498 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 81.7 mtp -102.03 -3.67 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.71 -44.86 88.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.109 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 51.9 t30 -81.28 118.65 22.8 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.06 29.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -139.49 81.76 1.85 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.175 178.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 2.2 t -142.81 118.8 10.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.506 ' HA ' HD22 ' A' ' 62' ' ' ASN . 71.9 m-85 -130.96 156.44 45.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.808 -178.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -145.17 88.72 6.66 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.241 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.4 -45.11 19.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.247 1.964 . . . . 0.0 112.822 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 89.8 m-20 -57.45 -16.66 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.21 72.56 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' OG ' ' A' ' 93' ' ' SER . 47.9 t80 -65.28 -45.56 83.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.83 -37.87 89.08 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.561 -178.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG21 ' NH1' ' A' ' 95' ' ' ARG . 91.1 mt -58.95 -52.74 56.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.817 0.341 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.8 mmm -67.26 -33.42 75.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.179 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.583 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.8 m -59.93 -49.73 76.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -66.95 -39.02 87.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 112.069 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' HG21 ' A' ' 91' ' ' ILE . 65.9 mtt85 -77.05 -32.43 56.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.51 -15.58 12.55 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.583 ' CG ' ' O ' ' A' ' 93' ' ' SER . 58.2 m-20 -61.32 133.77 56.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.034 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 70.36 14.74 7.45 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -111.44 143.95 41.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.07 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.0 m -68.67 -28.28 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.09 158.3 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.064 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.9 t -152.81 139.06 18.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.465 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.09 126.63 64.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.038 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.3 t -143.49 141.57 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.036 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 107' ' ' GLY . 64.7 t -76.73 115.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.957 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.66 35.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.091 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -177.44 -127.7 1.08 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.51 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.635 ' HG ' ' H ' ' A' ' 109' ' ' ASP . 1.4 t 32.29 -159.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.017 0.437 . . . . 0.0 111.02 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.635 ' H ' ' HG ' ' A' ' 108' ' ' SER . 92.3 m-20 -66.43 1.94 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.25 -179.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.54 -13.0 55.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.688 -179.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 44.4 m-85 -144.6 133.07 10.9 Favored Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.984 179.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.3 Cg_exo -56.05 -145.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.6 1.533 . . . . 0.0 111.471 178.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -145.25 90.55 6.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.93 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.414 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 95.7 Cg_endo -81.16 -4.09 12.42 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.297 2.664 . . . . 0.0 114.25 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.448 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -167.68 66.36 0.78 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -52.74 147.7 30.7 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.71 2.273 . . . . 0.0 111.588 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.16 -6.76 74.31 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 119' ' ' TYR . 87.2 m -118.88 148.08 43.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 45.8 t80 -85.72 120.74 27.48 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.5 mttm -96.86 -157.51 0.6 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -176.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.623 ' HH ' ' H ' ' A' ' 66' ' ' THR . 7.1 p90 -174.6 177.27 2.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.498 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.88 122.29 24.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.82 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -116.49 127.89 54.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -136.82 127.37 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.008 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -114.6 132.28 56.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 56' ' ' ILE . 31.8 p90 -155.01 169.98 22.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.219 0.533 . . . . 0.0 112.427 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 79.6 m-20 -120.91 160.45 23.45 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.4 m -112.05 118.33 35.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.694 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.79 159.35 61.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.774 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.22 144.9 68.58 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.121 1.881 . . . . 0.0 112.331 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.653 ' CD1' ' N ' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -76.29 -154.01 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.082 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.653 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 20.6 pttp -98.08 160.27 14.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.68 126.78 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.353 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.653 179.732 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -150.58 137.11 18.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.944 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HG3' HD23 ' A' ' 48' ' ' LEU . 73.0 mm-40 -129.8 144.7 51.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.991 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.01 141.91 38.3 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.759 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.77 142.67 31.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.399 0.619 . . . . 0.0 111.49 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.6 m -66.78 135.17 53.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.133 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG3' ' OH ' ' A' ' 63' ' ' TYR . 77.3 tt0 -47.61 134.93 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.509 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.61 -16.67 60.63 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.452 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 13.4 m-85 -107.47 155.86 38.83 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 118.272 1.036 . . . . 0.0 108.831 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.23 154.47 28.65 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.512 1.475 . . . . 0.0 112.188 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 46' ' ' ILE . 12.9 tt -116.44 150.68 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.035 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 33.0 tt0 -126.93 130.89 50.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.672 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.0 mt -122.07 136.1 54.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.692 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 87.0 mtt180 -146.43 134.7 21.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.0 110.705 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.1 m -103.63 145.53 30.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.092 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -70.23 155.74 63.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.988 1.792 . . . . 0.0 112.51 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.21 -131.69 24.88 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.63 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.9 p -102.86 22.32 14.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.497 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.95 165.07 24.53 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 129' ' ' VAL . 30.0 m -125.58 145.67 32.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.837 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.9 mt -67.89 135.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.6 ptm -131.65 98.04 4.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.8 t -61.73 122.44 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.591 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -99.33 -51.66 3.74 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -151.24 150.01 30.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.97 154.21 7.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 84' ' ' TYR . 2.5 t30 -148.75 146.19 27.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' OH ' ' HG3' ' A' ' 42' ' ' GLU . 49.3 t80 -114.49 118.08 32.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.34 -139.3 5.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.949 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.694 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 11.5 ttm-85 -151.36 119.69 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.123 0.487 . . . . 0.0 111.475 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.402 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.3 p -126.86 4.78 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.116 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 51.7 t0 -146.99 153.28 39.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.777 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 24.8 p-10 -110.31 4.87 21.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.956 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -103.98 4.07 34.16 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.138 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.7 mm -110.23 133.84 54.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m 57.14 70.12 0.68 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.138 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -54.01 120.43 6.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.572 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.44 -161.88 1.25 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.782 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.662 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.4 p-10 -61.96 137.21 95.4 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.801 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 7.0 Cg_endo -55.38 -36.2 93.38 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.351 2.034 . . . . 0.0 113.327 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.55 -33.4 74.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 0.0 110.753 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 118' ' ' THR . 81.5 mt-30 -85.08 -18.87 32.97 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.293 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 68.6 mtp -97.87 -0.4 45.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 56.9 mt-10 -64.68 -46.65 81.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -78.49 112.99 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.12 30.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.163 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -142.04 84.37 1.88 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.082 0.468 . . . . 0.0 111.92 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.463 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 44.1 t -145.24 119.94 9.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.0 m-85 -127.16 155.15 43.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 111.077 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.28 90.0 5.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.779 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.1 -47.38 24.08 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.523 2.149 . . . . 0.0 113.457 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.0 -22.4 15.17 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.24 -0.287 . . . . 0.0 111.701 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.59 -33.94 48.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.72 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 58' ' ' VAL . 70.8 t80 -64.96 -45.44 85.7 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 12.0 ptmt -64.43 -38.77 92.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.922 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 70.2 mt -60.34 -48.93 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.905 0.383 . . . . 0.0 111.666 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.0 mmm -70.39 -37.74 74.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.501 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.4 m -60.42 -46.99 88.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -64.79 -36.39 84.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 111.231 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.622 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -78.47 -32.7 48.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.509 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.8 m -112.22 -15.01 13.28 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 93' ' ' SER . 61.7 m-20 -59.84 133.05 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.043 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 67.7 14.28 9.46 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.118 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -115.95 147.21 41.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.272 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.7 m -72.28 -33.51 67.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 151.48 33.83 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.34 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.9 p -152.75 147.27 25.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.791 0.329 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.8 t -128.45 129.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.02 0.438 . . . . 0.0 110.032 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.581 ' CG1' HH11 ' A' ' 95' ' ' ARG . 46.3 t -135.65 148.75 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 107' ' ' GLY . 59.6 t -82.56 115.33 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.93 39.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.96 -127.31 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.98 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.469 0.652 . . . . 0.0 112.033 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -66.56 1.09 1.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.557 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.622 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.34 -11.64 55.98 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.647 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.4 m-85 -143.74 128.31 9.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.672 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 38.1 Cg_exo -50.64 -149.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.148 1.898 . . . . 0.0 111.125 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.37 97.11 5.19 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.463 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 61.6 Cg_endo -88.35 -10.49 4.66 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.592 2.195 . . . . 0.0 112.325 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.455 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.5 p -166.58 90.29 0.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.635 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -76.55 155.61 35.94 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.355 2.037 . . . . 0.0 111.912 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.22 89.62 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 77' ' ' GLN . 89.0 m -126.49 147.66 49.79 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 t80 -79.25 108.73 12.98 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 30.9 mtmm -87.61 -167.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.388 1.09 . . . . 0.0 113.093 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -171.6 174.64 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.044 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 22.1 tp -133.01 125.2 29.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -119.34 125.61 49.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.9 t -130.73 123.94 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.57 130.23 54.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.623 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.5 p90 -155.9 164.42 38.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.555 0.693 . . . . 0.0 112.259 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -119.16 156.27 30.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.228 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.9 m -107.78 120.98 43.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.5 m -121.63 152.87 59.21 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--N 1.308 -1.584 0 C-N-CA 122.258 1.972 . . . . 0.0 112.128 179.432 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.4 ttp180 -147.05 131.38 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.725 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' HD23 ' A' ' 48' ' ' LEU . 72.1 mm-40 -128.16 143.85 51.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.98 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -138.57 136.61 36.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.824 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.16 140.1 46.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.113 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.404 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 64.9 m -65.3 138.18 58.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 64.8 tt0 -45.56 129.84 8.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.598 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.04 -12.37 67.03 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.856 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -109.19 149.27 39.49 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 118.841 1.321 . . . . 0.0 110.19 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.75 150.82 87.54 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.852 1.701 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -121.33 141.91 39.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.638 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 74.4 tt0 -130.16 130.29 44.54 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.664 -0.814 . . . . 0.0 112.519 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.594 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.9 mt -116.24 139.35 50.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.048 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.638 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 48.2 mtt180 -145.75 135.22 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.442 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.458 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.4 m -100.59 146.59 32.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -70.0 160.37 49.89 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.764 2.309 . . . . 0.0 112.489 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.26 -120.98 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.738 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -120.94 25.29 9.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.31 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -76.18 169.91 17.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.0 110.02 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.26 145.24 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.801 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.4 137.15 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.603 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.1 ptm -130.85 99.67 5.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.561 0.696 . . . . 0.0 109.257 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG12 ' CE1' ' A' ' 89' ' ' PHE . 24.1 t -63.21 123.25 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 80.5 mm-40 -100.31 -51.67 3.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 58.6 m-20 -151.72 148.98 28.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.056 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.33 153.97 8.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.862 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.6 t30 -147.88 148.05 30.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.457 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -114.21 114.98 26.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.27 -142.22 7.57 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.38 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -150.84 119.2 6.39 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.317 0.58 . . . . 0.0 111.568 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.51 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 59.9 p -125.95 6.97 7.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.811 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.646 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 35.0 t0 -140.44 -174.75 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.128 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 22.4 p30 -144.96 -1.06 0.87 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.5 mtmp? -101.59 3.88 40.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.408 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' SG ' ' A' ' 71' ' ' CYS . 30.5 mm -112.76 135.35 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.981 0.42 . . . . 0.0 110.309 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' A' ' 70' ' ' ILE . 67.1 m 60.46 64.24 1.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.256 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.592 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 42.5 p30 -50.02 96.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.539 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.52 -163.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.683 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -60.68 139.1 93.15 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.639 178.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.453 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.62 -38.01 96.43 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.433 2.089 . . . . 0.0 113.326 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -62.19 -33.32 74.31 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.71 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.8 mt-30 -85.01 -6.36 59.33 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.438 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 83.9 mtp -109.95 -3.02 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 82.2 mt-10 -64.79 -46.15 83.3 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.97 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -79.68 112.88 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.072 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 67' ' ' ASP . 35.8 m -107.3 31.38 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -138.24 84.53 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.86 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.0 t -146.1 125.84 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.563 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HA ' HD21 ' A' ' 62' ' ' ASN . 59.0 m-85 -134.04 154.71 50.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 112' ' ' PRO . 37.4 tp -146.91 93.67 4.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.346 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.61 -48.4 22.17 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.497 2.798 . . . . 0.0 114.576 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -57.81 -19.92 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.88 -32.03 63.34 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.717 ' CE1' HG12 ' A' ' 58' ' ' VAL . 48.3 t80 -63.72 -43.81 95.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.714 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.21 -39.61 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 65.2 mt -58.08 -51.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.084 ' SD ' HD21 ' A' ' 122' ' ' LEU . 40.0 mtp -70.46 -33.22 71.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.528 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 20.1 m -58.39 -47.17 84.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.83 -34.67 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.501 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NE ' HG22 ' A' ' 104' ' ' VAL . 17.7 mtp180 -80.54 -32.4 36.75 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.2 m -111.74 -20.16 12.19 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.479 ' CG ' ' O ' ' A' ' 93' ' ' SER . 42.6 m-20 -56.16 135.19 53.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.845 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 64.44 13.84 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.972 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -112.95 144.3 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.604 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -33.21 73.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.099 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 158.71 42.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.043 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.594 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.2 p -155.38 135.0 12.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.138 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 129.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.5 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.2 t -143.41 145.72 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.769 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.2 t -79.05 116.4 22.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.58 41.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.67 -116.82 0.53 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.659 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 28.56 -160.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.14 0.495 . . . . 0.0 111.737 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.659 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-20 -69.47 2.09 3.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.968 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.05 -13.75 49.45 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.383 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.574 ' O ' ' O ' ' A' ' 112' ' ' PRO . 72.8 m-85 -141.09 126.62 11.1 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.7 Cg_exo -51.41 -150.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.224 1.949 . . . . 0.0 111.575 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -144.9 90.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.77 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.55 -8.68 13.65 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.093 2.528 . . . . 0.0 113.236 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -172.22 80.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.437 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.32 159.02 55.39 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.149 1.899 . . . . 0.0 111.505 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.1 -4.71 86.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 77' ' ' GLN . 63.2 m -125.36 147.87 48.98 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.494 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 45.3 t80 -85.81 118.7 25.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.479 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mttt -95.17 -156.91 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.0 p90 -174.86 176.5 2.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.556 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.084 HD21 ' SD ' ' A' ' 92' ' ' MET . 34.3 tp -133.69 126.79 31.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.816 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.67 ' CD ' ' N ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -120.74 130.72 54.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 11.8 t -133.28 123.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -107.04 125.72 51.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.801 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -154.65 170.08 22.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.302 0.572 . . . . 0.0 112.223 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' A' ' 57' ' ' MET . 10.8 m-20 -127.0 161.57 28.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.941 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.8 115.86 29.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.115 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.78 158.93 44.36 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.495 1.599 0 C-N-CA 122.181 1.92 . . . . 0.0 112.055 179.441 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.609 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -151.74 138.68 19.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.343 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -133.78 146.77 51.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.36 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -134.88 132.11 38.15 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.67 139.96 51.25 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.546 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.1 137.16 53.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.597 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 87.2 tt0 -48.06 133.37 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.028 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.8 -17.96 58.0 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.94 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -111.72 148.18 38.36 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 118.283 1.041 . . . . 0.0 110.308 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.76 151.71 82.42 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.489 2.126 . . . . 0.0 113.36 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.9 tt -119.07 147.01 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 103' ' ' VAL . 81.5 tt0 -136.0 125.38 24.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -110.9 145.93 37.43 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -148.47 136.56 21.03 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.9 m -104.41 143.99 27.8 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.23 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 56.6 Cg_endo -71.71 161.19 45.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.361 2.041 . . . . 0.0 112.13 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.34 -132.2 34.23 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.449 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.8 p -107.92 23.36 14.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.351 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -78.58 167.89 20.59 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -130.73 145.21 35.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.82 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.874 HG23 ' CD2' ' A' ' 126' ' ' TYR . 82.7 mt -68.66 139.78 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.068 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.3 ptm -131.98 99.53 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.834 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 89' ' ' PHE . 55.8 t -63.05 124.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.361 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -101.98 -48.53 4.22 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -151.41 147.52 26.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.06 155.58 11.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.492 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.0 t30 -151.81 145.65 25.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 67.3 t80 -116.73 118.04 31.46 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.49 -138.04 5.16 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' H ' ' HB3' ' A' ' 83' ' ' CYS . 12.3 ttm-85 -152.4 118.94 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.232 0.539 . . . . 0.0 111.717 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 p -121.99 8.4 9.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 27.6 t0 -143.54 -164.23 1.82 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.059 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 47.2 p30 -149.16 -1.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.237 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -102.88 4.49 37.7 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.576 HG22 ' SG ' ' A' ' 71' ' ' CYS . 14.3 mm -106.64 135.28 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.576 ' SG ' HG22 ' A' ' 70' ' ' ILE . 47.7 m 59.44 66.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.481 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.3 p30 -47.8 108.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.95 -162.99 1.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.015 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.6 p-10 -63.44 138.31 97.32 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.529 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.8 Cg_endo -58.81 -32.45 97.16 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.212 1.941 . . . . 0.0 112.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -60.79 -37.82 83.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.654 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 118' ' ' THR . 78.6 mt-30 -86.21 -10.88 53.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.334 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -108.84 0.52 20.34 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.128 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 75.5 mt-10 -64.78 -43.92 91.65 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.365 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.2 t30 -78.78 114.28 17.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 67' ' ' ASP . 25.2 m -106.1 32.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -140.68 86.51 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.75 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.551 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 32.8 t -147.7 120.88 8.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 89.2 m-85 -132.51 152.71 51.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.883 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -144.13 93.42 6.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.027 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.48 -49.05 16.69 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.558 2.838 . . . . 0.0 113.829 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -57.37 -24.58 56.17 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.24 -31.52 21.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE1' HG12 ' A' ' 58' ' ' VAL . 83.5 t80 -66.63 -45.8 77.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.89 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 ptmt -64.38 -39.24 93.47 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.675 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 94.4 mt -60.18 -52.91 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.3 mmm -70.12 -35.24 73.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 111.526 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.4 m -59.95 -47.33 86.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -66.87 -36.75 83.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.421 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 1.025 ' HE ' HG22 ' A' ' 104' ' ' VAL . 72.9 mtp85 -77.23 -32.68 55.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 23.7 m -112.69 -17.24 12.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -57.17 136.22 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.297 0.57 . . . . 0.0 111.964 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 64.76 12.98 8.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.653 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 67.2 mtt-85 -112.32 144.93 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.228 0.537 . . . . 0.0 110.307 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 m -70.31 -33.76 71.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.38 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 154.29 37.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.88 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.0 p -155.01 139.03 16.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.859 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.492 HG22 ' HG3' ' A' ' 47' ' ' GLU . 48.5 t -122.46 135.82 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.025 HG22 ' HE ' ' A' ' 95' ' ' ARG . 33.4 t -143.04 152.99 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.98 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.449 ' N ' HG12 ' A' ' 104' ' ' VAL . 70.6 t -84.05 115.74 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.03 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.32 36.64 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -176.62 -118.23 0.53 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.646 ' O ' ' O ' ' A' ' 107' ' ' GLY . 46.5 t 27.0 -158.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.424 0.631 . . . . 0.0 112.02 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.1 m-20 -69.27 1.09 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.08 -11.2 58.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.671 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.1 m-85 -144.94 133.69 11.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.805 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.1 Cg_exo -53.2 -147.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.04 1.826 . . . . 0.0 110.559 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.493 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 11.0 t0 -144.38 91.24 6.37 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.0 110.255 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.416 ' HD2' ' CE ' ' A' ' 120' ' ' LYS . 62.4 Cg_endo -80.94 -11.7 12.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.124 2.549 . . . . 0.0 113.734 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.584 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -165.27 76.58 1.35 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 121.538 0.685 . . . . 0.0 111.531 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.84 153.25 38.18 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.753 2.302 . . . . 0.0 112.619 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.19 8.09 53.41 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.049 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.8 m -119.3 148.88 42.66 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 6.5 t80 -83.31 108.88 16.82 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.584 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 28.1 mttt -89.56 -163.06 0.94 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.754 1.264 . . . . 0.0 112.833 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -173.54 175.52 2.98 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.007 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 tp -133.4 125.75 29.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -123.62 128.64 49.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 99.0 t -133.27 126.94 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -108.17 128.58 54.83 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.874 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.4 p90 -155.6 175.32 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.236 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -131.85 161.16 33.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.272 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.609 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 88.4 m -108.38 122.53 47.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.183 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.93 155.84 57.2 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.519 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 C--N 1.31 -1.461 0 C-N-CA 122.33 2.02 . . . . 0.0 111.904 -179.805 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.559 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 28.3 ttm180 -147.21 134.51 20.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.0 111.673 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 40.5 mp0 -131.35 144.11 50.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.751 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -138.75 141.28 38.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.841 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.31 141.63 33.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.397 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -66.36 135.32 54.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.66 138.95 7.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.294 0.569 . . . . 0.0 112.032 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 -16.64 60.59 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.961 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -109.32 150.34 40.96 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 117.741 0.77 . . . . 0.0 110.117 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.97 151.18 67.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.884 2.39 . . . . 0.0 113.264 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -123.98 142.0 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 65.9 tt0 -128.02 130.36 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 111.82 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 64.7 mt -111.21 145.99 37.72 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.095 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.641 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 96.6 mtt180 -149.43 128.23 12.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.7 m -101.01 144.43 28.54 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.05 158.08 50.01 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.424 2.083 . . . . 0.0 112.543 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.73 -139.18 36.41 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.428 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 p -99.57 23.87 8.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.405 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 63.4 m-20 -81.29 165.16 21.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.243 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.8 m -129.95 146.55 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 110.584 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.96 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.2 mt -68.25 136.59 26.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.753 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -130.8 99.39 4.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.503 HG12 ' HE1' ' A' ' 89' ' ' PHE . 53.0 t -63.01 123.06 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.512 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.502 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.8 mm-40 -103.39 -46.94 4.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.184 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 24.7 m-20 -147.16 144.48 29.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.78 149.99 11.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.743 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.571 ' O ' HD12 ' A' ' 122' ' ' LEU . 29.7 t30 -148.07 147.45 29.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.167 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -118.64 120.02 36.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -138.68 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.997 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -154.79 116.29 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.661 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' CE2' ' A' ' 84' ' ' TYR . 14.9 p -122.43 9.65 9.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.923 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.617 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.0 t0 -147.59 -173.52 4.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.2 p30 -145.78 1.99 0.91 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.051 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.67 5.01 41.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.323 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.451 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.2 mm -115.42 137.84 47.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.74 0.305 . . . . 0.0 110.523 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 30.9 m 52.88 75.91 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -56.41 122.19 11.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.484 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.84 -167.55 2.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.552 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -61.4 134.15 93.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.7 Cg_endo -53.1 -33.57 64.21 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.789 1.66 . . . . 0.0 113.506 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -63.65 -34.91 78.9 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.039 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 72.9 mt-30 -83.35 -14.88 51.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.548 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 mtp -99.54 -0.61 40.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.3 mt-10 -62.05 -52.13 65.19 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 39.2 t30 -81.72 115.98 21.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.7 m -105.03 35.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.559 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -139.52 85.8 2.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 4.0 t -148.56 118.56 7.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CE2' HG21 ' A' ' 66' ' ' THR . 69.7 m-85 -130.02 154.24 47.61 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.814 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 88' ' ' ALA . 40.4 tp -146.28 85.69 7.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.388 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -47.09 -47.69 16.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.902 2.402 . . . . 0.0 113.614 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -56.79 -22.76 38.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.73 -31.35 62.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.972 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HE1' HG12 ' A' ' 58' ' ' VAL . 11.6 t80 -64.1 -42.53 96.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.4 ptpt -66.09 -42.17 89.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.963 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.484 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 82.2 mt -58.39 -49.73 81.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.529 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.092 ' SD ' HD21 ' A' ' 122' ' ' LEU . 31.7 mtp -71.07 -33.19 70.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.745 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.6 m -59.14 -45.57 90.6 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.919 0.39 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -65.59 -37.4 86.54 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.078 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 93.6 mtt-85 -76.73 -35.3 57.89 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.432 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -109.28 -21.5 12.51 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CG ' ' O ' ' A' ' 93' ' ' SER . 75.9 m-20 -57.24 134.09 55.64 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.207 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 67.95 12.48 8.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.798 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 99' ' ' ARG . 51.3 mtt180 -113.47 146.44 39.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.215 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.7 m -73.45 -28.74 62.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.452 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 2.2 pp0? -151.98 152.48 32.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.498 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.1 p -153.58 142.81 21.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.716 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.67 126.06 72.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.9 t -139.04 146.68 25.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.845 0.355 . . . . 0.0 111.374 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.9 t -78.78 113.67 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.95 42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.581 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -121.62 0.8 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.6 t 28.05 -157.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 111.892 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.38 1.22 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.175 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.87 -12.49 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.433 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 63.9 m-85 -144.58 128.14 8.75 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.979 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -50.45 -146.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.387 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -142.88 84.62 10.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.01 -5.53 14.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.812 2.341 . . . . 0.0 113.424 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.505 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -164.68 71.6 1.53 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.544 0.688 . . . . 0.0 111.47 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.43 140.46 93.22 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.396 2.064 . . . . 0.0 110.594 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.77 71.51 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.951 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 21.3 m -124.4 146.3 48.97 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.538 0.669 . . . . 0.0 110.331 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.556 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 26.0 t80 -81.64 116.23 21.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 24.3 mttt -89.82 -165.93 1.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.805 1.288 . . . . 0.0 114.037 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.2 p90 -167.68 169.49 11.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.17 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.092 HD21 ' SD ' ' A' ' 92' ' ' MET . 65.8 tp -130.31 122.71 28.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.687 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 71.5 tt0 -117.94 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' A' ' 92' ' ' MET . 45.7 t -133.64 125.17 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 128.71 55.15 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.96 ' CD2' HG23 ' A' ' 56' ' ' ILE . 28.6 p90 -154.3 169.64 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.23 0.538 . . . . 0.0 111.735 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.488 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 76.9 m-20 -123.04 159.31 28.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.965 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.9 m -109.15 112.13 24.13 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 4.2 m -121.02 158.68 51.92 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 N--CA 1.493 1.447 0 C-N-CA 121.9 1.733 . . . . 0.0 112.154 -179.756 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.589 HH21 ' HG3' ' A' ' 51' ' ' PRO . 94.6 mtt-85 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -145.15 132.91 21.07 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.495 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' HG3' HD23 ' A' ' 48' ' ' LEU . 79.5 mm-40 -124.4 145.33 49.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -137.26 141.03 41.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.811 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.79 139.86 36.52 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.471 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.03 135.73 55.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.911 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 82.0 tt0 -46.17 134.27 8.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.284 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 -11.89 68.29 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.267 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.8 m-85 -112.26 148.75 39.8 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 118.451 1.125 . . . . 0.0 109.828 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.91 150.26 73.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.288 1.992 . . . . 0.0 112.867 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.6 tt -116.34 147.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.42 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -125.2 127.94 47.57 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.036 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 38' ' ' GLU . 24.3 mt -116.23 138.29 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.059 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' A' ' 101' ' ' GLN . 65.5 mtp85 -148.2 135.46 20.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.021 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -100.34 144.14 27.88 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HG3' HH21 ' A' ' 36' ' ' ARG . 61.2 Cg_endo -72.02 159.17 50.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.258 2.638 . . . . 0.0 112.55 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.79 -131.02 27.46 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.9 p -108.42 23.93 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.78 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.38 165.4 24.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.31 147.71 32.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.136 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.773 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.0 mt -69.92 136.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.104 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.7 ptp -134.44 106.06 6.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 89' ' ' PHE . 36.4 t -64.44 124.5 19.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -102.96 -53.12 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.225 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -147.17 143.47 28.25 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.168 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.37 154.46 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.82 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.3 t30 -149.96 145.97 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.405 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -116.84 118.31 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.29 -133.64 3.34 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.7 ttm-85 -157.71 117.11 3.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.334 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 p -122.29 9.46 9.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 14.5 t70 -144.86 -168.99 3.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.5 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 8.0 p30 -148.41 -0.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.402 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -101.42 7.71 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.039 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.53 136.61 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.089 0.471 . . . . 0.0 111.07 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.8 m 51.96 78.95 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 59.1 p30 -55.77 125.04 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.72 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.99 -164.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.931 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.66 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -64.72 142.97 98.66 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 110.61 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.6 Cg_endo -60.96 -35.78 86.26 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 113.713 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.74 -36.16 82.11 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 118' ' ' THR . 72.3 mt-30 -86.34 -14.13 44.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.453 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 74.9 mtp -106.27 -2.54 22.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.001 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 4.6 mt-10 -65.58 -44.75 85.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.897 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -80.82 121.04 25.46 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -110.08 34.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.626 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -139.62 90.1 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.456 . . . . 0.0 110.886 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 25.5 t -152.62 119.2 5.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.584 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 13.6 m-85 -132.45 154.01 50.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.64 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -144.29 96.15 5.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.72 -44.08 46.94 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.558 2.172 . . . . 0.0 112.623 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.4 m-20 -58.08 -21.59 46.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.91 62.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.977 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.619 ' O ' ' OG ' ' A' ' 93' ' ' SER . 57.1 t80 -63.96 -46.43 84.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.1 pttp -66.64 -39.74 88.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.351 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.63 -46.5 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.203 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.31 -37.74 77.93 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.789 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.5 m -59.88 -48.43 81.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -65.72 -37.45 86.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.015 0.435 . . . . 0.0 111.213 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -76.94 -33.52 57.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.8 m -113.88 -16.44 12.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -57.81 137.89 56.17 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.693 -0.629 . . . . 0.0 111.974 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 49.9 m-20 69.5 14.39 8.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -117.2 149.3 40.63 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.401 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -72.17 -31.37 65.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.526 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.583 ' CD ' HH12 ' A' ' 49' ' ' ARG . 0.1 OUTLIER -142.88 156.99 45.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.318 178.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 39.7 t -152.93 135.8 15.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 111.747 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.9 132.32 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.054 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.5 146.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.735 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 107' ' ' GLY . 46.5 t -79.43 117.13 24.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.834 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.37 35.49 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.287 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.14 -121.01 0.69 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.5 t 33.42 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.242 0.544 . . . . 0.0 110.905 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.07 4.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.035 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -87.66 -7.58 57.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.374 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' O ' ' A' ' 112' ' ' PRO . 35.4 m-85 -147.76 132.82 9.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.95 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.9 Cg_exo -51.79 -148.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.702 1.601 . . . . 0.0 110.639 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.707 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 46.4 t0 -146.83 92.15 5.09 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.1 Cg_endo -79.37 -4.65 13.83 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.979 2.453 . . . . 0.0 113.241 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.493 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -167.91 67.99 0.82 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.672 0.749 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -52.26 149.81 21.46 Favored 'Trans proline' 0 C--N 1.292 -2.426 0 C-N-CA 122.487 2.124 . . . . 0.0 110.867 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.0 -4.36 76.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.871 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 77' ' ' GLN . 54.5 m -116.97 149.59 39.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.406 0.603 . . . . 0.0 110.602 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.53 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.7 t80 -83.94 112.42 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 19.0 mttt -92.22 -161.5 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.653 1.215 . . . . 0.0 114.169 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 8.3 p90 -174.91 175.98 2.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.754 -2.021 . . . . 0.0 111.046 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 62' ' ' ASN . 45.2 tp -132.57 123.45 26.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.348 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -115.94 124.03 49.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 57.9 t -134.5 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.555 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.5 128.6 56.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' A' ' 56' ' ' ILE . 47.8 p90 -146.23 162.2 38.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.128 0.489 . . . . 0.0 111.295 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -113.4 157.14 22.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.214 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.466 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.0 m -113.3 108.38 17.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.364 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.28 161.07 33.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 121.532 1.488 . . . . 0.0 111.517 179.666 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.734 ' NH1' ' SG ' ' A' ' 128' ' ' CYS . 14.4 mmt85 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.625 HH21 ' CD ' ' A' ' 123' ' ' GLU . 40.2 ttt180 -143.2 138.51 29.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.647 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.1 mp0 -135.67 139.89 44.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.123 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -137.78 136.48 37.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.914 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.835 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.61 142.47 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.564 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.6 140.79 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.518 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 81.0 tt0 -47.67 129.52 13.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.85 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 -11.49 71.97 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.92 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 24.8 m-85 -106.47 150.06 39.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.907 0.853 . . . . 0.0 109.883 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.09 152.62 45.89 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.195 1.93 . . . . 0.0 112.856 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -122.97 142.26 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.19 128.84 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.191 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 102' ' ' CYS . 36.3 mt -113.05 144.9 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.726 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 14.9 mtp180 -150.52 135.2 17.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.846 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -102.74 149.65 36.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.316 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 47.9 Cg_endo -71.63 160.15 49.05 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.027 2.485 . . . . 0.0 113.403 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.18 -126.36 22.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.587 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.5 p -113.75 23.15 13.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.361 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.22 170.2 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.751 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.16 146.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.298 0.571 . . . . 0.0 110.544 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.75 HG23 ' CD1' ' A' ' 126' ' ' TYR . 81.6 mt -68.84 136.93 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.298 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.605 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.7 ptm -132.45 98.29 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.984 0.897 . . . . 0.0 108.946 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 5.9 t -64.5 124.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.519 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.8 mt-10 -103.86 -48.92 3.78 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 20.6 m-20 -146.6 144.3 29.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.15 151.97 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.054 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.601 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.4 t30 -150.56 151.52 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.571 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -118.72 114.92 23.46 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.35 -139.56 5.92 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.091 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.696 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -153.57 119.02 5.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.026 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 11.7 p -125.44 3.96 7.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.679 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 48.2 t0 -143.48 149.24 37.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.184 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 45.1 p30 -110.5 1.21 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 1.4 mtpm? -102.7 8.43 39.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.51 137.75 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.192 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.598 ' O ' ' C ' ' A' ' 72' ' ' ASP . 63.8 m 60.3 17.45 7.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' ' O ' ' A' ' 71' ' ' CYS . 42.1 m-20 3.44 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.976 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.36 -165.22 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -61.79 146.48 90.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.22 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 14.7 Cg_endo -58.31 -40.74 73.03 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.41 2.073 . . . . 0.0 112.856 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.81 -37.81 88.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.581 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 78.6 mt-30 -83.95 -7.57 59.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -104.19 -1.48 27.13 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.98 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 91.6 mt-10 -63.31 -51.17 67.14 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -76.79 110.67 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.861 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.711 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.2 m -103.5 27.23 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.7 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.711 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 6.2 mm-40 -140.46 87.85 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.89 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.7 t -144.74 120.95 10.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 81.7 m-85 -133.31 157.07 46.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.336 0.589 . . . . 0.0 112.221 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -147.07 87.13 6.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.501 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -47.65 -47.98 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.56 2.174 . . . . 0.0 112.865 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -56.69 -18.4 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.1 -35.2 66.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.816 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.622 ' CE1' HG12 ' A' ' 58' ' ' VAL . 81.3 t80 -65.14 -44.65 87.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.732 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.3 pttp -64.33 -42.89 96.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.782 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 68.7 mt -59.17 -44.5 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.558 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 97.2 mmm -70.49 -40.28 73.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.227 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.7 m -56.63 -43.21 80.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.368 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.53 -41.51 88.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.645 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.864 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 46.1 mtm180 -73.85 -33.53 64.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.5 m -111.55 -15.09 13.58 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 38.6 m-20 -61.65 133.7 55.92 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.159 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 66.02 14.46 9.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -116.0 148.52 40.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.595 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -70.04 -31.78 69.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.82 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.03 157.08 41.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.092 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.7 p -153.64 140.94 19.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -120.95 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.299 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.59 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 98.0 t -140.65 147.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.212 0.529 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 107' ' ' GLY . 62.1 t -81.86 115.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.052 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -69.77 38.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.842 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.6 -120.69 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.692 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.591 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.4 t 27.16 -155.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.857 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.25 -0.57 8.22 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.621 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.98 58.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.187 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -143.22 129.91 10.55 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -54.4 -146.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.662 1.575 . . . . 0.0 111.231 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.62 90.03 7.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.047 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.34 -6.12 12.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.807 2.338 . . . . 0.0 113.545 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.529 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -167.53 71.63 0.95 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.707 0.765 . . . . 0.0 112.192 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.05 141.54 56.99 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.243 2.629 . . . . 0.0 111.989 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.33 -3.29 86.67 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.621 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 77' ' ' GLN . 71.2 m -118.2 148.69 42.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.778 0.789 . . . . 0.0 110.325 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.1 t80 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.529 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.0 mttp -93.48 -160.32 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.459 1.123 . . . . 0.0 113.655 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.0 p90 -176.34 178.21 1.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.627 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 62' ' ' ASN . 24.0 tp -133.7 127.52 33.05 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.787 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.625 ' CD ' HH21 ' A' ' 37' ' ' ARG . 77.0 tt0 -119.65 129.47 54.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 48.9 t -133.26 122.93 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.86 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.2 128.15 54.81 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.75 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.8 p90 -156.07 170.9 21.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.767 -0.773 . . . . 0.0 112.023 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.52 159.09 34.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.436 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.734 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 78.5 m -109.8 118.82 37.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.259 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.36 157.77 48.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 C-N-CA 122.045 1.83 . . . . 0.0 112.227 179.477 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.634 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 77.5 mtt85 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.727 ' HE ' ' CD ' ' A' ' 123' ' ' GLU . 13.9 ttt180 -146.69 126.68 13.66 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.394 0.616 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.672 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 32.1 mp0 -126.13 143.35 51.16 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.024 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -139.2 145.04 38.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.995 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.06 141.19 32.76 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.23 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.81 135.47 54.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.46 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -47.71 135.44 11.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 111.444 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.63 -15.77 62.16 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.985 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 7.0 m-85 -111.4 149.75 41.09 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 118.132 0.966 . . . . 0.0 110.79 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.25 151.28 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.652 2.235 . . . . 0.0 113.033 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 tt -120.65 140.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.222 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -121.09 128.45 52.6 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.005 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.779 HD12 ' SG ' ' A' ' 96' ' ' CYS . 24.4 mt -115.82 141.42 48.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -150.74 132.91 15.35 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.933 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -102.91 143.0 25.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.839 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.58 158.76 52.95 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.579 2.186 . . . . 0.0 112.913 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.84 -137.19 40.28 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.446 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.1 p -102.08 23.89 10.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.384 -0.408 . . . . 0.0 111.14 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 75.9 m-20 -81.06 165.77 21.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 m -128.2 147.0 32.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.547 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 126' ' ' TYR . 77.8 mt -68.34 138.45 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -132.42 100.02 4.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 89' ' ' PHE . 32.6 t -65.49 125.22 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.715 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.02 -48.79 3.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.626 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -152.08 150.27 29.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.4 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.6 157.97 10.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.892 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.9 t30 -150.73 143.17 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.83 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -112.36 114.53 27.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 163.16 -134.37 3.39 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.15 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 9.7 ttm180 -156.64 117.79 3.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.499 0.666 . . . . 0.0 110.727 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 84' ' ' TYR . 15.9 p -126.22 6.35 7.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.892 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 49.0 t0 -145.31 151.72 38.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.214 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.671 ' O ' ' CE ' ' A' ' 78' ' ' MET . 54.5 p30 -110.78 3.7 19.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.956 0.408 . . . . 0.0 109.943 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -102.72 1.75 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.985 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -110.93 135.12 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.837 0.351 . . . . 0.0 110.199 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m 58.81 65.26 1.26 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.904 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -48.61 99.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.524 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -111.03 -166.93 1.12 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.272 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.84 144.97 97.96 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.419 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.86 -41.99 60.08 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.461 2.107 . . . . 0.0 112.792 -178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.85 -35.93 81.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.988 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 118' ' ' THR . 76.2 mt-30 -87.01 -6.86 58.61 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.671 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 85.1 mtp -104.68 -6.09 20.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.63 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.4 mt-10 -65.16 -47.0 78.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.216 -0.593 . . . . 0.0 112.095 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.88 117.71 19.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.8 m -109.15 32.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.837 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -143.18 88.53 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.8 t -145.84 122.18 10.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' THR . 59.0 m-85 -135.09 152.74 51.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.319 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.6 tp -145.58 88.66 6.49 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.871 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.56 -49.83 12.59 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 123.042 2.494 . . . . 0.0 113.367 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 46.5 m-20 -55.01 -19.2 6.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.55 0.214 . . . . 0.0 111.307 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.54 69.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.398 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 58' ' ' VAL . 25.6 t80 -64.62 -40.87 96.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.11 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 ptmt -65.96 -40.54 91.36 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.747 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 73.0 mt -59.61 -48.66 86.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.477 ' SD ' HG11 ' A' ' 104' ' ' VAL . 96.3 mmm -69.55 -39.54 77.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.267 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 61.3 m -59.44 -45.56 91.23 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.038 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -66.02 -36.01 82.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 61.6 mtt180 -76.63 -32.11 57.82 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 48' ' ' LEU . 76.4 m -112.94 -14.58 13.01 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.9 m-20 -61.76 134.84 57.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.488 0.661 . . . . 0.0 112.464 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 63.84 13.04 7.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -112.93 145.02 41.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.298 0.571 . . . . 0.0 109.865 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -32.71 67.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.645 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -153.02 153.74 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.4 p -152.53 156.28 39.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.06 124.75 53.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 92' ' ' MET . 59.7 t -133.44 145.66 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.514 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.6 116.71 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.126 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.71 36.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.19 -123.33 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.599 ' O ' ' O ' ' A' ' 107' ' ' GLY . 20.9 t 31.28 -160.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.73 1.68 0.82 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.384 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -85.1 -13.77 49.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.069 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.8 m-85 -145.23 129.94 9.02 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.414 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.3 Cg_exo -51.79 -144.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.057 1.838 . . . . 0.0 111.182 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.649 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 15.2 t0 -146.42 87.25 6.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.235 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.478 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.1 Cg_endo -77.74 -4.44 14.53 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.749 2.299 . . . . 0.0 113.466 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.613 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.11 63.35 0.82 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.289 0.566 . . . . 0.0 111.669 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.41 145.81 65.9 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 121.763 1.642 . . . . 0.0 110.463 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.16 -8.54 79.38 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.0 m -122.72 148.85 44.84 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.687 -0.302 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.5 t80 -84.05 118.4 24.04 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.649 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 11.6 mttp -94.61 -160.52 0.78 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.592 1.187 . . . . 0.0 113.798 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -172.4 173.29 4.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.953 -1.931 . . . . 0.0 110.669 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.8 tp -131.99 125.01 30.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.719 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.727 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 10.2 tp10 -120.01 127.48 52.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.85 123.23 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.359 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 129.12 54.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.902 ' CD1' HG23 ' A' ' 56' ' ' ILE . 33.0 p90 -154.04 171.97 18.23 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.439 0.637 . . . . 0.0 112.077 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.475 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 97.8 m-20 -129.06 161.7 29.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.578 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.634 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.9 m -111.55 127.77 55.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.236 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 33.6 m -132.5 153.58 81.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.09 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 C--N 1.312 -1.377 0 C-N-CA 121.531 1.488 . . . . 0.0 112.165 -178.68 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 36' ' ' ARG . 56.5 mtp85 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.617 HH11 ' HG3' ' A' ' 123' ' ' GLU . 66.7 ttp85 -148.82 138.95 22.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.545 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HG3' HD23 ' A' ' 48' ' ' LEU . 77.4 mm-40 -130.19 145.79 51.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.791 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -137.33 142.98 41.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.898 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.63 139.71 36.78 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.6 m -65.81 137.25 57.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.107 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 76.5 tt0 -45.08 129.39 7.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.12 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.92 -12.41 67.17 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.029 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.17 148.72 38.93 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 118.532 1.166 . . . . 0.0 110.349 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.07 150.47 88.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.783 2.322 . . . . 0.0 112.884 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 104' ' ' VAL . 21.0 tt -116.64 149.42 18.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.666 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 35.6 tt0 -132.0 129.83 40.64 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.899 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.8 mt -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.334 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.666 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 89.2 mtt180 -147.76 132.42 17.84 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.023 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.5 m -98.51 146.69 32.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 34.4 Cg_endo -67.37 158.86 55.05 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.866 2.377 . . . . 0.0 112.069 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.1 -119.05 5.7 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.213 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.4 p -121.52 23.82 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.595 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -76.08 169.53 18.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.97 149.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.847 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.669 HG23 ' CD2' ' A' ' 126' ' ' TYR . 59.6 mt -70.35 136.73 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.219 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -131.7 98.12 4.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.4 t -65.09 125.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.231 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -100.23 -48.11 4.72 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -152.21 150.56 29.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.253 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.27 156.71 12.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.1 t30 -151.39 142.28 22.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.357 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -112.39 116.94 31.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.59 -139.73 6.05 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.343 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.612 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.0 ttm-85 -152.1 117.44 5.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.078 0.466 . . . . 0.0 111.697 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 p -124.3 4.82 8.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.183 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.4 t0 -149.76 157.23 43.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 36.6 p30 -113.05 5.53 17.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.964 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 28.2 mttt -105.16 3.67 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.569 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.2 mm -112.5 136.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.803 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.8 m 52.55 76.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p30 -54.36 119.25 4.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.407 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.71 -164.86 1.52 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.531 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.7 p-10 -66.35 140.36 96.69 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.331 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.1 Cg_endo -53.26 -38.46 81.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.42 2.08 . . . . 0.0 113.57 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.52 -36.99 84.31 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.154 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.517 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 78.8 mt-30 -85.56 -9.89 56.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.521 ' HE3' HH22 ' A' ' 65' ' ' ARG . 82.4 mtp -103.89 -3.79 24.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.145 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.0 mt-10 -64.62 -48.22 75.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -81.61 116.31 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.548 0.69 . . . . 0.0 112.374 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.567 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -106.57 36.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.017 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -141.38 86.88 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.155 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.501 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.7 t -147.92 119.18 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.482 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.6 m-85 -131.4 153.44 49.68 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.302 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.9 tp -147.41 88.12 5.84 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.655 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -47.73 -47.57 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.277 1.985 . . . . 0.0 112.402 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -52.59 -25.53 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.334 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -54.91 -36.29 65.05 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.947 0.403 . . . . 0.0 111.22 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CE1' HG12 ' A' ' 58' ' ' VAL . 76.2 t80 -64.46 -42.27 96.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.6 pttm -64.82 -39.82 94.19 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.104 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.429 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.6 mt -59.83 -46.65 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.83 -35.98 79.55 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.938 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.0 m -58.85 -45.74 89.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.9 -40.51 91.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.235 0.54 . . . . 0.0 110.847 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.78 -35.49 72.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.352 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.737 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -112.8 -14.72 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 30.3 m-20 -62.3 132.24 51.99 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.079 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 63.76 13.17 7.23 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.27 146.45 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.291 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.7 m -69.83 -32.68 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.312 0.577 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -151.27 158.14 43.47 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.484 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.899 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.5 p -156.81 139.44 15.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -124.07 125.1 70.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 46' ' ' ILE . 43.5 t -134.86 146.34 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.938 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.0 t -77.83 118.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.262 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.14 35.77 0.05 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.086 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.675 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.44 -117.51 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 27.97 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.207 0.527 . . . . 0.0 111.608 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.76 1.97 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.392 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.73 -13.78 47.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.399 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.9 m-85 -145.72 130.19 8.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.113 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 111' ' ' PHE . 45.2 Cg_exo -51.53 -146.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.282 1.988 . . . . 0.0 112.027 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 17.9 t0 -145.27 84.57 8.51 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.622 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.24 -4.95 14.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.345 2.696 . . . . 0.0 113.527 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.578 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.88 60.74 0.58 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.111 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.35 147.47 21.74 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.56 -11.25 70.68 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.664 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.92 150.33 35.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.466 0.633 . . . . 0.0 109.913 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.612 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 27.8 t80 -82.16 111.95 18.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.578 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.0 mttp -90.73 -163.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.824 1.297 . . . . 0.0 113.539 -176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.3 p90 -173.58 175.81 2.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.807 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.7 tp -133.0 126.72 32.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HG3' HH11 ' A' ' 37' ' ' ARG . 79.5 tt0 -121.34 128.66 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.607 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' HB1' ' A' ' 61' ' ' ALA . 45.1 t -132.89 123.61 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.377 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 127.61 53.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.669 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.7 p90 -152.88 167.97 27.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.886 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -128.46 161.94 28.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.18 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.3 m -111.05 116.5 31.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.97 158.98 41.02 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.311 -1.425 0 C-N-CA 121.793 1.662 . . . . 0.0 111.38 178.527 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.535 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 65.3 mtp85 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -151.45 140.83 21.48 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 48' ' ' LEU . 59.2 mm-40 -133.18 145.31 50.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.011 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -135.6 133.15 37.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.849 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.748 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.93 140.54 46.85 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.377 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.2 m -66.48 136.21 55.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.271 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -48.63 134.68 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.73 -18.54 56.34 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.718 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -104.1 153.17 39.1 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 118.114 0.957 . . . . 0.0 108.905 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.98 154.41 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.259 1.973 . . . . 0.0 112.614 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 tt -119.62 151.09 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.853 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.691 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 55.5 tt0 -131.78 130.65 42.1 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' SG ' ' A' ' 102' ' ' CYS . 34.4 mt -120.68 138.96 53.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.158 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.691 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 55.9 mtt180 -148.31 129.64 14.73 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.816 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -98.69 143.97 27.31 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 30.4 Cg_endo -66.48 162.28 37.35 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.93 2.42 . . . . 0.0 113.267 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -121.26 9.34 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.792 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -120.62 26.18 9.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -77.88 169.51 18.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.662 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.87 145.86 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.427 0.632 . . . . 0.0 110.884 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.831 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.8 mt -68.77 138.49 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.928 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.2 ptm -130.62 104.04 6.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.565 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.5 t -68.54 124.73 24.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.168 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -105.01 -51.57 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -147.01 142.96 28.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.13 0.49 . . . . 0.0 110.479 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.981 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -163.19 152.42 14.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.406 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.5 t30 -148.75 143.92 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -114.93 120.0 38.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.99 -135.2 3.87 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.736 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.3 ttm-85 -154.09 116.83 4.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.364 0.602 . . . . 0.0 111.157 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.508 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.7 p -124.02 4.33 8.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.877 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 16.7 t70 -144.67 151.96 39.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 26.7 p30 -109.17 0.47 19.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 43.3 mtpt -101.22 3.22 40.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.287 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 70' ' ' ILE . 21.0 mm -109.71 137.27 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.809 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.0 m 55.66 66.24 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 10.5 p30 -50.58 111.63 0.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.935 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.54 -161.89 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -58.8 136.96 87.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.673 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.9 Cg_endo -59.39 -33.45 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.834 1.69 . . . . 0.0 112.63 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -62.68 -33.91 76.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.658 0.266 . . . . 0.0 110.878 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 118' ' ' THR . 73.1 mt-30 -85.64 -17.99 34.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.419 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.3 mtp -97.72 -0.35 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.454 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -60.99 -50.74 72.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.475 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.3 t30 -76.48 113.93 14.63 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.25 -0.281 . . . . 0.0 111.595 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.68 25.61 2.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.089 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -137.87 82.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.277 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.1 t -143.98 121.86 12.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.474 ' HA ' HD21 ' A' ' 62' ' ' ASN . 90.6 m-85 -130.4 154.78 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.405 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.466 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.1 tp -144.86 90.65 6.24 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.89 -44.74 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.783 2.322 . . . . 0.0 113.06 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -55.21 -21.15 12.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.67 71.17 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.745 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.0 t80 -65.06 -44.69 88.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.851 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.7 pttm -63.62 -43.43 96.87 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.863 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 59.0 mt -58.44 -50.59 78.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.552 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 1.5 mtp -69.62 -32.34 70.98 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.474 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.456 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 58.2 m -61.12 -45.4 94.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.207 0.527 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.16 -37.71 84.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.36 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.712 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 99.6 mtt180 -78.1 -33.14 50.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.0 m -111.52 -19.22 12.63 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -61.5 138.97 58.3 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.605 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 62.52 12.54 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.499 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.712 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 65.7 mtt180 -114.93 147.47 39.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.149 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 m -70.75 -34.52 71.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.162 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -150.74 155.46 39.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.729 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.918 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.8 p -154.07 132.78 12.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.83 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.42 132.21 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.696 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG13 ' NH1' ' A' ' 95' ' ' ARG . 86.6 t -144.96 151.67 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.624 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 107' ' ' GLY . 90.6 t -83.83 114.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.04 41.32 0.1 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.8 -126.07 0.98 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.325 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.606 ' O ' ' O ' ' A' ' 107' ' ' GLY . 5.0 t 28.49 -156.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.076 0.465 . . . . 0.0 111.24 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.38 1.4 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.828 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.3 -8.98 58.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.849 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -144.1 134.49 12.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.926 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.3 Cg_exo -58.86 -150.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.92 1.747 . . . . 0.0 111.929 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.638 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 26.1 t0 -144.9 92.5 5.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.468 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.21 -10.84 14.92 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.729 2.286 . . . . 0.0 112.625 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.3 p -171.15 87.96 0.47 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.301 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.13 157.75 55.71 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.38 12.01 84.3 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.699 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.6 m -126.32 146.62 49.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.037 0.418 . . . . 0.0 110.137 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.683 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.5 t80 -82.66 107.18 15.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.638 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 24.9 mttt -88.99 -164.1 1.09 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.638 1.208 . . . . 0.0 113.019 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.3 p90 -171.89 174.81 4.06 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.771 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 20.6 tp -132.37 124.7 29.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.429 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG2' HE21 ' A' ' 125' ' ' GLN . 78.7 tt0 -122.53 124.31 43.26 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.981 HG13 ' HB2' ' A' ' 61' ' ' ALA . 6.0 t -133.18 130.54 57.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.638 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.505 HE21 ' HG2' ' A' ' 123' ' ' GLU . 7.2 mp0 -109.91 132.66 53.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.719 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.831 ' CD2' HG23 ' A' ' 56' ' ' ILE . 49.4 p90 -152.83 168.45 25.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.416 0.627 . . . . 0.0 111.896 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.497 ' H ' ' HG2' ' A' ' 57' ' ' MET . 71.1 m-20 -126.22 158.24 36.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.434 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.535 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 74.7 m -108.53 124.89 51.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.528 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 m -126.53 159.37 63.76 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo . . . . . 0 N--CA 1.492 1.388 0 C-N-CA 121.537 1.491 . . . . 0.0 111.854 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.729 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 52.4 mtt-85 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -146.71 137.41 23.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.613 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 19.1 mt-10 -135.54 144.91 46.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.593 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.19 137.7 37.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.768 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -135.3 139.24 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.304 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.12 140.41 58.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.29 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -45.97 129.62 9.67 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.785 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.42 -12.51 69.5 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.708 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -104.15 155.21 37.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 118.248 1.024 . . . . 0.0 109.396 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.16 153.5 36.43 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.71 1.607 . . . . 0.0 112.577 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.7 tt -125.06 143.23 39.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.0 tt0 -126.88 130.52 50.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.124 0.488 . . . . 0.0 112.165 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.3 mt -114.18 141.71 47.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -148.1 131.16 16.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.754 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.04 142.03 23.8 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.49 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 24.2 Cg_endo -69.6 161.66 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.269 1.979 . . . . 0.0 112.208 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.64 20.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.719 0.621 . . . . 0.0 112.311 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -101.17 21.2 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.06 165.0 25.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.21 144.04 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.792 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -67.81 134.84 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.733 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.641 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.8 ptm -130.46 100.59 5.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.511 0.672 . . . . 0.0 109.232 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.2 t -70.41 124.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.866 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.22 -43.73 4.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -146.23 143.42 29.21 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.02 149.11 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.531 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 84' ' ' TYR . 7.5 t30 -148.74 152.12 36.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 76.2 t80 -121.57 120.11 33.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.81 -134.91 3.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -159.7 119.79 3.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.215 0.531 . . . . 0.0 111.463 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.9 8.3 8.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.085 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 44.8 t0 -144.1 150.63 38.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.369 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 14.6 p30 -104.46 -1.11 27.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 8.1 mtmp? -105.03 10.86 33.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.37 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.556 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 12.5 mm -107.52 135.03 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' ALA . 71.8 m 56.76 67.37 1.0 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 52.2 p-10 -46.35 93.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.594 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -111.82 -162.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.645 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p-10 -63.68 140.52 97.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.578 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 5.5 Cg_endo -56.54 -38.94 94.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.596 2.197 . . . . 0.0 113.526 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 2.9 m-30 -61.4 -36.53 80.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.333 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.479 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 68.2 mt-30 -86.52 -11.79 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.434 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 78.6 mmm -101.95 -3.11 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 43.9 mt-10 -66.26 -44.69 82.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -78.61 114.02 17.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.99 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.586 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 35.6 m -105.67 32.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 8.3 mm-40 -142.13 85.93 1.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.313 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 21.7 t -143.81 125.67 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.9 m-85 -135.66 149.73 49.39 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.3 tp -148.9 88.5 5.16 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.438 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.07 -44.24 47.1 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.503 2.135 . . . . 0.0 113.848 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 83.1 m-20 -53.7 -24.58 15.06 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.188 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.22 -34.26 44.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 40.2 t80 -64.79 -42.24 95.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.478 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.52 -36.18 83.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.028 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.538 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 71.5 mt -62.99 -50.37 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.258 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.99 -38.63 86.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 42.0 m -58.15 -45.74 86.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.56 -36.51 82.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.686 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 70.1 mtt180 -78.74 -31.36 46.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.8 m -111.81 -19.9 12.26 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 84.5 m-20 -56.6 134.04 54.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.406 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 67.12 13.14 9.33 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.786 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.686 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 75.2 mtt180 -113.0 146.0 39.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.36 0.6 . . . . 0.0 110.132 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.9 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.488 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 155.76 40.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -154.6 146.3 23.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.419 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.47 127.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.743 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' NH1' ' A' ' 95' ' ' ARG . 48.5 t -137.12 143.81 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.353 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.2 t -78.1 115.29 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.759 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.84 35.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.212 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.51 -119.92 0.65 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.302 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.2 t 31.26 -160.38 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.405 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.12 1.67 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.25 -13.49 55.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.9 m-85 -144.36 131.98 10.57 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.819 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 111' ' ' PHE . 21.7 Cg_exo -56.6 -147.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.104 1.869 . . . . 0.0 112.345 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -146.21 86.28 7.08 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.492 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.22 -9.92 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.544 2.163 . . . . 0.0 112.814 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -166.38 77.19 1.14 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.654 0.74 . . . . 0.0 111.05 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.25 149.93 42.97 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.337 2.025 . . . . 0.0 110.857 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.2 -4.93 64.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.386 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.3 m -113.25 148.32 35.78 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.932 0.866 . . . . 0.0 109.343 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.745 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.1 t80 -84.94 113.7 21.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 13.7 mtmm -93.87 -162.9 0.98 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.854 1.312 . . . . 0.0 113.82 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.9 p90 -168.84 170.29 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.55 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 62' ' ' ASN . 39.7 tp -128.89 124.67 35.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 126.31 49.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 61' ' ' ALA . 22.8 t -130.88 125.18 57.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.561 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -105.8 127.88 53.38 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.247 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.645 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.4 p90 -151.48 170.3 19.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.353 0.597 . . . . 0.0 111.372 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.477 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.5 m-20 -127.47 158.75 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.057 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.729 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 86.7 m -108.05 114.74 28.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.74 158.26 45.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.951 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo . . . . . 0 N--CA 1.498 1.767 0 C-N-CA 122.29 1.994 . . . . 0.0 112.798 179.62 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.703 0.763 . . . . 0.0 111.194 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 54.9 mp0 -134.21 140.16 46.3 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.433 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -137.74 135.33 36.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.822 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.794 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.22 136.64 56.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.991 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -46.67 133.11 10.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.336 0.589 . . . . 0.0 112.526 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.74 -13.28 67.48 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.593 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.94 147.03 34.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 118.437 1.118 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.99 147.71 89.22 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.391 2.061 . . . . 0.0 112.064 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.0 tt -117.68 147.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.68 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.4 tt0 -123.15 129.47 51.47 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.096 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.5 mt -118.0 137.31 52.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.68 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 87.3 mtt180 -149.2 127.85 12.42 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -95.45 149.55 36.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.557 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 49.2 Cg_endo -72.11 157.41 54.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.951 2.434 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 48.43 -134.96 19.15 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.912 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -101.82 24.12 10.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -78.45 164.96 24.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.5 146.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.662 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.6 mt -67.62 133.53 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.627 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -130.71 99.1 4.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.66 HG12 ' CE1' ' A' ' 89' ' ' PHE . 34.1 t -66.45 124.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.913 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -108.75 -47.33 3.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.203 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -146.85 145.82 29.99 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.309 0.576 . . . . 0.0 110.324 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.93 155.73 16.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.594 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.4 t30 -147.13 138.57 24.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.212 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -115.36 117.65 31.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.5 -135.26 4.06 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 17.8 ttm180 -155.21 117.76 4.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.367 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' CE2' ' A' ' 84' ' ' TYR . 5.1 p -123.45 5.79 9.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -146.97 154.08 40.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.236 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 36.9 p30 -113.69 2.44 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.357 . . . . 0.0 110.426 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 30.0 mttp -103.65 6.69 37.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.7 mm -108.28 135.62 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.895 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m 52.18 71.89 0.43 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 10.3 p-10 -45.03 114.34 0.71 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.847 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.14 -169.32 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.553 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.663 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -61.05 139.41 94.25 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.6 Cg_endo -57.83 -34.49 98.34 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.149 1.899 . . . . 0.0 112.988 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -64.72 -35.49 81.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.793 ' O ' HG23 ' A' ' 118' ' ' THR . 74.1 mt-30 -86.93 -13.43 44.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.607 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.498 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mtm -104.61 0.85 29.01 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.598 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 3.7 mt-10 -67.31 -43.83 80.68 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -79.87 114.26 18.66 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.692 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -104.55 34.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 79.9 mm-40 -141.07 84.44 1.93 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.05 119.17 8.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.4 m-85 -132.49 152.56 51.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.695 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.606 HD21 ' HG2' ' A' ' 112' ' ' PRO . 53.1 tp -142.09 87.6 9.64 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.91 -50.26 11.12 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.0 -26.97 40.6 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.56 -33.42 45.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.89 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 58' ' ' VAL . 15.5 t80 -64.71 -43.9 91.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.24 -38.75 92.38 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.247 -178.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -59.94 -51.81 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.814 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.649 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.1 mtp -68.44 -33.02 73.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.175 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 33.2 m -59.89 -45.54 92.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 51.9 mt-30 -64.68 -37.75 88.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.35 0.595 . . . . 0.0 110.957 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.676 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 25.2 mtp180 -75.86 -33.11 59.99 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.532 ' N ' HH21 ' A' ' 99' ' ' ARG . 6.9 m -113.7 -14.01 12.63 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.774 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 53.8 m-20 -60.06 131.65 51.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.844 -0.743 . . . . 0.0 111.641 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 66.59 13.2 9.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.902 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 97' ' ' ASN . 29.6 mtm-85 -111.29 144.29 40.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.9 m -71.18 -30.51 66.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 154.09 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.428 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.2 p -154.69 137.26 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.712 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.79 128.63 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.656 HG22 ' HE ' ' A' ' 95' ' ' ARG . 23.1 t -141.04 151.87 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.158 0.504 . . . . 0.0 112.051 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 108' ' ' SER . 45.2 t -82.16 116.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.005 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.6 39.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.96 -120.68 0.69 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.709 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER 31.87 -161.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 110.76 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.709 ' N ' ' OG ' ' A' ' 108' ' ' SER . 66.5 m-20 -68.93 2.9 2.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.419 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.07 -11.99 48.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.68 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.0 m-85 -142.87 126.89 9.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.001 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.606 ' HG2' HD21 ' A' ' 85' ' ' LEU . 18.1 Cg_exo -50.78 -148.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.34 2.026 . . . . 0.0 111.765 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.652 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 32.4 t0 -144.48 85.59 8.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -5.1 14.73 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.901 2.401 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.477 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.5 p -166.04 67.31 1.07 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.546 0.689 . . . . 0.0 111.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 142.73 98.67 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 121.997 1.798 . . . . 0.0 110.269 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.25 69.57 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -122.87 147.06 47.0 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 19.3 t80 -81.28 118.44 22.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.652 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 33.9 mttt -92.17 -162.11 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 123.091 1.424 . . . . 0.0 113.868 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -170.54 172.92 5.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.543 -2.117 . . . . 0.0 110.876 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.649 HD21 ' SD ' ' A' ' 92' ' ' MET . 45.0 tp -132.92 123.76 26.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -121.09 126.28 49.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.592 HG21 ' SD ' ' A' ' 92' ' ' MET . 59.0 t -127.4 121.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.258 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -104.23 125.4 50.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.6 p90 -153.92 169.03 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.002 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -124.2 159.39 30.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.259 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.9 m -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.18 153.56 68.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.105 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 C--N 1.313 -1.315 0 C-N-CA 121.636 1.557 . . . . 0.0 111.331 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.446 HH21 ' HG3' ' A' ' 51' ' ' PRO . 78.3 mtt-85 . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.126 0.488 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HE ' ' HG3' ' A' ' 123' ' ' GLU . 58.4 ttt180 -145.46 130.06 17.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.73 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.1 mm-40 -127.8 143.1 51.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.677 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -138.21 135.24 35.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.805 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -132.48 138.18 47.48 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.351 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 14.3 m -65.32 136.83 57.03 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -45.78 132.67 8.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 0.0 112.348 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.53 -12.58 66.22 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.195 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.3 149.21 40.24 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.536 1.168 . . . . 0.0 110.316 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.36 151.46 85.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.68 2.254 . . . . 0.0 113.02 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.4 tt -119.12 144.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -128.7 128.45 44.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.302 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' SG ' ' A' ' 102' ' ' CYS . 33.5 mt -116.38 141.18 48.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.073 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 49' ' ' ARG . 17.7 mtp180 -148.13 135.05 20.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.809 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.0 m -102.36 141.03 21.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.853 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HG3' HH21 ' A' ' 36' ' ' ARG . 29.4 Cg_endo -67.16 157.74 60.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.469 2.112 . . . . 0.0 112.332 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.76 -134.49 11.13 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.604 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 p -99.82 22.12 11.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.505 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.32 167.3 21.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.07 148.81 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 111.461 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.832 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.2 mt -72.41 138.43 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.723 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.8 ptm -133.26 103.71 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 89' ' ' PHE . 38.4 t -66.75 124.98 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.18 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 86.3 mt-10 -105.6 -51.13 3.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.963 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -146.85 147.52 30.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.103 0.478 . . . . 0.0 110.126 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.606 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.68 157.53 10.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.56 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 122' ' ' LEU . 15.0 t30 -151.1 148.94 28.92 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.275 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -118.57 115.24 24.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.86 -136.3 4.25 Favored Glycine 0 C--N 1.319 -0.379 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 10.2 ttm-85 -156.68 117.1 3.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.204 0.526 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 p -121.68 9.58 10.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.567 ' C ' HG12 ' A' ' 81' ' ' VAL . 35.3 t0 -145.58 -174.82 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 50.1 p30 -141.33 -0.03 1.46 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.199 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 54.2 mttm -101.52 5.3 41.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.137 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 32.2 mm -107.59 133.64 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.963 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.9 m 52.72 75.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.932 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 36.1 t0 -55.11 106.77 0.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.091 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HG3' ' A' ' 78' ' ' MET . . . -118.72 -164.6 1.05 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.295 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.703 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -60.79 142.14 92.3 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.303 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 9.5 Cg_endo -55.34 -39.09 92.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.462 2.108 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -64.51 -36.24 83.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.423 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.55 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 85.0 mt-30 -89.34 -6.59 56.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.692 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.554 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 61.3 mmm -115.47 -1.31 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.164 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.0 mt-10 -67.47 -42.79 82.44 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -79.98 120.62 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.567 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.9 m -111.25 34.7 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.816 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.83 85.39 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.804 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.6 t -149.21 124.88 10.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.285 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' HA ' HD21 ' A' ' 62' ' ' ASN . 92.7 m-85 -132.6 149.77 52.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.723 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 112' ' ' PRO . 51.0 tp -142.1 94.84 6.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -54.34 -47.63 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.948 2.432 . . . . 0.0 114.106 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.1 m-20 -55.13 -26.09 36.17 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.692 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.95 51.38 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.91 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 58' ' ' VAL . 35.7 t80 -66.81 -47.17 72.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 6.0 pttm -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -59.27 -50.85 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.729 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . 1.016 ' SD ' HD21 ' A' ' 122' ' ' LEU . 6.0 mtp -68.46 -33.62 74.51 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.505 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.5 m -59.59 -44.04 93.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.934 ' HE ' HG22 ' A' ' 104' ' ' VAL . 75.5 mtp85 -76.21 -34.57 59.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.625 ' SG ' HD12 ' A' ' 48' ' ' LEU . 37.5 m -113.69 -11.47 12.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 93' ' ' SER . 59.1 m-20 -62.79 134.77 56.77 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.653 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 67.62 14.93 9.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -114.58 147.43 39.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.112 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.5 m -70.11 -32.98 71.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 158.44 44.15 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.509 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.822 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.5 p -157.02 145.0 19.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.384 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.94 128.43 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.934 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.5 t -138.14 140.72 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.168 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 107' ' ' GLY . 48.4 t -77.45 116.39 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.27 38.56 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.127 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.643 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.86 -119.43 0.63 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.643 ' O ' ' O ' ' A' ' 107' ' ' GLY . 48.4 t 27.55 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.291 0.567 . . . . 0.0 111.776 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.523 ' N ' ' OG ' ' A' ' 108' ' ' SER . 91.4 m-20 -68.83 1.85 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.01 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.11 54.67 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.064 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -144.88 129.95 9.26 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.152 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.3 Cg_exo -51.03 -148.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.85 2.366 . . . . 0.0 112.461 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.05 89.45 6.04 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.529 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.97 -10.31 18.07 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.009 2.473 . . . . 0.0 114.095 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.411 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -170.81 69.76 0.53 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.92 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.33 155.51 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.082 1.855 . . . . 0.0 111.531 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.88 85.14 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.7 m -126.27 149.91 48.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 41.8 t80 -83.99 113.54 21.07 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 21.2 mttp -90.06 -162.84 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.314 1.054 . . . . 0.0 113.376 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -171.77 172.75 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.091 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.016 HD21 ' SD ' ' A' ' 92' ' ' MET . 28.0 tp -132.77 126.57 32.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.575 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 81.9 tt0 -122.05 126.06 47.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.783 HG21 ' SD ' ' A' ' 92' ' ' MET . 47.4 t -130.55 127.87 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.24 127.0 53.9 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.832 ' CD2' HG23 ' A' ' 56' ' ' ILE . 46.2 p90 -151.37 162.12 41.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.635 . . . . 0.0 112.146 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.417 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 78.5 m-20 -117.96 158.99 23.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.592 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 36' ' ' ARG . 95.6 m -109.93 108.6 18.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.719 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.77 156.67 43.37 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.757 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 122.079 1.852 . . . . 0.0 112.316 178.568 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.584 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 48.9 ttp180 -146.92 136.94 23.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.605 . . . . 0.0 111.289 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.599 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 18.6 mp0 -130.77 141.33 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.595 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.03 144.11 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.817 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.868 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.82 140.04 34.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.662 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -48.18 133.81 14.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.374 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.54 -15.58 62.98 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.187 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -107.09 147.35 34.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.927 0.863 . . . . 0.0 111.323 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.41 149.68 75.16 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.739 2.293 . . . . 0.0 112.445 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -120.92 143.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.585 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -121.29 129.33 53.07 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.275 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.781 HD12 ' SG ' ' A' ' 102' ' ' CYS . 60.9 mt -117.23 140.1 49.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.548 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -152.19 134.05 14.83 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.549 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.7 m -95.22 137.9 22.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.99 164.71 32.71 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.517 1.478 . . . . 0.0 110.85 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.53 -140.19 29.71 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.703 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 p -106.38 21.3 17.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.757 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.35 170.19 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.714 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.07 144.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.0 0.429 . . . . 0.0 110.665 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 94.8 mt -69.02 138.43 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.299 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.5 ptp -130.95 100.94 5.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.0 t -64.79 123.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.04 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -101.38 -48.85 4.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HB2' ' NE2' ' A' ' 125' ' ' GLN . 45.7 m-80 -148.63 146.59 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.415 0.626 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.798 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.12 152.1 12.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.147 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.3 t30 -148.74 144.44 27.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.841 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -115.63 118.88 34.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.27 -135.33 4.01 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.4 ttm180 -155.58 118.7 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.317 0.579 . . . . 0.0 111.753 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 25.9 p -125.21 3.62 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.739 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 52.8 t0 -146.42 154.64 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.792 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.659 ' O ' ' CE ' ' A' ' 78' ' ' MET . 29.3 p30 -113.73 0.34 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.777 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -102.48 7.9 40.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.767 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.1 133.78 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.1 m 49.49 83.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -61.05 106.02 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -112.44 -166.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.178 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -64.54 139.97 97.88 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.467 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -52.92 -39.38 78.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.375 2.05 . . . . 0.0 113.212 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -64.77 -36.32 83.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.725 0.298 . . . . 0.0 111.468 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 68.0 mt-30 -85.74 -6.67 59.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.646 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.659 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 95.1 mtp -105.6 -4.8 20.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.181 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.2 mt-10 -63.25 -47.55 81.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.982 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -79.33 119.57 22.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 m -108.79 33.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.824 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -141.41 83.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.786 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.464 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 37.1 t -142.8 123.24 13.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -135.07 156.17 49.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 112' ' ' PRO . 50.9 tp -148.04 88.68 5.44 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.877 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.18 -48.18 13.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.791 2.327 . . . . 0.0 113.16 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 79.3 m-20 -57.26 -21.85 37.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.49 -35.11 67.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.474 ' CE1' HG12 ' A' ' 58' ' ' VAL . 60.2 t80 -65.05 -45.04 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.124 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -66.02 -35.88 81.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.255 -179.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.569 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 76.5 mt -61.96 -50.12 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.625 0.25 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 53.8 mtp -71.44 -34.23 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.301 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.2 m -59.85 -46.2 90.04 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.564 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.536 ' OE1' ' O ' ' A' ' 90' ' ' LYS . 1.7 mp0 -66.56 -35.22 79.69 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.748 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.618 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 28.4 mtp180 -76.72 -34.26 58.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.1 m -113.02 -10.1 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.592 ' CG ' ' O ' ' A' ' 93' ' ' SER . 28.1 m-20 -63.45 132.52 51.65 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 65.77 13.14 8.81 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -111.55 144.58 40.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.303 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -72.08 -30.58 65.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.994 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.34 152.4 35.76 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.315 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.781 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -156.78 131.61 8.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.03 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -116.85 134.07 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.787 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.618 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 61.0 t -143.68 150.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.2 t -82.23 117.46 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.436 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.84 39.95 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.769 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.95 -120.45 0.68 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.87 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 28.04 -157.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.489 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -69.02 -1.04 6.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.99 -16.3 47.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.6 m-85 -139.57 130.08 14.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.553 ' HG2' HD21 ' A' ' 85' ' ' LEU . 39.7 Cg_exo -52.93 -149.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.255 1.97 . . . . 0.0 111.186 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.524 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 28.3 t0 -145.34 82.64 9.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 70.1 Cg_endo -73.01 -6.05 18.3 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.728 2.286 . . . . 0.0 113.65 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.89 68.54 0.98 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.422 0.629 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -52.42 149.02 24.47 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.249 1.966 . . . . 0.0 111.197 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.16 -0.49 83.65 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.5 m -118.54 148.68 42.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.619 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 41.3 t80 -86.04 111.6 20.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.524 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 12.1 mttt -91.52 -162.61 0.94 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.149 1.452 . . . . 0.0 113.964 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.484 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.1 p90 -173.84 176.11 2.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 112.152 -2.295 . . . . 0.0 110.143 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 40.4 tp -130.82 120.74 24.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.8 tt0 -118.14 129.73 55.7 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.836 HG21 ' SD ' ' A' ' 92' ' ' MET . 93.5 t -137.21 127.24 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -107.48 131.84 53.86 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.506 ' CD1' HG23 ' A' ' 56' ' ' ILE . 22.7 p90 -155.78 171.91 19.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.647 0.736 . . . . 0.0 112.622 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 72.7 m-20 -130.37 158.87 38.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.027 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.0 m -112.13 109.1 18.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -104.95 156.24 36.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.967 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 C-N-CA 121.981 1.787 . . . . 0.0 110.732 179.234 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 47.9 ttp180 -141.79 137.72 31.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.1 mp0 -133.47 137.43 45.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.828 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.4 tt -139.02 139.49 37.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.939 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.745 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.37 141.85 35.59 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.848 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -63.95 134.91 55.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.278 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -46.21 131.47 10.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.66 67.7 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.375 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 145.47 31.76 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.655 1.228 . . . . 0.0 111.661 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.0 149.95 89.41 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.083 2.522 . . . . 0.0 112.519 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 tt -122.07 145.97 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 83.7 tt0 -125.79 127.53 46.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.09 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 46.1 mt -116.21 145.76 42.86 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.852 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.678 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 87.6 mtt-85 -151.2 135.96 17.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.303 0.573 . . . . 0.0 112.033 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.477 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.4 m -100.49 137.77 20.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.837 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.7 157.8 53.9 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.331 2.02 . . . . 0.0 111.623 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.14 -126.1 29.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.447 -0.406 . . . . 0.0 112.522 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -116.52 24.24 11.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.093 0.473 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.31 169.4 18.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.61 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.98 144.98 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 111.018 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -67.41 136.99 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.988 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -132.35 100.02 4.87 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' HE1' ' A' ' 89' ' ' PHE . 38.2 t -63.87 123.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.705 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.5 mm-40 -101.6 -51.57 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.941 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 66.2 m-20 -149.11 143.18 25.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.624 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -162.75 155.24 18.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.079 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.4 t30 -152.34 146.76 25.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.653 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -114.02 115.1 27.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.1 -136.54 4.29 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.203 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.5 ttm180 -162.17 122.4 2.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.277 0.561 . . . . 0.0 111.905 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 43.5 p -123.72 12.52 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.593 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 29.7 t0 -146.82 -168.72 3.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 44.6 p30 -146.88 4.57 0.85 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.705 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 59.0 mttt -103.45 0.43 31.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.63 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.86 138.46 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.913 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.3 m 53.49 72.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.324 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -57.25 120.32 7.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.512 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.46 -161.71 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -57.55 133.74 82.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.235 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -55.61 -34.48 90.33 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.613 1.542 . . . . 0.0 111.715 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -61.44 -39.19 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.392 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' HG23 ' A' ' 118' ' ' THR . 70.7 mt-30 -83.94 -10.28 58.07 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.02 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.519 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 86.3 mtp -103.2 -1.93 28.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.019 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 54.9 mm-40 -63.84 -45.76 88.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.44 114.64 19.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.77 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.535 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 19.2 m -104.64 34.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.104 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.535 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 28.8 mm100 -142.72 84.17 1.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.251 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.4 t -142.01 126.05 17.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' HD21 ' A' ' 62' ' ' ASN . 41.3 m-85 -136.13 154.0 51.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -146.71 89.26 5.79 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.174 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -50.67 -49.88 15.39 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.88 2.387 . . . . 0.0 113.343 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 54.3 m-20 -58.23 -21.94 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.34 -31.33 43.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.483 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.9 t80 -66.27 -45.9 78.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.735 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.6 ptpt -66.33 -39.86 89.5 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.701 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.758 HG22 ' HE ' ' A' ' 95' ' ' ARG . 56.9 mt -59.75 -49.79 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.679 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 122' ' ' LEU . 58.2 mtp -70.01 -37.95 75.81 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.042 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 48.1 m -55.97 -42.91 77.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -66.24 -38.54 88.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.051 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.758 ' HE ' HG22 ' A' ' 91' ' ' ILE . 14.3 mtm105 -74.86 -34.14 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 71.0 m -110.15 -18.91 13.21 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' CG ' ' O ' ' A' ' 93' ' ' SER . 79.7 m-20 -54.65 135.38 46.77 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.059 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 65.79 14.58 9.63 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.24 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -113.6 145.64 40.95 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.646 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.0 m -69.67 -33.39 72.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.297 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -152.91 155.93 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.674 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 24.8 p -155.1 136.84 14.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.244 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.4 127.63 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.612 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.683 HG21 HH11 ' A' ' 95' ' ' ARG . 42.5 t -142.59 145.55 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 111.374 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 107' ' ' GLY . 66.4 t -75.8 114.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.977 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.98 40.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.48 -121.93 0.73 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 27.2 -155.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.322 0.582 . . . . 0.0 111.868 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -68.52 1.15 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.295 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.01 -15.63 46.95 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.518 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.9 m-85 -146.13 125.15 6.57 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.542 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.9 Cg_exo -51.16 -142.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.528 2.152 . . . . 0.0 112.607 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 116' ' ' PRO . 9.4 t0 -145.31 87.72 6.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.199 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.14 -8.58 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.55 2.167 . . . . 0.0 113.131 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -165.09 69.69 1.36 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.53 0.681 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.2 Cg_exo -53.73 147.25 41.22 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.381 2.054 . . . . 0.0 111.048 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.51 -5.38 81.44 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.881 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' GLN . 88.8 m -118.3 148.05 42.85 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.8 t80 -84.42 116.37 23.03 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.454 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 7.9 mtmm -94.24 -157.83 0.58 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.576 1.179 . . . . 0.0 113.994 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.6 p90 -174.01 175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.881 -1.963 . . . . 0.0 110.239 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 92' ' ' MET . 52.2 tp -130.78 123.67 29.67 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.079 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.469 ' HG2' HE21 ' A' ' 125' ' ' GLN . 66.1 tt0 -121.28 126.79 50.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 61' ' ' ALA . 77.9 t -132.73 127.15 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.452 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.469 HE21 ' HG2' ' A' ' 123' ' ' GLU . 9.4 mp0 -108.61 129.02 55.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 19.7 p90 -156.02 171.69 19.67 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.698 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -131.64 162.24 30.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.0 m -108.3 131.23 54.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.623 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' SD ' ' A' ' 57' ' ' MET . 28.5 m -130.99 157.57 77.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.491 1.358 0 C-N-CA 122.014 1.81 . . . . 0.0 111.576 179.121 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt85 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -146.22 135.5 22.84 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.559 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 58.8 mm-40 -134.0 146.68 50.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.221 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.96 139.68 38.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.742 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.36 142.27 39.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.452 0.644 . . . . 0.0 111.009 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 23.9 m -64.58 137.72 58.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.757 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 72.5 tt0 -43.44 126.32 4.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.179 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.47 -8.21 74.79 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.241 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.34 148.62 38.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.945 1.373 . . . . 0.0 110.005 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.78 149.95 67.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.899 2.399 . . . . 0.0 113.287 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -118.99 146.62 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.673 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 49' ' ' ARG . 82.0 tt0 -126.05 129.84 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.109 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 48.7 mt -116.01 139.81 49.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.986 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 47' ' ' GLU . 3.9 mtp180 -150.28 131.49 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.287 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 56' ' ' ILE . 11.6 m -97.98 151.92 37.8 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.058 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HG3' HH21 ' A' ' 36' ' ' ARG . 93.4 Cg_endo -77.11 160.03 33.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.908 2.406 . . . . 0.0 112.318 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.64 -116.69 6.21 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -131.54 27.47 4.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.05 170.71 15.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.765 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.2 142.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.41 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.5 mt -67.15 137.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.785 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.3 ptp -134.9 102.52 5.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.532 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.8 t -64.09 124.54 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.123 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -100.41 -52.1 3.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.245 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -152.27 150.65 30.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -168.5 155.31 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.855 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.461 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.0 t30 -145.58 147.77 32.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CE2' ' HB3' ' A' ' 111' ' ' PHE . 40.2 t80 -119.59 117.94 29.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.86 -133.14 3.2 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.663 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -157.34 120.46 4.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 0.0 111.191 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.585 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 20.7 p -120.27 8.66 10.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.854 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.5 t0 -145.21 -166.13 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.185 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 38.0 p-10 -150.24 0.31 0.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 51.7 mtpt -102.78 2.91 36.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.252 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.89 135.68 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m 52.71 74.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.1 p30 -52.37 102.93 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.662 0.744 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 -170.21 1.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.838 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -59.56 141.99 87.82 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.21 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.5 Cg_endo -53.63 -40.08 80.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.932 2.421 . . . . 0.0 112.993 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.54 -33.62 76.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.963 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.511 ' O ' HG23 ' A' ' 118' ' ' THR . 78.2 mt-30 -90.2 -8.26 51.56 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 74.5 mmm -107.36 -4.8 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 2.6 mt-10 -67.06 -42.34 84.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 6.1 t-20 -77.98 121.22 23.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.26 31.63 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -138.74 86.7 2.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.008 0.432 . . . . 0.0 110.148 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.472 ' SG ' ' HA3' ' A' ' 64' ' ' GLY . 4.4 t -147.6 120.96 9.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' HG22 ' A' ' 66' ' ' THR . 73.8 m-85 -135.74 157.13 47.63 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.192 0.52 . . . . 0.0 112.372 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -147.53 89.44 5.44 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.434 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.16 -51.33 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.759 2.306 . . . . 0.0 113.123 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 53.8 m-20 -54.93 -22.79 16.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.69 68.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE1' HG12 ' A' ' 58' ' ' VAL . 31.0 t80 -64.14 -44.14 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 111.515 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.04 -38.3 90.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 65.8 mt -61.03 -47.79 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.03 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.7 -36.45 80.67 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.5 m -59.39 -46.55 88.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.48 -35.98 81.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 111.145 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 51.1 mtp85 -75.34 -35.22 61.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.3 m -112.92 -18.1 12.32 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 46.3 m-20 -52.82 136.39 34.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 66.34 13.19 9.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.207 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -112.89 145.38 40.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.0 m -74.62 -32.32 62.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.013 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -149.2 150.24 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.4 p -153.5 143.64 22.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.287 0.565 . . . . 0.0 111.448 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.12 123.59 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.443 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.549 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.7 t -135.56 143.88 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.432 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.87 119.47 32.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.329 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.17 42.45 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.75 -125.27 0.95 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 29.54 -157.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 110.855 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.63 2.75 3.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.967 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.05 -12.71 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.727 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.1 m-85 -143.53 126.13 8.72 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -51.86 -144.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.137 1.891 . . . . 0.0 111.178 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.51 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 8.7 t0 -146.02 96.34 4.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 92.5 Cg_endo -84.89 -8.92 9.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.029 2.486 . . . . 0.0 112.768 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -162.02 64.45 1.7 Allowed Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.275 0.56 . . . . 0.0 111.475 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.51 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 23.4 Cg_exo -53.94 145.29 52.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.925 1.75 . . . . 0.0 111.022 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.8 -11.66 71.6 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.865 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.2 m -117.93 150.41 39.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.1 0.45 . . . . 0.0 110.099 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 45.3 t80 -81.26 116.34 21.08 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.43 ' C ' ' HB2' ' A' ' 42' ' ' GLU . 10.7 mttt -93.19 -162.52 0.95 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.508 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -173.21 174.14 3.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.369 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.3 tp -131.86 123.65 27.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.233 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -118.76 126.69 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.6 t -130.49 125.2 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.43 128.22 53.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 56' ' ' ILE . 38.7 p90 -153.68 168.76 25.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.819 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.6 OUTLIER -127.57 163.1 24.92 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.556 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.489 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 72.9 m -113.21 114.55 26.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.31 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.8 m -116.66 151.69 47.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.056 1.838 . . . . 0.0 111.799 179.191 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.799 HH12 ' CD ' ' A' ' 51' ' ' PRO . 52.1 mtt180 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -153.54 134.88 14.18 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.201 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.43 148.6 45.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.583 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -139.88 140.94 36.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.833 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.57 142.5 33.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.457 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.34 137.26 54.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.721 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 84.2 tt0 -48.88 136.22 14.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.9 38.23 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.981 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.4 m-30 -108.14 151.5 41.4 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 118.129 0.965 . . . . 0.0 109.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.47 155.0 70.59 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.515 2.143 . . . . 0.0 113.453 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.2 tt -118.48 146.35 23.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.068 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' CG ' HH11 ' A' ' 49' ' ' ARG . 0.7 OUTLIER -122.09 130.72 53.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.569 0.7 . . . . 0.0 112.511 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.026 HD12 ' SG ' ' A' ' 102' ' ' CYS . 76.1 mt -121.99 130.88 53.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.661 177.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 47' ' ' GLU . 3.6 mtt85 -147.23 130.54 16.58 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.218 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.472 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.4 m -97.56 143.57 26.43 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.799 ' CD ' HH12 ' A' ' 36' ' ' ARG . 18.8 Cg_endo -70.6 163.61 38.34 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.677 2.251 . . . . 0.0 112.717 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.63 -126.65 21.26 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -115.73 24.74 11.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.497 -0.352 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.94 169.15 18.77 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.911 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.91 145.91 33.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.398 0.618 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.8 mt -68.91 138.06 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.649 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -131.14 100.09 5.09 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.608 HG12 ' CE1' ' A' ' 89' ' ' PHE . 75.0 t -65.09 122.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.032 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.551 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 61.4 mt-10 -100.05 -47.06 5.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.551 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 59.4 m-20 -151.24 150.8 31.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.555 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.804 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.83 154.52 13.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.785 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.455 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.6 t30 -152.19 149.9 29.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 112.115 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.522 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 87.2 t80 -121.93 119.08 30.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.509 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.64 -136.79 4.56 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.02 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.611 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.8 ttm180 -155.29 117.55 4.18 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.135 0.493 . . . . 0.0 110.797 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -123.66 10.66 9.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 30.8 t0 -146.65 -169.01 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 29.6 p30 -145.33 -0.17 0.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.784 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 31.9 mtpt -102.7 6.23 39.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.538 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.403 HG22 ' SG ' ' A' ' 71' ' ' CYS . 18.9 mm -110.52 135.02 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' ALA . 83.5 m 62.13 51.58 3.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.951 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.56 95.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.738 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -116.68 -162.46 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -60.1 132.51 89.93 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.691 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.8 Cg_endo -54.64 -34.77 84.69 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.94 2.426 . . . . 0.0 114.278 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -62.32 -33.43 74.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.448 0.642 . . . . 0.0 109.79 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.632 ' O ' HG23 ' A' ' 118' ' ' THR . 81.9 mt-30 -87.41 -0.05 56.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 4.8 mtm -119.8 0.3 10.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.9 mt-10 -62.69 -50.05 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.218 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -80.13 111.53 16.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.0 m -102.59 35.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.236 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -141.49 87.81 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.2 t -145.16 122.24 11.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.455 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.7 m-85 -132.61 153.87 50.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.232 0.539 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -148.59 88.33 5.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.303 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.69 -47.77 21.75 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.864 2.376 . . . . 0.0 113.868 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -54.61 -24.98 23.7 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.22 -30.96 40.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.673 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.608 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -65.77 -45.51 82.26 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.1 pttt -65.2 -43.03 92.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.681 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 1.0 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 59.6 mt -58.83 -45.68 91.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 93.8 mmm -69.78 -35.63 75.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.198 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.499 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 50.8 m -61.0 -47.32 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.25 -37.85 88.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.165 0.507 . . . . 0.0 111.049 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 1.0 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 47.8 mtm180 -77.55 -33.91 53.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.1 m -112.52 -19.75 12.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -176.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 90.3 m-20 -61.15 135.61 57.81 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.353 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 67.34 13.68 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.303 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -113.04 145.34 41.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.328 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -70.97 -31.68 68.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.76 155.01 38.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.938 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 1.026 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.5 p -156.39 132.86 10.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.25 129.28 71.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 43.8 t -136.72 139.05 45.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.762 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' GLY . 58.2 t -72.94 116.18 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.81 40.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.701 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -122.66 0.85 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.6 t 29.58 -157.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.651 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -67.38 0.37 2.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.337 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.82 -13.7 50.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.571 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 112' ' ' PRO . 47.8 m-85 -144.43 126.69 8.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.199 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.593 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -48.88 -149.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.756 2.304 . . . . 0.0 112.202 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 21.8 t0 -145.18 80.11 11.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.483 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 69.6 Cg_endo -75.33 -3.56 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.25 2.633 . . . . 0.0 112.842 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.58 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.2 p -164.05 63.43 1.14 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.752 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.08 144.09 59.54 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.096 1.864 . . . . 0.0 110.299 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.72 -4.34 81.89 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 77' ' ' GLN . 80.4 m -125.73 147.86 49.24 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.666 0.733 . . . . 0.0 109.869 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.611 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 4.6 t80 -80.54 113.7 18.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 28.0 mttp -91.85 -160.3 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.575 1.178 . . . . 0.0 113.291 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.0 p90 -175.41 177.11 1.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.13 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.7 tp -130.39 121.45 25.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -120.9 127.44 51.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.799 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.804 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -135.38 129.03 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.479 ' NE2' ' HB2' ' A' ' 60' ' ' ASN . 0.7 OUTLIER -107.97 130.26 55.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.633 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.7 p90 -154.2 173.72 15.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.364 0.602 . . . . 0.0 111.764 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 80.0 m-20 -133.23 161.13 35.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.835 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 95.4 m -111.71 111.05 21.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.97 158.53 37.55 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.355 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 C--N 1.313 -1.302 0 C-N-CA 121.862 1.708 . . . . 0.0 111.698 179.315 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 36' ' ' ARG . 79.9 mtt-85 . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 49.1 ttp180 -148.99 137.76 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.7 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 31.5 mp0 -130.8 145.62 52.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.536 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.53 141.74 37.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.821 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.18 140.17 35.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.449 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.2 m -67.76 137.2 55.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.505 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -46.7 134.53 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.02 52.39 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.3 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.7 m-85 -107.28 147.01 34.41 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.279 1.039 . . . . 0.0 110.139 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -67.14 153.27 78.03 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.546 2.164 . . . . 0.0 112.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.6 tt -118.14 141.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -120.22 128.22 53.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.464 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 73.2 mt -116.78 142.62 46.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.391 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -152.94 133.41 13.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.84 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.2 m -102.01 147.52 34.04 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.06 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.2 Cg_endo -70.35 158.21 56.88 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 123.686 2.924 . . . . 0.0 113.317 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.92 -132.89 32.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.9 p -105.26 27.89 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.353 0.597 . . . . 0.0 109.742 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.44 162.37 25.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.097 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -126.49 147.99 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.58 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.799 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -71.18 134.8 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.635 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.6 ptm -130.32 100.72 5.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.49 0.662 . . . . 0.0 109.264 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 93' ' ' SER . 6.9 t -65.16 122.67 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.602 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -102.51 -48.05 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -149.4 148.66 29.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.474 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.834 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.18 154.4 10.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.8 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' O ' HD12 ' A' ' 122' ' ' LEU . 7.3 t-20 -152.3 149.69 28.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.692 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.88 121.16 37.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.81 -135.5 4.25 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.76 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -158.12 119.63 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.271 0.558 . . . . 0.0 111.1 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 84' ' ' TYR . 38.6 p -122.6 9.77 9.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.557 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 28.5 t0 -145.36 -169.36 3.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 59.8 p30 -147.21 -1.01 0.66 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.657 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -100.09 3.41 43.97 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.708 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 44.7 mm -106.27 133.45 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 72.8 m 63.09 57.52 1.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.1 p30 -42.33 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.303 0.573 . . . . 0.0 111.843 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.95 -165.1 1.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.681 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -59.06 137.29 87.95 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.595 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.38 -35.55 75.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.383 2.056 . . . . 0.0 112.261 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -62.45 -40.53 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.523 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 53.3 mt-30 -88.3 -5.42 58.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.983 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.472 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.8 mmm -107.22 -4.6 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.507 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.3 mt-10 -65.56 -48.65 71.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -77.79 122.32 25.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 112.338 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 32.25 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -140.44 86.28 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.136 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.544 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 28.8 t -144.76 123.06 12.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.413 ' CE1' HG21 ' A' ' 66' ' ' THR . 88.8 m-85 -134.83 153.76 51.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.241 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.435 ' H ' HD22 ' A' ' 62' ' ' ASN . 29.1 tp -147.0 91.81 5.09 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.78 -45.26 42.36 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.773 2.315 . . . . 0.0 113.718 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.82 -15.68 32.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.51 -28.93 57.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.6 -44.16 91.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.11 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.44 -42.07 92.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.734 HG23 ' NH1' ' A' ' 95' ' ' ARG . 68.6 mt -59.68 -47.57 90.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.216 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.9 mmm -70.07 -35.51 74.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG21 ' A' ' 58' ' ' VAL . 74.1 m -63.44 -45.28 91.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.755 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.99 -36.91 85.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 0.0 111.407 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.734 ' NH1' HG23 ' A' ' 91' ' ' ILE . 51.1 mtt85 -79.9 -32.68 40.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.1 m -113.45 -13.29 12.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 87.6 m-20 -61.56 135.28 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.554 -0.859 . . . . 0.0 112.054 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 65.31 11.02 6.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -110.62 144.43 39.52 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.407 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 m -70.56 -31.79 68.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.904 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.81 154.15 41.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.738 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.88 137.08 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.511 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.94 128.92 75.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.516 HG22 ' HD3' ' A' ' 95' ' ' ARG . 19.2 t -136.87 144.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.623 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.6 t -76.72 115.57 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.77 33.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.952 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.6 -119.76 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.99 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.4 t 32.1 -159.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.75 0.309 . . . . 0.0 111.042 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -67.5 2.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.577 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.72 -11.81 56.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.187 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.587 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -146.6 129.97 8.22 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.2 Cg_exo -50.43 -146.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.461 2.107 . . . . 0.0 112.207 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -144.34 83.73 9.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.27 -7.02 17.76 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.024 2.483 . . . . 0.0 114.234 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.557 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.45 68.77 1.07 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 121.605 0.717 . . . . 0.0 111.267 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -51.74 144.28 35.0 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 122.667 2.245 . . . . 0.0 111.2 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.86 2.23 90.48 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.942 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.6 m -120.43 146.06 46.59 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.055 0.928 . . . . 0.0 109.542 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.76 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 7.6 t80 -80.88 110.5 16.46 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.557 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.9 mttp -90.49 -164.84 1.23 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.517 1.151 . . . . 0.0 113.858 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB2' HD21 ' A' ' 39' ' ' LEU . 4.3 p90 -170.56 169.57 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.033 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 62' ' ' ASN . 32.8 tp -127.43 124.57 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HG2' HE21 ' A' ' 125' ' ' GLN . 73.0 tt0 -120.42 125.62 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.834 HG22 ' HB1' ' A' ' 61' ' ' ALA . 71.9 t -132.2 125.66 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.587 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.46 HE21 ' HG2' ' A' ' 123' ' ' GLU . 4.2 mp0 -108.57 126.1 52.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.752 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.799 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.5 p90 -153.31 173.03 16.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.9 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -125.27 159.39 31.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.198 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 95.3 m -108.95 121.34 44.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.009 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 29.9 m -132.03 158.63 75.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.51 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 C--N 1.313 -1.32 0 C-N-CA 122.053 1.835 . . . . 0.0 112.424 -179.494 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -152.0 138.25 18.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.124 0.488 . . . . 0.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.618 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.3 mt-10 -130.18 149.76 51.74 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.836 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -137.42 140.45 41.32 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.717 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.99 138.0 38.47 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.338 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 45.8 m -66.68 137.02 56.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -45.2 130.73 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.992 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.2 -14.44 62.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.004 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 12.5 m-85 -109.34 151.59 42.18 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.884 1.342 . . . . 0.0 110.083 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.36 155.48 60.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.664 2.243 . . . . 0.0 113.039 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 tt -123.21 147.97 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.2 tt0 -128.98 124.23 34.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.508 HD12 ' SG ' ' A' ' 102' ' ' CYS . 57.1 mt -113.27 141.89 46.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 17.8 mtp-105 -147.86 138.92 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.919 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.511 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.3 m -106.79 142.76 25.66 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.351 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 31.5 Cg_endo -68.83 160.8 48.21 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.532 2.155 . . . . 0.0 112.907 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.94 -132.34 10.19 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.364 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -101.74 22.23 13.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.201 -0.5 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -77.39 165.51 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.258 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.947 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.5 mt -68.66 139.7 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.669 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.458 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -132.45 100.57 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.5 t -63.44 125.33 19.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.755 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 93.3 mt-10 -101.67 -48.79 4.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.2 m-20 -149.98 150.69 32.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.203 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.478 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -170.66 157.38 5.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.878 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 84' ' ' TYR . 13.7 t30 -150.18 146.91 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -117.61 120.63 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 155.88 -131.23 2.98 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.789 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 7.3 ttm-85 -157.1 115.01 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.483 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.429 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.0 p -118.25 11.14 13.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' C ' HG12 ' A' ' 81' ' ' VAL . 46.0 t0 -147.89 -171.67 3.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.785 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.547 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 26.1 p-10 -145.62 -2.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 34.9 mttp -100.7 6.32 43.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.0 mm -111.9 135.83 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.15 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.3 m 53.63 75.0 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.281 0.562 . . . . 0.0 109.894 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.77 120.12 7.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.55 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.82 -164.15 1.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.607 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -59.96 134.55 90.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 119.159 -1.017 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -53.6 -33.28 68.09 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.545 2.163 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.28 -37.68 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.691 0.281 . . . . 0.0 111.146 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 66.7 mt-30 -86.48 2.51 47.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.203 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 38.8 mmm -121.85 -0.18 9.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 63.0 mt-10 -64.96 -48.52 73.76 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.29 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -78.38 116.85 19.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' C ' ' A' ' 67' ' ' ASP . 26.5 m -105.34 36.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 71.9 mm-40 -141.14 83.42 1.88 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.547 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 31.7 t -147.13 116.86 7.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 8.7 m-85 -130.18 157.49 42.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.606 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.35 90.75 5.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -48.73 -46.8 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.121 2.547 . . . . 0.0 113.805 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -57.84 -18.33 21.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.53 65.38 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.627 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.47 -46.39 79.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.765 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -64.65 -41.05 96.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.669 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.548 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 97.8 mt -60.38 -49.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.741 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.91 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.7 mtp -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.401 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.1 m -55.74 -44.01 77.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.96 -37.94 82.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.589 ' NE ' HG22 ' A' ' 104' ' ' VAL . 20.2 mtp180 -75.77 -34.41 60.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -110.38 -19.78 12.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 76.4 m-20 -58.34 136.95 57.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.613 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 65.2 13.55 8.82 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.646 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -114.29 146.22 40.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.202 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.0 m -69.45 -31.03 69.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 156.15 41.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.605 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -152.4 130.18 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.09 131.59 66.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.629 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' NE ' ' A' ' 95' ' ' ARG . 78.0 t -145.82 148.8 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.359 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.44 118.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.01 38.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.083 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.662 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.3 -118.65 0.58 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.156 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.662 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.1 t 24.63 -156.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.231 0.539 . . . . 0.0 111.823 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -69.51 2.7 2.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.82 -14.38 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.548 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -144.8 130.17 9.42 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.41 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.6 Cg_exo -51.72 -145.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.981 1.787 . . . . 0.0 112.063 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -144.96 86.63 7.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.548 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.491 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.5 Cg_endo -75.63 -5.03 16.05 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.376 2.051 . . . . 0.0 112.666 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -169.78 73.7 0.67 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.246 0.546 . . . . 0.0 111.636 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -53.23 148.09 33.3 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.674 2.25 . . . . 0.0 111.6 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.58 75.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.09 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.9 m -118.97 146.79 44.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 14.5 t80 -82.82 109.24 16.78 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 28.0 mtmm -87.88 -165.2 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.507 1.146 . . . . 0.0 113.799 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 64' ' ' GLY . 5.3 p90 -170.53 171.24 6.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.048 -1.887 . . . . 0.0 111.034 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.91 HD21 ' SD ' ' A' ' 92' ' ' MET . 27.8 tp -129.67 120.71 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.116 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' CD ' ' OE1' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -114.16 125.59 54.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.787 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.755 HG21 ' SD ' ' A' ' 92' ' ' MET . 38.8 t -134.37 122.51 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.839 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.46 ' OE1' ' CD ' ' A' ' 123' ' ' GLU . 1.9 mt-30 -105.97 127.28 53.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.358 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.947 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.5 p90 -149.83 168.26 24.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 111.846 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -124.96 160.08 29.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.1 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -110.77 122.11 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.0 156.35 62.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.149 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo . . . . . 0 N--CA 1.492 1.414 0 C-N-CA 122.194 1.929 . . . . 0.0 111.845 179.253 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 41.5 ttm180 -142.4 138.89 31.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.392 0.615 . . . . 0.0 110.742 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -135.03 140.61 45.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.61 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.6 133.6 30.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.49 141.1 46.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.203 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.4 m -67.67 136.65 54.69 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.573 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 88.6 tt0 -49.31 134.14 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.629 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.73 -17.94 56.74 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.21 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 72.1 m-85 -113.12 152.66 45.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 118.302 1.051 . . . . 0.0 109.943 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.56 153.76 76.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.272 1.981 . . . . 0.0 113.14 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.61 139.51 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 81.2 tt0 -128.49 129.05 45.51 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.293 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.87 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.5 mt -111.85 144.58 40.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.44 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.641 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 91.6 mtt180 -149.26 130.33 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.675 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -96.93 145.13 29.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.813 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.84 161.91 40.49 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.329 2.019 . . . . 0.0 111.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.43 -126.73 31.99 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.69 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -117.92 23.87 11.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -75.16 168.46 19.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 m -125.84 145.6 33.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.89 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.1 mt -69.0 137.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.782 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.639 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.1 ptm -131.6 99.35 4.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.516 HG12 ' HE1' ' A' ' 89' ' ' PHE . 55.8 t -63.95 125.92 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.955 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.73 -50.78 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.736 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 42.8 m-20 -149.83 149.12 30.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.487 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.4 154.06 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.696 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.5 t30 -151.18 144.1 24.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.508 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -115.41 120.32 39.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.65 -135.88 4.34 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.859 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.573 HH12 ' HB3' ' A' ' 119' ' ' TYR . 11.8 ttm180 -156.91 117.12 3.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 111.246 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.0 p -121.2 11.53 10.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 81' ' ' VAL . 35.5 t0 -144.96 -167.02 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.422 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 13.1 p30 -149.83 -1.71 0.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -100.86 6.35 43.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.287 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.47 131.92 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.1 m 50.06 81.0 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.606 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 37.7 p30 -53.79 98.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.502 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.65 -172.94 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.097 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -58.15 134.71 84.36 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.191 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.1 Cg_endo -50.18 -35.82 44.06 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.629 1.553 . . . . 0.0 112.096 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -61.95 -38.34 88.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.783 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.698 ' O ' HG23 ' A' ' 118' ' ' THR . 80.6 mt-30 -84.3 -8.69 58.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.26 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 74.0 mtp -104.43 -0.86 27.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.267 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.4 mt-10 -61.82 -49.91 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -78.22 117.89 19.92 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 67' ' ' ASP . 20.8 m -109.74 30.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.969 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.6 mm-40 -140.99 86.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 3.7 t -145.37 122.09 11.18 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.0 m-85 -131.96 157.42 44.11 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 112' ' ' PRO . 42.9 tp -148.18 90.12 5.07 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.821 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -46.8 -47.79 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.673 2.248 . . . . 0.0 112.783 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 83.6 m-20 -56.38 -24.55 45.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.49 62.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.529 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' HE1' HG12 ' A' ' 58' ' ' VAL . 40.5 t80 -66.03 -44.97 83.11 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -64.66 -38.3 90.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 99.0 mt -59.33 -48.63 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.37 -36.13 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 15.6 m -58.25 -45.58 87.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.17 -38.25 85.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.67 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.622 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 80.9 mtt180 -75.76 -34.05 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.4 m -110.31 -20.51 12.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.48 ' CG ' ' O ' ' A' ' 93' ' ' SER . 72.5 m-20 -57.33 137.82 55.6 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.614 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.94 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -115.69 147.21 41.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.241 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.4 m -70.07 -35.75 74.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.966 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -150.18 157.76 43.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.521 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.87 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -153.84 141.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 111.822 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.9 126.52 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.535 HG11 HH11 ' A' ' 95' ' ' ARG . 21.9 t -139.26 141.55 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.964 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 107' ' ' GLY . 88.5 t -72.68 113.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.528 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -68.05 34.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.895 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.11 -123.21 0.81 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.9 t 32.76 -161.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.785 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.06 4.49 1.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.28 -11.93 59.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.4 m-85 -143.01 129.82 10.68 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.0 Cg_exo -51.86 -149.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.249 1.966 . . . . 0.0 111.213 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.82 88.92 6.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 68.0 Cg_endo -84.67 -4.98 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.245 2.63 . . . . 0.0 113.274 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -168.4 73.9 0.84 Allowed Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.873 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.67 154.24 70.41 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.635 2.223 . . . . 0.0 112.728 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.25 4.65 90.43 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.8 m -127.11 148.01 50.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.573 ' HB3' HH12 ' A' ' 65' ' ' ARG . 48.6 t80 -83.85 114.48 21.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.433 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 12.6 mttt -91.14 -163.83 1.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.6 p90 -171.41 172.77 5.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.513 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 62' ' ' ASN . 48.1 tp -133.72 126.82 31.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.418 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 87.3 tt0 -121.49 127.21 50.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 61' ' ' ALA . 24.5 t -131.09 125.1 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.159 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 60' ' ' ASN . 12.0 mp0 -110.3 129.14 55.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.026 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.3 p90 -153.09 166.91 30.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.377 0.608 . . . . 0.0 112.065 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 38.8 m-20 -118.22 157.69 26.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.31 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.4 m -108.82 118.47 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.37 155.81 58.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.139 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 C--N 1.31 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 111.597 179.763 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.507 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 62.4 mtp85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -153.04 142.92 22.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.204 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.1 mt-10 -133.91 149.91 51.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.946 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -141.3 134.5 29.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.243 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.6 143.77 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.705 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 m -67.39 139.04 57.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.952 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -45.13 133.12 6.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.628 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.1 63.95 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.333 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -108.24 149.43 39.21 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 118.733 1.267 . . . . 0.0 110.722 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.0 149.54 77.32 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.387 2.058 . . . . 0.0 112.935 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.8 tt -121.46 143.63 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 56.8 tt0 -129.6 128.34 42.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.252 0.549 . . . . 0.0 112.148 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.4 mt -113.25 141.98 46.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.952 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.622 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 82.2 mtt180 -146.95 127.55 14.18 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 m -96.52 141.56 23.29 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 50.7 Cg_endo -71.76 163.79 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.59 2.193 . . . . 0.0 112.264 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.68 -138.65 18.62 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -102.37 23.2 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.745 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 92.9 m-20 -79.35 164.82 23.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.34 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.5 m -128.67 149.04 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.328 0.585 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 126' ' ' TYR . 99.1 mt -69.79 135.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.504 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -131.24 98.61 4.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.475 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.9 t -61.97 122.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.713 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 59' ' ' GLU . 71.4 mm-40 -100.61 -46.21 5.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.6 144.13 25.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.127 0.489 . . . . 0.0 110.572 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.35 147.49 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 84' ' ' TYR . 27.7 t30 -149.85 155.83 40.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.958 0.409 . . . . 0.0 111.545 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -121.01 120.59 35.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.8 -139.74 6.17 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.68 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 13.6 ttm180 -155.35 115.07 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.943 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -126.95 8.49 6.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.953 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -148.57 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.149 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 78' ' ' MET . 23.7 p-10 -114.37 5.13 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.441 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -102.48 3.4 37.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.918 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' LEU . 26.3 mm -112.52 134.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.536 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.85 67.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.199 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 26.4 p-10 -52.57 102.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.009 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.696 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -116.52 -165.7 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -60.04 139.25 90.96 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.898 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 Cg_endo -54.14 -40.25 82.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.261 1.974 . . . . 0.0 113.078 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -61.95 -37.29 84.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.248 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 118' ' ' THR . 71.4 mt-30 -86.4 -4.79 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.53 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 89.3 mtp -107.16 -1.11 22.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 79.7 mt-10 -64.35 -48.52 75.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -79.9 119.79 23.24 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.27 31.23 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -138.47 84.2 2.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.071 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.3 t -146.78 121.04 9.55 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' ASN . 80.1 m-85 -130.98 153.95 48.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.517 HD21 ' HG2' ' A' ' 112' ' ' PRO . 48.7 tp -147.12 91.36 5.15 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.68 -46.14 28.47 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 123.303 2.669 . . . . 0.0 113.972 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.2 m-20 -57.91 -20.22 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.67 65.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE1' HG12 ' A' ' 58' ' ' VAL . 74.0 t80 -63.54 -42.75 98.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 4.0 ptmm? -66.86 -40.57 87.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.128 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.481 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 44.8 mt -59.51 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.91 -37.8 76.08 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.5 m -59.76 -46.74 88.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.803 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -65.83 -38.9 90.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.169 0.509 . . . . 0.0 111.127 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 95' ' ' ARG . 51.9 mtt180 -75.37 -34.13 61.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.5 m -111.59 -16.05 13.35 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 25.0 m-20 -58.85 136.73 57.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.854 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 65.89 13.86 9.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.02 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -112.34 144.45 41.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.559 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.3 m -71.93 -30.91 65.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.976 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 152.65 36.58 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.02 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -155.28 137.21 14.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 47' ' ' GLU . 57.5 t -125.09 127.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.806 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.473 ' O ' HG22 ' A' ' 46' ' ' ILE . 60.9 t -138.15 149.12 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 107' ' ' GLY . 97.3 t -78.56 115.03 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.355 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.11 36.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.564 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.52 -119.95 0.65 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 107' ' ' GLY . 17.0 t 28.45 -158.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.98 0.93 5.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.242 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.48 -14.81 56.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.123 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.2 m-85 -141.75 130.82 12.32 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.228 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.9 Cg_exo -51.44 -150.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.216 1.944 . . . . 0.0 111.628 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -146.99 93.86 4.7 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 96.6 Cg_endo -84.23 -11.35 8.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.04 2.493 . . . . 0.0 114.814 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 3.9 p -166.85 66.94 0.92 Allowed Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.4 153.56 33.91 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.315 2.01 . . . . 0.0 110.743 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.36 73.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -126.12 148.33 49.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 10.6 t80 -81.04 113.36 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mtmm -91.29 -160.77 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.131 0.967 . . . . 0.0 113.166 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.498 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.9 p90 -174.35 175.33 2.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.801 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.2 tp -133.58 127.14 32.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -119.23 130.11 55.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.8 t -133.08 121.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.928 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 132.21 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 56' ' ' ILE . 48.6 p90 -155.02 173.18 16.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.485 0.659 . . . . 0.0 111.856 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 57' ' ' MET . 41.9 m-20 -125.5 156.0 39.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.453 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 85.7 m -108.66 115.76 30.69 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.163 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.9 m -120.49 155.24 56.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 122.28 1.987 . . . . 0.0 112.682 179.468 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.485 HH21 ' HG3' ' A' ' 51' ' ' PRO . 92.9 mtt-85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.973 0.415 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -146.14 130.05 17.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.558 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.569 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.1 mm-40 -127.25 145.21 50.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.73 140.78 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.283 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.739 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.72 136.61 37.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.559 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.7 m -65.01 140.76 58.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 110.481 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.07 126.66 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.488 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.2 65.87 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.691 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.4 m-85 -107.36 154.59 40.52 Favored Pre-proline 0 C--O 1.226 -0.136 0 CA-C-N 118.801 1.301 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -71.93 152.08 57.24 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.953 1.769 . . . . 0.0 112.38 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.0 tt -120.19 147.49 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.65 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 72.1 tt0 -130.01 129.76 44.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.466 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.1 mt -115.84 136.93 52.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.65 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 90.6 mtt180 -144.48 140.1 28.7 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.877 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -104.41 143.99 27.79 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.154 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HG3' HH21 ' A' ' 36' ' ' ARG . 37.8 Cg_endo -70.76 160.44 49.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.988 2.458 . . . . 0.0 112.193 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -127.06 23.85 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.0 p -114.3 24.97 11.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.46 168.28 20.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.202 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 129' ' ' VAL . 18.8 m -127.24 144.86 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.196 179.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 82.7 mt -68.89 138.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.779 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.611 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.5 ptm -132.54 100.66 5.04 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 25.4 t -66.12 125.0 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.524 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 90.3 mt-10 -102.66 -47.82 4.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.3 m-20 -149.73 149.35 30.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.662 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.69 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.0 153.82 14.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.325 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 84' ' ' TYR . 9.3 t30 -150.27 139.45 21.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -111.65 118.01 34.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.42 -137.37 4.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 10.0 ttm-85 -154.77 120.27 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.493 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p -121.43 9.19 10.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.636 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 34.4 t0 -143.47 -164.6 1.9 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.566 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 4.1 p30 -149.18 -1.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 109.808 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -104.61 5.88 34.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.887 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.3 mm -107.82 136.85 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.106 179.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.1 m 54.22 69.71 0.69 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.1 p-10 -49.26 103.67 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.786 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.47 -165.62 1.22 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.689 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -61.97 144.76 93.62 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 111.333 -179.693 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.3 Cg_endo -61.17 -39.4 59.1 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.606 2.204 . . . . 0.0 112.838 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -62.67 -32.13 73.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.692 ' O ' HG23 ' A' ' 118' ' ' THR . 71.0 mt-30 -89.23 -11.53 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 67.1 mmm -104.13 -2.76 25.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.877 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.1 mt-10 -66.9 -45.24 78.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.65 114.52 19.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.478 0.656 . . . . 0.0 112.091 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 15.9 m -104.94 34.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.06 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.5 mm-40 -142.64 87.37 2.0 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.372 0.606 . . . . 0.0 110.894 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.8 t -145.22 118.08 8.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -130.77 154.18 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.715 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 88' ' ' ALA . 13.3 tp -143.29 85.86 9.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.45 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.64 -50.0 11.21 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.052 2.501 . . . . 0.0 114.006 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -57.61 -22.99 48.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.588 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.01 -32.63 34.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.95 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 29.2 t80 -64.87 -42.23 95.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.565 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.5 pttt -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.925 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.3 mt -60.52 -47.74 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.795 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -70.03 -37.5 75.61 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.013 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.8 m -60.35 -46.64 89.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.03 -36.0 82.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.612 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.732 ' NE ' HG22 ' A' ' 104' ' ' VAL . 22.9 mtp180 -79.34 -30.93 42.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.7 m -112.03 -19.74 12.22 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 71.6 m-20 -55.61 131.4 46.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.86 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 69.37 13.8 8.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -113.89 146.53 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.131 178.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 m -69.91 -29.04 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.901 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 158.3 41.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.907 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -156.44 139.08 15.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.9 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.56 127.32 75.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.248 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.732 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.8 t -136.66 144.02 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.0 t -77.14 114.15 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -71.24 36.99 0.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.417 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.02 -121.42 0.71 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.7 t 29.0 -158.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.124 0.487 . . . . 0.0 111.222 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' N ' ' OG ' ' A' ' 108' ' ' SER . 21.7 m-20 -68.72 2.76 2.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.36 -15.82 48.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.281 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.6 m-85 -143.42 126.26 8.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.589 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.0 Cg_exo -52.03 -143.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.945 . . . . 0.0 111.495 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 23.8 t0 -143.25 83.39 11.04 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.68 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.26 -5.19 16.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.938 2.426 . . . . 0.0 112.763 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.581 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -168.35 74.29 0.85 Allowed Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 110.974 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.98 144.2 94.82 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 121.901 1.734 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.3 -8.32 78.99 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.266 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.9 m -115.37 148.45 39.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.036 0.918 . . . . 0.0 109.759 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.509 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 28.9 t80 -81.28 113.92 19.72 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.581 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 14.8 mttp -92.98 -161.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.939 1.352 . . . . 0.0 114.161 -176.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -174.06 174.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.377 -2.192 . . . . 0.0 110.491 176.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 31.0 tp -128.32 122.11 30.8 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 61' ' ' ALA . 20.6 t -131.51 127.45 59.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.841 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 124.66 49.93 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 29.5 p90 -149.86 168.35 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 m-20 -124.64 161.52 26.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 68.0 m -110.1 113.0 25.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 55' ' ' VAL . 2.0 m -118.61 159.41 44.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.92 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.5 1.901 0 C-N-CA 122.695 2.263 . . . . 0.0 112.573 179.284 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 23.5 mtp180 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' OE2' ' A' ' 123' ' ' GLU . 32.2 ttp180 -150.99 139.43 20.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.274 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 52.4 mp0 -132.87 145.64 51.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.819 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -137.09 138.76 40.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.083 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.825 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.32 143.92 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.218 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 m -68.17 135.62 52.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.686 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -46.94 136.0 8.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.443 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 -17.45 58.78 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.044 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 31.7 m-85 -108.69 149.78 39.91 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 118.135 0.968 . . . . 0.0 110.314 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.59 149.68 68.28 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.08 1.853 . . . . 0.0 112.636 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.57 146.54 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.181 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 49' ' ' ARG . 80.6 tt0 -130.98 127.26 38.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.75 -179.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.568 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -111.37 140.06 46.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.427 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.575 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 6.5 mtt180 -145.17 133.04 21.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -99.85 144.11 27.75 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.041 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.6 Cg_endo -68.22 161.51 44.28 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.376 2.051 . . . . 0.0 112.57 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.32 -133.13 25.19 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.512 178.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.8 p -103.3 22.87 13.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.679 -0.761 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -78.95 167.6 20.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.23 0.538 . . . . 0.0 111.65 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.99 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.321 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.802 HG23 ' CD2' ' A' ' 126' ' ' TYR . 62.1 mt -71.06 137.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.651 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.626 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -131.81 98.4 4.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.814 0.816 . . . . 0.0 109.222 178.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.69 124.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.648 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.508 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 97.7 mt-10 -104.01 -47.2 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.541 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 33.2 m-20 -149.61 147.17 27.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.747 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.47 154.16 9.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 84' ' ' TYR . 12.7 t30 -149.3 144.5 26.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -113.87 116.49 29.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.67 -133.74 3.34 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.736 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 4.8 ttm180 -153.97 117.68 4.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -122.53 3.21 9.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.049 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -148.33 156.68 42.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -114.4 3.86 15.14 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -104.19 4.0 33.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.698 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.472 HG21 HD13 ' A' ' 39' ' ' LEU . 45.3 mm -112.16 138.41 41.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 m 56.83 69.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.679 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -57.14 118.89 5.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.378 0.608 . . . . 0.0 111.815 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.41 -162.07 1.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.623 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -63.2 134.9 96.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.037 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.0 Cg_endo -56.1 -34.52 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.195 1.93 . . . . 0.0 113.584 -177.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -61.85 -37.04 83.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.22 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 118' ' ' THR . 70.8 mt-30 -84.92 -1.23 56.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.736 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 mtm -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.308 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.0 mt-10 -63.19 -43.41 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.854 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -79.87 117.02 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.74 33.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -141.72 83.02 1.83 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.191 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 24.1 t -143.16 125.85 15.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HA ' HD21 ' A' ' 62' ' ' ASN . 65.0 m-85 -136.0 153.6 51.33 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.53 HD21 ' HG2' ' A' ' 112' ' ' PRO . 15.0 tp -147.88 92.61 4.66 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.584 177.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -49.97 -44.78 35.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.783 2.322 . . . . 0.0 113.147 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.58 -19.13 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.22 67.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 110.29 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.78 -46.57 74.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.563 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.64 -39.55 93.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.789 -178.307 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -62.15 -54.01 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.402 ' HB3' ' HE3' ' A' ' 92' ' ' MET . 97.6 mmm -66.58 -36.26 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.699 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.9 m -60.88 -45.38 94.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.004 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -65.3 -36.21 83.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.36 0.6 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -78.36 -32.64 49.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.9 m -112.28 -16.55 12.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 44.1 m-20 -61.18 133.43 55.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.378 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 66.75 10.88 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.394 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -110.6 144.93 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.321 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -68.77 -35.16 76.71 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.98 156.56 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.54 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -153.59 138.89 17.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 0.0 111.486 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 47' ' ' GLU . 30.8 t -118.92 130.94 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.549 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -143.46 148.69 18.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.103 -178.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 115.66 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.171 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.11 38.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.514 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.82 -124.11 0.88 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.8 t 30.24 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -65.91 0.84 1.62 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.224 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -84.62 -11.3 56.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.583 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.8 m-85 -145.96 128.17 7.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.1 Cg_exo -49.55 -149.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.177 1.918 . . . . 0.0 111.945 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.22 82.16 12.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.313 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 91.1 Cg_endo -76.97 -6.6 16.84 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.149 2.566 . . . . 0.0 113.459 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.5 p -165.94 74.23 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.343 0.592 . . . . 0.0 111.171 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.94 148.45 88.72 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.974 1.782 . . . . 0.0 111.476 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.11 -5.04 78.54 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.0 m -115.88 148.8 39.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.972 0.886 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 13.6 t80 -83.31 114.14 21.2 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.454 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 16.3 mttp -91.11 -161.45 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.574 1.178 . . . . 0.0 113.245 -176.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.578 ' HB2' HD21 ' A' ' 39' ' ' LEU . 3.5 p90 -171.98 172.03 4.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.062 -1.881 . . . . 0.0 110.643 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 40.3 tp -129.0 123.3 32.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 79.4 tt0 -118.6 122.79 43.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 61' ' ' ALA . 25.1 t -130.21 126.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -109.55 130.79 55.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.802 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.61 171.99 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 111.691 -179.158 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.508 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 74.3 m-20 -125.19 158.59 33.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.89 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.4 m -107.66 119.98 40.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.57 154.82 63.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.183 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.026 1.817 . . . . 0.0 111.098 178.828 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.516 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 32.4 ttp180 -146.91 133.81 20.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.531 0.682 . . . . 0.0 111.899 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.688 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -133.07 144.76 50.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.484 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.12 137.52 34.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.541 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.85 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.9 140.99 42.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.247 0.546 . . . . 0.0 110.618 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -66.39 136.18 55.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.23 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -47.12 136.06 9.19 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 111.628 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.94 61.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.12 178.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.18 156.02 38.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 118.118 0.959 . . . . 0.0 110.732 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.08 149.99 29.13 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.998 1.799 . . . . 0.0 111.38 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.4 tt -120.74 145.63 26.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.685 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 75.8 tt0 -128.69 128.28 43.77 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.871 -178.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.8 mt -111.53 145.34 39.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.179 178.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.685 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 69.6 mtt180 -148.69 133.28 17.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.662 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -100.75 148.35 34.9 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.937 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.23 159.29 40.7 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.509 2.14 . . . . 0.0 112.169 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.22 -128.42 34.59 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.491 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.8 p -112.8 24.86 11.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.333 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.95 167.3 21.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 179.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.53 145.98 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.485 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.7 mt -69.62 137.95 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.723 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.5 ptp -130.93 102.11 5.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 93' ' ' SER . 21.4 t -63.87 124.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.873 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -102.46 -51.83 3.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.993 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 22.9 m-80 -148.59 144.32 27.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 0.0 110.463 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.467 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.97 150.85 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.945 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.738 ' O ' HD12 ' A' ' 122' ' ' LEU . 39.4 t30 -148.81 157.25 43.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -125.53 121.94 35.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.559 179.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.7 -134.5 3.73 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.709 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 14.6 ttm180 -157.96 119.5 3.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 0.0 111.579 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 HG21 ' CE2' ' A' ' 84' ' ' TYR . 4.7 p -125.09 9.86 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.506 178.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.28 158.62 44.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.128 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 53.7 p-10 -117.59 5.77 12.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -100.59 4.83 43.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.98 135.63 51.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.707 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.3 m 57.25 66.13 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.172 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 56.6 p30 -45.82 94.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.988 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -112.53 -162.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -62.67 142.59 96.86 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 121.446 0.641 . . . . 0.0 111.488 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 15.1 Cg_endo -57.21 -39.54 89.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.402 2.068 . . . . 0.0 112.78 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -64.74 -35.12 80.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.482 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.558 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 86.8 mt-30 -85.9 -7.18 58.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.825 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.709 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 3.8 mmm -107.64 -2.52 20.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.44 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 40.4 mm-40 -62.88 -49.95 72.81 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -78.06 113.13 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.598 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.7 m -104.55 30.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.362 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -142.14 89.63 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 16.7 t -146.06 120.05 9.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.786 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 95.1 m-85 -132.1 151.63 51.67 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.998 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.598 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.9 tp -146.89 88.46 5.94 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.102 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -48.5 -48.4 17.4 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.25 2.633 . . . . 0.0 113.847 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 78.5 m-20 -51.65 -29.58 18.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.549 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.1 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.135 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 48.1 t80 -62.45 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.492 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' CD ' ' A' ' 94' ' ' GLN . 3.5 pttt -66.03 -38.93 89.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.853 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.516 HG23 ' NE ' ' A' ' 95' ' ' ARG . 18.6 mt -60.26 -52.47 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.353 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.3 mmm -66.86 -37.55 84.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.385 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.4 m -61.78 -47.37 85.46 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.139 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.457 ' CD ' ' O ' ' A' ' 90' ' ' LYS . 3.4 mp0 -69.84 -34.38 73.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.08 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NE ' HG23 ' A' ' 91' ' ' ILE . 61.0 mtt180 -75.4 -32.46 60.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.6 m -112.46 -16.96 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.565 ' CG ' ' O ' ' A' ' 93' ' ' SER . 89.7 m-20 -58.15 133.87 55.98 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.052 -178.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 67.69 13.12 9.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.283 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -115.19 148.27 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.036 178.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.5 m -71.44 -31.6 67.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.009 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -151.71 157.47 42.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 179.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.5 p -155.68 143.03 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.907 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 89.1 t -121.58 125.06 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.509 HG13 HH11 ' A' ' 95' ' ' ARG . 39.2 t -137.68 145.43 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 107' ' ' GLY . 43.3 t -79.7 117.02 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.018 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.97 36.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.71 -121.65 0.75 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.733 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 31.9 -160.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.197 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.39 -0.42 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.12 -14.33 50.61 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.812 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 112' ' ' PRO . 48.9 m-85 -143.38 127.37 9.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.166 178.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.3 Cg_exo -49.62 -149.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.331 2.021 . . . . 0.0 112.119 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -145.82 82.46 9.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.431 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.5 Cg_endo -77.24 -2.25 12.45 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.103 2.535 . . . . 0.0 113.697 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.541 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -167.85 68.51 0.84 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 110.511 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.14 151.09 29.48 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.98 2.454 . . . . 0.0 111.775 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 -1.71 60.37 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.337 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 77' ' ' GLN . 25.6 m -117.65 146.7 43.5 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.628 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.1 t80 -84.89 115.81 22.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.074 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.541 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 17.8 mttp -92.62 -160.33 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -174.18 176.49 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.525 -1.671 . . . . 0.0 111.909 176.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 62' ' ' ASN . 59.0 tp -135.68 125.82 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.1 tt0 -118.68 127.24 53.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.467 HG22 ' HB1' ' A' ' 61' ' ' ALA . 30.1 t -131.47 123.75 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.199 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.07 129.66 55.65 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.327 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -152.94 169.56 22.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.352 0.596 . . . . 0.0 111.437 -178.06 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.452 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 85.9 m-20 -122.88 158.44 30.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.57 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 96.7 m -111.33 111.67 22.89 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.55 154.2 44.72 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo . . . . . 0 N--CA 1.49 1.316 0 C-N-CA 122.109 1.873 . . . . 0.0 112.216 -179.792 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.475 0.178 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 31.4 ttm105 -146.44 136.08 23.13 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.839 0.828 . . . . 0.0 111.373 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 45.5 mp0 -134.67 145.54 48.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.238 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 ' OE1' ' A' ' 123' ' ' GLU . 5.5 tt -140.32 139.78 35.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.389 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.771 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.65 137.42 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.13 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.2 m -70.41 139.67 51.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 0.0 110.503 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -47.51 135.17 11.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.129 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.96 -19.0 56.3 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.93 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.56 148.71 38.67 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 118.376 1.088 . . . . 0.0 109.78 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.57 154.57 73.15 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.38 144.15 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 37.8 tt0 -124.79 127.04 46.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.582 -179.202 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 72.2 mt -118.1 141.06 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.037 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 73.7 mtt-85 -148.58 136.31 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.909 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.9 147.97 35.11 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.205 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 62.8 Cg_endo -75.3 156.92 41.71 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.005 2.47 . . . . 0.0 112.136 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -132.23 39.75 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.5 p -109.4 27.45 9.53 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.18 0.514 . . . . 0.0 111.143 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.45 163.9 25.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.28 145.28 34.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.927 178.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.2 mt -68.67 138.09 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.409 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.447 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.4 ptp -131.24 98.6 4.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.67 124.76 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.165 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.3 mm-40 -100.99 -47.33 4.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.3 m-20 -149.21 147.47 28.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.825 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.887 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.47 151.15 11.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.585 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 32.0 t30 -150.26 146.49 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.229 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -117.17 120.73 39.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.32 -137.72 5.16 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.132 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.0 ttm-85 -155.78 113.45 3.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.218 0.532 . . . . 0.0 109.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 p -121.23 11.05 10.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.968 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 47.3 t0 -146.74 -173.67 4.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.431 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.604 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 39.4 p30 -145.55 1.05 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.501 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -101.24 4.86 42.21 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.724 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.06 135.5 52.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.472 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.3 m 58.05 66.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.311 0.577 . . . . 0.0 109.814 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -53.2 122.15 8.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.105 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.82 -164.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.872 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.8 p30 -59.91 135.41 90.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.828 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.523 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.19 -32.22 59.01 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 113.283 -178.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -63.62 -38.03 89.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 118' ' ' THR . 39.0 mt-30 -85.5 -0.92 56.37 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.417 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 81.5 mtp -115.27 -1.25 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.172 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -62.42 -47.56 83.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 50.7 t30 -80.97 117.62 21.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.49 33.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.172 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -140.05 84.55 1.97 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 54.1 t -147.2 117.33 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.9 m-85 -128.02 155.72 43.87 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.322 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.5 tp -148.55 83.47 6.98 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.92 -45.36 20.94 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.792 2.328 . . . . 0.0 114.441 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -57.21 -20.77 29.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.929 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.34 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.868 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 93' ' ' SER . 24.4 t80 -65.29 -43.56 90.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.776 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.32 -39.85 92.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.178 -179.038 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 75.8 mt -58.38 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.48 -38.68 87.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.038 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.597 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.1 m -59.28 -45.67 90.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.93 -37.95 89.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.979 0.418 . . . . 0.0 110.56 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.583 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 92.7 mtt-85 -73.59 -34.46 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.6 m -112.51 -16.57 12.84 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 93' ' ' SER . 24.0 m-20 -58.79 133.54 56.07 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.798 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 65.9 13.45 9.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.13 178.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -115.44 147.31 40.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.17 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.8 m -74.12 -30.26 62.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 153.27 32.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 27.2 p -154.92 141.63 18.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.622 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.61 127.73 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.85 146.87 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.731 0.3 . . . . 0.0 111.01 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 107' ' ' GLY . 89.5 t -78.98 114.41 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.214 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.76 39.26 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.849 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.45 -125.09 0.9 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.418 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.65 -157.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.395 0.616 . . . . 0.0 111.935 -179.298 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -66.39 -1.49 3.54 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.426 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.09 -14.9 57.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.243 -179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 58.2 m-85 -144.99 127.07 8.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.9 Cg_exo -51.78 -145.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.904 1.736 . . . . 0.0 112.355 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 12.4 t0 -145.75 85.2 7.85 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.537 -179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 74.2 Cg_endo -74.24 -6.25 18.14 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.225 . . . . 0.0 113.537 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.564 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -169.93 70.78 0.63 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.634 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 51.6 Cg_exo -48.76 153.52 3.58 Favored 'Trans proline' 0 C--N 1.294 -2.296 0 C-N-CA 123.003 2.469 . . . . 0.0 111.922 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.76 10.46 83.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.795 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.9 m -124.67 147.73 48.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.499 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 11.4 t80 -86.15 109.49 18.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.1 mttp -91.28 -161.75 0.85 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.46 1.124 . . . . 0.0 114.02 -175.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -171.76 171.43 5.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.694 177.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.1 tp -130.37 127.97 40.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.165 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.961 ' OE1' HD12 ' A' ' 39' ' ' LEU . 8.0 tp10 -124.19 128.35 49.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.887 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.1 t -135.55 129.09 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.444 -178.071 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.567 HE21 ' HG3' ' A' ' 123' ' ' GLU . 10.0 mp0 -109.97 130.59 55.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD1' HG23 ' A' ' 56' ' ' ILE . 24.2 p90 -153.37 173.08 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 -178.344 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 57' ' ' MET . 76.9 m-20 -128.57 163.05 25.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.333 178.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.444 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -109.82 120.43 42.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.574 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.67 152.15 74.35 Favored Pre-proline 0 N--CA 1.463 0.184 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 C-N-CA 121.555 1.503 . . . . 0.0 112.034 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.32 138.31 29.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.495 0.664 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -135.62 141.56 45.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.86 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.902 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -137.92 137.09 37.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.129 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.902 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.79 140.5 40.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.491 . . . . 0.0 110.446 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.71 136.72 55.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -178.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 86.2 tt0 -47.85 137.9 9.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.003 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.3 56.96 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.823 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -105.71 150.71 39.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.904 0.852 . . . . 0.0 110.241 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.26 149.73 46.03 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.593 2.195 . . . . 0.0 112.761 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.5 tt -118.4 147.73 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.612 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 84.0 tt0 -129.39 126.51 39.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.118 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -113.84 148.08 37.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.042 178.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.612 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 95.4 mtt180 -153.8 129.63 10.15 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.67 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.3 m -96.23 147.25 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.871 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.0 Cg_endo -70.07 156.64 62.06 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.07 1.847 . . . . 0.0 111.669 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.7 -139.28 17.45 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.845 0.691 . . . . 0.0 113.099 177.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.4 p -96.25 21.25 9.2 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.237 -0.981 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.54 165.07 24.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.732 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.32 147.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.755 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 62.0 mt -69.92 137.41 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.847 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.6 ptp -130.82 100.11 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 89' ' ' PHE . 51.7 t -63.63 123.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.362 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.513 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 93.6 mt-10 -102.08 -51.75 3.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.816 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -150.02 146.37 26.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.232 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.66 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.08 155.74 12.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.353 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.8 t30 -149.91 144.33 25.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 78.3 t80 -116.65 121.62 42.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.68 -141.09 7.23 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 16.0 ttm180 -146.57 116.91 7.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.23 0.538 . . . . 0.0 110.805 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 22.1 p -125.26 2.51 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.644 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 61.2 t0 -144.76 150.21 36.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.795 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 54.6 p30 -110.12 5.46 22.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 58.8 mttm -100.33 -0.46 38.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.416 -178.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.38 136.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.516 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.1 m 59.23 64.0 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -54.33 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.066 -178.275 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.25 -160.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.79 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.694 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -60.01 134.96 90.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.885 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.91 -34.32 75.7 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.127 1.885 . . . . 0.0 112.81 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.14 -36.8 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.679 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.2 mt-30 -86.72 -10.72 53.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.491 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.518 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 81.7 mtp -102.03 -3.67 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.71 -44.86 88.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.109 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 51.9 t30 -81.28 118.65 22.8 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.427 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.06 29.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -139.49 81.76 1.85 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.175 178.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 2.2 t -142.81 118.8 10.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HA ' HD21 ' A' ' 62' ' ' ASN . 71.9 m-85 -130.96 156.44 45.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.808 -178.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -145.17 88.72 6.66 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.241 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.4 -45.11 19.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.247 1.964 . . . . 0.0 112.822 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 89.8 m-20 -57.45 -16.66 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.21 72.56 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 58' ' ' VAL . 47.9 t80 -65.28 -45.56 83.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.83 -37.87 89.08 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.561 -178.727 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.7 HG23 ' NH1' ' A' ' 95' ' ' ARG . 91.1 mt -58.95 -52.74 56.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.817 0.341 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.8 mmm -67.26 -33.42 75.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.179 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.583 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.8 m -59.93 -49.73 76.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -66.95 -39.02 87.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 112.069 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.7 ' NH1' HG23 ' A' ' 91' ' ' ILE . 65.9 mtt85 -77.05 -32.43 56.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.51 -15.58 12.55 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.583 ' CG ' ' O ' ' A' ' 93' ' ' SER . 58.2 m-20 -61.32 133.77 56.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.034 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 70.36 14.74 7.45 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -111.44 143.95 41.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.07 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.0 m -68.67 -28.28 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -147.09 158.3 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.064 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.9 t -152.81 139.06 18.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.465 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.09 126.63 64.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.038 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 46' ' ' ILE . 47.3 t -143.49 141.57 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLY . 64.7 t -76.73 115.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.957 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.66 35.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.091 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -177.44 -127.7 1.08 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.51 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.58 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 32.29 -159.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.017 0.437 . . . . 0.0 111.02 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -66.43 1.94 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.25 -179.107 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.54 -13.0 55.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.688 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 44.4 m-85 -144.6 133.07 10.9 Favored Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.984 179.144 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.3 Cg_exo -56.05 -145.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.6 1.533 . . . . 0.0 111.471 178.095 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -145.25 90.55 6.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.93 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 95.7 Cg_endo -81.16 -4.09 12.42 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.297 2.664 . . . . 0.0 114.25 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.434 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -167.68 66.36 0.78 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -52.74 147.7 30.7 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.71 2.273 . . . . 0.0 111.588 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.16 -6.76 74.31 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' GLN . 87.2 m -118.88 148.08 43.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 45.8 t80 -85.72 120.74 27.48 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.5 mttm -96.86 -157.51 0.6 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -176.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.1 p90 -174.6 177.27 2.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.498 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.88 122.29 24.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.82 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -116.49 127.89 54.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.66 HG22 ' HB1' ' A' ' 61' ' ' ALA . 96.1 t -136.82 127.37 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.008 -178.443 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.6 132.28 56.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 31.8 p90 -155.01 169.98 22.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.219 0.533 . . . . 0.0 112.427 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 79.6 m-20 -120.91 160.45 23.45 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.481 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.4 m -112.05 118.33 35.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.694 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.79 159.35 61.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.774 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.497 1.734 0 C-N-CA 122.121 1.881 . . . . 0.0 112.331 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 mt 55.95 72.22 1.06 Allowed Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -47.84 155.68 1.56 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 123.123 2.549 . . . . 0.0 112.85 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -80.37 -20.12 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.83 13.1 82.74 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -157.82 65.41 0.47 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.972 0.415 . . . . 0.0 110.411 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 34' ' ' LEU . 13.9 mtt 54.87 150.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -90.76 149.0 22.19 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -150.58 137.11 18.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.944 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HG3' HD23 ' A' ' 48' ' ' LEU . 73.0 mm-40 -129.8 144.7 51.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.991 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.01 141.91 38.3 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.759 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.77 142.67 31.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.399 0.619 . . . . 0.0 111.49 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.6 m -66.78 135.17 53.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.133 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG3' ' OH ' ' A' ' 63' ' ' TYR . 77.3 tt0 -47.61 134.93 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.509 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.61 -16.67 60.63 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.452 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 13.4 m-85 -107.47 155.86 38.83 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 118.272 1.036 . . . . 0.0 108.831 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.23 154.47 28.65 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.512 1.475 . . . . 0.0 112.188 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 46' ' ' ILE . 12.9 tt -116.44 150.68 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.035 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 33.0 tt0 -126.93 130.89 50.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.672 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.0 mt -122.07 136.1 54.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.692 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 87.0 mtt180 -146.43 134.7 21.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.0 110.705 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.1 m -103.63 145.53 30.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.092 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -70.23 155.74 63.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.988 1.792 . . . . 0.0 112.51 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.21 -131.69 24.88 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.63 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.9 p -102.86 22.32 14.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.497 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.95 165.07 24.53 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG11 ' HD1' ' A' ' 131' ' ' TYR . 30.0 m -125.58 145.67 32.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.837 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.9 mt -67.89 135.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.6 ptm -131.65 98.04 4.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.8 t -61.73 122.44 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.591 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -99.33 -51.66 3.74 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -151.24 150.01 30.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.97 154.21 7.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 84' ' ' TYR . 2.5 t30 -148.75 146.19 27.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' OH ' ' HG3' ' A' ' 42' ' ' GLU . 49.3 t80 -114.49 118.08 32.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.34 -139.3 5.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.949 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.694 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 11.5 ttm-85 -151.36 119.69 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.123 0.487 . . . . 0.0 111.475 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.402 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.3 p -126.86 4.78 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.116 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 51.7 t0 -146.99 153.28 39.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.777 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 24.8 p-10 -110.31 4.87 21.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.956 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -103.98 4.07 34.16 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.138 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.7 mm -110.23 133.84 54.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m 57.14 70.12 0.68 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.138 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -54.01 120.43 6.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.572 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.44 -161.88 1.25 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.782 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.662 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.4 p-10 -61.96 137.21 95.4 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.801 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 7.0 Cg_endo -55.38 -36.2 93.38 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.351 2.034 . . . . 0.0 113.327 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.55 -33.4 74.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 0.0 110.753 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 118' ' ' THR . 81.5 mt-30 -85.08 -18.87 32.97 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.293 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 68.6 mtp -97.87 -0.4 45.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 56.9 mt-10 -64.68 -46.65 81.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -78.49 112.99 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.12 30.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.163 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -142.04 84.37 1.88 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.082 0.468 . . . . 0.0 111.92 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.463 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 44.1 t -145.24 119.94 9.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.0 m-85 -127.16 155.15 43.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 111.077 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.28 90.0 5.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.779 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.1 -47.38 24.08 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.523 2.149 . . . . 0.0 113.457 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.0 -22.4 15.17 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.24 -0.287 . . . . 0.0 111.701 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.59 -33.94 48.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.72 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 58' ' ' VAL . 70.8 t80 -64.96 -45.44 85.7 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 12.0 ptmt -64.43 -38.77 92.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.922 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 70.2 mt -60.34 -48.93 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.905 0.383 . . . . 0.0 111.666 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.0 mmm -70.39 -37.74 74.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.501 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.4 m -60.42 -46.99 88.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -64.79 -36.39 84.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 111.231 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.622 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -78.47 -32.7 48.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.509 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.8 m -112.22 -15.01 13.28 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 93' ' ' SER . 61.7 m-20 -59.84 133.05 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.043 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 67.7 14.28 9.46 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.118 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -115.95 147.21 41.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.272 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.7 m -72.28 -33.51 67.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 151.48 33.83 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.34 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.9 p -152.75 147.27 25.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.791 0.329 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.8 t -128.45 129.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.02 0.438 . . . . 0.0 110.032 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.581 ' CG1' HH11 ' A' ' 95' ' ' ARG . 46.3 t -135.65 148.75 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 107' ' ' GLY . 59.6 t -82.56 115.33 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.93 39.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.96 -127.31 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.98 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.469 0.652 . . . . 0.0 112.033 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -66.56 1.09 1.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.557 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.622 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.34 -11.64 55.98 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.647 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.4 m-85 -143.74 128.31 9.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.672 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 38.1 Cg_exo -50.64 -149.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.148 1.898 . . . . 0.0 111.125 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.37 97.11 5.19 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.463 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 61.6 Cg_endo -88.35 -10.49 4.66 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.592 2.195 . . . . 0.0 112.325 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.455 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.5 p -166.58 90.29 0.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.635 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -76.55 155.61 35.94 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.355 2.037 . . . . 0.0 111.912 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.22 89.62 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 77' ' ' GLN . 89.0 m -126.49 147.66 49.79 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 t80 -79.25 108.73 12.98 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 30.9 mtmm -87.61 -167.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.388 1.09 . . . . 0.0 113.093 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -171.6 174.64 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.044 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 22.1 tp -133.01 125.2 29.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -119.34 125.61 49.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.9 t -130.73 123.94 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.57 130.23 54.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.623 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.5 p90 -155.9 164.42 38.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.555 0.693 . . . . 0.0 112.259 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -119.16 156.27 30.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.228 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.9 m -107.78 120.98 43.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.5 m -121.63 152.87 59.21 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -55.58 145.21 70.97 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.258 1.972 . . . . 0.0 112.128 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.5 ' HD2' ' HZ3' ' A' ' 132' ' ' LYS . 40.4 t80 -73.32 -4.65 34.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.135 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HZ3' ' HD2' ' A' ' 131' ' ' TYR . 31.5 mttm -149.4 -92.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.288 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 133' ' ' VAL . 7.6 p -153.45 124.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.868 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.484 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -120.92 162.47 34.93 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 121.185 0.517 . . . . 0.0 111.145 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.72 -91.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.224 2.616 . . . . 0.0 112.49 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -79.02 -15.38 58.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.686 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 30' ' ' LEU . . . 64.98 -48.99 0.11 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.215 -0.448 . . . . 0.0 113.208 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -160.67 119.53 2.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.112 0.456 . . . . 0.0 110.427 -178.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' LEU . 28.2 mtt 60.04 136.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.063 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.77 151.35 22.45 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.4 ttp180 -147.05 131.38 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.725 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' HD23 ' A' ' 48' ' ' LEU . 72.1 mm-40 -128.16 143.85 51.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.98 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -138.57 136.61 36.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.824 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.16 140.1 46.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.113 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.404 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 64.9 m -65.3 138.18 58.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 64.8 tt0 -45.56 129.84 8.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.598 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.04 -12.37 67.03 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.856 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -109.19 149.27 39.49 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 118.841 1.321 . . . . 0.0 110.19 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.75 150.82 87.54 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.852 1.701 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -121.33 141.91 39.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.638 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 74.4 tt0 -130.16 130.29 44.54 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.664 -0.814 . . . . 0.0 112.519 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.594 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.9 mt -116.24 139.35 50.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.048 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.638 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 48.2 mtt180 -145.75 135.22 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.442 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.458 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.4 m -100.59 146.59 32.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -70.0 160.37 49.89 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.764 2.309 . . . . 0.0 112.489 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.26 -120.98 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.738 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -120.94 25.29 9.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.31 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -76.18 169.91 17.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.0 110.02 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.26 145.24 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.801 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.4 137.15 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.603 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.1 ptm -130.85 99.67 5.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.561 0.696 . . . . 0.0 109.257 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.717 HG12 ' CE1' ' A' ' 89' ' ' PHE . 24.1 t -63.21 123.25 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 80.5 mm-40 -100.31 -51.67 3.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 58.6 m-20 -151.72 148.98 28.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.056 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.33 153.97 8.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.862 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.6 t30 -147.88 148.05 30.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.457 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -114.21 114.98 26.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.27 -142.22 7.57 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.38 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -150.84 119.2 6.39 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.317 0.58 . . . . 0.0 111.568 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.51 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 59.9 p -125.95 6.97 7.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.811 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.646 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 35.0 t0 -140.44 -174.75 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.128 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 22.4 p30 -144.96 -1.06 0.87 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.5 mtmp? -101.59 3.88 40.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.408 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' SG ' ' A' ' 71' ' ' CYS . 30.5 mm -112.76 135.35 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.981 0.42 . . . . 0.0 110.309 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' A' ' 70' ' ' ILE . 67.1 m 60.46 64.24 1.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.256 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.592 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 42.5 p30 -50.02 96.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.539 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.52 -163.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.683 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -60.68 139.1 93.15 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.639 178.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.62 -38.01 96.43 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.433 2.089 . . . . 0.0 113.326 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -62.19 -33.32 74.31 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.71 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.8 mt-30 -85.01 -6.36 59.33 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.438 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 83.9 mtp -109.95 -3.02 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 82.2 mt-10 -64.79 -46.15 83.3 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.97 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -79.68 112.88 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.072 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 67' ' ' ASP . 35.8 m -107.3 31.38 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -138.24 84.53 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.86 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.0 t -146.1 125.84 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.563 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HA ' HD21 ' A' ' 62' ' ' ASN . 59.0 m-85 -134.04 154.71 50.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 112' ' ' PRO . 37.4 tp -146.91 93.67 4.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.346 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.61 -48.4 22.17 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.497 2.798 . . . . 0.0 114.576 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -57.81 -19.92 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.88 -32.03 63.34 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.717 ' CE1' HG12 ' A' ' 58' ' ' VAL . 48.3 t80 -63.72 -43.81 95.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.714 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.21 -39.61 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 65.2 mt -58.08 -51.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.084 ' SD ' HD21 ' A' ' 122' ' ' LEU . 40.0 mtp -70.46 -33.22 71.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.528 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 20.1 m -58.39 -47.17 84.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.83 -34.67 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.501 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NE ' HG22 ' A' ' 104' ' ' VAL . 17.7 mtp180 -80.54 -32.4 36.75 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.2 m -111.74 -20.16 12.19 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.479 ' CG ' ' O ' ' A' ' 93' ' ' SER . 42.6 m-20 -56.16 135.19 53.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.845 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 64.44 13.84 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.972 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -112.95 144.3 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.604 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -33.21 73.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.099 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 158.71 42.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.043 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.594 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.2 p -155.38 135.0 12.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.138 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 129.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.5 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.2 t -143.41 145.72 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.769 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.2 t -79.05 116.4 22.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.58 41.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.67 -116.82 0.53 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.659 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 28.56 -160.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.14 0.495 . . . . 0.0 111.737 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.659 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-20 -69.47 2.09 3.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.968 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.05 -13.75 49.45 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.383 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.574 ' O ' ' O ' ' A' ' 112' ' ' PRO . 72.8 m-85 -141.09 126.62 11.1 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.7 Cg_exo -51.41 -150.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.224 1.949 . . . . 0.0 111.575 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -144.9 90.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.77 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.55 -8.68 13.65 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.093 2.528 . . . . 0.0 113.236 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -172.22 80.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.437 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.32 159.02 55.39 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.149 1.899 . . . . 0.0 111.505 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.1 -4.71 86.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 77' ' ' GLN . 63.2 m -125.36 147.87 48.98 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.494 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 45.3 t80 -85.81 118.7 25.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.479 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mttt -95.17 -156.91 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.0 p90 -174.86 176.5 2.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.556 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.084 HD21 ' SD ' ' A' ' 92' ' ' MET . 34.3 tp -133.69 126.79 31.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.816 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.67 ' CD ' ' N ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -120.74 130.72 54.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 11.8 t -133.28 123.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -107.04 125.72 51.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.801 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -154.65 170.08 22.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.302 0.572 . . . . 0.0 112.223 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' A' ' 57' ' ' MET . 10.8 m-20 -127.0 161.57 28.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.941 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.8 115.86 29.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.115 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.78 158.93 44.36 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.42 146.79 96.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.181 1.92 . . . . 0.0 112.055 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -79.35 134.68 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -95.8 136.07 36.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 134' ' ' GLU . 8.9 p -103.44 127.49 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.695 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HG2' HG22 ' A' ' 133' ' ' VAL . 79.1 mm-40 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.2 mt -121.16 78.42 33.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.859 0.362 . . . . 0.0 110.599 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' LEU . 52.7 Cg_exo -52.86 -162.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.694 2.263 . . . . 0.0 111.508 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.83 -13.2 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.889 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.97 70.44 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.462 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.648 ' O ' ' O ' ' A' ' 35' ' ' MET . 25.9 tp -154.36 99.28 2.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.718 0.259 . . . . 0.0 110.449 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.648 ' O ' ' O ' ' A' ' 34' ' ' LEU . 7.3 mtt 49.95 132.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.28 0.562 . . . . 0.0 111.067 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.609 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt-85 -92.96 143.66 26.02 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -151.74 138.68 19.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.343 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -133.78 146.77 51.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.36 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -134.88 132.11 38.15 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.67 139.96 51.25 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.546 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.1 137.16 53.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.597 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 87.2 tt0 -48.06 133.37 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.028 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.8 -17.96 58.0 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.94 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -111.72 148.18 38.36 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 118.283 1.041 . . . . 0.0 110.308 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.76 151.71 82.42 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.489 2.126 . . . . 0.0 113.36 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.9 tt -119.07 147.01 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 103' ' ' VAL . 81.5 tt0 -136.0 125.38 24.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -110.9 145.93 37.43 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -148.47 136.56 21.03 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.9 m -104.41 143.99 27.8 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.23 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 56.6 Cg_endo -71.71 161.19 45.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.361 2.041 . . . . 0.0 112.13 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.34 -132.2 34.23 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.449 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.8 p -107.92 23.36 14.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.351 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -78.58 167.89 20.59 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -130.73 145.21 35.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.82 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.874 HG23 ' CD2' ' A' ' 126' ' ' TYR . 82.7 mt -68.66 139.78 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.068 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.3 ptm -131.98 99.53 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.834 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 89' ' ' PHE . 55.8 t -63.05 124.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.361 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -101.98 -48.53 4.22 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -151.41 147.52 26.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.06 155.58 11.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.492 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.0 t30 -151.81 145.65 25.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 67.3 t80 -116.73 118.04 31.46 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.49 -138.04 5.16 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' H ' ' HB3' ' A' ' 83' ' ' CYS . 12.3 ttm-85 -152.4 118.94 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.232 0.539 . . . . 0.0 111.717 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 p -121.99 8.4 9.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 27.6 t0 -143.54 -164.23 1.82 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.059 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 47.2 p30 -149.16 -1.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.237 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -102.88 4.49 37.7 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.576 HG22 ' SG ' ' A' ' 71' ' ' CYS . 14.3 mm -106.64 135.28 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.576 ' SG ' HG22 ' A' ' 70' ' ' ILE . 47.7 m 59.44 66.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.481 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.3 p30 -47.8 108.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.95 -162.99 1.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.015 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.6 p-10 -63.44 138.31 97.32 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.529 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.8 Cg_endo -58.81 -32.45 97.16 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.212 1.941 . . . . 0.0 112.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -60.79 -37.82 83.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.654 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 118' ' ' THR . 78.6 mt-30 -86.21 -10.88 53.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.334 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -108.84 0.52 20.34 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.128 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 75.5 mt-10 -64.78 -43.92 91.65 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.365 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.2 t30 -78.78 114.28 17.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 67' ' ' ASP . 25.2 m -106.1 32.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -140.68 86.51 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.75 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.551 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 32.8 t -147.7 120.88 8.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 89.2 m-85 -132.51 152.71 51.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.883 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -144.13 93.42 6.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.027 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.48 -49.05 16.69 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.558 2.838 . . . . 0.0 113.829 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -57.37 -24.58 56.17 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.24 -31.52 21.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE1' HG12 ' A' ' 58' ' ' VAL . 83.5 t80 -66.63 -45.8 77.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.89 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 ptmt -64.38 -39.24 93.47 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.675 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 94.4 mt -60.18 -52.91 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.3 mmm -70.12 -35.24 73.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 111.526 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.4 m -59.95 -47.33 86.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -66.87 -36.75 83.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.421 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 1.025 ' HE ' HG22 ' A' ' 104' ' ' VAL . 72.9 mtp85 -77.23 -32.68 55.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 23.7 m -112.69 -17.24 12.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -57.17 136.22 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.297 0.57 . . . . 0.0 111.964 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 64.76 12.98 8.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.653 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 67.2 mtt-85 -112.32 144.93 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.228 0.537 . . . . 0.0 110.307 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 m -70.31 -33.76 71.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.38 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 154.29 37.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.88 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.0 p -155.01 139.03 16.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.859 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.492 HG22 ' HG3' ' A' ' 47' ' ' GLU . 48.5 t -122.46 135.82 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.025 HG22 ' HE ' ' A' ' 95' ' ' ARG . 33.4 t -143.04 152.99 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.98 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.449 ' N ' HG12 ' A' ' 104' ' ' VAL . 70.6 t -84.05 115.74 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.03 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.32 36.64 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -176.62 -118.23 0.53 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.646 ' O ' ' O ' ' A' ' 107' ' ' GLY . 46.5 t 27.0 -158.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.424 0.631 . . . . 0.0 112.02 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.1 m-20 -69.27 1.09 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.08 -11.2 58.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.671 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.1 m-85 -144.94 133.69 11.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.805 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.1 Cg_exo -53.2 -147.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.04 1.826 . . . . 0.0 110.559 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.493 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 11.0 t0 -144.38 91.24 6.37 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.0 110.255 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.416 ' HD2' ' CE ' ' A' ' 120' ' ' LYS . 62.4 Cg_endo -80.94 -11.7 12.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.124 2.549 . . . . 0.0 113.734 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.584 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -165.27 76.58 1.35 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 121.538 0.685 . . . . 0.0 111.531 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.84 153.25 38.18 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.753 2.302 . . . . 0.0 112.619 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.19 8.09 53.41 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.049 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.8 m -119.3 148.88 42.66 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 6.5 t80 -83.31 108.88 16.82 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.584 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 28.1 mttt -89.56 -163.06 0.94 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.754 1.264 . . . . 0.0 112.833 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -173.54 175.52 2.98 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.007 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 tp -133.4 125.75 29.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -123.62 128.64 49.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 99.0 t -133.27 126.94 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -108.17 128.58 54.83 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.874 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.4 p90 -155.6 175.32 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.236 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -131.85 161.16 33.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.272 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.609 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 88.4 m -108.38 122.53 47.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.183 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.93 155.84 57.2 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.519 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.21 143.99 95.02 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.33 2.02 . . . . 0.0 111.904 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -82.13 153.84 25.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.583 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.52 114.01 26.12 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.008 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.67 129.97 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.812 0.339 . . . . 0.0 110.69 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.026 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -39.15 -52.58 4.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.863 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 32.3 Cg_exo -52.32 -178.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.012 1.808 . . . . 0.0 111.075 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.03 -61.37 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.397 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.663 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 76.61 43.64 18.35 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.663 HD22 ' O ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -158.19 -10.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.9 0.381 . . . . 0.0 110.372 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' LEU . 6.6 mtt 58.81 140.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.874 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -90.57 150.28 21.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.925 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 28.3 ttm180 -147.21 134.51 20.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.0 111.673 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 40.5 mp0 -131.35 144.11 50.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.751 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -138.75 141.28 38.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.841 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.31 141.63 33.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.397 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -66.36 135.32 54.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.66 138.95 7.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.294 0.569 . . . . 0.0 112.032 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 -16.64 60.59 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.961 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -109.32 150.34 40.96 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 117.741 0.77 . . . . 0.0 110.117 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.97 151.18 67.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.884 2.39 . . . . 0.0 113.264 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -123.98 142.0 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 65.9 tt0 -128.02 130.36 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 111.82 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 64.7 mt -111.21 145.99 37.72 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.095 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.641 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 96.6 mtt180 -149.43 128.23 12.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.7 m -101.01 144.43 28.54 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.05 158.08 50.01 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.424 2.083 . . . . 0.0 112.543 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.73 -139.18 36.41 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.428 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 p -99.57 23.87 8.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.405 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 63.4 m-20 -81.29 165.16 21.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.243 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.8 m -129.95 146.55 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 110.584 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.96 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.2 mt -68.25 136.59 26.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.753 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -130.8 99.39 4.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.503 HG12 ' HE1' ' A' ' 89' ' ' PHE . 53.0 t -63.01 123.06 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.512 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.502 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.8 mm-40 -103.39 -46.94 4.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.184 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 24.7 m-20 -147.16 144.48 29.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.78 149.99 11.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.743 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.571 ' O ' HD12 ' A' ' 122' ' ' LEU . 29.7 t30 -148.07 147.45 29.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.167 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -118.64 120.02 36.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -138.68 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.997 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -154.79 116.29 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.661 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' CE2' ' A' ' 84' ' ' TYR . 14.9 p -122.43 9.65 9.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.923 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.617 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.0 t0 -147.59 -173.52 4.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.2 p30 -145.78 1.99 0.91 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.051 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.67 5.01 41.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.323 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.451 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.2 mm -115.42 137.84 47.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.74 0.305 . . . . 0.0 110.523 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 30.9 m 52.88 75.91 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -56.41 122.19 11.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.484 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.84 -167.55 2.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.552 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -61.4 134.15 93.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.7 Cg_endo -53.1 -33.57 64.21 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.789 1.66 . . . . 0.0 113.506 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -63.65 -34.91 78.9 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.039 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 72.9 mt-30 -83.35 -14.88 51.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.548 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 mtp -99.54 -0.61 40.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.3 mt-10 -62.05 -52.13 65.19 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 39.2 t30 -81.72 115.98 21.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.7 m -105.03 35.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.559 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -139.52 85.8 2.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 4.0 t -148.56 118.56 7.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CE2' HG21 ' A' ' 66' ' ' THR . 69.7 m-85 -130.02 154.24 47.61 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.814 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 88' ' ' ALA . 40.4 tp -146.28 85.69 7.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.388 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -47.09 -47.69 16.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.902 2.402 . . . . 0.0 113.614 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -56.79 -22.76 38.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.73 -31.35 62.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.972 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HE1' HG12 ' A' ' 58' ' ' VAL . 11.6 t80 -64.1 -42.53 96.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.4 ptpt -66.09 -42.17 89.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.963 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.484 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 82.2 mt -58.39 -49.73 81.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.529 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.092 ' SD ' HD21 ' A' ' 122' ' ' LEU . 31.7 mtp -71.07 -33.19 70.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.745 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.6 m -59.14 -45.57 90.6 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.919 0.39 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -65.59 -37.4 86.54 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.078 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 93.6 mtt-85 -76.73 -35.3 57.89 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.432 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -109.28 -21.5 12.51 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CG ' ' O ' ' A' ' 93' ' ' SER . 75.9 m-20 -57.24 134.09 55.64 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.207 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 67.95 12.48 8.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.798 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 99' ' ' ARG . 51.3 mtt180 -113.47 146.44 39.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.215 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.7 m -73.45 -28.74 62.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.452 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 2.2 pp0? -151.98 152.48 32.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.498 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.1 p -153.58 142.81 21.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.716 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.67 126.06 72.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.9 t -139.04 146.68 25.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.845 0.355 . . . . 0.0 111.374 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.9 t -78.78 113.67 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.95 42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.581 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -121.62 0.8 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.6 t 28.05 -157.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 111.892 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.38 1.22 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.175 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.87 -12.49 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.433 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 63.9 m-85 -144.58 128.14 8.75 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.979 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -50.45 -146.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.387 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -142.88 84.62 10.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.01 -5.53 14.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.812 2.341 . . . . 0.0 113.424 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.505 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -164.68 71.6 1.53 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.544 0.688 . . . . 0.0 111.47 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.43 140.46 93.22 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.396 2.064 . . . . 0.0 110.594 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.77 71.51 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.951 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 21.3 m -124.4 146.3 48.97 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.538 0.669 . . . . 0.0 110.331 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.556 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 26.0 t80 -81.64 116.23 21.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 24.3 mttt -89.82 -165.93 1.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.805 1.288 . . . . 0.0 114.037 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.2 p90 -167.68 169.49 11.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.17 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.092 HD21 ' SD ' ' A' ' 92' ' ' MET . 65.8 tp -130.31 122.71 28.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.687 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 71.5 tt0 -117.94 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' A' ' 92' ' ' MET . 45.7 t -133.64 125.17 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 128.71 55.15 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.96 ' CD2' HG23 ' A' ' 56' ' ' ILE . 28.6 p90 -154.3 169.64 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.23 0.538 . . . . 0.0 111.735 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.488 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 76.9 m-20 -123.04 159.31 28.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.965 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.9 m -109.15 112.13 24.13 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 4.2 m -121.02 158.68 51.92 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.51 146.22 53.94 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.9 1.733 . . . . 0.0 112.154 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -72.01 -30.32 65.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -97.33 140.9 31.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 133' ' ' VAL . 11.6 p -88.62 132.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.838 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.22 75.56 77.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.609 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -50.89 146.08 22.41 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.136 1.891 . . . . 0.0 110.902 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' LEU . 97.3 m-85 -82.34 -9.57 59.41 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.05 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.11 -45.03 0.91 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -162.92 123.31 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.963 0.411 . . . . 0.0 111.017 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.9 mtm 64.33 149.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.499 0.666 . . . . 0.0 111.349 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.589 HH21 ' HG3' ' A' ' 51' ' ' PRO . 94.6 mtt-85 -91.75 150.75 20.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.261 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -145.15 132.91 21.07 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.495 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' HG3' HD23 ' A' ' 48' ' ' LEU . 79.5 mm-40 -124.4 145.33 49.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -137.26 141.03 41.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.811 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.79 139.86 36.52 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.471 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.03 135.73 55.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.911 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 82.0 tt0 -46.17 134.27 8.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.284 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 -11.89 68.29 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.267 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.8 m-85 -112.26 148.75 39.8 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 118.451 1.125 . . . . 0.0 109.828 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.91 150.26 73.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.288 1.992 . . . . 0.0 112.867 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.6 tt -116.34 147.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.42 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -125.2 127.94 47.57 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.036 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 38' ' ' GLU . 24.3 mt -116.23 138.29 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.059 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' A' ' 101' ' ' GLN . 65.5 mtp85 -148.2 135.46 20.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.021 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -100.34 144.14 27.88 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HG3' HH21 ' A' ' 36' ' ' ARG . 61.2 Cg_endo -72.02 159.17 50.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.258 2.638 . . . . 0.0 112.55 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.79 -131.02 27.46 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.9 p -108.42 23.93 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.78 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.38 165.4 24.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.31 147.71 32.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.136 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.773 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.0 mt -69.92 136.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.104 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.7 ptp -134.44 106.06 6.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 89' ' ' PHE . 36.4 t -64.44 124.5 19.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -102.96 -53.12 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.225 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -147.17 143.47 28.25 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.168 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.37 154.46 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.82 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.3 t30 -149.96 145.97 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.405 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -116.84 118.31 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.29 -133.64 3.34 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.7 ttm-85 -157.71 117.11 3.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.334 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 p -122.29 9.46 9.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 14.5 t70 -144.86 -168.99 3.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.5 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 8.0 p30 -148.41 -0.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.402 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -101.42 7.71 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.039 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.53 136.61 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.089 0.471 . . . . 0.0 111.07 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.8 m 51.96 78.95 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 59.1 p30 -55.77 125.04 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.72 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.99 -164.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.931 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.66 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -64.72 142.97 98.66 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 110.61 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.6 Cg_endo -60.96 -35.78 86.26 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 113.713 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.74 -36.16 82.11 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 118' ' ' THR . 72.3 mt-30 -86.34 -14.13 44.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.453 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 74.9 mtp -106.27 -2.54 22.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.001 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 4.6 mt-10 -65.58 -44.75 85.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.897 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -80.82 121.04 25.46 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -110.08 34.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.626 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -139.62 90.1 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.456 . . . . 0.0 110.886 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 25.5 t -152.62 119.2 5.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.584 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 13.6 m-85 -132.45 154.01 50.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.64 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -144.29 96.15 5.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.72 -44.08 46.94 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.558 2.172 . . . . 0.0 112.623 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.4 m-20 -58.08 -21.59 46.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.91 62.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.977 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.619 ' O ' ' OG ' ' A' ' 93' ' ' SER . 57.1 t80 -63.96 -46.43 84.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.1 pttp -66.64 -39.74 88.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.351 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.63 -46.5 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.203 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.31 -37.74 77.93 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.789 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.5 m -59.88 -48.43 81.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -65.72 -37.45 86.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.015 0.435 . . . . 0.0 111.213 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -76.94 -33.52 57.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.8 m -113.88 -16.44 12.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -57.81 137.89 56.17 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.693 -0.629 . . . . 0.0 111.974 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 49.9 m-20 69.5 14.39 8.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -117.2 149.3 40.63 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.401 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -72.17 -31.37 65.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.526 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.583 ' CD ' HH12 ' A' ' 49' ' ' ARG . 0.1 OUTLIER -142.88 156.99 45.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.318 178.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 39.7 t -152.93 135.8 15.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 111.747 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.9 132.32 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.054 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.5 146.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.735 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 107' ' ' GLY . 46.5 t -79.43 117.13 24.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.834 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.37 35.49 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.287 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.14 -121.01 0.69 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.5 t 33.42 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.242 0.544 . . . . 0.0 110.905 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.07 4.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.035 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -87.66 -7.58 57.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.374 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' O ' ' A' ' 112' ' ' PRO . 35.4 m-85 -147.76 132.82 9.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.95 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.9 Cg_exo -51.79 -148.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.702 1.601 . . . . 0.0 110.639 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.707 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 46.4 t0 -146.83 92.15 5.09 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.1 Cg_endo -79.37 -4.65 13.83 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.979 2.453 . . . . 0.0 113.241 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.493 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -167.91 67.99 0.82 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.672 0.749 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -52.26 149.81 21.46 Favored 'Trans proline' 0 C--N 1.292 -2.426 0 C-N-CA 122.487 2.124 . . . . 0.0 110.867 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.0 -4.36 76.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.871 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 77' ' ' GLN . 54.5 m -116.97 149.59 39.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.406 0.603 . . . . 0.0 110.602 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.53 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.7 t80 -83.94 112.42 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 19.0 mttt -92.22 -161.5 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.653 1.215 . . . . 0.0 114.169 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 8.3 p90 -174.91 175.98 2.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.754 -2.021 . . . . 0.0 111.046 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 62' ' ' ASN . 45.2 tp -132.57 123.45 26.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.348 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -115.94 124.03 49.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 57.9 t -134.5 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.555 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.5 128.6 56.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' A' ' 56' ' ' ILE . 47.8 p90 -146.23 162.2 38.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.128 0.489 . . . . 0.0 111.295 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -113.4 157.14 22.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.214 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.466 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.0 m -113.3 108.38 17.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.364 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.28 161.07 33.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.94 150.97 60.46 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.532 1.488 . . . . 0.0 111.517 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.657 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 24.2 t80 -76.19 9.21 2.67 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.318 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.76 -133.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.62 135.11 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 0.0 111.444 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.085 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -127.8 80.42 72.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 30' ' ' LEU . 34.5 Cg_exo -51.99 -129.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 28.9 m-85 -147.44 37.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.091 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.29 -39.84 0.58 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.361 -0.382 . . . . 0.0 112.802 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' MET . 6.0 mt -154.63 83.4 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.872 0.336 . . . . 0.0 110.282 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.478 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 49.2 178.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.318 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.734 ' NH1' ' SG ' ' A' ' 128' ' ' CYS . 14.4 mmt85 -90.71 139.69 30.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.716 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.625 HH21 ' CD ' ' A' ' 123' ' ' GLU . 40.2 ttt180 -143.2 138.51 29.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.647 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.1 mp0 -135.67 139.89 44.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.123 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -137.78 136.48 37.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.914 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.835 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.61 142.47 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.564 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.6 140.79 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.518 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 81.0 tt0 -47.67 129.52 13.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.85 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 -11.49 71.97 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.92 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 24.8 m-85 -106.47 150.06 39.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.907 0.853 . . . . 0.0 109.883 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.09 152.62 45.89 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.195 1.93 . . . . 0.0 112.856 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -122.97 142.26 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.19 128.84 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.191 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 102' ' ' CYS . 36.3 mt -113.05 144.9 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.726 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 14.9 mtp180 -150.52 135.2 17.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.846 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -102.74 149.65 36.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.316 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 47.9 Cg_endo -71.63 160.15 49.05 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.027 2.485 . . . . 0.0 113.403 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.18 -126.36 22.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.587 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.5 p -113.75 23.15 13.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.361 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.22 170.2 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.751 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.16 146.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.298 0.571 . . . . 0.0 110.544 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.75 HG23 ' CD1' ' A' ' 126' ' ' TYR . 81.6 mt -68.84 136.93 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.298 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.605 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.7 ptm -132.45 98.29 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.984 0.897 . . . . 0.0 108.946 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 5.9 t -64.5 124.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.519 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.8 mt-10 -103.86 -48.92 3.78 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 20.6 m-20 -146.6 144.3 29.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.15 151.97 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.054 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.601 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.4 t30 -150.56 151.52 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.571 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -118.72 114.92 23.46 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.35 -139.56 5.92 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.091 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.696 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -153.57 119.02 5.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.026 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 11.7 p -125.44 3.96 7.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.679 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 48.2 t0 -143.48 149.24 37.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.184 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 45.1 p30 -110.5 1.21 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 1.4 mtpm? -102.7 8.43 39.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.51 137.75 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.192 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.598 ' O ' ' C ' ' A' ' 72' ' ' ASP . 63.8 m 60.3 17.45 7.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' ' O ' ' A' ' 71' ' ' CYS . 42.1 m-20 3.44 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.976 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.36 -165.22 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -61.79 146.48 90.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.22 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 14.7 Cg_endo -58.31 -40.74 73.03 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.41 2.073 . . . . 0.0 112.856 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.81 -37.81 88.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.581 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 78.6 mt-30 -83.95 -7.57 59.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -104.19 -1.48 27.13 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.98 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 91.6 mt-10 -63.31 -51.17 67.14 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -76.79 110.67 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.861 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.711 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 27.2 m -103.5 27.23 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.7 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.711 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 6.2 mm-40 -140.46 87.85 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.89 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.7 t -144.74 120.95 10.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 81.7 m-85 -133.31 157.07 46.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.336 0.589 . . . . 0.0 112.221 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -147.07 87.13 6.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.501 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -47.65 -47.98 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.56 2.174 . . . . 0.0 112.865 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -56.69 -18.4 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.1 -35.2 66.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.816 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.622 ' CE1' HG12 ' A' ' 58' ' ' VAL . 81.3 t80 -65.14 -44.65 87.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.732 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.3 pttp -64.33 -42.89 96.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.782 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 68.7 mt -59.17 -44.5 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.558 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 97.2 mmm -70.49 -40.28 73.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.227 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.7 m -56.63 -43.21 80.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.368 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.53 -41.51 88.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.645 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.864 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 46.1 mtm180 -73.85 -33.53 64.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.5 m -111.55 -15.09 13.58 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 38.6 m-20 -61.65 133.7 55.92 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.159 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 66.02 14.46 9.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -116.0 148.52 40.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.595 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -70.04 -31.78 69.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.82 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.03 157.08 41.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.092 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.7 p -153.64 140.94 19.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -120.95 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.299 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.59 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 98.0 t -140.65 147.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.212 0.529 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 107' ' ' GLY . 62.1 t -81.86 115.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.052 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -69.77 38.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.842 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.6 -120.69 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.692 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.591 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.4 t 27.16 -155.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.857 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.25 -0.57 8.22 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.621 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.98 58.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.187 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -143.22 129.91 10.55 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -54.4 -146.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.662 1.575 . . . . 0.0 111.231 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.62 90.03 7.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.047 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.34 -6.12 12.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.807 2.338 . . . . 0.0 113.545 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.529 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -167.53 71.63 0.95 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.707 0.765 . . . . 0.0 112.192 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.05 141.54 56.99 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.243 2.629 . . . . 0.0 111.989 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.33 -3.29 86.67 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.621 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 77' ' ' GLN . 71.2 m -118.2 148.69 42.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.778 0.789 . . . . 0.0 110.325 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.1 t80 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.529 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.0 mttp -93.48 -160.32 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.459 1.123 . . . . 0.0 113.655 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.0 p90 -176.34 178.21 1.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.627 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 62' ' ' ASN . 24.0 tp -133.7 127.52 33.05 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.787 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.625 ' CD ' HH21 ' A' ' 37' ' ' ARG . 77.0 tt0 -119.65 129.47 54.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 48.9 t -133.26 122.93 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.86 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.2 128.15 54.81 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.75 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.8 p90 -156.07 170.9 21.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.767 -0.773 . . . . 0.0 112.023 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 35' ' ' MET . 95.2 m-20 -126.52 159.09 34.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.734 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 78.5 m -109.8 118.82 37.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.259 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.36 157.77 48.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.93 144.62 99.44 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.045 1.83 . . . . 0.0 112.227 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -76.65 159.97 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.844 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.441 ' HG2' ' H ' ' A' ' 133' ' ' VAL . 14.5 ttmm -86.86 164.53 16.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.061 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.441 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 8.0 t -83.52 133.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.125 0.488 . . . . 0.0 111.405 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.222 -0.369 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.371 179.655 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.549 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.65 88.49 53.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -52.61 146.01 35.99 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.758 2.306 . . . . 0.0 112.375 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.655 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 44.9 t80 -84.36 5.55 26.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.044 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.98 3.31 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.32 64.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.563 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 0.1 OUTLIER 58.72 172.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.27 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.634 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 77.5 mtt85 -90.36 147.89 23.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.727 ' HE ' ' CD ' ' A' ' 123' ' ' GLU . 13.9 ttt180 -146.69 126.68 13.66 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.394 0.616 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.672 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 32.1 mp0 -126.13 143.35 51.16 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.024 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -139.2 145.04 38.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.995 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.06 141.19 32.76 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.23 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.81 135.47 54.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.46 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -47.71 135.44 11.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 111.444 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.63 -15.77 62.16 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.985 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 7.0 m-85 -111.4 149.75 41.09 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 118.132 0.966 . . . . 0.0 110.79 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.25 151.28 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.652 2.235 . . . . 0.0 113.033 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 tt -120.65 140.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.222 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -121.09 128.45 52.6 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.005 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.779 HD12 ' SG ' ' A' ' 96' ' ' CYS . 24.4 mt -115.82 141.42 48.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -150.74 132.91 15.35 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.933 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -102.91 143.0 25.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.839 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.58 158.76 52.95 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.579 2.186 . . . . 0.0 112.913 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.84 -137.19 40.28 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.446 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.1 p -102.08 23.89 10.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.384 -0.408 . . . . 0.0 111.14 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 75.9 m-20 -81.06 165.77 21.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 131' ' ' TYR . 14.2 m -128.2 147.0 32.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.547 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 126' ' ' TYR . 77.8 mt -68.34 138.45 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -132.42 100.02 4.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 89' ' ' PHE . 32.6 t -65.49 125.22 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.715 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.02 -48.79 3.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.626 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -152.08 150.27 29.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.4 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.6 157.97 10.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.892 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.9 t30 -150.73 143.17 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.83 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -112.36 114.53 27.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 163.16 -134.37 3.39 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.15 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 9.7 ttm180 -156.64 117.79 3.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.499 0.666 . . . . 0.0 110.727 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 84' ' ' TYR . 15.9 p -126.22 6.35 7.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.892 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 49.0 t0 -145.31 151.72 38.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.214 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.671 ' O ' ' CE ' ' A' ' 78' ' ' MET . 54.5 p30 -110.78 3.7 19.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.956 0.408 . . . . 0.0 109.943 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -102.72 1.75 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.985 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -110.93 135.12 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.837 0.351 . . . . 0.0 110.199 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m 58.81 65.26 1.26 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.904 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -48.61 99.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.524 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -111.03 -166.93 1.12 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.272 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.84 144.97 97.96 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.419 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.86 -41.99 60.08 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.461 2.107 . . . . 0.0 112.792 -178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.85 -35.93 81.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.988 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 118' ' ' THR . 76.2 mt-30 -87.01 -6.86 58.61 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.671 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 85.1 mtp -104.68 -6.09 20.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.63 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.4 mt-10 -65.16 -47.0 78.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.216 -0.593 . . . . 0.0 112.095 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.88 117.71 19.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.8 m -109.15 32.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.837 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -143.18 88.53 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.8 t -145.84 122.18 10.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' THR . 59.0 m-85 -135.09 152.74 51.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.319 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.6 tp -145.58 88.66 6.49 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.871 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.56 -49.83 12.59 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 123.042 2.494 . . . . 0.0 113.367 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 46.5 m-20 -55.01 -19.2 6.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.55 0.214 . . . . 0.0 111.307 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.54 69.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.398 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 58' ' ' VAL . 25.6 t80 -64.62 -40.87 96.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.11 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 ptmt -65.96 -40.54 91.36 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.747 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 73.0 mt -59.61 -48.66 86.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.477 ' SD ' HG11 ' A' ' 104' ' ' VAL . 96.3 mmm -69.55 -39.54 77.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.267 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 61.3 m -59.44 -45.56 91.23 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.038 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -66.02 -36.01 82.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 61.6 mtt180 -76.63 -32.11 57.82 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 48' ' ' LEU . 76.4 m -112.94 -14.58 13.01 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.9 m-20 -61.76 134.84 57.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.488 0.661 . . . . 0.0 112.464 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 63.84 13.04 7.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -112.93 145.02 41.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.298 0.571 . . . . 0.0 109.865 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -32.71 67.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.645 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -153.02 153.74 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.4 p -152.53 156.28 39.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.06 124.75 53.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 92' ' ' MET . 59.7 t -133.44 145.66 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.514 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.6 116.71 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.126 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.71 36.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.19 -123.33 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.599 ' O ' ' O ' ' A' ' 107' ' ' GLY . 20.9 t 31.28 -160.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.73 1.68 0.82 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.384 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -85.1 -13.77 49.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.069 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.8 m-85 -145.23 129.94 9.02 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.414 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.3 Cg_exo -51.79 -144.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.057 1.838 . . . . 0.0 111.182 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.649 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 15.2 t0 -146.42 87.25 6.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.235 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.478 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.1 Cg_endo -77.74 -4.44 14.53 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.749 2.299 . . . . 0.0 113.466 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.613 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.11 63.35 0.82 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.289 0.566 . . . . 0.0 111.669 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.41 145.81 65.9 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 121.763 1.642 . . . . 0.0 110.463 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.16 -8.54 79.38 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.0 m -122.72 148.85 44.84 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.687 -0.302 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.5 t80 -84.05 118.4 24.04 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.649 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 11.6 mttp -94.61 -160.52 0.78 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.592 1.187 . . . . 0.0 113.798 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -172.4 173.29 4.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.953 -1.931 . . . . 0.0 110.669 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.8 tp -131.99 125.01 30.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.719 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.727 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 10.2 tp10 -120.01 127.48 52.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.85 123.23 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.359 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.95 129.12 54.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.902 ' CD1' HG23 ' A' ' 56' ' ' ILE . 33.0 p90 -154.04 171.97 18.23 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.439 0.637 . . . . 0.0 112.077 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.563 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 97.8 m-20 -129.06 161.7 29.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.578 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.634 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.9 m -111.55 127.77 55.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.236 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 33.6 m -132.5 153.58 81.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.09 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 132' ' ' LYS . 16.9 Cg_exo -55.48 142.99 79.74 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.531 1.488 . . . . 0.0 112.165 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.489 ' CD1' HG11 ' A' ' 55' ' ' VAL . 15.7 t80 -76.55 44.59 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.108 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 130' ' ' PRO . 55.9 mttm -138.89 -70.06 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.535 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.2 134.09 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.55 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.853 -178.903 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.406 ' H83' HD22 ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.901 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -58.87 146.25 76.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.603 0.239 . . . . 0.0 111.181 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.53 142.14 13.84 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.101 1.867 . . . . 0.0 111.986 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.43 ' C ' ' H ' ' A' ' 34' ' ' LEU . 98.2 m-85 -77.79 -51.6 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.697 ' C ' HD23 ' A' ' 34' ' ' LEU . . . 70.7 -34.22 0.47 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.163 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -156.96 144.28 18.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.42 0.61 . . . . 0.0 111.725 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt 58.91 135.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.625 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 36' ' ' ARG . 56.5 mtp85 -93.96 151.72 19.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.496 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.617 HH11 ' HG3' ' A' ' 123' ' ' GLU . 66.7 ttp85 -148.82 138.95 22.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.545 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HG3' HD23 ' A' ' 48' ' ' LEU . 77.4 mm-40 -130.19 145.79 51.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.791 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -137.33 142.98 41.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.898 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.63 139.71 36.78 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.6 m -65.81 137.25 57.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.107 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 76.5 tt0 -45.08 129.39 7.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.12 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.92 -12.41 67.17 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.029 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.17 148.72 38.93 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 118.532 1.166 . . . . 0.0 110.349 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.07 150.47 88.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.783 2.322 . . . . 0.0 112.884 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 104' ' ' VAL . 21.0 tt -116.64 149.42 18.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.666 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 35.6 tt0 -132.0 129.83 40.64 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.899 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.8 mt -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.334 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.666 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 89.2 mtt180 -147.76 132.42 17.84 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.023 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.5 m -98.51 146.69 32.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 34.4 Cg_endo -67.37 158.86 55.05 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.866 2.377 . . . . 0.0 112.069 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.1 -119.05 5.7 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.213 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.4 p -121.52 23.82 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.595 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -76.08 169.53 18.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.97 149.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.847 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.669 HG23 ' CD2' ' A' ' 126' ' ' TYR . 59.6 mt -70.35 136.73 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.219 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -131.7 98.12 4.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.4 t -65.09 125.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.231 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -100.23 -48.11 4.72 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -152.21 150.56 29.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.253 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.27 156.71 12.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.1 t30 -151.39 142.28 22.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.357 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -112.39 116.94 31.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.59 -139.73 6.05 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.343 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.612 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.0 ttm-85 -152.1 117.44 5.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.078 0.466 . . . . 0.0 111.697 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 p -124.3 4.82 8.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.183 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.4 t0 -149.76 157.23 43.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 36.6 p30 -113.05 5.53 17.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.964 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 28.2 mttt -105.16 3.67 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.569 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.2 mm -112.5 136.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.803 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.8 m 52.55 76.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p30 -54.36 119.25 4.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.407 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.71 -164.86 1.52 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.531 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.7 p-10 -66.35 140.36 96.69 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.331 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.1 Cg_endo -53.26 -38.46 81.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.42 2.08 . . . . 0.0 113.57 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.52 -36.99 84.31 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.154 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.517 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 78.8 mt-30 -85.56 -9.89 56.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.521 ' HE3' HH22 ' A' ' 65' ' ' ARG . 82.4 mtp -103.89 -3.79 24.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.145 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.0 mt-10 -64.62 -48.22 75.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -81.61 116.31 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.548 0.69 . . . . 0.0 112.374 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.567 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -106.57 36.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.017 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -141.38 86.88 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.155 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.501 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.7 t -147.92 119.18 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.482 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.6 m-85 -131.4 153.44 49.68 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.302 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.9 tp -147.41 88.12 5.84 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.655 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -47.73 -47.57 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.277 1.985 . . . . 0.0 112.402 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -52.59 -25.53 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.334 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -54.91 -36.29 65.05 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.947 0.403 . . . . 0.0 111.22 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CE1' HG12 ' A' ' 58' ' ' VAL . 76.2 t80 -64.46 -42.27 96.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.6 pttm -64.82 -39.82 94.19 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.104 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.429 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.6 mt -59.83 -46.65 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.83 -35.98 79.55 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.938 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.0 m -58.85 -45.74 89.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.9 -40.51 91.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.235 0.54 . . . . 0.0 110.847 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.78 -35.49 72.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.352 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.737 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -112.8 -14.72 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.636 ' HB3' ' H82' ' A' ' 135' ' ' NAG . 30.3 m-20 -62.3 132.24 51.99 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.079 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 63.76 13.17 7.23 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.27 146.45 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.291 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.7 m -69.83 -32.68 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.312 0.577 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -151.27 158.14 43.47 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.484 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.899 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.5 p -156.81 139.44 15.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -124.07 125.1 70.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 46' ' ' ILE . 43.5 t -134.86 146.34 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.938 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.0 t -77.83 118.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.262 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.14 35.77 0.05 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.086 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.675 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.44 -117.51 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 27.97 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.207 0.527 . . . . 0.0 111.608 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.76 1.97 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.392 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.73 -13.78 47.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.399 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.9 m-85 -145.72 130.19 8.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.113 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 111' ' ' PHE . 45.2 Cg_exo -51.53 -146.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.282 1.988 . . . . 0.0 112.027 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 17.9 t0 -145.27 84.57 8.51 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.622 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.24 -4.95 14.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.345 2.696 . . . . 0.0 113.527 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.578 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.88 60.74 0.58 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.111 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.35 147.47 21.74 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.56 -11.25 70.68 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.664 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.92 150.33 35.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.466 0.633 . . . . 0.0 109.913 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.612 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 27.8 t80 -82.16 111.95 18.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.578 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.0 mttp -90.73 -163.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.824 1.297 . . . . 0.0 113.539 -176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.3 p90 -173.58 175.81 2.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.807 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.7 tp -133.0 126.72 32.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HG3' HH11 ' A' ' 37' ' ' ARG . 79.5 tt0 -121.34 128.66 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.607 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' HB1' ' A' ' 61' ' ' ALA . 45.1 t -132.89 123.61 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.377 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 127.61 53.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.669 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.7 p90 -152.88 167.97 27.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.886 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -128.46 161.94 28.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.18 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.3 m -111.05 116.5 31.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.97 158.98 41.02 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -61.55 143.4 97.03 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.793 1.662 . . . . 0.0 111.38 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 87.8 t80 -78.37 -0.58 29.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.918 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -96.46 -72.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.648 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.2 m -91.33 132.1 36.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.498 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.934 -1.032 . . . . 0.0 111.482 178.601 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.636 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.79 116.54 66.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.518 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.52 -110.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.876 2.384 . . . . 0.0 113.155 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -79.42 -8.37 59.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.672 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 74.62 36.1 49.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.314 -0.47 . . . . 0.0 111.972 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' MET . 2.1 mt -158.59 -168.68 2.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 111.48 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.592 ' O ' ' O ' ' A' ' 34' ' ' LEU . 1.5 mtt 51.69 134.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.03 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.535 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 65.3 mtp85 -93.63 144.17 25.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.36 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -151.45 140.83 21.48 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 48' ' ' LEU . 59.2 mm-40 -133.18 145.31 50.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.011 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -135.6 133.15 37.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.849 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.748 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.93 140.54 46.85 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.377 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.2 m -66.48 136.21 55.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.271 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -48.63 134.68 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.73 -18.54 56.34 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.718 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -104.1 153.17 39.1 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 118.114 0.957 . . . . 0.0 108.905 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.98 154.41 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.259 1.973 . . . . 0.0 112.614 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 tt -119.62 151.09 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.853 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.691 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 55.5 tt0 -131.78 130.65 42.1 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' SG ' ' A' ' 102' ' ' CYS . 34.4 mt -120.68 138.96 53.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.158 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.691 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 55.9 mtt180 -148.31 129.64 14.73 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.816 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -98.69 143.97 27.31 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 30.4 Cg_endo -66.48 162.28 37.35 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.93 2.42 . . . . 0.0 113.267 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -121.26 9.34 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.792 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -120.62 26.18 9.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -77.88 169.51 18.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.662 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.87 145.86 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.427 0.632 . . . . 0.0 110.884 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.831 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.8 mt -68.77 138.49 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.928 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.2 ptm -130.62 104.04 6.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.565 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.5 t -68.54 124.73 24.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.168 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -105.01 -51.57 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -147.01 142.96 28.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.13 0.49 . . . . 0.0 110.479 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.981 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -163.19 152.42 14.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.406 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.5 t30 -148.75 143.92 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -114.93 120.0 38.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.99 -135.2 3.87 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.736 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.3 ttm-85 -154.09 116.83 4.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.364 0.602 . . . . 0.0 111.157 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.508 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.7 p -124.02 4.33 8.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.877 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 16.7 t70 -144.67 151.96 39.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 26.7 p30 -109.17 0.47 19.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 43.3 mtpt -101.22 3.22 40.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.287 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 70' ' ' ILE . 21.0 mm -109.71 137.27 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.809 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.0 m 55.66 66.24 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 10.5 p30 -50.58 111.63 0.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.935 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.54 -161.89 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -58.8 136.96 87.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.673 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.9 Cg_endo -59.39 -33.45 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.834 1.69 . . . . 0.0 112.63 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -62.68 -33.91 76.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.658 0.266 . . . . 0.0 110.878 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 118' ' ' THR . 73.1 mt-30 -85.64 -17.99 34.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.419 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.3 mtp -97.72 -0.35 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.454 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -60.99 -50.74 72.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.475 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.3 t30 -76.48 113.93 14.63 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.25 -0.281 . . . . 0.0 111.595 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.68 25.61 2.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.089 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -137.87 82.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.277 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.1 t -143.98 121.86 12.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.474 ' HA ' HD21 ' A' ' 62' ' ' ASN . 90.6 m-85 -130.4 154.78 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.405 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.466 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.1 tp -144.86 90.65 6.24 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.89 -44.74 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.783 2.322 . . . . 0.0 113.06 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -55.21 -21.15 12.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.67 71.17 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.745 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.0 t80 -65.06 -44.69 88.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.851 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.7 pttm -63.62 -43.43 96.87 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.863 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 59.0 mt -58.44 -50.59 78.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.552 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 1.5 mtp -69.62 -32.34 70.98 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.474 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.456 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 58.2 m -61.12 -45.4 94.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.207 0.527 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.16 -37.71 84.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.36 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.712 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 99.6 mtt180 -78.1 -33.14 50.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.0 m -111.52 -19.22 12.63 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -61.5 138.97 58.3 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.605 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 62.52 12.54 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.499 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.712 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 65.7 mtt180 -114.93 147.47 39.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.149 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 m -70.75 -34.52 71.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.162 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -150.74 155.46 39.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.729 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.918 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.8 p -154.07 132.78 12.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.83 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.42 132.21 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.696 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG13 ' NH1' ' A' ' 95' ' ' ARG . 86.6 t -144.96 151.67 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.624 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 107' ' ' GLY . 90.6 t -83.83 114.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.04 41.32 0.1 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.8 -126.07 0.98 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.325 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.606 ' O ' ' O ' ' A' ' 107' ' ' GLY . 5.0 t 28.49 -156.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.076 0.465 . . . . 0.0 111.24 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.38 1.4 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.828 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.3 -8.98 58.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.849 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -144.1 134.49 12.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.926 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.3 Cg_exo -58.86 -150.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.92 1.747 . . . . 0.0 111.929 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.638 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 26.1 t0 -144.9 92.5 5.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.468 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.21 -10.84 14.92 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.729 2.286 . . . . 0.0 112.625 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.3 p -171.15 87.96 0.47 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.301 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.13 157.75 55.71 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.38 12.01 84.3 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.699 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.6 m -126.32 146.62 49.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.037 0.418 . . . . 0.0 110.137 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.683 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.5 t80 -82.66 107.18 15.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.638 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 24.9 mttt -88.99 -164.1 1.09 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.638 1.208 . . . . 0.0 113.019 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.3 p90 -171.89 174.81 4.06 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.771 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 20.6 tp -132.37 124.7 29.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.429 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG2' HE21 ' A' ' 125' ' ' GLN . 78.7 tt0 -122.53 124.31 43.26 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.981 HG13 ' HB2' ' A' ' 61' ' ' ALA . 6.0 t -133.18 130.54 57.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.638 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.505 HE21 ' HG2' ' A' ' 123' ' ' GLU . 7.2 mp0 -109.91 132.66 53.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.719 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.831 ' CD2' HG23 ' A' ' 56' ' ' ILE . 49.4 p90 -152.83 168.45 25.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.416 0.627 . . . . 0.0 111.896 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.497 ' H ' ' HG2' ' A' ' 57' ' ' MET . 71.1 m-20 -126.22 158.24 36.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.434 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.535 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 74.7 m -108.53 124.89 51.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.528 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 m -126.53 159.37 63.76 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -59.35 144.82 99.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.537 1.491 . . . . 0.0 111.854 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -77.16 -86.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.51 ' C ' ' CD ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -140.42 154.5 46.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.359 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.5 133.06 29.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.13 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.679 -179.465 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 tt 39.69 66.27 3.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -82.53 -78.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.793 2.329 . . . . 0.0 112.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 97.1 m-85 -77.88 -15.49 59.0 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.25 -55.83 0.11 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.332 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' PHE . 20.1 tp -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.1 mtt 60.69 120.65 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.729 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 52.4 mtt-85 -88.33 152.82 21.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.425 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -146.71 137.41 23.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.613 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 19.1 mt-10 -135.54 144.91 46.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.593 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.19 137.7 37.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.768 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -135.3 139.24 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.304 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.12 140.41 58.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.29 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -45.97 129.62 9.67 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.785 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.42 -12.51 69.5 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.708 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -104.15 155.21 37.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 118.248 1.024 . . . . 0.0 109.396 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.16 153.5 36.43 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.71 1.607 . . . . 0.0 112.577 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.7 tt -125.06 143.23 39.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.0 tt0 -126.88 130.52 50.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.124 0.488 . . . . 0.0 112.165 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.3 mt -114.18 141.71 47.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -148.1 131.16 16.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.754 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.04 142.03 23.8 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.49 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 24.2 Cg_endo -69.6 161.66 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.269 1.979 . . . . 0.0 112.208 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.64 20.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.719 0.621 . . . . 0.0 112.311 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -101.17 21.2 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.06 165.0 25.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.21 144.04 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.792 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -67.81 134.84 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.733 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.641 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.8 ptm -130.46 100.59 5.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.511 0.672 . . . . 0.0 109.232 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.2 t -70.41 124.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.866 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.22 -43.73 4.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -146.23 143.42 29.21 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.02 149.11 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.531 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 84' ' ' TYR . 7.5 t30 -148.74 152.12 36.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 76.2 t80 -121.57 120.11 33.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.81 -134.91 3.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -159.7 119.79 3.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.215 0.531 . . . . 0.0 111.463 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.9 8.3 8.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.085 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 44.8 t0 -144.1 150.63 38.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.369 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 14.6 p30 -104.46 -1.11 27.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 8.1 mtmp? -105.03 10.86 33.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.37 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.556 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 12.5 mm -107.52 135.03 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' ALA . 71.8 m 56.76 67.37 1.0 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 52.2 p-10 -46.35 93.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.594 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -111.82 -162.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.645 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p-10 -63.68 140.52 97.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.578 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 5.5 Cg_endo -56.54 -38.94 94.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.596 2.197 . . . . 0.0 113.526 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 2.9 m-30 -61.4 -36.53 80.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.333 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.479 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 68.2 mt-30 -86.52 -11.79 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.434 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 78.6 mmm -101.95 -3.11 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 43.9 mt-10 -66.26 -44.69 82.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -78.61 114.02 17.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.99 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.586 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 35.6 m -105.67 32.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 8.3 mm-40 -142.13 85.93 1.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.313 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 21.7 t -143.81 125.67 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.9 m-85 -135.66 149.73 49.39 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.3 tp -148.9 88.5 5.16 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.438 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.07 -44.24 47.1 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.503 2.135 . . . . 0.0 113.848 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 83.1 m-20 -53.7 -24.58 15.06 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.188 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.22 -34.26 44.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 40.2 t80 -64.79 -42.24 95.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.478 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.52 -36.18 83.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.028 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.538 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 71.5 mt -62.99 -50.37 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.258 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.99 -38.63 86.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 42.0 m -58.15 -45.74 86.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.56 -36.51 82.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.686 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 70.1 mtt180 -78.74 -31.36 46.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.8 m -111.81 -19.9 12.26 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 84.5 m-20 -56.6 134.04 54.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.406 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 67.12 13.14 9.33 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.786 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.686 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 75.2 mtt180 -113.0 146.0 39.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.36 0.6 . . . . 0.0 110.132 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.9 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.488 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 155.76 40.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -154.6 146.3 23.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.419 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.47 127.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.743 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' NH1' ' A' ' 95' ' ' ARG . 48.5 t -137.12 143.81 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.353 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.2 t -78.1 115.29 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.759 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.84 35.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.212 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.51 -119.92 0.65 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.302 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.2 t 31.26 -160.38 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.405 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.12 1.67 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.25 -13.49 55.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.9 m-85 -144.36 131.98 10.57 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.819 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 111' ' ' PHE . 21.7 Cg_exo -56.6 -147.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.104 1.869 . . . . 0.0 112.345 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -146.21 86.28 7.08 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.492 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.22 -9.92 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.544 2.163 . . . . 0.0 112.814 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -166.38 77.19 1.14 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.654 0.74 . . . . 0.0 111.05 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.25 149.93 42.97 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.337 2.025 . . . . 0.0 110.857 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.2 -4.93 64.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.386 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.3 m -113.25 148.32 35.78 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.932 0.866 . . . . 0.0 109.343 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.745 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.1 t80 -84.94 113.7 21.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 13.7 mtmm -93.87 -162.9 0.98 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.854 1.312 . . . . 0.0 113.82 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.9 p90 -168.84 170.29 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.55 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 62' ' ' ASN . 39.7 tp -128.89 124.67 35.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 126.31 49.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 61' ' ' ALA . 22.8 t -130.88 125.18 57.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.561 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -105.8 127.88 53.38 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.247 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.645 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.4 p90 -151.48 170.3 19.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.353 0.597 . . . . 0.0 111.372 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.477 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.5 m-20 -127.47 158.75 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.057 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.729 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 86.7 m -108.05 114.74 28.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.74 158.26 45.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.951 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.48 149.21 91.65 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.29 1.994 . . . . 0.0 112.798 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.649 ' CD2' ' O ' ' A' ' 131' ' ' TYR . 67.7 t80 -77.61 12.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -90.68 165.48 13.68 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.29 137.13 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 111.46 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.733 178.844 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -41.51 -52.23 8.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.371 0.129 . . . . 0.0 111.244 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 52.8 Cg_exo -51.83 157.16 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.339 2.026 . . . . 0.0 112.338 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -61.03 2.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.188 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.94 32.05 79.83 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -157.51 45.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.145 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.553 ' CE ' ' OE1' ' A' ' 59' ' ' GLU . 1.4 mtt 54.71 149.45 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -89.11 144.8 25.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.337 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.703 0.763 . . . . 0.0 111.194 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 54.9 mp0 -134.21 140.16 46.3 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.433 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -137.74 135.33 36.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.822 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.794 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.22 136.64 56.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.991 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -46.67 133.11 10.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.336 0.589 . . . . 0.0 112.526 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.74 -13.28 67.48 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.593 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.94 147.03 34.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 118.437 1.118 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.99 147.71 89.22 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.391 2.061 . . . . 0.0 112.064 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.0 tt -117.68 147.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.68 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.4 tt0 -123.15 129.47 51.47 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.096 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.5 mt -118.0 137.31 52.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.68 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 87.3 mtt180 -149.2 127.85 12.42 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -95.45 149.55 36.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.557 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 49.2 Cg_endo -72.11 157.41 54.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.951 2.434 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 48.43 -134.96 19.15 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.912 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -101.82 24.12 10.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -78.45 164.96 24.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG11 ' HD1' ' A' ' 131' ' ' TYR . 27.2 m -125.5 146.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.662 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.6 mt -67.62 133.53 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.627 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -130.71 99.1 4.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.66 HG12 ' CE1' ' A' ' 89' ' ' PHE . 34.1 t -66.45 124.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.913 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.553 ' OE1' ' CE ' ' A' ' 35' ' ' MET . 92.9 mt-10 -108.75 -47.33 3.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.203 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -146.85 145.82 29.99 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.309 0.576 . . . . 0.0 110.324 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.93 155.73 16.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.594 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.4 t30 -147.13 138.57 24.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.212 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -115.36 117.65 31.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.5 -135.26 4.06 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 17.8 ttm180 -155.21 117.76 4.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.367 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' CE2' ' A' ' 84' ' ' TYR . 5.1 p -123.45 5.79 9.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -146.97 154.08 40.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.236 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 36.9 p30 -113.69 2.44 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.357 . . . . 0.0 110.426 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 30.0 mttp -103.65 6.69 37.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.7 mm -108.28 135.62 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.895 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m 52.18 71.89 0.43 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 10.3 p-10 -45.03 114.34 0.71 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.847 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.14 -169.32 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.553 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.663 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -61.05 139.41 94.25 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.6 Cg_endo -57.83 -34.49 98.34 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.149 1.899 . . . . 0.0 112.988 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -64.72 -35.49 81.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.793 ' O ' HG23 ' A' ' 118' ' ' THR . 74.1 mt-30 -86.93 -13.43 44.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.607 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.498 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mtm -104.61 0.85 29.01 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.598 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 3.7 mt-10 -67.31 -43.83 80.68 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -79.87 114.26 18.66 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.692 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -104.55 34.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 79.9 mm-40 -141.07 84.44 1.93 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.05 119.17 8.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.4 m-85 -132.49 152.56 51.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.695 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.606 HD21 ' HG2' ' A' ' 112' ' ' PRO . 53.1 tp -142.09 87.6 9.64 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.91 -50.26 11.12 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.0 -26.97 40.6 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.56 -33.42 45.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.89 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 58' ' ' VAL . 15.5 t80 -64.71 -43.9 91.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.24 -38.75 92.38 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.247 -178.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -59.94 -51.81 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.814 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.649 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.1 mtp -68.44 -33.02 73.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.175 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 33.2 m -59.89 -45.54 92.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 51.9 mt-30 -64.68 -37.75 88.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.35 0.595 . . . . 0.0 110.957 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.676 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 25.2 mtp180 -75.86 -33.11 59.99 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.532 ' N ' HH21 ' A' ' 99' ' ' ARG . 6.9 m -113.7 -14.01 12.63 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.774 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 53.8 m-20 -60.06 131.65 51.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.844 -0.743 . . . . 0.0 111.641 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 66.59 13.2 9.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.902 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 97' ' ' ASN . 29.6 mtm-85 -111.29 144.29 40.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.9 m -71.18 -30.51 66.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 154.09 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.428 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.2 p -154.69 137.26 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.712 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.79 128.63 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.656 HG22 ' HE ' ' A' ' 95' ' ' ARG . 23.1 t -141.04 151.87 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.158 0.504 . . . . 0.0 112.051 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 108' ' ' SER . 45.2 t -82.16 116.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.005 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.6 39.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.96 -120.68 0.69 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.709 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER 31.87 -161.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 110.76 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.709 ' N ' ' OG ' ' A' ' 108' ' ' SER . 66.5 m-20 -68.93 2.9 2.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.419 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.07 -11.99 48.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.68 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.0 m-85 -142.87 126.89 9.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.001 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.606 ' HG2' HD21 ' A' ' 85' ' ' LEU . 18.1 Cg_exo -50.78 -148.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.34 2.026 . . . . 0.0 111.765 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.652 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 32.4 t0 -144.48 85.59 8.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -5.1 14.73 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.901 2.401 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.477 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.5 p -166.04 67.31 1.07 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.546 0.689 . . . . 0.0 111.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 142.73 98.67 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 121.997 1.798 . . . . 0.0 110.269 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.25 69.57 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -122.87 147.06 47.0 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 19.3 t80 -81.28 118.44 22.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.652 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 33.9 mttt -92.17 -162.11 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 123.091 1.424 . . . . 0.0 113.868 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -170.54 172.92 5.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.543 -2.117 . . . . 0.0 110.876 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.649 HD21 ' SD ' ' A' ' 92' ' ' MET . 45.0 tp -132.92 123.76 26.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -121.09 126.28 49.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.592 HG21 ' SD ' ' A' ' 92' ' ' MET . 59.0 t -127.4 121.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.258 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -104.23 125.4 50.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.6 p90 -153.92 169.03 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.002 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -124.2 159.39 30.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.259 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.9 m -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.18 153.56 68.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.105 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -56.2 144.39 81.3 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.636 1.557 . . . . 0.0 111.331 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 62.4 t80 -73.63 -3.72 29.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.727 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -98.53 163.24 12.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.64 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.56 125.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.997 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.277 -179.25 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.35 64.68 72.14 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.36 150.42 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.395 2.063 . . . . 0.0 111.718 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -79.38 -12.13 59.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.343 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.03 23.81 75.31 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.7 tt -161.06 121.54 2.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.747 0.308 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.454 ' N ' HD23 ' A' ' 34' ' ' LEU . 8.8 mtt 59.75 129.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.385 0.612 . . . . 0.0 111.658 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.446 HH21 ' HG3' ' A' ' 51' ' ' PRO . 78.3 mtt-85 -90.65 147.99 22.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HE ' ' HG3' ' A' ' 123' ' ' GLU . 58.4 ttt180 -145.46 130.06 17.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.73 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.1 mm-40 -127.8 143.1 51.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.677 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -138.21 135.24 35.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.805 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -132.48 138.18 47.48 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.351 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 14.3 m -65.32 136.83 57.03 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -45.78 132.67 8.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 0.0 112.348 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.53 -12.58 66.22 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.195 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.3 149.21 40.24 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.536 1.168 . . . . 0.0 110.316 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.36 151.46 85.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.68 2.254 . . . . 0.0 113.02 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.4 tt -119.12 144.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -128.7 128.45 44.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.302 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' SG ' ' A' ' 102' ' ' CYS . 33.5 mt -116.38 141.18 48.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.073 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 49' ' ' ARG . 17.7 mtp180 -148.13 135.05 20.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.809 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.0 m -102.36 141.03 21.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.853 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HG3' HH21 ' A' ' 36' ' ' ARG . 29.4 Cg_endo -67.16 157.74 60.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.469 2.112 . . . . 0.0 112.332 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.76 -134.49 11.13 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.604 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 p -99.82 22.12 11.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.505 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.32 167.3 21.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.07 148.81 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 111.461 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.832 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.2 mt -72.41 138.43 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.723 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.8 ptm -133.26 103.71 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 89' ' ' PHE . 38.4 t -66.75 124.98 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.18 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 86.3 mt-10 -105.6 -51.13 3.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.963 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -146.85 147.52 30.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.103 0.478 . . . . 0.0 110.126 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.606 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.68 157.53 10.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.56 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 122' ' ' LEU . 15.0 t30 -151.1 148.94 28.92 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.275 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -118.57 115.24 24.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.86 -136.3 4.25 Favored Glycine 0 C--N 1.319 -0.379 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 10.2 ttm-85 -156.68 117.1 3.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.204 0.526 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 p -121.68 9.58 10.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.567 ' C ' HG12 ' A' ' 81' ' ' VAL . 35.3 t0 -145.58 -174.82 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 50.1 p30 -141.33 -0.03 1.46 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.199 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 54.2 mttm -101.52 5.3 41.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.137 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 32.2 mm -107.59 133.64 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.963 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.9 m 52.72 75.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.932 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 36.1 t0 -55.11 106.77 0.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.091 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HG3' ' A' ' 78' ' ' MET . . . -118.72 -164.6 1.05 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.295 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.703 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -60.79 142.14 92.3 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.303 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 9.5 Cg_endo -55.34 -39.09 92.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.462 2.108 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -64.51 -36.24 83.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.423 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.55 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 85.0 mt-30 -89.34 -6.59 56.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.692 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.554 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 61.3 mmm -115.47 -1.31 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.164 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.0 mt-10 -67.47 -42.79 82.44 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -79.98 120.62 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.567 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.9 m -111.25 34.7 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.816 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.83 85.39 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.804 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.6 t -149.21 124.88 10.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.285 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' HA ' HD21 ' A' ' 62' ' ' ASN . 92.7 m-85 -132.6 149.77 52.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.723 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 112' ' ' PRO . 51.0 tp -142.1 94.84 6.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -54.34 -47.63 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.948 2.432 . . . . 0.0 114.106 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.1 m-20 -55.13 -26.09 36.17 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.692 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.95 51.38 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.91 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 58' ' ' VAL . 35.7 t80 -66.81 -47.17 72.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 6.0 pttm -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -59.27 -50.85 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.729 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . 1.016 ' SD ' HD21 ' A' ' 122' ' ' LEU . 6.0 mtp -68.46 -33.62 74.51 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.505 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.5 m -59.59 -44.04 93.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.934 ' HE ' HG22 ' A' ' 104' ' ' VAL . 75.5 mtp85 -76.21 -34.57 59.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.625 ' SG ' HD12 ' A' ' 48' ' ' LEU . 37.5 m -113.69 -11.47 12.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.532 HD22 ' H83' ' A' ' 135' ' ' NAG . 59.1 m-20 -62.79 134.77 56.77 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.653 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 67.62 14.93 9.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -114.58 147.43 39.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.112 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.5 m -70.11 -32.98 71.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 158.44 44.15 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.509 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.822 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.5 p -157.02 145.0 19.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.384 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.94 128.43 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.934 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.5 t -138.14 140.72 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.168 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 107' ' ' GLY . 48.4 t -77.45 116.39 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.27 38.56 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.127 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.643 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.86 -119.43 0.63 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.643 ' O ' ' O ' ' A' ' 107' ' ' GLY . 48.4 t 27.55 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.291 0.567 . . . . 0.0 111.776 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.523 ' N ' ' OG ' ' A' ' 108' ' ' SER . 91.4 m-20 -68.83 1.85 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.01 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.11 54.67 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.064 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -144.88 129.95 9.26 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.152 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.3 Cg_exo -51.03 -148.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.85 2.366 . . . . 0.0 112.461 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.05 89.45 6.04 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.529 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.97 -10.31 18.07 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.009 2.473 . . . . 0.0 114.095 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.411 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -170.81 69.76 0.53 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.92 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.33 155.51 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.082 1.855 . . . . 0.0 111.531 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.88 85.14 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.7 m -126.27 149.91 48.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 41.8 t80 -83.99 113.54 21.07 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 21.2 mttp -90.06 -162.84 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.314 1.054 . . . . 0.0 113.376 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -171.77 172.75 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.091 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.016 HD21 ' SD ' ' A' ' 92' ' ' MET . 28.0 tp -132.77 126.57 32.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.575 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 81.9 tt0 -122.05 126.06 47.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.783 HG21 ' SD ' ' A' ' 92' ' ' MET . 47.4 t -130.55 127.87 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.24 127.0 53.9 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.832 ' CD2' HG23 ' A' ' 56' ' ' ILE . 46.2 p90 -151.37 162.12 41.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.635 . . . . 0.0 112.146 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.417 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 78.5 m-20 -117.96 158.99 23.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.592 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 36' ' ' ARG . 95.6 m -109.93 108.6 18.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.719 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.77 156.67 43.37 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.757 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.84 142.99 83.11 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.079 1.852 . . . . 0.0 112.316 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -76.68 -3.15 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.009 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -91.43 1.71 56.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.136 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.3 t -83.69 133.1 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.244 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.941 -179.237 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.616 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.498 2.779 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.512 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.3 mt -37.32 -59.86 0.95 Allowed Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.878 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 30' ' ' LEU . 10.8 Cg_endo -60.56 145.64 98.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.557 2.171 . . . . 0.0 111.523 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.638 ' O ' ' N ' ' A' ' 34' ' ' LEU . 26.5 p90 -80.78 -16.6 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.128 0.489 . . . . 0.0 109.682 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.974 ' C ' HD13 ' A' ' 34' ' ' LEU . . . 55.0 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.033 HD22 ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -151.15 113.37 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.149 0.499 . . . . 0.0 110.21 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 34' ' ' LEU . 9.3 mtp 58.32 154.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.755 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -95.19 150.99 19.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.985 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.584 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 48.9 ttp180 -146.92 136.94 23.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.605 . . . . 0.0 111.289 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.599 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 18.6 mp0 -130.77 141.33 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.595 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.03 144.11 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.817 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.868 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.82 140.04 34.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.662 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -48.18 133.81 14.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.374 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.54 -15.58 62.98 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.187 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -107.09 147.35 34.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.927 0.863 . . . . 0.0 111.323 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.41 149.68 75.16 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.739 2.293 . . . . 0.0 112.445 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -120.92 143.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.585 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -121.29 129.33 53.07 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.275 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.781 HD12 ' SG ' ' A' ' 102' ' ' CYS . 60.9 mt -117.23 140.1 49.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.548 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -152.19 134.05 14.83 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.549 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.7 m -95.22 137.9 22.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.99 164.71 32.71 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.517 1.478 . . . . 0.0 110.85 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.53 -140.19 29.71 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.703 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 p -106.38 21.3 17.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.757 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.35 170.19 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.714 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.07 144.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.0 0.429 . . . . 0.0 110.665 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 94.8 mt -69.02 138.43 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.299 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.5 ptp -130.95 100.94 5.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.0 t -64.79 123.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.04 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -101.38 -48.85 4.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HB2' ' NE2' ' A' ' 125' ' ' GLN . 45.7 m-80 -148.63 146.59 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.415 0.626 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.798 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.12 152.1 12.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.147 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.3 t30 -148.74 144.44 27.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.841 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -115.63 118.88 34.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.27 -135.33 4.01 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.4 ttm180 -155.58 118.7 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.317 0.579 . . . . 0.0 111.753 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 25.9 p -125.21 3.62 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.739 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 52.8 t0 -146.42 154.64 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.792 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.659 ' O ' ' CE ' ' A' ' 78' ' ' MET . 29.3 p30 -113.73 0.34 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.777 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -102.48 7.9 40.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.767 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.1 133.78 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.1 m 49.49 83.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -61.05 106.02 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -112.44 -166.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.178 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -64.54 139.97 97.88 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.467 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -52.92 -39.38 78.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.375 2.05 . . . . 0.0 113.212 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -64.77 -36.32 83.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.725 0.298 . . . . 0.0 111.468 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 68.0 mt-30 -85.74 -6.67 59.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.646 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.659 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 95.1 mtp -105.6 -4.8 20.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.181 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.2 mt-10 -63.25 -47.55 81.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.982 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -79.33 119.57 22.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 m -108.79 33.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.824 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -141.41 83.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.786 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.464 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 37.1 t -142.8 123.24 13.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -135.07 156.17 49.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 112' ' ' PRO . 50.9 tp -148.04 88.68 5.44 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.877 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.18 -48.18 13.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.791 2.327 . . . . 0.0 113.16 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 79.3 m-20 -57.26 -21.85 37.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.49 -35.11 67.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.474 ' CE1' HG12 ' A' ' 58' ' ' VAL . 60.2 t80 -65.05 -45.04 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.124 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -66.02 -35.88 81.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.255 -179.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.569 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 76.5 mt -61.96 -50.12 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.625 0.25 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 53.8 mtp -71.44 -34.23 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.301 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.2 m -59.85 -46.2 90.04 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.564 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.536 ' OE1' ' O ' ' A' ' 90' ' ' LYS . 1.7 mp0 -66.56 -35.22 79.69 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.748 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.618 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 28.4 mtp180 -76.72 -34.26 58.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.1 m -113.02 -10.1 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.592 ' CG ' ' O ' ' A' ' 93' ' ' SER . 28.1 m-20 -63.45 132.52 51.65 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 65.77 13.14 8.81 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -111.55 144.58 40.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.303 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -72.08 -30.58 65.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.994 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.34 152.4 35.76 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.315 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.781 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -156.78 131.61 8.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.03 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -116.85 134.07 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.787 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.618 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 61.0 t -143.68 150.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.2 t -82.23 117.46 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.436 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.84 39.95 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.769 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.95 -120.45 0.68 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.87 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 28.04 -157.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.489 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -69.02 -1.04 6.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.99 -16.3 47.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.6 m-85 -139.57 130.08 14.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.553 ' HG2' HD21 ' A' ' 85' ' ' LEU . 39.7 Cg_exo -52.93 -149.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.255 1.97 . . . . 0.0 111.186 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.524 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 28.3 t0 -145.34 82.64 9.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 70.1 Cg_endo -73.01 -6.05 18.3 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.728 2.286 . . . . 0.0 113.65 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.89 68.54 0.98 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.422 0.629 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -52.42 149.02 24.47 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.249 1.966 . . . . 0.0 111.197 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.16 -0.49 83.65 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.5 m -118.54 148.68 42.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.619 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 41.3 t80 -86.04 111.6 20.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.524 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 12.1 mttt -91.52 -162.61 0.94 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.149 1.452 . . . . 0.0 113.964 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.484 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.1 p90 -173.84 176.11 2.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 112.152 -2.295 . . . . 0.0 110.143 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 40.4 tp -130.82 120.74 24.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.8 tt0 -118.14 129.73 55.7 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.836 HG21 ' SD ' ' A' ' 92' ' ' MET . 93.5 t -137.21 127.24 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -107.48 131.84 53.86 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.506 ' CD1' HG23 ' A' ' 56' ' ' ILE . 22.7 p90 -155.78 171.91 19.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.647 0.736 . . . . 0.0 112.622 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 72.7 m-20 -130.37 158.87 38.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.027 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.0 m -112.13 109.1 18.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -104.95 156.24 36.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.967 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -57.4 144.7 90.91 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.981 1.787 . . . . 0.0 110.732 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -79.29 5.11 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.715 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.87 -73.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -85.29 134.45 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.708 -179.383 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 30' ' ' LEU . 8.2 mp -66.91 144.1 98.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.78 140.29 92.6 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.791 2.327 . . . . 0.0 112.096 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -87.06 5.98 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.64 16.48 73.13 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -162.58 92.1 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.33 . . . . 0.0 110.417 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 125' ' ' GLN . 48.5 ttm 58.38 154.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.468 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -90.44 152.05 21.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.678 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 47.9 ttp180 -141.79 137.72 31.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.1 mp0 -133.47 137.43 45.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.828 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.4 tt -139.02 139.49 37.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.939 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.745 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.37 141.85 35.59 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.848 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -63.95 134.91 55.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.278 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -46.21 131.47 10.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.66 67.7 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.375 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 145.47 31.76 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.655 1.228 . . . . 0.0 111.661 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.0 149.95 89.41 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.083 2.522 . . . . 0.0 112.519 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 tt -122.07 145.97 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 83.7 tt0 -125.79 127.53 46.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.09 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 46.1 mt -116.21 145.76 42.86 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.852 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.678 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 87.6 mtt-85 -151.2 135.96 17.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.303 0.573 . . . . 0.0 112.033 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.477 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.4 m -100.49 137.77 20.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.837 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.7 157.8 53.9 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.331 2.02 . . . . 0.0 111.623 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.14 -126.1 29.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.447 -0.406 . . . . 0.0 112.522 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -116.52 24.24 11.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.093 0.473 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.31 169.4 18.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.61 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.98 144.98 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 111.018 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -67.41 136.99 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.988 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -132.35 100.02 4.87 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' HE1' ' A' ' 89' ' ' PHE . 38.2 t -63.87 123.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.705 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.5 mm-40 -101.6 -51.57 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.941 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 66.2 m-20 -149.11 143.18 25.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.624 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -162.75 155.24 18.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.079 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.4 t30 -152.34 146.76 25.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.653 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -114.02 115.1 27.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.1 -136.54 4.29 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.203 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.5 ttm180 -162.17 122.4 2.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.277 0.561 . . . . 0.0 111.905 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 43.5 p -123.72 12.52 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.593 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 29.7 t0 -146.82 -168.72 3.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 44.6 p30 -146.88 4.57 0.85 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.705 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 59.0 mttt -103.45 0.43 31.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.63 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.86 138.46 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.913 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.3 m 53.49 72.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.324 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -57.25 120.32 7.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.512 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.46 -161.71 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -57.55 133.74 82.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.235 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -55.61 -34.48 90.33 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.613 1.542 . . . . 0.0 111.715 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -61.44 -39.19 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.392 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' HG23 ' A' ' 118' ' ' THR . 70.7 mt-30 -83.94 -10.28 58.07 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.02 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.519 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 86.3 mtp -103.2 -1.93 28.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.019 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 54.9 mm-40 -63.84 -45.76 88.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.44 114.64 19.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.77 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.535 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 19.2 m -104.64 34.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.104 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.535 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 28.8 mm100 -142.72 84.17 1.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.251 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.4 t -142.01 126.05 17.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' HD21 ' A' ' 62' ' ' ASN . 41.3 m-85 -136.13 154.0 51.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -146.71 89.26 5.79 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.174 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -50.67 -49.88 15.39 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.88 2.387 . . . . 0.0 113.343 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 54.3 m-20 -58.23 -21.94 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.34 -31.33 43.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.483 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.9 t80 -66.27 -45.9 78.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.735 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.6 ptpt -66.33 -39.86 89.5 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.701 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.758 HG22 ' HE ' ' A' ' 95' ' ' ARG . 56.9 mt -59.75 -49.79 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.679 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 122' ' ' LEU . 58.2 mtp -70.01 -37.95 75.81 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.042 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 48.1 m -55.97 -42.91 77.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -66.24 -38.54 88.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.051 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.758 ' HE ' HG22 ' A' ' 91' ' ' ILE . 14.3 mtm105 -74.86 -34.14 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 71.0 m -110.15 -18.91 13.21 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' CG ' ' O ' ' A' ' 93' ' ' SER . 79.7 m-20 -54.65 135.38 46.77 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.059 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 65.79 14.58 9.63 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.24 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -113.6 145.64 40.95 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.646 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.0 m -69.67 -33.39 72.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.297 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -152.91 155.93 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.674 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 24.8 p -155.1 136.84 14.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.244 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.4 127.63 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.612 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.683 HG21 HH11 ' A' ' 95' ' ' ARG . 42.5 t -142.59 145.55 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 111.374 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 107' ' ' GLY . 66.4 t -75.8 114.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.977 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.98 40.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.48 -121.93 0.73 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 27.2 -155.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.322 0.582 . . . . 0.0 111.868 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -68.52 1.15 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.295 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.01 -15.63 46.95 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.518 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.9 m-85 -146.13 125.15 6.57 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.542 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.9 Cg_exo -51.16 -142.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.528 2.152 . . . . 0.0 112.607 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 116' ' ' PRO . 9.4 t0 -145.31 87.72 6.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.199 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.14 -8.58 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.55 2.167 . . . . 0.0 113.131 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -165.09 69.69 1.36 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.53 0.681 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.2 Cg_exo -53.73 147.25 41.22 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.381 2.054 . . . . 0.0 111.048 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.51 -5.38 81.44 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.881 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' GLN . 88.8 m -118.3 148.05 42.85 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.8 t80 -84.42 116.37 23.03 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.454 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 7.9 mtmm -94.24 -157.83 0.58 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.576 1.179 . . . . 0.0 113.994 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.6 p90 -174.01 175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.881 -1.963 . . . . 0.0 110.239 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 92' ' ' MET . 52.2 tp -130.78 123.67 29.67 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.079 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.469 ' HG2' HE21 ' A' ' 125' ' ' GLN . 66.1 tt0 -121.28 126.79 50.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 61' ' ' ALA . 77.9 t -132.73 127.15 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.452 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.469 HE21 ' HG2' ' A' ' 123' ' ' GLU . 9.4 mp0 -108.61 129.02 55.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 19.7 p90 -156.02 171.69 19.67 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.698 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 35' ' ' MET . 49.9 m-20 -131.64 162.24 30.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.427 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.0 m -108.3 131.23 54.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.623 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' SD ' ' A' ' 57' ' ' MET . 28.5 m -130.99 157.57 77.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -57.16 145.33 87.11 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.014 1.81 . . . . 0.0 111.576 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -77.4 29.08 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.404 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -89.8 135.37 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.626 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.564 ' O ' ' O ' ' A' ' 134' ' ' GLU . 12.7 p -89.97 140.57 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.766 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' O ' ' O ' ' A' ' 133' ' ' VAL . 41.4 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.81 140.13 60.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.24 137.71 52.91 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.291 1.994 . . . . 0.0 111.842 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 34' ' ' LEU . 87.3 m-85 -81.45 -13.09 58.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.58 -38.06 0.17 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 35' ' ' MET . 0.3 OUTLIER -161.23 123.31 3.02 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.747 ' N ' HD13 ' A' ' 34' ' ' LEU . 46.0 mtt 60.88 148.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.296 0.57 . . . . 0.0 112.042 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt85 -87.69 145.48 26.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -146.22 135.5 22.84 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.559 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 58.8 mm-40 -134.0 146.68 50.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.221 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.96 139.68 38.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.742 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.36 142.27 39.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.452 0.644 . . . . 0.0 111.009 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 23.9 m -64.58 137.72 58.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.757 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 72.5 tt0 -43.44 126.32 4.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.179 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.47 -8.21 74.79 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.241 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.34 148.62 38.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.945 1.373 . . . . 0.0 110.005 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.78 149.95 67.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.899 2.399 . . . . 0.0 113.287 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -118.99 146.62 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.673 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 49' ' ' ARG . 82.0 tt0 -126.05 129.84 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.109 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 48.7 mt -116.01 139.81 49.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.986 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 47' ' ' GLU . 3.9 mtp180 -150.28 131.49 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.287 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 56' ' ' ILE . 11.6 m -97.98 151.92 37.8 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.058 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HG3' HH21 ' A' ' 36' ' ' ARG . 93.4 Cg_endo -77.11 160.03 33.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.908 2.406 . . . . 0.0 112.318 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.64 -116.69 6.21 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -131.54 27.47 4.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.05 170.71 15.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.765 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.2 142.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.41 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.5 mt -67.15 137.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.785 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.3 ptp -134.9 102.52 5.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.532 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.8 t -64.09 124.54 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.123 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -100.41 -52.1 3.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.245 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -152.27 150.65 30.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -168.5 155.31 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.855 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.461 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.0 t30 -145.58 147.77 32.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CE2' ' HB3' ' A' ' 111' ' ' PHE . 40.2 t80 -119.59 117.94 29.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.86 -133.14 3.2 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.663 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -157.34 120.46 4.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 0.0 111.191 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.585 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 20.7 p -120.27 8.66 10.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.854 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.5 t0 -145.21 -166.13 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.185 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 38.0 p-10 -150.24 0.31 0.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 51.7 mtpt -102.78 2.91 36.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.252 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.89 135.68 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m 52.71 74.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.1 p30 -52.37 102.93 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.662 0.744 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 -170.21 1.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.838 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -59.56 141.99 87.82 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.21 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.5 Cg_endo -53.63 -40.08 80.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.932 2.421 . . . . 0.0 112.993 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.54 -33.62 76.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.963 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.511 ' O ' HG23 ' A' ' 118' ' ' THR . 78.2 mt-30 -90.2 -8.26 51.56 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 74.5 mmm -107.36 -4.8 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 2.6 mt-10 -67.06 -42.34 84.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 6.1 t-20 -77.98 121.22 23.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.26 31.63 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -138.74 86.7 2.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.008 0.432 . . . . 0.0 110.148 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.472 ' SG ' ' HA3' ' A' ' 64' ' ' GLY . 4.4 t -147.6 120.96 9.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' HG22 ' A' ' 66' ' ' THR . 73.8 m-85 -135.74 157.13 47.63 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.192 0.52 . . . . 0.0 112.372 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -147.53 89.44 5.44 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.434 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.16 -51.33 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.759 2.306 . . . . 0.0 113.123 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 53.8 m-20 -54.93 -22.79 16.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.69 68.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE1' HG12 ' A' ' 58' ' ' VAL . 31.0 t80 -64.14 -44.14 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 111.515 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.04 -38.3 90.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 65.8 mt -61.03 -47.79 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.03 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.7 -36.45 80.67 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.5 m -59.39 -46.55 88.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.48 -35.98 81.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 111.145 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 51.1 mtp85 -75.34 -35.22 61.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.3 m -112.92 -18.1 12.32 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CB ' ' H82' ' A' ' 135' ' ' NAG . 46.3 m-20 -52.82 136.39 34.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 66.34 13.19 9.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.207 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -112.89 145.38 40.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.0 m -74.62 -32.32 62.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.013 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -149.2 150.24 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.4 p -153.5 143.64 22.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.287 0.565 . . . . 0.0 111.448 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.12 123.59 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.443 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.549 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.7 t -135.56 143.88 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.432 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.87 119.47 32.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.329 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.17 42.45 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.75 -125.27 0.95 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 29.54 -157.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 110.855 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.63 2.75 3.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.967 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.05 -12.71 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.727 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.1 m-85 -143.53 126.13 8.72 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -51.86 -144.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.137 1.891 . . . . 0.0 111.178 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.51 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 8.7 t0 -146.02 96.34 4.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 92.5 Cg_endo -84.89 -8.92 9.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.029 2.486 . . . . 0.0 112.768 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -162.02 64.45 1.7 Allowed Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.275 0.56 . . . . 0.0 111.475 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.51 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 23.4 Cg_exo -53.94 145.29 52.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.925 1.75 . . . . 0.0 111.022 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.8 -11.66 71.6 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.865 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.2 m -117.93 150.41 39.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.1 0.45 . . . . 0.0 110.099 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 45.3 t80 -81.26 116.34 21.08 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' C ' ' HB2' ' A' ' 42' ' ' GLU . 10.7 mttt -93.19 -162.52 0.95 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.508 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -173.21 174.14 3.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.369 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.3 tp -131.86 123.65 27.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.233 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -118.76 126.69 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.6 t -130.49 125.2 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.43 128.22 53.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 56' ' ' ILE . 38.7 p90 -153.68 168.76 25.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.819 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.6 OUTLIER -127.57 163.1 24.92 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.556 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.489 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 72.9 m -113.21 114.55 26.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.31 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.8 m -116.66 151.69 47.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.56 150.21 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.056 1.838 . . . . 0.0 111.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -84.15 -4.9 59.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.644 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.63 165.75 13.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.217 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.46 135.11 26.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.421 -178.417 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.55 ' H82' ' CB ' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.01 75.84 40.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.48 155.2 17.29 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.386 2.724 . . . . 0.0 112.287 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.692 ' O ' ' N ' ' A' ' 34' ' ' LEU . 99.3 m-85 -79.41 -0.31 32.37 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.961 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.69 -67.27 0.0 OUTLIER Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.692 ' N ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -158.21 47.85 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.404 ' HG2' ' OD1' ' A' ' 127' ' ' ASP . 3.2 mtp 59.62 160.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.729 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.799 HH12 ' CD ' ' A' ' 51' ' ' PRO . 52.1 mtt180 -93.08 147.27 22.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -153.54 134.88 14.18 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.201 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.43 148.6 45.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.583 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -139.88 140.94 36.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.833 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.57 142.5 33.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.457 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.34 137.26 54.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.721 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 84.2 tt0 -48.88 136.22 14.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.9 38.23 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.981 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.4 m-30 -108.14 151.5 41.4 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 118.129 0.965 . . . . 0.0 109.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.47 155.0 70.59 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.515 2.143 . . . . 0.0 113.453 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.2 tt -118.48 146.35 23.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.068 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' CG ' HH11 ' A' ' 49' ' ' ARG . 0.7 OUTLIER -122.09 130.72 53.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.569 0.7 . . . . 0.0 112.511 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.026 HD12 ' SG ' ' A' ' 102' ' ' CYS . 76.1 mt -121.99 130.88 53.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.661 177.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 47' ' ' GLU . 3.6 mtt85 -147.23 130.54 16.58 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.218 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.472 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.4 m -97.56 143.57 26.43 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.799 ' CD ' HH12 ' A' ' 36' ' ' ARG . 18.8 Cg_endo -70.6 163.61 38.34 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.677 2.251 . . . . 0.0 112.717 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.63 -126.65 21.26 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -115.73 24.74 11.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.497 -0.352 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.94 169.15 18.77 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.911 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.91 145.91 33.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.398 0.618 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.8 mt -68.91 138.06 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.649 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -131.14 100.09 5.09 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.608 HG12 ' CE1' ' A' ' 89' ' ' PHE . 75.0 t -65.09 122.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.032 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 61.4 mt-10 -100.05 -47.06 5.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.551 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 59.4 m-20 -151.24 150.8 31.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.555 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.804 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.83 154.52 13.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.785 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.455 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.6 t30 -152.19 149.9 29.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 112.115 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.522 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 87.2 t80 -121.93 119.08 30.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.509 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.64 -136.79 4.56 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.02 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.611 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.8 ttm180 -155.29 117.55 4.18 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.135 0.493 . . . . 0.0 110.797 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -123.66 10.66 9.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 30.8 t0 -146.65 -169.01 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 29.6 p30 -145.33 -0.17 0.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.784 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 31.9 mtpt -102.7 6.23 39.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.538 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.403 HG22 ' SG ' ' A' ' 71' ' ' CYS . 18.9 mm -110.52 135.02 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' ALA . 83.5 m 62.13 51.58 3.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.951 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.56 95.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.738 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -116.68 -162.46 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -60.1 132.51 89.93 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.691 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.8 Cg_endo -54.64 -34.77 84.69 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.94 2.426 . . . . 0.0 114.278 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -62.32 -33.43 74.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.448 0.642 . . . . 0.0 109.79 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.632 ' O ' HG23 ' A' ' 118' ' ' THR . 81.9 mt-30 -87.41 -0.05 56.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 4.8 mtm -119.8 0.3 10.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.9 mt-10 -62.69 -50.05 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.218 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -80.13 111.53 16.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.0 m -102.59 35.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.236 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -141.49 87.81 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.2 t -145.16 122.24 11.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.455 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.7 m-85 -132.61 153.87 50.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.232 0.539 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -148.59 88.33 5.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.303 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.69 -47.77 21.75 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.864 2.376 . . . . 0.0 113.868 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -54.61 -24.98 23.7 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.22 -30.96 40.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.673 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.608 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -65.77 -45.51 82.26 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.1 pttt -65.2 -43.03 92.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.681 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.0 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 59.6 mt -58.83 -45.68 91.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 93.8 mmm -69.78 -35.63 75.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.198 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.499 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 50.8 m -61.0 -47.32 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.25 -37.85 88.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.165 0.507 . . . . 0.0 111.049 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 1.0 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 47.8 mtm180 -77.55 -33.91 53.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.1 m -112.52 -19.75 12.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -176.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 90.3 m-20 -61.15 135.61 57.81 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.353 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 67.34 13.68 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.303 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -113.04 145.34 41.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.328 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -70.97 -31.68 68.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.76 155.01 38.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.938 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 1.026 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.5 p -156.39 132.86 10.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.25 129.28 71.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 43.8 t -136.72 139.05 45.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.762 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' GLY . 58.2 t -72.94 116.18 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.81 40.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.701 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -122.66 0.85 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.6 t 29.58 -157.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.651 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -67.38 0.37 2.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.337 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.82 -13.7 50.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.571 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 112' ' ' PRO . 47.8 m-85 -144.43 126.69 8.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.199 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.593 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -48.88 -149.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.756 2.304 . . . . 0.0 112.202 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 21.8 t0 -145.18 80.11 11.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.483 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 69.6 Cg_endo -75.33 -3.56 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.25 2.633 . . . . 0.0 112.842 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.58 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.2 p -164.05 63.43 1.14 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.752 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.08 144.09 59.54 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.096 1.864 . . . . 0.0 110.299 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.72 -4.34 81.89 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 77' ' ' GLN . 80.4 m -125.73 147.86 49.24 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.666 0.733 . . . . 0.0 109.869 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.611 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 4.6 t80 -80.54 113.7 18.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 28.0 mttp -91.85 -160.3 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.575 1.178 . . . . 0.0 113.291 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.0 p90 -175.41 177.11 1.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.13 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.7 tp -130.39 121.45 25.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -120.9 127.44 51.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.799 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.804 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -135.38 129.03 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.479 ' NE2' ' HB2' ' A' ' 60' ' ' ASN . 0.7 OUTLIER -107.97 130.26 55.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.633 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.7 p90 -154.2 173.72 15.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.364 0.602 . . . . 0.0 111.764 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 80.0 m-20 -133.23 161.13 35.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.835 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 95.4 m -111.71 111.05 21.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.97 158.53 37.55 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.355 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.99 142.04 96.48 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.862 1.708 . . . . 0.0 111.698 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -75.68 137.12 40.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.781 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -134.65 134.22 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.208 0.528 . . . . 0.0 111.154 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 133' ' ' VAL . 12.2 p -92.27 129.55 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.856 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 C--O 1.223 -0.32 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.825 -179.191 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 tp -130.52 80.09 70.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.31 143.47 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.119 1.879 . . . . 0.0 112.182 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.31 -8.99 58.55 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.28 37.35 32.14 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.3 OUTLIER -164.67 49.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 0.0 110.766 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.6 mtp 55.25 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 111.075 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 36' ' ' ARG . 79.9 mtt-85 -93.21 148.21 22.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 49.1 ttp180 -148.99 137.76 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.7 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 31.5 mp0 -130.8 145.62 52.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.536 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.53 141.74 37.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.821 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.18 140.17 35.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.449 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.2 m -67.76 137.2 55.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.505 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -46.7 134.53 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.02 52.39 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.3 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.7 m-85 -107.28 147.01 34.41 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.279 1.039 . . . . 0.0 110.139 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -67.14 153.27 78.03 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.546 2.164 . . . . 0.0 112.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.6 tt -118.14 141.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -120.22 128.22 53.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.464 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 73.2 mt -116.78 142.62 46.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.391 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -152.94 133.41 13.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.84 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.2 m -102.01 147.52 34.04 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.06 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.2 Cg_endo -70.35 158.21 56.88 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 123.686 2.924 . . . . 0.0 113.317 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.92 -132.89 32.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.9 p -105.26 27.89 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.353 0.597 . . . . 0.0 109.742 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.44 162.37 25.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.097 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -126.49 147.99 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.58 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.799 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -71.18 134.8 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.635 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.6 ptm -130.32 100.72 5.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.49 0.662 . . . . 0.0 109.264 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 93' ' ' SER . 6.9 t -65.16 122.67 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.602 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -102.51 -48.05 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -149.4 148.66 29.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.474 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.834 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.18 154.4 10.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.8 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' O ' HD12 ' A' ' 122' ' ' LEU . 7.3 t-20 -152.3 149.69 28.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.692 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.88 121.16 37.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.81 -135.5 4.25 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.76 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -158.12 119.63 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.271 0.558 . . . . 0.0 111.1 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 84' ' ' TYR . 38.6 p -122.6 9.77 9.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.557 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 28.5 t0 -145.36 -169.36 3.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 59.8 p30 -147.21 -1.01 0.66 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.657 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -100.09 3.41 43.97 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.708 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 44.7 mm -106.27 133.45 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 72.8 m 63.09 57.52 1.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.1 p30 -42.33 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.303 0.573 . . . . 0.0 111.843 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.95 -165.1 1.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.681 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -59.06 137.29 87.95 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.595 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.38 -35.55 75.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.383 2.056 . . . . 0.0 112.261 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -62.45 -40.53 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.523 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 53.3 mt-30 -88.3 -5.42 58.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.983 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.472 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.8 mmm -107.22 -4.6 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.507 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.3 mt-10 -65.56 -48.65 71.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -77.79 122.32 25.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 112.338 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 32.25 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -140.44 86.28 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.136 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.544 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 28.8 t -144.76 123.06 12.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.413 ' CE1' HG21 ' A' ' 66' ' ' THR . 88.8 m-85 -134.83 153.76 51.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.241 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.435 ' H ' HD22 ' A' ' 62' ' ' ASN . 29.1 tp -147.0 91.81 5.09 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.78 -45.26 42.36 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.773 2.315 . . . . 0.0 113.718 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.82 -15.68 32.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.51 -28.93 57.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.6 -44.16 91.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.11 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.44 -42.07 92.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.734 HG23 ' NH1' ' A' ' 95' ' ' ARG . 68.6 mt -59.68 -47.57 90.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.216 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.9 mmm -70.07 -35.51 74.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG21 ' A' ' 58' ' ' VAL . 74.1 m -63.44 -45.28 91.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.755 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.99 -36.91 85.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 0.0 111.407 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.734 ' NH1' HG23 ' A' ' 91' ' ' ILE . 51.1 mtt85 -79.9 -32.68 40.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.1 m -113.45 -13.29 12.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 87.6 m-20 -61.56 135.28 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.554 -0.859 . . . . 0.0 112.054 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 65.31 11.02 6.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -110.62 144.43 39.52 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.407 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 m -70.56 -31.79 68.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.904 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.81 154.15 41.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.738 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.88 137.08 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.511 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.94 128.92 75.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.516 HG22 ' HD3' ' A' ' 95' ' ' ARG . 19.2 t -136.87 144.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.623 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.6 t -76.72 115.57 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.77 33.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.952 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.6 -119.76 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.99 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.4 t 32.1 -159.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.75 0.309 . . . . 0.0 111.042 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -67.5 2.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.577 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.72 -11.81 56.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.187 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.587 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -146.6 129.97 8.22 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.2 Cg_exo -50.43 -146.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.461 2.107 . . . . 0.0 112.207 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -144.34 83.73 9.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.27 -7.02 17.76 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.024 2.483 . . . . 0.0 114.234 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.557 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.45 68.77 1.07 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 121.605 0.717 . . . . 0.0 111.267 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -51.74 144.28 35.0 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 122.667 2.245 . . . . 0.0 111.2 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.86 2.23 90.48 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.942 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.6 m -120.43 146.06 46.59 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.055 0.928 . . . . 0.0 109.542 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.76 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 7.6 t80 -80.88 110.5 16.46 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.557 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.9 mttp -90.49 -164.84 1.23 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.517 1.151 . . . . 0.0 113.858 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB2' HD21 ' A' ' 39' ' ' LEU . 4.3 p90 -170.56 169.57 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.033 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 62' ' ' ASN . 32.8 tp -127.43 124.57 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HG2' HE21 ' A' ' 125' ' ' GLN . 73.0 tt0 -120.42 125.62 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.834 HG22 ' HB1' ' A' ' 61' ' ' ALA . 71.9 t -132.2 125.66 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.587 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.46 HE21 ' HG2' ' A' ' 123' ' ' GLU . 4.2 mp0 -108.57 126.1 52.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.752 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.799 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.5 p90 -153.31 173.03 16.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.9 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.422 ' OD1' ' HG2' ' A' ' 35' ' ' MET . 64.9 m-20 -125.27 159.39 31.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.198 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 95.3 m -108.95 121.34 44.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.009 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 29.9 m -132.03 158.63 75.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.51 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.89 144.04 79.37 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.053 1.835 . . . . 0.0 112.424 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.433 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 14.8 t80 -76.1 -10.11 59.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.665 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -141.02 128.87 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.575 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 p -92.87 138.99 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.131 -179.308 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.832 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -109.22 159.15 32.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.69 136.51 71.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.109 1.873 . . . . 0.0 111.137 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 34' ' ' LEU . 1.6 m-85 -78.95 -2.8 41.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.43 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 54.63 -69.35 0.0 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tp -164.07 109.99 1.05 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.849 -0.206 . . . . 0.0 110.894 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.4 ttm 58.13 164.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.001 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 -99.04 140.37 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -152.0 138.25 18.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.124 0.488 . . . . 0.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.618 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.3 mt-10 -130.18 149.76 51.74 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.836 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -137.42 140.45 41.32 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.717 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.99 138.0 38.47 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.338 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 45.8 m -66.68 137.02 56.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -45.2 130.73 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.992 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.2 -14.44 62.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.004 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 12.5 m-85 -109.34 151.59 42.18 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.884 1.342 . . . . 0.0 110.083 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.36 155.48 60.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.664 2.243 . . . . 0.0 113.039 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 tt -123.21 147.97 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.2 tt0 -128.98 124.23 34.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.508 HD12 ' SG ' ' A' ' 102' ' ' CYS . 57.1 mt -113.27 141.89 46.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 17.8 mtp-105 -147.86 138.92 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.919 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.511 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.3 m -106.79 142.76 25.66 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.351 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 31.5 Cg_endo -68.83 160.8 48.21 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.532 2.155 . . . . 0.0 112.907 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.94 -132.34 10.19 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.364 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -101.74 22.23 13.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.201 -0.5 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -77.39 165.51 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.258 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.947 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.5 mt -68.66 139.7 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.669 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.458 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -132.45 100.57 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.5 t -63.44 125.33 19.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.755 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 93.3 mt-10 -101.67 -48.79 4.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.2 m-20 -149.98 150.69 32.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.203 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.478 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -170.66 157.38 5.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.878 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 84' ' ' TYR . 13.7 t30 -150.18 146.91 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -117.61 120.63 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 155.88 -131.23 2.98 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.789 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 7.3 ttm-85 -157.1 115.01 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.483 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.429 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.0 p -118.25 11.14 13.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' C ' HG12 ' A' ' 81' ' ' VAL . 46.0 t0 -147.89 -171.67 3.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.785 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.547 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 26.1 p-10 -145.62 -2.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 34.9 mttp -100.7 6.32 43.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.0 mm -111.9 135.83 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.15 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.3 m 53.63 75.0 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.281 0.562 . . . . 0.0 109.894 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.77 120.12 7.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.55 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.82 -164.15 1.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.607 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -59.96 134.55 90.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 119.159 -1.017 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -53.6 -33.28 68.09 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.545 2.163 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.28 -37.68 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.691 0.281 . . . . 0.0 111.146 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 66.7 mt-30 -86.48 2.51 47.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.203 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 38.8 mmm -121.85 -0.18 9.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 63.0 mt-10 -64.96 -48.52 73.76 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.29 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -78.38 116.85 19.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' C ' ' A' ' 67' ' ' ASP . 26.5 m -105.34 36.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 71.9 mm-40 -141.14 83.42 1.88 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.547 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 31.7 t -147.13 116.86 7.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 8.7 m-85 -130.18 157.49 42.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.606 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.35 90.75 5.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -48.73 -46.8 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.121 2.547 . . . . 0.0 113.805 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -57.84 -18.33 21.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.53 65.38 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.627 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.47 -46.39 79.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.765 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -64.65 -41.05 96.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.669 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.548 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 97.8 mt -60.38 -49.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.741 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.91 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.7 mtp -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.401 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.1 m -55.74 -44.01 77.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.96 -37.94 82.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.589 ' NE ' HG22 ' A' ' 104' ' ' VAL . 20.2 mtp180 -75.77 -34.41 60.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -110.38 -19.78 12.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 76.4 m-20 -58.34 136.95 57.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.613 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 65.2 13.55 8.82 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.646 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -114.29 146.22 40.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.202 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.0 m -69.45 -31.03 69.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 156.15 41.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.605 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -152.4 130.18 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.09 131.59 66.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.629 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' NE ' ' A' ' 95' ' ' ARG . 78.0 t -145.82 148.8 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.359 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.44 118.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.01 38.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.083 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.662 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.3 -118.65 0.58 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.156 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.662 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.1 t 24.63 -156.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.231 0.539 . . . . 0.0 111.823 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -69.51 2.7 2.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.82 -14.38 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.548 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -144.8 130.17 9.42 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.41 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.6 Cg_exo -51.72 -145.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.981 1.787 . . . . 0.0 112.063 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -144.96 86.63 7.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.548 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.491 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.5 Cg_endo -75.63 -5.03 16.05 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.376 2.051 . . . . 0.0 112.666 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -169.78 73.7 0.67 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.246 0.546 . . . . 0.0 111.636 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -53.23 148.09 33.3 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.674 2.25 . . . . 0.0 111.6 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.58 75.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.09 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.9 m -118.97 146.79 44.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 14.5 t80 -82.82 109.24 16.78 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 28.0 mtmm -87.88 -165.2 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.507 1.146 . . . . 0.0 113.799 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 64' ' ' GLY . 5.3 p90 -170.53 171.24 6.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.048 -1.887 . . . . 0.0 111.034 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.91 HD21 ' SD ' ' A' ' 92' ' ' MET . 27.8 tp -129.67 120.71 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.116 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.46 ' CD ' ' OE1' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -114.16 125.59 54.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.787 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.755 HG21 ' SD ' ' A' ' 92' ' ' MET . 38.8 t -134.37 122.51 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.839 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.46 ' OE1' ' CD ' ' A' ' 123' ' ' GLU . 1.9 mt-30 -105.97 127.28 53.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.358 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.947 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.5 p90 -149.83 168.26 24.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 111.846 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -124.96 160.08 29.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.1 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -110.77 122.11 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.0 156.35 62.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.149 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -62.63 144.84 94.88 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.194 1.929 . . . . 0.0 111.845 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -79.03 -7.56 58.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.435 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -93.42 157.06 16.41 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.276 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.621 ' O ' ' O ' ' A' ' 134' ' ' GLU . 15.5 m -94.58 135.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.356 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.621 ' O ' ' O ' ' A' ' 133' ' ' VAL . 96.5 mt-10 . . . . . 0 C--O 1.218 -0.592 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.8 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.622 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.0 tp -123.78 78.94 56.77 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.622 ' O ' ' O ' ' A' ' 30' ' ' LEU . 72.7 Cg_exo -46.46 -131.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.975 2.45 . . . . 0.0 112.537 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 34' ' ' LEU . 55.4 p90 -77.66 -36.1 51.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.508 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.572 ' C ' HD12 ' A' ' 34' ' ' LEU . . . 64.67 -47.95 0.11 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 33' ' ' GLY . 2.2 mp -160.1 117.79 2.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.034 0.445 . . . . 0.0 110.542 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 125' ' ' GLN . 43.0 ttm 70.83 144.12 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.736 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -88.13 158.02 18.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 41.5 ttm180 -142.4 138.89 31.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.392 0.615 . . . . 0.0 110.742 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -135.03 140.61 45.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.61 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.6 133.6 30.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.49 141.1 46.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.203 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.4 m -67.67 136.65 54.69 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.573 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 88.6 tt0 -49.31 134.14 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.629 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.73 -17.94 56.74 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.21 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 72.1 m-85 -113.12 152.66 45.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 118.302 1.051 . . . . 0.0 109.943 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.56 153.76 76.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.272 1.981 . . . . 0.0 113.14 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.61 139.51 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 81.2 tt0 -128.49 129.05 45.51 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.293 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.87 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.5 mt -111.85 144.58 40.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.44 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.641 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 91.6 mtt180 -149.26 130.33 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.675 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -96.93 145.13 29.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.813 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.84 161.91 40.49 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.329 2.019 . . . . 0.0 111.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.43 -126.73 31.99 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.69 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -117.92 23.87 11.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -75.16 168.46 19.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG11 ' HD1' ' A' ' 131' ' ' TYR . 23.0 m -125.84 145.6 33.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.89 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.1 mt -69.0 137.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.782 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.639 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.1 ptm -131.6 99.35 4.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.516 HG12 ' HE1' ' A' ' 89' ' ' PHE . 55.8 t -63.95 125.92 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.955 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.73 -50.78 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.736 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 42.8 m-20 -149.83 149.12 30.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.487 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.4 154.06 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.696 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.5 t30 -151.18 144.1 24.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.508 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -115.41 120.32 39.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.65 -135.88 4.34 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.859 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.573 HH12 ' HB3' ' A' ' 119' ' ' TYR . 11.8 ttm180 -156.91 117.12 3.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 111.246 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.0 p -121.2 11.53 10.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 81' ' ' VAL . 35.5 t0 -144.96 -167.02 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.422 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 13.1 p30 -149.83 -1.71 0.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -100.86 6.35 43.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.287 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.47 131.92 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.1 m 50.06 81.0 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.606 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 37.7 p30 -53.79 98.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.502 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.65 -172.94 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.097 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -58.15 134.71 84.36 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.191 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.1 Cg_endo -50.18 -35.82 44.06 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.629 1.553 . . . . 0.0 112.096 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -61.95 -38.34 88.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.783 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.698 ' O ' HG23 ' A' ' 118' ' ' THR . 80.6 mt-30 -84.3 -8.69 58.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.26 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 74.0 mtp -104.43 -0.86 27.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.267 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.4 mt-10 -61.82 -49.91 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -78.22 117.89 19.92 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 67' ' ' ASP . 20.8 m -109.74 30.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.969 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.6 mm-40 -140.99 86.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 3.7 t -145.37 122.09 11.18 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.0 m-85 -131.96 157.42 44.11 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 112' ' ' PRO . 42.9 tp -148.18 90.12 5.07 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.821 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -46.8 -47.79 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.673 2.248 . . . . 0.0 112.783 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 83.6 m-20 -56.38 -24.55 45.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.49 62.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.529 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' HE1' HG12 ' A' ' 58' ' ' VAL . 40.5 t80 -66.03 -44.97 83.11 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -64.66 -38.3 90.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 99.0 mt -59.33 -48.63 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.37 -36.13 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 15.6 m -58.25 -45.58 87.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.17 -38.25 85.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.67 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 80.9 mtt180 -75.76 -34.05 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.4 m -110.31 -20.51 12.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.48 ' CG ' ' O ' ' A' ' 93' ' ' SER . 72.5 m-20 -57.33 137.82 55.6 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.614 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.94 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -115.69 147.21 41.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.241 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.4 m -70.07 -35.75 74.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.966 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -150.18 157.76 43.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.521 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.87 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -153.84 141.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 111.822 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.9 126.52 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.535 HG11 HH11 ' A' ' 95' ' ' ARG . 21.9 t -139.26 141.55 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.964 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 107' ' ' GLY . 88.5 t -72.68 113.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.528 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -68.05 34.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.895 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.11 -123.21 0.81 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.9 t 32.76 -161.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.785 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.06 4.49 1.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.28 -11.93 59.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.4 m-85 -143.01 129.82 10.68 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.0 Cg_exo -51.86 -149.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.249 1.966 . . . . 0.0 111.213 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.82 88.92 6.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 68.0 Cg_endo -84.67 -4.98 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.245 2.63 . . . . 0.0 113.274 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -168.4 73.9 0.84 Allowed Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.873 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.67 154.24 70.41 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.635 2.223 . . . . 0.0 112.728 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.25 4.65 90.43 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.8 m -127.11 148.01 50.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.573 ' HB3' HH12 ' A' ' 65' ' ' ARG . 48.6 t80 -83.85 114.48 21.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.433 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 12.6 mttt -91.14 -163.83 1.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.6 p90 -171.41 172.77 5.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.513 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 62' ' ' ASN . 48.1 tp -133.72 126.82 31.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.418 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 87.3 tt0 -121.49 127.21 50.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 61' ' ' ALA . 24.5 t -131.09 125.1 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.159 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 60' ' ' ASN . 12.0 mp0 -110.3 129.14 55.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.026 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.3 p90 -153.09 166.91 30.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.377 0.608 . . . . 0.0 112.065 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 38.8 m-20 -118.22 157.69 26.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.31 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.4 m -108.82 118.47 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.37 155.81 58.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.139 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -53.81 147.49 41.0 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 111.597 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 41.2 t80 -75.58 -2.97 31.66 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.11 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -132.77 112.83 12.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.5 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 134' ' ' GLU . 94.1 t -93.77 132.15 38.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.522 ' C ' ' CD ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.779 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.051 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.7 mp -44.0 -50.06 20.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.009 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 55.8 Cg_exo -47.32 134.62 20.03 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.566 2.177 . . . . 0.0 112.305 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -84.96 0.46 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.34 -67.24 0.24 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' PHE . 14.1 tp -159.21 51.85 0.37 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.285 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.437 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 48.6 mtm 54.22 170.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.877 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.507 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 62.4 mtp85 -94.45 148.47 22.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -153.04 142.92 22.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.204 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.1 mt-10 -133.91 149.91 51.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.946 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -141.3 134.5 29.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.243 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.6 143.77 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.705 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 m -67.39 139.04 57.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.952 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -45.13 133.12 6.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.628 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.1 63.95 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.333 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -108.24 149.43 39.21 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 118.733 1.267 . . . . 0.0 110.722 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.0 149.54 77.32 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.387 2.058 . . . . 0.0 112.935 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.8 tt -121.46 143.63 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 56.8 tt0 -129.6 128.34 42.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.252 0.549 . . . . 0.0 112.148 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.4 mt -113.25 141.98 46.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.952 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.622 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 82.2 mtt180 -146.95 127.55 14.18 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 m -96.52 141.56 23.29 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 50.7 Cg_endo -71.76 163.79 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.59 2.193 . . . . 0.0 112.264 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.68 -138.65 18.62 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -102.37 23.2 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.745 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 92.9 m-20 -79.35 164.82 23.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.34 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.5 m -128.67 149.04 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.328 0.585 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 126' ' ' TYR . 99.1 mt -69.79 135.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.504 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -131.24 98.61 4.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.475 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.9 t -61.97 122.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.713 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 59' ' ' GLU . 71.4 mm-40 -100.61 -46.21 5.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.6 144.13 25.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.127 0.489 . . . . 0.0 110.572 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.35 147.49 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 84' ' ' TYR . 27.7 t30 -149.85 155.83 40.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.958 0.409 . . . . 0.0 111.545 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -121.01 120.59 35.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.8 -139.74 6.17 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.68 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 13.6 ttm180 -155.35 115.07 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.943 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -126.95 8.49 6.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.953 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -148.57 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.149 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 78' ' ' MET . 23.7 p-10 -114.37 5.13 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.441 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -102.48 3.4 37.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.918 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' LEU . 26.3 mm -112.52 134.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.536 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.85 67.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.199 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 26.4 p-10 -52.57 102.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.009 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.696 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -116.52 -165.7 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -60.04 139.25 90.96 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.898 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 Cg_endo -54.14 -40.25 82.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.261 1.974 . . . . 0.0 113.078 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -61.95 -37.29 84.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.248 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 118' ' ' THR . 71.4 mt-30 -86.4 -4.79 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.53 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 89.3 mtp -107.16 -1.11 22.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 79.7 mt-10 -64.35 -48.52 75.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -79.9 119.79 23.24 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.27 31.23 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -138.47 84.2 2.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.071 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.3 t -146.78 121.04 9.55 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' ASN . 80.1 m-85 -130.98 153.95 48.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.517 HD21 ' HG2' ' A' ' 112' ' ' PRO . 48.7 tp -147.12 91.36 5.15 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.68 -46.14 28.47 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 123.303 2.669 . . . . 0.0 113.972 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.2 m-20 -57.91 -20.22 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.67 65.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE1' HG12 ' A' ' 58' ' ' VAL . 74.0 t80 -63.54 -42.75 98.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 4.0 ptmm? -66.86 -40.57 87.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.128 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.481 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 44.8 mt -59.51 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.91 -37.8 76.08 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.5 m -59.76 -46.74 88.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.803 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -65.83 -38.9 90.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.169 0.509 . . . . 0.0 111.127 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 95' ' ' ARG . 51.9 mtt180 -75.37 -34.13 61.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.5 m -111.59 -16.05 13.35 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 25.0 m-20 -58.85 136.73 57.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.854 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 65.89 13.86 9.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.02 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -112.34 144.45 41.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.559 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.3 m -71.93 -30.91 65.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.976 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 152.65 36.58 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.02 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -155.28 137.21 14.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 47' ' ' GLU . 57.5 t -125.09 127.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.806 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.473 ' O ' HG22 ' A' ' 46' ' ' ILE . 60.9 t -138.15 149.12 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 107' ' ' GLY . 97.3 t -78.56 115.03 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.355 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.11 36.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.564 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.52 -119.95 0.65 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 107' ' ' GLY . 17.0 t 28.45 -158.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.98 0.93 5.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.242 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.48 -14.81 56.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.123 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.2 m-85 -141.75 130.82 12.32 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.228 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.9 Cg_exo -51.44 -150.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.216 1.944 . . . . 0.0 111.628 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -146.99 93.86 4.7 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 96.6 Cg_endo -84.23 -11.35 8.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.04 2.493 . . . . 0.0 114.814 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 3.9 p -166.85 66.94 0.92 Allowed Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.4 153.56 33.91 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.315 2.01 . . . . 0.0 110.743 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.36 73.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -126.12 148.33 49.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 10.6 t80 -81.04 113.36 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mtmm -91.29 -160.77 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.131 0.967 . . . . 0.0 113.166 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.498 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.9 p90 -174.35 175.33 2.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.801 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.2 tp -133.58 127.14 32.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -119.23 130.11 55.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.8 t -133.08 121.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.928 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.8 132.21 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 56' ' ' ILE . 48.6 p90 -155.02 173.18 16.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.485 0.659 . . . . 0.0 111.856 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.437 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 41.9 m-20 -125.5 156.0 39.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.453 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 85.7 m -108.66 115.76 30.69 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.163 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.9 m -120.49 155.24 56.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -54.84 145.62 60.62 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.28 1.987 . . . . 0.0 112.682 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.522 ' HD1' HG11 ' A' ' 55' ' ' VAL . 75.1 t80 -76.38 127.41 32.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.46 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -120.01 133.95 55.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.226 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 134' ' ' GLU . 7.2 p -100.87 140.53 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' A' ' 133' ' ' VAL . 72.9 mm-40 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp 52.17 77.84 0.43 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.07 154.13 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.805 2.336 . . . . 0.0 111.736 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.35 -29.8 42.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.618 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.26 8.61 12.71 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 35' ' ' MET . 14.6 tp -160.82 119.13 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.576 ' O ' ' O ' ' A' ' 34' ' ' LEU . 1.6 mtm 52.95 130.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.599 0.714 . . . . 0.0 111.1 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.485 HH21 ' HG3' ' A' ' 51' ' ' PRO . 92.9 mtt-85 -91.26 149.9 21.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.216 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -146.14 130.05 17.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.558 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.569 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.1 mm-40 -127.25 145.21 50.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.73 140.78 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.283 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.739 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.72 136.61 37.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.559 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.7 m -65.01 140.76 58.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 110.481 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.07 126.66 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.488 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.2 65.87 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.691 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.4 m-85 -107.36 154.59 40.52 Favored Pre-proline 0 C--O 1.226 -0.136 0 CA-C-N 118.801 1.301 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -71.93 152.08 57.24 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.953 1.769 . . . . 0.0 112.38 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.0 tt -120.19 147.49 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.65 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 72.1 tt0 -130.01 129.76 44.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.466 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.1 mt -115.84 136.93 52.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.65 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 90.6 mtt180 -144.48 140.1 28.7 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.877 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -104.41 143.99 27.79 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.154 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HG3' HH21 ' A' ' 36' ' ' ARG . 37.8 Cg_endo -70.76 160.44 49.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.988 2.458 . . . . 0.0 112.193 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -127.06 23.85 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.0 p -114.3 24.97 11.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.46 168.28 20.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.202 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 129' ' ' VAL . 18.8 m -127.24 144.86 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.196 179.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 82.7 mt -68.89 138.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.779 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.611 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.5 ptm -132.54 100.66 5.04 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 25.4 t -66.12 125.0 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.524 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 90.3 mt-10 -102.66 -47.82 4.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.3 m-20 -149.73 149.35 30.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.662 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.69 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.0 153.82 14.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.325 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 84' ' ' TYR . 9.3 t30 -150.27 139.45 21.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -111.65 118.01 34.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.42 -137.37 4.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 10.0 ttm-85 -154.77 120.27 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.493 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p -121.43 9.19 10.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.636 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 34.4 t0 -143.47 -164.6 1.9 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.566 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 4.1 p30 -149.18 -1.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 109.808 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -104.61 5.88 34.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.887 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.3 mm -107.82 136.85 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.106 179.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.1 m 54.22 69.71 0.69 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.1 p-10 -49.26 103.67 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.786 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.47 -165.62 1.22 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.689 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -61.97 144.76 93.62 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 111.333 -179.693 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.3 Cg_endo -61.17 -39.4 59.1 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.606 2.204 . . . . 0.0 112.838 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -62.67 -32.13 73.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.692 ' O ' HG23 ' A' ' 118' ' ' THR . 71.0 mt-30 -89.23 -11.53 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 67.1 mmm -104.13 -2.76 25.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.877 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.1 mt-10 -66.9 -45.24 78.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.65 114.52 19.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.478 0.656 . . . . 0.0 112.091 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 15.9 m -104.94 34.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.06 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.5 mm-40 -142.64 87.37 2.0 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.372 0.606 . . . . 0.0 110.894 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.8 t -145.22 118.08 8.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -130.77 154.18 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.715 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 88' ' ' ALA . 13.3 tp -143.29 85.86 9.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.45 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.64 -50.0 11.21 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.052 2.501 . . . . 0.0 114.006 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -57.61 -22.99 48.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.588 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.01 -32.63 34.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.95 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 29.2 t80 -64.87 -42.23 95.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.565 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.5 pttt -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.925 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.3 mt -60.52 -47.74 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.795 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -70.03 -37.5 75.61 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.013 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.8 m -60.35 -46.64 89.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.03 -36.0 82.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.612 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.732 ' NE ' HG22 ' A' ' 104' ' ' VAL . 22.9 mtp180 -79.34 -30.93 42.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.7 m -112.03 -19.74 12.22 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 71.6 m-20 -55.61 131.4 46.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.86 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 69.37 13.8 8.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -113.89 146.53 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.131 178.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 m -69.91 -29.04 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.901 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 158.3 41.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.907 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -156.44 139.08 15.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.9 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.56 127.32 75.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.248 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.732 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.8 t -136.66 144.02 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.0 t -77.14 114.15 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -71.24 36.99 0.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.417 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.02 -121.42 0.71 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.7 t 29.0 -158.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.124 0.487 . . . . 0.0 111.222 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' N ' ' OG ' ' A' ' 108' ' ' SER . 21.7 m-20 -68.72 2.76 2.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.36 -15.82 48.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.281 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.6 m-85 -143.42 126.26 8.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.589 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.0 Cg_exo -52.03 -143.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.945 . . . . 0.0 111.495 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 23.8 t0 -143.25 83.39 11.04 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.68 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.26 -5.19 16.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.938 2.426 . . . . 0.0 112.763 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.581 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -168.35 74.29 0.85 Allowed Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 110.974 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.98 144.2 94.82 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 121.901 1.734 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.3 -8.32 78.99 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.266 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.9 m -115.37 148.45 39.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.036 0.918 . . . . 0.0 109.759 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.509 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 28.9 t80 -81.28 113.92 19.72 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.581 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 14.8 mttp -92.98 -161.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.939 1.352 . . . . 0.0 114.161 -176.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -174.06 174.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.377 -2.192 . . . . 0.0 110.491 176.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 31.0 tp -128.32 122.11 30.8 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 61' ' ' ALA . 20.6 t -131.51 127.45 59.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.841 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.92 124.66 49.93 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 29.5 p90 -149.86 168.35 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 m-20 -124.64 161.52 26.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 68.0 m -110.1 113.0 25.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 55' ' ' VAL . 2.0 m -118.61 159.41 44.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.92 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.49 150.24 69.82 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.695 2.263 . . . . 0.0 112.573 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.86 -14.25 59.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.195 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -91.59 139.7 30.45 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.505 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 134' ' ' GLU . 7.9 p -93.78 137.3 23.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.849 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 133' ' ' VAL . 64.3 mt-10 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.534 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -50.52 -52.19 57.81 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.897 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 30' ' ' LEU . 39.6 Cg_endo -71.27 -110.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.536 2.158 . . . . 0.0 112.551 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.405 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 74.9 m-85 -77.43 -40.32 43.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.849 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.77 42.88 30.18 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 34' ' ' LEU . 7.0 tt -158.08 11.59 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.551 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.446 ' O ' ' O ' ' A' ' 34' ' ' LEU . 3.4 mtt 56.46 140.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.317 0.58 . . . . 0.0 112.104 178.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 23.5 mtp180 -93.98 148.55 22.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' OE2' ' A' ' 123' ' ' GLU . 32.2 ttp180 -150.99 139.43 20.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.274 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 52.4 mp0 -132.87 145.64 51.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.819 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -137.09 138.76 40.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.083 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.825 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.32 143.92 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.218 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 m -68.17 135.62 52.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.686 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -46.94 136.0 8.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.443 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 -17.45 58.78 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.044 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 31.7 m-85 -108.69 149.78 39.91 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 118.135 0.968 . . . . 0.0 110.314 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.59 149.68 68.28 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.08 1.853 . . . . 0.0 112.636 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.57 146.54 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.181 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 49' ' ' ARG . 80.6 tt0 -130.98 127.26 38.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.75 -179.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.568 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -111.37 140.06 46.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.427 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.575 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 6.5 mtt180 -145.17 133.04 21.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -99.85 144.11 27.75 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.041 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.6 Cg_endo -68.22 161.51 44.28 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.376 2.051 . . . . 0.0 112.57 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.32 -133.13 25.19 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.512 178.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.8 p -103.3 22.87 13.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.679 -0.761 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -78.95 167.6 20.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.23 0.538 . . . . 0.0 111.65 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.99 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.321 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.802 HG23 ' CD2' ' A' ' 126' ' ' TYR . 62.1 mt -71.06 137.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.651 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.626 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -131.81 98.4 4.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.814 0.816 . . . . 0.0 109.222 178.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.69 124.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.648 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 97.7 mt-10 -104.01 -47.2 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.541 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 33.2 m-20 -149.61 147.17 27.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.747 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.47 154.16 9.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 84' ' ' TYR . 12.7 t30 -149.3 144.5 26.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -113.87 116.49 29.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.67 -133.74 3.34 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.736 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 4.8 ttm180 -153.97 117.68 4.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -122.53 3.21 9.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.049 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -148.33 156.68 42.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -114.4 3.86 15.14 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -104.19 4.0 33.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.698 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.472 HG21 HD13 ' A' ' 39' ' ' LEU . 45.3 mm -112.16 138.41 41.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 m 56.83 69.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.679 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -57.14 118.89 5.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.378 0.608 . . . . 0.0 111.815 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.41 -162.07 1.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.623 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -63.2 134.9 96.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.037 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.0 Cg_endo -56.1 -34.52 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.195 1.93 . . . . 0.0 113.584 -177.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -61.85 -37.04 83.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.22 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 118' ' ' THR . 70.8 mt-30 -84.92 -1.23 56.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.736 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 mtm -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.308 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.0 mt-10 -63.19 -43.41 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.854 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -79.87 117.02 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.74 33.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -141.72 83.02 1.83 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.191 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 24.1 t -143.16 125.85 15.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HA ' HD21 ' A' ' 62' ' ' ASN . 65.0 m-85 -136.0 153.6 51.33 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.53 HD21 ' HG2' ' A' ' 112' ' ' PRO . 15.0 tp -147.88 92.61 4.66 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.584 177.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -49.97 -44.78 35.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.783 2.322 . . . . 0.0 113.147 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.58 -19.13 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.22 67.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 110.29 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.78 -46.57 74.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.563 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.64 -39.55 93.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.789 -178.307 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -62.15 -54.01 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.402 ' HB3' ' HE3' ' A' ' 92' ' ' MET . 97.6 mmm -66.58 -36.26 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.699 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.9 m -60.88 -45.38 94.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.004 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -65.3 -36.21 83.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.36 0.6 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -78.36 -32.64 49.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.9 m -112.28 -16.55 12.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 44.1 m-20 -61.18 133.43 55.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.378 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 66.75 10.88 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.394 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -110.6 144.93 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.321 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -68.77 -35.16 76.71 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.98 156.56 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.54 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -153.59 138.89 17.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 0.0 111.486 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 47' ' ' GLU . 30.8 t -118.92 130.94 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.549 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -143.46 148.69 18.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.103 -178.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 115.66 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.171 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.11 38.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.514 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.82 -124.11 0.88 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.8 t 30.24 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -65.91 0.84 1.62 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.224 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -84.62 -11.3 56.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.583 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.8 m-85 -145.96 128.17 7.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.1 Cg_exo -49.55 -149.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.177 1.918 . . . . 0.0 111.945 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.22 82.16 12.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.313 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 91.1 Cg_endo -76.97 -6.6 16.84 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.149 2.566 . . . . 0.0 113.459 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.5 p -165.94 74.23 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.343 0.592 . . . . 0.0 111.171 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.94 148.45 88.72 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.974 1.782 . . . . 0.0 111.476 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.11 -5.04 78.54 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.0 m -115.88 148.8 39.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.972 0.886 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 13.6 t80 -83.31 114.14 21.2 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.454 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 16.3 mttp -91.11 -161.45 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.574 1.178 . . . . 0.0 113.245 -176.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.578 ' HB2' HD21 ' A' ' 39' ' ' LEU . 3.5 p90 -171.98 172.03 4.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.062 -1.881 . . . . 0.0 110.643 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 40.3 tp -129.0 123.3 32.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 79.4 tt0 -118.6 122.79 43.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 61' ' ' ALA . 25.1 t -130.21 126.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -109.55 130.79 55.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.802 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.61 171.99 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 111.691 -179.158 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.508 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 74.3 m-20 -125.19 158.59 33.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.89 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.4 m -107.66 119.98 40.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.57 154.82 63.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.183 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.5 143.81 54.06 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.026 1.817 . . . . 0.0 111.098 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.51 105.07 7.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -92.68 141.16 28.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.743 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -85.55 137.42 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.575 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.918 179.714 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.456 ' H82' ' HB2' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -38.77 -64.11 0.52 Allowed Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 30' ' ' LEU . 10.4 Cg_endo -54.72 150.94 34.03 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.005 2.47 . . . . 0.0 112.25 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.704 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 47.1 p90 -151.68 -62.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.704 ' N ' ' CD2' ' A' ' 32' ' ' PHE . . . 61.64 6.36 8.59 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -157.1 107.64 2.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 110.75 -179.902 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 7.4 mtt 53.71 137.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -88.26 151.12 22.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.943 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 32.4 ttp180 -146.91 133.81 20.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.531 0.682 . . . . 0.0 111.899 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.688 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -133.07 144.76 50.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.484 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.12 137.52 34.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.541 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.85 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.9 140.99 42.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.247 0.546 . . . . 0.0 110.618 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -66.39 136.18 55.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.23 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -47.12 136.06 9.19 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 111.628 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.94 61.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.12 178.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.18 156.02 38.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 118.118 0.959 . . . . 0.0 110.732 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.08 149.99 29.13 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.998 1.799 . . . . 0.0 111.38 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.4 tt -120.74 145.63 26.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.685 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 75.8 tt0 -128.69 128.28 43.77 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.871 -178.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.8 mt -111.53 145.34 39.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.179 178.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.685 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 69.6 mtt180 -148.69 133.28 17.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.662 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -100.75 148.35 34.9 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.937 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.23 159.29 40.7 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.509 2.14 . . . . 0.0 112.169 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.22 -128.42 34.59 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.491 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.8 p -112.8 24.86 11.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.333 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.95 167.3 21.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 179.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.53 145.98 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.485 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.7 mt -69.62 137.95 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.723 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.5 ptp -130.93 102.11 5.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 93' ' ' SER . 21.4 t -63.87 124.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.873 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -102.46 -51.83 3.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.993 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 22.9 m-80 -148.59 144.32 27.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 0.0 110.463 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.467 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.97 150.85 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.945 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.738 ' O ' HD12 ' A' ' 122' ' ' LEU . 39.4 t30 -148.81 157.25 43.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -125.53 121.94 35.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.559 179.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.7 -134.5 3.73 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.709 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 14.6 ttm180 -157.96 119.5 3.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 0.0 111.579 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 HG21 ' CE2' ' A' ' 84' ' ' TYR . 4.7 p -125.09 9.86 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.506 178.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.28 158.62 44.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.128 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 53.7 p-10 -117.59 5.77 12.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -100.59 4.83 43.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.98 135.63 51.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.707 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.3 m 57.25 66.13 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.172 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 56.6 p30 -45.82 94.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.988 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -112.53 -162.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -62.67 142.59 96.86 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 121.446 0.641 . . . . 0.0 111.488 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 15.1 Cg_endo -57.21 -39.54 89.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.402 2.068 . . . . 0.0 112.78 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -64.74 -35.12 80.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.482 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.558 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 86.8 mt-30 -85.9 -7.18 58.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.825 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.709 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 3.8 mmm -107.64 -2.52 20.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.44 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 40.4 mm-40 -62.88 -49.95 72.81 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -78.06 113.13 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.598 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.7 m -104.55 30.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.362 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -142.14 89.63 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 16.7 t -146.06 120.05 9.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.786 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 95.1 m-85 -132.1 151.63 51.67 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.998 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.598 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.9 tp -146.89 88.46 5.94 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.102 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -48.5 -48.4 17.4 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.25 2.633 . . . . 0.0 113.847 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 78.5 m-20 -51.65 -29.58 18.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.549 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.1 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.135 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 48.1 t80 -62.45 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.492 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' CD ' ' A' ' 94' ' ' GLN . 3.5 pttt -66.03 -38.93 89.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.853 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.516 HG23 ' NE ' ' A' ' 95' ' ' ARG . 18.6 mt -60.26 -52.47 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.353 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.3 mmm -66.86 -37.55 84.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.385 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.4 m -61.78 -47.37 85.46 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.139 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.457 ' CD ' ' O ' ' A' ' 90' ' ' LYS . 3.4 mp0 -69.84 -34.38 73.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.08 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NE ' HG23 ' A' ' 91' ' ' ILE . 61.0 mtt180 -75.4 -32.46 60.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.6 m -112.46 -16.96 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.618 ' HB3' ' H82' ' A' ' 135' ' ' NAG . 89.7 m-20 -58.15 133.87 55.98 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.052 -178.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 67.69 13.12 9.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.283 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -115.19 148.27 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.036 178.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.5 m -71.44 -31.6 67.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.009 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -151.71 157.47 42.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 179.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.5 p -155.68 143.03 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.907 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 89.1 t -121.58 125.06 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG13 HH11 ' A' ' 95' ' ' ARG . 39.2 t -137.68 145.43 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 107' ' ' GLY . 43.3 t -79.7 117.02 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.018 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.97 36.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.71 -121.65 0.75 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.733 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 31.9 -160.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.197 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.39 -0.42 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.12 -14.33 50.61 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.812 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 112' ' ' PRO . 48.9 m-85 -143.38 127.37 9.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.166 178.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.3 Cg_exo -49.62 -149.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.331 2.021 . . . . 0.0 112.119 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -145.82 82.46 9.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.431 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.5 Cg_endo -77.24 -2.25 12.45 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.103 2.535 . . . . 0.0 113.697 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.541 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -167.85 68.51 0.84 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 110.511 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.14 151.09 29.48 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.98 2.454 . . . . 0.0 111.775 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 -1.71 60.37 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.337 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 77' ' ' GLN . 25.6 m -117.65 146.7 43.5 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.628 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.1 t80 -84.89 115.81 22.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.074 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.541 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 17.8 mttp -92.62 -160.33 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -174.18 176.49 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.525 -1.671 . . . . 0.0 111.909 176.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 62' ' ' ASN . 59.0 tp -135.68 125.82 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.1 tt0 -118.68 127.24 53.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.467 HG22 ' HB1' ' A' ' 61' ' ' ALA . 30.1 t -131.47 123.75 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.199 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.07 129.66 55.65 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.327 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -152.94 169.56 22.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.352 0.596 . . . . 0.0 111.437 -178.06 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.452 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 85.9 m-20 -122.88 158.44 30.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.57 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 96.7 m -111.33 111.67 22.89 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.55 154.2 44.72 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -58.27 145.82 91.7 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.109 1.873 . . . . 0.0 112.216 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -74.58 136.63 42.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -94.03 146.22 24.1 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.083 -178.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.4 t -86.67 132.89 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.478 -179.431 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 135' ' ' NAG . . . . . 0.618 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER 56.44 49.39 4.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.809 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 10.7 Cg_endo -60.87 146.85 96.93 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.467 2.111 . . . . 0.0 111.825 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -79.38 -9.29 59.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.556 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 0.01 25.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 35' ' ' MET . 25.8 tp -164.98 88.77 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.043 0.449 . . . . 0.0 110.281 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.3 mtt 60.41 142.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -91.1 148.39 22.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.668 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 31.4 ttm105 -146.44 136.08 23.13 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.839 0.828 . . . . 0.0 111.373 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 45.5 mp0 -134.67 145.54 48.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.238 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 ' OE1' ' A' ' 123' ' ' GLU . 5.5 tt -140.32 139.78 35.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.389 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.771 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.65 137.42 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.13 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.2 m -70.41 139.67 51.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 0.0 110.503 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -47.51 135.17 11.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.129 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.96 -19.0 56.3 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.93 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.56 148.71 38.67 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 118.376 1.088 . . . . 0.0 109.78 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.57 154.57 73.15 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.38 144.15 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 37.8 tt0 -124.79 127.04 46.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.582 -179.202 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 72.2 mt -118.1 141.06 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.037 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 73.7 mtt-85 -148.58 136.31 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.909 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.9 147.97 35.11 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.205 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 62.8 Cg_endo -75.3 156.92 41.71 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.005 2.47 . . . . 0.0 112.136 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -132.23 39.75 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.5 p -109.4 27.45 9.53 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.18 0.514 . . . . 0.0 111.143 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.45 163.9 25.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.28 145.28 34.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.927 178.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.2 mt -68.67 138.09 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.409 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.447 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.4 ptp -131.24 98.6 4.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.67 124.76 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.165 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.3 mm-40 -100.99 -47.33 4.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.3 m-20 -149.21 147.47 28.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.825 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.887 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.47 151.15 11.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.585 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 32.0 t30 -150.26 146.49 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.229 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -117.17 120.73 39.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.32 -137.72 5.16 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.132 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.0 ttm-85 -155.78 113.45 3.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.218 0.532 . . . . 0.0 109.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 p -121.23 11.05 10.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.968 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 47.3 t0 -146.74 -173.67 4.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.431 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.604 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 39.4 p30 -145.55 1.05 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.501 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -101.24 4.86 42.21 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.724 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.06 135.5 52.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.472 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.3 m 58.05 66.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.311 0.577 . . . . 0.0 109.814 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -53.2 122.15 8.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.105 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.82 -164.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.872 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.8 p30 -59.91 135.41 90.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.828 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.523 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.19 -32.22 59.01 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 113.283 -178.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -63.62 -38.03 89.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 118' ' ' THR . 39.0 mt-30 -85.5 -0.92 56.37 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.417 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 81.5 mtp -115.27 -1.25 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.172 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -62.42 -47.56 83.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 50.7 t30 -80.97 117.62 21.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.49 33.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.172 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -140.05 84.55 1.97 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 54.1 t -147.2 117.33 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.9 m-85 -128.02 155.72 43.87 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.322 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.5 tp -148.55 83.47 6.98 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.92 -45.36 20.94 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.792 2.328 . . . . 0.0 114.441 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -57.21 -20.77 29.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.929 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.34 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.868 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 93' ' ' SER . 24.4 t80 -65.29 -43.56 90.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.776 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.32 -39.85 92.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.178 -179.038 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 75.8 mt -58.38 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.48 -38.68 87.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.038 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.597 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.1 m -59.28 -45.67 90.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.93 -37.95 89.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.979 0.418 . . . . 0.0 110.56 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.583 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 92.7 mtt-85 -73.59 -34.46 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.6 m -112.51 -16.57 12.84 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 93' ' ' SER . 24.0 m-20 -58.79 133.54 56.07 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.798 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 65.9 13.45 9.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.13 178.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -115.44 147.31 40.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.17 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.8 m -74.12 -30.26 62.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 153.27 32.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 27.2 p -154.92 141.63 18.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.622 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.61 127.73 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.85 146.87 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.731 0.3 . . . . 0.0 111.01 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 107' ' ' GLY . 89.5 t -78.98 114.41 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.214 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.76 39.26 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.849 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.45 -125.09 0.9 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.418 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.65 -157.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.395 0.616 . . . . 0.0 111.935 -179.298 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -66.39 -1.49 3.54 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.426 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.09 -14.9 57.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.243 -179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 58.2 m-85 -144.99 127.07 8.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.9 Cg_exo -51.78 -145.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.904 1.736 . . . . 0.0 112.355 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 12.4 t0 -145.75 85.2 7.85 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.537 -179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 74.2 Cg_endo -74.24 -6.25 18.14 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.225 . . . . 0.0 113.537 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.564 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -169.93 70.78 0.63 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.634 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 51.6 Cg_exo -48.76 153.52 3.58 Favored 'Trans proline' 0 C--N 1.294 -2.296 0 C-N-CA 123.003 2.469 . . . . 0.0 111.922 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.76 10.46 83.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.795 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.9 m -124.67 147.73 48.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.499 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 11.4 t80 -86.15 109.49 18.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.1 mttp -91.28 -161.75 0.85 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.46 1.124 . . . . 0.0 114.02 -175.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -171.76 171.43 5.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.694 177.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.1 tp -130.37 127.97 40.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.165 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.961 ' OE1' HD12 ' A' ' 39' ' ' LEU . 8.0 tp10 -124.19 128.35 49.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.887 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.1 t -135.55 129.09 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.444 -178.071 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.567 HE21 ' HG3' ' A' ' 123' ' ' GLU . 10.0 mp0 -109.97 130.59 55.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD1' HG23 ' A' ' 56' ' ' ILE . 24.2 p90 -153.37 173.08 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 -178.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 57' ' ' MET . 76.9 m-20 -128.57 163.05 25.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.333 178.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.444 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -109.82 120.43 42.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.574 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.67 152.15 74.35 Favored Pre-proline 0 N--CA 1.463 0.184 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -54.27 142.74 67.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.555 1.503 . . . . 0.0 112.034 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 31.2 t80 -75.05 12.47 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.261 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.79 152.76 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.5 t -93.07 141.31 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.507 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.5 -179.382 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -66.8 123.62 86.44 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.519 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -51.71 132.26 40.76 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.645 1.563 . . . . 0.0 111.159 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' O ' ' N ' ' A' ' 34' ' ' LEU . 39.4 p90 -78.13 -9.34 59.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.083 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.34 -67.38 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 32' ' ' PHE . 13.7 tp -160.01 115.08 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.1 mtp 57.23 157.65 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -90.76 146.22 24.15 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.32 138.31 29.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.495 0.664 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -135.62 141.56 45.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.86 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.902 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -137.92 137.09 37.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.129 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.902 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.79 140.5 40.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.491 . . . . 0.0 110.446 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.71 136.72 55.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -178.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 86.2 tt0 -47.85 137.9 9.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.003 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.3 56.96 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.823 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -105.71 150.71 39.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.904 0.852 . . . . 0.0 110.241 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.26 149.73 46.03 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.593 2.195 . . . . 0.0 112.761 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.5 tt -118.4 147.73 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.612 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 84.0 tt0 -129.39 126.51 39.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.118 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -113.84 148.08 37.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.042 178.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.612 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 95.4 mtt180 -153.8 129.63 10.15 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.67 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.3 m -96.23 147.25 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.871 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.0 Cg_endo -70.07 156.64 62.06 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.07 1.847 . . . . 0.0 111.669 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.7 -139.28 17.45 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.845 0.691 . . . . 0.0 113.099 177.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.4 p -96.25 21.25 9.2 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.237 -0.981 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.54 165.07 24.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.732 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG11 ' CG ' ' A' ' 131' ' ' TYR . 35.1 m -130.32 147.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.755 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 62.0 mt -69.92 137.41 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.847 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.6 ptp -130.82 100.11 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 89' ' ' PHE . 51.7 t -63.63 123.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.362 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.513 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 93.6 mt-10 -102.08 -51.75 3.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.816 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -150.02 146.37 26.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.232 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.66 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.08 155.74 12.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.353 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.8 t30 -149.91 144.33 25.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 78.3 t80 -116.65 121.62 42.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.68 -141.09 7.23 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 16.0 ttm180 -146.57 116.91 7.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.23 0.538 . . . . 0.0 110.805 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 22.1 p -125.26 2.51 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.644 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 61.2 t0 -144.76 150.21 36.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.795 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 54.6 p30 -110.12 5.46 22.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 58.8 mttm -100.33 -0.46 38.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.416 -178.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.38 136.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.516 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.1 m 59.23 64.0 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -54.33 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.066 -178.275 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.25 -160.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.79 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.694 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -60.01 134.96 90.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.885 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.91 -34.32 75.7 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.127 1.885 . . . . 0.0 112.81 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.14 -36.8 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.679 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.2 mt-30 -86.72 -10.72 53.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.491 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.518 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 81.7 mtp -102.03 -3.67 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.71 -44.86 88.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.109 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 51.9 t30 -81.28 118.65 22.8 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.427 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.06 29.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -139.49 81.76 1.85 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.175 178.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 2.2 t -142.81 118.8 10.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HA ' HD21 ' A' ' 62' ' ' ASN . 71.9 m-85 -130.96 156.44 45.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.808 -178.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -145.17 88.72 6.66 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.241 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.4 -45.11 19.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.247 1.964 . . . . 0.0 112.822 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 89.8 m-20 -57.45 -16.66 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.014 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.21 72.56 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 58' ' ' VAL . 47.9 t80 -65.28 -45.56 83.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.83 -37.87 89.08 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.561 -178.727 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.7 HG23 ' NH1' ' A' ' 95' ' ' ARG . 91.1 mt -58.95 -52.74 56.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.817 0.341 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.8 mmm -67.26 -33.42 75.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.179 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.583 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.8 m -59.93 -49.73 76.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -66.95 -39.02 87.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 112.069 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.7 ' NH1' HG23 ' A' ' 91' ' ' ILE . 65.9 mtt85 -77.05 -32.43 56.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.51 -15.58 12.55 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.583 ' CG ' ' O ' ' A' ' 93' ' ' SER . 58.2 m-20 -61.32 133.77 56.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.034 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 70.36 14.74 7.45 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -111.44 143.95 41.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.07 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.0 m -68.67 -28.28 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -147.09 158.3 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.064 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.9 t -152.81 139.06 18.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.465 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.09 126.63 64.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.038 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 46' ' ' ILE . 47.3 t -143.49 141.57 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLY . 64.7 t -76.73 115.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.957 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.66 35.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.091 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -177.44 -127.7 1.08 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.51 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.58 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 32.29 -159.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.017 0.437 . . . . 0.0 111.02 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -66.43 1.94 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.25 -179.107 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.54 -13.0 55.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.688 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 44.4 m-85 -144.6 133.07 10.9 Favored Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.984 179.144 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.3 Cg_exo -56.05 -145.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.6 1.533 . . . . 0.0 111.471 178.095 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -145.25 90.55 6.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.93 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 95.7 Cg_endo -81.16 -4.09 12.42 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.297 2.664 . . . . 0.0 114.25 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.434 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -167.68 66.36 0.78 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -52.74 147.7 30.7 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.71 2.273 . . . . 0.0 111.588 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.16 -6.76 74.31 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' GLN . 87.2 m -118.88 148.08 43.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 45.8 t80 -85.72 120.74 27.48 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.5 mttm -96.86 -157.51 0.6 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -176.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.1 p90 -174.6 177.27 2.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.498 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.88 122.29 24.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.82 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -116.49 127.89 54.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.66 HG22 ' HB1' ' A' ' 61' ' ' ALA . 96.1 t -136.82 127.37 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.008 -178.443 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.6 132.28 56.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 31.8 p90 -155.01 169.98 22.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.219 0.533 . . . . 0.0 112.427 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 79.6 m-20 -120.91 160.45 23.45 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.481 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.4 m -112.05 118.33 35.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.694 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.79 159.35 61.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.774 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.22 144.9 68.58 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.121 1.881 . . . . 0.0 112.331 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -76.29 -154.01 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.082 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.654 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 20.6 pttp -98.08 160.27 14.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.722 HG12 ' HG2' ' A' ' 134' ' ' GLU . 60.2 t -92.68 126.78 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.353 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.722 ' HG2' HG12 ' A' ' 133' ' ' VAL . 71.5 mm-40 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -150.58 137.11 18.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.944 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HG3' HD23 ' A' ' 48' ' ' LEU . 73.0 mm-40 -129.8 144.7 51.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.991 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.01 141.91 38.3 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.759 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.77 142.67 31.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.399 0.619 . . . . 0.0 111.49 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.6 m -66.78 135.17 53.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.133 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG3' ' OH ' ' A' ' 63' ' ' TYR . 77.3 tt0 -47.61 134.93 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.509 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.61 -16.67 60.63 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.452 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 13.4 m-85 -107.47 155.86 38.83 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 118.272 1.036 . . . . 0.0 108.831 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.23 154.47 28.65 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.512 1.475 . . . . 0.0 112.188 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 46' ' ' ILE . 12.9 tt -116.44 150.68 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.035 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 33.0 tt0 -126.93 130.89 50.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.672 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.0 mt -122.07 136.1 54.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.692 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 87.0 mtt180 -146.43 134.7 21.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.0 110.705 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.1 m -103.63 145.53 30.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.092 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -70.23 155.74 63.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.988 1.792 . . . . 0.0 112.51 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.21 -131.69 24.88 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.63 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.9 p -102.86 22.32 14.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.497 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.95 165.07 24.53 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 129' ' ' VAL . 30.0 m -125.58 145.67 32.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.837 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.9 mt -67.89 135.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.6 ptm -131.65 98.04 4.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.8 t -61.73 122.44 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.591 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -99.33 -51.66 3.74 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -151.24 150.01 30.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.97 154.21 7.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 84' ' ' TYR . 2.5 t30 -148.75 146.19 27.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' OH ' ' HG3' ' A' ' 42' ' ' GLU . 49.3 t80 -114.49 118.08 32.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.34 -139.3 5.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.949 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.694 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 11.5 ttm-85 -151.36 119.69 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.123 0.487 . . . . 0.0 111.475 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.402 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.3 p -126.86 4.78 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.116 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 51.7 t0 -146.99 153.28 39.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.777 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 24.8 p-10 -110.31 4.87 21.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.956 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -103.98 4.07 34.16 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.138 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.7 mm -110.23 133.84 54.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m 57.14 70.12 0.68 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.138 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -54.01 120.43 6.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.572 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.44 -161.88 1.25 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.782 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.662 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.4 p-10 -61.96 137.21 95.4 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.801 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 7.0 Cg_endo -55.38 -36.2 93.38 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.351 2.034 . . . . 0.0 113.327 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.55 -33.4 74.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 0.0 110.753 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 118' ' ' THR . 25.0 mt-30 -85.08 -18.87 32.97 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.293 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 68.6 mtp -97.87 -0.4 45.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 56.9 mt-10 -64.68 -46.65 81.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -78.49 112.99 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.12 30.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.163 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -142.04 84.37 1.88 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.082 0.468 . . . . 0.0 111.92 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.463 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 44.1 t -145.24 119.94 9.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.0 m-85 -127.16 155.15 43.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 111.077 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.28 90.0 5.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.779 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.1 -47.38 24.08 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.523 2.149 . . . . 0.0 113.457 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.0 -22.4 15.17 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.24 -0.287 . . . . 0.0 111.701 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.59 -33.94 48.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.72 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 58' ' ' VAL . 70.8 t80 -64.96 -45.44 85.7 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 12.0 ptmt -64.43 -38.77 92.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.922 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 70.2 mt -60.34 -48.93 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.905 0.383 . . . . 0.0 111.666 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.0 mmm -70.39 -37.74 74.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.501 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.4 m -60.42 -46.99 88.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -64.79 -36.39 84.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 111.231 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.622 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -78.47 -32.7 48.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.509 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.8 m -112.22 -15.01 13.28 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 93' ' ' SER . 61.7 m-20 -59.84 133.05 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.043 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 67.7 14.28 9.46 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.118 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -115.95 147.21 41.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.272 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.7 m -72.28 -33.51 67.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 151.48 33.83 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.34 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.9 p -152.75 147.27 25.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.791 0.329 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.8 t -128.45 129.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.02 0.438 . . . . 0.0 110.032 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.581 ' CG1' HH11 ' A' ' 95' ' ' ARG . 46.3 t -135.65 148.75 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 107' ' ' GLY . 59.6 t -82.56 115.33 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.93 39.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.96 -127.31 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.98 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.469 0.652 . . . . 0.0 112.033 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -66.56 1.09 1.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.557 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.622 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.34 -11.64 55.98 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.647 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.4 m-85 -143.74 128.31 9.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.672 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 38.1 Cg_exo -50.64 -149.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.148 1.898 . . . . 0.0 111.125 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.37 97.11 5.19 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.463 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 61.6 Cg_endo -88.35 -10.49 4.66 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.592 2.195 . . . . 0.0 112.325 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.455 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.5 p -166.58 90.29 0.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.635 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -76.55 155.61 35.94 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.355 2.037 . . . . 0.0 111.912 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.22 89.62 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 77' ' ' GLN . 89.0 m -126.49 147.66 49.79 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 t80 -79.25 108.73 12.98 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 30.9 mtmm -87.61 -167.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.388 1.09 . . . . 0.0 113.093 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -171.6 174.64 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.044 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 22.1 tp -133.01 125.2 29.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.458 ' HG2' HE21 ' A' ' 125' ' ' GLN . 65.4 tt0 -119.34 125.61 49.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.9 t -130.73 123.94 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.458 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.2 mt-30 -107.57 130.23 54.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.623 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.5 p90 -155.9 164.42 38.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.555 0.693 . . . . 0.0 112.259 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -119.16 156.27 30.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.228 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.9 m -107.78 120.98 43.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.5 m -121.63 152.87 59.21 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--N 1.308 -1.584 0 C-N-CA 122.258 1.972 . . . . 0.0 112.128 179.432 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.4 ttp180 -147.05 131.38 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.725 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' HD23 ' A' ' 48' ' ' LEU . 72.1 mm-40 -128.16 143.85 51.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.98 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -138.57 136.61 36.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.824 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.16 140.1 46.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.113 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.404 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 64.9 m -65.3 138.18 58.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 64.8 tt0 -45.56 129.84 8.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.598 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.04 -12.37 67.03 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.856 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -109.19 149.27 39.49 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 118.841 1.321 . . . . 0.0 110.19 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.75 150.82 87.54 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.852 1.701 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -121.33 141.91 39.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.638 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 74.4 tt0 -130.16 130.29 44.54 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.664 -0.814 . . . . 0.0 112.519 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.594 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.9 mt -116.24 139.35 50.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.048 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.638 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 48.2 mtt180 -145.75 135.22 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.442 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.458 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.4 m -100.59 146.59 32.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -70.0 160.37 49.89 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.764 2.309 . . . . 0.0 112.489 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.26 -120.98 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.738 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -120.94 25.29 9.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.31 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -76.18 169.91 17.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.0 110.02 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.26 145.24 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.801 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.4 137.15 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.603 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.1 ptm -130.85 99.67 5.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.561 0.696 . . . . 0.0 109.257 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG12 ' CE1' ' A' ' 89' ' ' PHE . 24.1 t -63.21 123.25 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 80.5 mm-40 -100.31 -51.67 3.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 58.6 m-20 -151.72 148.98 28.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.056 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.33 153.97 8.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.862 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.6 t30 -147.88 148.05 30.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.457 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -114.21 114.98 26.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.27 -142.22 7.57 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.38 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -150.84 119.2 6.39 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.317 0.58 . . . . 0.0 111.568 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.51 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 59.9 p -125.95 6.97 7.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.811 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.646 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 35.0 t0 -140.44 -174.75 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.128 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 22.4 p30 -144.96 -1.06 0.87 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.5 mtmp? -101.59 3.88 40.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.408 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' SG ' ' A' ' 71' ' ' CYS . 30.5 mm -112.76 135.35 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.981 0.42 . . . . 0.0 110.309 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' A' ' 70' ' ' ILE . 67.1 m 60.46 64.24 1.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.256 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.592 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 42.5 p30 -50.02 96.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.539 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.52 -163.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.683 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -60.68 139.1 93.15 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.639 178.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.453 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.62 -38.01 96.43 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.433 2.089 . . . . 0.0 113.326 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -62.19 -33.32 74.31 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.71 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.8 mt-30 -85.01 -6.36 59.33 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.438 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 83.9 mtp -109.95 -3.02 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 82.2 mt-10 -64.79 -46.15 83.3 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.97 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -79.68 112.88 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.072 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 67' ' ' ASP . 35.8 m -107.3 31.38 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.6 mm-40 -138.24 84.53 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.86 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.0 t -146.1 125.84 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.563 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HA ' HD21 ' A' ' 62' ' ' ASN . 59.0 m-85 -134.04 154.71 50.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 112' ' ' PRO . 37.4 tp -146.91 93.67 4.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.346 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.61 -48.4 22.17 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.497 2.798 . . . . 0.0 114.576 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -57.81 -19.92 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.88 -32.03 63.34 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.717 ' CE1' HG12 ' A' ' 58' ' ' VAL . 48.3 t80 -63.72 -43.81 95.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.714 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.21 -39.61 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 65.2 mt -58.08 -51.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.084 ' SD ' HD21 ' A' ' 122' ' ' LEU . 40.0 mtp -70.46 -33.22 71.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.528 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 20.1 m -58.39 -47.17 84.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.83 -34.67 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.501 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NE ' HG22 ' A' ' 104' ' ' VAL . 17.7 mtp180 -80.54 -32.4 36.75 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.2 m -111.74 -20.16 12.19 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.479 ' CG ' ' O ' ' A' ' 93' ' ' SER . 42.6 m-20 -56.16 135.19 53.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.845 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 64.44 13.84 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.972 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -112.95 144.3 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.604 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -33.21 73.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.099 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 158.71 42.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.043 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.594 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.2 p -155.38 135.0 12.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.138 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 129.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.5 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.2 t -143.41 145.72 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.769 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.2 t -79.05 116.4 22.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.58 41.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.67 -116.82 0.53 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.659 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 28.56 -160.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.14 0.495 . . . . 0.0 111.737 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.659 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-20 -69.47 2.09 3.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.968 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.05 -13.75 49.45 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.383 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.574 ' O ' ' O ' ' A' ' 112' ' ' PRO . 72.8 m-85 -141.09 126.62 11.1 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.7 Cg_exo -51.41 -150.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.224 1.949 . . . . 0.0 111.575 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -144.9 90.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.77 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.55 -8.68 13.65 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.093 2.528 . . . . 0.0 113.236 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -172.22 80.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.437 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.32 159.02 55.39 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.149 1.899 . . . . 0.0 111.505 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.1 -4.71 86.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 77' ' ' GLN . 63.2 m -125.36 147.87 48.98 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.494 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 45.3 t80 -85.81 118.7 25.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.479 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mttt -95.17 -156.91 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.0 p90 -174.86 176.5 2.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.556 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.084 HD21 ' SD ' ' A' ' 92' ' ' MET . 34.3 tp -133.69 126.79 31.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.816 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.67 ' CD ' ' N ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -120.74 130.72 54.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 11.8 t -133.28 123.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -107.04 125.72 51.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.801 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -154.65 170.08 22.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.302 0.572 . . . . 0.0 112.223 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' A' ' 57' ' ' MET . 10.8 m-20 -127.0 161.57 28.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.941 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.8 115.86 29.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.115 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.78 158.93 44.36 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.495 1.599 0 C-N-CA 122.181 1.92 . . . . 0.0 112.055 179.441 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.609 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -151.74 138.68 19.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.343 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -133.78 146.77 51.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.36 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -134.88 132.11 38.15 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.67 139.96 51.25 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.546 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.1 137.16 53.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.597 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 87.2 tt0 -48.06 133.37 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.028 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.8 -17.96 58.0 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.94 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -111.72 148.18 38.36 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 118.283 1.041 . . . . 0.0 110.308 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.76 151.71 82.42 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.489 2.126 . . . . 0.0 113.36 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.9 tt -119.07 147.01 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 103' ' ' VAL . 81.5 tt0 -136.0 125.38 24.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -110.9 145.93 37.43 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -148.47 136.56 21.03 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.9 m -104.41 143.99 27.8 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.23 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 56.6 Cg_endo -71.71 161.19 45.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.361 2.041 . . . . 0.0 112.13 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.34 -132.2 34.23 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.449 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.8 p -107.92 23.36 14.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.351 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -78.58 167.89 20.59 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -130.73 145.21 35.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.82 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.874 HG23 ' CD2' ' A' ' 126' ' ' TYR . 82.7 mt -68.66 139.78 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.068 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.3 ptm -131.98 99.53 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.834 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 89' ' ' PHE . 55.8 t -63.05 124.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.361 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -101.98 -48.53 4.22 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -151.41 147.52 26.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.06 155.58 11.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.492 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.0 t30 -151.81 145.65 25.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 67.3 t80 -116.73 118.04 31.46 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.49 -138.04 5.16 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' H ' ' HB3' ' A' ' 83' ' ' CYS . 12.3 ttm-85 -152.4 118.94 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.232 0.539 . . . . 0.0 111.717 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 p -121.99 8.4 9.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 27.6 t0 -143.54 -164.23 1.82 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.059 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 47.2 p30 -149.16 -1.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.237 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -102.88 4.49 37.7 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.576 HG22 ' SG ' ' A' ' 71' ' ' CYS . 14.3 mm -106.64 135.28 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.576 ' SG ' HG22 ' A' ' 70' ' ' ILE . 47.7 m 59.44 66.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.481 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.3 p30 -47.8 108.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.95 -162.99 1.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.015 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.6 p-10 -63.44 138.31 97.32 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.529 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.8 Cg_endo -58.81 -32.45 97.16 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.212 1.941 . . . . 0.0 112.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -60.79 -37.82 83.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.654 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 118' ' ' THR . 24.5 mt-30 -86.21 -10.88 53.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.334 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -108.84 0.52 20.34 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.128 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 75.5 mt-10 -64.78 -43.92 91.65 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.365 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.2 t30 -78.78 114.28 17.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -106.1 32.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.4 mm-40 -140.68 86.51 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.75 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.551 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 32.8 t -147.7 120.88 8.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 89.2 m-85 -132.51 152.71 51.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.883 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -144.13 93.42 6.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.027 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.48 -49.05 16.69 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.558 2.838 . . . . 0.0 113.829 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -57.37 -24.58 56.17 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.24 -31.52 21.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE1' HG12 ' A' ' 58' ' ' VAL . 83.5 t80 -66.63 -45.8 77.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.89 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 ptmt -64.38 -39.24 93.47 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.675 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 94.4 mt -60.18 -52.91 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.3 mmm -70.12 -35.24 73.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 111.526 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.4 m -59.95 -47.33 86.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -66.87 -36.75 83.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.421 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 1.025 ' HE ' HG22 ' A' ' 104' ' ' VAL . 72.9 mtp85 -77.23 -32.68 55.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 23.7 m -112.69 -17.24 12.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -57.17 136.22 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.297 0.57 . . . . 0.0 111.964 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 64.76 12.98 8.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.653 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 67.2 mtt-85 -112.32 144.93 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.228 0.537 . . . . 0.0 110.307 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 m -70.31 -33.76 71.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.38 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 154.29 37.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.88 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.0 p -155.01 139.03 16.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.859 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.492 HG22 ' HG3' ' A' ' 47' ' ' GLU . 48.5 t -122.46 135.82 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.025 HG22 ' HE ' ' A' ' 95' ' ' ARG . 33.4 t -143.04 152.99 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.98 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.449 ' N ' HG12 ' A' ' 104' ' ' VAL . 70.6 t -84.05 115.74 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.03 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.32 36.64 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -176.62 -118.23 0.53 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.646 ' O ' ' O ' ' A' ' 107' ' ' GLY . 46.5 t 27.0 -158.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.424 0.631 . . . . 0.0 112.02 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.1 m-20 -69.27 1.09 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.08 -11.2 58.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.671 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.1 m-85 -144.94 133.69 11.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.805 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.1 Cg_exo -53.2 -147.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.04 1.826 . . . . 0.0 110.559 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.493 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 11.0 t0 -144.38 91.24 6.37 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.0 110.255 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.416 ' HD2' ' CE ' ' A' ' 120' ' ' LYS . 62.4 Cg_endo -80.94 -11.7 12.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.124 2.549 . . . . 0.0 113.734 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.584 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -165.27 76.58 1.35 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 121.538 0.685 . . . . 0.0 111.531 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.84 153.25 38.18 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.753 2.302 . . . . 0.0 112.619 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.19 8.09 53.41 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.049 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.8 m -119.3 148.88 42.66 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 6.5 t80 -83.31 108.88 16.82 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.584 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 28.1 mttt -89.56 -163.06 0.94 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.754 1.264 . . . . 0.0 112.833 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -173.54 175.52 2.98 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.007 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 tp -133.4 125.75 29.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -123.62 128.64 49.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 99.0 t -133.27 126.94 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -108.17 128.58 54.83 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.874 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.4 p90 -155.6 175.32 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.236 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -131.85 161.16 33.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.272 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.609 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 88.4 m -108.38 122.53 47.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.183 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.93 155.84 57.2 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.519 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 C--N 1.31 -1.461 0 C-N-CA 122.33 2.02 . . . . 0.0 111.904 -179.805 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.559 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 28.3 ttm180 -147.21 134.51 20.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.0 111.673 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 40.5 mp0 -131.35 144.11 50.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.751 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -138.75 141.28 38.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.841 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.31 141.63 33.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.397 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -66.36 135.32 54.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.66 138.95 7.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.294 0.569 . . . . 0.0 112.032 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 -16.64 60.59 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.961 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -109.32 150.34 40.96 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 117.741 0.77 . . . . 0.0 110.117 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.97 151.18 67.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.884 2.39 . . . . 0.0 113.264 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -123.98 142.0 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 65.9 tt0 -128.02 130.36 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 111.82 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 64.7 mt -111.21 145.99 37.72 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.095 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.641 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 96.6 mtt180 -149.43 128.23 12.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.7 m -101.01 144.43 28.54 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.05 158.08 50.01 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.424 2.083 . . . . 0.0 112.543 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.73 -139.18 36.41 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.428 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 p -99.57 23.87 8.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.405 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 63.4 m-20 -81.29 165.16 21.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.243 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.8 m -129.95 146.55 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 110.584 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.96 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.2 mt -68.25 136.59 26.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.753 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -130.8 99.39 4.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.503 HG12 ' HE1' ' A' ' 89' ' ' PHE . 53.0 t -63.01 123.06 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.512 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.502 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.8 mm-40 -103.39 -46.94 4.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.184 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 24.7 m-20 -147.16 144.48 29.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.78 149.99 11.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.743 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.571 ' O ' HD12 ' A' ' 122' ' ' LEU . 29.7 t30 -148.07 147.45 29.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.167 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -118.64 120.02 36.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -138.68 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.997 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -154.79 116.29 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.661 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' CE2' ' A' ' 84' ' ' TYR . 14.9 p -122.43 9.65 9.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.923 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.617 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.0 t0 -147.59 -173.52 4.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.2 p30 -145.78 1.99 0.91 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.051 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.67 5.01 41.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.323 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.451 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.2 mm -115.42 137.84 47.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.74 0.305 . . . . 0.0 110.523 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 30.9 m 52.88 75.91 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -56.41 122.19 11.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.484 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.84 -167.55 2.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.552 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -61.4 134.15 93.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.7 Cg_endo -53.1 -33.57 64.21 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.789 1.66 . . . . 0.0 113.506 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -63.65 -34.91 78.9 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.039 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 72.9 mt-30 -83.35 -14.88 51.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.548 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 mtp -99.54 -0.61 40.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.3 mt-10 -62.05 -52.13 65.19 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 39.2 t30 -81.72 115.98 21.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.7 m -105.03 35.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.559 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.422 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 2.4 mm100 -139.52 85.8 2.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 4.0 t -148.56 118.56 7.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CE2' HG21 ' A' ' 66' ' ' THR . 69.7 m-85 -130.02 154.24 47.61 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.814 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 88' ' ' ALA . 40.4 tp -146.28 85.69 7.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.388 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -47.09 -47.69 16.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.902 2.402 . . . . 0.0 113.614 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -56.79 -22.76 38.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.73 -31.35 62.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.972 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HE1' HG12 ' A' ' 58' ' ' VAL . 11.6 t80 -64.1 -42.53 96.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.4 ptpt -66.09 -42.17 89.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.963 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.484 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 82.2 mt -58.39 -49.73 81.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.529 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.092 ' SD ' HD21 ' A' ' 122' ' ' LEU . 31.7 mtp -71.07 -33.19 70.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.745 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.6 m -59.14 -45.57 90.6 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.919 0.39 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -65.59 -37.4 86.54 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.078 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 93.6 mtt-85 -76.73 -35.3 57.89 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.432 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -109.28 -21.5 12.51 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CG ' ' O ' ' A' ' 93' ' ' SER . 75.9 m-20 -57.24 134.09 55.64 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.207 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 67.95 12.48 8.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.798 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 99' ' ' ARG . 51.3 mtt180 -113.47 146.44 39.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.215 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.7 m -73.45 -28.74 62.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.452 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -151.98 152.48 32.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.498 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.1 p -153.58 142.81 21.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.716 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.67 126.06 72.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.9 t -139.04 146.68 25.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.845 0.355 . . . . 0.0 111.374 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.9 t -78.78 113.67 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.95 42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.581 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -121.62 0.8 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.6 t 28.05 -157.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 111.892 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.38 1.22 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.175 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.87 -12.49 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.433 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 63.9 m-85 -144.58 128.14 8.75 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.979 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -50.45 -146.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.387 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -142.88 84.62 10.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.01 -5.53 14.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.812 2.341 . . . . 0.0 113.424 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.505 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -164.68 71.6 1.53 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.544 0.688 . . . . 0.0 111.47 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.43 140.46 93.22 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.396 2.064 . . . . 0.0 110.594 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.77 71.51 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.951 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 21.3 m -124.4 146.3 48.97 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.538 0.669 . . . . 0.0 110.331 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.556 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 26.0 t80 -81.64 116.23 21.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 24.3 mttt -89.82 -165.93 1.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.805 1.288 . . . . 0.0 114.037 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.2 p90 -167.68 169.49 11.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.17 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.092 HD21 ' SD ' ' A' ' 92' ' ' MET . 65.8 tp -130.31 122.71 28.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.687 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 71.5 tt0 -117.94 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' A' ' 92' ' ' MET . 45.7 t -133.64 125.17 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.88 128.71 55.15 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.96 ' CD2' HG23 ' A' ' 56' ' ' ILE . 28.6 p90 -154.3 169.64 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.23 0.538 . . . . 0.0 111.735 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.488 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 76.9 m-20 -123.04 159.31 28.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.965 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.9 m -109.15 112.13 24.13 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 4.2 m -121.02 158.68 51.92 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo . . . . . 0 N--CA 1.493 1.447 0 C-N-CA 121.9 1.733 . . . . 0.0 112.154 -179.756 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.589 HH21 ' HG3' ' A' ' 51' ' ' PRO . 94.6 mtt-85 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -145.15 132.91 21.07 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.495 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' HG3' HD23 ' A' ' 48' ' ' LEU . 79.5 mm-40 -124.4 145.33 49.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -137.26 141.03 41.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.811 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.79 139.86 36.52 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.471 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.03 135.73 55.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.911 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 82.0 tt0 -46.17 134.27 8.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.284 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 -11.89 68.29 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.267 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.8 m-85 -112.26 148.75 39.8 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 118.451 1.125 . . . . 0.0 109.828 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.91 150.26 73.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.288 1.992 . . . . 0.0 112.867 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.6 tt -116.34 147.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.42 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -125.2 127.94 47.57 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.036 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 38' ' ' GLU . 24.3 mt -116.23 138.29 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.059 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' A' ' 101' ' ' GLN . 65.5 mtp85 -148.2 135.46 20.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.021 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -100.34 144.14 27.88 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HG3' HH21 ' A' ' 36' ' ' ARG . 61.2 Cg_endo -72.02 159.17 50.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.258 2.638 . . . . 0.0 112.55 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.79 -131.02 27.46 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.9 p -108.42 23.93 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.78 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.38 165.4 24.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.31 147.71 32.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.136 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.773 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.0 mt -69.92 136.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.104 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.7 ptp -134.44 106.06 6.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 89' ' ' PHE . 36.4 t -64.44 124.5 19.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -102.96 -53.12 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.225 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -147.17 143.47 28.25 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.168 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.37 154.46 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.82 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.3 t30 -149.96 145.97 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.405 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -116.84 118.31 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.29 -133.64 3.34 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.7 ttm-85 -157.71 117.11 3.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.334 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 p -122.29 9.46 9.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 14.5 t70 -144.86 -168.99 3.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.5 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 8.0 p30 -148.41 -0.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.402 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -101.42 7.71 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.039 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.53 136.61 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.089 0.471 . . . . 0.0 111.07 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.8 m 51.96 78.95 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 59.1 p30 -55.77 125.04 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.72 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.99 -164.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.931 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.66 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -64.72 142.97 98.66 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 110.61 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.6 Cg_endo -60.96 -35.78 86.26 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 113.713 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.74 -36.16 82.11 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 118' ' ' THR . 22.3 mt-30 -86.34 -14.13 44.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.453 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 74.9 mtp -106.27 -2.54 22.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.001 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 4.6 mt-10 -65.58 -44.75 85.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.897 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -80.82 121.04 25.46 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -110.08 34.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.626 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -139.62 90.1 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.456 . . . . 0.0 110.886 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 25.5 t -152.62 119.2 5.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.584 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 13.6 m-85 -132.45 154.01 50.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.64 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -144.29 96.15 5.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.72 -44.08 46.94 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.558 2.172 . . . . 0.0 112.623 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.4 m-20 -58.08 -21.59 46.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.91 62.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.977 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.619 ' O ' ' OG ' ' A' ' 93' ' ' SER . 57.1 t80 -63.96 -46.43 84.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.1 pttp -66.64 -39.74 88.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.351 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.63 -46.5 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.203 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.31 -37.74 77.93 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.789 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.5 m -59.88 -48.43 81.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -65.72 -37.45 86.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.015 0.435 . . . . 0.0 111.213 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -76.94 -33.52 57.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.8 m -113.88 -16.44 12.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -57.81 137.89 56.17 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.693 -0.629 . . . . 0.0 111.974 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 49.9 m-20 69.5 14.39 8.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -117.2 149.3 40.63 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.401 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -72.17 -31.37 65.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.526 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.583 ' CD ' HH12 ' A' ' 49' ' ' ARG . 0.1 OUTLIER -142.88 156.99 45.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.318 178.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 39.7 t -152.93 135.8 15.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 111.747 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.9 132.32 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.054 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.5 146.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.735 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 107' ' ' GLY . 46.5 t -79.43 117.13 24.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.834 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.37 35.49 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.287 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.14 -121.01 0.69 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.5 t 33.42 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.242 0.544 . . . . 0.0 110.905 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.07 4.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.035 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -87.66 -7.58 57.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.374 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' O ' ' A' ' 112' ' ' PRO . 35.4 m-85 -147.76 132.82 9.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.95 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.9 Cg_exo -51.79 -148.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.702 1.601 . . . . 0.0 110.639 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.707 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 46.4 t0 -146.83 92.15 5.09 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.1 Cg_endo -79.37 -4.65 13.83 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.979 2.453 . . . . 0.0 113.241 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.493 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -167.91 67.99 0.82 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.672 0.749 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -52.26 149.81 21.46 Favored 'Trans proline' 0 C--N 1.292 -2.426 0 C-N-CA 122.487 2.124 . . . . 0.0 110.867 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.0 -4.36 76.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.871 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 77' ' ' GLN . 54.5 m -116.97 149.59 39.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.406 0.603 . . . . 0.0 110.602 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.53 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.7 t80 -83.94 112.42 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 19.0 mttt -92.22 -161.5 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.653 1.215 . . . . 0.0 114.169 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 8.3 p90 -174.91 175.98 2.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.754 -2.021 . . . . 0.0 111.046 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 62' ' ' ASN . 45.2 tp -132.57 123.45 26.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.348 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.561 ' HG2' HE21 ' A' ' 125' ' ' GLN . 84.8 tt0 -115.94 124.03 49.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 57.9 t -134.5 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.555 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.561 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.4 mp0 -113.5 128.6 56.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' A' ' 56' ' ' ILE . 47.8 p90 -146.23 162.2 38.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.128 0.489 . . . . 0.0 111.295 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -113.4 157.14 22.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.214 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.466 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.0 m -113.3 108.38 17.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.364 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.28 161.07 33.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 121.532 1.488 . . . . 0.0 111.517 179.666 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.734 ' NH1' ' SG ' ' A' ' 128' ' ' CYS . 14.4 mmt85 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.625 HH21 ' CD ' ' A' ' 123' ' ' GLU . 40.2 ttt180 -143.2 138.51 29.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.647 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.1 mp0 -135.67 139.89 44.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.123 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -137.78 136.48 37.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.914 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.835 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.61 142.47 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.564 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.6 140.79 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.518 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 81.0 tt0 -47.67 129.52 13.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.85 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 -11.49 71.97 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.92 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 24.8 m-85 -106.47 150.06 39.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.907 0.853 . . . . 0.0 109.883 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.09 152.62 45.89 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.195 1.93 . . . . 0.0 112.856 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -122.97 142.26 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.19 128.84 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.191 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 102' ' ' CYS . 36.3 mt -113.05 144.9 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.726 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 14.9 mtp180 -150.52 135.2 17.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.846 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -102.74 149.65 36.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.316 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 47.9 Cg_endo -71.63 160.15 49.05 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.027 2.485 . . . . 0.0 113.403 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.18 -126.36 22.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.587 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.5 p -113.75 23.15 13.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.361 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.22 170.2 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.751 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.16 146.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.298 0.571 . . . . 0.0 110.544 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.75 HG23 ' CD1' ' A' ' 126' ' ' TYR . 81.6 mt -68.84 136.93 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.298 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.605 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.7 ptm -132.45 98.29 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.984 0.897 . . . . 0.0 108.946 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 5.9 t -64.5 124.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.519 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.8 mt-10 -103.86 -48.92 3.78 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 20.6 m-20 -146.6 144.3 29.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.15 151.97 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.054 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.601 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.4 t30 -150.56 151.52 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.571 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -118.72 114.92 23.46 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.35 -139.56 5.92 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.091 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.696 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -153.57 119.02 5.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.026 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 11.7 p -125.44 3.96 7.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.679 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 48.2 t0 -143.48 149.24 37.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.184 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 45.1 p30 -110.5 1.21 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 1.4 mtpm? -102.7 8.43 39.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.51 137.75 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.192 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.598 ' O ' ' C ' ' A' ' 72' ' ' ASP . 63.8 m 60.3 17.45 7.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' ' O ' ' A' ' 71' ' ' CYS . 42.1 m-20 3.44 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.976 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.36 -165.22 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -61.79 146.48 90.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.22 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 14.7 Cg_endo -58.31 -40.74 73.03 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.41 2.073 . . . . 0.0 112.856 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.81 -37.81 88.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.581 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 23.4 mt-30 -83.95 -7.57 59.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -104.19 -1.48 27.13 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.98 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 91.6 mt-10 -63.31 -51.17 67.14 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -76.79 110.67 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.861 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.569 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 27.2 m -103.5 27.23 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.7 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.569 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 14.1 mm100 -140.46 87.85 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.89 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.7 t -144.74 120.95 10.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 81.7 m-85 -133.31 157.07 46.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.336 0.589 . . . . 0.0 112.221 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -147.07 87.13 6.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.501 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -47.65 -47.98 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.56 2.174 . . . . 0.0 112.865 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -56.69 -18.4 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.1 -35.2 66.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.816 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.622 ' CE1' HG12 ' A' ' 58' ' ' VAL . 81.3 t80 -65.14 -44.65 87.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.732 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.3 pttp -64.33 -42.89 96.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.782 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 68.7 mt -59.17 -44.5 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.558 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 97.2 mmm -70.49 -40.28 73.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.227 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.7 m -56.63 -43.21 80.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.368 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.53 -41.51 88.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.645 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.864 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 46.1 mtm180 -73.85 -33.53 64.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.5 m -111.55 -15.09 13.58 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 38.6 m-20 -61.65 133.7 55.92 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.159 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 66.02 14.46 9.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -116.0 148.52 40.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.595 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -70.04 -31.78 69.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.82 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.03 157.08 41.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.092 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.7 p -153.64 140.94 19.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -120.95 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.299 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.59 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 98.0 t -140.65 147.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.212 0.529 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 107' ' ' GLY . 62.1 t -81.86 115.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.052 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -69.77 38.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.842 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.6 -120.69 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.692 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.591 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.4 t 27.16 -155.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.857 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.25 -0.57 8.22 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.621 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.98 58.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.187 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -143.22 129.91 10.55 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -54.4 -146.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.662 1.575 . . . . 0.0 111.231 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.62 90.03 7.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.047 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.34 -6.12 12.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.807 2.338 . . . . 0.0 113.545 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.529 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -167.53 71.63 0.95 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.707 0.765 . . . . 0.0 112.192 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.05 141.54 56.99 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.243 2.629 . . . . 0.0 111.989 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.33 -3.29 86.67 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.621 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 77' ' ' GLN . 71.2 m -118.2 148.69 42.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.778 0.789 . . . . 0.0 110.325 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.1 t80 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.529 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.0 mttp -93.48 -160.32 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.459 1.123 . . . . 0.0 113.655 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.0 p90 -176.34 178.21 1.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.627 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 62' ' ' ASN . 24.0 tp -133.7 127.52 33.05 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.787 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.625 ' CD ' HH21 ' A' ' 37' ' ' ARG . 77.0 tt0 -119.65 129.47 54.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 48.9 t -133.26 122.93 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.86 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.47 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -109.2 128.15 54.81 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.75 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.8 p90 -156.07 170.9 21.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.767 -0.773 . . . . 0.0 112.023 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.52 159.09 34.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.436 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.734 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 78.5 m -109.8 118.82 37.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.259 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.36 157.77 48.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 C-N-CA 122.045 1.83 . . . . 0.0 112.227 179.477 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.634 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 77.5 mtt85 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.752 0.311 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.727 ' HE ' ' CD ' ' A' ' 123' ' ' GLU . 13.9 ttt180 -146.69 126.68 13.66 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.394 0.616 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.672 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 32.1 mp0 -126.13 143.35 51.16 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.024 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -139.2 145.04 38.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.995 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.06 141.19 32.76 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.23 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.81 135.47 54.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.46 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -47.71 135.44 11.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 111.444 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.63 -15.77 62.16 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.985 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 7.0 m-85 -111.4 149.75 41.09 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 118.132 0.966 . . . . 0.0 110.79 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.25 151.28 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.652 2.235 . . . . 0.0 113.033 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 tt -120.65 140.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.222 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -121.09 128.45 52.6 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.005 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.779 HD12 ' SG ' ' A' ' 96' ' ' CYS . 24.4 mt -115.82 141.42 48.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -150.74 132.91 15.35 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.933 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -102.91 143.0 25.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.839 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.58 158.76 52.95 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.579 2.186 . . . . 0.0 112.913 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.84 -137.19 40.28 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.446 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.1 p -102.08 23.89 10.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.384 -0.408 . . . . 0.0 111.14 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 75.9 m-20 -81.06 165.77 21.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 m -128.2 147.0 32.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.547 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 126' ' ' TYR . 77.8 mt -68.34 138.45 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -132.42 100.02 4.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 89' ' ' PHE . 32.6 t -65.49 125.22 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.715 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.02 -48.79 3.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.626 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -152.08 150.27 29.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.4 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.6 157.97 10.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.892 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.9 t30 -150.73 143.17 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.83 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -112.36 114.53 27.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 163.16 -134.37 3.39 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.15 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 9.7 ttm180 -156.64 117.79 3.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.499 0.666 . . . . 0.0 110.727 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 84' ' ' TYR . 15.9 p -126.22 6.35 7.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.892 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 49.0 t0 -145.31 151.72 38.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.214 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.671 ' O ' ' CE ' ' A' ' 78' ' ' MET . 54.5 p30 -110.78 3.7 19.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.956 0.408 . . . . 0.0 109.943 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -102.72 1.75 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.985 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -110.93 135.12 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.837 0.351 . . . . 0.0 110.199 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m 58.81 65.26 1.26 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.904 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -48.61 99.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.524 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -111.03 -166.93 1.12 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.272 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.84 144.97 97.96 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.419 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.86 -41.99 60.08 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.461 2.107 . . . . 0.0 112.792 -178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.85 -35.93 81.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.988 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 118' ' ' THR . 22.8 mt-30 -87.01 -6.86 58.61 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.671 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 85.1 mtp -104.68 -6.09 20.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.63 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.4 mt-10 -65.16 -47.0 78.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.216 -0.593 . . . . 0.0 112.095 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.88 117.71 19.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.8 m -109.15 32.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.837 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -143.18 88.53 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.8 t -145.84 122.18 10.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' THR . 59.0 m-85 -135.09 152.74 51.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.319 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.6 tp -145.58 88.66 6.49 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.871 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.56 -49.83 12.59 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 123.042 2.494 . . . . 0.0 113.367 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 46.5 m-20 -55.01 -19.2 6.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.55 0.214 . . . . 0.0 111.307 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.54 69.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.398 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 58' ' ' VAL . 25.6 t80 -64.62 -40.87 96.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.11 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 ptmt -65.96 -40.54 91.36 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.747 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 73.0 mt -59.61 -48.66 86.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.477 ' SD ' HG11 ' A' ' 104' ' ' VAL . 96.3 mmm -69.55 -39.54 77.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.267 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 61.3 m -59.44 -45.56 91.23 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.038 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -66.02 -36.01 82.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 61.6 mtt180 -76.63 -32.11 57.82 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 48' ' ' LEU . 76.4 m -112.94 -14.58 13.01 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.9 m-20 -61.76 134.84 57.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.488 0.661 . . . . 0.0 112.464 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 63.84 13.04 7.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -112.93 145.02 41.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.298 0.571 . . . . 0.0 109.865 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -32.71 67.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.645 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.503 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -153.02 153.74 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.4 p -152.53 156.28 39.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.06 124.75 53.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 92' ' ' MET . 59.7 t -133.44 145.66 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.514 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.6 116.71 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.126 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.71 36.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.19 -123.33 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.599 ' O ' ' O ' ' A' ' 107' ' ' GLY . 20.9 t 31.28 -160.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.73 1.68 0.82 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.384 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -85.1 -13.77 49.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.069 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.8 m-85 -145.23 129.94 9.02 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.414 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.3 Cg_exo -51.79 -144.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.057 1.838 . . . . 0.0 111.182 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.649 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 15.2 t0 -146.42 87.25 6.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.235 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.478 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.1 Cg_endo -77.74 -4.44 14.53 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.749 2.299 . . . . 0.0 113.466 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.613 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.11 63.35 0.82 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.289 0.566 . . . . 0.0 111.669 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.41 145.81 65.9 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 121.763 1.642 . . . . 0.0 110.463 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.16 -8.54 79.38 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.0 m -122.72 148.85 44.84 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.687 -0.302 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.5 t80 -84.05 118.4 24.04 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.649 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 11.6 mttp -94.61 -160.52 0.78 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.592 1.187 . . . . 0.0 113.798 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -172.4 173.29 4.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.953 -1.931 . . . . 0.0 110.669 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.8 tp -131.99 125.01 30.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.719 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.727 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 10.2 tp10 -120.01 127.48 52.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.85 123.23 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.359 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.506 HE21 ' HG3' ' A' ' 123' ' ' GLU . 1.8 mt-30 -106.95 129.12 54.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.902 ' CD1' HG23 ' A' ' 56' ' ' ILE . 33.0 p90 -154.04 171.97 18.23 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.439 0.637 . . . . 0.0 112.077 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.475 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 97.8 m-20 -129.06 161.7 29.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.578 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.634 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.9 m -111.55 127.77 55.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.236 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 33.6 m -132.5 153.58 81.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.09 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 C--N 1.312 -1.377 0 C-N-CA 121.531 1.488 . . . . 0.0 112.165 -178.68 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 36' ' ' ARG . 56.5 mtp85 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.617 HH11 ' HG3' ' A' ' 123' ' ' GLU . 66.7 ttp85 -148.82 138.95 22.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.545 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HG3' HD23 ' A' ' 48' ' ' LEU . 77.4 mm-40 -130.19 145.79 51.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.791 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -137.33 142.98 41.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.898 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.63 139.71 36.78 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.6 m -65.81 137.25 57.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.107 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 76.5 tt0 -45.08 129.39 7.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.12 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.92 -12.41 67.17 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.029 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.17 148.72 38.93 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 118.532 1.166 . . . . 0.0 110.349 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.07 150.47 88.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.783 2.322 . . . . 0.0 112.884 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 104' ' ' VAL . 21.0 tt -116.64 149.42 18.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.666 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 35.6 tt0 -132.0 129.83 40.64 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.899 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.8 mt -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.334 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.666 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 89.2 mtt180 -147.76 132.42 17.84 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.023 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.5 m -98.51 146.69 32.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 34.4 Cg_endo -67.37 158.86 55.05 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.866 2.377 . . . . 0.0 112.069 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.1 -119.05 5.7 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.213 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.4 p -121.52 23.82 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.595 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -76.08 169.53 18.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.97 149.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.847 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.669 HG23 ' CD2' ' A' ' 126' ' ' TYR . 59.6 mt -70.35 136.73 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.219 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -131.7 98.12 4.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.4 t -65.09 125.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.231 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -100.23 -48.11 4.72 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -152.21 150.56 29.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.253 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.27 156.71 12.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.1 t30 -151.39 142.28 22.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.357 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -112.39 116.94 31.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.59 -139.73 6.05 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.343 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.612 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.0 ttm-85 -152.1 117.44 5.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.078 0.466 . . . . 0.0 111.697 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 p -124.3 4.82 8.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.183 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.4 t0 -149.76 157.23 43.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 36.6 p30 -113.05 5.53 17.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.964 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 28.2 mttt -105.16 3.67 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.569 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.2 mm -112.5 136.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.803 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.8 m 52.55 76.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p30 -54.36 119.25 4.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.407 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.71 -164.86 1.52 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.531 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.7 p-10 -66.35 140.36 96.69 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.331 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.1 Cg_endo -53.26 -38.46 81.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.42 2.08 . . . . 0.0 113.57 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.52 -36.99 84.31 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.154 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.517 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 23.5 mt-30 -85.56 -9.89 56.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.521 ' HE3' HH22 ' A' ' 65' ' ' ARG . 82.4 mtp -103.89 -3.79 24.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.145 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.0 mt-10 -64.62 -48.22 75.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -81.61 116.31 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.548 0.69 . . . . 0.0 112.374 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.567 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -106.57 36.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.017 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -141.38 86.88 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.155 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.501 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.7 t -147.92 119.18 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.482 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.6 m-85 -131.4 153.44 49.68 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.302 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.9 tp -147.41 88.12 5.84 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.655 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -47.73 -47.57 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.277 1.985 . . . . 0.0 112.402 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -52.59 -25.53 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.334 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -54.91 -36.29 65.05 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.947 0.403 . . . . 0.0 111.22 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CE1' HG12 ' A' ' 58' ' ' VAL . 76.2 t80 -64.46 -42.27 96.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.6 pttm -64.82 -39.82 94.19 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.104 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.429 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.6 mt -59.83 -46.65 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.83 -35.98 79.55 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.938 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.0 m -58.85 -45.74 89.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.9 -40.51 91.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.235 0.54 . . . . 0.0 110.847 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.78 -35.49 72.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.352 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.737 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -112.8 -14.72 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.577 ' CG ' ' O ' ' A' ' 93' ' ' SER . 30.3 m-20 -62.3 132.24 51.99 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.079 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 63.76 13.17 7.23 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.27 146.45 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.291 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.7 m -69.83 -32.68 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.312 0.577 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 158.14 43.47 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.484 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.899 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.5 p -156.81 139.44 15.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -124.07 125.1 70.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 46' ' ' ILE . 43.5 t -134.86 146.34 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.938 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.0 t -77.83 118.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.262 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.14 35.77 0.05 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.086 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.675 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.44 -117.51 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 27.97 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.207 0.527 . . . . 0.0 111.608 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.76 1.97 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.392 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.73 -13.78 47.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.399 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.9 m-85 -145.72 130.19 8.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.113 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 111' ' ' PHE . 45.2 Cg_exo -51.53 -146.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.282 1.988 . . . . 0.0 112.027 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 17.9 t0 -145.27 84.57 8.51 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.622 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.24 -4.95 14.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.345 2.696 . . . . 0.0 113.527 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.578 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.88 60.74 0.58 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.111 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.35 147.47 21.74 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.56 -11.25 70.68 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.664 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.92 150.33 35.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.466 0.633 . . . . 0.0 109.913 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.612 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 27.8 t80 -82.16 111.95 18.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.578 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.0 mttp -90.73 -163.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.824 1.297 . . . . 0.0 113.539 -176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.3 p90 -173.58 175.81 2.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.807 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.7 tp -133.0 126.72 32.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HG3' HH11 ' A' ' 37' ' ' ARG . 79.5 tt0 -121.34 128.66 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.607 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' HB1' ' A' ' 61' ' ' ALA . 45.1 t -132.89 123.61 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.377 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.443 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mp0 -105.36 127.61 53.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.669 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.7 p90 -152.88 167.97 27.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.886 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -128.46 161.94 28.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.18 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.3 m -111.05 116.5 31.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.97 158.98 41.02 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.311 -1.425 0 C-N-CA 121.793 1.662 . . . . 0.0 111.38 178.527 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.535 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 65.3 mtp85 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -151.45 140.83 21.48 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 48' ' ' LEU . 59.2 mm-40 -133.18 145.31 50.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.011 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -135.6 133.15 37.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.849 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.748 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.93 140.54 46.85 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.377 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.2 m -66.48 136.21 55.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.271 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -48.63 134.68 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.73 -18.54 56.34 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.718 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -104.1 153.17 39.1 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 118.114 0.957 . . . . 0.0 108.905 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.98 154.41 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.259 1.973 . . . . 0.0 112.614 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 tt -119.62 151.09 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.853 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.691 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 55.5 tt0 -131.78 130.65 42.1 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' SG ' ' A' ' 102' ' ' CYS . 34.4 mt -120.68 138.96 53.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.158 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.691 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 55.9 mtt180 -148.31 129.64 14.73 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.816 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -98.69 143.97 27.31 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 30.4 Cg_endo -66.48 162.28 37.35 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.93 2.42 . . . . 0.0 113.267 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -121.26 9.34 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.792 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -120.62 26.18 9.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -77.88 169.51 18.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.662 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.87 145.86 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.427 0.632 . . . . 0.0 110.884 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.831 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.8 mt -68.77 138.49 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.928 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.2 ptm -130.62 104.04 6.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.565 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.5 t -68.54 124.73 24.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.168 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -105.01 -51.57 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -147.01 142.96 28.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.13 0.49 . . . . 0.0 110.479 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.981 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -163.19 152.42 14.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.406 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.5 t30 -148.75 143.92 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -114.93 120.0 38.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.99 -135.2 3.87 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.736 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.3 ttm-85 -154.09 116.83 4.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.364 0.602 . . . . 0.0 111.157 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.508 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.7 p -124.02 4.33 8.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.877 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 16.7 t70 -144.67 151.96 39.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 26.7 p30 -109.17 0.47 19.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 43.3 mtpt -101.22 3.22 40.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.287 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 70' ' ' ILE . 21.0 mm -109.71 137.27 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.809 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.0 m 55.66 66.24 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 10.5 p30 -50.58 111.63 0.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.935 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.54 -161.89 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -58.8 136.96 87.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.673 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.9 Cg_endo -59.39 -33.45 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.834 1.69 . . . . 0.0 112.63 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -62.68 -33.91 76.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.658 0.266 . . . . 0.0 110.878 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 118' ' ' THR . 22.6 mt-30 -85.64 -17.99 34.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.419 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.3 mtp -97.72 -0.35 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.454 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -60.99 -50.74 72.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.475 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.3 t30 -76.48 113.93 14.63 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.25 -0.281 . . . . 0.0 111.595 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.68 25.61 2.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.089 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -137.87 82.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.277 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.1 t -143.98 121.86 12.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.474 ' HA ' HD21 ' A' ' 62' ' ' ASN . 90.6 m-85 -130.4 154.78 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.405 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.466 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.1 tp -144.86 90.65 6.24 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.89 -44.74 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.783 2.322 . . . . 0.0 113.06 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -55.21 -21.15 12.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.67 71.17 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.745 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.0 t80 -65.06 -44.69 88.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.851 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.7 pttm -63.62 -43.43 96.87 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.863 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 59.0 mt -58.44 -50.59 78.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.552 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 1.5 mtp -69.62 -32.34 70.98 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.474 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.456 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 58.2 m -61.12 -45.4 94.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.207 0.527 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.16 -37.71 84.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.36 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.712 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 99.6 mtt180 -78.1 -33.14 50.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.0 m -111.52 -19.22 12.63 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -61.5 138.97 58.3 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.605 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 62.52 12.54 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.499 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.712 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 65.7 mtt180 -114.93 147.47 39.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.149 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 m -70.75 -34.52 71.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.162 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.74 155.46 39.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.729 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.918 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.8 p -154.07 132.78 12.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.83 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.42 132.21 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.696 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG13 ' NH1' ' A' ' 95' ' ' ARG . 86.6 t -144.96 151.67 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.624 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 107' ' ' GLY . 90.6 t -83.83 114.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.04 41.32 0.1 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.8 -126.07 0.98 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.325 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.606 ' O ' ' O ' ' A' ' 107' ' ' GLY . 5.0 t 28.49 -156.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.076 0.465 . . . . 0.0 111.24 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.38 1.4 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.828 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.3 -8.98 58.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.849 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -144.1 134.49 12.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.926 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.3 Cg_exo -58.86 -150.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.92 1.747 . . . . 0.0 111.929 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.638 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 26.1 t0 -144.9 92.5 5.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.468 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.21 -10.84 14.92 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.729 2.286 . . . . 0.0 112.625 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.3 p -171.15 87.96 0.47 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.301 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.13 157.75 55.71 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.38 12.01 84.3 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.699 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.6 m -126.32 146.62 49.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.037 0.418 . . . . 0.0 110.137 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.683 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.5 t80 -82.66 107.18 15.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.638 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 24.9 mttt -88.99 -164.1 1.09 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.638 1.208 . . . . 0.0 113.019 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.3 p90 -171.89 174.81 4.06 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.771 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 20.6 tp -132.37 124.7 29.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.429 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG2' HE21 ' A' ' 125' ' ' GLN . 78.7 tt0 -122.53 124.31 43.26 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.981 HG13 ' HB2' ' A' ' 61' ' ' ALA . 6.0 t -133.18 130.54 57.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.638 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.505 HE21 ' HG2' ' A' ' 123' ' ' GLU . 7.2 mp0 -109.91 132.66 53.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.719 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.831 ' CD2' HG23 ' A' ' 56' ' ' ILE . 49.4 p90 -152.83 168.45 25.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.416 0.627 . . . . 0.0 111.896 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.497 ' H ' ' HG2' ' A' ' 57' ' ' MET . 71.1 m-20 -126.22 158.24 36.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.434 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.535 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 74.7 m -108.53 124.89 51.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.528 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 m -126.53 159.37 63.76 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo . . . . . 0 N--CA 1.492 1.388 0 C-N-CA 121.537 1.491 . . . . 0.0 111.854 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.729 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 52.4 mtt-85 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -146.71 137.41 23.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.613 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 19.1 mt-10 -135.54 144.91 46.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.593 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.19 137.7 37.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.768 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -135.3 139.24 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.304 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.12 140.41 58.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.29 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -45.97 129.62 9.67 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.785 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.42 -12.51 69.5 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.708 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -104.15 155.21 37.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 118.248 1.024 . . . . 0.0 109.396 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.16 153.5 36.43 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.71 1.607 . . . . 0.0 112.577 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.7 tt -125.06 143.23 39.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.0 tt0 -126.88 130.52 50.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.124 0.488 . . . . 0.0 112.165 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.3 mt -114.18 141.71 47.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -148.1 131.16 16.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.754 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.04 142.03 23.8 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.49 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 24.2 Cg_endo -69.6 161.66 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.269 1.979 . . . . 0.0 112.208 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.64 20.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.719 0.621 . . . . 0.0 112.311 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -101.17 21.2 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.06 165.0 25.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.21 144.04 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.792 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -67.81 134.84 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.733 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.641 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.8 ptm -130.46 100.59 5.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.511 0.672 . . . . 0.0 109.232 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.2 t -70.41 124.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.866 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.22 -43.73 4.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -146.23 143.42 29.21 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.02 149.11 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.531 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 84' ' ' TYR . 7.5 t30 -148.74 152.12 36.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 76.2 t80 -121.57 120.11 33.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.81 -134.91 3.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -159.7 119.79 3.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.215 0.531 . . . . 0.0 111.463 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.9 8.3 8.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.085 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.57 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 44.8 t0 -144.1 150.63 38.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.369 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 14.6 p30 -104.46 -1.11 27.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 8.1 mtmp? -105.03 10.86 33.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.37 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.556 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 12.5 mm -107.52 135.03 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' ALA . 71.8 m 56.76 67.37 1.0 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 52.2 p-10 -46.35 93.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.594 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -111.82 -162.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.645 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p-10 -63.68 140.52 97.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.578 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 5.5 Cg_endo -56.54 -38.94 94.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.596 2.197 . . . . 0.0 113.526 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 2.9 m-30 -61.4 -36.53 80.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.333 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.479 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 20.4 mt-30 -86.52 -11.79 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.434 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 78.6 mmm -101.95 -3.11 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 43.9 mt-10 -66.26 -44.69 82.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -78.61 114.02 17.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.99 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.6 m -105.67 32.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -142.13 85.93 1.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.313 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 21.7 t -143.81 125.67 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.9 m-85 -135.66 149.73 49.39 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.3 tp -148.9 88.5 5.16 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.438 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.07 -44.24 47.1 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.503 2.135 . . . . 0.0 113.848 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 83.1 m-20 -53.7 -24.58 15.06 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.188 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.22 -34.26 44.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 40.2 t80 -64.79 -42.24 95.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.478 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.52 -36.18 83.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.028 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.538 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 71.5 mt -62.99 -50.37 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.258 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.99 -38.63 86.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 42.0 m -58.15 -45.74 86.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.56 -36.51 82.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.686 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 70.1 mtt180 -78.74 -31.36 46.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.8 m -111.81 -19.9 12.26 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 84.5 m-20 -56.6 134.04 54.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.406 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 67.12 13.14 9.33 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.786 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.686 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 75.2 mtt180 -113.0 146.0 39.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.36 0.6 . . . . 0.0 110.132 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.9 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.488 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 155.76 40.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -154.6 146.3 23.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.419 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.47 127.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.743 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' NH1' ' A' ' 95' ' ' ARG . 48.5 t -137.12 143.81 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.353 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.2 t -78.1 115.29 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.759 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.84 35.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.212 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.51 -119.92 0.65 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.302 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.2 t 31.26 -160.38 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.405 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.12 1.67 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.25 -13.49 55.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.9 m-85 -144.36 131.98 10.57 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.819 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 111' ' ' PHE . 21.7 Cg_exo -56.6 -147.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.104 1.869 . . . . 0.0 112.345 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -146.21 86.28 7.08 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.492 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.22 -9.92 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.544 2.163 . . . . 0.0 112.814 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -166.38 77.19 1.14 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.654 0.74 . . . . 0.0 111.05 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.25 149.93 42.97 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.337 2.025 . . . . 0.0 110.857 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.2 -4.93 64.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.386 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.3 m -113.25 148.32 35.78 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.932 0.866 . . . . 0.0 109.343 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.745 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.1 t80 -84.94 113.7 21.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 13.7 mtmm -93.87 -162.9 0.98 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.854 1.312 . . . . 0.0 113.82 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.9 p90 -168.84 170.29 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.55 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 62' ' ' ASN . 39.7 tp -128.89 124.67 35.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 126.31 49.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 61' ' ' ALA . 22.8 t -130.88 125.18 57.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.561 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -105.8 127.88 53.38 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.247 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.645 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.4 p90 -151.48 170.3 19.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.353 0.597 . . . . 0.0 111.372 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.477 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.5 m-20 -127.47 158.75 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.057 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.729 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 86.7 m -108.05 114.74 28.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.74 158.26 45.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.951 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo . . . . . 0 N--CA 1.498 1.767 0 C-N-CA 122.29 1.994 . . . . 0.0 112.798 179.62 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.703 0.763 . . . . 0.0 111.194 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 54.9 mp0 -134.21 140.16 46.3 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.433 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -137.74 135.33 36.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.822 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.794 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.22 136.64 56.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.991 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -46.67 133.11 10.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.336 0.589 . . . . 0.0 112.526 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.74 -13.28 67.48 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.593 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.94 147.03 34.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 118.437 1.118 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.99 147.71 89.22 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.391 2.061 . . . . 0.0 112.064 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.0 tt -117.68 147.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.68 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.4 tt0 -123.15 129.47 51.47 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.096 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.5 mt -118.0 137.31 52.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.68 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 87.3 mtt180 -149.2 127.85 12.42 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -95.45 149.55 36.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.557 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 49.2 Cg_endo -72.11 157.41 54.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.951 2.434 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 48.43 -134.96 19.15 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.912 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -101.82 24.12 10.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -78.45 164.96 24.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.5 146.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.662 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.6 mt -67.62 133.53 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.627 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -130.71 99.1 4.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.66 HG12 ' CE1' ' A' ' 89' ' ' PHE . 34.1 t -66.45 124.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.913 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -108.75 -47.33 3.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.203 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -146.85 145.82 29.99 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.309 0.576 . . . . 0.0 110.324 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.93 155.73 16.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.594 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.4 t30 -147.13 138.57 24.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.212 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -115.36 117.65 31.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.5 -135.26 4.06 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 17.8 ttm180 -155.21 117.76 4.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.367 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' CE2' ' A' ' 84' ' ' TYR . 5.1 p -123.45 5.79 9.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -146.97 154.08 40.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.236 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 36.9 p30 -113.69 2.44 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.357 . . . . 0.0 110.426 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 30.0 mttp -103.65 6.69 37.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.7 mm -108.28 135.62 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.895 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m 52.18 71.89 0.43 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 10.3 p-10 -45.03 114.34 0.71 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.847 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.14 -169.32 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.553 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.663 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -61.05 139.41 94.25 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.6 Cg_endo -57.83 -34.49 98.34 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.149 1.899 . . . . 0.0 112.988 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -64.72 -35.49 81.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.793 ' O ' HG23 ' A' ' 118' ' ' THR . 22.8 mt-30 -86.93 -13.43 44.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.607 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.498 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mtm -104.61 0.85 29.01 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.598 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 3.7 mt-10 -67.31 -43.83 80.68 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -79.87 114.26 18.66 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.692 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -104.55 34.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 79.9 mm-40 -141.07 84.44 1.93 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.05 119.17 8.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.4 m-85 -132.49 152.56 51.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.695 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.606 HD21 ' HG2' ' A' ' 112' ' ' PRO . 53.1 tp -142.09 87.6 9.64 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.91 -50.26 11.12 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.0 -26.97 40.6 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.56 -33.42 45.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.89 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 58' ' ' VAL . 15.5 t80 -64.71 -43.9 91.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.24 -38.75 92.38 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.247 -178.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -59.94 -51.81 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.814 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.649 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.1 mtp -68.44 -33.02 73.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.175 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 33.2 m -59.89 -45.54 92.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 54.8 mt-30 -64.68 -37.75 88.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.35 0.595 . . . . 0.0 110.957 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.676 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 25.2 mtp180 -75.86 -33.11 59.99 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.532 ' N ' HH21 ' A' ' 99' ' ' ARG . 6.9 m -113.7 -14.01 12.63 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.774 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 53.8 m-20 -60.06 131.65 51.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.844 -0.743 . . . . 0.0 111.641 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 66.59 13.2 9.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.902 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 97' ' ' ASN . 29.6 mtm-85 -111.29 144.29 40.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.9 m -71.18 -30.51 66.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 154.09 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.428 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.2 p -154.69 137.26 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.712 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.79 128.63 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.656 HG22 ' HE ' ' A' ' 95' ' ' ARG . 23.1 t -141.04 151.87 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.158 0.504 . . . . 0.0 112.051 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 108' ' ' SER . 45.2 t -82.16 116.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.005 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.6 39.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.96 -120.68 0.69 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.709 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER 31.87 -161.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 110.76 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.709 ' N ' ' OG ' ' A' ' 108' ' ' SER . 66.5 m-20 -68.93 2.9 2.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.419 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.07 -11.99 48.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.68 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.0 m-85 -142.87 126.89 9.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.001 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.606 ' HG2' HD21 ' A' ' 85' ' ' LEU . 18.1 Cg_exo -50.78 -148.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.34 2.026 . . . . 0.0 111.765 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.652 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 32.4 t0 -144.48 85.59 8.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -5.1 14.73 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.901 2.401 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.477 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.5 p -166.04 67.31 1.07 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.546 0.689 . . . . 0.0 111.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 142.73 98.67 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 121.997 1.798 . . . . 0.0 110.269 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.25 69.57 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -122.87 147.06 47.0 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 19.3 t80 -81.28 118.44 22.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.652 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 33.9 mttt -92.17 -162.11 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 123.091 1.424 . . . . 0.0 113.868 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -170.54 172.92 5.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.543 -2.117 . . . . 0.0 110.876 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.649 HD21 ' SD ' ' A' ' 92' ' ' MET . 45.0 tp -132.92 123.76 26.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -121.09 126.28 49.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.592 HG21 ' SD ' ' A' ' 92' ' ' MET . 59.0 t -127.4 121.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.258 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -104.23 125.4 50.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.6 p90 -153.92 169.03 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.002 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -124.2 159.39 30.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.259 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.9 m -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.18 153.56 68.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.105 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 C--N 1.313 -1.315 0 C-N-CA 121.636 1.557 . . . . 0.0 111.331 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.446 HH21 ' HG3' ' A' ' 51' ' ' PRO . 78.3 mtt-85 . . . . . 0 N--CA 1.448 -0.569 0 CA-C-O 121.126 0.488 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HE ' ' HG3' ' A' ' 123' ' ' GLU . 58.4 ttt180 -145.46 130.06 17.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.73 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.1 mm-40 -127.8 143.1 51.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.677 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -138.21 135.24 35.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.805 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -132.48 138.18 47.48 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.351 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 14.3 m -65.32 136.83 57.03 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -45.78 132.67 8.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 0.0 112.348 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.53 -12.58 66.22 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.195 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.3 149.21 40.24 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.536 1.168 . . . . 0.0 110.316 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.36 151.46 85.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.68 2.254 . . . . 0.0 113.02 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.4 tt -119.12 144.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -128.7 128.45 44.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.302 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' SG ' ' A' ' 102' ' ' CYS . 33.5 mt -116.38 141.18 48.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.073 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 49' ' ' ARG . 17.7 mtp180 -148.13 135.05 20.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.809 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.0 m -102.36 141.03 21.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.853 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HG3' HH21 ' A' ' 36' ' ' ARG . 29.4 Cg_endo -67.16 157.74 60.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.469 2.112 . . . . 0.0 112.332 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.76 -134.49 11.13 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.604 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 p -99.82 22.12 11.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.505 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.32 167.3 21.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.07 148.81 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 111.461 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.832 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.2 mt -72.41 138.43 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.723 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.8 ptm -133.26 103.71 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 89' ' ' PHE . 38.4 t -66.75 124.98 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.18 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 86.3 mt-10 -105.6 -51.13 3.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.963 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -146.85 147.52 30.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.103 0.478 . . . . 0.0 110.126 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.606 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.68 157.53 10.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.56 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 122' ' ' LEU . 15.0 t30 -151.1 148.94 28.92 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.275 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -118.57 115.24 24.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.86 -136.3 4.25 Favored Glycine 0 C--N 1.319 -0.379 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 10.2 ttm-85 -156.68 117.1 3.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.204 0.526 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 p -121.68 9.58 10.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.567 ' C ' HG12 ' A' ' 81' ' ' VAL . 35.3 t0 -145.58 -174.82 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 50.1 p30 -141.33 -0.03 1.46 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.199 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 54.2 mttm -101.52 5.3 41.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.137 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 32.2 mm -107.59 133.64 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.963 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.9 m 52.72 75.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.932 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 36.1 t0 -55.11 106.77 0.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.091 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HG3' ' A' ' 78' ' ' MET . . . -118.72 -164.6 1.05 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.295 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.703 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -60.79 142.14 92.3 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.303 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 9.5 Cg_endo -55.34 -39.09 92.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.462 2.108 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -64.51 -36.24 83.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.423 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.55 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.6 mt-30 -89.34 -6.59 56.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.692 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.554 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 61.3 mmm -115.47 -1.31 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.164 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.0 mt-10 -67.47 -42.79 82.44 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -79.98 120.62 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.567 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.9 m -111.25 34.7 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.816 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.83 85.39 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.804 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.6 t -149.21 124.88 10.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.285 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' HA ' HD21 ' A' ' 62' ' ' ASN . 92.7 m-85 -132.6 149.77 52.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.723 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 112' ' ' PRO . 51.0 tp -142.1 94.84 6.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -54.34 -47.63 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.948 2.432 . . . . 0.0 114.106 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.1 m-20 -55.13 -26.09 36.17 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.692 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.95 51.38 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.91 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 58' ' ' VAL . 35.7 t80 -66.81 -47.17 72.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 6.0 pttm -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -59.27 -50.85 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.729 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 1.016 ' SD ' HD21 ' A' ' 122' ' ' LEU . 6.0 mtp -68.46 -33.62 74.51 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.505 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.5 m -59.59 -44.04 93.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.934 ' HE ' HG22 ' A' ' 104' ' ' VAL . 75.5 mtp85 -76.21 -34.57 59.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.625 ' SG ' HD12 ' A' ' 48' ' ' LEU . 37.5 m -113.69 -11.47 12.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 93' ' ' SER . 59.1 m-20 -62.79 134.77 56.77 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.653 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 67.62 14.93 9.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -114.58 147.43 39.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.112 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.5 m -70.11 -32.98 71.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 158.44 44.15 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.509 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.822 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.5 p -157.02 145.0 19.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.384 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.94 128.43 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.934 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.5 t -138.14 140.72 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.168 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 107' ' ' GLY . 48.4 t -77.45 116.39 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.27 38.56 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.127 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.643 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.86 -119.43 0.63 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.643 ' O ' ' O ' ' A' ' 107' ' ' GLY . 48.4 t 27.55 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.291 0.567 . . . . 0.0 111.776 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.523 ' N ' ' OG ' ' A' ' 108' ' ' SER . 91.4 m-20 -68.83 1.85 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.01 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.11 54.67 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.064 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -144.88 129.95 9.26 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.152 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.3 Cg_exo -51.03 -148.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.85 2.366 . . . . 0.0 112.461 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.05 89.45 6.04 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.529 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.97 -10.31 18.07 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.009 2.473 . . . . 0.0 114.095 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.411 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -170.81 69.76 0.53 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.92 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.33 155.51 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.082 1.855 . . . . 0.0 111.531 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.88 85.14 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.7 m -126.27 149.91 48.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 41.8 t80 -83.99 113.54 21.07 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 21.2 mttp -90.06 -162.84 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.314 1.054 . . . . 0.0 113.376 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -171.77 172.75 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.091 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.016 HD21 ' SD ' ' A' ' 92' ' ' MET . 28.0 tp -132.77 126.57 32.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.575 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 81.9 tt0 -122.05 126.06 47.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.783 HG21 ' SD ' ' A' ' 92' ' ' MET . 47.4 t -130.55 127.87 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.24 127.0 53.9 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.832 ' CD2' HG23 ' A' ' 56' ' ' ILE . 46.2 p90 -151.37 162.12 41.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.635 . . . . 0.0 112.146 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.417 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 78.5 m-20 -117.96 158.99 23.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.592 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 36' ' ' ARG . 95.6 m -109.93 108.6 18.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.719 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.77 156.67 43.37 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.757 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 122.079 1.852 . . . . 0.0 112.316 178.568 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.584 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 48.9 ttp180 -146.92 136.94 23.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.605 . . . . 0.0 111.289 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.599 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 18.6 mp0 -130.77 141.33 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.595 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.03 144.11 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.817 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.868 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.82 140.04 34.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.662 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -48.18 133.81 14.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.374 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.54 -15.58 62.98 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.187 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -107.09 147.35 34.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.927 0.863 . . . . 0.0 111.323 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.41 149.68 75.16 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.739 2.293 . . . . 0.0 112.445 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -120.92 143.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.585 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -121.29 129.33 53.07 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.275 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.781 HD12 ' SG ' ' A' ' 102' ' ' CYS . 60.9 mt -117.23 140.1 49.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.548 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -152.19 134.05 14.83 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.549 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.7 m -95.22 137.9 22.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.99 164.71 32.71 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.517 1.478 . . . . 0.0 110.85 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.53 -140.19 29.71 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.703 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 p -106.38 21.3 17.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.757 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.35 170.19 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.714 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.07 144.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.0 0.429 . . . . 0.0 110.665 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 94.8 mt -69.02 138.43 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.299 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.5 ptp -130.95 100.94 5.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.0 t -64.79 123.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.04 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -101.38 -48.85 4.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -148.63 146.59 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.415 0.626 . . . . 0.0 110.9 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.798 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.12 152.1 12.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.147 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.3 t30 -148.74 144.44 27.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.841 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -115.63 118.88 34.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.27 -135.33 4.01 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.4 ttm180 -155.58 118.7 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.317 0.579 . . . . 0.0 111.753 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 25.9 p -125.21 3.62 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.739 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 52.8 t0 -146.42 154.64 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.792 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.659 ' O ' ' CE ' ' A' ' 78' ' ' MET . 29.3 p30 -113.73 0.34 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.777 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -102.48 7.9 40.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.767 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.1 133.78 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.1 m 49.49 83.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -61.05 106.02 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -112.44 -166.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.178 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -64.54 139.97 97.88 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.467 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -52.92 -39.38 78.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.375 2.05 . . . . 0.0 113.212 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -64.77 -36.32 83.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.725 0.298 . . . . 0.0 111.468 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 21.6 mt-30 -85.74 -6.67 59.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.646 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.659 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 95.1 mtp -105.6 -4.8 20.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.181 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.2 mt-10 -63.25 -47.55 81.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.982 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -79.33 119.57 22.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.7 m -108.79 33.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.824 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -141.41 83.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.464 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 37.1 t -142.8 123.24 13.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -135.07 156.17 49.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 112' ' ' PRO . 50.9 tp -148.04 88.68 5.44 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.877 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.18 -48.18 13.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.791 2.327 . . . . 0.0 113.16 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 79.3 m-20 -57.26 -21.85 37.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.49 -35.11 67.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.474 ' CE1' HG12 ' A' ' 58' ' ' VAL . 60.2 t80 -65.05 -45.04 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.124 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.688 ' O ' ' NE2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -66.02 -35.88 81.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.255 -179.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.569 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 76.5 mt -61.96 -50.12 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.625 0.25 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 53.8 mtp -71.44 -34.23 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.301 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.2 m -59.85 -46.2 90.04 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.564 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.56 -35.22 79.69 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.748 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.618 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 28.4 mtp180 -76.72 -34.26 58.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.1 m -113.02 -10.1 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.592 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -63.45 132.52 51.65 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 65.77 13.14 8.81 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -111.55 144.58 40.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.303 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -72.08 -30.58 65.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.994 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.34 152.4 35.76 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.315 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.781 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -156.78 131.61 8.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.03 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -116.85 134.07 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.787 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.618 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 61.0 t -143.68 150.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.2 t -82.23 117.46 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.436 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.84 39.95 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.769 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.95 -120.45 0.68 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.87 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 28.04 -157.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.489 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -69.02 -1.04 6.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.99 -16.3 47.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.6 m-85 -139.57 130.08 14.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.553 ' HG2' HD21 ' A' ' 85' ' ' LEU . 39.7 Cg_exo -52.93 -149.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.255 1.97 . . . . 0.0 111.186 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.524 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 28.3 t0 -145.34 82.64 9.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 70.1 Cg_endo -73.01 -6.05 18.3 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.728 2.286 . . . . 0.0 113.65 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.89 68.54 0.98 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.422 0.629 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -52.42 149.02 24.47 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.249 1.966 . . . . 0.0 111.197 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.16 -0.49 83.65 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.5 m -118.54 148.68 42.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.619 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 41.3 t80 -86.04 111.6 20.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.524 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 12.1 mttt -91.52 -162.61 0.94 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.149 1.452 . . . . 0.0 113.964 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.484 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.1 p90 -173.84 176.11 2.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 112.152 -2.295 . . . . 0.0 110.143 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 40.4 tp -130.82 120.74 24.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.8 tt0 -118.14 129.73 55.7 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.836 HG21 ' SD ' ' A' ' 92' ' ' MET . 93.5 t -137.21 127.24 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.542 ' NE2' ' N ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -107.48 131.84 53.86 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.506 ' CD1' HG23 ' A' ' 56' ' ' ILE . 22.7 p90 -155.78 171.91 19.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.647 0.736 . . . . 0.0 112.622 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 72.7 m-20 -130.37 158.87 38.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.027 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.0 m -112.13 109.1 18.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -104.95 156.24 36.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.967 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 C-N-CA 121.981 1.787 . . . . 0.0 110.732 179.234 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.749 0.309 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 47.9 ttp180 -141.79 137.72 31.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.1 mp0 -133.47 137.43 45.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.828 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.4 tt -139.02 139.49 37.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.939 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.745 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.37 141.85 35.59 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.848 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -63.95 134.91 55.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.278 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -46.21 131.47 10.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.66 67.7 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.375 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 145.47 31.76 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.655 1.228 . . . . 0.0 111.661 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.0 149.95 89.41 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.083 2.522 . . . . 0.0 112.519 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 tt -122.07 145.97 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 83.7 tt0 -125.79 127.53 46.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.09 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 46.1 mt -116.21 145.76 42.86 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.852 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.678 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 87.6 mtt-85 -151.2 135.96 17.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.303 0.573 . . . . 0.0 112.033 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.477 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.4 m -100.49 137.77 20.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.837 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.7 157.8 53.9 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.331 2.02 . . . . 0.0 111.623 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.14 -126.1 29.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.447 -0.406 . . . . 0.0 112.522 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -116.52 24.24 11.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.093 0.473 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.31 169.4 18.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.61 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.98 144.98 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 111.018 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -67.41 136.99 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.988 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -132.35 100.02 4.87 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' HE1' ' A' ' 89' ' ' PHE . 38.2 t -63.87 123.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.705 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.5 mm-40 -101.6 -51.57 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.941 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 66.2 m-20 -149.11 143.18 25.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.624 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -162.75 155.24 18.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.079 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.4 t30 -152.34 146.76 25.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.653 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -114.02 115.1 27.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.1 -136.54 4.29 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.203 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.5 ttm180 -162.17 122.4 2.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.277 0.561 . . . . 0.0 111.905 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 43.5 p -123.72 12.52 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.593 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 29.7 t0 -146.82 -168.72 3.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 44.6 p30 -146.88 4.57 0.85 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.705 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 59.0 mttt -103.45 0.43 31.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.63 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.86 138.46 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.913 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.3 m 53.49 72.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.324 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -57.25 120.32 7.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.512 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.46 -161.71 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -57.55 133.74 82.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.235 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -55.61 -34.48 90.33 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.613 1.542 . . . . 0.0 111.715 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -61.44 -39.19 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.392 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' HG23 ' A' ' 118' ' ' THR . 19.9 mt-30 -83.94 -10.28 58.07 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.02 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.519 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 86.3 mtp -103.2 -1.93 28.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.019 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 54.9 mm-40 -63.84 -45.76 88.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.44 114.64 19.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.77 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 19.2 m -104.64 34.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.104 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.692 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.1 mm-40 -142.72 84.17 1.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.251 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.4 t -142.01 126.05 17.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' HD21 ' A' ' 62' ' ' ASN . 41.3 m-85 -136.13 154.0 51.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -146.71 89.26 5.79 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.174 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -50.67 -49.88 15.39 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.88 2.387 . . . . 0.0 113.343 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 54.3 m-20 -58.23 -21.94 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.34 -31.33 43.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.483 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.9 t80 -66.27 -45.9 78.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.735 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.6 ptpt -66.33 -39.86 89.5 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.701 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.758 HG22 ' HE ' ' A' ' 95' ' ' ARG . 56.9 mt -59.75 -49.79 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.679 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 122' ' ' LEU . 58.2 mtp -70.01 -37.95 75.81 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.042 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 48.1 m -55.97 -42.91 77.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -66.24 -38.54 88.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.051 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.758 ' HE ' HG22 ' A' ' 91' ' ' ILE . 14.3 mtm105 -74.86 -34.14 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 71.0 m -110.15 -18.91 13.21 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' CG ' ' O ' ' A' ' 93' ' ' SER . 79.7 m-20 -54.65 135.38 46.77 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.059 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 65.79 14.58 9.63 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.24 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -113.6 145.64 40.95 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.646 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.0 m -69.67 -33.39 72.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.297 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.435 HE21 ' CZ ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -152.91 155.93 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.674 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 24.8 p -155.1 136.84 14.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.244 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.4 127.63 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.612 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.683 HG21 HH11 ' A' ' 95' ' ' ARG . 42.5 t -142.59 145.55 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 111.374 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 107' ' ' GLY . 66.4 t -75.8 114.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.977 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.98 40.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.48 -121.93 0.73 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 27.2 -155.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.322 0.582 . . . . 0.0 111.868 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -68.52 1.15 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.295 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.01 -15.63 46.95 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.518 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.9 m-85 -146.13 125.15 6.57 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.542 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.9 Cg_exo -51.16 -142.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.528 2.152 . . . . 0.0 112.607 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 116' ' ' PRO . 9.4 t0 -145.31 87.72 6.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.199 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.14 -8.58 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.55 2.167 . . . . 0.0 113.131 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -165.09 69.69 1.36 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.53 0.681 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.2 Cg_exo -53.73 147.25 41.22 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.381 2.054 . . . . 0.0 111.048 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.51 -5.38 81.44 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.881 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' GLN . 88.8 m -118.3 148.05 42.85 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.8 t80 -84.42 116.37 23.03 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.454 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 7.9 mtmm -94.24 -157.83 0.58 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.576 1.179 . . . . 0.0 113.994 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.6 p90 -174.01 175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.881 -1.963 . . . . 0.0 110.239 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 92' ' ' MET . 52.2 tp -130.78 123.67 29.67 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.079 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.469 ' HG2' HE21 ' A' ' 125' ' ' GLN . 66.1 tt0 -121.28 126.79 50.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 61' ' ' ALA . 77.9 t -132.73 127.15 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.452 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.469 HE21 ' HG2' ' A' ' 123' ' ' GLU . 9.4 mp0 -108.61 129.02 55.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 19.7 p90 -156.02 171.69 19.67 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.698 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -131.64 162.24 30.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.427 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.0 m -108.3 131.23 54.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.623 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' SD ' ' A' ' 57' ' ' MET . 28.5 m -130.99 157.57 77.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.491 1.358 0 C-N-CA 122.014 1.81 . . . . 0.0 111.576 179.121 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt85 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -146.22 135.5 22.84 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.559 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 58.8 mm-40 -134.0 146.68 50.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.221 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.96 139.68 38.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.742 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.36 142.27 39.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.452 0.644 . . . . 0.0 111.009 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 23.9 m -64.58 137.72 58.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.757 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 72.5 tt0 -43.44 126.32 4.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.179 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.47 -8.21 74.79 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.241 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.34 148.62 38.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.945 1.373 . . . . 0.0 110.005 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.78 149.95 67.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.899 2.399 . . . . 0.0 113.287 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -118.99 146.62 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.673 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 49' ' ' ARG . 82.0 tt0 -126.05 129.84 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.109 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 48.7 mt -116.01 139.81 49.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.986 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 47' ' ' GLU . 3.9 mtp180 -150.28 131.49 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.287 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 56' ' ' ILE . 11.6 m -97.98 151.92 37.8 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.058 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HG3' HH21 ' A' ' 36' ' ' ARG . 93.4 Cg_endo -77.11 160.03 33.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.908 2.406 . . . . 0.0 112.318 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.64 -116.69 6.21 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -131.54 27.47 4.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.05 170.71 15.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.765 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.2 142.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.41 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.5 mt -67.15 137.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.785 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.3 ptp -134.9 102.52 5.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.532 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.8 t -64.09 124.54 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.123 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -100.41 -52.1 3.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.245 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -152.27 150.65 30.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -168.5 155.31 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.855 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.461 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.0 t30 -145.58 147.77 32.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CE2' ' HB3' ' A' ' 111' ' ' PHE . 40.2 t80 -119.59 117.94 29.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.86 -133.14 3.2 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.663 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -157.34 120.46 4.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 0.0 111.191 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.585 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 20.7 p -120.27 8.66 10.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.854 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.5 t0 -145.21 -166.13 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.185 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 38.0 p-10 -150.24 0.31 0.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 51.7 mtpt -102.78 2.91 36.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.252 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.89 135.68 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m 52.71 74.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.1 p30 -52.37 102.93 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.662 0.744 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 -170.21 1.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.838 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -59.56 141.99 87.82 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.21 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.5 Cg_endo -53.63 -40.08 80.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.932 2.421 . . . . 0.0 112.993 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.54 -33.62 76.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.963 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.511 ' O ' HG23 ' A' ' 118' ' ' THR . 22.2 mt-30 -90.2 -8.26 51.56 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 74.5 mmm -107.36 -4.8 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 2.6 mt-10 -67.06 -42.34 84.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 9.3 t30 -77.98 121.22 23.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.26 31.63 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -138.74 86.7 2.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.008 0.432 . . . . 0.0 110.148 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.472 ' SG ' ' HA3' ' A' ' 64' ' ' GLY . 4.4 t -147.6 120.96 9.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' HG22 ' A' ' 66' ' ' THR . 73.8 m-85 -135.74 157.13 47.63 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.192 0.52 . . . . 0.0 112.372 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -147.53 89.44 5.44 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.434 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.16 -51.33 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.759 2.306 . . . . 0.0 113.123 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 53.8 m-20 -54.93 -22.79 16.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.69 68.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE1' HG12 ' A' ' 58' ' ' VAL . 31.0 t80 -64.14 -44.14 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 111.515 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.04 -38.3 90.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 65.8 mt -61.03 -47.79 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.03 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.7 -36.45 80.67 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.5 m -59.39 -46.55 88.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -66.48 -35.98 81.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 111.145 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 51.1 mtp85 -75.34 -35.22 61.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.3 m -112.92 -18.1 12.32 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 46.3 m-20 -52.82 136.39 34.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 66.34 13.19 9.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.207 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -112.89 145.38 40.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.0 m -74.62 -32.32 62.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.013 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -149.2 150.24 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.4 p -153.5 143.64 22.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.287 0.565 . . . . 0.0 111.448 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.12 123.59 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.443 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.549 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.7 t -135.56 143.88 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.432 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.87 119.47 32.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.329 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.17 42.45 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.75 -125.27 0.95 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 29.54 -157.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 110.855 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.63 2.75 3.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.967 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.05 -12.71 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.727 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.1 m-85 -143.53 126.13 8.72 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -51.86 -144.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.137 1.891 . . . . 0.0 111.178 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.51 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 8.7 t0 -146.02 96.34 4.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 92.5 Cg_endo -84.89 -8.92 9.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.029 2.486 . . . . 0.0 112.768 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -162.02 64.45 1.7 Allowed Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.275 0.56 . . . . 0.0 111.475 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.51 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 23.4 Cg_exo -53.94 145.29 52.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.925 1.75 . . . . 0.0 111.022 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.8 -11.66 71.6 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.865 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.2 m -117.93 150.41 39.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.1 0.45 . . . . 0.0 110.099 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 45.3 t80 -81.26 116.34 21.08 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.43 ' C ' ' HB2' ' A' ' 42' ' ' GLU . 10.7 mttt -93.19 -162.52 0.95 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.508 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -173.21 174.14 3.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.369 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.3 tp -131.86 123.65 27.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.233 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' HG2' HE21 ' A' ' 125' ' ' GLN . 77.1 tt0 -118.76 126.69 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.6 t -130.49 125.2 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.1 mp0 -106.43 128.22 53.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 56' ' ' ILE . 38.7 p90 -153.68 168.76 25.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.819 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.6 OUTLIER -127.57 163.1 24.92 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.556 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.489 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 72.9 m -113.21 114.55 26.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.31 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.8 m -116.66 151.69 47.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.056 1.838 . . . . 0.0 111.799 179.191 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.799 HH12 ' CD ' ' A' ' 51' ' ' PRO . 52.1 mtt180 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -153.54 134.88 14.18 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.201 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.43 148.6 45.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.583 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -139.88 140.94 36.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.833 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.57 142.5 33.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.457 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.34 137.26 54.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.721 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 84.2 tt0 -48.88 136.22 14.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.9 38.23 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.981 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.4 m-30 -108.14 151.5 41.4 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 118.129 0.965 . . . . 0.0 109.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.47 155.0 70.59 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.515 2.143 . . . . 0.0 113.453 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.2 tt -118.48 146.35 23.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.068 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' CG ' HH11 ' A' ' 49' ' ' ARG . 0.7 OUTLIER -122.09 130.72 53.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.569 0.7 . . . . 0.0 112.511 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.026 HD12 ' SG ' ' A' ' 102' ' ' CYS . 76.1 mt -121.99 130.88 53.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.661 177.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 47' ' ' GLU . 3.6 mtt85 -147.23 130.54 16.58 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.218 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.472 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.4 m -97.56 143.57 26.43 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.799 ' CD ' HH12 ' A' ' 36' ' ' ARG . 18.8 Cg_endo -70.6 163.61 38.34 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.677 2.251 . . . . 0.0 112.717 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.63 -126.65 21.26 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -115.73 24.74 11.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.497 -0.352 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.94 169.15 18.77 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.911 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.91 145.91 33.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.398 0.618 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.8 mt -68.91 138.06 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.649 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -131.14 100.09 5.09 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.608 HG12 ' CE1' ' A' ' 89' ' ' PHE . 75.0 t -65.09 122.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.032 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.551 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 61.4 mt-10 -100.05 -47.06 5.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.551 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 59.4 m-20 -151.24 150.8 31.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.555 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.804 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.83 154.52 13.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.785 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.455 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.6 t30 -152.19 149.9 29.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 112.115 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.522 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 87.2 t80 -121.93 119.08 30.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.509 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.64 -136.79 4.56 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.02 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.611 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.8 ttm180 -155.29 117.55 4.18 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.135 0.493 . . . . 0.0 110.797 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -123.66 10.66 9.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 30.8 t0 -146.65 -169.01 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 29.6 p30 -145.33 -0.17 0.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.784 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 31.9 mtpt -102.7 6.23 39.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.538 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.403 HG22 ' SG ' ' A' ' 71' ' ' CYS . 18.9 mm -110.52 135.02 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' ALA . 83.5 m 62.13 51.58 3.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.951 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.56 95.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.738 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -116.68 -162.46 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -60.1 132.51 89.93 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.691 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.8 Cg_endo -54.64 -34.77 84.69 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.94 2.426 . . . . 0.0 114.278 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -62.32 -33.43 74.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.448 0.642 . . . . 0.0 109.79 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.632 ' O ' HG23 ' A' ' 118' ' ' THR . 25.2 mt-30 -87.41 -0.05 56.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 4.8 mtm -119.8 0.3 10.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.9 mt-10 -62.69 -50.05 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.218 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -80.13 111.53 16.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.0 m -102.59 35.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.236 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -141.49 87.81 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.2 t -145.16 122.24 11.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.455 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.7 m-85 -132.61 153.87 50.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.232 0.539 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -148.59 88.33 5.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.303 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.69 -47.77 21.75 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.864 2.376 . . . . 0.0 113.868 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -54.61 -24.98 23.7 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.22 -30.96 40.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.673 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.608 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -65.77 -45.51 82.26 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.1 pttt -65.2 -43.03 92.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.681 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 1.0 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 59.6 mt -58.83 -45.68 91.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 93.8 mmm -69.78 -35.63 75.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.198 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.499 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 50.8 m -61.0 -47.32 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.25 -37.85 88.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.165 0.507 . . . . 0.0 111.049 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 1.0 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 47.8 mtm180 -77.55 -33.91 53.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.1 m -112.52 -19.75 12.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -176.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 90.3 m-20 -61.15 135.61 57.81 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.353 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 67.34 13.68 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.303 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -113.04 145.34 41.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.328 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -70.97 -31.68 68.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.76 155.01 38.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.938 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 1.026 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.5 p -156.39 132.86 10.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.25 129.28 71.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 43.8 t -136.72 139.05 45.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.762 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' GLY . 58.2 t -72.94 116.18 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.81 40.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.701 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -122.66 0.85 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.6 t 29.58 -157.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.651 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -67.38 0.37 2.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.337 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.82 -13.7 50.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.571 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 112' ' ' PRO . 47.8 m-85 -144.43 126.69 8.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.199 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.593 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -48.88 -149.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.756 2.304 . . . . 0.0 112.202 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 21.8 t0 -145.18 80.11 11.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.483 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 69.6 Cg_endo -75.33 -3.56 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.25 2.633 . . . . 0.0 112.842 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.58 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.2 p -164.05 63.43 1.14 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.752 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.08 144.09 59.54 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.096 1.864 . . . . 0.0 110.299 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.72 -4.34 81.89 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 77' ' ' GLN . 80.4 m -125.73 147.86 49.24 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.666 0.733 . . . . 0.0 109.869 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.611 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 4.6 t80 -80.54 113.7 18.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 28.0 mttp -91.85 -160.3 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.575 1.178 . . . . 0.0 113.291 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.0 p90 -175.41 177.11 1.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.13 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.7 tp -130.39 121.45 25.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.605 ' HG2' HE21 ' A' ' 125' ' ' GLN . 56.0 tt0 -120.9 127.44 51.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.799 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.804 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -135.38 129.03 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.605 HE21 ' HG2' ' A' ' 123' ' ' GLU . 8.6 mp0 -107.97 130.26 55.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.633 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.7 p90 -154.2 173.72 15.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.364 0.602 . . . . 0.0 111.764 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 80.0 m-20 -133.23 161.13 35.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.835 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 95.4 m -111.71 111.05 21.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.97 158.53 37.55 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.355 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 C--N 1.313 -1.302 0 C-N-CA 121.862 1.708 . . . . 0.0 111.698 179.315 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 36' ' ' ARG . 79.9 mtt-85 . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.523 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 49.1 ttp180 -148.99 137.76 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.7 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 31.5 mp0 -130.8 145.62 52.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.536 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.53 141.74 37.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.821 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.18 140.17 35.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.449 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.2 m -67.76 137.2 55.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.505 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -46.7 134.53 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.02 52.39 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.3 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.7 m-85 -107.28 147.01 34.41 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.279 1.039 . . . . 0.0 110.139 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -67.14 153.27 78.03 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.546 2.164 . . . . 0.0 112.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.6 tt -118.14 141.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -120.22 128.22 53.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.464 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 73.2 mt -116.78 142.62 46.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.391 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -152.94 133.41 13.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.84 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.2 m -102.01 147.52 34.04 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.06 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.2 Cg_endo -70.35 158.21 56.88 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 123.686 2.924 . . . . 0.0 113.317 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.92 -132.89 32.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.9 p -105.26 27.89 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.353 0.597 . . . . 0.0 109.742 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.44 162.37 25.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.097 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -126.49 147.99 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.58 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.799 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -71.18 134.8 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.635 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.6 ptm -130.32 100.72 5.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.49 0.662 . . . . 0.0 109.264 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 93' ' ' SER . 6.9 t -65.16 122.67 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.602 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -102.51 -48.05 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -149.4 148.66 29.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.474 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.834 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.18 154.4 10.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.8 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.556 HD21 ' HA ' ' A' ' 84' ' ' TYR . 17.7 t30 -152.3 149.69 28.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.692 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.88 121.16 37.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.81 -135.5 4.25 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.76 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -158.12 119.63 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.271 0.558 . . . . 0.0 111.1 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 84' ' ' TYR . 38.6 p -122.6 9.77 9.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.557 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 28.5 t0 -145.36 -169.36 3.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 59.8 p30 -147.21 -1.01 0.66 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.657 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -100.09 3.41 43.97 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.708 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 44.7 mm -106.27 133.45 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 72.8 m 63.09 57.52 1.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.1 p30 -42.33 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.303 0.573 . . . . 0.0 111.843 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.95 -165.1 1.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.681 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -59.06 137.29 87.95 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.595 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.38 -35.55 75.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.383 2.056 . . . . 0.0 112.261 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -62.45 -40.53 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.523 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 15.1 mt-30 -88.3 -5.42 58.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.983 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.472 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.8 mmm -107.22 -4.6 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.507 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.3 mt-10 -65.56 -48.65 71.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -77.79 122.32 25.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 112.338 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 32.25 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -140.44 86.28 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.136 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.544 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 28.8 t -144.76 123.06 12.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.8 m-85 -134.83 153.76 51.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.241 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.1 tp -147.0 91.81 5.09 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.78 -45.26 42.36 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.773 2.315 . . . . 0.0 113.718 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.82 -15.68 32.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.51 -28.93 57.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.6 -44.16 91.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.11 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.44 -42.07 92.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.734 HG23 ' NH1' ' A' ' 95' ' ' ARG . 68.6 mt -59.68 -47.57 90.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.216 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.9 mmm -70.07 -35.51 74.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG21 ' A' ' 58' ' ' VAL . 74.1 m -63.44 -45.28 91.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.755 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.99 -36.91 85.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 0.0 111.407 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.734 ' NH1' HG23 ' A' ' 91' ' ' ILE . 51.1 mtt85 -79.9 -32.68 40.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.1 m -113.45 -13.29 12.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 87.6 m-20 -61.56 135.28 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.554 -0.859 . . . . 0.0 112.054 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 65.31 11.02 6.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -110.62 144.43 39.52 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.407 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 m -70.56 -31.79 68.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.904 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.81 154.15 41.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.738 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.88 137.08 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.511 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.94 128.92 75.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.516 HG22 ' HD3' ' A' ' 95' ' ' ARG . 19.2 t -136.87 144.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.623 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.6 t -76.72 115.57 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.77 33.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.952 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.6 -119.76 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.99 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.4 t 32.1 -159.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.75 0.309 . . . . 0.0 111.042 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -67.5 2.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.577 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.72 -11.81 56.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.187 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.587 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -146.6 129.97 8.22 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.2 Cg_exo -50.43 -146.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.461 2.107 . . . . 0.0 112.207 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -144.34 83.73 9.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.27 -7.02 17.76 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.024 2.483 . . . . 0.0 114.234 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.557 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.45 68.77 1.07 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 121.605 0.717 . . . . 0.0 111.267 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -51.74 144.28 35.0 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 122.667 2.245 . . . . 0.0 111.2 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.86 2.23 90.48 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.942 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.6 m -120.43 146.06 46.59 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.055 0.928 . . . . 0.0 109.542 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.76 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 7.6 t80 -80.88 110.5 16.46 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.557 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.9 mttp -90.49 -164.84 1.23 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.517 1.151 . . . . 0.0 113.858 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB2' HD21 ' A' ' 39' ' ' LEU . 4.3 p90 -170.56 169.57 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.033 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 62' ' ' ASN . 32.8 tp -127.43 124.57 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HG2' HE21 ' A' ' 125' ' ' GLN . 73.0 tt0 -120.42 125.62 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.834 HG22 ' HB1' ' A' ' 61' ' ' ALA . 71.9 t -132.2 125.66 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.587 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.46 HE21 ' HG2' ' A' ' 123' ' ' GLU . 4.2 mp0 -108.57 126.1 52.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.752 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.799 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.5 p90 -153.31 173.03 16.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.9 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -125.27 159.39 31.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.198 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 95.3 m -108.95 121.34 44.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.009 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 29.9 m -132.03 158.63 75.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.51 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 C--N 1.313 -1.32 0 C-N-CA 122.053 1.835 . . . . 0.0 112.424 -179.494 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -152.0 138.25 18.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.124 0.488 . . . . 0.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.618 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.3 mt-10 -130.18 149.76 51.74 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.836 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -137.42 140.45 41.32 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.717 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.99 138.0 38.47 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.338 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 45.8 m -66.68 137.02 56.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -45.2 130.73 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.992 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.2 -14.44 62.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.004 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 12.5 m-85 -109.34 151.59 42.18 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.884 1.342 . . . . 0.0 110.083 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.36 155.48 60.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.664 2.243 . . . . 0.0 113.039 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 tt -123.21 147.97 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.2 tt0 -128.98 124.23 34.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.508 HD12 ' SG ' ' A' ' 102' ' ' CYS . 57.1 mt -113.27 141.89 46.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 17.8 mtp-105 -147.86 138.92 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.919 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.511 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.3 m -106.79 142.76 25.66 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.351 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 31.5 Cg_endo -68.83 160.8 48.21 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.532 2.155 . . . . 0.0 112.907 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.94 -132.34 10.19 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.364 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -101.74 22.23 13.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.201 -0.5 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -77.39 165.51 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.258 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.947 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.5 mt -68.66 139.7 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.669 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.458 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -132.45 100.57 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.5 t -63.44 125.33 19.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.755 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 93.3 mt-10 -101.67 -48.79 4.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.2 m-20 -149.98 150.69 32.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.203 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.478 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -170.66 157.38 5.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.878 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 84' ' ' TYR . 13.7 t30 -150.18 146.91 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -117.61 120.63 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 155.88 -131.23 2.98 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.789 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 7.3 ttm-85 -157.1 115.01 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.483 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.429 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.0 p -118.25 11.14 13.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' C ' HG12 ' A' ' 81' ' ' VAL . 46.0 t0 -147.89 -171.67 3.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.785 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.547 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 26.1 p-10 -145.62 -2.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 34.9 mttp -100.7 6.32 43.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.0 mm -111.9 135.83 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.15 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.3 m 53.63 75.0 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.281 0.562 . . . . 0.0 109.894 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.77 120.12 7.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.55 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.82 -164.15 1.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.607 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -59.96 134.55 90.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 119.159 -1.017 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -53.6 -33.28 68.09 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.545 2.163 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.28 -37.68 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.691 0.281 . . . . 0.0 111.146 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 19.9 mt-30 -86.48 2.51 47.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.203 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 38.8 mmm -121.85 -0.18 9.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 63.0 mt-10 -64.96 -48.52 73.76 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.29 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -78.38 116.85 19.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' C ' ' A' ' 67' ' ' ASP . 26.5 m -105.34 36.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 71.9 mm-40 -141.14 83.42 1.88 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.547 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 31.7 t -147.13 116.86 7.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 8.7 m-85 -130.18 157.49 42.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.606 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.35 90.75 5.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -48.73 -46.8 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.121 2.547 . . . . 0.0 113.805 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -57.84 -18.33 21.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.53 65.38 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.627 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.47 -46.39 79.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.765 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -64.65 -41.05 96.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.669 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.548 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 97.8 mt -60.38 -49.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.741 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.91 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.7 mtp -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.401 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.1 m -55.74 -44.01 77.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.96 -37.94 82.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.589 ' NE ' HG22 ' A' ' 104' ' ' VAL . 20.2 mtp180 -75.77 -34.41 60.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -110.38 -19.78 12.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 76.4 m-20 -58.34 136.95 57.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.613 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 65.2 13.55 8.82 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.646 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -114.29 146.22 40.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.202 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.0 m -69.45 -31.03 69.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 156.15 41.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.605 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -152.4 130.18 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.09 131.59 66.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.629 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' NE ' ' A' ' 95' ' ' ARG . 78.0 t -145.82 148.8 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.359 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.44 118.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.01 38.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.083 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.662 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.3 -118.65 0.58 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.156 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.662 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.1 t 24.63 -156.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.231 0.539 . . . . 0.0 111.823 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -69.51 2.7 2.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.82 -14.38 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.548 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -144.8 130.17 9.42 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.41 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.6 Cg_exo -51.72 -145.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.981 1.787 . . . . 0.0 112.063 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -144.96 86.63 7.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.548 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.491 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.5 Cg_endo -75.63 -5.03 16.05 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.376 2.051 . . . . 0.0 112.666 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -169.78 73.7 0.67 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.246 0.546 . . . . 0.0 111.636 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -53.23 148.09 33.3 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.674 2.25 . . . . 0.0 111.6 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.58 75.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.09 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.9 m -118.97 146.79 44.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 14.5 t80 -82.82 109.24 16.78 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 28.0 mtmm -87.88 -165.2 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.507 1.146 . . . . 0.0 113.799 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 64' ' ' GLY . 5.3 p90 -170.53 171.24 6.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.048 -1.887 . . . . 0.0 111.034 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.91 HD21 ' SD ' ' A' ' 92' ' ' MET . 27.8 tp -129.67 120.71 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.116 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.61 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -114.16 125.59 54.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.787 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.755 HG21 ' SD ' ' A' ' 92' ' ' MET . 38.8 t -134.37 122.51 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.839 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.61 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 3.4 mt-30 -105.97 127.28 53.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.358 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.947 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.5 p90 -149.83 168.26 24.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 111.846 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -124.96 160.08 29.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.1 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -110.77 122.11 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.0 156.35 62.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.149 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo . . . . . 0 N--CA 1.492 1.414 0 C-N-CA 122.194 1.929 . . . . 0.0 111.845 179.253 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 41.5 ttm180 -142.4 138.89 31.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.392 0.615 . . . . 0.0 110.742 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -135.03 140.61 45.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.61 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.6 133.6 30.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.49 141.1 46.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.203 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.4 m -67.67 136.65 54.69 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.573 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 88.6 tt0 -49.31 134.14 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.629 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.73 -17.94 56.74 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.21 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 72.1 m-85 -113.12 152.66 45.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 118.302 1.051 . . . . 0.0 109.943 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.56 153.76 76.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.272 1.981 . . . . 0.0 113.14 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.61 139.51 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 81.2 tt0 -128.49 129.05 45.51 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.293 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.87 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.5 mt -111.85 144.58 40.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.44 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.641 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 91.6 mtt180 -149.26 130.33 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.675 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -96.93 145.13 29.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.813 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.84 161.91 40.49 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.329 2.019 . . . . 0.0 111.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.43 -126.73 31.99 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.69 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -117.92 23.87 11.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -75.16 168.46 19.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 m -125.84 145.6 33.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.89 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.1 mt -69.0 137.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.782 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.639 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.1 ptm -131.6 99.35 4.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.516 HG12 ' HE1' ' A' ' 89' ' ' PHE . 55.8 t -63.95 125.92 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.955 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.73 -50.78 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.736 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 42.8 m-20 -149.83 149.12 30.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.487 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.4 154.06 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.696 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.5 t30 -151.18 144.1 24.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.508 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -115.41 120.32 39.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.65 -135.88 4.34 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.859 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.573 HH12 ' HB3' ' A' ' 119' ' ' TYR . 11.8 ttm180 -156.91 117.12 3.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 111.246 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.0 p -121.2 11.53 10.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 81' ' ' VAL . 35.5 t0 -144.96 -167.02 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.422 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 13.1 p30 -149.83 -1.71 0.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -100.86 6.35 43.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.287 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.47 131.92 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.1 m 50.06 81.0 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.606 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 37.7 p30 -53.79 98.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.502 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.65 -172.94 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.097 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -58.15 134.71 84.36 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.191 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.1 Cg_endo -50.18 -35.82 44.06 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.629 1.553 . . . . 0.0 112.096 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -61.95 -38.34 88.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.783 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.698 ' O ' HG23 ' A' ' 118' ' ' THR . 24.2 mt-30 -84.3 -8.69 58.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.26 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 74.0 mtp -104.43 -0.86 27.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.267 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.4 mt-10 -61.82 -49.91 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -78.22 117.89 19.92 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 67' ' ' ASP . 20.8 m -109.74 30.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.969 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.6 mm-40 -140.99 86.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 3.7 t -145.37 122.09 11.18 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.0 m-85 -131.96 157.42 44.11 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 112' ' ' PRO . 42.9 tp -148.18 90.12 5.07 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.821 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -46.8 -47.79 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.673 2.248 . . . . 0.0 112.783 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 83.6 m-20 -56.38 -24.55 45.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.49 62.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.529 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' HE1' HG12 ' A' ' 58' ' ' VAL . 40.5 t80 -66.03 -44.97 83.11 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -64.66 -38.3 90.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 99.0 mt -59.33 -48.63 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.37 -36.13 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 15.6 m -58.25 -45.58 87.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.17 -38.25 85.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.67 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.622 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 80.9 mtt180 -75.76 -34.05 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.4 m -110.31 -20.51 12.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.48 ' CG ' ' O ' ' A' ' 93' ' ' SER . 72.5 m-20 -57.33 137.82 55.6 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.614 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.94 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -115.69 147.21 41.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.241 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.4 m -70.07 -35.75 74.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.966 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -150.18 157.76 43.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.521 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.87 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -153.84 141.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 111.822 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.9 126.52 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.535 HG11 HH11 ' A' ' 95' ' ' ARG . 21.9 t -139.26 141.55 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.964 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 107' ' ' GLY . 88.5 t -72.68 113.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.528 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -68.05 34.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.895 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.11 -123.21 0.81 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.9 t 32.76 -161.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.785 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.06 4.49 1.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.28 -11.93 59.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.4 m-85 -143.01 129.82 10.68 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.0 Cg_exo -51.86 -149.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.249 1.966 . . . . 0.0 111.213 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.82 88.92 6.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 68.0 Cg_endo -84.67 -4.98 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.245 2.63 . . . . 0.0 113.274 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -168.4 73.9 0.84 Allowed Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.873 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.67 154.24 70.41 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.635 2.223 . . . . 0.0 112.728 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.25 4.65 90.43 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.8 m -127.11 148.01 50.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.573 ' HB3' HH12 ' A' ' 65' ' ' ARG . 48.6 t80 -83.85 114.48 21.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.433 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 12.6 mttt -91.14 -163.83 1.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.6 p90 -171.41 172.77 5.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.513 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 62' ' ' ASN . 48.1 tp -133.72 126.82 31.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.418 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 87.3 tt0 -121.49 127.21 50.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 61' ' ' ALA . 24.5 t -131.09 125.1 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.159 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 60' ' ' ASN . 12.0 mp0 -110.3 129.14 55.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.026 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.3 p90 -153.09 166.91 30.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.377 0.608 . . . . 0.0 112.065 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 38.8 m-20 -118.22 157.69 26.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.31 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.4 m -108.82 118.47 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.37 155.81 58.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.139 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 C--N 1.31 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 111.597 179.763 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.507 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 62.4 mtp85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -153.04 142.92 22.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.204 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.1 mt-10 -133.91 149.91 51.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.946 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -141.3 134.5 29.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.243 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.6 143.77 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.705 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 m -67.39 139.04 57.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.952 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -45.13 133.12 6.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.628 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.1 63.95 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.333 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -108.24 149.43 39.21 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 118.733 1.267 . . . . 0.0 110.722 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.0 149.54 77.32 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.387 2.058 . . . . 0.0 112.935 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.8 tt -121.46 143.63 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 56.8 tt0 -129.6 128.34 42.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.252 0.549 . . . . 0.0 112.148 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.4 mt -113.25 141.98 46.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.952 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.622 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 82.2 mtt180 -146.95 127.55 14.18 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 m -96.52 141.56 23.29 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 50.7 Cg_endo -71.76 163.79 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.59 2.193 . . . . 0.0 112.264 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.68 -138.65 18.62 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -102.37 23.2 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.745 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 92.9 m-20 -79.35 164.82 23.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.34 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.5 m -128.67 149.04 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.328 0.585 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 126' ' ' TYR . 99.1 mt -69.79 135.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.504 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -131.24 98.61 4.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.475 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.9 t -61.97 122.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.713 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 59' ' ' GLU . 71.4 mm-40 -100.61 -46.21 5.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -149.6 144.13 25.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.127 0.489 . . . . 0.0 110.572 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.35 147.49 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 84' ' ' TYR . 27.7 t30 -149.85 155.83 40.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.958 0.409 . . . . 0.0 111.545 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -121.01 120.59 35.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.8 -139.74 6.17 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.68 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 13.6 ttm180 -155.35 115.07 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.943 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -126.95 8.49 6.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.953 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -148.57 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.149 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 78' ' ' MET . 23.7 p-10 -114.37 5.13 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.441 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -102.48 3.4 37.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.918 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' LEU . 26.3 mm -112.52 134.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.536 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.85 67.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.199 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 26.4 p-10 -52.57 102.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.009 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.696 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -116.52 -165.7 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -60.04 139.25 90.96 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.898 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 Cg_endo -54.14 -40.25 82.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.261 1.974 . . . . 0.0 113.078 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -61.95 -37.29 84.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.248 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 118' ' ' THR . 21.5 mt-30 -86.4 -4.79 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.53 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 89.3 mtp -107.16 -1.11 22.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 79.7 mt-10 -64.35 -48.52 75.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -79.9 119.79 23.24 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.27 31.23 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -138.47 84.2 2.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.071 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.3 t -146.78 121.04 9.55 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' ASN . 80.1 m-85 -130.98 153.95 48.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.517 HD21 ' HG2' ' A' ' 112' ' ' PRO . 48.7 tp -147.12 91.36 5.15 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.68 -46.14 28.47 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 123.303 2.669 . . . . 0.0 113.972 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.2 m-20 -57.91 -20.22 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.67 65.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE1' HG12 ' A' ' 58' ' ' VAL . 74.0 t80 -63.54 -42.75 98.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.518 ' NZ ' HE22 ' A' ' 94' ' ' GLN . 4.0 ptmm? -66.86 -40.57 87.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.128 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.481 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 44.8 mt -59.51 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.91 -37.8 76.08 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.5 m -59.76 -46.74 88.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.803 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.518 HE22 ' NZ ' ' A' ' 90' ' ' LYS . 66.8 mt-30 -65.83 -38.9 90.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.169 0.509 . . . . 0.0 111.127 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 95' ' ' ARG . 51.9 mtt180 -75.37 -34.13 61.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.5 m -111.59 -16.05 13.35 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 25.0 m-20 -58.85 136.73 57.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.854 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 65.89 13.86 9.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.02 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -112.34 144.45 41.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.559 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.3 m -71.93 -30.91 65.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.976 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 152.65 36.58 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.02 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -155.28 137.21 14.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 47' ' ' GLU . 57.5 t -125.09 127.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.806 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.473 ' O ' HG22 ' A' ' 46' ' ' ILE . 60.9 t -138.15 149.12 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 107' ' ' GLY . 97.3 t -78.56 115.03 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.355 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.11 36.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.564 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.52 -119.95 0.65 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 107' ' ' GLY . 17.0 t 28.45 -158.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.98 0.93 5.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.242 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.48 -14.81 56.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.123 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.2 m-85 -141.75 130.82 12.32 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.228 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.9 Cg_exo -51.44 -150.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.216 1.944 . . . . 0.0 111.628 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -146.99 93.86 4.7 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 96.6 Cg_endo -84.23 -11.35 8.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.04 2.493 . . . . 0.0 114.814 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 3.9 p -166.85 66.94 0.92 Allowed Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.4 153.56 33.91 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.315 2.01 . . . . 0.0 110.743 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.36 73.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -126.12 148.33 49.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.696 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 10.6 t80 -81.04 113.36 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mtmm -91.29 -160.77 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.131 0.967 . . . . 0.0 113.166 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.498 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.9 p90 -174.35 175.33 2.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.801 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.2 tp -133.58 127.14 32.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.0 tt0 -119.23 130.11 55.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.8 t -133.08 121.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.928 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.508 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mt-30 -108.8 132.21 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 56' ' ' ILE . 48.6 p90 -155.02 173.18 16.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.485 0.659 . . . . 0.0 111.856 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 57' ' ' MET . 41.9 m-20 -125.5 156.0 39.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.453 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 85.7 m -108.66 115.76 30.69 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.163 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.9 m -120.49 155.24 56.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 122.28 1.987 . . . . 0.0 112.682 179.468 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.485 HH21 ' HG3' ' A' ' 51' ' ' PRO . 92.9 mtt-85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.973 0.415 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -146.14 130.05 17.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.558 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.569 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.1 mm-40 -127.25 145.21 50.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.73 140.78 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.283 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.739 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.72 136.61 37.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.559 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.7 m -65.01 140.76 58.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 110.481 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.07 126.66 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.488 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.2 65.87 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.691 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.4 m-85 -107.36 154.59 40.52 Favored Pre-proline 0 C--O 1.226 -0.136 0 CA-C-N 118.801 1.301 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -71.93 152.08 57.24 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.953 1.769 . . . . 0.0 112.38 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.0 tt -120.19 147.49 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.65 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 72.1 tt0 -130.01 129.76 44.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.466 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.1 mt -115.84 136.93 52.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.65 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 90.6 mtt180 -144.48 140.1 28.7 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.877 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -104.41 143.99 27.79 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.154 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HG3' HH21 ' A' ' 36' ' ' ARG . 37.8 Cg_endo -70.76 160.44 49.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.988 2.458 . . . . 0.0 112.193 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -127.06 23.85 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.0 p -114.3 24.97 11.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.46 168.28 20.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.202 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 129' ' ' VAL . 18.8 m -127.24 144.86 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.196 179.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 82.7 mt -68.89 138.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.779 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.611 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.5 ptm -132.54 100.66 5.04 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 25.4 t -66.12 125.0 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.524 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 90.3 mt-10 -102.66 -47.82 4.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.3 m-20 -149.73 149.35 30.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.662 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.69 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.0 153.82 14.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.325 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 84' ' ' TYR . 9.3 t30 -150.27 139.45 21.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -111.65 118.01 34.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.42 -137.37 4.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 10.0 ttm-85 -154.77 120.27 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.493 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p -121.43 9.19 10.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.636 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 34.4 t0 -143.47 -164.6 1.9 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.566 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 4.1 p30 -149.18 -1.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 109.808 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -104.61 5.88 34.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.887 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.3 mm -107.82 136.85 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.106 179.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.1 m 54.22 69.71 0.69 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.1 p-10 -49.26 103.67 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.786 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.47 -165.62 1.22 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.689 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -61.97 144.76 93.62 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 111.333 -179.693 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.3 Cg_endo -61.17 -39.4 59.1 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.606 2.204 . . . . 0.0 112.838 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -62.67 -32.13 73.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.692 ' O ' HG23 ' A' ' 118' ' ' THR . 71.0 mt-30 -89.23 -11.53 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 67.1 mmm -104.13 -2.76 25.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.877 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.1 mt-10 -66.9 -45.24 78.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.65 114.52 19.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.478 0.656 . . . . 0.0 112.091 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 15.9 m -104.94 34.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.06 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.5 mm-40 -142.64 87.37 2.0 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.372 0.606 . . . . 0.0 110.894 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.8 t -145.22 118.08 8.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -130.77 154.18 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.715 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 88' ' ' ALA . 13.3 tp -143.29 85.86 9.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.45 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.64 -50.0 11.21 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.052 2.501 . . . . 0.0 114.006 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -57.61 -22.99 48.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.588 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.01 -32.63 34.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.95 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 29.2 t80 -64.87 -42.23 95.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.565 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.5 pttt -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.925 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.3 mt -60.52 -47.74 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.795 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -70.03 -37.5 75.61 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.013 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.8 m -60.35 -46.64 89.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.03 -36.0 82.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.612 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.732 ' NE ' HG22 ' A' ' 104' ' ' VAL . 22.9 mtp180 -79.34 -30.93 42.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.7 m -112.03 -19.74 12.22 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 71.6 m-20 -55.61 131.4 46.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.86 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 69.37 13.8 8.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -113.89 146.53 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.131 178.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 m -69.91 -29.04 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.901 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 158.3 41.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.907 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -156.44 139.08 15.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.9 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.56 127.32 75.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.248 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.732 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.8 t -136.66 144.02 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.0 t -77.14 114.15 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -71.24 36.99 0.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.417 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.02 -121.42 0.71 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.7 t 29.0 -158.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.124 0.487 . . . . 0.0 111.222 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' N ' ' OG ' ' A' ' 108' ' ' SER . 21.7 m-20 -68.72 2.76 2.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.36 -15.82 48.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.281 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.6 m-85 -143.42 126.26 8.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.589 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.0 Cg_exo -52.03 -143.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.945 . . . . 0.0 111.495 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 23.8 t0 -143.25 83.39 11.04 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.68 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.26 -5.19 16.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.938 2.426 . . . . 0.0 112.763 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.581 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -168.35 74.29 0.85 Allowed Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 110.974 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.98 144.2 94.82 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 121.901 1.734 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.3 -8.32 78.99 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.266 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.9 m -115.37 148.45 39.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.036 0.918 . . . . 0.0 109.759 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.509 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 28.9 t80 -81.28 113.92 19.72 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.581 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 14.8 mttp -92.98 -161.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.939 1.352 . . . . 0.0 114.161 -176.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -174.06 174.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.377 -2.192 . . . . 0.0 110.491 176.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 31.0 tp -128.32 122.11 30.8 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 61' ' ' ALA . 20.6 t -131.51 127.45 59.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.841 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -105.92 124.66 49.93 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 29.5 p90 -149.86 168.35 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 m-20 -124.64 161.52 26.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 68.0 m -110.1 113.0 25.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 55' ' ' VAL . 2.0 m -118.61 159.41 44.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.92 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.5 1.901 0 C-N-CA 122.695 2.263 . . . . 0.0 112.573 179.284 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 23.5 mtp180 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' OE2' ' A' ' 123' ' ' GLU . 32.2 ttp180 -150.99 139.43 20.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.274 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 52.4 mp0 -132.87 145.64 51.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.819 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -137.09 138.76 40.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.825 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.32 143.92 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.218 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 m -68.17 135.62 52.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.686 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -46.94 136.0 8.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.443 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 -17.45 58.78 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.044 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 31.7 m-85 -108.69 149.78 39.91 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 118.135 0.968 . . . . 0.0 110.314 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.59 149.68 68.28 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.08 1.853 . . . . 0.0 112.636 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.57 146.54 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.181 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 49' ' ' ARG . 80.6 tt0 -130.98 127.26 38.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.75 -179.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.568 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -111.37 140.06 46.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.427 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.575 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 6.5 mtt180 -145.17 133.04 21.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -99.85 144.11 27.75 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.041 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.6 Cg_endo -68.22 161.51 44.28 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.376 2.051 . . . . 0.0 112.57 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.32 -133.13 25.19 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.512 178.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.8 p -103.3 22.87 13.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.679 -0.761 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -78.95 167.6 20.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.23 0.538 . . . . 0.0 111.65 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.99 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.321 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.802 HG23 ' CD2' ' A' ' 126' ' ' TYR . 62.1 mt -71.06 137.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.651 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.626 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -131.81 98.4 4.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.814 0.816 . . . . 0.0 109.222 178.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.69 124.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.648 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.508 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 97.7 mt-10 -104.01 -47.2 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.541 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 33.2 m-20 -149.61 147.17 27.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.747 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.47 154.16 9.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 84' ' ' TYR . 12.7 t30 -149.3 144.5 26.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -113.87 116.49 29.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.67 -133.74 3.34 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.736 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 4.8 ttm180 -153.97 117.68 4.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -122.53 3.21 9.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.049 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -148.33 156.68 42.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -114.4 3.86 15.14 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -104.19 4.0 33.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.698 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.472 HG21 HD13 ' A' ' 39' ' ' LEU . 45.3 mm -112.16 138.41 41.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 m 56.83 69.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.679 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -57.14 118.89 5.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.378 0.608 . . . . 0.0 111.815 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.41 -162.07 1.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.623 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -63.2 134.9 96.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.037 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.0 Cg_endo -56.1 -34.52 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.195 1.93 . . . . 0.0 113.584 -177.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -61.85 -37.04 83.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.22 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 118' ' ' THR . 21.6 mt-30 -84.92 -1.23 56.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.736 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 mtm -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.308 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.0 mt-10 -63.19 -43.41 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.854 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -79.87 117.02 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.74 33.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -141.72 83.02 1.83 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.191 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 24.1 t -143.16 125.85 15.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HA ' HD21 ' A' ' 62' ' ' ASN . 65.0 m-85 -136.0 153.6 51.33 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.53 HD21 ' HG2' ' A' ' 112' ' ' PRO . 15.0 tp -147.88 92.61 4.66 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.584 177.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -49.97 -44.78 35.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.783 2.322 . . . . 0.0 113.147 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.58 -19.13 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.22 67.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 110.29 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.78 -46.57 74.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.563 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.64 -39.55 93.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.789 -178.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -62.15 -54.01 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.402 ' HB3' ' HE3' ' A' ' 92' ' ' MET . 97.6 mmm -66.58 -36.26 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.699 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.9 m -60.88 -45.38 94.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.004 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -65.3 -36.21 83.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.36 0.6 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -78.36 -32.64 49.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.9 m -112.28 -16.55 12.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 44.1 m-20 -61.18 133.43 55.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.378 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 66.75 10.88 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.394 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -110.6 144.93 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.321 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -68.77 -35.16 76.71 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.98 156.56 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.54 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -153.59 138.89 17.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 0.0 111.486 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 47' ' ' GLU . 30.8 t -118.92 130.94 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.549 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -143.46 148.69 18.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.103 -178.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 115.66 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.171 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.11 38.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.514 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.82 -124.11 0.88 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.8 t 30.24 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -65.91 0.84 1.62 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.224 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -84.62 -11.3 56.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.583 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.8 m-85 -145.96 128.17 7.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.1 Cg_exo -49.55 -149.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.177 1.918 . . . . 0.0 111.945 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.22 82.16 12.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.313 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 91.1 Cg_endo -76.97 -6.6 16.84 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.149 2.566 . . . . 0.0 113.459 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.5 p -165.94 74.23 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.343 0.592 . . . . 0.0 111.171 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.94 148.45 88.72 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.974 1.782 . . . . 0.0 111.476 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.11 -5.04 78.54 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.0 m -115.88 148.8 39.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.972 0.886 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 13.6 t80 -83.31 114.14 21.2 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.454 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 16.3 mttp -91.11 -161.45 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.574 1.178 . . . . 0.0 113.245 -176.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.578 ' HB2' HD21 ' A' ' 39' ' ' LEU . 3.5 p90 -171.98 172.03 4.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.062 -1.881 . . . . 0.0 110.643 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 40.3 tp -129.0 123.3 32.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 79.4 tt0 -118.6 122.79 43.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 61' ' ' ALA . 25.1 t -130.21 126.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -109.55 130.79 55.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.802 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.61 171.99 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 111.691 -179.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.508 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 74.3 m-20 -125.19 158.59 33.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.89 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.4 m -107.66 119.98 40.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.57 154.82 63.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.183 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.026 1.817 . . . . 0.0 111.098 178.828 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.516 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 32.4 ttp180 -146.91 133.81 20.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.531 0.682 . . . . 0.0 111.899 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.688 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -133.07 144.76 50.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.484 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.12 137.52 34.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.541 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.85 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.9 140.99 42.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.247 0.546 . . . . 0.0 110.618 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -66.39 136.18 55.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.23 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -47.12 136.06 9.19 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 111.628 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.94 61.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.12 178.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.18 156.02 38.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 118.118 0.959 . . . . 0.0 110.732 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.08 149.99 29.13 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.998 1.799 . . . . 0.0 111.38 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.4 tt -120.74 145.63 26.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.685 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 75.8 tt0 -128.69 128.28 43.77 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.871 -178.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.8 mt -111.53 145.34 39.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.179 178.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.685 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 69.6 mtt180 -148.69 133.28 17.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.662 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -100.75 148.35 34.9 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.937 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.23 159.29 40.7 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.509 2.14 . . . . 0.0 112.169 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.22 -128.42 34.59 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.491 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.8 p -112.8 24.86 11.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.333 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.95 167.3 21.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 179.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.53 145.98 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.485 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.7 mt -69.62 137.95 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.723 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.5 ptp -130.93 102.11 5.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 93' ' ' SER . 21.4 t -63.87 124.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.873 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -102.46 -51.83 3.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.993 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 22.9 m-80 -148.59 144.32 27.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 0.0 110.463 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.467 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.97 150.85 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.945 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.738 ' O ' HD12 ' A' ' 122' ' ' LEU . 39.4 t30 -148.81 157.25 43.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -125.53 121.94 35.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.559 179.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.7 -134.5 3.73 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.709 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 14.6 ttm180 -157.96 119.5 3.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 0.0 111.579 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 HG21 ' CE2' ' A' ' 84' ' ' TYR . 4.7 p -125.09 9.86 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.506 178.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.28 158.62 44.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.128 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 53.7 p-10 -117.59 5.77 12.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -100.59 4.83 43.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.98 135.63 51.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.707 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.3 m 57.25 66.13 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 56.6 p30 -45.82 94.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.988 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -112.53 -162.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -62.67 142.59 96.86 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 121.446 0.641 . . . . 0.0 111.488 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 15.1 Cg_endo -57.21 -39.54 89.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.402 2.068 . . . . 0.0 112.78 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -64.74 -35.12 80.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.482 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.558 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.8 mt-30 -85.9 -7.18 58.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.825 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.709 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 3.8 mmm -107.64 -2.52 20.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.44 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 40.4 mm-40 -62.88 -49.95 72.81 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -78.06 113.13 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.598 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.7 m -104.55 30.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.362 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -142.14 89.63 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 16.7 t -146.06 120.05 9.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.786 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 95.1 m-85 -132.1 151.63 51.67 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.998 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.598 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.9 tp -146.89 88.46 5.94 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.102 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -48.5 -48.4 17.4 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.25 2.633 . . . . 0.0 113.847 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 78.5 m-20 -51.65 -29.58 18.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.549 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.1 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.135 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 48.1 t80 -62.45 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.492 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.585 ' HG3' HE22 ' A' ' 94' ' ' GLN . 3.5 pttt -66.03 -38.93 89.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.853 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.516 HG23 ' NE ' ' A' ' 95' ' ' ARG . 18.6 mt -60.26 -52.47 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.353 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.3 mmm -66.86 -37.55 84.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.385 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.4 m -61.78 -47.37 85.46 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.139 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.585 HE22 ' HG3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -69.84 -34.38 73.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.08 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NE ' HG23 ' A' ' 91' ' ' ILE . 61.0 mtt180 -75.4 -32.46 60.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.6 m -112.46 -16.96 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.565 ' CG ' ' O ' ' A' ' 93' ' ' SER . 89.7 m-20 -58.15 133.87 55.98 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.052 -178.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 67.69 13.12 9.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.283 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -115.19 148.27 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.036 178.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.5 m -71.44 -31.6 67.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.009 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.433 ' HB2' HE21 ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.71 157.47 42.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.5 p -155.68 143.03 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.907 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 89.1 t -121.58 125.06 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.509 HG13 HH11 ' A' ' 95' ' ' ARG . 39.2 t -137.68 145.43 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 107' ' ' GLY . 43.3 t -79.7 117.02 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.018 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.97 36.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.71 -121.65 0.75 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.733 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 31.9 -160.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.197 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.39 -0.42 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.12 -14.33 50.61 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.812 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 112' ' ' PRO . 48.9 m-85 -143.38 127.37 9.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.166 178.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.3 Cg_exo -49.62 -149.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.331 2.021 . . . . 0.0 112.119 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -145.82 82.46 9.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.431 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.5 Cg_endo -77.24 -2.25 12.45 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.103 2.535 . . . . 0.0 113.697 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.541 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -167.85 68.51 0.84 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 110.511 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.14 151.09 29.48 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.98 2.454 . . . . 0.0 111.775 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 -1.71 60.37 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 77' ' ' GLN . 25.6 m -117.65 146.7 43.5 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.628 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.1 t80 -84.89 115.81 22.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.074 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.541 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 17.8 mttp -92.62 -160.33 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -174.18 176.49 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.525 -1.671 . . . . 0.0 111.909 176.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 62' ' ' ASN . 59.0 tp -135.68 125.82 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.487 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.1 tt0 -118.68 127.24 53.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.467 HG22 ' HB1' ' A' ' 61' ' ' ALA . 30.1 t -131.47 123.75 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.199 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.487 HE21 ' HG2' ' A' ' 123' ' ' GLU . 1.8 mt-30 -110.07 129.66 55.65 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.327 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -152.94 169.56 22.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.352 0.596 . . . . 0.0 111.437 -178.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.452 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 85.9 m-20 -122.88 158.44 30.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.57 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 96.7 m -111.33 111.67 22.89 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.55 154.2 44.72 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo . . . . . 0 N--CA 1.49 1.316 0 C-N-CA 122.109 1.873 . . . . 0.0 112.216 -179.792 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.475 0.178 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 31.4 ttm105 -146.44 136.08 23.13 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.839 0.828 . . . . 0.0 111.373 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 45.5 mp0 -134.67 145.54 48.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.238 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 ' OE1' ' A' ' 123' ' ' GLU . 5.5 tt -140.32 139.78 35.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.389 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.771 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.65 137.42 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.13 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.2 m -70.41 139.67 51.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 0.0 110.503 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -47.51 135.17 11.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.129 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.96 -19.0 56.3 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.93 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.56 148.71 38.67 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 118.376 1.088 . . . . 0.0 109.78 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.57 154.57 73.15 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.38 144.15 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 37.8 tt0 -124.79 127.04 46.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.582 -179.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 72.2 mt -118.1 141.06 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.037 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 73.7 mtt-85 -148.58 136.31 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.909 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.9 147.97 35.11 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.205 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 62.8 Cg_endo -75.3 156.92 41.71 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.005 2.47 . . . . 0.0 112.136 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -132.23 39.75 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.5 p -109.4 27.45 9.53 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.18 0.514 . . . . 0.0 111.143 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.45 163.9 25.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.28 145.28 34.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.927 178.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.2 mt -68.67 138.09 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.409 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.447 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.4 ptp -131.24 98.6 4.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.67 124.76 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.165 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.3 mm-40 -100.99 -47.33 4.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.3 m-20 -149.21 147.47 28.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.825 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.887 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.47 151.15 11.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.585 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 32.0 t30 -150.26 146.49 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.229 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -117.17 120.73 39.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.32 -137.72 5.16 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.132 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.0 ttm-85 -155.78 113.45 3.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.218 0.532 . . . . 0.0 109.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 p -121.23 11.05 10.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.968 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 47.3 t0 -146.74 -173.67 4.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.431 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.604 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 39.4 p30 -145.55 1.05 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.501 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -101.24 4.86 42.21 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.724 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.06 135.5 52.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.472 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.3 m 58.05 66.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.311 0.577 . . . . 0.0 109.814 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -53.2 122.15 8.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.105 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.82 -164.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.872 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.71 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.8 p30 -59.91 135.41 90.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.828 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.523 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.19 -32.22 59.01 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 113.283 -178.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -63.62 -38.03 89.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.71 HE21 ' CG ' ' A' ' 74' ' ' ASP . 35.3 mt-30 -85.5 -0.92 56.37 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.417 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 81.5 mtp -115.27 -1.25 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.172 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -62.42 -47.56 83.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 50.7 t30 -80.97 117.62 21.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.49 33.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.172 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -140.05 84.55 1.97 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 54.1 t -147.2 117.33 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.9 m-85 -128.02 155.72 43.87 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.322 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.5 tp -148.55 83.47 6.98 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.92 -45.36 20.94 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.792 2.328 . . . . 0.0 114.441 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -57.21 -20.77 29.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.929 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.34 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.868 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 93' ' ' SER . 24.4 t80 -65.29 -43.56 90.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.776 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.32 -39.85 92.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.178 -179.038 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 75.8 mt -58.38 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.48 -38.68 87.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.038 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.597 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.1 m -59.28 -45.67 90.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.93 -37.95 89.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.979 0.418 . . . . 0.0 110.56 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.583 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 92.7 mtt-85 -73.59 -34.46 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.6 m -112.51 -16.57 12.84 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -58.79 133.54 56.07 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.798 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 65.9 13.45 9.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.13 178.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -115.44 147.31 40.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.17 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.8 m -74.12 -30.26 62.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 153.27 32.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 27.2 p -154.92 141.63 18.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.622 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.61 127.73 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.85 146.87 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.731 0.3 . . . . 0.0 111.01 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 107' ' ' GLY . 89.5 t -78.98 114.41 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.214 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.76 39.26 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.849 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.45 -125.09 0.9 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.418 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.65 -157.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.395 0.616 . . . . 0.0 111.935 -179.298 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -66.39 -1.49 3.54 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.426 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.09 -14.9 57.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.243 -179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 58.2 m-85 -144.99 127.07 8.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.9 Cg_exo -51.78 -145.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.904 1.736 . . . . 0.0 112.355 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 12.4 t0 -145.75 85.2 7.85 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.537 -179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 74.2 Cg_endo -74.24 -6.25 18.14 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.225 . . . . 0.0 113.537 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.564 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -169.93 70.78 0.63 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.634 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 51.6 Cg_exo -48.76 153.52 3.58 Favored 'Trans proline' 0 C--N 1.294 -2.296 0 C-N-CA 123.003 2.469 . . . . 0.0 111.922 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.76 10.46 83.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.795 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.9 m -124.67 147.73 48.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.499 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 11.4 t80 -86.15 109.49 18.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.1 mttp -91.28 -161.75 0.85 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.46 1.124 . . . . 0.0 114.02 -175.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -171.76 171.43 5.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.694 177.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.1 tp -130.37 127.97 40.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.165 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.961 ' OE1' HD12 ' A' ' 39' ' ' LEU . 8.0 tp10 -124.19 128.35 49.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.887 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.1 t -135.55 129.09 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.444 -178.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.567 HE21 ' HG3' ' A' ' 123' ' ' GLU . 10.0 mp0 -109.97 130.59 55.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD1' HG23 ' A' ' 56' ' ' ILE . 24.2 p90 -153.37 173.08 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 -178.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 57' ' ' MET . 76.9 m-20 -128.57 163.05 25.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.333 178.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.444 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -109.82 120.43 42.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.574 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.67 152.15 74.35 Favored Pre-proline 0 N--CA 1.463 0.184 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 C-N-CA 121.555 1.503 . . . . 0.0 112.034 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.32 138.31 29.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.495 0.664 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -135.62 141.56 45.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.86 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.902 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -137.92 137.09 37.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.129 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.902 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.79 140.5 40.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.491 . . . . 0.0 110.446 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.71 136.72 55.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -178.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 86.2 tt0 -47.85 137.9 9.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.003 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.3 56.96 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.823 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -105.71 150.71 39.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.904 0.852 . . . . 0.0 110.241 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.26 149.73 46.03 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.593 2.195 . . . . 0.0 112.761 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.5 tt -118.4 147.73 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.612 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 84.0 tt0 -129.39 126.51 39.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.118 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -113.84 148.08 37.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.042 178.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.612 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 95.4 mtt180 -153.8 129.63 10.15 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.67 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.3 m -96.23 147.25 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.871 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.0 Cg_endo -70.07 156.64 62.06 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.07 1.847 . . . . 0.0 111.669 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.7 -139.28 17.45 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.845 0.691 . . . . 0.0 113.099 177.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.4 p -96.25 21.25 9.2 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.237 -0.981 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.54 165.07 24.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.732 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.32 147.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.755 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 62.0 mt -69.92 137.41 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.847 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.6 ptp -130.82 100.11 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 89' ' ' PHE . 51.7 t -63.63 123.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.362 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.513 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 93.6 mt-10 -102.08 -51.75 3.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.816 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -150.02 146.37 26.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.232 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.66 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.08 155.74 12.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.353 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.8 t30 -149.91 144.33 25.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 78.3 t80 -116.65 121.62 42.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.68 -141.09 7.23 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 16.0 ttm180 -146.57 116.91 7.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.23 0.538 . . . . 0.0 110.805 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 22.1 p -125.26 2.51 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.644 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 61.2 t0 -144.76 150.21 36.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.795 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 54.6 p30 -110.12 5.46 22.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 58.8 mttm -100.33 -0.46 38.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.416 -178.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.38 136.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.516 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.1 m 59.23 64.0 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -54.33 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.066 -178.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.25 -160.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.79 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.694 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -60.01 134.96 90.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.885 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.91 -34.32 75.7 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.127 1.885 . . . . 0.0 112.81 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.14 -36.8 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.679 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.2 mt-30 -86.72 -10.72 53.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.491 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.518 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 81.7 mtp -102.03 -3.67 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.71 -44.86 88.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.109 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 51.9 t30 -81.28 118.65 22.8 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.06 29.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -139.49 81.76 1.85 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.175 178.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 2.2 t -142.81 118.8 10.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HA ' HD21 ' A' ' 62' ' ' ASN . 71.9 m-85 -130.96 156.44 45.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.808 -178.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -145.17 88.72 6.66 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.241 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.4 -45.11 19.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.247 1.964 . . . . 0.0 112.822 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 89.8 m-20 -57.45 -16.66 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.21 72.56 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 58' ' ' VAL . 47.9 t80 -65.28 -45.56 83.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.83 -37.87 89.08 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.561 -178.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.7 HG23 ' NH1' ' A' ' 95' ' ' ARG . 91.1 mt -58.95 -52.74 56.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.817 0.341 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.8 mmm -67.26 -33.42 75.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.179 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.583 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.8 m -59.93 -49.73 76.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -66.95 -39.02 87.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 112.069 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.7 ' NH1' HG23 ' A' ' 91' ' ' ILE . 65.9 mtt85 -77.05 -32.43 56.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.51 -15.58 12.55 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.583 ' CG ' ' O ' ' A' ' 93' ' ' SER . 58.2 m-20 -61.32 133.77 56.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.034 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 70.36 14.74 7.45 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -111.44 143.95 41.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.07 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.0 m -68.67 -28.28 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.09 158.3 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.064 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.9 t -152.81 139.06 18.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.465 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.09 126.63 64.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.038 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 46' ' ' ILE . 47.3 t -143.49 141.57 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLY . 64.7 t -76.73 115.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.957 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.66 35.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.091 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -177.44 -127.7 1.08 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.51 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.58 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 32.29 -159.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.017 0.437 . . . . 0.0 111.02 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -66.43 1.94 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.25 -179.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.54 -13.0 55.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.688 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 44.4 m-85 -144.6 133.07 10.9 Favored Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.984 179.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.3 Cg_exo -56.05 -145.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.6 1.533 . . . . 0.0 111.471 178.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -145.25 90.55 6.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.93 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 95.7 Cg_endo -81.16 -4.09 12.42 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.297 2.664 . . . . 0.0 114.25 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.434 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -167.68 66.36 0.78 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -52.74 147.7 30.7 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.71 2.273 . . . . 0.0 111.588 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.16 -6.76 74.31 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' GLN . 87.2 m -118.88 148.08 43.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 45.8 t80 -85.72 120.74 27.48 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.5 mttm -96.86 -157.51 0.6 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -176.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.1 p90 -174.6 177.27 2.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.498 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.88 122.29 24.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.82 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' HG2' HE21 ' A' ' 125' ' ' GLN . 75.7 tt0 -116.49 127.89 54.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.4 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.66 HG22 ' HB1' ' A' ' 61' ' ' ALA . 96.1 t -136.82 127.37 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.008 -178.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.424 HE21 ' HG2' ' A' ' 123' ' ' GLU . 3.2 mp0 -114.6 132.28 56.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 31.8 p90 -155.01 169.98 22.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.219 0.533 . . . . 0.0 112.427 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 79.6 m-20 -120.91 160.45 23.45 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.481 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.4 m -112.05 118.33 35.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.694 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.79 159.35 61.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.774 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.497 1.734 0 C-N-CA 122.121 1.881 . . . . 0.0 112.331 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 mt 55.95 72.22 1.06 Allowed Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -47.84 155.68 1.56 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 123.123 2.549 . . . . 0.0 112.85 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -80.37 -20.12 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.83 13.1 82.74 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -157.82 65.41 0.47 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.972 0.415 . . . . 0.0 110.411 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 34' ' ' LEU . 13.9 mtt 54.87 150.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.737 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -90.76 149.0 22.19 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -150.58 137.11 18.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.944 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HG3' HD23 ' A' ' 48' ' ' LEU . 73.0 mm-40 -129.8 144.7 51.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.991 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.01 141.91 38.3 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.759 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.77 142.67 31.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.399 0.619 . . . . 0.0 111.49 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.6 m -66.78 135.17 53.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.133 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HG3' ' OH ' ' A' ' 63' ' ' TYR . 77.3 tt0 -47.61 134.93 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.509 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.61 -16.67 60.63 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.452 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 13.4 m-85 -107.47 155.86 38.83 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 118.272 1.036 . . . . 0.0 108.831 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.23 154.47 28.65 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.512 1.475 . . . . 0.0 112.188 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 46' ' ' ILE . 12.9 tt -116.44 150.68 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.035 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 33.0 tt0 -126.93 130.89 50.99 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.672 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.0 mt -122.07 136.1 54.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.692 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 87.0 mtt180 -146.43 134.7 21.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.0 110.705 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.1 m -103.63 145.53 30.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.092 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -70.23 155.74 63.71 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.988 1.792 . . . . 0.0 112.51 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.21 -131.69 24.88 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.63 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.9 p -102.86 22.32 14.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.497 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.95 165.07 24.53 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG11 ' HD1' ' A' ' 131' ' ' TYR . 30.0 m -125.58 145.67 32.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.837 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.9 mt -67.89 135.79 27.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.819 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.6 ptm -131.65 98.04 4.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.8 t -61.73 122.44 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.591 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -99.33 -51.66 3.74 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -151.24 150.01 30.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.643 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.97 154.21 7.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.098 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 84' ' ' TYR . 2.5 t30 -148.75 146.19 27.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' OH ' ' HG3' ' A' ' 42' ' ' GLU . 49.3 t80 -114.49 118.08 32.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.34 -139.3 5.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.949 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.694 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 11.5 ttm-85 -151.36 119.69 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.123 0.487 . . . . 0.0 111.475 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.402 HG21 ' CE1' ' A' ' 84' ' ' TYR . 8.3 p -126.86 4.78 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.116 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 51.7 t0 -146.99 153.28 39.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.777 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 24.8 p-10 -110.31 4.87 21.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.956 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -103.98 4.07 34.16 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.138 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.7 mm -110.23 133.84 54.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 77.2 m 57.14 70.12 0.68 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.138 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -54.01 120.43 6.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.572 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.44 -161.88 1.25 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.782 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.662 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.4 p-10 -61.96 137.21 95.4 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.801 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 7.0 Cg_endo -55.38 -36.2 93.38 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.351 2.034 . . . . 0.0 113.327 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.55 -33.4 74.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.89 0.376 . . . . 0.0 110.753 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 118' ' ' THR . 25.0 mt-30 -85.08 -18.87 32.97 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.293 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 68.6 mtp -97.87 -0.4 45.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 56.9 mt-10 -64.68 -46.65 81.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -78.49 112.99 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 0.0 111.834 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -106.12 30.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.163 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -142.04 84.37 1.88 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.082 0.468 . . . . 0.0 111.92 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.463 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 44.1 t -145.24 119.94 9.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.0 m-85 -127.16 155.15 43.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 111.077 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.28 90.0 5.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.779 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.1 -47.38 24.08 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.523 2.149 . . . . 0.0 113.457 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.0 -22.4 15.17 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.24 -0.287 . . . . 0.0 111.701 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.59 -33.94 48.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.72 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 58' ' ' VAL . 70.8 t80 -64.96 -45.44 85.7 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 12.0 ptmt -64.43 -38.77 92.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.922 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 95' ' ' ARG . 70.2 mt -60.34 -48.93 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.905 0.383 . . . . 0.0 111.666 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.0 mmm -70.39 -37.74 74.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.501 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.4 m -60.42 -46.99 88.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -64.79 -36.39 84.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 111.231 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.622 HH12 ' HB1' ' A' ' 110' ' ' ALA . 99.5 mtt180 -78.47 -32.7 48.48 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.509 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.8 m -112.22 -15.01 13.28 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 93' ' ' SER . 61.7 m-20 -59.84 133.05 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.043 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 67.7 14.28 9.46 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.118 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -115.95 147.21 41.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.272 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.7 m -72.28 -33.51 67.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.148 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 151.48 33.83 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.34 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.9 p -152.75 147.27 25.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.791 0.329 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.8 t -128.45 129.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.02 0.438 . . . . 0.0 110.032 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.581 ' CG1' HH11 ' A' ' 95' ' ' ARG . 46.3 t -135.65 148.75 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 107' ' ' GLY . 59.6 t -82.56 115.33 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.93 39.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.96 -127.31 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.98 -157.89 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.469 0.652 . . . . 0.0 112.033 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -66.56 1.09 1.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.557 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.622 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.34 -11.64 55.98 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.647 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 51.4 m-85 -143.74 128.31 9.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.672 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 38.1 Cg_exo -50.64 -149.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.148 1.898 . . . . 0.0 111.125 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.37 97.11 5.19 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.463 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 61.6 Cg_endo -88.35 -10.49 4.66 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.592 2.195 . . . . 0.0 112.325 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.455 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.5 p -166.58 90.29 0.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.635 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -76.55 155.61 35.94 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.355 2.037 . . . . 0.0 111.912 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.95 5.22 89.62 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 77' ' ' GLN . 89.0 m -126.49 147.66 49.79 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 t80 -79.25 108.73 12.98 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 30.9 mtmm -87.61 -167.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.388 1.09 . . . . 0.0 113.093 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -171.6 174.64 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.439 -1.709 . . . . 0.0 111.044 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 22.1 tp -133.01 125.2 29.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.458 ' HG2' HE21 ' A' ' 125' ' ' GLN . 65.4 tt0 -119.34 125.61 49.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.9 t -130.73 123.94 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.458 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.2 mt-30 -107.57 130.23 54.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.623 ' CD2' HG23 ' A' ' 56' ' ' ILE . 33.5 p90 -155.9 164.42 38.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.555 0.693 . . . . 0.0 112.259 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -119.16 156.27 30.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.228 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 92.9 m -107.78 120.98 43.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.5 m -121.63 152.87 59.21 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -55.58 145.21 70.97 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.258 1.972 . . . . 0.0 112.128 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.5 ' HD2' ' HZ3' ' A' ' 132' ' ' LYS . 40.4 t80 -73.32 -4.65 34.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.135 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HZ3' ' HD2' ' A' ' 131' ' ' TYR . 31.5 mttm -149.4 -92.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.288 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 133' ' ' VAL . 7.6 p -153.45 124.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.868 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.484 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -120.92 162.47 34.93 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 121.185 0.517 . . . . 0.0 111.145 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.72 -91.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.224 2.616 . . . . 0.0 112.49 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -79.02 -15.38 58.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.686 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 30' ' ' LEU . . . 64.98 -48.99 0.11 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.215 -0.448 . . . . 0.0 113.208 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -160.67 119.53 2.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.112 0.456 . . . . 0.0 110.427 -178.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 34' ' ' LEU . 28.2 mtt 60.04 136.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.063 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.77 151.35 22.45 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.4 ttp180 -147.05 131.38 17.53 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.725 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.556 ' HG3' HD23 ' A' ' 48' ' ' LEU . 72.1 mm-40 -128.16 143.85 51.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.98 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.824 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.2 tt -138.57 136.61 36.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.824 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.16 140.1 46.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.113 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.404 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 64.9 m -65.3 138.18 58.02 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 64.8 tt0 -45.56 129.84 8.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.598 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.04 -12.37 67.03 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.856 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -109.19 149.27 39.49 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 118.841 1.321 . . . . 0.0 110.19 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.75 150.82 87.54 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.852 1.701 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -121.33 141.91 39.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.638 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 74.4 tt0 -130.16 130.29 44.54 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.664 -0.814 . . . . 0.0 112.519 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.594 HD12 ' SG ' ' A' ' 102' ' ' CYS . 43.9 mt -116.24 139.35 50.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.048 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.638 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 48.2 mtt180 -145.75 135.22 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.442 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.458 ' SG ' HG12 ' A' ' 56' ' ' ILE . 7.4 m -100.59 146.59 32.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -70.0 160.37 49.89 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.764 2.309 . . . . 0.0 112.489 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.26 -120.98 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.738 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -120.94 25.29 9.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.581 -0.31 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -76.18 169.91 17.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.0 110.02 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.26 145.24 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.635 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.801 HG23 ' CD2' ' A' ' 126' ' ' TYR . 77.9 mt -68.4 137.15 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.603 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.1 ptm -130.85 99.67 5.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.561 0.696 . . . . 0.0 109.257 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.717 HG12 ' CE1' ' A' ' 89' ' ' PHE . 24.1 t -63.21 123.25 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 80.5 mm-40 -100.31 -51.67 3.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 58.6 m-20 -151.72 148.98 28.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.056 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -167.33 153.97 8.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.862 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.6 t30 -147.88 148.05 30.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.457 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -114.21 114.98 26.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.27 -142.22 7.57 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.38 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -150.84 119.2 6.39 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.317 0.58 . . . . 0.0 111.568 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.51 ' N ' ' OH ' ' A' ' 121' ' ' TYR . 59.9 p -125.95 6.97 7.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.811 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.646 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 35.0 t0 -140.44 -174.75 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.128 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 22.4 p30 -144.96 -1.06 0.87 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 3.5 mtmp? -101.59 3.88 40.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.408 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 ' SG ' ' A' ' 71' ' ' CYS . 30.5 mm -112.76 135.35 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.981 0.42 . . . . 0.0 110.309 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' A' ' 70' ' ' ILE . 67.1 m 60.46 64.24 1.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.256 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.592 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 42.5 p30 -50.02 96.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.539 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.52 -163.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.683 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -60.68 139.1 93.15 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.639 178.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.7 Cg_endo -56.62 -38.01 96.43 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.433 2.089 . . . . 0.0 113.326 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -62.19 -33.32 74.31 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.71 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 70.8 mt-30 -85.01 -6.36 59.33 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.438 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 83.9 mtp -109.95 -3.02 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.383 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 82.2 mt-10 -64.79 -46.15 83.3 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.97 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -79.68 112.88 17.38 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.072 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 67' ' ' ASP . 35.8 m -107.3 31.38 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.6 mm-40 -138.24 84.53 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.86 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 51.0 t -146.1 125.84 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.563 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HA ' HD21 ' A' ' 62' ' ' ASN . 59.0 m-85 -134.04 154.71 50.97 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 112' ' ' PRO . 37.4 tp -146.91 93.67 4.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.346 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.61 -48.4 22.17 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.497 2.798 . . . . 0.0 114.576 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -57.81 -19.92 32.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.88 -32.03 63.34 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.646 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.717 ' CE1' HG12 ' A' ' 58' ' ' VAL . 48.3 t80 -63.72 -43.81 95.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.714 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.21 -39.61 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 65.2 mt -58.08 -51.02 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.942 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.084 ' SD ' HD21 ' A' ' 122' ' ' LEU . 40.0 mtp -70.46 -33.22 71.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.528 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 20.1 m -58.39 -47.17 84.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.83 -34.67 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.501 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NE ' HG22 ' A' ' 104' ' ' VAL . 17.7 mtp180 -80.54 -32.4 36.75 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.511 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.2 m -111.74 -20.16 12.19 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.479 ' CG ' ' O ' ' A' ' 93' ' ' SER . 42.6 m-20 -56.16 135.19 53.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.845 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 64.44 13.84 8.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.972 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -112.95 144.3 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.604 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -33.21 73.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.099 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.87 158.71 42.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.043 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.594 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.2 p -155.38 135.0 12.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.138 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.38 129.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.5 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.2 t -143.41 145.72 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.769 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.2 t -79.05 116.4 22.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.58 41.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.629 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.67 -116.82 0.53 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.659 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER 28.56 -160.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.14 0.495 . . . . 0.0 111.737 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.659 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-20 -69.47 2.09 3.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.968 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.05 -13.75 49.45 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.383 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.574 ' O ' ' O ' ' A' ' 112' ' ' PRO . 72.8 m-85 -141.09 126.62 11.1 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 111' ' ' PHE . 16.7 Cg_exo -51.41 -150.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.224 1.949 . . . . 0.0 111.575 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -144.9 90.45 6.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.77 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.55 -8.68 13.65 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.093 2.528 . . . . 0.0 113.236 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.0 p -172.22 80.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.437 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -69.32 159.02 55.39 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.149 1.899 . . . . 0.0 111.505 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.1 -4.71 86.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 77' ' ' GLN . 63.2 m -125.36 147.87 48.98 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.494 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 45.3 t80 -85.81 118.7 25.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.479 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mttt -95.17 -156.91 0.54 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.0 p90 -174.86 176.5 2.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.556 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.084 HD21 ' SD ' ' A' ' 92' ' ' MET . 34.3 tp -133.69 126.79 31.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.816 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.67 ' CD ' ' N ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -120.74 130.72 54.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 123' ' ' GLU . 11.8 t -133.28 123.36 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -107.04 125.72 51.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.801 ' CD2' HG23 ' A' ' 56' ' ' ILE . 37.3 p90 -154.65 170.08 22.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.302 0.572 . . . . 0.0 112.223 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' A' ' 57' ' ' MET . 10.8 m-20 -127.0 161.57 28.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.941 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.5 m -111.8 115.86 29.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.115 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.78 158.93 44.36 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.42 146.79 96.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.181 1.92 . . . . 0.0 112.055 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -79.35 134.68 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -95.8 136.07 36.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 134' ' ' GLU . 8.9 p -103.44 127.49 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.695 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HG2' HG22 ' A' ' 133' ' ' VAL . 79.1 mm-40 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.012 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.2 mt -121.16 78.42 33.79 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 120.859 0.362 . . . . 0.0 110.599 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' LEU . 52.7 Cg_exo -52.86 -162.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.694 2.263 . . . . 0.0 111.508 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.83 -13.2 59.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.889 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.97 70.44 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.462 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.648 ' O ' ' O ' ' A' ' 35' ' ' MET . 25.9 tp -154.36 99.28 2.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.718 0.259 . . . . 0.0 110.449 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.648 ' O ' ' O ' ' A' ' 34' ' ' LEU . 7.3 mtt 49.95 132.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.28 0.562 . . . . 0.0 111.067 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.609 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt-85 -92.96 143.66 26.02 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -151.74 138.68 19.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.343 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -133.78 146.77 51.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.36 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.7 tt -134.88 132.11 38.15 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -129.67 139.96 51.25 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.546 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -69.1 137.16 53.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.597 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 87.2 tt0 -48.06 133.37 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.028 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.8 -17.96 58.0 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.94 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -111.72 148.18 38.36 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 118.283 1.041 . . . . 0.0 110.308 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.76 151.71 82.42 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.489 2.126 . . . . 0.0 113.36 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.9 tt -119.07 147.01 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 103' ' ' VAL . 81.5 tt0 -136.0 125.38 24.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.4 mt -110.9 145.93 37.43 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -148.47 136.56 21.03 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.2 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 5.9 m -104.41 143.99 27.8 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.23 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 56.6 Cg_endo -71.71 161.19 45.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.361 2.041 . . . . 0.0 112.13 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 51.34 -132.2 34.23 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.449 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.8 p -107.92 23.36 14.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.351 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -78.58 167.89 20.59 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.5 m -130.73 145.21 35.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.82 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.874 HG23 ' CD2' ' A' ' 126' ' ' TYR . 82.7 mt -68.66 139.78 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.068 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.599 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.3 ptm -131.98 99.53 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.834 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 89' ' ' PHE . 55.8 t -63.05 124.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.361 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -101.98 -48.53 4.22 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -151.41 147.52 26.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.06 155.58 11.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.492 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.0 t30 -151.81 145.65 25.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CZ ' ' HD2' ' A' ' 120' ' ' LYS . 67.3 t80 -116.73 118.04 31.46 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.49 -138.04 5.16 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' H ' ' HB3' ' A' ' 83' ' ' CYS . 12.3 ttm-85 -152.4 118.94 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.232 0.539 . . . . 0.0 111.717 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 p -121.99 8.4 9.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 27.6 t0 -143.54 -164.23 1.82 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.059 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 47.2 p30 -149.16 -1.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.237 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -102.88 4.49 37.7 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.576 HG22 ' SG ' ' A' ' 71' ' ' CYS . 14.3 mm -106.64 135.28 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.576 ' SG ' HG22 ' A' ' 70' ' ' ILE . 47.7 m 59.44 66.52 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.481 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 55.3 p30 -47.8 108.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.363 0.601 . . . . 0.0 112.25 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.95 -162.99 1.26 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.015 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 2.6 p-10 -63.44 138.31 97.32 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.529 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.8 Cg_endo -58.81 -32.45 97.16 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.212 1.941 . . . . 0.0 112.199 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -60.79 -37.82 83.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.654 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 118' ' ' THR . 24.5 mt-30 -86.21 -10.88 53.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.334 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -108.84 0.52 20.34 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.128 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 75.5 mt-10 -64.78 -43.92 91.65 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.365 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 45.2 t30 -78.78 114.28 17.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.2 m -106.1 32.62 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 98.4 mm-40 -140.68 86.51 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.75 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.551 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 32.8 t -147.7 120.88 8.9 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 89.2 m-85 -132.51 152.71 51.46 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.883 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -144.13 93.42 6.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.027 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.48 -49.05 16.69 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.558 2.838 . . . . 0.0 113.829 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -57.37 -24.58 56.17 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.24 -31.52 21.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE1' HG12 ' A' ' 58' ' ' VAL . 83.5 t80 -66.63 -45.8 77.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.89 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 11.9 ptmt -64.38 -39.24 93.47 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.675 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 94.4 mt -60.18 -52.91 55.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.3 mmm -70.12 -35.24 73.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 111.526 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 65.4 m -59.95 -47.33 86.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -66.87 -36.75 83.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.421 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 1.025 ' HE ' HG22 ' A' ' 104' ' ' VAL . 72.9 mtp85 -77.23 -32.68 55.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 23.7 m -112.69 -17.24 12.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 85.9 m-20 -57.17 136.22 56.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.297 0.57 . . . . 0.0 111.964 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 64.76 12.98 8.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.653 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 95' ' ' ARG . 67.2 mtt-85 -112.32 144.93 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.228 0.537 . . . . 0.0 110.307 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 m -70.31 -33.76 71.91 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.38 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.59 154.29 37.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.88 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 2.0 p -155.01 139.03 16.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.859 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.492 HG22 ' HG3' ' A' ' 47' ' ' GLU . 48.5 t -122.46 135.82 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.025 HG22 ' HE ' ' A' ' 95' ' ' ARG . 33.4 t -143.04 152.99 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.98 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.449 ' N ' HG12 ' A' ' 104' ' ' VAL . 70.6 t -84.05 115.74 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.03 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.32 36.64 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -176.62 -118.23 0.53 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.646 ' O ' ' O ' ' A' ' 107' ' ' GLY . 46.5 t 27.0 -158.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.424 0.631 . . . . 0.0 112.02 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' N ' ' OG ' ' A' ' 108' ' ' SER . 89.1 m-20 -69.27 1.09 4.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.08 -11.2 58.22 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.671 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.1 m-85 -144.94 133.69 11.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.805 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 111' ' ' PHE . 26.1 Cg_exo -53.2 -147.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.04 1.826 . . . . 0.0 110.559 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.493 ' CG ' ' HZ1' ' A' ' 120' ' ' LYS . 11.0 t0 -144.38 91.24 6.37 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.0 110.255 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.416 ' HD2' ' CE ' ' A' ' 120' ' ' LYS . 62.4 Cg_endo -80.94 -11.7 12.3 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.124 2.549 . . . . 0.0 113.734 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.584 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -165.27 76.58 1.35 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 121.538 0.685 . . . . 0.0 111.531 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.84 153.25 38.18 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.753 2.302 . . . . 0.0 112.619 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.19 8.09 53.41 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.049 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 77' ' ' GLN . 30.8 m -119.3 148.88 42.66 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.55 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 6.5 t80 -83.31 108.88 16.82 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.584 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 28.1 mttt -89.56 -163.06 0.94 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.754 1.264 . . . . 0.0 112.833 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -173.54 175.52 2.98 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.007 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 tp -133.4 125.75 29.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.282 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -123.62 128.64 49.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 61' ' ' ALA . 99.0 t -133.27 126.94 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -108.17 128.58 54.83 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.874 ' CD2' HG23 ' A' ' 56' ' ' ILE . 39.4 p90 -155.6 175.32 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.236 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -131.85 161.16 33.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.272 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.609 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 88.4 m -108.38 122.53 47.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.183 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.93 155.84 57.2 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.519 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.21 143.99 95.02 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.33 2.02 . . . . 0.0 111.904 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -82.13 153.84 25.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.583 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.52 114.01 26.12 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.008 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.67 129.97 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-O 120.812 0.339 . . . . 0.0 110.69 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.026 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -39.15 -52.58 4.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.863 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 32.3 Cg_exo -52.32 -178.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.012 1.808 . . . . 0.0 111.075 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.03 -61.37 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.397 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.663 ' O ' HD22 ' A' ' 34' ' ' LEU . . . 76.61 43.64 18.35 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.663 HD22 ' O ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -158.19 -10.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.9 0.381 . . . . 0.0 110.372 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' LEU . 6.6 mtt 58.81 140.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.874 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -90.57 150.28 21.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.925 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.559 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 28.3 ttm180 -147.21 134.51 20.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.0 111.673 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 40.5 mp0 -131.35 144.11 50.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.751 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -138.75 141.28 38.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.841 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.31 141.63 33.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.397 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -66.36 135.32 54.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.66 138.95 7.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.294 0.569 . . . . 0.0 112.032 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 -16.64 60.59 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.961 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -109.32 150.34 40.96 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 117.741 0.77 . . . . 0.0 110.117 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.97 151.18 67.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.884 2.39 . . . . 0.0 113.264 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -123.98 142.0 42.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 65.9 tt0 -128.02 130.36 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 111.82 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 64.7 mt -111.21 145.99 37.72 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.095 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.641 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 96.6 mtt180 -149.43 128.23 12.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.792 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.7 m -101.01 144.43 28.54 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.854 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.05 158.08 50.01 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.424 2.083 . . . . 0.0 112.543 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.73 -139.18 36.41 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.428 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 p -99.57 23.87 8.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.405 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 63.4 m-20 -81.29 165.16 21.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.243 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.8 m -129.95 146.55 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 110.584 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.96 HG23 ' CD2' ' A' ' 126' ' ' TYR . 81.2 mt -68.25 136.59 26.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.753 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -130.8 99.39 4.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.503 HG12 ' HE1' ' A' ' 89' ' ' PHE . 53.0 t -63.01 123.06 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.512 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.502 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.8 mm-40 -103.39 -46.94 4.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.184 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 24.7 m-20 -147.16 144.48 29.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.168 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -163.78 149.99 11.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.743 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.571 ' O ' HD12 ' A' ' 122' ' ' LEU . 29.7 t30 -148.07 147.45 29.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.167 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -118.64 120.02 36.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -138.68 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.997 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -154.79 116.29 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.661 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.52 HG21 ' CE2' ' A' ' 84' ' ' TYR . 14.9 p -122.43 9.65 9.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.923 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.617 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.0 t0 -147.59 -173.52 4.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.2 p30 -145.78 1.99 0.91 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.051 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.67 5.01 41.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.323 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.451 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.2 mm -115.42 137.84 47.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.74 0.305 . . . . 0.0 110.523 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 30.9 m 52.88 75.91 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -56.41 122.19 11.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.484 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.84 -167.55 2.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.552 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -61.4 134.15 93.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.7 Cg_endo -53.1 -33.57 64.21 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.789 1.66 . . . . 0.0 113.506 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -63.65 -34.91 78.9 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.039 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.79 ' O ' HG23 ' A' ' 118' ' ' THR . 72.9 mt-30 -83.35 -14.88 51.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.548 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 mtp -99.54 -0.61 40.2 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.3 mt-10 -62.05 -52.13 65.19 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 39.2 t30 -81.72 115.98 21.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.7 m -105.03 35.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.559 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.422 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 2.4 mm100 -139.52 85.8 2.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 4.0 t -148.56 118.56 7.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CE2' HG21 ' A' ' 66' ' ' THR . 69.7 m-85 -130.02 154.24 47.61 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.814 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 88' ' ' ALA . 40.4 tp -146.28 85.69 7.3 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.388 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -47.09 -47.69 16.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.902 2.402 . . . . 0.0 113.614 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -56.79 -22.76 38.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -55.73 -31.35 62.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.972 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' HE1' HG12 ' A' ' 58' ' ' VAL . 11.6 t80 -64.1 -42.53 96.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.016 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.4 ptpt -66.09 -42.17 89.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.963 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.484 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 82.2 mt -58.39 -49.73 81.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.529 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.092 ' SD ' HD21 ' A' ' 122' ' ' LEU . 31.7 mtp -71.07 -33.19 70.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.745 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.6 m -59.14 -45.57 90.6 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.919 0.39 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -65.59 -37.4 86.54 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.078 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 93.6 mtt-85 -76.73 -35.3 57.89 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.432 ' SG ' HD12 ' A' ' 48' ' ' LEU . 59.4 m -109.28 -21.5 12.51 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CG ' ' O ' ' A' ' 93' ' ' SER . 75.9 m-20 -57.24 134.09 55.64 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.207 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 67.95 12.48 8.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.902 -1.044 . . . . 0.0 112.798 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 99' ' ' ARG . 51.3 mtt180 -113.47 146.44 39.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.215 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.7 m -73.45 -28.74 62.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.452 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -151.98 152.48 32.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.498 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.1 p -153.58 142.81 21.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.716 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.67 126.06 72.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.92 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.9 t -139.04 146.68 25.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.845 0.355 . . . . 0.0 111.374 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.9 t -78.78 113.67 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.95 42.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 111.581 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -121.62 0.8 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.6 t 28.05 -157.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.183 0.516 . . . . 0.0 111.892 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.38 1.22 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.175 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.87 -12.49 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.433 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' O ' ' O ' ' A' ' 112' ' ' PRO . 63.9 m-85 -144.58 128.14 8.75 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.979 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 111' ' ' PHE . 46.8 Cg_exo -50.45 -146.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.387 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -142.88 84.62 10.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.01 -5.53 14.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.812 2.341 . . . . 0.0 113.424 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.505 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.4 p -164.68 71.6 1.53 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.544 0.688 . . . . 0.0 111.47 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.43 140.46 93.22 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.396 2.064 . . . . 0.0 110.594 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.77 71.51 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.951 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 77' ' ' GLN . 21.3 m -124.4 146.3 48.97 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.538 0.669 . . . . 0.0 110.331 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.556 ' H ' ' HB3' ' A' ' 77' ' ' GLN . 26.0 t80 -81.64 116.23 21.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HE2' ' SG ' ' A' ' 115' ' ' CYS . 24.3 mttt -89.82 -165.93 1.47 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.805 1.288 . . . . 0.0 114.037 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.2 p90 -167.68 169.49 11.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 112.685 -2.052 . . . . 0.0 111.17 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.092 HD21 ' SD ' ' A' ' 92' ' ' MET . 65.8 tp -130.31 122.71 28.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.687 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 71.5 tt0 -117.94 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' A' ' 92' ' ' MET . 45.7 t -133.64 125.17 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.88 128.71 55.15 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.96 ' CD2' HG23 ' A' ' 56' ' ' ILE . 28.6 p90 -154.3 169.64 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.23 0.538 . . . . 0.0 111.735 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.488 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 76.9 m-20 -123.04 159.31 28.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.965 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 88.9 m -109.15 112.13 24.13 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 4.2 m -121.02 158.68 51.92 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.51 146.22 53.94 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.9 1.733 . . . . 0.0 112.154 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -72.01 -30.32 65.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.381 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -97.33 140.9 31.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.358 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 133' ' ' VAL . 11.6 p -88.62 132.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.838 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.22 75.56 77.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.609 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -50.89 146.08 22.41 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.136 1.891 . . . . 0.0 110.902 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' LEU . 97.3 m-85 -82.34 -9.57 59.41 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.05 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.11 -45.03 0.91 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -162.92 123.31 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.963 0.411 . . . . 0.0 111.017 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.9 mtm 64.33 149.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.499 0.666 . . . . 0.0 111.349 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.589 HH21 ' HG3' ' A' ' 51' ' ' PRO . 94.6 mtt-85 -91.75 150.75 20.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.261 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -145.15 132.91 21.07 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.495 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' HG3' HD23 ' A' ' 48' ' ' LEU . 79.5 mm-40 -124.4 145.33 49.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.8 tt -137.26 141.03 41.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.811 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.79 139.86 36.52 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.471 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.03 135.73 55.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.911 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 82.0 tt0 -46.17 134.27 8.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.284 -178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 -11.89 68.29 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.267 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 3.8 m-85 -112.26 148.75 39.8 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 118.451 1.125 . . . . 0.0 109.828 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.91 150.26 73.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.288 1.992 . . . . 0.0 112.867 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.6 tt -116.34 147.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.42 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -125.2 127.94 47.57 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.036 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 38' ' ' GLU . 24.3 mt -116.23 138.29 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.059 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' A' ' 101' ' ' GLN . 65.5 mtp85 -148.2 135.46 20.4 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.021 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -100.34 144.14 27.88 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HG3' HH21 ' A' ' 36' ' ' ARG . 61.2 Cg_endo -72.02 159.17 50.86 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.258 2.638 . . . . 0.0 112.55 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.79 -131.02 27.46 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.9 p -108.42 23.93 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.78 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.38 165.4 24.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.31 147.71 32.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.136 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.773 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.0 mt -69.92 136.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.104 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 3.7 ptp -134.44 106.06 6.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 89' ' ' PHE . 36.4 t -64.44 124.5 19.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -102.96 -53.12 2.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.225 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -147.17 143.47 28.25 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.168 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -165.37 154.46 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.82 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.3 t30 -149.96 145.97 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.405 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -116.84 118.31 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.29 -133.64 3.34 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.7 ttm-85 -157.71 117.11 3.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.98 0.419 . . . . 0.0 110.334 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 p -122.29 9.46 9.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 14.5 t70 -144.86 -168.99 3.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.5 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 8.0 p30 -148.41 -0.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.402 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -101.42 7.71 42.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.039 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.53 136.61 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.089 0.471 . . . . 0.0 111.07 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.8 m 51.96 78.95 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 59.1 p30 -55.77 125.04 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.72 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.99 -164.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.931 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.66 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -64.72 142.97 98.66 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 110.61 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.6 Cg_endo -60.96 -35.78 86.26 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 113.713 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.74 -36.16 82.11 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.474 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 118' ' ' THR . 22.3 mt-30 -86.34 -14.13 44.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.453 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 74.9 mtp -106.27 -2.54 22.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.001 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 4.6 mt-10 -65.58 -44.75 85.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.897 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -80.82 121.04 25.46 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.2 m -110.08 34.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.626 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -139.62 90.1 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.059 0.456 . . . . 0.0 110.886 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 25.5 t -152.62 119.2 5.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.584 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 13.6 m-85 -132.45 154.01 50.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.64 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -144.29 96.15 5.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.72 -44.08 46.94 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.558 2.172 . . . . 0.0 112.623 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 85.4 m-20 -58.08 -21.59 46.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 111.921 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.91 62.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.977 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.619 ' O ' ' OG ' ' A' ' 93' ' ' SER . 57.1 t80 -63.96 -46.43 84.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.641 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 1.1 pttp -66.64 -39.74 88.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.351 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.63 -46.5 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.203 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.9 mmm -69.31 -37.74 77.93 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.789 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.619 ' OG ' ' O ' ' A' ' 89' ' ' PHE . 3.5 m -59.88 -48.43 81.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -65.72 -37.45 86.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.015 0.435 . . . . 0.0 111.213 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -76.94 -33.52 57.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.8 m -113.88 -16.44 12.22 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 93' ' ' SER . 71.9 m-20 -57.81 137.89 56.17 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.693 -0.629 . . . . 0.0 111.974 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 49.9 m-20 69.5 14.39 8.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -117.2 149.3 40.63 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.401 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -72.17 -31.37 65.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.526 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.583 ' CD ' HH12 ' A' ' 49' ' ' ARG . 0.1 OUTLIER -142.88 156.99 45.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.318 178.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 39.7 t -152.93 135.8 15.44 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 111.747 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.9 132.32 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.054 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.5 146.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.735 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 107' ' ' GLY . 46.5 t -79.43 117.13 24.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.834 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.37 35.49 0.07 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.287 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.14 -121.01 0.69 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.5 t 33.42 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.242 0.544 . . . . 0.0 110.905 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.07 4.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.035 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -87.66 -7.58 57.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.374 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' O ' ' O ' ' A' ' 112' ' ' PRO . 35.4 m-85 -147.76 132.82 9.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.95 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 111' ' ' PHE . 42.9 Cg_exo -51.79 -148.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.702 1.601 . . . . 0.0 110.639 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.707 ' CG ' ' HZ3' ' A' ' 120' ' ' LYS . 46.4 t0 -146.83 92.15 5.09 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.1 Cg_endo -79.37 -4.65 13.83 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.979 2.453 . . . . 0.0 113.241 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.493 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -167.91 67.99 0.82 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.672 0.749 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -52.26 149.81 21.46 Favored 'Trans proline' 0 C--N 1.292 -2.426 0 C-N-CA 122.487 2.124 . . . . 0.0 110.867 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.0 -4.36 76.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.871 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 77' ' ' GLN . 54.5 m -116.97 149.59 39.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.406 0.603 . . . . 0.0 110.602 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.53 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 10.7 t80 -83.94 112.42 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HZ3' ' CG ' ' A' ' 113' ' ' ASP . 19.0 mttt -92.22 -161.5 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.653 1.215 . . . . 0.0 114.169 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 8.3 p90 -174.91 175.98 2.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.754 -2.021 . . . . 0.0 111.046 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 62' ' ' ASN . 45.2 tp -132.57 123.45 26.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.348 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.561 ' HG2' HE21 ' A' ' 125' ' ' GLN . 84.8 tt0 -115.94 124.03 49.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 61' ' ' ALA . 57.9 t -134.5 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.555 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.561 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.4 mp0 -113.5 128.6 56.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' A' ' 56' ' ' ILE . 47.8 p90 -146.23 162.2 38.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.128 0.489 . . . . 0.0 111.295 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -113.4 157.14 22.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.214 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.466 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.0 m -113.3 108.38 17.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.364 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.28 161.07 33.3 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.94 150.97 60.46 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.532 1.488 . . . . 0.0 111.517 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.657 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 24.2 t80 -76.19 9.21 2.67 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.318 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.76 -133.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -88.62 135.11 26.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 0.0 111.444 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.085 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -127.8 80.42 72.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 30' ' ' LEU . 34.5 Cg_exo -51.99 -129.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.752 2.301 . . . . 0.0 112.644 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 28.9 m-85 -147.44 37.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.091 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.29 -39.84 0.58 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.361 -0.382 . . . . 0.0 112.802 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' MET . 6.0 mt -154.63 83.4 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.872 0.336 . . . . 0.0 110.282 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.478 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 49.2 178.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.318 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.734 ' NH1' ' SG ' ' A' ' 128' ' ' CYS . 14.4 mmt85 -90.71 139.69 30.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.716 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.625 HH21 ' CD ' ' A' ' 123' ' ' GLU . 40.2 ttt180 -143.2 138.51 29.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.647 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 41.1 mp0 -135.67 139.89 44.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.123 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.5 tt -137.78 136.48 37.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.914 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.835 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.61 142.47 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.564 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.6 140.79 58.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.518 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 81.0 tt0 -47.67 129.52 13.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.85 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 -11.49 71.97 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.92 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 24.8 m-85 -106.47 150.06 39.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.907 0.853 . . . . 0.0 109.883 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.09 152.62 45.89 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.195 1.93 . . . . 0.0 112.856 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 tt -122.97 142.26 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.19 128.84 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.191 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.746 HD12 ' SG ' ' A' ' 102' ' ' CYS . 36.3 mt -113.05 144.9 41.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.726 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 14.9 mtp180 -150.52 135.2 17.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.846 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.1 m -102.74 149.65 36.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.316 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 47.9 Cg_endo -71.63 160.15 49.05 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.027 2.485 . . . . 0.0 113.403 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.18 -126.36 22.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.587 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.5 p -113.75 23.15 13.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.361 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -78.22 170.2 17.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.751 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.16 146.97 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.298 0.571 . . . . 0.0 110.544 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.75 HG23 ' CD1' ' A' ' 126' ' ' TYR . 81.6 mt -68.84 136.93 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.298 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.605 ' O ' ' CG ' ' A' ' 57' ' ' MET . 11.7 ptm -132.45 98.29 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.984 0.897 . . . . 0.0 108.946 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 5.9 t -64.5 124.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.519 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 88.8 mt-10 -103.86 -48.92 3.78 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 20.6 m-20 -146.6 144.3 29.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.547 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.15 151.97 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.054 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.601 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.4 t30 -150.56 151.52 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.571 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -118.72 114.92 23.46 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.35 -139.56 5.92 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.091 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.696 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -153.57 119.02 5.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.026 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 84' ' ' TYR . 11.7 p -125.44 3.96 7.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.08 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.679 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 48.2 t0 -143.48 149.24 37.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.184 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' OD1' ' HG3' ' A' ' 69' ' ' LYS . 45.1 p30 -110.5 1.21 18.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 1.4 mtpm? -102.7 8.43 39.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.51 137.75 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.019 0.438 . . . . 0.0 111.192 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.598 ' O ' ' C ' ' A' ' 72' ' ' ASP . 63.8 m 60.3 17.45 7.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.988 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' C ' ' O ' ' A' ' 71' ' ' CYS . 42.1 m-20 3.44 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.976 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.36 -165.22 0.97 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -61.79 146.48 90.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.22 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 14.7 Cg_endo -58.31 -40.74 73.03 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 122.41 2.073 . . . . 0.0 112.856 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.81 -37.81 88.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.469 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.581 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 23.4 mt-30 -83.95 -7.57 59.38 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -104.19 -1.48 27.13 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.98 179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 91.6 mt-10 -63.31 -51.17 67.14 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -76.79 110.67 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.861 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.569 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 27.2 m -103.5 27.23 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.7 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.569 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 14.1 mm100 -140.46 87.85 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.89 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.7 t -144.74 120.95 10.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.424 ' CZ ' ' CG2' ' A' ' 66' ' ' THR . 81.7 m-85 -133.31 157.07 46.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.336 0.589 . . . . 0.0 112.221 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 tp -147.07 87.13 6.26 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.501 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -47.65 -47.98 16.89 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.56 2.174 . . . . 0.0 112.865 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -56.69 -18.4 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.1 -35.2 66.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.816 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.622 ' CE1' HG12 ' A' ' 58' ' ' VAL . 81.3 t80 -65.14 -44.65 87.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.732 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 7.3 pttp -64.33 -42.89 96.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.782 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 68.7 mt -59.17 -44.5 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.558 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 97.2 mmm -70.49 -40.28 73.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.227 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.7 m -56.63 -43.21 80.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.368 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.53 -41.51 88.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.645 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.864 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 46.1 mtm180 -73.85 -33.53 64.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' A' ' 48' ' ' LEU . 27.5 m -111.55 -15.09 13.58 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 38.6 m-20 -61.65 133.7 55.92 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.159 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 66.02 14.46 9.62 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -116.0 148.52 40.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.595 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -70.04 -31.78 69.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.82 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.03 157.08 41.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.092 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.7 p -153.64 140.94 19.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 0.0 111.041 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.3 t -120.95 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.299 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.59 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 98.0 t -140.65 147.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.212 0.529 . . . . 0.0 111.421 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 107' ' ' GLY . 62.1 t -81.86 115.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.052 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -69.77 38.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.842 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.6 -120.69 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.692 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.591 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.4 t 27.16 -155.77 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.857 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -70.25 -0.57 8.22 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.621 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.98 58.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.187 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.5 m-85 -143.22 129.91 10.55 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -54.4 -146.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.662 1.575 . . . . 0.0 111.231 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.62 90.03 7.24 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.047 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.34 -6.12 12.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.807 2.338 . . . . 0.0 113.545 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.529 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -167.53 71.63 0.95 Allowed Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.707 0.765 . . . . 0.0 112.192 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.05 141.54 56.99 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.243 2.629 . . . . 0.0 111.989 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.33 -3.29 86.67 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.621 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 77' ' ' GLN . 71.2 m -118.2 148.69 42.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.778 0.789 . . . . 0.0 110.325 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 32.1 t80 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.529 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.0 mttp -93.48 -160.32 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.459 1.123 . . . . 0.0 113.655 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.0 p90 -176.34 178.21 1.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.971 -1.922 . . . . 0.0 110.627 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 62' ' ' ASN . 24.0 tp -133.7 127.52 33.05 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.787 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.625 ' CD ' HH21 ' A' ' 37' ' ' ARG . 77.0 tt0 -119.65 129.47 54.6 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.547 HG22 ' HB1' ' A' ' 61' ' ' ALA . 48.9 t -133.26 122.93 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.86 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.47 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.6 mt-30 -109.2 128.15 54.81 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.75 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.8 p90 -156.07 170.9 21.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.767 -0.773 . . . . 0.0 112.023 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 35' ' ' MET . 95.2 m-20 -126.52 159.09 34.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.734 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 78.5 m -109.8 118.82 37.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.259 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -118.36 157.77 48.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.93 144.62 99.44 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.045 1.83 . . . . 0.0 112.227 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -76.65 159.97 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.844 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.441 ' HG2' ' H ' ' A' ' 133' ' ' VAL . 14.5 ttmm -86.86 164.53 16.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.061 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.441 ' H ' ' HG2' ' A' ' 132' ' ' LYS . 8.0 t -83.52 133.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.125 0.488 . . . . 0.0 111.405 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.222 -0.369 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.371 179.655 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.549 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.65 88.49 53.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -52.61 146.01 35.99 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.758 2.306 . . . . 0.0 112.375 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.655 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 44.9 t80 -84.36 5.55 26.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.044 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 -34.98 3.31 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.32 64.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.563 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 0.1 OUTLIER 58.72 172.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.27 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.634 ' NH1' ' H ' ' A' ' 128' ' ' CYS . 77.5 mtt85 -90.36 147.89 23.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.727 ' HE ' ' CD ' ' A' ' 123' ' ' GLU . 13.9 ttt180 -146.69 126.68 13.66 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.394 0.616 . . . . 0.0 110.643 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.672 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 32.1 mp0 -126.13 143.35 51.16 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.024 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -139.2 145.04 38.8 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.995 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -142.06 141.19 32.76 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.23 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.81 135.47 54.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.46 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -47.71 135.44 11.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 111.444 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.63 -15.77 62.16 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.985 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 7.0 m-85 -111.4 149.75 41.09 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 118.132 0.966 . . . . 0.0 110.79 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.25 151.28 76.74 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.652 2.235 . . . . 0.0 113.033 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 tt -120.65 140.55 44.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.222 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -121.09 128.45 52.6 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.005 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.779 HD12 ' SG ' ' A' ' 96' ' ' CYS . 24.4 mt -115.82 141.42 48.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -150.74 132.91 15.35 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.933 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.1 m -102.91 143.0 25.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.839 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.58 158.76 52.95 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.579 2.186 . . . . 0.0 112.913 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.84 -137.19 40.28 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.446 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.1 p -102.08 23.89 10.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.384 -0.408 . . . . 0.0 111.14 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 75.9 m-20 -81.06 165.77 21.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 131' ' ' TYR . 14.2 m -128.2 147.0 32.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.476 -0.489 . . . . 0.0 110.547 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 126' ' ' TYR . 77.8 mt -68.34 138.45 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.8 ptp -132.42 100.02 4.85 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 89' ' ' PHE . 32.6 t -65.49 125.22 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.715 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.02 -48.79 3.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.626 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -152.08 150.27 29.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.4 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.6 157.97 10.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.892 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.9 t30 -150.73 143.17 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.83 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -112.36 114.53 27.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 163.16 -134.37 3.39 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.15 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 121' ' ' TYR . 9.7 ttm180 -156.64 117.79 3.75 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.499 0.666 . . . . 0.0 110.727 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.427 HG21 ' CE2' ' A' ' 84' ' ' TYR . 15.9 p -126.22 6.35 7.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.892 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 49.0 t0 -145.31 151.72 38.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.214 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.671 ' O ' ' CE ' ' A' ' 78' ' ' MET . 54.5 p30 -110.78 3.7 19.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.956 0.408 . . . . 0.0 109.943 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -102.72 1.75 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.985 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.2 mm -110.93 135.12 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.837 0.351 . . . . 0.0 110.199 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m 58.81 65.26 1.26 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.904 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -48.61 99.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.524 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -111.03 -166.93 1.12 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.272 178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.84 144.97 97.96 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.419 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.86 -41.99 60.08 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.461 2.107 . . . . 0.0 112.792 -178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.85 -35.93 81.59 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.988 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 118' ' ' THR . 22.8 mt-30 -87.01 -6.86 58.61 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.981 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.671 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 85.1 mtp -104.68 -6.09 20.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.63 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.4 mt-10 -65.16 -47.0 78.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.216 -0.593 . . . . 0.0 112.095 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.88 117.71 19.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 32.8 m -109.15 32.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.837 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -143.18 88.53 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.301 0.572 . . . . 0.0 111.182 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.8 t -145.84 122.18 10.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' THR . 59.0 m-85 -135.09 152.74 51.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.319 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' HG2' ' A' ' 112' ' ' PRO . 26.6 tp -145.58 88.66 6.49 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.871 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -47.56 -49.83 12.59 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 123.042 2.494 . . . . 0.0 113.367 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 46.5 m-20 -55.01 -19.2 6.35 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.55 0.214 . . . . 0.0 111.307 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.54 69.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.398 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 58' ' ' VAL . 25.6 t80 -64.62 -40.87 96.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.11 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.0 ptmt -65.96 -40.54 91.36 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.747 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 73.0 mt -59.61 -48.66 86.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.003 0.43 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.477 ' SD ' HG11 ' A' ' 104' ' ' VAL . 96.3 mmm -69.55 -39.54 77.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.267 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 61.3 m -59.44 -45.56 91.23 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.038 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -66.02 -36.01 82.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.653 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 91' ' ' ILE . 61.6 mtt180 -76.63 -32.11 57.82 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.779 ' SG ' HD12 ' A' ' 48' ' ' LEU . 76.4 m -112.94 -14.58 13.01 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 56.9 m-20 -61.76 134.84 57.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.488 0.661 . . . . 0.0 112.464 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 63.84 13.04 7.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -112.93 145.02 41.5 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.298 0.571 . . . . 0.0 109.865 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -32.71 67.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.645 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.503 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -153.02 153.74 33.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.4 p -152.53 156.28 39.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.06 124.75 53.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 92' ' ' MET . 59.7 t -133.44 145.66 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.514 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.6 116.71 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.126 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.71 36.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.19 -123.33 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.599 ' O ' ' O ' ' A' ' 107' ' ' GLY . 20.9 t 31.28 -160.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.207 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.73 1.68 0.82 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.384 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -85.1 -13.77 49.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.069 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.604 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.8 m-85 -145.23 129.94 9.02 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.414 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.604 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.3 Cg_exo -51.79 -144.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.057 1.838 . . . . 0.0 111.182 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.649 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 15.2 t0 -146.42 87.25 6.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.235 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.478 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.1 Cg_endo -77.74 -4.44 14.53 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.749 2.299 . . . . 0.0 113.466 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.613 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.11 63.35 0.82 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.289 0.566 . . . . 0.0 111.669 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.41 145.81 65.9 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 121.763 1.642 . . . . 0.0 110.463 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.16 -8.54 79.38 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.0 m -122.72 148.85 44.84 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.687 -0.302 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.5 t80 -84.05 118.4 24.04 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.649 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 11.6 mttp -94.61 -160.52 0.78 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.592 1.187 . . . . 0.0 113.798 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.8 p90 -172.4 173.29 4.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.953 -1.931 . . . . 0.0 110.669 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.8 tp -131.99 125.01 30.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.719 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.727 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 10.2 tp10 -120.01 127.48 52.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -129.85 123.23 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.359 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.506 HE21 ' HG3' ' A' ' 123' ' ' GLU . 1.8 mt-30 -106.95 129.12 54.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.902 ' CD1' HG23 ' A' ' 56' ' ' ILE . 33.0 p90 -154.04 171.97 18.23 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.439 0.637 . . . . 0.0 112.077 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.563 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 97.8 m-20 -129.06 161.7 29.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.578 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.634 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 73.9 m -111.55 127.77 55.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.236 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 33.6 m -132.5 153.58 81.22 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.09 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 132' ' ' LYS . 16.9 Cg_exo -55.48 142.99 79.74 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.531 1.488 . . . . 0.0 112.165 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.489 ' CD1' HG11 ' A' ' 55' ' ' VAL . 15.7 t80 -76.55 44.59 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.108 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 130' ' ' PRO . 55.9 mttm -138.89 -70.06 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.535 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.2 134.09 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.55 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.853 -178.903 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.406 ' H83' HD22 ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.901 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -58.87 146.25 76.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.603 0.239 . . . . 0.0 111.181 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -47.53 142.14 13.84 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.101 1.867 . . . . 0.0 111.986 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.43 ' C ' ' H ' ' A' ' 34' ' ' LEU . 98.2 m-85 -77.79 -51.6 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.697 ' C ' HD23 ' A' ' 34' ' ' LEU . . . 70.7 -34.22 0.47 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.163 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -156.96 144.28 18.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.42 0.61 . . . . 0.0 111.725 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt 58.91 135.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.625 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 36' ' ' ARG . 56.5 mtp85 -93.96 151.72 19.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.496 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.617 HH11 ' HG3' ' A' ' 123' ' ' GLU . 66.7 ttp85 -148.82 138.95 22.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.545 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HG3' HD23 ' A' ' 48' ' ' LEU . 77.4 mm-40 -130.19 145.79 51.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.791 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.898 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -137.33 142.98 41.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.898 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -139.63 139.71 36.78 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.274 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.6 m -65.81 137.25 57.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.107 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 76.5 tt0 -45.08 129.39 7.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.12 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.92 -12.41 67.17 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.029 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.17 148.72 38.93 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 118.532 1.166 . . . . 0.0 110.349 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.07 150.47 88.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.783 2.322 . . . . 0.0 112.884 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 104' ' ' VAL . 21.0 tt -116.64 149.42 18.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.666 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 35.6 tt0 -132.0 129.83 40.64 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.899 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.8 mt -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.334 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.666 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 89.2 mtt180 -147.76 132.42 17.84 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.023 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.5 m -98.51 146.69 32.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 34.4 Cg_endo -67.37 158.86 55.05 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.866 2.377 . . . . 0.0 112.069 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.1 -119.05 5.7 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.213 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.4 p -121.52 23.82 10.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.595 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -76.08 169.53 18.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.97 149.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.847 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.669 HG23 ' CD2' ' A' ' 126' ' ' TYR . 59.6 mt -70.35 136.73 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.219 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -131.7 98.12 4.4 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.586 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.4 t -65.09 125.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.231 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -100.23 -48.11 4.72 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -152.21 150.56 29.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.253 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.27 156.71 12.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.704 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.1 t30 -151.39 142.28 22.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.357 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -112.39 116.94 31.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.59 -139.73 6.05 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.343 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.612 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.0 ttm-85 -152.1 117.44 5.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.078 0.466 . . . . 0.0 111.697 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 p -124.3 4.82 8.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.183 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 53.4 t0 -149.76 157.23 43.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 36.6 p30 -113.05 5.53 17.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.964 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 28.2 mttt -105.16 3.67 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.569 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.2 mm -112.5 136.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.803 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.8 m 52.55 76.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p30 -54.36 119.25 4.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.407 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.71 -164.86 1.52 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.531 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.7 p-10 -66.35 140.36 96.69 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.331 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.1 Cg_endo -53.26 -38.46 81.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.42 2.08 . . . . 0.0 113.57 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.52 -36.99 84.31 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.154 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.517 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 23.5 mt-30 -85.56 -9.89 56.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.521 ' HE3' HH22 ' A' ' 65' ' ' ARG . 82.4 mtp -103.89 -3.79 24.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.145 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.0 mt-10 -64.62 -48.22 75.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -81.61 116.31 21.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.548 0.69 . . . . 0.0 112.374 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.567 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.3 m -106.57 36.64 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.017 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 99.5 mm-40 -141.38 86.88 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.155 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.501 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.7 t -147.92 119.18 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.482 ' HA ' HD21 ' A' ' 62' ' ' ASN . 91.6 m-85 -131.4 153.44 49.68 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.081 0.467 . . . . 0.0 111.302 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.9 tp -147.41 88.12 5.84 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.655 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -47.73 -47.57 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.277 1.985 . . . . 0.0 112.402 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -52.59 -25.53 10.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.334 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -54.91 -36.29 65.05 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.947 0.403 . . . . 0.0 111.22 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CE1' HG12 ' A' ' 58' ' ' VAL . 76.2 t80 -64.46 -42.27 96.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 9.6 pttm -64.82 -39.82 94.19 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.104 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.429 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.6 mt -59.83 -46.65 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.347 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 99.7 mmm -67.83 -35.98 79.55 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.938 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 67.0 m -58.85 -45.74 89.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.9 -40.51 91.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.235 0.54 . . . . 0.0 110.847 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.78 -35.49 72.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.352 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.737 ' SG ' HD12 ' A' ' 48' ' ' LEU . 35.8 m -112.8 -14.72 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.636 ' HB3' ' H82' ' A' ' 135' ' ' NAG . 30.3 m-20 -62.3 132.24 51.99 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.079 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 63.76 13.17 7.23 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.27 146.45 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.291 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.7 m -69.83 -32.68 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.312 0.577 . . . . 0.0 109.905 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 158.14 43.47 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.484 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.899 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.5 p -156.81 139.44 15.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -124.07 125.1 70.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 46' ' ' ILE . 43.5 t -134.86 146.34 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.938 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.0 t -77.83 118.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.262 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.14 35.77 0.05 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.086 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.675 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.44 -117.51 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 27.97 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.207 0.527 . . . . 0.0 111.608 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.76 1.97 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.392 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -85.73 -13.78 47.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.399 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 112' ' ' PRO . 45.9 m-85 -145.72 130.19 8.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.113 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 111' ' ' PHE . 45.2 Cg_exo -51.53 -146.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.282 1.988 . . . . 0.0 112.027 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 17.9 t0 -145.27 84.57 8.51 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.622 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.24 -4.95 14.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.345 2.696 . . . . 0.0 113.527 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.578 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.88 60.74 0.58 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.143 0.497 . . . . 0.0 111.111 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.35 147.47 21.74 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.56 -11.25 70.68 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.664 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.92 150.33 35.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.466 0.633 . . . . 0.0 109.913 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.612 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 27.8 t80 -82.16 111.95 18.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.578 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.0 mttp -90.73 -163.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.824 1.297 . . . . 0.0 113.539 -176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.3 p90 -173.58 175.81 2.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.807 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 62' ' ' ASN . 61.7 tp -133.0 126.72 32.55 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HG3' HH11 ' A' ' 37' ' ' ARG . 79.5 tt0 -121.34 128.66 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.607 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 ' HB1' ' A' ' 61' ' ' ALA . 45.1 t -132.89 123.61 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.377 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.443 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.0 mp0 -105.36 127.61 53.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.669 ' CD2' HG23 ' A' ' 56' ' ' ILE . 41.7 p90 -152.88 167.97 27.32 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.886 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -128.46 161.94 28.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.18 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 72.3 m -111.05 116.5 31.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.97 158.98 41.02 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -61.55 143.4 97.03 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.793 1.662 . . . . 0.0 111.38 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 87.8 t80 -78.37 -0.58 29.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.918 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -96.46 -72.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.648 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.2 m -91.33 132.1 36.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.498 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.934 -1.032 . . . . 0.0 111.482 178.601 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.636 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -85.79 116.54 66.07 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.59 0.233 . . . . 0.0 110.518 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.52 -110.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.876 2.384 . . . . 0.0 113.155 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -79.42 -8.37 59.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.672 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 74.62 36.1 49.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.314 -0.47 . . . . 0.0 111.972 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' MET . 2.1 mt -158.59 -168.68 2.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 111.48 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.592 ' O ' ' O ' ' A' ' 34' ' ' LEU . 1.5 mtt 51.69 134.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.03 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.535 ' CD ' ' SG ' ' A' ' 128' ' ' CYS . 65.3 mtp85 -93.63 144.17 25.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.36 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -151.45 140.83 21.48 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.378 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 48' ' ' LEU . 59.2 mm-40 -133.18 145.31 50.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.011 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.3 tt -135.6 133.15 37.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.849 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.748 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.93 140.54 46.85 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.377 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.2 m -66.48 136.21 55.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.271 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -48.63 134.68 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.823 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.73 -18.54 56.34 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.718 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -104.1 153.17 39.1 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 118.114 0.957 . . . . 0.0 108.905 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.98 154.41 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.259 1.973 . . . . 0.0 112.614 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 tt -119.62 151.09 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.853 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.691 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 55.5 tt0 -131.78 130.65 42.1 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' SG ' ' A' ' 102' ' ' CYS . 34.4 mt -120.68 138.96 53.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.158 178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.691 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 55.9 mtt180 -148.31 129.64 14.73 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.816 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -98.69 143.97 27.31 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 30.4 Cg_endo -66.48 162.28 37.35 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.93 2.42 . . . . 0.0 113.267 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -121.26 9.34 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.792 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -120.62 26.18 9.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -77.88 169.51 18.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.662 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.87 145.86 35.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.427 0.632 . . . . 0.0 110.884 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.831 HG23 ' CD2' ' A' ' 126' ' ' TYR . 72.8 mt -68.77 138.49 22.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.928 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.61 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.2 ptm -130.62 104.04 6.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.565 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.5 t -68.54 124.73 24.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.168 -177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -105.01 -51.57 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -147.01 142.96 28.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.13 0.49 . . . . 0.0 110.479 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.981 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -163.19 152.42 14.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.406 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.5 t30 -148.75 143.92 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -114.93 120.0 38.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.99 -135.2 3.87 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.736 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 9.3 ttm-85 -154.09 116.83 4.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.364 0.602 . . . . 0.0 111.157 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.508 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.7 p -124.02 4.33 8.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.877 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 16.7 t70 -144.67 151.96 39.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.875 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 26.7 p30 -109.17 0.47 19.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.586 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 43.3 mtpt -101.22 3.22 40.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.287 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 70' ' ' ILE . 21.0 mm -109.71 137.27 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.809 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.0 m 55.66 66.24 1.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 10.5 p30 -50.58 111.63 0.57 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.935 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.54 -161.89 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -58.8 136.96 87.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.673 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.558 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.9 Cg_endo -59.39 -33.45 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 121.834 1.69 . . . . 0.0 112.63 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -62.68 -33.91 76.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.658 0.266 . . . . 0.0 110.878 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 118' ' ' THR . 22.6 mt-30 -85.64 -17.99 34.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.458 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.419 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 77.3 mtp -97.72 -0.35 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.454 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -60.99 -50.74 72.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.475 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.419 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 63.3 t30 -76.48 113.93 14.63 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.25 -0.281 . . . . 0.0 111.595 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.68 25.61 2.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.089 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -137.87 82.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.277 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 11.1 t -143.98 121.86 12.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.474 ' HA ' HD21 ' A' ' 62' ' ' ASN . 90.6 m-85 -130.4 154.78 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.405 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.466 HD21 ' HG2' ' A' ' 112' ' ' PRO . 28.1 tp -144.86 90.65 6.24 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -46.89 -44.74 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.783 2.322 . . . . 0.0 113.06 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 92.7 m-20 -55.21 -21.15 12.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.67 71.17 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.745 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.0 t80 -65.06 -44.69 88.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.851 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.7 pttm -63.62 -43.43 96.87 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.863 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 59.0 mt -58.44 -50.59 78.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.552 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.918 ' SD ' HD21 ' A' ' 122' ' ' LEU . 1.5 mtp -69.62 -32.34 70.98 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.474 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.456 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 58.2 m -61.12 -45.4 94.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.207 0.527 . . . . 0.0 110.709 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.16 -37.71 84.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.36 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.712 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 99.6 mtt180 -78.1 -33.14 50.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.633 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.0 m -111.52 -19.22 12.63 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 94.4 m-20 -61.5 138.97 58.3 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.605 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 62.52 12.54 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.499 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.712 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 65.7 mtt180 -114.93 147.47 39.95 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.149 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 m -70.75 -34.52 71.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.162 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.74 155.46 39.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.729 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.918 ' SG ' HD12 ' A' ' 48' ' ' LEU . 19.8 p -154.07 132.78 12.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.83 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.42 132.21 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.696 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG13 ' NH1' ' A' ' 95' ' ' ARG . 86.6 t -144.96 151.67 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.624 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 107' ' ' GLY . 90.6 t -83.83 114.95 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.04 41.32 0.1 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.257 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.8 -126.07 0.98 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.325 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.606 ' O ' ' O ' ' A' ' 107' ' ' GLY . 5.0 t 28.49 -156.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.076 0.465 . . . . 0.0 111.24 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.38 1.4 3.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.828 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HH12 ' A' ' 95' ' ' ARG . . . -84.3 -8.98 58.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.849 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -144.1 134.49 12.06 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.926 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.466 ' HG2' HD21 ' A' ' 85' ' ' LEU . 15.3 Cg_exo -58.86 -150.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.92 1.747 . . . . 0.0 111.929 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.638 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 26.1 t0 -144.9 92.5 5.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.468 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.21 -10.84 14.92 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.729 2.286 . . . . 0.0 112.625 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 2.3 p -171.15 87.96 0.47 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.301 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.13 157.75 55.71 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.589 1.526 . . . . 0.0 112.026 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.38 12.01 84.3 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.699 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.6 m -126.32 146.62 49.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.037 0.418 . . . . 0.0 110.137 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.683 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 5.5 t80 -82.66 107.18 15.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.638 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 24.9 mttt -88.99 -164.1 1.09 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.638 1.208 . . . . 0.0 113.019 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.3 p90 -171.89 174.81 4.06 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.771 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.918 HD21 ' SD ' ' A' ' 92' ' ' MET . 20.6 tp -132.37 124.7 29.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.429 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HG2' HE21 ' A' ' 125' ' ' GLN . 78.7 tt0 -122.53 124.31 43.26 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.981 HG13 ' HB2' ' A' ' 61' ' ' ALA . 6.0 t -133.18 130.54 57.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.638 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.505 HE21 ' HG2' ' A' ' 123' ' ' GLU . 7.2 mp0 -109.91 132.66 53.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.719 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.831 ' CD2' HG23 ' A' ' 56' ' ' ILE . 49.4 p90 -152.83 168.45 25.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.416 0.627 . . . . 0.0 111.896 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.497 ' H ' ' HG2' ' A' ' 57' ' ' MET . 71.1 m-20 -126.22 158.24 36.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.434 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.535 ' SG ' ' CD ' ' A' ' 36' ' ' ARG . 74.7 m -108.53 124.89 51.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.528 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 m -126.53 159.37 63.76 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -59.35 144.82 99.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.537 1.491 . . . . 0.0 111.854 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -77.16 -86.38 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.51 ' C ' ' CD ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -140.42 154.5 46.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.359 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.5 133.06 29.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.13 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.679 -179.465 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 tt 39.69 66.27 3.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -82.53 -78.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.793 2.329 . . . . 0.0 112.015 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 97.1 m-85 -77.88 -15.49 59.0 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.25 -55.83 0.11 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.332 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 32' ' ' PHE . 20.1 tp -81.56 142.85 32.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.1 mtt 60.69 120.65 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.729 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 52.4 mtt-85 -88.33 152.82 21.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.425 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -146.71 137.41 23.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.613 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 19.1 mt-10 -135.54 144.91 46.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.593 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.19 137.7 37.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.768 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -135.3 139.24 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.304 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.12 140.41 58.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.29 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -45.97 129.62 9.67 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.785 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.42 -12.51 69.5 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.708 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -104.15 155.21 37.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 118.248 1.024 . . . . 0.0 109.396 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.16 153.5 36.43 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.71 1.607 . . . . 0.0 112.577 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 104' ' ' VAL . 11.7 tt -125.06 143.23 39.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.0 tt0 -126.88 130.52 50.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.124 0.488 . . . . 0.0 112.165 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 20.3 mt -114.18 141.71 47.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -148.1 131.16 16.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.754 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.04 142.03 23.8 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.49 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 24.2 Cg_endo -69.6 161.66 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.269 1.979 . . . . 0.0 112.208 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.2 -136.64 20.64 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.719 0.621 . . . . 0.0 112.311 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -101.17 21.2 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.504 -0.848 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.06 165.0 25.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.21 144.04 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.792 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 126' ' ' TYR . 70.4 mt -67.81 134.84 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.733 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.641 ' O ' ' CG ' ' A' ' 57' ' ' MET . 5.8 ptm -130.46 100.59 5.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.511 0.672 . . . . 0.0 109.232 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 89' ' ' PHE . 41.2 t -70.41 124.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.866 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -107.22 -43.73 4.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -146.23 143.42 29.21 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.721 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.02 149.11 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.531 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.505 HD21 ' HA ' ' A' ' 84' ' ' TYR . 7.5 t30 -148.74 152.12 36.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.25 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 76.2 t80 -121.57 120.11 33.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.81 -134.91 3.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.745 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -159.7 119.79 3.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.215 0.531 . . . . 0.0 111.463 -179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 p -124.9 8.3 8.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.085 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.57 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 44.8 t0 -144.1 150.63 38.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.369 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 14.6 p30 -104.46 -1.11 27.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 8.1 mtmp? -105.03 10.86 33.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.37 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.556 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 12.5 mm -107.52 135.03 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' ALA . 71.8 m 56.76 67.37 1.0 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 52.2 p-10 -46.35 93.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.594 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -111.82 -162.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.645 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 p-10 -63.68 140.52 97.81 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.578 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 5.5 Cg_endo -56.54 -38.94 94.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.596 2.197 . . . . 0.0 113.526 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 2.9 m-30 -61.4 -36.53 80.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.333 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.479 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 20.4 mt-30 -86.52 -11.79 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.5 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.434 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 78.6 mmm -101.95 -3.11 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 43.9 mt-10 -66.26 -44.69 82.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -78.61 114.02 17.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.99 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' OE1' ' A' ' 82' ' ' GLN . 35.6 m -105.67 32.9 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 81' ' ' VAL . 15.3 mm100 -142.13 85.93 1.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.313 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 21.7 t -143.81 125.67 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.9 m-85 -135.66 149.73 49.39 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 88' ' ' ALA . 14.3 tp -148.9 88.5 5.16 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.438 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.07 -44.24 47.1 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.503 2.135 . . . . 0.0 113.848 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 83.1 m-20 -53.7 -24.58 15.06 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.188 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.22 -34.26 44.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 40.2 t80 -64.79 -42.24 95.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.478 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.52 -36.18 83.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.028 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.538 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 71.5 mt -62.99 -50.37 79.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 0.0 111.258 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.99 -38.63 86.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.469 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 42.0 m -58.15 -45.74 86.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -66.56 -36.51 82.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.686 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 70.1 mtt180 -78.74 -31.36 46.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.8 m -111.81 -19.9 12.26 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 84.5 m-20 -56.6 134.04 54.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.406 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 67.12 13.14 9.33 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.786 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.686 ' NH1' ' O ' ' A' ' 95' ' ' ARG . 75.2 mtt180 -113.0 146.0 39.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.36 0.6 . . . . 0.0 110.132 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 48.9 m -69.96 -33.53 72.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.488 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 155.76 40.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.529 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -154.6 146.3 23.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.419 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.47 127.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.743 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' NH1' ' A' ' 95' ' ' ARG . 48.5 t -137.12 143.81 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.353 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' GLY . 71.2 t -78.1 115.29 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.759 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.84 35.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.212 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.51 -119.92 0.65 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.302 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.2 t 31.26 -160.38 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.405 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -68.12 1.67 2.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 108' ' ' SER . . . -83.25 -13.49 55.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.9 m-85 -144.36 131.98 10.57 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.819 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 111' ' ' PHE . 21.7 Cg_exo -56.6 -147.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.104 1.869 . . . . 0.0 112.345 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -146.21 86.28 7.08 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.492 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.22 -9.92 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.544 2.163 . . . . 0.0 112.814 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.6 p -166.38 77.19 1.14 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.654 0.74 . . . . 0.0 111.05 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.25 149.93 42.97 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.337 2.025 . . . . 0.0 110.857 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.2 -4.93 64.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.386 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 77' ' ' GLN . 31.3 m -113.25 148.32 35.78 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.932 0.866 . . . . 0.0 109.343 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.745 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 27.1 t80 -84.94 113.7 21.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 13.7 mtmm -93.87 -162.9 0.98 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.854 1.312 . . . . 0.0 113.82 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.9 p90 -168.84 170.29 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 112.583 -2.098 . . . . 0.0 110.55 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 62' ' ' ASN . 39.7 tp -128.89 124.67 35.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 126.31 49.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 61' ' ' ALA . 22.8 t -130.88 125.18 57.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.561 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -105.8 127.88 53.38 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.247 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.645 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.4 p90 -151.48 170.3 19.95 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.353 0.597 . . . . 0.0 111.372 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.477 ' H ' ' HG2' ' A' ' 57' ' ' MET . 73.5 m-20 -127.47 158.75 36.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.057 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.729 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 86.7 m -108.05 114.74 28.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.74 158.26 45.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.951 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.48 149.21 91.65 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.29 1.994 . . . . 0.0 112.798 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.649 ' CD2' ' O ' ' A' ' 131' ' ' TYR . 67.7 t80 -77.61 12.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -90.68 165.48 13.68 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.29 137.13 22.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 111.46 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.733 178.844 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -41.51 -52.23 8.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.371 0.129 . . . . 0.0 111.244 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 52.8 Cg_exo -51.83 157.16 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.339 2.026 . . . . 0.0 112.338 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -61.03 2.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.188 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.94 32.05 79.83 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -157.51 45.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.145 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.553 ' CE ' ' OE1' ' A' ' 59' ' ' GLU . 1.4 mtt 54.71 149.45 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -89.11 144.8 25.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.337 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.703 0.763 . . . . 0.0 111.194 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 54.9 mp0 -134.21 140.16 46.3 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.433 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.9 tt -137.74 135.33 36.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.822 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.71 139.98 46.73 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.794 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 m -65.22 136.64 56.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.991 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -46.67 133.11 10.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.336 0.589 . . . . 0.0 112.526 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.74 -13.28 67.48 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.593 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.94 147.03 34.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 118.437 1.118 . . . . 0.0 110.995 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.99 147.71 89.22 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.391 2.061 . . . . 0.0 112.064 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.0 tt -117.68 147.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.68 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 40.4 tt0 -123.15 129.47 51.47 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.096 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 102' ' ' CYS . 44.5 mt -118.0 137.31 52.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.68 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 87.3 mtt180 -149.2 127.85 12.42 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.3 m -95.45 149.55 36.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.557 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 49.2 Cg_endo -72.11 157.41 54.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.951 2.434 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 48.43 -134.96 19.15 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.912 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -101.82 24.12 10.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -78.45 164.96 24.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG11 ' HD1' ' A' ' 131' ' ' TYR . 27.2 m -125.5 146.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.662 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' TYR . 66.6 mt -67.62 133.53 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.627 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -130.71 99.1 4.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.66 HG12 ' CE1' ' A' ' 89' ' ' PHE . 34.1 t -66.45 124.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.913 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.553 ' OE1' ' CE ' ' A' ' 35' ' ' MET . 92.9 mt-10 -108.75 -47.33 3.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.203 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -146.85 145.82 29.99 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.309 0.576 . . . . 0.0 110.324 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -163.93 155.73 16.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.594 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.4 t30 -147.13 138.57 24.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.212 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -115.36 117.65 31.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.5 -135.26 4.06 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.703 ' NH1' ' O ' ' A' ' 77' ' ' GLN . 17.8 ttm180 -155.21 117.76 4.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 111.367 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.432 HG21 ' CE2' ' A' ' 84' ' ' TYR . 5.1 p -123.45 5.79 9.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -146.97 154.08 40.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.236 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 36.9 p30 -113.69 2.44 15.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.357 . . . . 0.0 110.426 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 30.0 mttp -103.65 6.69 37.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.7 mm -108.28 135.62 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.895 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m 52.18 71.89 0.43 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 10.3 p-10 -45.03 114.34 0.71 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.847 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.14 -169.32 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.553 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.663 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -61.05 139.41 94.25 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 13.6 Cg_endo -57.83 -34.49 98.34 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.149 1.899 . . . . 0.0 112.988 -177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -64.72 -35.49 81.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.793 ' O ' HG23 ' A' ' 118' ' ' THR . 22.8 mt-30 -86.93 -13.43 44.75 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.607 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.498 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mtm -104.61 0.85 29.01 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.598 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 3.7 mt-10 -67.31 -43.83 80.68 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -79.87 114.26 18.66 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.692 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 33.5 m -104.55 34.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 79.9 mm-40 -141.07 84.44 1.93 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.05 119.17 8.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 93.4 m-85 -132.49 152.56 51.49 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.695 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.606 HD21 ' HG2' ' A' ' 112' ' ' PRO . 53.1 tp -142.09 87.6 9.64 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.91 -50.26 11.12 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.0 -26.97 40.6 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.56 -33.42 45.73 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.416 -0.513 . . . . 0.0 110.89 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 58' ' ' VAL . 15.5 t80 -64.71 -43.9 91.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -63.24 -38.75 92.38 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.247 -178.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 96.7 mt -59.94 -51.81 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.814 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.649 ' SD ' HD21 ' A' ' 122' ' ' LEU . 2.1 mtp -68.44 -33.02 73.45 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.175 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 33.2 m -59.89 -45.54 92.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.592 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 54.8 mt-30 -64.68 -37.75 88.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.35 0.595 . . . . 0.0 110.957 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.676 ' O ' ' NE ' ' A' ' 99' ' ' ARG . 25.2 mtp180 -75.86 -33.11 59.99 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.532 ' N ' HH21 ' A' ' 99' ' ' ARG . 6.9 m -113.7 -14.01 12.63 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.774 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 53.8 m-20 -60.06 131.65 51.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.844 -0.743 . . . . 0.0 111.641 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 66.59 13.2 9.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.902 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 97' ' ' ASN . 29.6 mtm-85 -111.29 144.29 40.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.9 m -71.18 -30.51 66.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 154.09 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.428 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.2 p -154.69 137.26 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.712 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.79 128.63 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.656 HG22 ' HE ' ' A' ' 95' ' ' ARG . 23.1 t -141.04 151.87 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.158 0.504 . . . . 0.0 112.051 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 108' ' ' SER . 45.2 t -82.16 116.41 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.005 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.6 39.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.358 . . . . 0.0 111.26 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.96 -120.68 0.69 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.709 ' OG ' ' N ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER 31.87 -161.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 110.76 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.709 ' N ' ' OG ' ' A' ' 108' ' ' SER . 66.5 m-20 -68.93 2.9 2.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.419 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.07 -11.99 48.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.68 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 43.0 m-85 -142.87 126.89 9.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.001 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.606 ' HG2' HD21 ' A' ' 85' ' ' LEU . 18.1 Cg_exo -50.78 -148.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.34 2.026 . . . . 0.0 111.765 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.652 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 32.4 t0 -144.48 85.59 8.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.42 -5.1 14.73 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.901 2.401 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.477 ' SG ' ' HE2' ' A' ' 120' ' ' LYS . 1.5 p -166.04 67.31 1.07 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.546 0.689 . . . . 0.0 111.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 142.73 98.67 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 121.997 1.798 . . . . 0.0 110.269 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.25 69.57 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 77' ' ' GLN . 90.3 m -122.87 147.06 47.0 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.694 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 19.3 t80 -81.28 118.44 22.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.652 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 33.9 mttt -92.17 -162.11 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 123.091 1.424 . . . . 0.0 113.868 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -170.54 172.92 5.72 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.543 -2.117 . . . . 0.0 110.876 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.649 HD21 ' SD ' ' A' ' 92' ' ' MET . 45.0 tp -132.92 123.76 26.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -121.09 126.28 49.38 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.592 HG21 ' SD ' ' A' ' 92' ' ' MET . 59.0 t -127.4 121.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.258 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -104.23 125.4 50.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 56' ' ' ILE . 26.6 p90 -153.92 169.03 24.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.002 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -124.2 159.39 30.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.259 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 90.9 m -109.41 123.47 49.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.18 153.56 68.36 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.105 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -56.2 144.39 81.3 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.636 1.557 . . . . 0.0 111.331 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 62.4 t80 -73.63 -3.72 29.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.727 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -98.53 163.24 12.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.64 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.56 125.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.997 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.277 -179.25 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.35 64.68 72.14 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.431 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -56.36 150.42 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.395 2.063 . . . . 0.0 111.718 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -79.38 -12.13 59.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.343 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.03 23.81 75.31 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.7 tt -161.06 121.54 2.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.747 0.308 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.454 ' N ' HD23 ' A' ' 34' ' ' LEU . 8.8 mtt 59.75 129.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.385 0.612 . . . . 0.0 111.658 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.446 HH21 ' HG3' ' A' ' 51' ' ' PRO . 78.3 mtt-85 -90.65 147.99 22.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HE ' ' HG3' ' A' ' 123' ' ' GLU . 58.4 ttt180 -145.46 130.06 17.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.73 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.1 mm-40 -127.8 143.1 51.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.677 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -138.21 135.24 35.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.805 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -132.48 138.18 47.48 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.351 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 14.3 m -65.32 136.83 57.03 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -45.78 132.67 8.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 0.0 112.348 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.53 -12.58 66.22 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.195 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.3 149.21 40.24 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.536 1.168 . . . . 0.0 110.316 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.36 151.46 85.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.68 2.254 . . . . 0.0 113.02 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.4 tt -119.12 144.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -128.7 128.45 44.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.302 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' SG ' ' A' ' 102' ' ' CYS . 33.5 mt -116.38 141.18 48.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.073 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 49' ' ' ARG . 17.7 mtp180 -148.13 135.05 20.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.809 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.461 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.0 m -102.36 141.03 21.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.853 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HG3' HH21 ' A' ' 36' ' ' ARG . 29.4 Cg_endo -67.16 157.74 60.27 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.469 2.112 . . . . 0.0 112.332 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 46.76 -134.49 11.13 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.604 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 p -99.82 22.12 11.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.505 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.32 167.3 21.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.07 148.81 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 111.461 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.832 HG23 ' CD2' ' A' ' 126' ' ' TYR . 97.2 mt -72.41 138.43 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.723 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.621 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.8 ptm -133.26 103.71 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 89' ' ' PHE . 38.4 t -66.75 124.98 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.18 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 86.3 mt-10 -105.6 -51.13 3.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.963 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -146.85 147.52 30.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.103 0.478 . . . . 0.0 110.126 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.606 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -167.68 157.53 10.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.56 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 122' ' ' LEU . 15.0 t30 -151.1 148.94 28.92 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.499 -0.48 . . . . 0.0 112.275 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -118.57 115.24 24.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.86 -136.3 4.25 Favored Glycine 0 C--N 1.319 -0.379 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 10.2 ttm-85 -156.68 117.1 3.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.204 0.526 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 p -121.68 9.58 10.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.567 ' C ' HG12 ' A' ' 81' ' ' VAL . 35.3 t0 -145.58 -174.82 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.119 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 50.1 p30 -141.33 -0.03 1.46 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.199 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 54.2 mttm -101.52 5.3 41.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.137 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 32.2 mm -107.59 133.64 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.963 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.9 m 52.72 75.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.932 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 36.1 t0 -55.11 106.77 0.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.091 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HG3' ' A' ' 78' ' ' MET . . . -118.72 -164.6 1.05 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.295 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.703 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -60.79 142.14 92.3 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.303 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 9.5 Cg_endo -55.34 -39.09 92.88 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.462 2.108 . . . . 0.0 112.134 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -64.51 -36.24 83.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.423 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.55 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.6 mt-30 -89.34 -6.59 56.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.692 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.554 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 61.3 mmm -115.47 -1.31 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.164 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 2.0 mt-10 -67.47 -42.79 82.44 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -79.98 120.62 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.567 HG12 ' C ' ' A' ' 67' ' ' ASP . 34.9 m -111.25 34.7 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.816 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -140.83 85.39 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.804 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.6 t -149.21 124.88 10.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.285 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' HA ' HD21 ' A' ' 62' ' ' ASN . 92.7 m-85 -132.6 149.77 52.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.723 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 112' ' ' PRO . 51.0 tp -142.1 94.84 6.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -54.34 -47.63 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.948 2.432 . . . . 0.0 114.106 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 93.1 m-20 -55.13 -26.09 36.17 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.692 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.86 -31.95 51.38 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.91 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 58' ' ' VAL . 35.7 t80 -66.81 -47.17 72.91 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 6.0 pttm -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -59.27 -50.85 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.729 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 1.016 ' SD ' HD21 ' A' ' 122' ' ' LEU . 6.0 mtp -68.46 -33.62 74.51 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.505 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 49.5 m -59.59 -44.04 93.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.99 -35.47 78.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.934 ' HE ' HG22 ' A' ' 104' ' ' VAL . 75.5 mtp85 -76.21 -34.57 59.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.625 ' SG ' HD12 ' A' ' 48' ' ' LEU . 37.5 m -113.69 -11.47 12.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.532 HD22 ' H83' ' A' ' 135' ' ' NAG . 59.1 m-20 -62.79 134.77 56.77 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.653 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 67.62 14.93 9.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -114.58 147.43 39.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.112 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.5 m -70.11 -32.98 71.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 158.44 44.15 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.509 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.822 ' SG ' HD12 ' A' ' 48' ' ' LEU . 14.5 p -157.02 145.0 19.27 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.384 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.94 128.43 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.934 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.5 t -138.14 140.72 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.168 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 107' ' ' GLY . 48.4 t -77.45 116.39 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.27 38.56 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.127 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.643 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.86 -119.43 0.63 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.643 ' O ' ' O ' ' A' ' 107' ' ' GLY . 48.4 t 27.55 -159.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.291 0.567 . . . . 0.0 111.776 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.523 ' N ' ' OG ' ' A' ' 108' ' ' SER . 91.4 m-20 -68.83 1.85 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.01 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.11 54.67 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.064 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 112' ' ' PRO . 66.2 m-85 -144.88 129.95 9.26 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.152 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.578 ' HG2' HD21 ' A' ' 85' ' ' LEU . 23.3 Cg_exo -51.03 -148.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.85 2.366 . . . . 0.0 112.461 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.05 89.45 6.04 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.529 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.97 -10.31 18.07 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.009 2.473 . . . . 0.0 114.095 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.411 ' H ' ' HE2' ' A' ' 120' ' ' LYS . 1.6 p -170.81 69.76 0.53 Allowed Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.92 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.33 155.51 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.082 1.855 . . . . 0.0 111.531 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.55 -3.88 85.14 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 95.7 m -126.27 149.91 48.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 41.8 t80 -83.99 113.54 21.07 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HE2' ' H ' ' A' ' 115' ' ' CYS . 21.2 mttp -90.06 -162.84 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.314 1.054 . . . . 0.0 113.376 -176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -171.77 172.75 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.091 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.016 HD21 ' SD ' ' A' ' 92' ' ' MET . 28.0 tp -132.77 126.57 32.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.575 ' HG3' ' HE ' ' A' ' 37' ' ' ARG . 81.9 tt0 -122.05 126.06 47.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.802 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.783 HG21 ' SD ' ' A' ' 92' ' ' MET . 47.4 t -130.55 127.87 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' NE2' ' HG2' ' A' ' 123' ' ' GLU . 2.5 mp0 -109.24 127.0 53.9 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.832 ' CD2' HG23 ' A' ' 56' ' ' ILE . 46.2 p90 -151.37 162.12 41.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.635 . . . . 0.0 112.146 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.417 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 78.5 m-20 -117.96 158.99 23.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.592 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 36' ' ' ARG . 95.6 m -109.93 108.6 18.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.719 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.77 156.67 43.37 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.757 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.84 142.99 83.11 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.079 1.852 . . . . 0.0 112.316 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -76.68 -3.15 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.009 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -91.43 1.71 56.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.136 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.3 t -83.69 133.1 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.244 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.941 -179.237 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.616 ' O7 ' ' O3 ' ' A' ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.498 2.779 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.512 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.3 mt -37.32 -59.86 0.95 Allowed Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.878 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 30' ' ' LEU . 10.8 Cg_endo -60.56 145.64 98.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.557 2.171 . . . . 0.0 111.523 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.638 ' O ' ' N ' ' A' ' 34' ' ' LEU . 26.5 p90 -80.78 -16.6 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.128 0.489 . . . . 0.0 109.682 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.974 ' C ' HD13 ' A' ' 34' ' ' LEU . . . 55.0 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.033 HD22 ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -151.15 113.37 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.149 0.499 . . . . 0.0 110.21 179.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 34' ' ' LEU . 9.3 mtp 58.32 154.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.755 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -95.19 150.99 19.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.985 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.584 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 48.9 ttp180 -146.92 136.94 23.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.369 0.605 . . . . 0.0 111.289 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.599 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 18.6 mp0 -130.77 141.33 50.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.595 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.03 144.11 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.817 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.868 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.82 140.04 34.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 110.699 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.662 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -48.18 133.81 14.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.374 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.54 -15.58 62.98 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.187 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -107.09 147.35 34.98 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.927 0.863 . . . . 0.0 111.323 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.41 149.68 75.16 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.739 2.293 . . . . 0.0 112.445 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.4 tt -120.92 143.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.585 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -121.29 129.33 53.07 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.275 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.781 HD12 ' SG ' ' A' ' 102' ' ' CYS . 60.9 mt -117.23 140.1 49.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.548 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -152.19 134.05 14.83 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.549 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.609 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.7 m -95.22 137.9 22.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.197 178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.99 164.71 32.71 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 121.517 1.478 . . . . 0.0 110.85 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.53 -140.19 29.71 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.703 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.2 p -106.38 21.3 17.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.757 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -77.35 170.19 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.714 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.07 144.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.0 0.429 . . . . 0.0 110.665 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CG1' ' SG ' ' A' ' 50' ' ' CYS . 94.8 mt -69.02 138.43 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.299 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.5 ptp -130.95 100.94 5.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 176.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 89' ' ' PHE . 22.0 t -64.79 123.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.04 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -101.38 -48.85 4.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -148.63 146.59 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.415 0.626 . . . . 0.0 110.9 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.798 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.12 152.1 12.64 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.147 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 84' ' ' TYR . 29.3 t30 -148.74 144.44 27.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.841 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -115.63 118.88 34.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.27 -135.33 4.01 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 6.4 ttm180 -155.58 118.7 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.317 0.579 . . . . 0.0 111.753 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 25.9 p -125.21 3.62 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.739 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 52.8 t0 -146.42 154.64 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.792 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.659 ' O ' ' CE ' ' A' ' 78' ' ' MET . 29.3 p30 -113.73 0.34 14.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.777 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -102.48 7.9 40.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.767 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.1 133.78 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.1 m 49.49 83.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -61.05 106.02 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -112.44 -166.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.178 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -64.54 139.97 97.88 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.467 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.9 Cg_endo -52.92 -39.38 78.78 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.375 2.05 . . . . 0.0 113.212 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -64.77 -36.32 83.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.725 0.298 . . . . 0.0 111.468 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 21.6 mt-30 -85.74 -6.67 59.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.646 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.659 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 95.1 mtp -105.6 -4.8 20.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.181 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 65.2 mt-10 -63.25 -47.55 81.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.982 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -79.33 119.57 22.56 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.482 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 25.7 m -108.79 33.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.824 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.8 mm-40 -141.41 83.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.464 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 37.1 t -142.8 123.24 13.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -135.07 156.17 49.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 112' ' ' PRO . 50.9 tp -148.04 88.68 5.44 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.877 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.18 -48.18 13.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.791 2.327 . . . . 0.0 113.16 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 79.3 m-20 -57.26 -21.85 37.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.49 -35.11 67.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.474 ' CE1' HG12 ' A' ' 58' ' ' VAL . 60.2 t80 -65.05 -45.04 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.124 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.688 ' O ' ' NE2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -66.02 -35.88 81.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.255 -179.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.569 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 76.5 mt -61.96 -50.12 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.625 0.25 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.939 ' SD ' HD21 ' A' ' 122' ' ' LEU . 53.8 mtp -71.44 -34.23 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.301 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 69.2 m -59.85 -46.2 90.04 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.564 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.56 -35.22 79.69 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.748 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.618 ' CZ ' HG13 ' A' ' 104' ' ' VAL . 28.4 mtp180 -76.72 -34.26 58.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 22.1 m -113.02 -10.1 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.592 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -63.45 132.52 51.65 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 65.77 13.14 8.81 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -111.55 144.58 40.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.303 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -72.08 -30.58 65.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.994 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.34 152.4 35.76 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.315 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.781 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -156.78 131.61 8.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.03 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -116.85 134.07 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.787 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.618 HG13 ' CZ ' ' A' ' 95' ' ' ARG . 61.0 t -143.68 150.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 107' ' ' GLY . 22.2 t -82.23 117.46 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.436 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.84 39.95 0.06 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.769 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.95 -120.45 0.68 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.87 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.8 OUTLIER 28.04 -157.63 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.489 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -69.02 -1.04 6.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.094 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.99 -16.3 47.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.335 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 112' ' ' PRO . 42.6 m-85 -139.57 130.08 14.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.864 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.553 ' HG2' HD21 ' A' ' 85' ' ' LEU . 39.7 Cg_exo -52.93 -149.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.255 1.97 . . . . 0.0 111.186 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.524 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 28.3 t0 -145.34 82.64 9.58 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 70.1 Cg_endo -73.01 -6.05 18.3 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.728 2.286 . . . . 0.0 113.65 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.89 68.54 0.98 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.422 0.629 . . . . 0.0 110.743 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -52.42 149.02 24.47 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.249 1.966 . . . . 0.0 111.197 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.16 -0.49 83.65 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.5 m -118.54 148.68 42.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.619 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 41.3 t80 -86.04 111.6 20.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.524 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 12.1 mttt -91.52 -162.61 0.94 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.149 1.452 . . . . 0.0 113.964 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.484 ' HB2' HD21 ' A' ' 39' ' ' LEU . 6.1 p90 -173.84 176.11 2.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 112.152 -2.295 . . . . 0.0 110.143 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.939 HD21 ' SD ' ' A' ' 92' ' ' MET . 40.4 tp -130.82 120.74 24.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 83.8 tt0 -118.14 129.73 55.7 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.836 HG21 ' SD ' ' A' ' 92' ' ' MET . 93.5 t -137.21 127.24 38.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.542 ' NE2' ' N ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -107.48 131.84 53.86 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.506 ' CD1' HG23 ' A' ' 56' ' ' ILE . 22.7 p90 -155.78 171.91 19.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.647 0.736 . . . . 0.0 112.622 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 57' ' ' MET . 72.7 m-20 -130.37 158.87 38.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.027 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.0 m -112.13 109.1 18.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -104.95 156.24 36.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.967 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -57.4 144.7 90.91 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.981 1.787 . . . . 0.0 110.732 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -79.29 5.11 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.715 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.87 -73.37 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -85.29 134.45 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 111.522 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.708 -179.383 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 30' ' ' LEU . 8.2 mp -66.91 144.1 98.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.436 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.78 140.29 92.6 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.791 2.327 . . . . 0.0 112.096 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -87.06 5.98 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.64 16.48 73.13 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -162.58 92.1 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.33 . . . . 0.0 110.417 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 125' ' ' GLN . 48.5 ttm 58.38 154.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.468 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -90.44 152.05 21.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.678 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 47.9 ttp180 -141.79 137.72 31.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.311 0.577 . . . . 0.0 111.336 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 49.1 mp0 -133.47 137.43 45.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.828 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.4 tt -139.02 139.49 37.85 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.939 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.745 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.37 141.85 35.59 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.848 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.3 m -63.95 134.91 55.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.278 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -46.21 131.47 10.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.66 67.7 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.375 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 145.47 31.76 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.655 1.228 . . . . 0.0 111.661 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.0 149.95 89.41 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.083 2.522 . . . . 0.0 112.519 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.4 tt -122.07 145.97 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 83.7 tt0 -125.79 127.53 46.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.09 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 102' ' ' CYS . 46.1 mt -116.21 145.76 42.86 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.852 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.678 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 87.6 mtt-85 -151.2 135.96 17.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.303 0.573 . . . . 0.0 112.033 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.477 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 4.4 m -100.49 137.77 20.0 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.837 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -64.7 157.8 53.9 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.331 2.02 . . . . 0.0 111.623 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.14 -126.1 29.51 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.447 -0.406 . . . . 0.0 112.522 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -116.52 24.24 11.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.093 0.473 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.31 169.4 18.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.61 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.98 144.98 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.155 0.502 . . . . 0.0 111.018 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -67.41 136.99 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.988 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.63 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.3 ptm -132.35 100.02 4.87 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG12 ' HE1' ' A' ' 89' ' ' PHE . 38.2 t -63.87 123.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.705 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.5 mm-40 -101.6 -51.57 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.941 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 66.2 m-20 -149.11 143.18 25.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.624 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -162.75 155.24 18.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.079 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.4 t30 -152.34 146.76 25.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.653 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -114.02 115.1 27.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.1 -136.54 4.29 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.203 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.5 ttm180 -162.17 122.4 2.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.277 0.561 . . . . 0.0 111.905 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 43.5 p -123.72 12.52 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.593 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 29.7 t0 -146.82 -168.72 3.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 44.6 p30 -146.88 4.57 0.85 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.705 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 59.0 mttt -103.45 0.43 31.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.63 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.2 mm -109.86 138.46 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 120.274 -0.571 . . . . 0.0 110.913 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.3 m 53.49 72.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.324 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -57.25 120.32 7.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.512 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.46 -161.71 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.672 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -57.55 133.74 82.15 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.235 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 3.7 Cg_endo -55.61 -34.48 90.33 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.613 1.542 . . . . 0.0 111.715 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -61.44 -39.19 89.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.392 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' HG23 ' A' ' 118' ' ' THR . 19.9 mt-30 -83.94 -10.28 58.07 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.02 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.519 ' HE2' ' O ' ' A' ' 68' ' ' ASP . 86.3 mtp -103.2 -1.93 28.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.019 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 54.9 mm-40 -63.84 -45.76 88.09 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.44 114.64 19.48 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.77 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 19.2 m -104.64 34.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.104 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.692 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.1 mm-40 -142.72 84.17 1.84 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.251 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.496 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 36.4 t -142.01 126.05 17.31 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HA ' HD21 ' A' ' 62' ' ' ASN . 41.3 m-85 -136.13 154.0 51.12 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 88' ' ' ALA . 27.8 tp -146.71 89.26 5.79 Favored Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.174 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -50.67 -49.88 15.39 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.88 2.387 . . . . 0.0 113.343 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 54.3 m-20 -58.23 -21.94 50.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.34 -31.33 43.89 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.042 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.483 ' O ' ' OG ' ' A' ' 93' ' ' SER . 48.9 t80 -66.27 -45.9 78.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.735 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 8.6 ptpt -66.33 -39.86 89.5 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.701 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.758 HG22 ' HE ' ' A' ' 95' ' ' ARG . 56.9 mt -59.75 -49.79 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.679 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 122' ' ' LEU . 58.2 mtp -70.01 -37.95 75.81 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.042 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 48.1 m -55.97 -42.91 77.0 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -66.24 -38.54 88.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.051 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.758 ' HE ' HG22 ' A' ' 91' ' ' ILE . 14.3 mtm105 -74.86 -34.14 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 48' ' ' LEU . 71.0 m -110.15 -18.91 13.21 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' CG ' ' O ' ' A' ' 93' ' ' SER . 79.7 m-20 -54.65 135.38 46.77 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.059 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 65.79 14.58 9.63 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.24 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -113.6 145.64 40.95 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.646 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.0 m -69.67 -33.39 72.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.297 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.435 HE21 ' CZ ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -152.91 155.93 37.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.674 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 48' ' ' LEU . 24.8 p -155.1 136.84 14.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.244 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.4 127.63 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.612 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.683 HG21 HH11 ' A' ' 95' ' ' ARG . 42.5 t -142.59 145.55 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 111.374 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 107' ' ' GLY . 66.4 t -75.8 114.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.977 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.98 40.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.48 -121.93 0.73 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER 27.2 -155.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.322 0.582 . . . . 0.0 111.868 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -68.52 1.15 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.295 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.01 -15.63 46.95 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.518 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 112' ' ' PRO . 96.9 m-85 -146.13 125.15 6.57 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.542 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.9 Cg_exo -51.16 -142.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.528 2.152 . . . . 0.0 112.607 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 116' ' ' PRO . 9.4 t0 -145.31 87.72 6.97 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.199 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.14 -8.58 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.55 2.167 . . . . 0.0 113.131 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -165.09 69.69 1.36 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.53 0.681 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 22.2 Cg_exo -53.73 147.25 41.22 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.381 2.054 . . . . 0.0 111.048 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.51 -5.38 81.44 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.881 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 77' ' ' GLN . 88.8 m -118.3 148.05 42.85 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 30.8 t80 -84.42 116.37 23.03 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.454 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 7.9 mtmm -94.24 -157.83 0.58 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.576 1.179 . . . . 0.0 113.994 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.6 p90 -174.01 175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.881 -1.963 . . . . 0.0 110.239 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 92' ' ' MET . 52.2 tp -130.78 123.67 29.67 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.079 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.469 ' HG2' HE21 ' A' ' 125' ' ' GLN . 66.1 tt0 -121.28 126.79 50.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 61' ' ' ALA . 77.9 t -132.73 127.15 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.452 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.469 HE21 ' HG2' ' A' ' 123' ' ' GLU . 9.4 mp0 -108.61 129.02 55.33 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.805 ' CD2' HG23 ' A' ' 56' ' ' ILE . 19.7 p90 -156.02 171.69 19.67 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.698 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 35' ' ' MET . 49.9 m-20 -131.64 162.24 30.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.427 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.0 m -108.3 131.23 54.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.623 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' SD ' ' A' ' 57' ' ' MET . 28.5 m -130.99 157.57 77.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -57.16 145.33 87.11 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.014 1.81 . . . . 0.0 111.576 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -77.4 29.08 0.15 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.404 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -89.8 135.37 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 110.626 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.564 ' O ' ' O ' ' A' ' 134' ' ' GLU . 12.7 p -89.97 140.57 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.766 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' O ' ' O ' ' A' ' 133' ' ' VAL . 41.4 tp10 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.595 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -54.81 140.13 60.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.24 137.71 52.91 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.291 1.994 . . . . 0.0 111.842 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 34' ' ' LEU . 87.3 m-85 -81.45 -13.09 58.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.58 -38.06 0.17 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 35' ' ' MET . 0.3 OUTLIER -161.23 123.31 3.02 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.747 ' N ' HD13 ' A' ' 34' ' ' LEU . 46.0 mtt 60.88 148.43 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.296 0.57 . . . . 0.0 112.042 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' NE ' ' SG ' ' A' ' 128' ' ' CYS . 58.8 mtt85 -87.69 145.48 26.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -146.22 135.5 22.84 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.559 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 58.8 mm-40 -134.0 146.68 50.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.221 178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.96 139.68 38.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.742 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -138.36 142.27 39.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.452 0.644 . . . . 0.0 111.009 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 23.9 m -64.58 137.72 58.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.757 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' C ' ' A' ' 120' ' ' LYS . 72.5 tt0 -43.44 126.32 4.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.179 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.47 -8.21 74.79 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.241 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.34 148.62 38.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.945 1.373 . . . . 0.0 110.005 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.78 149.95 67.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.899 2.399 . . . . 0.0 113.287 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 tt -118.99 146.62 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.673 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' OE2' ' NH1' ' A' ' 49' ' ' ARG . 82.0 tt0 -126.05 129.84 49.95 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.109 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD12 ' SG ' ' A' ' 102' ' ' CYS . 48.7 mt -116.01 139.81 49.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.986 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' ' OE2' ' A' ' 47' ' ' GLU . 3.9 mtp180 -150.28 131.49 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.287 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 56' ' ' ILE . 11.6 m -97.98 151.92 37.8 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.058 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HG3' HH21 ' A' ' 36' ' ' ARG . 93.4 Cg_endo -77.11 160.03 33.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.908 2.406 . . . . 0.0 112.318 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 53.64 -116.69 6.21 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.6 p -131.54 27.47 4.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.27 0.557 . . . . 0.0 110.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -76.05 170.71 15.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.765 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.2 142.62 39.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.41 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.704 HG23 ' CD2' ' A' ' 126' ' ' TYR . 93.5 mt -67.15 137.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.785 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 1.3 ptp -134.9 102.52 5.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.532 HG12 ' CE1' ' A' ' 89' ' ' PHE . 21.8 t -64.09 124.54 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.123 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -100.41 -52.1 3.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.245 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -152.27 150.65 30.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -168.5 155.31 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.855 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.461 ' O ' HD12 ' A' ' 122' ' ' LEU . 14.0 t30 -145.58 147.77 32.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.545 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CE2' ' HB3' ' A' ' 111' ' ' PHE . 40.2 t80 -119.59 117.94 29.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.86 -133.14 3.2 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.663 ' NE ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -157.34 120.46 4.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 0.0 111.191 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.585 HG22 ' CZ ' ' A' ' 84' ' ' TYR . 20.7 p -120.27 8.66 10.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.854 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.663 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 43.5 t0 -145.21 -166.13 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.185 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 38.0 p-10 -150.24 0.31 0.44 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 51.7 mtpt -102.78 2.91 36.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.252 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.89 135.68 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m 52.71 74.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 46.1 p30 -52.37 102.93 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.662 0.744 . . . . 0.0 112.046 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 -170.21 1.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.649 -1.159 . . . . 0.0 108.838 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.679 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.8 OUTLIER -59.56 141.99 87.82 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.21 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.5 Cg_endo -53.63 -40.08 80.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.932 2.421 . . . . 0.0 112.993 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -65.54 -33.62 76.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.963 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.511 ' O ' HG23 ' A' ' 118' ' ' THR . 22.2 mt-30 -90.2 -8.26 51.56 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 74.5 mmm -107.36 -4.8 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 2.6 mt-10 -67.06 -42.34 84.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 9.3 t30 -77.98 121.22 23.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.26 31.63 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.026 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -138.74 86.7 2.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.008 0.432 . . . . 0.0 110.148 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.472 ' SG ' ' HA3' ' A' ' 64' ' ' GLY . 4.4 t -147.6 120.96 9.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.585 ' CZ ' HG22 ' A' ' 66' ' ' THR . 73.8 m-85 -135.74 157.13 47.63 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.192 0.52 . . . . 0.0 112.372 -178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 tp -147.53 89.44 5.44 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.434 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.16 -51.33 10.23 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.759 2.306 . . . . 0.0 113.123 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 53.8 m-20 -54.93 -22.79 16.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.69 68.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE1' HG12 ' A' ' 58' ' ' VAL . 31.0 t80 -64.14 -44.14 93.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.049 0.452 . . . . 0.0 111.515 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.04 -38.3 90.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.353 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 65.8 mt -61.03 -47.79 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.03 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.9 mmm -67.7 -36.45 80.67 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.5 m -59.39 -46.55 88.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.39 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -66.48 -35.98 81.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 111.145 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' A' ' 104' ' ' VAL . 51.1 mtp85 -75.34 -35.22 61.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.3 m -112.92 -18.1 12.32 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' CB ' ' H82' ' A' ' 135' ' ' NAG . 46.3 m-20 -52.82 136.39 34.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 66.34 13.19 9.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.207 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -112.89 145.38 40.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.0 m -74.62 -32.32 62.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.013 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -149.2 150.24 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.482 ' SG ' HD12 ' A' ' 48' ' ' LEU . 9.4 p -153.5 143.64 22.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.287 0.565 . . . . 0.0 111.448 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.12 123.59 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.443 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.549 HG22 ' HE ' ' A' ' 95' ' ' ARG . 41.7 t -135.56 143.88 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.432 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.87 119.47 32.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.329 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.17 42.45 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.75 -125.27 0.95 Allowed Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.1 t 29.54 -157.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 110.855 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.63 2.75 3.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.967 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.05 -12.71 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.727 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.1 m-85 -143.53 126.13 8.72 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.956 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' O ' ' O ' ' A' ' 111' ' ' PHE . 22.6 Cg_exo -51.86 -144.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.137 1.891 . . . . 0.0 111.178 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.51 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 8.7 t0 -146.02 96.34 4.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 92.5 Cg_endo -84.89 -8.92 9.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.029 2.486 . . . . 0.0 112.768 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -162.02 64.45 1.7 Allowed Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.275 0.56 . . . . 0.0 111.475 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.51 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 23.4 Cg_exo -53.94 145.29 52.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.925 1.75 . . . . 0.0 111.022 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.8 -11.66 71.6 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.865 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 77' ' ' GLN . 47.2 m -117.93 150.41 39.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.1 0.45 . . . . 0.0 110.099 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 45.3 t80 -81.26 116.34 21.08 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' C ' ' HB2' ' A' ' 42' ' ' GLU . 10.7 mttt -93.19 -162.52 0.95 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.508 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -173.21 174.14 3.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.776 -2.011 . . . . 0.0 111.369 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' ASN . 54.3 tp -131.86 123.65 27.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.233 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' HG2' HE21 ' A' ' 125' ' ' GLN . 77.1 tt0 -118.76 126.69 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ALA . 18.6 t -130.49 125.2 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.1 mp0 -106.43 128.22 53.89 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.704 ' CD2' HG23 ' A' ' 56' ' ' ILE . 38.7 p90 -153.68 168.76 25.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.819 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.6 OUTLIER -127.57 163.1 24.92 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.556 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.489 ' SG ' ' NE ' ' A' ' 36' ' ' ARG . 72.9 m -113.21 114.55 26.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.31 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.8 m -116.66 151.69 47.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.56 150.21 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.056 1.838 . . . . 0.0 111.799 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -84.15 -4.9 59.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.644 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.63 165.75 13.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.217 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.46 135.11 26.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.421 -178.417 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.55 ' H82' ' CB ' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.01 75.84 40.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.48 155.2 17.29 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.386 2.724 . . . . 0.0 112.287 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.692 ' O ' ' N ' ' A' ' 34' ' ' LEU . 99.3 m-85 -79.41 -0.31 32.37 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.961 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.69 -67.27 0.0 OUTLIER Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.692 ' N ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -158.21 47.85 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.404 ' HG2' ' OD1' ' A' ' 127' ' ' ASP . 3.2 mtp 59.62 160.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.729 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.799 HH12 ' CD ' ' A' ' 51' ' ' PRO . 52.1 mtt180 -93.08 147.27 22.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -153.54 134.88 14.18 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.201 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.43 148.6 45.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.583 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 40' ' ' ALA . 7.0 tt -139.88 140.94 36.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.833 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -141.57 142.5 33.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.457 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.34 137.26 54.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.721 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 84.2 tt0 -48.88 136.22 14.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.9 38.23 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.981 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 2.4 m-30 -108.14 151.5 41.4 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 118.129 0.965 . . . . 0.0 109.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.47 155.0 70.59 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.515 2.143 . . . . 0.0 113.453 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 104' ' ' VAL . 20.2 tt -118.48 146.35 23.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.068 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' CG ' HH11 ' A' ' 49' ' ' ARG . 0.7 OUTLIER -122.09 130.72 53.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.569 0.7 . . . . 0.0 112.511 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.026 HD12 ' SG ' ' A' ' 102' ' ' CYS . 76.1 mt -121.99 130.88 53.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.661 177.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 47' ' ' GLU . 3.6 mtt85 -147.23 130.54 16.58 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.218 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.472 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 7.4 m -97.56 143.57 26.43 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.799 ' CD ' HH12 ' A' ' 36' ' ' ARG . 18.8 Cg_endo -70.6 163.61 38.34 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.677 2.251 . . . . 0.0 112.717 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.63 -126.65 21.26 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.9 p -115.73 24.74 11.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.497 -0.352 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.94 169.15 18.77 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.911 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.91 145.91 33.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 121.398 0.618 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.8 mt -68.91 138.06 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.301 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.649 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.3 ptm -131.14 100.09 5.09 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.608 HG12 ' CE1' ' A' ' 89' ' ' PHE . 75.0 t -65.09 122.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.032 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 61.4 mt-10 -100.05 -47.06 5.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.551 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 59.4 m-20 -151.24 150.8 31.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.555 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.804 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.83 154.52 13.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.785 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.455 HD21 ' HA ' ' A' ' 84' ' ' TYR . 11.6 t30 -152.19 149.9 29.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.065 0.46 . . . . 0.0 112.115 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.522 ' OH ' ' OE2' ' A' ' 42' ' ' GLU . 87.2 t80 -121.93 119.08 30.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.509 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.64 -136.79 4.56 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.02 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.611 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 4.8 ttm180 -155.29 117.55 4.18 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.135 0.493 . . . . 0.0 110.797 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -123.66 10.66 9.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 30.8 t0 -146.65 -169.01 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 29.6 p30 -145.33 -0.17 0.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.784 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 31.9 mtpt -102.7 6.23 39.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.538 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.403 HG22 ' SG ' ' A' ' 71' ' ' CYS . 18.9 mm -110.52 135.02 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' ALA . 83.5 m 62.13 51.58 3.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.951 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.56 95.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.738 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -116.68 -162.46 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.684 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -60.1 132.51 89.93 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.691 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 2.8 Cg_endo -54.64 -34.77 84.69 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.94 2.426 . . . . 0.0 114.278 -177.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -62.32 -33.43 74.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.448 0.642 . . . . 0.0 109.79 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.632 ' O ' HG23 ' A' ' 118' ' ' THR . 25.2 mt-30 -87.41 -0.05 56.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 4.8 mtm -119.8 0.3 10.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 77.9 mt-10 -62.69 -50.05 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.218 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -80.13 111.53 16.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.0 m -102.59 35.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.236 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -141.49 87.81 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 4.2 t -145.16 122.24 11.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.455 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.7 m-85 -132.61 153.87 50.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.232 0.539 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.5 tp -148.59 88.33 5.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.303 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.69 -47.77 21.75 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.864 2.376 . . . . 0.0 113.868 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -54.61 -24.98 23.7 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -53.22 -30.96 40.77 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.673 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.608 ' CE1' HG12 ' A' ' 58' ' ' VAL . 57.1 t80 -65.77 -45.51 82.26 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 1.1 pttt -65.2 -43.03 92.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.681 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.0 HG22 ' CZ ' ' A' ' 95' ' ' ARG . 59.6 mt -58.83 -45.68 91.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.823 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.766 ' SD ' ' NH2' ' A' ' 95' ' ' ARG . 93.8 mmm -69.78 -35.63 75.06 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.198 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.499 ' HB3' ' ND2' ' A' ' 97' ' ' ASN . 50.8 m -61.0 -47.32 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.25 -37.85 88.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.165 0.507 . . . . 0.0 111.049 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 1.0 ' CZ ' HG22 ' A' ' 91' ' ' ILE . 47.8 mtm180 -77.55 -33.91 53.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 48' ' ' LEU . 33.1 m -112.52 -19.75 12.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -176.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 90.3 m-20 -61.15 135.61 57.81 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.353 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 67.34 13.68 9.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.303 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -113.04 145.34 41.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.328 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -70.97 -31.68 68.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.76 155.01 38.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.938 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 1.026 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.5 p -156.39 132.86 10.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.25 129.28 71.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 95' ' ' ARG . 43.8 t -136.72 139.05 45.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.762 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' GLY . 58.2 t -72.94 116.18 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.81 40.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.701 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.03 -122.66 0.85 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' GLY . 10.6 t 29.58 -157.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.651 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -67.38 0.37 2.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.337 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.82 -13.7 50.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.571 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 112' ' ' PRO . 47.8 m-85 -144.43 126.69 8.28 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.199 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.593 ' O ' ' O ' ' A' ' 111' ' ' PHE . 31.6 Cg_exo -48.88 -149.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.756 2.304 . . . . 0.0 112.202 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 21.8 t0 -145.18 80.11 11.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.483 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 69.6 Cg_endo -75.33 -3.56 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.25 2.633 . . . . 0.0 112.842 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.58 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.2 p -164.05 63.43 1.14 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.268 0.556 . . . . 0.0 111.752 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.08 144.09 59.54 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.096 1.864 . . . . 0.0 110.299 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.72 -4.34 81.89 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 77' ' ' GLN . 80.4 m -125.73 147.86 49.24 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.666 0.733 . . . . 0.0 109.869 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.611 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 4.6 t80 -80.54 113.7 18.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 113' ' ' ASP . 28.0 mttp -91.85 -160.3 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.575 1.178 . . . . 0.0 113.291 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 10.0 p90 -175.41 177.11 1.88 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.13 176.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.7 tp -130.39 121.45 25.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.493 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.605 ' HG2' HE21 ' A' ' 125' ' ' GLN . 56.0 tt0 -120.9 127.44 51.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.799 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.804 HG22 ' HB1' ' A' ' 61' ' ' ALA . 58.0 t -135.38 129.03 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.605 HE21 ' HG2' ' A' ' 123' ' ' GLU . 8.6 mp0 -107.97 130.26 55.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.633 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.7 p90 -154.2 173.72 15.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.364 0.602 . . . . 0.0 111.764 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 80.0 m-20 -133.23 161.13 35.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.835 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.445 ' SG ' ' NH1' ' A' ' 36' ' ' ARG . 95.4 m -111.71 111.05 21.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.97 158.53 37.55 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.355 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -57.99 142.04 96.48 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.862 1.708 . . . . 0.0 111.698 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -75.68 137.12 40.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.781 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -134.65 134.22 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.208 0.528 . . . . 0.0 111.154 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 133' ' ' VAL . 12.2 p -92.27 129.55 42.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.856 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 C--O 1.223 -0.32 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.825 -179.191 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 tp -130.52 80.09 70.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.31 143.47 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.119 1.879 . . . . 0.0 112.182 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.31 -8.99 58.55 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.28 37.35 32.14 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.3 OUTLIER -164.67 49.19 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 0.0 110.766 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.6 mtp 55.25 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 111.075 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 36' ' ' ARG . 79.9 mtt-85 -93.21 148.21 22.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.523 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 49.1 ttp180 -148.99 137.76 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.7 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 31.5 mp0 -130.8 145.62 52.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.536 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.7 tt -139.53 141.74 37.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.821 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -140.18 140.17 35.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.449 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.2 m -67.76 137.2 55.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.505 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -46.7 134.53 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.02 52.39 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.3 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 1.7 m-85 -107.28 147.01 34.41 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.279 1.039 . . . . 0.0 110.139 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -67.14 153.27 78.03 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.546 2.164 . . . . 0.0 112.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.6 tt -118.14 141.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -120.22 128.22 53.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.464 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD12 ' SG ' ' A' ' 102' ' ' CYS . 73.2 mt -116.78 142.62 46.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.391 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -152.94 133.41 13.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.84 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 56' ' ' ILE . 6.2 m -102.01 147.52 34.04 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.06 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 37.2 Cg_endo -70.35 158.21 56.88 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 123.686 2.924 . . . . 0.0 113.317 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.92 -132.89 32.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.9 p -105.26 27.89 7.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.353 0.597 . . . . 0.0 109.742 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.44 162.37 25.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.097 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 129' ' ' VAL . 4.5 m -126.49 147.99 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.58 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.799 HG23 ' CD2' ' A' ' 126' ' ' TYR . 80.4 mt -71.18 134.8 29.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.635 ' O ' ' CG ' ' A' ' 57' ' ' MET . 9.6 ptm -130.32 100.72 5.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.49 0.662 . . . . 0.0 109.264 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 93' ' ' SER . 6.9 t -65.16 122.67 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.602 -178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -102.51 -48.05 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -149.4 148.66 29.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.474 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.834 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.18 154.4 10.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.8 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.556 HD21 ' HA ' ' A' ' 84' ' ' TYR . 17.7 t30 -152.3 149.69 28.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.692 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.88 121.16 37.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.81 -135.5 4.25 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.76 ' NH1' ' O ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -158.12 119.63 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.271 0.558 . . . . 0.0 111.1 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 84' ' ' TYR . 38.6 p -122.6 9.77 9.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.557 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 28.5 t0 -145.36 -169.36 3.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.823 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 59.8 p30 -147.21 -1.01 0.66 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.657 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -100.09 3.41 43.97 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.708 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 44.7 mm -106.27 133.45 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 72.8 m 63.09 57.52 1.6 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 51.1 p30 -42.33 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.303 0.573 . . . . 0.0 111.843 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.95 -165.1 1.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.681 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -59.06 137.29 87.95 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.595 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.38 -35.55 75.68 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.383 2.056 . . . . 0.0 112.261 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -62.45 -40.53 96.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.523 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 15.1 mt-30 -88.3 -5.42 58.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.983 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.472 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 86.8 mmm -107.22 -4.6 18.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.507 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.3 mt-10 -65.56 -48.65 71.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -77.79 122.32 25.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.22 0.533 . . . . 0.0 112.338 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 32.25 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -140.44 86.28 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.136 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.544 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 28.8 t -144.76 123.06 12.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.8 m-85 -134.83 153.76 51.9 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.241 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.1 tp -147.0 91.81 5.09 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.78 -45.26 42.36 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.773 2.315 . . . . 0.0 113.718 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.82 -15.68 32.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.51 -28.93 57.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.6 -44.16 91.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.11 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -65.44 -42.07 92.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.734 HG23 ' NH1' ' A' ' 95' ' ' ARG . 68.6 mt -59.68 -47.57 90.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.216 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.9 mmm -70.07 -35.51 74.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG21 ' A' ' 58' ' ' VAL . 74.1 m -63.44 -45.28 91.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.755 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.99 -36.91 85.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.184 0.516 . . . . 0.0 111.407 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.734 ' NH1' HG23 ' A' ' 91' ' ' ILE . 51.1 mtt85 -79.9 -32.68 40.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.1 m -113.45 -13.29 12.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 93' ' ' SER . 87.6 m-20 -61.56 135.28 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.554 -0.859 . . . . 0.0 112.054 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 65.31 11.02 6.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -110.62 144.43 39.52 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.407 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.1 m -70.56 -31.79 68.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.904 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.81 154.15 41.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.738 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.708 ' SG ' HD12 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.88 137.08 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.511 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.7 t -121.94 128.92 75.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.516 HG22 ' HD3' ' A' ' 95' ' ' ARG . 19.2 t -136.87 144.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.623 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.6 t -76.72 115.57 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.77 33.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.952 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 177.6 -119.76 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.99 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 2.4 t 32.1 -159.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.75 0.309 . . . . 0.0 111.042 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -67.5 2.29 1.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.577 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.72 -11.81 56.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.187 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.587 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -146.6 129.97 8.22 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.2 Cg_exo -50.43 -146.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.461 2.107 . . . . 0.0 112.207 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -144.34 83.73 9.79 Favored Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.27 -7.02 17.76 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.024 2.483 . . . . 0.0 114.234 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.557 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -166.45 68.77 1.07 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 121.605 0.717 . . . . 0.0 111.267 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -51.74 144.28 35.0 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 122.667 2.245 . . . . 0.0 111.2 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.86 2.23 90.48 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.942 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.6 m -120.43 146.06 46.59 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.055 0.928 . . . . 0.0 109.542 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.76 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 7.6 t80 -80.88 110.5 16.46 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.557 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 12.9 mttp -90.49 -164.84 1.23 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.517 1.151 . . . . 0.0 113.858 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB2' HD21 ' A' ' 39' ' ' LEU . 4.3 p90 -170.56 169.57 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.062 -1.881 . . . . 0.0 111.033 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 62' ' ' ASN . 32.8 tp -127.43 124.57 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HG2' HE21 ' A' ' 125' ' ' GLN . 73.0 tt0 -120.42 125.62 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.834 HG22 ' HB1' ' A' ' 61' ' ' ALA . 71.9 t -132.2 125.66 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.208 -0.597 . . . . 0.0 112.587 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.46 HE21 ' HG2' ' A' ' 123' ' ' GLU . 4.2 mp0 -108.57 126.1 52.57 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.752 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.799 ' CD2' HG23 ' A' ' 56' ' ' ILE . 44.5 p90 -153.31 173.03 16.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.9 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.422 ' OD1' ' HG2' ' A' ' 35' ' ' MET . 64.9 m-20 -125.27 159.39 31.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.198 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 95.3 m -108.95 121.34 44.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.009 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' VAL . 29.9 m -132.03 158.63 75.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.51 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.89 144.04 79.37 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.053 1.835 . . . . 0.0 112.424 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.433 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 14.8 t80 -76.1 -10.11 59.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.665 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -141.02 128.87 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.575 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 p -92.87 138.99 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.131 -179.308 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.832 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -109.22 159.15 32.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.69 136.51 71.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.109 1.873 . . . . 0.0 111.137 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 34' ' ' LEU . 1.6 m-85 -78.95 -2.8 41.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.43 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 54.63 -69.35 0.0 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 32' ' ' PHE . 7.0 tp -164.07 109.99 1.05 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.849 -0.206 . . . . 0.0 110.894 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.4 ttm 58.13 164.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.001 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.1 mtt85 -99.04 140.37 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -152.0 138.25 18.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.124 0.488 . . . . 0.0 110.729 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.618 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.3 mt-10 -130.18 149.76 51.74 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.836 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -137.42 140.45 41.32 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.717 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.99 138.0 38.47 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.338 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 119' ' ' TYR . 45.8 m -66.68 137.02 56.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.149 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -45.2 130.73 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.992 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.2 -14.44 62.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.004 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 12.5 m-85 -109.34 151.59 42.18 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.884 1.342 . . . . 0.0 110.083 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.36 155.48 60.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.664 2.243 . . . . 0.0 113.039 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.3 tt -123.21 147.97 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 79.2 tt0 -128.98 124.23 34.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.508 HD12 ' SG ' ' A' ' 102' ' ' CYS . 57.1 mt -113.27 141.89 46.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 17.8 mtp-105 -147.86 138.92 23.39 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.919 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.511 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.3 m -106.79 142.76 25.66 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.351 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 31.5 Cg_endo -68.83 160.8 48.21 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.532 2.155 . . . . 0.0 112.907 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 45.94 -132.34 10.19 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.364 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -101.74 22.23 13.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.201 -0.5 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -77.39 165.51 24.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.258 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.16 142.39 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.947 HG23 ' CD2' ' A' ' 126' ' ' TYR . 95.5 mt -68.66 139.7 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.669 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.458 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.5 ptp -132.45 100.57 5.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.5 t -63.44 125.33 19.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.755 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 93.3 mt-10 -101.67 -48.79 4.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 67.2 m-20 -149.98 150.69 32.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.203 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.478 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -170.66 157.38 5.68 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.878 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 84' ' ' TYR . 13.7 t30 -150.18 146.91 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -117.61 120.63 38.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 155.88 -131.23 2.98 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.789 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.596 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 7.3 ttm-85 -157.1 115.01 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.483 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.429 ' OG1' ' OH ' ' A' ' 121' ' ' TYR . 28.0 p -118.25 11.14 13.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' C ' HG12 ' A' ' 81' ' ' VAL . 46.0 t0 -147.89 -171.67 3.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.785 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.547 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 26.1 p-10 -145.62 -2.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.778 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HG3' ' OD1' ' A' ' 68' ' ' ASP . 34.9 mttp -100.7 6.32 43.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 28.0 mm -111.9 135.83 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.15 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.3 m 53.63 75.0 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.281 0.562 . . . . 0.0 109.894 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.77 120.12 7.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.55 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.82 -164.15 1.56 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.607 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -59.96 134.55 90.05 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 119.159 -1.017 . . . . 0.0 108.728 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 8.7 Cg_endo -53.6 -33.28 68.09 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.545 2.163 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.28 -37.68 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.691 0.281 . . . . 0.0 111.146 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB3' ' N ' ' A' ' 119' ' ' TYR . 19.9 mt-30 -86.48 2.51 47.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.203 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.596 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 38.8 mmm -121.85 -0.18 9.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 63.0 mt-10 -64.96 -48.52 73.76 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.29 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -78.38 116.85 19.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' C ' ' A' ' 67' ' ' ASP . 26.5 m -105.34 36.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.803 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 71.9 mm-40 -141.14 83.42 1.88 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.547 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 31.7 t -147.13 116.86 7.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' TYR . 8.7 m-85 -130.18 157.49 42.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.606 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.35 90.75 5.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -48.73 -46.8 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.121 2.547 . . . . 0.0 113.805 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -57.84 -18.33 21.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.53 65.38 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.627 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.47 -46.39 79.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.765 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -64.65 -41.05 96.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.669 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.548 ' N ' ' HG3' ' A' ' 90' ' ' LYS . 97.8 mt -60.38 -49.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.741 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.91 ' SD ' HD21 ' A' ' 122' ' ' LEU . 74.7 mtp -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.401 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.1 m -55.74 -44.01 77.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.96 -37.94 82.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.589 ' NE ' HG22 ' A' ' 104' ' ' VAL . 20.2 mtp180 -75.77 -34.41 60.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -110.38 -19.78 12.84 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 93' ' ' SER . 76.4 m-20 -58.34 136.95 57.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.613 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 65.2 13.55 8.82 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.646 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -114.29 146.22 40.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.202 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.0 m -69.45 -31.03 69.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 156.15 41.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.605 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.515 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -152.4 130.18 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.09 131.59 66.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.629 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 ' NE ' ' A' ' 95' ' ' ARG . 78.0 t -145.82 148.8 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.359 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.44 118.75 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.01 38.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.083 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.662 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.3 -118.65 0.58 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.151 -1.023 . . . . 0.0 111.156 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.662 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.1 t 24.63 -156.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.231 0.539 . . . . 0.0 111.823 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -69.51 2.7 2.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.82 -14.38 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.548 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 112' ' ' PRO . 55.3 m-85 -144.8 130.17 9.42 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.41 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.6 Cg_exo -51.72 -145.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.981 1.787 . . . . 0.0 112.063 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -144.96 86.63 7.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.548 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.491 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 56.5 Cg_endo -75.63 -5.03 16.05 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.376 2.051 . . . . 0.0 112.666 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -169.78 73.7 0.67 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.246 0.546 . . . . 0.0 111.636 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -53.23 148.09 33.3 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.674 2.25 . . . . 0.0 111.6 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.58 75.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.09 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.9 m -118.97 146.79 44.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 41' ' ' CYS . 14.5 t80 -82.82 109.24 16.78 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 28.0 mtmm -87.88 -165.2 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.507 1.146 . . . . 0.0 113.799 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 64' ' ' GLY . 5.3 p90 -170.53 171.24 6.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.048 -1.887 . . . . 0.0 111.034 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.91 HD21 ' SD ' ' A' ' 92' ' ' MET . 27.8 tp -129.67 120.71 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.116 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.61 ' CD ' ' NE2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -114.16 125.59 54.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.787 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.755 HG21 ' SD ' ' A' ' 92' ' ' MET . 38.8 t -134.37 122.51 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.839 -178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.61 ' NE2' ' CD ' ' A' ' 123' ' ' GLU . 3.4 mt-30 -105.97 127.28 53.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.358 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.947 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.5 p90 -149.83 168.26 24.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 111.846 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER -124.96 160.08 29.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.1 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -110.77 122.11 47.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.0 156.35 62.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.149 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -62.63 144.84 94.88 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.194 1.929 . . . . 0.0 111.845 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -79.03 -7.56 58.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.435 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -93.42 157.06 16.41 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.276 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.621 ' O ' ' O ' ' A' ' 134' ' ' GLU . 15.5 m -94.58 135.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.356 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.621 ' O ' ' O ' ' A' ' 133' ' ' VAL . 96.5 mt-10 . . . . . 0 C--O 1.218 -0.592 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.8 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.622 ' O ' ' O ' ' A' ' 31' ' ' PRO . 4.0 tp -123.78 78.94 56.77 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.622 ' O ' ' O ' ' A' ' 30' ' ' LEU . 72.7 Cg_exo -46.46 -131.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.975 2.45 . . . . 0.0 112.537 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 34' ' ' LEU . 55.4 p90 -77.66 -36.1 51.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.508 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.572 ' C ' HD12 ' A' ' 34' ' ' LEU . . . 64.67 -47.95 0.11 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 33' ' ' GLY . 2.2 mp -160.1 117.79 2.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.034 0.445 . . . . 0.0 110.542 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 125' ' ' GLN . 43.0 ttm 70.83 144.12 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.736 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -88.13 158.02 18.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' C ' ' CD ' ' A' ' 38' ' ' GLU . 41.5 ttm180 -142.4 138.89 31.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.392 0.615 . . . . 0.0 110.742 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -135.03 140.61 45.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.61 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.4 tt -139.6 133.6 30.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -134.49 141.1 46.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.203 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.4 m -67.67 136.65 54.69 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.573 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 120' ' ' LYS . 88.6 tt0 -49.31 134.14 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.629 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.73 -17.94 56.74 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.21 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 72.1 m-85 -113.12 152.66 45.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 118.302 1.051 . . . . 0.0 109.943 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.56 153.76 76.74 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.272 1.981 . . . . 0.0 113.14 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 tt -120.61 139.51 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 81.2 tt0 -128.49 129.05 45.51 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.293 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.87 HD12 ' SG ' ' A' ' 102' ' ' CYS . 30.5 mt -111.85 144.58 40.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.44 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.641 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 91.6 mtt180 -149.26 130.33 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.675 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.0 m -96.93 145.13 29.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.813 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.84 161.91 40.49 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.329 2.019 . . . . 0.0 111.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.43 -126.73 31.99 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.69 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -117.92 23.87 11.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -75.16 168.46 19.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG11 ' HD1' ' A' ' 131' ' ' TYR . 23.0 m -125.84 145.6 33.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.89 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 126' ' ' TYR . 69.1 mt -69.0 137.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.782 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.639 ' O ' ' CG ' ' A' ' 57' ' ' MET . 7.1 ptm -131.6 99.35 4.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.516 HG12 ' HE1' ' A' ' 89' ' ' PHE . 55.8 t -63.95 125.92 21.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.955 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 74.7 mm-40 -102.73 -50.78 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.736 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 42.8 m-20 -149.83 149.12 30.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.951 0.405 . . . . 0.0 110.633 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.487 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.4 154.06 9.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.696 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.5 t30 -151.18 144.1 24.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.508 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -115.41 120.32 39.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.65 -135.88 4.34 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.859 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.573 HH12 ' HB3' ' A' ' 119' ' ' TYR . 11.8 ttm180 -156.91 117.12 3.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 111.246 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 26.0 p -121.2 11.53 10.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.341 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 81' ' ' VAL . 35.5 t0 -144.96 -167.02 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.422 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 13.1 p30 -149.83 -1.71 0.43 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.138 0.494 . . . . 0.0 109.85 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -100.86 6.35 43.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.287 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.47 131.92 52.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.1 m 50.06 81.0 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.606 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 37.7 p30 -53.79 98.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.502 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.65 -172.94 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.097 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -58.15 134.71 84.36 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.191 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.1 Cg_endo -50.18 -35.82 44.06 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.629 1.553 . . . . 0.0 112.096 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -61.95 -38.34 88.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.783 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.698 ' O ' HG23 ' A' ' 118' ' ' THR . 24.2 mt-30 -84.3 -8.69 58.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.26 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 74.0 mtp -104.43 -0.86 27.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.267 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 64.4 mt-10 -61.82 -49.91 74.42 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -78.22 117.89 19.92 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 67' ' ' ASP . 20.8 m -109.74 30.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.969 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 97.6 mm-40 -140.99 86.64 2.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.499 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 3.7 t -145.37 122.09 11.18 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HA ' HD21 ' A' ' 62' ' ' ASN . 97.0 m-85 -131.96 157.42 44.11 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 112' ' ' PRO . 42.9 tp -148.18 90.12 5.07 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.821 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -46.8 -47.79 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.673 2.248 . . . . 0.0 112.783 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 83.6 m-20 -56.38 -24.55 45.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.49 62.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.529 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' HE1' HG12 ' A' ' 58' ' ' VAL . 40.5 t80 -66.03 -44.97 83.11 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -64.66 -38.3 90.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.121 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' CG2' ' NH1' ' A' ' 95' ' ' ARG . 99.0 mt -59.33 -48.63 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.37 -36.13 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 15.6 m -58.25 -45.58 87.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.482 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -67.17 -38.25 85.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.67 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.622 ' NH1' ' CG2' ' A' ' 91' ' ' ILE . 80.9 mtt180 -75.76 -34.05 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 48' ' ' LEU . 58.4 m -110.31 -20.51 12.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.48 ' CG ' ' O ' ' A' ' 93' ' ' SER . 72.5 m-20 -57.33 137.82 55.6 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.614 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.94 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -115.69 147.21 41.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.241 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.4 m -70.07 -35.75 74.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.966 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -150.18 157.76 43.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.521 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.87 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -153.84 141.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.3 0.572 . . . . 0.0 111.822 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.9 126.52 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.535 HG11 HH11 ' A' ' 95' ' ' ARG . 21.9 t -139.26 141.55 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.964 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 107' ' ' GLY . 88.5 t -72.68 113.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.528 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -68.05 34.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.895 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.11 -123.21 0.81 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.9 t 32.76 -161.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.785 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.06 4.49 1.55 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.28 -11.93 59.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 112' ' ' PRO . 40.4 m-85 -143.01 129.82 10.68 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 111' ' ' PHE . 33.0 Cg_exo -51.86 -149.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.249 1.966 . . . . 0.0 111.213 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -144.82 88.92 6.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.431 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 68.0 Cg_endo -84.67 -4.98 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.245 2.63 . . . . 0.0 113.274 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 1.8 p -168.4 73.9 0.84 Allowed Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.873 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -63.67 154.24 70.41 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.635 2.223 . . . . 0.0 112.728 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.25 4.65 90.43 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 77' ' ' GLN . 29.8 m -127.11 148.01 50.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.573 ' HB3' HH12 ' A' ' 65' ' ' ARG . 48.6 t80 -83.85 114.48 21.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.433 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 12.6 mttt -91.14 -163.83 1.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.6 p90 -171.41 172.77 5.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.513 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 62' ' ' ASN . 48.1 tp -133.72 126.82 31.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.418 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 87.3 tt0 -121.49 127.21 50.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 61' ' ' ALA . 24.5 t -131.09 125.1 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.309 -0.556 . . . . 0.0 112.159 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 60' ' ' ASN . 12.0 mp0 -110.3 129.14 55.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.026 ' CD2' HG23 ' A' ' 56' ' ' ILE . 31.3 p90 -153.09 166.91 30.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.377 0.608 . . . . 0.0 112.065 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.441 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 38.8 m-20 -118.22 157.69 26.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.31 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 87.4 m -108.82 118.47 36.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 m -121.37 155.81 58.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.139 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -53.81 147.49 41.0 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 111.597 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 41.2 t80 -75.58 -2.97 31.66 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.11 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -132.77 112.83 12.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.5 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 134' ' ' GLU . 94.1 t -93.77 132.15 38.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.522 ' C ' ' CD ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.779 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.051 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.7 mp -44.0 -50.06 20.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.009 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 55.8 Cg_exo -47.32 134.62 20.03 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.566 2.177 . . . . 0.0 112.305 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -84.96 0.46 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.34 -67.24 0.24 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' PHE . 14.1 tp -159.21 51.85 0.37 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.889 0.376 . . . . 0.0 110.285 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.437 ' CG ' ' OD1' ' A' ' 127' ' ' ASP . 48.6 mtm 54.22 170.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.877 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.507 ' HD3' ' SG ' ' A' ' 128' ' ' CYS . 62.4 mtp85 -94.45 148.47 22.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -153.04 142.92 22.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.204 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 42.1 mt-10 -133.91 149.91 51.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.946 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.8 tt -141.3 134.5 29.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.243 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -133.6 143.77 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.705 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 m -67.39 139.04 57.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.952 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -45.13 133.12 6.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.628 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.1 63.95 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.333 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -108.24 149.43 39.21 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 118.733 1.267 . . . . 0.0 110.722 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -68.0 149.54 77.32 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.387 2.058 . . . . 0.0 112.935 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 104' ' ' VAL . 16.8 tt -121.46 143.63 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 56.8 tt0 -129.6 128.34 42.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.252 0.549 . . . . 0.0 112.148 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD12 ' SG ' ' A' ' 102' ' ' CYS . 32.4 mt -113.25 141.98 46.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.952 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.622 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 82.2 mtt180 -146.95 127.55 14.18 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' SG ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 m -96.52 141.56 23.29 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 50.7 Cg_endo -71.76 163.79 37.78 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.59 2.193 . . . . 0.0 112.264 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.68 -138.65 18.62 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -102.37 23.2 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.745 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 129' ' ' VAL . 92.9 m-20 -79.35 164.82 23.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.34 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' VAL . 27.5 m -128.67 149.04 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.328 0.585 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 126' ' ' TYR . 99.1 mt -69.79 135.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.504 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.1 ptp -131.24 98.61 4.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.475 HG12 ' CE1' ' A' ' 89' ' ' PHE . 48.9 t -61.97 122.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.713 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 59' ' ' GLU . 71.4 mm-40 -100.61 -46.21 5.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -149.6 144.13 25.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.127 0.489 . . . . 0.0 110.572 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -166.35 147.49 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 84' ' ' TYR . 27.7 t30 -149.85 155.83 40.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.958 0.409 . . . . 0.0 111.545 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -121.01 120.59 35.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.8 -139.74 6.17 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.68 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 13.6 ttm180 -155.35 115.07 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.232 -0.484 . . . . 0.0 109.943 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 p -126.95 8.49 6.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.953 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -148.57 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.149 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' O ' ' CE ' ' A' ' 78' ' ' MET . 23.7 p-10 -114.37 5.13 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.441 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -102.48 3.4 37.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.918 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' LEU . 26.3 mm -112.52 134.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.536 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.4 m 58.85 67.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.199 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 26.4 p-10 -52.57 102.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.009 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.696 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . . . -116.52 -165.7 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -60.04 139.25 90.96 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.898 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 Cg_endo -54.14 -40.25 82.63 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.261 1.974 . . . . 0.0 113.078 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -61.95 -37.29 84.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.248 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 118' ' ' THR . 21.5 mt-30 -86.4 -4.79 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.53 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.521 ' SD ' ' N ' ' A' ' 73' ' ' ALA . 89.3 mtp -107.16 -1.11 22.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.789 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 79.7 mt-10 -64.35 -48.52 75.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -79.9 119.79 23.24 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.27 31.23 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -138.47 84.2 2.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.071 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 43.3 t -146.78 121.04 9.55 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' ASN . 80.1 m-85 -130.98 153.95 48.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.517 HD21 ' HG2' ' A' ' 112' ' ' PRO . 48.7 tp -147.12 91.36 5.15 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.68 -46.14 28.47 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 123.303 2.669 . . . . 0.0 113.972 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 61.2 m-20 -57.91 -20.22 35.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.67 65.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE1' HG12 ' A' ' 58' ' ' VAL . 74.0 t80 -63.54 -42.75 98.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.518 ' NZ ' HE22 ' A' ' 94' ' ' GLN . 4.0 ptmm? -66.86 -40.57 87.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.128 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.481 ' N ' ' HG2' ' A' ' 90' ' ' LYS . 44.8 mt -59.51 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.91 -37.8 76.08 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 25.5 m -59.76 -46.74 88.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.803 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.518 HE22 ' NZ ' ' A' ' 90' ' ' LYS . 66.8 mt-30 -65.83 -38.9 90.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.169 0.509 . . . . 0.0 111.127 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 95' ' ' ARG . 51.9 mtt180 -75.37 -34.13 61.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 31.5 m -111.59 -16.05 13.35 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.572 ' CG ' ' O ' ' A' ' 93' ' ' SER . 25.0 m-20 -58.85 136.73 57.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.854 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 65.89 13.86 9.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.02 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -112.34 144.45 41.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.559 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.3 m -71.93 -30.91 65.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.976 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 152.65 36.58 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.02 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -155.28 137.21 14.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 47' ' ' GLU . 57.5 t -125.09 127.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.806 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.473 ' O ' HG22 ' A' ' 46' ' ' ILE . 60.9 t -138.15 149.12 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 107' ' ' GLY . 97.3 t -78.56 115.03 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.355 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.11 36.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.564 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.637 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.52 -119.95 0.65 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.637 ' O ' ' O ' ' A' ' 107' ' ' GLY . 17.0 t 28.45 -158.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -69.98 0.93 5.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.242 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.48 -14.81 56.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.123 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.563 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.2 m-85 -141.75 130.82 12.32 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.228 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.9 Cg_exo -51.44 -150.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.216 1.944 . . . . 0.0 111.628 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -146.99 93.86 4.7 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 96.6 Cg_endo -84.23 -11.35 8.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.04 2.493 . . . . 0.0 114.814 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 3.9 p -166.85 66.94 0.92 Allowed Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.451 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.4 153.56 33.91 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.315 2.01 . . . . 0.0 110.743 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.67 -6.36 73.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 77' ' ' GLN . 97.5 m -126.12 148.33 49.41 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.696 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 10.6 t80 -81.04 113.36 19.19 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.465 ' HD3' ' SG ' ' A' ' 115' ' ' CYS . 13.0 mtmm -91.29 -160.77 0.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.131 0.967 . . . . 0.0 113.166 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.498 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 6.9 p90 -174.35 175.33 2.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.801 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.2 tp -133.58 127.14 32.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG2' HE21 ' A' ' 125' ' ' GLN . 80.0 tt0 -119.23 130.11 55.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.8 t -133.08 121.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.928 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.508 HE21 ' HG2' ' A' ' 123' ' ' GLU . 2.5 mt-30 -108.8 132.21 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.71 ' CD2' HG23 ' A' ' 56' ' ' ILE . 48.6 p90 -155.02 173.18 16.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.485 0.659 . . . . 0.0 111.856 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.437 ' OD1' ' CG ' ' A' ' 35' ' ' MET . 41.9 m-20 -125.5 156.0 39.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.453 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 85.7 m -108.66 115.76 30.69 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.163 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.9 m -120.49 155.24 56.74 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.613 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -54.84 145.62 60.62 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.28 1.987 . . . . 0.0 112.682 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.522 ' HD1' HG11 ' A' ' 55' ' ' VAL . 75.1 t80 -76.38 127.41 32.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.46 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -120.01 133.95 55.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.226 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 134' ' ' GLU . 7.2 p -100.87 140.53 19.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' A' ' 133' ' ' VAL . 72.9 mm-40 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.358 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp 52.17 77.84 0.43 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.936 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.07 154.13 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.805 2.336 . . . . 0.0 111.736 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.35 -29.8 42.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.618 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.26 8.61 12.71 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 35' ' ' MET . 14.6 tp -160.82 119.13 2.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.576 ' O ' ' O ' ' A' ' 34' ' ' LEU . 1.6 mtm 52.95 130.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.599 0.714 . . . . 0.0 111.1 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.485 HH21 ' HG3' ' A' ' 51' ' ' PRO . 92.9 mtt-85 -91.26 149.9 21.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.216 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -146.14 130.05 17.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.558 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.569 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.1 mm-40 -127.25 145.21 50.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.5 tt -138.73 140.78 38.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.283 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.739 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.72 136.61 37.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.559 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.7 m -65.01 140.76 58.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 110.481 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.07 126.66 6.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.488 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.2 65.87 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.691 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 106' ' ' ALA . 8.4 m-85 -107.36 154.59 40.52 Favored Pre-proline 0 C--O 1.226 -0.136 0 CA-C-N 118.801 1.301 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -71.93 152.08 57.24 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.953 1.769 . . . . 0.0 112.38 179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 104' ' ' VAL . 17.0 tt -120.19 147.49 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.65 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 72.1 tt0 -130.01 129.76 44.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.466 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 102' ' ' CYS . 31.1 mt -115.84 136.93 52.58 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.65 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 90.6 mtt180 -144.48 140.1 28.7 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.877 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.6 m -104.41 143.99 27.79 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.154 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HG3' HH21 ' A' ' 36' ' ' ARG . 37.8 Cg_endo -70.76 160.44 49.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.988 2.458 . . . . 0.0 112.193 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.0 -127.06 23.85 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.0 p -114.3 24.97 11.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.46 168.28 20.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.202 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 129' ' ' VAL . 18.8 m -127.24 144.86 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.196 179.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 82.7 mt -68.89 138.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.779 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.611 ' O ' ' CG ' ' A' ' 57' ' ' MET . 8.5 ptm -132.54 100.66 5.04 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.622 HG12 ' CE1' ' A' ' 89' ' ' PHE . 25.4 t -66.12 125.0 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.524 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 90.3 mt-10 -102.66 -47.82 4.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 62.3 m-20 -149.73 149.35 30.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.662 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.69 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -164.0 153.82 14.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.325 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 84' ' ' TYR . 9.3 t30 -150.27 139.45 21.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.514 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -111.65 118.01 34.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.42 -137.37 4.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 67' ' ' ASP . 10.0 ttm-85 -154.77 120.27 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.493 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p -121.43 9.19 10.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.542 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.636 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 34.4 t0 -143.47 -164.6 1.9 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.566 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 4.1 p30 -149.18 -1.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.035 0.445 . . . . 0.0 109.808 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -104.61 5.88 34.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.887 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.3 mm -107.82 136.85 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.898 0.38 . . . . 0.0 110.106 179.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.1 m 54.22 69.71 0.69 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 24.1 p-10 -49.26 103.67 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.786 -178.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.47 -165.62 1.22 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.689 ' OD2' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -61.97 144.76 93.62 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 111.333 -179.693 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.3 Cg_endo -61.17 -39.4 59.1 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.606 2.204 . . . . 0.0 112.838 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -62.67 -32.13 73.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.692 ' O ' HG23 ' A' ' 118' ' ' THR . 71.0 mt-30 -89.23 -11.53 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 179.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 68' ' ' ASP . 67.1 mmm -104.13 -2.76 25.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.877 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.1 mt-10 -66.9 -45.24 78.6 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.65 114.52 19.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.478 0.656 . . . . 0.0 112.091 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' O ' ' NE2' ' A' ' 82' ' ' GLN . 15.9 m -104.94 34.16 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.06 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' NE2' ' O ' ' A' ' 81' ' ' VAL . 95.5 mm-40 -142.64 87.37 2.0 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.372 0.606 . . . . 0.0 110.894 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.428 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 8.8 t -145.22 118.08 8.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.417 ' HA ' HD21 ' A' ' 62' ' ' ASN . 88.7 m-85 -130.77 154.18 48.27 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.715 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 88' ' ' ALA . 13.3 tp -143.29 85.86 9.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.45 178.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.64 -50.0 11.21 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.052 2.501 . . . . 0.0 114.006 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 70.3 m-20 -57.61 -22.99 48.51 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.588 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -52.01 -32.63 34.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.95 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 61' ' ' ALA . 29.2 t80 -64.87 -42.23 95.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.565 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' ASP . 3.5 pttt -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.925 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 85.3 mt -60.52 -47.74 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.795 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 96.0 mmm -70.03 -37.5 75.61 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.013 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.8 m -60.35 -46.64 89.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -65.03 -36.0 82.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.612 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.732 ' NE ' HG22 ' A' ' 104' ' ' VAL . 22.9 mtp180 -79.34 -30.93 42.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 48' ' ' LEU . 7.7 m -112.03 -19.74 12.22 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 71.6 m-20 -55.61 131.4 46.26 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.86 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 69.37 13.8 8.46 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.123 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -113.89 146.53 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.131 178.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 m -69.91 -29.04 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.901 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 158.3 41.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.907 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -156.44 139.08 15.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.9 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.56 127.32 75.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.248 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.732 HG22 ' NE ' ' A' ' 95' ' ' ARG . 59.8 t -136.66 144.02 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 107' ' ' GLY . 72.0 t -77.14 114.15 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 44' ' ' TYR . . . -71.24 36.99 0.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.417 -178.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -179.02 -121.42 0.71 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.618 ' O ' ' O ' ' A' ' 107' ' ' GLY . 32.7 t 29.0 -158.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.124 0.487 . . . . 0.0 111.222 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' N ' ' OG ' ' A' ' 108' ' ' SER . 21.7 m-20 -68.72 2.76 2.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.64 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.36 -15.82 48.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.281 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.589 ' O ' ' O ' ' A' ' 112' ' ' PRO . 56.6 m-85 -143.42 126.26 8.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.504 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.589 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.0 Cg_exo -52.03 -143.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.945 . . . . 0.0 111.495 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 23.8 t0 -143.25 83.39 11.04 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.68 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.26 -5.19 16.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.938 2.426 . . . . 0.0 112.763 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.581 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.7 p -168.35 74.29 0.85 Allowed Pre-proline 0 C--O 1.237 0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 110.974 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -57.98 144.2 94.82 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 121.901 1.734 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.3 -8.32 78.99 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.266 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.9 m -115.37 148.45 39.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.036 0.918 . . . . 0.0 109.759 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.509 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 28.9 t80 -81.28 113.92 19.72 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.581 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 14.8 mttp -92.98 -161.91 0.88 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.939 1.352 . . . . 0.0 114.161 -176.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 4.9 p90 -174.06 174.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.377 -2.192 . . . . 0.0 110.491 176.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 31.0 tp -128.32 122.11 30.8 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 61' ' ' ALA . 20.6 t -131.51 127.45 59.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.841 -179.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -105.92 124.66 49.93 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 29.5 p90 -149.86 168.35 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 m-20 -124.64 161.52 26.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.541 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 68.0 m -110.1 113.0 25.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.561 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 55' ' ' VAL . 2.0 m -118.61 159.41 44.16 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.92 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.49 150.24 69.82 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.695 2.263 . . . . 0.0 112.573 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -77.86 -14.25 59.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.195 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -91.59 139.7 30.45 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.505 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 134' ' ' GLU . 7.9 p -93.78 137.3 23.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.849 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 133' ' ' VAL . 64.3 mt-10 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.534 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -50.52 -52.19 57.81 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.897 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 30' ' ' LEU . 39.6 Cg_endo -71.27 -110.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.536 2.158 . . . . 0.0 112.551 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.405 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 74.9 m-85 -77.43 -40.32 43.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.849 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.77 42.88 30.18 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 34' ' ' LEU . 7.0 tt -158.08 11.59 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.911 0.386 . . . . 0.0 110.551 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.446 ' O ' ' O ' ' A' ' 34' ' ' LEU . 3.4 mtt 56.46 140.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.317 0.58 . . . . 0.0 112.104 178.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' NH1' ' HD3' ' A' ' 51' ' ' PRO . 23.5 mtp180 -93.98 148.55 22.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.549 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' OE2' ' A' ' 123' ' ' GLU . 32.2 ttp180 -150.99 139.43 20.44 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.274 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 52.4 mp0 -132.87 145.64 51.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.819 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 40' ' ' ALA . 6.0 tt -137.09 138.76 40.7 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.825 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.32 143.92 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.218 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 m -68.17 135.62 52.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.686 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -46.94 136.0 8.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.443 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.1 -17.45 58.78 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.044 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 31.7 m-85 -108.69 149.78 39.91 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 118.135 0.968 . . . . 0.0 110.314 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.59 149.68 68.28 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.08 1.853 . . . . 0.0 112.636 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.57 146.54 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.181 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' OE2' ' CZ ' ' A' ' 49' ' ' ARG . 80.6 tt0 -130.98 127.26 38.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.75 -179.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.568 HD12 ' SG ' ' A' ' 102' ' ' CYS . 24.6 mt -111.37 140.06 46.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.427 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.575 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 6.5 mtt180 -145.17 133.04 21.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.295 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.0 m -99.85 144.11 27.75 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.041 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 24.6 Cg_endo -68.22 161.51 44.28 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.376 2.051 . . . . 0.0 112.57 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.32 -133.13 25.19 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.512 178.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.8 p -103.3 22.87 13.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.679 -0.761 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -78.95 167.6 20.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.23 0.538 . . . . 0.0 111.65 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.99 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.321 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.802 HG23 ' CD2' ' A' ' 126' ' ' TYR . 62.1 mt -71.06 137.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.651 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.626 ' O ' ' CG ' ' A' ' 57' ' ' MET . 6.7 ptm -131.81 98.4 4.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.814 0.816 . . . . 0.0 109.222 178.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.69 124.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.648 -178.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 97.7 mt-10 -104.01 -47.2 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.541 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 33.2 m-20 -149.61 147.17 27.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.067 0.46 . . . . 0.0 110.747 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 124' ' ' VAL . . . -166.47 154.16 9.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 84' ' ' TYR . 12.7 t30 -149.3 144.5 26.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -113.87 116.49 29.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.67 -133.74 3.34 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.736 ' NH1' ' SD ' ' A' ' 78' ' ' MET . 4.8 ttm180 -153.97 117.68 4.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 0.0 111.462 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -122.53 3.21 9.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.049 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -148.33 156.68 42.83 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -114.4 3.86 15.14 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.471 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -104.19 4.0 33.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.698 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.472 HG21 HD13 ' A' ' 39' ' ' LEU . 45.3 mm -112.16 138.41 41.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 m 56.83 69.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.679 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -57.14 118.89 5.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.378 0.608 . . . . 0.0 111.815 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.41 -162.07 1.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.623 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.1 p-10 -63.2 134.9 96.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.037 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 10.0 Cg_endo -56.1 -34.52 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.195 1.93 . . . . 0.0 113.584 -177.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -61.85 -37.04 83.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.22 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 118' ' ' THR . 21.6 mt-30 -84.92 -1.23 56.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.736 ' SD ' ' NH1' ' A' ' 65' ' ' ARG . 5.7 mtm -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.308 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 71.0 mt-10 -63.19 -43.41 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.854 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -79.87 117.02 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.9 m -106.74 33.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.892 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -141.72 83.02 1.83 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.191 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 24.1 t -143.16 125.85 15.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HA ' HD21 ' A' ' 62' ' ' ASN . 65.0 m-85 -136.0 153.6 51.33 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.53 HD21 ' HG2' ' A' ' 112' ' ' PRO . 15.0 tp -147.88 92.61 4.66 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.584 177.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -49.97 -44.78 35.7 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.783 2.322 . . . . 0.0 113.147 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.58 -19.13 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -178.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.22 67.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.974 0.416 . . . . 0.0 110.29 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.78 -46.57 74.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.563 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -64.64 -39.55 93.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.789 -178.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' LYS . 83.7 mt -62.15 -54.01 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.402 ' HB3' ' HE3' ' A' ' 92' ' ' MET . 97.6 mmm -66.58 -36.26 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.699 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.499 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 50.9 m -60.88 -45.38 94.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.004 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -65.3 -36.21 83.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.36 0.6 . . . . 0.0 110.515 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -78.36 -32.64 49.1 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.9 m -112.28 -16.55 12.94 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.499 ' CG ' ' O ' ' A' ' 93' ' ' SER . 44.1 m-20 -61.18 133.43 55.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.378 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 66.75 10.88 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.394 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -110.6 144.93 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.321 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -68.77 -35.16 76.71 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.98 156.56 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.54 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.568 ' SG ' HD12 ' A' ' 48' ' ' LEU . 8.6 p -153.59 138.89 17.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.427 0.632 . . . . 0.0 111.486 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 47' ' ' GLU . 30.8 t -118.92 130.94 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.549 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -143.46 148.69 18.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.103 -178.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 115.66 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.171 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.11 38.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.514 -179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.82 -124.11 0.88 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 107' ' ' GLY . 6.8 t 30.24 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 111.55 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -65.91 0.84 1.62 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.224 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 111' ' ' PHE . . . -84.62 -11.3 56.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.583 -178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 112' ' ' PRO . 36.8 m-85 -145.96 128.17 7.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.915 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 111' ' ' PHE . 24.1 Cg_exo -49.55 -149.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.177 1.918 . . . . 0.0 111.945 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.22 82.16 12.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.313 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.413 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 91.1 Cg_endo -76.97 -6.6 16.84 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.149 2.566 . . . . 0.0 113.459 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.454 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.5 p -165.94 74.23 1.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.343 0.592 . . . . 0.0 111.171 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.94 148.45 88.72 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.974 1.782 . . . . 0.0 111.476 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.11 -5.04 78.54 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' GLN . 94.0 m -115.88 148.8 39.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.972 0.886 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 13.6 t80 -83.31 114.14 21.2 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.454 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 16.3 mttp -91.11 -161.45 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.574 1.178 . . . . 0.0 113.245 -176.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.578 ' HB2' HD21 ' A' ' 39' ' ' LEU . 3.5 p90 -171.98 172.03 4.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.062 -1.881 . . . . 0.0 110.643 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 40.3 tp -129.0 123.3 32.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' OE2' ' NH1' ' A' ' 37' ' ' ARG . 79.4 tt0 -118.6 122.79 43.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 61' ' ' ALA . 25.1 t -130.21 126.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -109.55 130.79 55.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.802 ' CD2' HG23 ' A' ' 56' ' ' ILE . 34.9 p90 -153.61 171.99 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 111.691 -179.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.508 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 74.3 m-20 -125.19 158.59 33.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.89 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.497 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 87.4 m -107.66 119.98 40.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.57 154.82 63.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.183 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -53.5 143.81 54.06 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.026 1.817 . . . . 0.0 111.098 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -76.51 105.07 7.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -92.68 141.16 28.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.743 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -85.55 137.42 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.575 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.918 179.714 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.456 ' H82' ' HB2' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -38.77 -64.11 0.52 Allowed Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 30' ' ' LEU . 10.4 Cg_endo -54.72 150.94 34.03 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.005 2.47 . . . . 0.0 112.25 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.704 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 47.1 p90 -151.68 -62.11 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.704 ' N ' ' CD2' ' A' ' 32' ' ' PHE . . . 61.64 6.36 8.59 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -157.1 107.64 2.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 110.75 -179.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 7.4 mtt 53.71 137.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -88.26 151.12 22.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.943 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 32.4 ttp180 -146.91 133.81 20.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.531 0.682 . . . . 0.0 111.899 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.688 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 43.6 mp0 -133.07 144.76 50.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.484 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.3 tt -140.12 137.52 34.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.541 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.85 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.9 140.99 42.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.247 0.546 . . . . 0.0 110.618 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -66.39 136.18 55.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.23 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -47.12 136.06 9.19 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 111.628 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.94 61.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.12 178.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.18 156.02 38.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 118.118 0.959 . . . . 0.0 110.732 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.08 149.99 29.13 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.998 1.799 . . . . 0.0 111.38 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 19.4 tt -120.74 145.63 26.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.685 ' OE2' ' NH2' ' A' ' 49' ' ' ARG . 75.8 tt0 -128.69 128.28 43.77 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.871 -178.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 102' ' ' CYS . 40.8 mt -111.53 145.34 39.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.179 178.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.685 ' NH2' ' OE2' ' A' ' 47' ' ' GLU . 69.6 mtt180 -148.69 133.28 17.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.662 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' SG ' HG12 ' A' ' 56' ' ' ILE . 4.5 m -100.75 148.35 34.9 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.937 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.23 159.29 40.7 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.509 2.14 . . . . 0.0 112.169 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.22 -128.42 34.59 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.491 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.8 p -112.8 24.86 11.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.186 -0.507 . . . . 0.0 110.333 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -77.95 167.3 21.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 179.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.53 145.98 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.485 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 79.7 mt -69.62 137.95 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.723 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 2.5 ptp -130.93 102.11 5.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 93' ' ' SER . 21.4 t -63.87 124.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.873 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -102.46 -51.83 3.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.993 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.442 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 22.9 m-80 -148.59 144.32 27.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 0.0 110.463 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.467 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.97 150.85 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.945 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.738 ' O ' HD12 ' A' ' 122' ' ' LEU . 39.4 t30 -148.81 157.25 43.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -125.53 121.94 35.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.559 179.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . 159.7 -134.5 3.73 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -178.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.709 ' CZ ' ' SD ' ' A' ' 78' ' ' MET . 14.6 ttm180 -157.96 119.5 3.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 0.0 111.579 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 HG21 ' CE2' ' A' ' 84' ' ' TYR . 4.7 p -125.09 9.86 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.506 178.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.28 158.62 44.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.128 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 68' ' ' ASP . 53.7 p-10 -117.59 5.77 12.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -100.59 4.83 43.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.191 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.98 135.63 51.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.707 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.3 m 57.25 66.13 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 56.6 p30 -45.82 94.15 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.988 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' CYS . . . -112.53 -162.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.682 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -62.67 142.59 96.86 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 121.446 0.641 . . . . 0.0 111.488 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 15.1 Cg_endo -57.21 -39.54 89.5 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.402 2.068 . . . . 0.0 112.78 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -64.74 -35.12 80.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.482 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.558 ' CD ' ' OD2' ' A' ' 74' ' ' ASP . 26.8 mt-30 -85.9 -7.18 58.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.825 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.709 ' SD ' ' CZ ' ' A' ' 65' ' ' ARG . 3.8 mmm -107.64 -2.52 20.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.44 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 75' ' ' PRO . 40.4 mm-40 -62.88 -49.95 72.81 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -78.06 113.13 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.598 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' THR . 32.7 m -104.55 30.78 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.362 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -142.14 89.63 2.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.442 0.639 . . . . 0.0 110.198 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.438 ' HB3' ' H ' ' A' ' 65' ' ' ARG . 16.7 t -146.06 120.05 9.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.786 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.498 ' HA ' HD21 ' A' ' 62' ' ' ASN . 95.1 m-85 -132.1 151.63 51.67 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.998 -179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.598 HD21 ' HG2' ' A' ' 112' ' ' PRO . 16.9 tp -146.89 88.46 5.94 Favored Pre-proline 0 N--CA 1.462 0.171 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.102 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -48.5 -48.4 17.4 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.25 2.633 . . . . 0.0 113.847 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 78.5 m-20 -51.65 -29.58 18.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.549 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -52.05 -31.1 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.135 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 60' ' ' ASN . 48.1 t80 -62.45 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.492 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.585 ' HG3' HE22 ' A' ' 94' ' ' GLN . 3.5 pttt -66.03 -38.93 89.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.853 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.516 HG23 ' NE ' ' A' ' 95' ' ' ARG . 18.6 mt -60.26 -52.47 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.353 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 93.3 mmm -66.86 -37.55 84.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.385 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.565 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 75.4 m -61.78 -47.37 85.46 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.139 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.585 HE22 ' HG3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -69.84 -34.38 73.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.08 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NE ' HG23 ' A' ' 91' ' ' ILE . 61.0 mtt180 -75.4 -32.46 60.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 26.6 m -112.46 -16.96 12.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.618 ' HB3' ' H82' ' A' ' 135' ' ' NAG . 89.7 m-20 -58.15 133.87 55.98 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.052 -178.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 67.69 13.12 9.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.283 178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -115.19 148.27 39.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.036 178.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.5 m -71.44 -31.6 67.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.009 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.433 ' HB2' HE21 ' A' ' 101' ' ' GLN . 0.0 OUTLIER -151.71 157.47 42.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 48' ' ' LEU . 15.5 p -155.68 143.03 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.907 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 89.1 t -121.58 125.06 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG13 HH11 ' A' ' 95' ' ' ARG . 39.2 t -137.68 145.43 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 107' ' ' GLY . 43.3 t -79.7 117.02 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.018 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.97 36.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 108' ' ' SER . . . 179.71 -121.65 0.75 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.733 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.592 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.6 t 31.9 -160.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.197 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.39 -0.42 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.587 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.12 -14.33 50.61 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.812 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 112' ' ' PRO . 48.9 m-85 -143.38 127.37 9.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.166 178.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' O ' ' A' ' 111' ' ' PHE . 35.3 Cg_exo -49.62 -149.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.331 2.021 . . . . 0.0 112.119 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -145.82 82.46 9.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.431 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 97.5 Cg_endo -77.24 -2.25 12.45 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.103 2.535 . . . . 0.0 113.697 -178.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.541 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.6 p -167.85 68.51 0.84 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 110.511 179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.14 151.09 29.48 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.98 2.454 . . . . 0.0 111.775 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.48 -1.71 60.37 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 77' ' ' GLN . 25.6 m -117.65 146.7 43.5 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.628 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 10.1 t80 -84.89 115.81 22.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.074 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.541 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 17.8 mttp -92.62 -160.33 0.74 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 5.8 p90 -174.18 176.49 2.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.525 -1.671 . . . . 0.0 111.909 176.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 62' ' ' ASN . 59.0 tp -135.68 125.82 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.995 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.487 ' HG2' HE21 ' A' ' 125' ' ' GLN . 83.1 tt0 -118.68 127.24 53.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.467 HG22 ' HB1' ' A' ' 61' ' ' ALA . 30.1 t -131.47 123.75 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.199 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.487 HE21 ' HG2' ' A' ' 123' ' ' GLU . 1.8 mt-30 -110.07 129.66 55.65 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.327 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 40.3 p90 -152.94 169.56 22.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.352 0.596 . . . . 0.0 111.437 -178.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.452 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 85.9 m-20 -122.88 158.44 30.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.57 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 96.7 m -111.33 111.67 22.89 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.55 154.2 44.72 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.168 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -58.27 145.82 91.7 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.109 1.873 . . . . 0.0 112.216 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -74.58 136.63 42.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -94.03 146.22 24.1 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.083 -178.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.4 t -86.67 132.89 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.478 -179.431 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . 0.618 ' H82' ' HB3' ' A' ' 97' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER 56.44 49.39 4.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.809 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 30' ' ' LEU . 10.7 Cg_endo -60.87 146.85 96.93 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.467 2.111 . . . . 0.0 111.825 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -79.38 -9.29 59.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.556 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.08 0.01 25.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 35' ' ' MET . 25.8 tp -164.98 88.77 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.043 0.449 . . . . 0.0 110.281 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.3 mtt 60.41 142.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -91.1 148.39 22.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.668 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' C ' ' OE1' ' A' ' 38' ' ' GLU . 31.4 ttm105 -146.44 136.08 23.13 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.839 0.828 . . . . 0.0 111.373 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 45.5 mp0 -134.67 145.54 48.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.238 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 ' OE1' ' A' ' 123' ' ' GLU . 5.5 tt -140.32 139.78 35.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.389 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.771 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -136.65 137.42 40.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.13 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.2 m -70.41 139.67 51.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 0.0 110.503 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -47.51 135.17 11.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.129 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.96 -19.0 56.3 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.93 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.56 148.71 38.67 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 118.376 1.088 . . . . 0.0 109.78 178.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -67.57 154.57 73.15 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 tt -116.38 144.15 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 37.8 tt0 -124.79 127.04 46.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.582 -179.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 72.2 mt -118.1 141.06 48.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.037 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 73.7 mtt-85 -148.58 136.31 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.909 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.9 147.97 35.11 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.205 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 62.8 Cg_endo -75.3 156.92 41.71 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.005 2.47 . . . . 0.0 112.136 -179.273 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 52.64 -132.23 39.75 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.5 p -109.4 27.45 9.53 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.18 0.514 . . . . 0.0 111.143 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -77.45 163.9 25.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.28 145.28 34.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.927 178.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.847 HG23 ' CD1' ' A' ' 126' ' ' TYR . 84.2 mt -68.67 138.09 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.409 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.447 ' CG ' ' O ' ' A' ' 127' ' ' ASP . 2.4 ptp -131.24 98.6 4.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.67 124.76 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.165 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 70.3 mm-40 -100.99 -47.33 4.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 59' ' ' GLU . 12.3 m-20 -149.21 147.47 28.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.825 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.887 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -164.47 151.15 11.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.585 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 84' ' ' TYR . 32.0 t30 -150.26 146.49 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.229 -179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.7 t80 -117.17 120.73 39.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.32 -137.72 5.16 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.132 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' NE ' ' O ' ' A' ' 119' ' ' TYR . 7.0 ttm-85 -155.78 113.45 3.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.218 0.532 . . . . 0.0 109.994 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.6 p -121.23 11.05 10.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.968 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 47.3 t0 -146.74 -173.67 4.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.431 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.604 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 39.4 p30 -145.55 1.05 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.501 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -101.24 4.86 42.21 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.724 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.7 mm -113.06 135.5 52.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.472 -179.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 94.3 m 58.05 66.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.311 0.577 . . . . 0.0 109.814 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -53.2 122.15 8.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.105 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.82 -164.37 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.872 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.71 ' CG ' HE21 ' A' ' 77' ' ' GLN . 2.8 p30 -59.91 135.41 90.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.828 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.523 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 4.5 Cg_endo -53.19 -32.22 59.01 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 113.283 -178.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -63.62 -38.03 89.58 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 -179.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.71 HE21 ' CG ' ' A' ' 74' ' ' ASP . 35.3 mt-30 -85.5 -0.92 56.37 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.417 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 68' ' ' ASP . 81.5 mtp -115.27 -1.25 12.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.172 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 75' ' ' PRO . 80.5 mt-10 -62.42 -47.56 83.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 50.7 t30 -80.97 117.62 21.74 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.5 m -109.49 33.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.172 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -140.05 84.55 1.97 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 54.1 t -147.2 117.33 7.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.514 ' HA ' HD21 ' A' ' 62' ' ' ASN . 96.9 m-85 -128.02 155.72 43.87 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.322 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.5 tp -148.55 83.47 6.98 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.92 -45.36 20.94 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.792 2.328 . . . . 0.0 114.441 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -57.21 -20.77 29.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.929 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.34 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.868 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 93' ' ' SER . 24.4 t80 -65.29 -43.56 90.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.776 179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -65.32 -39.85 92.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.178 -179.038 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 75.8 mt -58.38 -51.35 72.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.48 -38.68 87.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.038 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.597 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 8.1 m -59.28 -45.67 90.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.93 -37.95 89.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.979 0.418 . . . . 0.0 110.56 178.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.583 ' HE ' ' CG2' ' A' ' 91' ' ' ILE . 92.7 mtt-85 -73.59 -34.46 65.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.6 m -112.51 -16.57 12.84 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.597 ' CG ' ' O ' ' A' ' 93' ' ' SER . 1.9 m120 -58.79 133.54 56.07 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.798 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 65.9 13.45 9.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.13 178.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -115.44 147.31 40.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.17 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 49.8 m -74.12 -30.26 62.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 153.27 32.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 48' ' ' LEU . 27.2 p -154.92 141.63 18.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.622 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.3 t -121.61 127.73 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -138.85 146.87 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.731 0.3 . . . . 0.0 111.01 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 107' ' ' GLY . 89.5 t -78.98 114.41 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.214 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.76 39.26 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.849 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -178.45 -125.09 0.9 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.418 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 28.65 -157.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.395 0.616 . . . . 0.0 111.935 -179.298 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -66.39 -1.49 3.54 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.426 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.09 -14.9 57.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.243 -179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.581 ' O ' ' O ' ' A' ' 112' ' ' PRO . 58.2 m-85 -144.99 127.07 8.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 111' ' ' PHE . 23.9 Cg_exo -51.78 -145.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.904 1.736 . . . . 0.0 112.355 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 116' ' ' PRO . 12.4 t0 -145.75 85.2 7.85 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.537 -179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 74.2 Cg_endo -74.24 -6.25 18.14 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.225 . . . . 0.0 113.537 -179.151 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.564 ' SG ' ' CE ' ' A' ' 120' ' ' LYS . 1.8 p -169.93 70.78 0.63 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.165 0.507 . . . . 0.0 110.634 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' CD ' ' OD1' ' A' ' 113' ' ' ASP . 51.6 Cg_exo -48.76 153.52 3.58 Favored 'Trans proline' 0 C--N 1.294 -2.296 0 C-N-CA 123.003 2.469 . . . . 0.0 111.922 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.76 10.46 83.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.795 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 77' ' ' GLN . 91.9 m -124.67 147.73 48.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.499 ' N ' ' HB3' ' A' ' 77' ' ' GLN . 11.4 t80 -86.15 109.49 18.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.564 ' CE ' ' SG ' ' A' ' 115' ' ' CYS . 15.1 mttp -91.28 -161.75 0.85 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.46 1.124 . . . . 0.0 114.02 -175.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB2' HD21 ' A' ' 39' ' ' LEU . 7.6 p90 -171.76 171.43 5.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.215 -1.811 . . . . 0.0 110.694 177.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 16.1 tp -130.37 127.97 40.46 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.165 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.961 ' OE1' HD12 ' A' ' 39' ' ' LEU . 8.0 tp10 -124.19 128.35 49.08 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.887 HG22 ' HB1' ' A' ' 61' ' ' ALA . 60.1 t -135.55 129.09 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.444 -178.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.567 HE21 ' HG3' ' A' ' 123' ' ' GLU . 10.0 mp0 -109.97 130.59 55.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.847 ' CD1' HG23 ' A' ' 56' ' ' ILE . 24.2 p90 -153.37 173.08 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.6 -178.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 57' ' ' MET . 76.9 m-20 -128.57 163.05 25.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.333 178.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.444 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 88.6 m -109.82 120.43 42.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.574 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.67 152.15 74.35 Favored Pre-proline 0 N--CA 1.463 0.184 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -54.27 142.74 67.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.555 1.503 . . . . 0.0 112.034 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 31.2 t80 -75.05 12.47 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.261 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.79 152.76 19.27 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.5 t -93.07 141.31 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.507 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.5 -179.382 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -66.8 123.62 86.44 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.519 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -51.71 132.26 40.76 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.645 1.563 . . . . 0.0 111.159 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' O ' ' N ' ' A' ' 34' ' ' LEU . 39.4 p90 -78.13 -9.34 59.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.083 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.34 -67.38 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 32' ' ' PHE . 13.7 tp -160.01 115.08 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' LEU . 2.1 mtp 57.23 157.65 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -90.76 146.22 24.15 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.32 138.31 29.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.495 0.664 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -135.62 141.56 45.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.86 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.902 HD23 ' N ' ' A' ' 40' ' ' ALA . 5.6 tt -137.92 137.09 37.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.129 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.902 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -137.79 140.5 40.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.13 0.491 . . . . 0.0 110.446 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.71 136.72 55.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -178.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE2' ' OH ' ' A' ' 63' ' ' TYR . 86.2 tt0 -47.85 137.9 9.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.003 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.3 56.96 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.823 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -105.71 150.71 39.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.904 0.852 . . . . 0.0 110.241 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.26 149.73 46.03 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.593 2.195 . . . . 0.0 112.761 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 104' ' ' VAL . 18.5 tt -118.4 147.73 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.612 ' OE2' ' NE ' ' A' ' 49' ' ' ARG . 84.0 tt0 -129.39 126.51 39.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.118 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -113.84 148.08 37.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.042 178.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.612 ' NE ' ' OE2' ' A' ' 47' ' ' GLU . 95.4 mtt180 -153.8 129.63 10.15 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.67 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 56' ' ' ILE . 3.3 m -96.23 147.25 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.871 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD2' ' SG ' ' A' ' 128' ' ' CYS . 29.0 Cg_endo -70.07 156.64 62.06 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.07 1.847 . . . . 0.0 111.669 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 49.7 -139.28 17.45 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.845 0.691 . . . . 0.0 113.099 177.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.4 p -96.25 21.25 9.2 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.237 -0.981 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.54 165.07 24.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.732 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG11 ' CG ' ' A' ' 131' ' ' TYR . 35.1 m -130.32 147.7 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.755 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 126' ' ' TYR . 62.0 mt -69.92 137.41 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.847 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 127' ' ' ASP . 1.6 ptp -130.82 100.11 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 89' ' ' PHE . 51.7 t -63.63 123.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.362 -178.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.513 ' OE2' ' OD2' ' A' ' 127' ' ' ASP . 93.6 mt-10 -102.08 -51.75 3.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.816 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -150.02 146.37 26.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.147 0.498 . . . . 0.0 110.232 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.66 ' HB1' HG22 ' A' ' 124' ' ' VAL . . . -166.08 155.74 12.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.353 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' HA ' ' A' ' 84' ' ' TYR . 10.8 t30 -149.91 144.33 25.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 120' ' ' LYS . 78.3 t80 -116.65 121.62 42.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.68 -141.09 7.23 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 119' ' ' TYR . 16.0 ttm180 -146.57 116.91 7.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.23 0.538 . . . . 0.0 110.805 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 84' ' ' TYR . 22.1 p -125.26 2.51 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.644 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 61.2 t0 -144.76 150.21 36.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.795 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 54.6 p30 -110.12 5.46 22.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 58.8 mttm -100.33 -0.46 38.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.416 -178.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.38 136.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.728 0.299 . . . . 0.0 110.516 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.1 m 59.23 64.0 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -54.33 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.066 -178.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' N ' ' SD ' ' A' ' 78' ' ' MET . . . -111.25 -160.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.79 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.694 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.6 OUTLIER -60.01 134.96 90.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.885 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.91 -34.32 75.7 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.127 1.885 . . . . 0.0 112.81 -178.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.14 -36.8 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.84 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.679 ' NE2' ' OD2' ' A' ' 74' ' ' ASP . 75.2 mt-30 -86.72 -10.72 53.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.491 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.518 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 81.7 mtp -102.03 -3.67 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.35 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.71 -44.86 88.9 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.109 -178.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 51.9 t30 -81.28 118.65 22.8 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.06 29.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -139.49 81.76 1.85 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.175 178.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 114' ' ' PRO . 2.2 t -142.81 118.8 10.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HA ' HD21 ' A' ' 62' ' ' ASN . 71.9 m-85 -130.96 156.44 45.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.808 -178.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -145.17 88.72 6.66 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.241 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.4 -45.11 19.59 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.247 1.964 . . . . 0.0 112.822 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 89.8 m-20 -57.45 -16.66 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.21 72.56 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.844 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 58' ' ' VAL . 47.9 t80 -65.28 -45.56 83.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -64.83 -37.87 89.08 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.561 -178.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.7 HG23 ' NH1' ' A' ' 95' ' ' ARG . 91.1 mt -58.95 -52.74 56.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.817 0.341 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.8 mmm -67.26 -33.42 75.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.179 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.583 ' O ' ' CG ' ' A' ' 97' ' ' ASN . 28.8 m -59.93 -49.73 76.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -66.95 -39.02 87.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 112.069 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.7 ' NH1' HG23 ' A' ' 91' ' ' ILE . 65.9 mtt85 -77.05 -32.43 56.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.6 m -113.51 -15.58 12.55 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.583 ' CG ' ' O ' ' A' ' 93' ' ' SER . 58.2 m-20 -61.32 133.77 56.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.891 -0.723 . . . . 0.0 112.034 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 70.36 14.74 7.45 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -111.44 143.95 41.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.07 178.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.0 m -68.67 -28.28 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.09 158.3 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.064 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.9 t -152.81 139.06 18.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.465 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.09 126.63 64.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.038 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 46' ' ' ILE . 47.3 t -143.49 141.57 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.036 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLY . 64.7 t -76.73 115.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.957 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.66 35.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.091 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 108' ' ' SER . . . -177.44 -127.7 1.08 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.51 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.58 ' O ' ' O ' ' A' ' 107' ' ' GLY . 1.4 t 32.29 -159.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.017 0.437 . . . . 0.0 111.02 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -66.43 1.94 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.25 -179.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.54 -13.0 55.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.688 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 112' ' ' PRO . 44.4 m-85 -144.6 133.07 10.9 Favored Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.984 179.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 111' ' ' PHE . 17.3 Cg_exo -56.05 -145.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.6 1.533 . . . . 0.0 111.471 178.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -145.25 90.55 6.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.93 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HG2' ' SG ' ' A' ' 83' ' ' CYS . 95.7 Cg_endo -81.16 -4.09 12.42 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.297 2.664 . . . . 0.0 114.25 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.434 ' SG ' ' HD3' ' A' ' 120' ' ' LYS . 1.6 p -167.68 66.36 0.78 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.703 0.763 . . . . 0.0 110.583 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -52.74 147.7 30.7 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.71 2.273 . . . . 0.0 111.588 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.16 -6.76 74.31 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 77' ' ' GLN . 87.2 m -118.88 148.08 43.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CZ ' ' A' ' 65' ' ' ARG . 45.8 t80 -85.72 120.74 27.48 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 63' ' ' TYR . 7.5 mttm -96.86 -157.51 0.6 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -176.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 7.1 p90 -174.6 177.27 2.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.498 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.88 122.29 24.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.82 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' HG2' HE21 ' A' ' 125' ' ' GLN . 75.7 tt0 -116.49 127.89 54.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.4 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.66 HG22 ' HB1' ' A' ' 61' ' ' ALA . 96.1 t -136.82 127.37 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.079 -0.648 . . . . 0.0 112.008 -178.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.424 HE21 ' HG2' ' A' ' 123' ' ' GLU . 3.2 mp0 -114.6 132.28 56.41 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.904 ' CD1' HG23 ' A' ' 56' ' ' ILE . 31.8 p90 -155.01 169.98 22.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.219 0.533 . . . . 0.0 112.427 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.513 ' OD2' ' OE2' ' A' ' 59' ' ' GLU . 79.6 m-20 -120.91 160.45 23.45 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.481 ' SG ' ' HD2' ' A' ' 51' ' ' PRO . 79.4 m -112.05 118.33 35.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.694 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.79 159.35 61.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.774 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.22 144.9 68.58 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.121 1.881 . . . . 0.0 112.331 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -76.29 -154.01 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.082 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.654 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 20.6 pttp -98.08 160.27 14.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.722 HG12 ' HG2' ' A' ' 134' ' ' GLU . 60.2 t -92.68 126.78 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.353 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.722 ' HG2' HG12 ' A' ' 133' ' ' VAL . 71.5 mm-40 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.653 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_